data_2lca_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lca _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.45 0 CA-C-O 120.706 0.288 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.88 81.31 2.79 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.093 0.473 . . . . 0.0 110.758 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.447 ' O ' HG12 ' A' ' 215' ' ' ILE . 32.5 mt -72.87 -26.67 61.53 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.509 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 59.9 tp60 -59.47 -56.29 23.8 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.542 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 4.2 p -66.38 -31.3 71.99 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 120.882 0.372 . . . . 0.0 110.293 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.16 -54.14 42.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.449 ' CG2' HG12 ' A' ' 243' ' ' VAL . 19.8 pt -69.04 -38.13 77.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.844 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.49 -34.44 69.05 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.598 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.29 -29.74 70.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.379 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.6 t -89.01 -45.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.895 0.379 . . . . 0.0 110.741 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.492 ' HA ' HG23 ' A' ' 239' ' ' ILE . 76.6 p -67.15 -35.42 79.67 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.251 0.548 . . . . 0.0 110.743 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.49 24.78 60.12 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 125.84 -134.66 8.8 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.2 164.98 14.92 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.449 2.099 . . . . 0.0 112.77 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.9 mm -82.61 109.21 16.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.976 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.825 0 CA-C-O 121.034 0.445 . . . . 0.0 111.103 179.193 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.073 0.463 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.492 HG23 ' HA ' ' A' ' 219' ' ' THR . 87.7 mt -62.0 -41.07 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.129 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.12 -32.07 73.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.067 0.461 . . . . 0.0 110.427 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.29 -37.27 69.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -45.78 69.76 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.328 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.559 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 42.5 t -56.78 -44.43 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.969 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -58.86 -34.32 71.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.434 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.2 -45.83 75.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -14.69 53.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.98 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.4 mt -79.29 -26.55 42.29 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -82.54 -21.83 35.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.386 176.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.06 -37.69 84.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.056 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 48.0 t -130.23 74.4 80.42 Favored Pre-proline 0 N--CA 1.434 -1.242 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.834 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -74.16 1.3 7.39 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.1 2.533 . . . . 0.0 112.283 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -74.96 -29.15 60.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.93 0.872 . . . . 0.0 108.773 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -73.63 164.47 26.6 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.058 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.75 137.23 54.61 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.675 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.2 m -120.37 134.61 63.29 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 121.198 0.523 . . . . 0.0 111.562 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 49.9 m -111.43 113.24 25.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.515 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 21.8 mt -91.87 111.58 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -98.87 125.54 44.3 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.532 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.419 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -106.58 144.16 15.83 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.389 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.58 165.04 17.83 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.961 0.41 . . . . 0.0 110.56 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 68.5 p -143.98 172.48 12.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.761 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 C--N 1.316 -0.849 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 175.081 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.444 -0.729 0 CA-C-O 122.005 0.907 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.435 HD21 ' HA3' ' A' ' 301' ' ' GLY . 1.0 OUTLIER -59.67 -33.6 71.77 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.873 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.515 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 32.8 mm -60.02 -65.53 2.04 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.043 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.515 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 8.3 Cg_endo -57.21 -32.67 94.23 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.211 1.94 . . . . 0.0 112.106 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.16 -55.13 20.41 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.718 0.294 . . . . 0.0 111.617 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.419 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 8.3 p -64.34 -27.87 69.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.788 0.328 . . . . 0.0 111.128 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.94 -27.55 64.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -73.89 -44.44 55.26 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -57.62 -46.49 84.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.568 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.58 91.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.287 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.469 ' HA ' HG23 ' A' ' 297' ' ' THR . 2.2 tmtp? -60.49 -35.8 76.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.333 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 56.6 mt -55.41 -45.09 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.855 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.706 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 9.1 t -67.42 -45.7 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.978 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.24 -44.26 79.46 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.43 -38.89 78.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.558 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.568 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 5.5 m-85 -69.51 -41.82 75.54 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.935 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 44.6 mt -64.11 -49.89 70.41 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.496 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 97.2 t -60.55 -38.9 79.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.533 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.93 -25.98 68.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.721 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.8 mmp_? -89.11 4.01 49.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.902 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.9 10.93 41.63 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.956 -1.116 . . . . 0.0 114.284 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.3 t -85.58 141.88 13.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.908 0.854 . . . . 0.0 109.752 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.1 108.1 2.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.995 0.426 . . . . 0.0 111.473 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.84 -33.36 68.04 Favored Glycine 0 C--O 1.228 -0.264 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.321 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.28 -15.08 63.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.173 0.511 . . . . 0.0 111.58 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -104.62 2.04 30.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.976 0.417 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . 0.424 HD13 ' CG1' ' A' ' 290' ' ' VAL . 55.5 mt -107.69 129.8 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -116.69 125.28 51.49 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.469 HG23 ' HA ' ' A' ' 279' ' ' LYS . 24.7 p -111.43 122.55 48.14 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.665 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.24 161.14 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-O 121.167 0.508 . . . . 0.0 111.158 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -126.49 111.61 1.44 Allowed Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 18.4 mt -97.38 -8.5 29.37 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.435 ' HA3' HD21 ' A' ' 270' ' ' ASN . . . 63.24 -130.92 41.76 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 119.806 -1.188 . . . . 0.0 111.579 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 55.9 p -91.91 114.33 26.84 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.035 0.445 . . . . 0.0 109.902 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.98 -67.72 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.4 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -108.09 91.34 7.79 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.221 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.601 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 7.6 Cg_exo -70.47 127.11 13.59 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.558 2.172 . . . . 0.0 111.891 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.7 tt -85.32 -42.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.774 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -131.08 170.36 14.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.128 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 27.7 m -69.62 136.16 50.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.86 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -76.62 -7.31 54.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.554 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -59.32 -29.77 67.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.942 0.401 . . . . 0.0 110.654 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.6 t -114.25 141.0 25.73 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.475 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.42 -31.45 94.83 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.723 2.282 . . . . 0.0 111.651 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -55.37 -50.75 68.89 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.953 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -63.01 -36.96 94.18 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.833 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -62.68 -35.56 80.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.846 0.355 . . . . 0.0 110.197 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.7 70.54 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.443 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -77.51 -41.31 39.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.947 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.601 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 42.0 m-20 -63.57 -24.4 67.79 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 12.0 ptm180 -83.68 6.44 20.96 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -58.18 170.86 0.62 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.153 0.978 . . . . 0.0 113.372 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 71.4 t -131.8 144.58 36.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.191 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -130.92 138.19 49.65 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.099 0.476 . . . . 0.0 111.186 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.4 mp -96.27 116.39 38.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.461 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.402 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 98.5 t -109.66 138.16 38.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.533 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 59.3 t -98.74 132.93 43.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.681 -179.33 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.485 0 CA-C-O 120.846 0.355 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -78.68 66.3 4.15 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.379 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.457 ' O ' HG12 ' A' ' 215' ' ' ILE . 22.1 mt -53.55 -27.09 24.12 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -60.18 -51.83 67.9 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 121.018 0.437 . . . . 0.0 110.205 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.7 t -72.45 -28.25 62.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.415 0.626 . . . . 0.0 109.687 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -67.16 -51.39 54.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.134 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 211' ' ' LEU . 26.1 pt -70.78 -38.5 73.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.485 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.79 -30.01 68.6 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.003 0.43 . . . . 0.0 110.767 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.17 -26.09 65.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.088 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.03 -46.28 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.993 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.509 ' HA ' HG22 ' A' ' 239' ' ' ILE . 40.1 p -67.13 -35.96 80.85 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.147 0.499 . . . . 0.0 110.855 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.96 18.97 68.5 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 129.27 -138.02 9.97 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.886 -0.657 . . . . 0.0 111.52 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . 0.605 ' HB2' ' NE ' ' A' ' 320' ' ' ARG . 1.4 Cg_endo -82.8 160.49 16.25 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.051 2.5 . . . . 0.0 112.498 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.557 ' O ' ' HB2' ' A' ' 320' ' ' ARG . 47.2 mm -81.1 115.88 24.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.201 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.796 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 174.538 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 CA--C 1.517 -0.294 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.509 HG22 ' HA ' ' A' ' 219' ' ' THR . 96.9 mt -59.01 -36.82 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.902 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.32 -30.48 70.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.431 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -70.59 -40.8 73.04 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -47.04 79.22 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.645 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.59 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 39.0 t -58.12 -44.06 86.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.042 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.74 -34.61 73.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.361 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.31 -44.67 80.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.011 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -15.01 55.09 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.798 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.7 mt -79.83 -28.09 40.16 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -81.47 -18.22 45.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.216 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.5 -38.08 80.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.723 176.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 29.1 t -135.18 72.87 65.91 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.568 176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.69 2.25 5.48 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.948 2.432 . . . . 0.0 113.165 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.13 -29.84 54.89 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.811 0.815 . . . . 0.0 109.285 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -77.57 135.86 38.21 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.526 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.86 142.26 27.96 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.5 m -114.83 131.38 67.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.134 0.493 . . . . 0.0 111.213 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.2 m -107.86 110.16 21.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.323 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.0 mt -93.07 109.43 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -98.13 128.47 44.65 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.537 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -110.47 145.9 17.32 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.496 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 28.5 m-85 -127.27 162.17 26.85 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.82 0.343 . . . . 0.0 110.309 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 59.2 p -138.75 173.68 11.32 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.618 177.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--N 1.311 -1.098 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.901 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 CA--C 1.51 -0.561 0 CA-C-O 121.828 0.823 . . . . 0.0 108.811 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -63.37 -34.92 78.77 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.197 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.458 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 29.7 mm -56.44 -65.68 1.51 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.764 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.458 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 21.0 Cg_endo -61.83 -28.19 81.26 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 121.95 1.767 . . . . 0.0 111.964 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.3 -55.75 16.54 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.738 0.304 . . . . 0.0 111.168 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 6.2 p -62.3 -31.08 71.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.706 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.63 -28.22 65.73 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.305 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.39 -40.87 49.74 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -61.67 -41.82 98.07 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.498 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.27 -32.99 74.93 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.059 0.457 . . . . 0.0 110.214 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.415 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.9 tmtt? -64.72 -36.06 83.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.387 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 53.0 mt -57.15 -42.42 79.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.034 0.445 . . . . 0.0 110.228 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.682 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 7.2 t -68.72 -47.15 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.057 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.77 -43.38 80.77 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.95 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -57.25 -42.11 80.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 1.5 m-85 -65.1 -52.05 57.71 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.511 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 33.8 mt -55.23 -50.72 68.72 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.591 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 77.6 t -60.71 -40.38 84.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.621 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.18 -23.54 67.48 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.232 0.539 . . . . 0.0 110.733 178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.545 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 4.5 mmp_? -88.93 5.03 45.95 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.228 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 98.06 12.67 45.36 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 119.93 -1.128 . . . . 0.0 114.109 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 48.5 t -88.61 145.95 6.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 117.604 0.702 . . . . 0.0 109.48 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -71.34 111.57 6.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.47 -34.84 77.07 Favored Glycine 0 N--CA 1.46 0.235 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.264 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.38 -18.41 65.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.242 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -101.64 -0.03 35.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.162 0.506 . . . . 0.0 110.364 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 66.5 mt -106.38 132.57 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.87 126.41 51.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.691 0.281 . . . . 0.0 110.726 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.415 HG21 ' HA ' ' A' ' 279' ' ' LYS . 53.0 p -104.98 121.14 43.14 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.14 113.18 35.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.256 0.551 . . . . 0.0 112.241 -175.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.9 103.72 3.04 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 24.5 mt -87.69 -0.24 56.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.47 -138.73 36.4 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.662 -176.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 7.8 p -84.27 114.3 21.74 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 120.728 0.299 . . . . 0.0 110.285 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.0 p -174.9 148.45 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 55.6 t30 64.08 75.03 0.4 Allowed Pre-proline 0 C--N 1.31 -1.128 0 O-C-N 123.712 0.633 . . . . 0.0 110.862 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.632 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 5.2 Cg_endo -80.87 133.61 9.17 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 122.305 2.003 . . . . 0.0 112.6 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.8 tt -94.37 -48.36 13.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.205 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -123.92 176.78 6.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.725 0.298 . . . . 0.0 111.025 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.428 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 47.8 m -66.39 128.08 34.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.43 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -80.54 -12.25 59.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.648 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.86 -18.32 63.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.956 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 5.2 t -116.39 144.23 32.69 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.858 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.49 -37.36 71.35 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.627 2.218 . . . . 0.0 111.894 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 1.8 mt-10 -58.96 -41.19 86.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.278 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -69.82 -40.3 75.35 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.859 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -60.24 -36.38 77.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.887 0.375 . . . . 0.0 110.253 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.8 -30.01 71.15 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.645 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 11.8 mmtp -80.64 -44.4 18.91 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.632 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 44.6 m-80 -61.66 -28.09 69.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 10.7 ptm85 -84.91 11.47 9.3 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.605 ' NE ' ' HB2' ' A' ' 222' ' ' PRO . 9.2 ptm180 -73.57 -178.0 2.91 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 99.6 t -135.18 151.76 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.866 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -131.72 142.05 49.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.843 0.354 . . . . 0.0 110.971 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.45 116.02 41.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.39 141.96 24.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.46 135.41 36.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 57.7 t30 . . . . . 0 C--N 1.313 -0.995 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.406 -179.811 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.339 0 CA-C-O 120.716 0.293 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.62 71.94 3.25 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.027 0.441 . . . . 0.0 110.035 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 246' ' ' LYS . 29.9 mt -70.22 -31.09 68.36 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.603 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -65.39 -41.61 93.53 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.53 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.5 t -71.73 -37.11 70.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.401 ' HB3' ' HZ1' ' A' ' 246' ' ' LYS . . . -63.91 -51.02 66.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.206 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.463 ' CG2' HG11 ' A' ' 243' ' ' VAL . 26.6 pt -67.63 -38.09 79.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.685 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.46 -36.25 73.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.115 0.484 . . . . 0.0 110.496 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.28 -26.02 68.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.574 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.7 t -91.87 -47.81 13.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.552 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.466 ' HA ' HG22 ' A' ' 239' ' ' ILE . 72.7 p -64.76 -39.75 94.14 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.878 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.12 15.22 79.23 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 140.99 -139.22 9.43 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.87 166.43 13.2 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.601 2.201 . . . . 0.0 112.559 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.0 mm -81.3 109.58 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.538 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.927 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.934 177.832 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 CA--C 1.516 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.466 HG22 ' HA ' ' A' ' 219' ' ' THR . 75.3 mt -59.97 -38.41 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.638 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 62.8 mt -67.85 -28.32 67.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.709 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -74.99 -36.8 61.98 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.45 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -65.9 -43.13 89.14 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.899 176.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.579 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 40.1 t -61.65 -46.18 97.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.818 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.53 -37.07 69.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.305 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -49.8 -50.49 44.74 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -83.14 -14.42 53.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.382 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 33.9 mt -81.37 -29.49 34.0 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -82.32 -22.27 35.69 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.506 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -71.75 -32.09 67.34 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.06 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 42.2 t -132.65 70.78 79.19 Favored Pre-proline 0 N--CA 1.434 -1.24 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.439 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.09 2.5 6.03 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.165 2.577 . . . . 0.0 113.194 -177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -75.26 -25.26 57.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.866 0.841 . . . . 0.0 109.597 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -77.51 169.82 17.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.603 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.44 144.9 48.76 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.67 125.47 74.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.296 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 41.9 m -103.1 108.6 19.85 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.92 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 21.2 mt -96.36 108.79 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.84 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.61 128.4 45.71 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.856 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -106.9 148.1 16.34 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.565 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 318' ' ' ASN . 24.7 m-85 -124.4 162.82 23.06 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.854 0.359 . . . . 0.0 110.39 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 270' ' ' ASN . 72.2 p -144.69 172.2 13.33 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--N 1.31 -1.135 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.352 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.436 ' N ' HD11 ' A' ' 269' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.462 0.145 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.489 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 8.4 p30 -57.92 -38.44 75.89 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.771 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.433 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 23.0 mm -59.55 -64.53 2.89 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.754 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.433 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 11.6 Cg_endo -59.98 -26.57 82.76 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 121.905 1.736 . . . . 0.0 112.073 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 59.0 tp -68.68 -54.22 17.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 111.227 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.8 p -63.71 -31.53 72.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.515 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.36 67.71 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.959 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -70.56 -47.31 60.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.579 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -61.36 -40.04 92.85 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.393 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.95 92.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.176 0.512 . . . . 0.0 109.816 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.405 ' HA ' HG23 ' A' ' 297' ' ' THR . 54.5 tptt -61.49 -35.46 77.75 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.939 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 59.8 mt -57.49 -44.31 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.017 0.437 . . . . 0.0 110.369 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.5 t -68.4 -46.28 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.746 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.6 -45.21 73.6 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -61.15 -37.79 84.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.937 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.504 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 2.0 m-85 -66.63 -44.05 83.04 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.074 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 39.1 mt -64.87 -51.16 63.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.795 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 84.4 t -60.23 -38.77 78.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.298 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.68 -31.13 71.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.288 0.566 . . . . 0.0 110.287 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 19.9 mmm180 -84.86 4.95 30.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.489 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.61 46.86 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.352 -0.928 . . . . 0.0 114.094 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 66.7 t -84.77 140.73 15.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 117.752 0.776 . . . . 0.0 109.026 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.72 108.11 2.81 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.639 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.38 -30.07 67.34 Favored Glycine 0 CA--C 1.509 -0.302 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.968 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.85 -21.18 64.45 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.537 0.335 . . . . 0.0 111.748 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -106.9 5.58 28.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 68.6 mt -106.23 128.45 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.42 127.59 53.81 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.25 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 279' ' ' LYS . 31.7 p -111.99 124.87 53.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.689 0.28 . . . . 0.0 110.683 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.79 121.25 52.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.093 0.473 . . . . 0.0 111.822 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -90.77 112.13 4.05 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 26.1 mt -90.45 -32.07 16.54 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 88.75 -140.13 15.76 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 47.2 t -88.62 114.27 25.07 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.94 -61.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.852 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -115.33 92.08 30.83 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.717 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 8.3 Cg_exo -67.98 127.82 16.69 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.803 2.336 . . . . 0.0 112.81 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.8 tt -85.74 -44.28 16.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.614 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -127.4 167.03 16.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.469 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 53.8 p -63.34 133.0 53.38 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.506 0.504 . . . . 0.0 111.104 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -80.84 -8.43 59.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.949 0.404 . . . . 0.0 110.651 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -62.69 -23.62 67.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.687 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.5 t -117.11 140.77 27.5 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -55.99 -35.78 94.99 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.82 2.347 . . . . 0.0 111.332 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -57.65 -47.01 83.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.853 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -63.43 -38.47 96.43 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.844 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -60.57 -37.19 80.49 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.16 -30.81 71.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.699 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -76.16 -41.96 48.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.08 0.467 . . . . 0.0 109.927 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.717 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 43.7 m-80 -61.75 -28.29 69.33 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 11.8 ptp180 -81.4 9.38 7.36 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -57.5 177.6 0.1 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.07 0.938 . . . . 0.0 113.341 174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 74.8 t -136.07 144.96 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.577 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -127.74 140.77 51.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.729 0.299 . . . . 0.0 111.057 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.93 117.17 49.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.17 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.62 132.66 53.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.074 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.68 130.48 40.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.316 0.579 . . . . 0.0 111.234 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 C--N 1.309 -1.17 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.314 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.338 0 CA-C-O 120.912 0.387 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.34 85.73 2.5 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.488 ' O ' HG12 ' A' ' 215' ' ' ILE . 23.4 mt -75.22 -34.57 61.47 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.447 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -62.62 -44.95 95.01 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 120.922 0.391 . . . . 0.0 110.061 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 36.2 t -65.49 -43.05 91.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.163 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.523 ' O ' HG21 ' A' ' 218' ' ' VAL . . . -64.44 -47.03 80.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.927 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 211' ' ' LEU . 17.7 pt -69.37 -38.04 76.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.467 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -60.25 -37.81 81.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.099 0.476 . . . . 0.0 110.023 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.82 -27.66 67.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.039 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 214' ' ' ALA . 43.1 t -83.01 -47.78 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 CA-C-O 121.069 0.461 . . . . 0.0 110.056 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.478 ' HA ' HG22 ' A' ' 239' ' ' ILE . 37.9 p -66.13 -35.25 79.98 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.017 -178.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.83 28.05 57.54 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 121.8 -132.24 8.86 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 114.54 -0.83 . . . . 0.0 111.192 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -89.34 169.25 5.0 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.734 2.289 . . . . 0.0 113.308 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.8 mm -85.67 105.18 14.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.196 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.946 0 CA-C-O 120.906 0.384 . . . . 0.0 111.371 -179.502 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.448 ' HA ' ' OD1' ' A' ' 241' ' ' ASN . 32.1 mt-10 . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 121.011 0.434 . . . . 0.0 112.169 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 219' ' ' THR . 82.8 mt -61.86 -37.62 78.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.694 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.1 mt -71.97 -21.63 61.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 238' ' ' GLU . 3.7 m120 -76.84 -41.74 43.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -42.82 84.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.954 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.613 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.4 t -58.35 -40.92 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.486 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.48 -36.83 76.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.317 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -48.54 -52.35 23.09 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.657 0.783 . . . . 0.0 112.813 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.432 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -81.01 -17.75 49.24 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.668 -176.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 36.2 mt -79.14 -30.81 43.81 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.241 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -82.63 -18.78 39.92 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.563 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.57 85.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.438 0.637 . . . . 0.0 110.01 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 49.9 t -128.98 69.06 80.62 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.08 -1.29 9.82 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.416 2.744 . . . . 0.0 114.715 -173.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.45 -23.76 29.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.558 0.694 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.98 141.01 58.34 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.4 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -96.31 136.55 36.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 5.9 m -113.53 137.24 47.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 121.191 0.52 . . . . 0.0 111.685 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.7 m -113.43 109.0 17.97 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.187 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.7 mt -91.92 112.47 25.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -99.41 130.98 45.72 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.843 -176.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.528 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -107.3 145.43 16.05 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.552 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 9.2 m-85 -123.26 171.73 9.16 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.644 ' O ' ' HA ' ' A' ' 302' ' ' SER . 10.0 t -175.3 174.18 2.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.798 0.332 . . . . 0.0 110.765 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 121.199 0.523 . . . . 0.0 111.358 -178.281 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.405 ' HB2' ' CG2' ' A' ' 261' ' ' THR . 9.5 p30 -57.89 -31.55 66.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.526 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.464 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 24.8 mm -62.31 -65.49 2.11 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.567 176.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.464 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.0 Cg_endo -57.54 -30.82 89.76 Favored 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 121.821 1.68 . . . . 0.0 111.807 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 40.1 tp -61.96 -56.64 17.06 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.169 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.528 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.5 p -63.41 -27.28 69.19 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.965 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.98 -30.05 62.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.28 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -49.2 65.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 48.0 mmt-85 -59.49 -37.14 77.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.296 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.47 -34.86 79.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.01 0.434 . . . . 0.0 110.539 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.503 ' HA ' HG23 ' A' ' 297' ' ' THR . 0.3 OUTLIER -68.06 -30.74 70.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.441 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 57.5 mt -60.13 -45.37 95.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.956 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.685 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 10.5 t -65.62 -45.14 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.788 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -53.15 -44.84 68.1 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.776 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.17 -43.12 87.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.51 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -66.17 -41.07 90.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.139 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 27.0 mt -67.6 -47.2 70.38 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.739 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.55 -41.48 87.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.36 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.8 -26.69 68.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.303 0.573 . . . . 0.0 110.515 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -86.95 4.98 39.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.426 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.64 8.42 49.05 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.043 -1.075 . . . . 0.0 114.4 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 63.0 t -85.29 143.68 11.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.91 106.72 3.28 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.829 0.347 . . . . 0.0 111.421 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.55 -31.45 77.73 Favored Glycine 0 CA--C 1.503 -0.703 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.304 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.62 -17.47 64.61 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.734 0.302 . . . . 0.0 110.946 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -105.05 3.85 30.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.525 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 67.5 mt -105.49 131.18 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -121.57 128.84 52.41 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.291 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.503 HG23 ' HA ' ' A' ' 279' ' ' LYS . 56.1 p -107.73 128.57 54.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.401 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 95.6 t -134.98 132.18 53.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.118 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -102.08 117.56 5.86 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 23.6 mt -91.56 -7.33 50.55 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 68.64 -136.93 29.97 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.445 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 261' ' ' THR . 7.3 p -74.52 97.76 3.2 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 120.927 0.394 . . . . 0.0 110.73 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.2 t -152.94 130.81 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.935 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 52.22 77.59 0.44 Allowed Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 123.786 0.679 . . . . 0.0 112.47 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.46 171.65 17.69 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.468 2.112 . . . . 0.0 112.394 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.7 -55.72 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.592 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.401 ' HB2' ' HA2' ' A' ' 314' ' ' GLY . . . -110.22 171.36 7.5 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.881 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 24.7 m -62.39 134.76 56.9 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 123.553 0.533 . . . . 0.0 111.261 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -81.31 -8.36 59.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.469 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.15 -10.38 59.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.001 0.429 . . . . 0.0 111.366 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.4 t -118.0 143.54 32.92 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.317 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.03 -31.06 56.06 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.22 1.946 . . . . 0.0 111.37 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 2.8 mt-10 -70.83 -35.4 72.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.779 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 307' ' ' ALA . . . -72.49 -40.19 54.85 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.82 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -65.2 -31.91 73.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.11 -26.73 68.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.107 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 10.6 mmtp -87.16 -37.07 17.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.806 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.4 ' N ' HD21 ' A' ' 318' ' ' ASN . 0.9 OUTLIER -62.35 -25.85 68.12 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 14.3 ptp180 -87.75 17.2 4.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.248 0.547 . . . . 0.0 111.556 -178.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -57.42 170.69 0.5 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.244 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 87.1 t -133.16 146.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.447 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -132.03 137.02 47.67 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.044 0.449 . . . . 0.0 110.788 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.9 mp -93.07 117.19 35.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.722 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 44.6 t -113.35 143.87 22.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 211' ' ' LEU . 46.9 t -106.06 140.29 24.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.0 t30 . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.306 -179.615 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -75.47 78.99 2.51 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.128 0.489 . . . . 0.0 110.57 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 215' ' ' ILE . 40.1 mt -57.66 -21.59 40.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.246 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.418 ' N ' HG23 ' A' ' 325' ' ' VAL . 20.3 tt0 -63.44 -45.05 92.7 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 120.966 0.413 . . . . 0.0 109.937 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 36.3 t -73.8 -35.41 64.91 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.82 82.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.444 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 211' ' ' LEU . 18.8 pt -72.24 -39.93 64.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.396 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.444 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 12.3 t-20 -61.25 -28.75 69.39 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.128 0.489 . . . . 0.0 110.755 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.88 69.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.983 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.435 HG13 ' CG ' ' A' ' 242' ' ' ARG . 2.5 t -93.37 -41.63 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.199 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.476 ' HA ' HG21 ' A' ' 239' ' ' ILE . 80.9 p -65.11 -36.52 84.56 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.251 0.548 . . . . 0.0 110.266 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.22 22.13 63.62 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 130.86 -125.2 4.44 Favored Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.14 162.27 5.77 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 122.499 2.133 . . . . 0.0 112.044 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.9 mm -73.46 111.14 7.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.756 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.898 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.865 176.114 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 N--CA 1.465 0.301 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 243' ' ' VAL . 58.1 mt -65.34 -36.15 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.484 ' CD2' HG11 ' A' ' 281' ' ' VAL . 41.0 mt -64.96 -35.62 81.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.492 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -71.54 -39.86 70.43 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.435 ' CG ' HG13 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -64.19 -48.66 75.07 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.037 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.623 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 55.2 t -55.47 -42.69 68.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.196 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.88 -37.51 87.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.936 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -52.49 -49.45 64.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.424 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -73.94 -29.42 62.01 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 119.491 -0.883 . . . . 0.0 111.292 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 24.5 mt -69.75 -27.78 65.23 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 121.614 0.721 . . . . 0.0 109.254 176.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -68.38 -33.9 75.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.549 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.96 70.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.439 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 52.1 t -126.16 72.5 71.23 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.78 -0.79 9.44 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.99 2.46 . . . . 0.0 113.074 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.55 -30.05 59.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.521 0.676 . . . . 0.0 109.271 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.58 135.98 50.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.652 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.44 145.07 24.93 Favored 'General case' 0 CA--C 1.479 -1.758 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.0 m -120.43 125.38 74.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.896 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 54.9 m -101.35 108.87 20.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.469 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.443 HG12 HG21 ' A' ' 323' ' ' ILE . 22.3 mt -94.92 112.19 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.109 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -103.48 124.34 48.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.109 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.446 ' C ' ' HG ' ' A' ' 274' ' ' SER . . . -103.65 163.62 15.46 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.352 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 32.4 m-85 -136.15 159.55 41.38 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.014 0.435 . . . . 0.0 110.63 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 63.2 p -141.3 164.87 29.07 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 C--N 1.319 -0.744 0 CA-C-O 120.969 0.414 . . . . 0.0 110.695 178.436 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 35.1 mm . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 121.736 0.779 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -63.21 -36.97 85.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.607 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.446 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.3 mm -56.27 -65.24 1.68 Allowed Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.829 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.446 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 27.0 Cg_endo -63.24 -25.12 72.12 Favored 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 122.159 1.906 . . . . 0.0 112.277 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 53.8 tp -69.78 -52.24 26.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.001 0.429 . . . . 0.0 110.019 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.446 ' HG ' ' C ' ' A' ' 259' ' ' GLY . 10.1 t -57.5 -39.71 77.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.019 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.63 78.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.803 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -68.08 -46.89 69.75 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.59 0.71 . . . . 0.0 109.703 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -59.7 -44.8 93.54 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.241 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.53 84.02 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.16 0.505 . . . . 0.0 110.182 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.444 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.5 tmtt? -64.22 -30.48 71.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.69 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.2 mt -57.2 -41.37 77.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.977 0.417 . . . . 0.0 109.963 177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.737 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 13.8 t -69.77 -47.91 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.868 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.09 -43.73 78.32 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.908 0.385 . . . . 0.0 110.919 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.1 -38.69 80.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.3 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.522 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 3.9 m-85 -72.83 -40.55 65.69 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.315 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.737 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 44.5 mt -64.18 -48.32 76.38 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 86.3 t -60.32 -39.66 81.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.1 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.43 -23.75 67.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.207 0.527 . . . . 0.0 110.895 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 5.0 mmp_? -89.02 2.9 53.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.394 178.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 97.83 13.14 44.51 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.203 -0.999 . . . . 0.0 114.053 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 62.0 t -87.63 139.96 16.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 117.514 0.657 . . . . 0.0 109.328 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.9 113.5 3.88 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.195 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -66.83 -11.27 57.51 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.893 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.71 -11.91 54.88 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 120.869 0.366 . . . . 0.0 110.224 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -110.23 2.25 19.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.736 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 57.7 mt -107.41 123.69 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -115.67 127.57 55.27 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.592 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 279' ' ' LYS . 47.5 p -104.89 126.28 51.79 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.39 113.04 30.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.305 0.574 . . . . 0.0 112.252 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.433 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -89.11 105.02 3.15 Favored Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.504 175.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 21.0 mt -94.06 1.4 56.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.665 0.269 . . . . 0.0 110.922 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.77 -128.08 42.31 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.539 -175.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 43.0 p -97.67 123.43 41.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.21 -60.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -112.32 94.07 25.14 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-O 120.906 0.384 . . . . 0.0 110.039 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -70.88 172.77 13.07 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.874 2.383 . . . . 0.0 113.311 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.4 tt -134.13 -48.62 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.685 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -126.25 171.02 11.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.581 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.43 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 14.6 m -65.16 124.48 22.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.072 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -80.06 -8.38 59.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -62.33 -23.31 66.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.25 0.548 . . . . 0.0 110.361 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.9 t -117.8 140.43 27.67 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.613 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -52.12 -38.32 70.61 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.133 2.555 . . . . 0.0 111.667 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -53.04 -52.27 59.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.715 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -65.61 -37.98 94.16 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.746 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -59.54 -37.51 78.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.37 . . . . 0.0 110.361 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.34 -31.37 72.54 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.386 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.87 -44.36 20.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.23 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -58.7 -26.28 63.74 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 13.4 ptp180 -83.08 11.09 6.77 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -58.34 179.0 0.08 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 121.61 0.719 . . . . 0.0 112.765 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.7 t -140.43 149.09 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.088 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -131.38 147.12 52.53 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.918 0.389 . . . . 0.0 111.003 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.443 HG21 HG12 ' A' ' 257' ' ' ILE . 1.3 mp -109.17 119.81 59.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.057 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.84 134.52 48.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.942 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 212' ' ' GLN . 91.2 t -94.8 135.21 29.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.501 0.667 . . . . 0.0 112.409 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.257 178.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 CA-C-O 120.949 0.404 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -83.18 77.96 9.68 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.413 ' O ' HG12 ' A' ' 215' ' ' ILE . 29.4 mt -67.34 -29.71 69.33 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.126 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.496 HE21 ' HA ' ' A' ' 324' ' ' VAL . 35.5 tt0 -62.2 -44.32 96.84 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.821 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.0 m -69.25 -36.2 76.91 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.115 0.483 . . . . 0.0 109.769 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.46 -51.08 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.069 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 211' ' ' LEU . 20.7 pt -68.37 -39.79 81.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.298 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -58.57 -32.11 68.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.861 0.362 . . . . 0.0 110.376 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.26 -32.59 73.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.185 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 t -85.96 -47.93 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 120.779 0.323 . . . . 0.0 110.686 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.475 ' HA ' HG21 ' A' ' 239' ' ' ILE . 58.1 p -62.71 -32.95 74.15 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.384 0.612 . . . . 0.0 110.055 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.52 22.47 47.1 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.95 -127.13 6.39 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . 0.455 ' CB ' ' HD2' ' A' ' 320' ' ' ARG . 71.6 Cg_endo -84.39 164.3 12.76 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.201 1.934 . . . . 0.0 111.738 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 42.1 mm -71.65 98.0 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.573 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.044 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.719 177.912 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 . . . . . 0 CA--C 1.518 -0.258 0 CA-C-O 120.708 0.29 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.475 HG21 ' HA ' ' A' ' 219' ' ' THR . 76.9 mt -62.23 -31.94 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.21 -32.26 72.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.215 0.531 . . . . 0.0 110.38 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.68 -37.07 36.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.686 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -39.93 84.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.414 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.542 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 38.6 t -61.21 -37.25 77.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.54 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 248' ' ' LYS . . . -58.23 -38.04 76.07 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.819 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -46.46 -49.18 18.64 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.821 0.848 . . . . 0.0 112.938 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.405 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -83.73 -18.16 38.79 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.1 mt -84.8 -25.41 28.19 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 244' ' ' ALA . 6.1 tptm -73.88 -29.86 62.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.701 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.87 75.85 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.268 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 45.0 t -133.44 70.81 76.6 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.71 1.81 7.15 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.845 2.363 . . . . 0.0 113.078 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.55 -31.81 57.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.746 0.784 . . . . 0.0 109.14 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.26 145.63 55.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.314 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -99.99 132.82 45.11 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.1 m -115.06 131.16 68.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.236 0.541 . . . . 0.0 111.383 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.5 m -107.35 112.02 24.64 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.734 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 18.8 mt -92.61 116.03 32.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -107.77 127.49 53.74 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.739 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.424 ' C ' ' HG ' ' A' ' 274' ' ' SER . . . -99.02 149.83 19.16 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.844 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -131.95 163.02 29.29 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 117.274 0.537 . . . . 0.0 110.171 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 3.1 t -159.08 152.48 22.65 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 42.9 t0 . . . . . 0 C--N 1.322 -0.589 0 CA-C-O 121.161 0.505 . . . . 0.0 111.082 -178.402 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 40.3 mm . . . . . 0 CA--C 1.517 -0.3 0 CA-C-O 121.703 0.763 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.0 -32.78 74.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.477 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.65 -64.26 3.29 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.12 -30.0 88.25 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.237 1.958 . . . . 0.0 111.947 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 50.9 tp -66.77 -51.33 57.06 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.037 0.446 . . . . 0.0 110.218 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.429 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 13.1 t -56.15 -39.21 71.95 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.263 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.21 -28.54 64.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.075 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -74.21 -44.4 53.38 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.259 0.552 . . . . 0.0 110.096 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 59.8 mtp85 -62.27 -41.0 98.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.997 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.88 -36.11 83.3 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.815 0.341 . . . . 0.0 111.014 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.426 ' HA ' HG22 ' A' ' 297' ' ' THR . 54.6 tptt -59.83 -35.36 74.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.0 mt -55.1 -46.28 77.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 15.8 t -68.51 -46.22 80.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.653 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.63 -42.78 79.45 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.872 0.367 . . . . 0.0 111.185 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.61 -36.15 77.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.68 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.427 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 3.3 m-85 -74.19 -39.68 63.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.117 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 45.2 mt -65.45 -49.47 68.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.502 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 80.8 t -60.21 -38.13 76.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.163 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.23 70.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.694 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.57 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 3.7 mmp_? -87.23 7.37 28.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.684 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 97.14 10.13 54.97 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.125 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 50.4 t -84.9 139.73 17.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 117.894 0.847 . . . . 0.0 109.547 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.99 111.97 2.74 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.071 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.3 -35.2 83.76 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.097 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.82 -11.87 61.21 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -101.44 -2.64 30.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.06 0.457 . . . . 0.0 109.878 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 64.5 mt -107.4 129.65 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.152 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.21 125.78 51.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.628 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 279' ' ' LYS . 22.6 p -111.1 118.74 36.82 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.045 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 18.6 m -121.56 162.76 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.034 0 CA-C-O 121.224 0.535 . . . . 0.0 111.365 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.429 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -129.11 104.46 0.64 Allowed Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.6 mt -89.44 -31.17 17.84 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.733 0.302 . . . . 0.0 111.615 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 106.7 -122.23 6.9 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.841 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.4 t -104.98 120.12 40.68 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 8.6 p 179.81 152.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 58.3 t30 66.44 79.03 0.24 Allowed Pre-proline 0 C--N 1.314 -0.953 0 O-C-N 123.756 0.66 . . . . 0.0 111.467 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.54 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 73.3 Cg_endo -77.79 149.5 26.4 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.606 2.204 . . . . 0.0 113.136 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.9 tt -108.14 -39.16 4.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.32 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.451 ' HB2' ' HA2' ' A' ' 314' ' ' GLY . . . -139.64 174.42 10.54 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.978 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 26.2 m -74.54 129.52 37.9 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.121 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -80.16 -7.66 59.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.587 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -57.39 -19.08 21.02 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.382 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.4 t -127.77 141.33 40.74 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.928 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.87 -21.68 34.36 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.188 2.592 . . . . 0.0 112.399 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.5 mm-40 -60.04 -46.36 89.77 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.392 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 307' ' ' ALA . . . -65.77 -39.73 95.33 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.14 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -60.53 -37.02 79.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.425 0.631 . . . . 0.0 110.121 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.59 -29.38 66.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.193 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 6.7 mmtp -87.11 -35.86 18.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.307 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.54 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 27.9 m-20 -65.47 -15.48 62.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.555 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 7.6 ptm180 -88.49 16.2 6.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.558 0.694 . . . . 0.0 111.036 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.455 ' HD2' ' CB ' ' A' ' 222' ' ' PRO . 14.4 ptt180 -63.18 -173.69 0.06 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.422 1.105 . . . . 0.0 113.246 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.84 145.63 25.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.783 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -135.74 145.01 46.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.231 0.539 . . . . 0.0 111.599 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.37 115.19 42.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.106 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.496 ' HA ' HE21 ' A' ' 212' ' ' GLN . 85.1 t -105.37 136.13 40.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.834 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 212' ' ' GLN . 69.5 t -101.27 136.18 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 C--N 1.311 -1.073 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.92 179.033 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.485 0 CA-C-O 120.606 0.241 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.98 82.02 4.35 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.184 0.516 . . . . 0.0 110.244 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.409 ' O ' HG22 ' A' ' 215' ' ' ILE . 52.9 mt -69.47 -24.76 63.83 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.875 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -68.86 -38.34 79.7 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.415 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 t -76.61 -32.22 57.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -67.84 -49.08 64.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.14 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.464 ' CG2' HG13 ' A' ' 243' ' ' VAL . 21.8 pt -69.39 -33.39 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.801 -0.181 . . . . 0.0 111.081 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -54.99 -34.17 63.16 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.134 0.492 . . . . 0.0 110.801 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.87 -31.76 72.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.243 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.406 HG13 ' CB ' ' A' ' 242' ' ' ARG . 2.5 t -91.81 -48.98 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.883 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.476 ' HA ' HG22 ' A' ' 239' ' ' ILE . 53.7 p -62.73 -43.61 98.35 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.302 0.573 . . . . 0.0 110.776 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.42 19.46 66.41 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.042 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 134.29 -136.95 8.92 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -82.27 162.39 17.54 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.638 2.226 . . . . 0.0 112.756 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.7 mm -78.58 104.14 6.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.546 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.897 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.389 177.943 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 . . . . . 0 C--O 1.235 0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.476 HG22 ' HA ' ' A' ' 219' ' ' THR . 56.8 mt -62.5 -38.28 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 50.6 mt -65.8 -31.61 72.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.796 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -71.4 -38.97 71.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.461 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.2 OUTLIER -65.85 -47.7 74.07 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.829 178.225 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.573 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.7 t -58.26 -45.43 89.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.062 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.01 -35.81 77.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.692 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -54.49 -47.94 72.43 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.461 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -75.26 -29.99 60.34 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.462 -178.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.0 mt -65.64 -34.41 78.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.435 0.635 . . . . 0.0 109.646 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -72.44 -24.7 61.25 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.146 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.84 69.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.049 0.452 . . . . 0.0 110.84 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 35.8 t -125.53 68.88 61.25 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.61 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.07 3.26 5.81 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.075 2.516 . . . . 0.0 113.388 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.91 -32.16 61.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.968 0.89 . . . . 0.0 108.879 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -74.56 148.04 41.21 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.442 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -101.1 139.42 36.8 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.8 m -115.0 130.01 70.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-O 121.327 0.584 . . . . 0.0 110.835 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.9 m -105.28 110.45 22.82 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.322 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 23.9 mt -92.8 111.1 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.96 126.31 46.11 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.146 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.462 ' C ' ' HG ' ' A' ' 274' ' ' SER . . . -105.07 159.02 15.84 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.152 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 301' ' ' GLY . 76.3 m-85 -132.55 165.97 23.16 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.816 0.341 . . . . 0.0 110.775 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.523 HG22 ' NH1' ' A' ' 277' ' ' ARG . 33.2 p -144.55 169.74 17.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.738 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 C--N 1.312 -1.046 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 175.337 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.9 mm . . . . . 0 CA--C 1.512 -0.49 0 CA-C-O 122.119 0.961 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -61.74 -28.54 69.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.838 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.496 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 33.9 mm -57.26 -65.19 1.88 Allowed Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.432 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.496 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.9 Cg_endo -58.59 -35.45 98.64 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 122.195 1.93 . . . . 0.0 111.979 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 54.2 tp -62.72 -53.87 47.79 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.277 0.56 . . . . 0.0 111.028 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.469 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 15.2 t -57.29 -35.59 69.99 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.005 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.35 -22.16 64.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.821 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -71.51 -53.1 14.97 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.523 ' NH1' HG22 ' A' ' 261' ' ' THR . 75.9 mtt85 -56.97 -44.14 82.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.62 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.43 77.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.962 0.41 . . . . 0.0 110.814 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.47 ' HA ' HG21 ' A' ' 297' ' ' THR . 11.9 tmtt? -69.37 -30.55 68.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.28 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 58.8 mt -59.82 -44.96 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.722 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.7 t -65.99 -48.19 82.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.047 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.77 76.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 120.919 0.39 . . . . 0.0 110.984 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.4 -42.27 91.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.935 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.683 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 5.7 m-85 -68.09 -43.36 78.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.893 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 36.4 mt -63.62 -46.15 87.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.835 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.7 t -61.27 -40.16 85.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.379 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.25 -30.74 71.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.549 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.683 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 13.8 mmm180 -81.83 5.07 19.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.472 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.6 2.75 50.1 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.164 -1.017 . . . . 0.0 114.629 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 57.9 t -80.91 145.96 8.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 117.923 0.861 . . . . 0.0 110.573 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.77 108.08 3.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.701 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.41 -33.8 82.56 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.792 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.97 -19.14 64.93 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -103.39 2.41 33.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 62.7 mt -104.35 130.36 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.52 127.21 53.77 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.646 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.47 HG21 ' HA ' ' A' ' 279' ' ' LYS . 53.8 p -106.25 119.97 40.63 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 77.2 t -124.25 114.91 43.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.357 0.599 . . . . 0.0 112.103 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.469 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -88.02 107.4 3.31 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.85 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 23.9 mt -94.64 -4.25 48.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.924 0.392 . . . . 0.0 110.43 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 260' ' ' TYR . . . 62.72 -133.07 44.11 Favored Glycine 0 N--CA 1.431 -1.657 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.66 -175.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.4 t -99.69 122.63 42.98 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.2 p -149.25 -56.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.666 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -113.33 93.73 27.96 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.441 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 14.9 Cg_endo -64.19 162.05 31.45 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.834 2.356 . . . . 0.0 112.934 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.438 HG21 ' HA ' ' A' ' 318' ' ' ASN . 4.7 tt -124.34 -53.59 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.874 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -119.8 171.41 8.43 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 22.2 m -61.91 127.33 30.88 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.564 0.54 . . . . 0.0 110.845 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -79.79 -8.16 59.1 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.015 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.79 -17.37 62.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.699 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.8 t -116.8 138.4 24.59 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.47 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.74 -34.25 97.94 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.921 2.414 . . . . 0.0 111.517 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.65 -45.92 90.57 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.35 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.37 -38.82 87.56 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -59.09 -37.31 76.83 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.032 0.444 . . . . 0.0 109.96 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.42 -27.72 68.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.57 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -80.93 -41.81 22.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.648 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.441 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 39.2 m-80 -60.19 -22.23 62.68 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -93.45 16.25 13.95 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.49 179.24 1.05 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.746 0.784 . . . . 0.0 112.358 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 98.8 t -129.27 143.34 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.504 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -131.61 140.46 49.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 111.378 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.4 119.92 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.095 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.49 141.74 27.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.268 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 96.0 t -98.38 135.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.713 -179.503 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.163 0.506 . . . . 0.0 112.148 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -87.69 83.09 7.22 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.828 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.447 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.5 mm? -69.59 -40.71 76.52 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.167 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -64.14 -40.66 96.65 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.719 0.295 . . . . 0.0 110.861 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 33.5 t -68.35 -44.17 75.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.066 0.46 . . . . 0.0 110.115 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.29 -44.66 87.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.031 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.466 ' CG2' HG12 ' A' ' 243' ' ' VAL . 27.1 pt -69.11 -37.6 76.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.212 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -60.72 -33.02 72.26 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.336 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.49 -25.09 65.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.213 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 t -90.25 -43.7 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 110.047 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.527 ' HA ' HG23 ' A' ' 239' ' ' ILE . 71.5 p -68.03 -36.71 80.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.579 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.97 24.68 51.94 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.98 -136.5 9.4 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.84 164.94 20.17 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.374 2.049 . . . . 0.0 112.267 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.7 mm -77.95 104.32 5.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.6 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.821 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.969 177.452 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 CA--C 1.511 -0.547 0 CA-C-O 121.418 0.627 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.527 HG23 ' HA ' ' A' ' 219' ' ' THR . 90.3 mt -58.63 -34.57 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.147 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.45 -33.77 76.66 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.213 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.429 ' HA ' ' HG2' ' A' ' 288' ' ' ARG . 44.8 m-20 -71.33 -37.32 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -49.91 57.42 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.82 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.622 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 38.8 t -57.93 -47.65 85.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.413 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.79 -28.18 68.17 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.848 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.92 -40.19 83.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 0.0 111.434 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 243' ' ' VAL . 0.0 OUTLIER -77.88 -26.69 49.38 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.038 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 38.3 mt -66.68 -27.34 67.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.157 0.503 . . . . 0.0 110.307 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -76.65 -17.23 59.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.377 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.91 -30.21 63.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.1 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 8.4 t -137.02 67.79 56.36 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.44 4.46 4.95 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.354 2.703 . . . . 0.0 114.621 -174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -78.16 -29.69 48.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.585 0.707 . . . . 0.0 109.474 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.44 136.66 51.85 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.779 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -86.33 138.36 31.88 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.8 m -111.53 126.26 68.91 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.839 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.3 m -104.2 106.57 17.12 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.379 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 28.0 mt -92.56 113.21 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.478 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -100.51 129.36 46.45 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.689 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.416 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -108.0 144.38 16.14 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -124.33 161.48 25.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.127 0.489 . . . . 0.0 110.61 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 72.7 p -147.0 164.22 33.69 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--N 1.32 -0.697 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.859 176.169 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 121.532 0.682 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -36.81 74.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.199 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.484 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.4 mm -61.17 -63.95 3.7 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.24 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.484 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.9 Cg_endo -58.37 -31.68 94.47 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.944 1.763 . . . . 0.0 111.866 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 62.4 tp -67.4 -54.2 22.49 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.568 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.416 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 18.5 p -62.48 -29.92 70.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.767 0.318 . . . . 0.0 110.898 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.44 -31.34 69.61 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -73.2 -41.28 63.99 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 60.7 mtp85 -61.92 -45.16 94.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.034 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.77 76.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.876 0.37 . . . . 0.0 110.872 176.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.46 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.6 tmtt? -65.94 -30.26 70.81 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.509 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.51 -44.21 80.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.23 0.538 . . . . 0.0 109.753 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.676 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.9 t -70.92 -46.54 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.574 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.87 71.01 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.877 0.37 . . . . 0.0 111.184 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -57.71 -43.28 85.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.502 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.492 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 4.8 m-85 -69.58 -38.52 77.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.461 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 41.3 mt -66.38 -46.31 77.13 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.1 -39.37 82.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.488 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.8 -26.75 68.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.295 0.569 . . . . 0.0 110.54 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -85.18 3.52 38.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.69 178.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.34 13.29 39.22 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.129 -1.034 . . . . 0.0 114.364 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 58.5 t -87.95 142.9 12.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 117.716 0.758 . . . . 0.0 109.504 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.63 112.8 4.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.433 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.18 -36.83 90.4 Favored Glycine 0 CA--C 1.511 -0.219 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.459 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -70.55 -11.41 60.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.859 0.361 . . . . 0.0 111.417 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -102.17 -1.43 31.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.058 0.456 . . . . 0.0 110.404 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 70.6 mt -106.13 130.93 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.727 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.47 125.02 49.03 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.649 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.46 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.3 p -104.24 122.44 45.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.487 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 67.5 t -127.23 115.03 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 121.153 0.501 . . . . 0.0 112.084 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.28 112.9 3.8 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.608 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 26.7 mt -97.05 -7.85 31.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.561 0.219 . . . . 0.0 111.559 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.8 -129.36 41.63 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.152 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 12.7 p -93.59 112.23 24.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.422 HG13 ' ND2' ' A' ' 304' ' ' ASN . 41.9 t -138.0 -69.38 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.422 ' ND2' HG13 ' A' ' 303' ' ' VAL . 67.7 m-80 -110.2 94.49 18.41 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.44 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 13.3 Cg_exo -65.57 163.2 30.93 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.24 1.96 . . . . 0.0 112.034 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 6.3 tt -117.9 -48.24 3.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.465 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -129.75 172.89 11.16 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 43.8 t -62.96 134.76 56.68 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 123.399 0.437 . . . . 0.0 110.734 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.17 -7.7 59.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.683 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.59 -20.31 64.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.1 t -113.54 145.34 33.13 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.891 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.86 -32.29 36.67 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.996 1.797 . . . . 0.0 110.806 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.524 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.8 mt-10 -59.66 -44.7 93.47 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.055 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.88 -38.87 89.56 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.707 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -63.16 -37.31 86.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.941 0.4 . . . . 0.0 110.259 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.21 -27.44 69.36 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.17 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 6.8 mmtp -84.73 -40.9 16.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.035 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.44 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 42.5 m-80 -62.31 -26.65 68.54 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -78.4 7.02 7.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.877 0.37 . . . . 0.0 111.471 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.8 ptt-85 -57.78 177.79 0.1 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.144 0.973 . . . . 0.0 113.18 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 86.5 t -136.52 143.15 36.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.583 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -129.57 137.58 50.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.831 0.348 . . . . 0.0 111.017 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.9 119.5 49.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 75.0 t -111.05 137.33 43.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 67.9 t -101.5 136.39 33.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.364 0.602 . . . . 0.0 111.221 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.084 179.264 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.63 0 CA-C-O 121.183 0.516 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.93 63.35 2.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.548 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 246' ' ' LYS . 17.9 mt -54.08 -29.9 46.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.308 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -65.25 -43.8 90.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.026 0.441 . . . . 0.0 109.932 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.7 t -74.96 -24.68 58.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.543 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 218' ' ' VAL . . . -75.51 -49.05 19.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.831 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 211' ' ' LEU . 23.4 pt -71.72 -38.08 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.607 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -58.62 -38.39 77.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.988 0.423 . . . . 0.0 110.516 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.89 -27.72 69.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.134 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 214' ' ' ALA . 21.3 t -83.67 -50.98 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 121.038 0.447 . . . . 0.0 110.751 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.455 ' HA ' HG21 ' A' ' 239' ' ' ILE . 42.6 p -69.1 -34.86 75.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.461 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.9 14.24 82.8 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 139.79 -134.69 6.74 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.34 166.63 6.57 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.73 2.287 . . . . 0.0 113.246 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 51.0 mm -82.58 106.09 13.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.009 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.589 0 CA-C-O 121.122 0.487 . . . . 0.0 111.864 -179.746 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 CA--C 1.516 -0.345 0 CA-C-O 120.513 0.197 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 243' ' ' VAL . 50.6 mt -64.73 -38.86 83.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.86 -31.23 72.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.226 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -75.57 -38.31 59.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -23.42 63.86 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.095 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.534 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 24.7 t -79.79 -42.19 22.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.487 176.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.01 68.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.154 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -45.82 -50.54 14.03 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.728 0.811 . . . . 0.0 112.497 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.504 ' HB2' HD23 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -85.33 -14.43 46.5 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 41.3 mt -83.56 -31.08 26.54 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -82.93 -18.85 38.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.64 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.94 -34.13 76.0 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.283 0.563 . . . . 0.0 109.816 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 35.4 t -132.03 69.35 80.71 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.5 -2.97 10.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.25 2.633 . . . . 0.0 113.846 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -84.0 -24.14 30.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.558 0.694 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -67.75 149.29 50.14 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.861 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -102.81 140.79 36.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.09 131.95 67.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 120.97 0.414 . . . . 0.0 110.897 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.2 m -107.63 108.76 20.16 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 16.3 mt -96.36 114.98 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.68 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -99.5 125.16 45.2 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.293 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 274' ' ' SER . . . -105.71 140.76 15.23 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -123.01 161.94 23.31 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.01 0.433 . . . . 0.0 110.005 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 10.0 t -148.1 167.1 25.88 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.402 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 C--N 1.304 -1.394 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.011 -178.276 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.676 0.75 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.94 -38.66 70.61 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.779 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.408 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 22.7 mm -58.78 -64.37 2.99 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.741 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.408 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 14.2 Cg_endo -61.21 -28.12 84.6 Favored 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 121.867 1.711 . . . . 0.0 112.426 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 53.2 tp -65.51 -52.95 48.94 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.965 0.412 . . . . 0.0 110.809 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 259' ' ' GLY . 14.5 p -62.64 -28.39 69.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.606 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.86 78.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.251 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -67.86 -39.59 83.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.73 -52.18 64.78 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.099 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.93 -35.0 75.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.214 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.452 ' HA ' HG21 ' A' ' 297' ' ' THR . 16.4 ttpt -62.68 -31.79 72.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.229 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 61.5 mt -56.36 -45.57 81.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.989 0.423 . . . . 0.0 110.118 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.734 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.5 t -67.48 -45.44 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.978 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.78 -45.37 74.26 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.919 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.84 -40.54 88.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.288 0.566 . . . . 0.0 110.635 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.673 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 6.9 m-85 -69.75 -41.41 75.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.208 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 47.6 mt -63.99 -46.91 82.45 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 79.4 t -59.9 -39.51 80.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.354 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.39 -30.54 71.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.339 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.673 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -80.93 1.51 30.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.597 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 98.81 15.69 33.23 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.136 -1.03 . . . . 0.0 114.033 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 58.2 t -90.64 142.86 12.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 117.416 0.608 . . . . 0.0 109.551 177.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.31 111.11 4.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.801 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.1 -34.12 77.94 Favored Glycine 0 C--N 1.33 0.197 0 CA-C-N 115.707 -0.679 . . . . 0.0 113.255 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.54 -21.0 66.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.922 0.391 . . . . 0.0 111.63 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.5 3.92 40.67 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.97 0.414 . . . . 0.0 110.99 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 66.4 mt -105.43 131.92 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.74 129.61 54.58 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 279' ' ' LYS . 31.8 p -115.72 125.38 52.73 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.683 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 94.7 t -130.04 127.58 63.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 0.0 111.499 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -96.02 114.12 4.83 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.87 -2.0 48.25 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 72.79 -129.85 13.85 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.661 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 23.2 t -90.49 114.92 27.21 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.1 p -179.33 147.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.6 t30 64.95 69.33 0.67 Allowed Pre-proline 0 C--N 1.314 -0.97 0 O-C-N 123.818 0.699 . . . . 0.0 110.404 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.44 168.45 12.99 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.591 2.194 . . . . 0.0 113.231 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.465 ' HB ' ' NH1' ' A' ' 320' ' ' ARG . 2.7 tt -128.12 -50.0 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.108 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.404 ' HB1' ' HA2' ' A' ' 314' ' ' GLY . . . -120.83 171.71 8.42 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.168 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 20.0 m -64.55 134.69 54.92 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.485 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -78.22 -7.72 57.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.184 0.516 . . . . 0.0 110.662 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.16 -16.88 60.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.158 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.76 144.61 31.79 Favored Pre-proline 0 CA--C 1.511 -0.522 0 CA-C-O 121.034 0.445 . . . . 0.0 110.941 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -66.22 -34.66 35.43 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 122.213 1.942 . . . . 0.0 111.354 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -60.87 -40.51 93.24 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.268 0.556 . . . . 0.0 109.85 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.404 ' HA2' ' HB1' ' A' ' 307' ' ' ALA . . . -70.25 -39.8 71.12 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.876 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.74 -33.43 72.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.125 0.488 . . . . 0.0 110.092 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -70.47 -29.14 65.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.79 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.38 -41.17 20.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.05 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -64.64 -17.42 64.02 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 19.6 ptp180 -86.98 13.19 9.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.146 0.498 . . . . 0.0 110.865 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.465 ' NH1' ' HB ' ' A' ' 306' ' ' ILE . 5.2 ptt180 -57.66 175.9 0.16 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.191 0.996 . . . . 0.0 113.189 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.48 147.76 28.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.427 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.02 136.15 48.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.146 0.498 . . . . 0.0 110.9 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.3 mp -98.38 117.27 43.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.919 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 48.8 t -112.53 141.87 26.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 97.3 t -88.93 118.85 35.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.028 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.6 t30 . . . . . 0 C--N 1.331 -0.2 0 C-N-CA 125.144 1.378 . . . . 0.0 112.549 -176.611 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.458 ' O ' HD21 ' A' ' 211' ' ' LEU . . . . . . . . 0 N--CA 1.468 0.469 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.65 80.75 9.02 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 209' ' ' ALA . 3.1 mm? -57.48 -53.29 59.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.71 -43.22 99.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.846 0.355 . . . . 0.0 110.697 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.4 t -70.92 -21.0 62.42 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.247 0.546 . . . . 0.0 110.346 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -84.24 -45.07 13.26 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.51 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 26.5 pt -69.48 -41.89 80.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.03 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -57.2 -32.47 66.51 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.459 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.42 67.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.236 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.2 t -87.7 -47.93 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-O 121.065 0.46 . . . . 0.0 110.091 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.409 ' HA ' HG22 ' A' ' 239' ' ' ILE . 76.2 p -66.29 -36.91 84.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.585 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.02 24.95 42.53 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.38 -136.02 10.22 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . 0.59 ' HB2' ' NE ' ' A' ' 320' ' ' ARG . 3.4 Cg_exo -79.98 159.26 24.08 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.463 2.109 . . . . 0.0 111.851 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 320' ' ' ARG . 41.7 mm -74.88 106.65 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.661 -176.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.939 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.34 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 CA--C 1.515 -0.366 0 CA-C-O 120.476 0.179 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.505 ' O ' HG22 ' A' ' 243' ' ' VAL . 76.7 mt -69.9 -42.42 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 8.1 mp -67.08 -33.52 75.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.597 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.68 -37.25 82.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.067 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -41.17 69.1 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.779 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.625 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 54.9 t -56.01 -40.82 65.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.231 0.539 . . . . 0.0 110.199 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.86 82.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.231 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -48.9 -52.98 21.53 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.436 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -73.66 -31.77 63.64 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.168 -178.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 25.6 mt -68.76 -29.64 68.07 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -64.86 -32.38 74.06 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.942 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -77.1 -29.41 54.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.57 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 7.8 t -137.82 65.02 44.88 Favored Pre-proline 0 C--N 1.316 -0.867 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.01 4.6 5.12 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.059 2.506 . . . . 0.0 114.461 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -81.21 -28.11 35.03 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.681 0.753 . . . . 0.0 109.077 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.3 141.14 54.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.639 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -93.74 137.08 33.36 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.047 0.451 . . . . 0.0 110.157 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 5.3 m -116.67 133.66 62.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.071 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 31.4 m -112.32 111.92 23.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.84 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 18.9 mt -92.79 114.36 29.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -104.79 128.21 52.85 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.597 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -109.49 144.82 16.7 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.798 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -126.24 158.72 34.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 10.0 t -174.13 114.18 0.19 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.125 0.964 . . . . 0.0 111.228 174.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 C--N 1.301 -1.531 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.488 -177.607 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 C--O 1.235 0.312 0 CA-C-O 120.978 0.418 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.635 HD21 ' N ' ' A' ' 271' ' ' ILE . 0.2 OUTLIER -61.06 -24.69 66.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.831 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.635 ' N ' HD21 ' A' ' 270' ' ' ASN . 19.8 mm -64.53 -64.89 2.32 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.869 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.431 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.3 Cg_endo -60.01 -30.01 90.6 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 121.779 1.653 . . . . 0.0 111.934 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 58.5 tp -68.36 -52.22 35.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.237 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 17.3 p -64.22 -27.15 68.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.15 -33.62 74.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.768 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -64.05 -50.47 68.27 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.852 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.518 ' NH1' ' HB2' ' A' ' 319' ' ' ARG . 72.8 mtt180 -61.96 -38.06 87.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.784 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.88 92.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.076 0.465 . . . . 0.0 110.172 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.483 ' HA ' HG23 ' A' ' 297' ' ' THR . 23.6 ttpt -66.71 -31.93 72.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.377 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 60.4 mt -55.09 -41.96 62.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.059 0.457 . . . . 0.0 110.145 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.7 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.6 t -70.2 -43.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.778 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.4 84.94 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.994 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -56.96 -37.58 71.77 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.937 0.398 . . . . 0.0 110.649 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.652 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 6.3 m-85 -70.86 -51.25 27.56 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.96 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 30.5 mt -55.38 -50.76 68.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.366 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.16 -41.22 85.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.007 0.432 . . . . 0.0 110.646 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.13 -21.96 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.001 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.652 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.8 mmp_? -88.52 7.1 34.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.499 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 92.42 14.8 55.12 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.683 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.41 144.9 8.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.6 111.49 5.45 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.832 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.1 -32.04 66.4 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.71 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.8 -15.47 63.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.967 0.413 . . . . 0.0 111.754 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -102.16 -1.8 30.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.023 0.44 . . . . 0.0 110.464 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 60.8 mt -106.92 129.49 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.067 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.03 124.43 48.1 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.483 HG23 ' HA ' ' A' ' 279' ' ' LYS . 18.1 p -107.68 124.9 50.67 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.887 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 69.6 t -134.02 123.45 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.057 0.456 . . . . 0.0 111.738 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -94.77 113.23 4.53 Favored Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 22.1 mt -93.06 1.43 57.25 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.775 0.321 . . . . 0.0 111.389 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.98 -131.2 33.53 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.631 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 45.4 t -91.02 117.6 29.72 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.7 p -178.81 151.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.716 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.35 69.43 1.64 Allowed Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 123.678 0.791 . . . . 0.0 110.831 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.571 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 74.1 Cg_endo -78.47 137.57 14.86 Favored 'Trans proline' 0 N--CA 1.44 -1.661 0 C-N-CA 122.403 2.069 . . . . 0.0 113.381 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.77 -38.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.498 176.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -131.18 169.35 16.04 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.961 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 45.0 m -77.22 146.06 37.2 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.638 0.256 . . . . 0.0 110.477 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -73.27 -7.24 50.67 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.758 0.313 . . . . 0.0 111.365 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -59.91 -24.72 64.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.453 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.6 t -115.73 137.75 23.45 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.543 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.99 -32.44 44.46 Favored 'Trans proline' 0 CA--C 1.518 -0.281 0 C-N-CA 122.452 2.101 . . . . 0.0 111.151 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -60.7 -40.84 93.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.758 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.0 -36.74 93.42 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.008 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -69.92 -25.82 63.86 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 319' ' ' ARG . . . -74.49 -26.47 60.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.062 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -37.06 29.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.571 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 57.0 m-20 -69.69 -3.56 15.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 17.5 ptm180 -98.21 9.12 43.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 120.75 0.31 . . . . 0.0 111.482 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.59 ' NE ' ' HB2' ' A' ' 222' ' ' PRO . 8.8 ptm180 -75.84 -175.95 3.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 75.7 t -135.7 153.05 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.608 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -132.64 139.23 47.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 111.193 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.94 115.05 34.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.86 137.01 39.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 211' ' ' LEU . 42.0 t -104.32 142.24 18.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 C--N 1.318 -0.763 0 O-C-N 123.542 0.526 . . . . 0.0 110.514 177.367 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.388 0 CA-C-O 120.662 0.267 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.15 90.15 3.09 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.033 0.444 . . . . 0.0 110.017 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.456 ' O ' HG12 ' A' ' 215' ' ' ILE . 41.9 mt -75.32 -28.6 59.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.002 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.01 -43.7 98.29 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 120.917 0.389 . . . . 0.0 110.305 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 33.0 t -71.15 -41.25 70.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.78 82.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.611 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 211' ' ' LEU . 24.5 pt -72.53 -37.84 58.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.94 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -58.24 -36.21 72.86 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.751 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.39 -26.64 68.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.288 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.1 t -92.9 -43.68 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.465 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.484 ' HA ' HG21 ' A' ' 239' ' ' ILE . 70.2 p -67.43 -40.81 85.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.081 0.467 . . . . 0.0 110.899 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.26 24.57 59.02 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.62 -134.39 8.25 Favored Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.38 166.18 10.75 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.797 2.332 . . . . 0.0 113.037 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.5 mm -85.2 110.97 20.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.211 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.573 179.125 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 CA--C 1.52 -0.209 0 CA-C-O 120.693 0.282 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.484 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.5 mt -58.97 -39.02 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.442 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.45 -32.1 73.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.103 0.478 . . . . 0.0 110.782 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -71.41 -36.62 71.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -42.62 70.77 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.753 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.608 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 46.0 t -57.59 -42.36 81.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.6 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.55 80.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.284 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -49.8 -53.18 26.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.266 0.627 . . . . 0.0 112.623 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.0 -31.57 63.01 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.561 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 33.8 mt -64.09 -36.81 85.22 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.377 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -73.06 -22.6 60.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.263 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.64 80.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 110.006 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 49.0 t -126.79 70.8 73.58 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.6 -1.33 9.63 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 123.266 2.644 . . . . 0.0 114.145 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -79.71 -24.8 41.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.642 0.734 . . . . 0.0 109.289 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -70.42 135.0 48.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.522 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.15 140.41 29.83 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.0 m -116.05 132.22 66.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.241 0.543 . . . . 0.0 111.436 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 39.8 m -109.02 108.72 19.55 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.17 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 23.3 mt -92.32 114.4 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.486 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -101.74 127.48 48.5 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.453 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -107.64 147.3 16.36 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.323 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 37.8 m-85 -123.66 162.01 23.92 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.119 0.485 . . . . 0.0 110.612 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 34.6 p -147.34 170.48 17.24 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 124.229 1.011 . . . . 0.0 108.95 175.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 C--N 1.316 -0.88 0 CA-C-O 120.924 0.392 . . . . 0.0 110.535 177.736 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.437 ' N ' HD11 ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.442 -0.855 0 CA-C-O 121.274 0.559 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -42.88 88.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.668 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.451 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 25.7 mm -58.11 -64.35 2.87 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.583 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.451 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.8 Cg_endo -58.92 -29.05 89.29 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.025 1.817 . . . . 0.0 112.272 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 58.4 tp -70.3 -52.93 19.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.335 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 14.7 p -63.5 -30.51 71.62 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.906 0.384 . . . . 0.0 110.512 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.6 73.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.785 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -67.0 -48.14 69.36 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -54.25 -49.02 70.49 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.382 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.2 90.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.176 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.488 ' HA ' HG23 ' A' ' 297' ' ' THR . 41.9 tptt -64.35 -30.57 71.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.227 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.85 -42.97 90.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.22 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.699 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.2 t -68.2 -45.81 82.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.836 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.7 -44.74 73.69 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.803 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.58 -38.82 82.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.914 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.49 -43.02 77.77 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.794 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 40.2 mt -62.78 -49.11 76.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.55 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 83.1 t -59.9 -40.83 83.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.511 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.74 -28.13 69.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.683 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -85.33 0.02 53.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.917 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.29 6.75 35.97 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.611 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 60.2 t -83.55 144.57 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 117.723 0.761 . . . . 0.0 109.793 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.09 109.95 6.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.305 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.48 -29.9 74.83 Favored Glycine 0 CA--C 1.509 -0.316 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.363 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -61.94 -19.29 62.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.204 0.526 . . . . 0.0 110.948 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -107.96 5.5 26.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.484 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.8 mt -106.26 129.1 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.76 124.64 48.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.71 0.291 . . . . 0.0 110.594 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.488 HG23 ' HA ' ' A' ' 279' ' ' LYS . 14.9 p -109.16 121.99 46.33 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.207 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 73.3 t -130.25 120.44 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.389 0.614 . . . . 0.0 112.045 -176.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -90.11 110.97 3.83 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 27.2 mt -90.41 -0.15 57.53 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 68.56 -125.38 20.2 Favored Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.54 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.1 t -105.81 121.92 45.03 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.448 HG13 ' ND2' ' A' ' 304' ' ' ASN . 75.5 t -136.95 -69.41 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.897 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.448 ' ND2' HG13 ' A' ' 303' ' ' VAL . 58.4 m-80 -112.38 91.68 17.21 Favored Pre-proline 0 C--O 1.242 0.702 0 CA-C-O 120.687 0.28 . . . . 0.0 110.747 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.63 135.32 41.52 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.611 2.207 . . . . 0.0 111.24 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.0 tt -84.65 -45.76 17.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.749 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -124.2 173.61 8.22 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.317 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.9 m -62.62 136.34 57.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.679 0.612 . . . . 0.0 111.253 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -80.64 -11.73 59.6 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.156 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.71 -19.7 65.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.07 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 3.2 t -113.34 139.47 23.23 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.329 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.0 -35.41 87.79 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.619 2.212 . . . . 0.0 111.535 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.565 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 71.5 mm-40 -60.34 -46.48 89.74 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.497 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -63.78 -37.77 95.18 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.717 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -61.85 -40.43 95.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.23 0.538 . . . . 0.0 109.948 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.7 -28.69 70.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.653 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 11.0 mmtp -79.49 -39.29 32.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.036 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -55.51 -28.26 53.59 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 32.0 ptt180 -83.58 12.07 6.27 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 28.6 ptt85 -57.53 173.66 0.26 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.901 0.88 . . . . 0.0 112.966 174.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 66.3 t -133.73 148.02 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.015 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -130.31 139.02 50.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.981 0.42 . . . . 0.0 111.071 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.2 mp -101.09 117.02 45.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.891 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.3 138.12 38.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.08 137.79 27.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.385 179.325 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 121.333 0.587 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.09 78.12 6.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.092 0.472 . . . . 0.0 110.186 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.419 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.2 mm? -69.78 -29.1 66.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.67 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -63.82 -46.49 84.88 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.796 0.332 . . . . 0.0 110.536 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.1 t -72.05 -32.13 66.8 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.37 -47.32 76.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.182 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.452 ' CG2' HG11 ' A' ' 243' ' ' VAL . 22.0 pt -75.4 -39.48 41.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.848 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.441 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 17.9 t-20 -60.8 -33.4 72.94 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.974 0.416 . . . . 0.0 110.621 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.22 -28.03 69.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.081 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.4 t -90.61 -44.51 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.22 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.458 ' HA ' HG22 ' A' ' 239' ' ' ILE . 58.4 p -63.72 -36.07 82.64 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.967 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.0 25.19 41.73 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 124.52 -132.73 8.34 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.29 166.86 10.75 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.421 2.08 . . . . 0.0 112.183 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 51.5 mm -80.96 101.9 6.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.388 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.398 -179.615 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 CA--C 1.519 -0.213 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 219' ' ' THR . 74.1 mt -61.73 -38.14 79.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.401 ' CD1' HG11 ' A' ' 281' ' ' VAL . 4.2 mm? -61.05 -36.89 80.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.077 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -78.77 -34.85 45.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.105 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.43 -43.74 84.83 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.574 177.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.533 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 34.0 t -58.51 -42.68 85.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.722 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.8 81.54 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.477 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -53.74 -50.53 65.76 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -29.45 63.52 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.214 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.1 mt -72.21 -28.57 63.26 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 109.627 176.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -64.65 -31.96 73.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.84 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.72 -37.72 73.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.235 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 53.5 t -125.76 72.59 68.88 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.59 0.46 7.53 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.774 2.316 . . . . 0.0 112.734 -178.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.03 -31.43 56.27 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.84 145.15 56.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.563 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.37 145.62 28.68 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.11 127.28 75.84 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.904 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.4 m -103.89 109.34 21.05 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.521 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.422 HG12 HG23 ' A' ' 323' ' ' ILE . 19.4 mt -96.79 114.23 33.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-O 121.024 0.44 . . . . 0.0 109.916 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -102.59 126.01 49.52 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.345 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.433 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -104.41 144.94 15.92 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.506 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -127.35 161.88 27.6 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 38.3 p -141.31 170.8 15.05 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.799 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--N 1.312 -1.061 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.017 177.5 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.797 0.808 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.542 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 22.2 p30 -55.56 -33.25 63.69 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.374 177.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.449 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 20.1 mm -62.72 -65.0 2.4 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.174 177.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.449 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 11.2 Cg_endo -59.99 -27.45 84.93 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 121.887 1.725 . . . . 0.0 112.18 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.8 tp -67.36 -53.83 25.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.774 0.321 . . . . 0.0 111.532 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.433 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 6.5 p -62.47 -30.37 71.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.757 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.64 -31.56 66.99 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.16 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -69.1 -51.48 38.17 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.787 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 54.3 mmt-85 -58.78 -39.26 80.53 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.954 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.69 91.96 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.21 0.528 . . . . 0.0 109.872 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.503 ' HA ' HG23 ' A' ' 297' ' ' THR . 23.5 tptm -63.03 -34.87 78.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.968 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 54.9 mt -56.73 -44.32 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.566 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.725 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.3 t -66.25 -46.11 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.623 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -54.47 -45.94 73.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.051 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.69 -36.44 82.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.904 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -68.83 -41.41 78.61 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.645 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 31.8 mt -66.14 -48.1 71.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.844 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 89.2 t -59.33 -43.05 89.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.511 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.0 -28.31 68.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.267 0.556 . . . . 0.0 110.438 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -85.98 3.04 43.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.046 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 108.5 5.08 32.21 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.74 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 49.6 t -88.26 140.29 16.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 117.782 0.791 . . . . 0.0 110.225 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.93 117.25 8.03 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.561 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.69 86.56 Favored Glycine 0 CA--C 1.51 -0.265 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.15 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -15.26 63.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.964 0.412 . . . . 0.0 111.444 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -98.52 0.31 44.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.0 110.65 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.3 mt -109.27 129.37 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.498 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.32 129.58 54.94 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.937 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.503 HG23 ' HA ' ' A' ' 279' ' ' LYS . 25.0 p -115.58 128.09 55.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.524 0.202 . . . . 0.0 111.172 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 26.9 t -133.54 128.09 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -99.81 108.64 3.57 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 18.5 mt -92.36 3.2 55.92 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 68.53 -127.74 23.56 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.559 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 15.1 m -93.6 115.61 28.1 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.834 0.35 . . . . 0.0 110.525 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.5 p -176.12 150.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 60.7 t30 70.29 74.52 0.26 Allowed Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 123.871 0.732 . . . . 0.0 111.078 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.587 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 73.5 Cg_endo -75.07 155.33 42.58 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.647 2.231 . . . . 0.0 112.792 -177.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.0 tt -124.59 -44.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.445 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -138.44 174.98 9.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.47 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 50.8 m -71.16 131.16 43.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.279 0.562 . . . . 0.0 111.702 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -80.81 -7.66 59.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.417 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.14 -16.88 63.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.808 178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 314' ' ' GLY . 5.2 t -123.23 144.39 43.49 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -54.49 -36.52 88.52 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.067 2.511 . . . . 0.0 112.118 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.1 mm-40 -55.49 -51.15 67.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.983 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -69.33 -40.85 80.2 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.693 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -56.35 -41.05 75.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.025 0.44 . . . . 0.0 110.339 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.96 70.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.737 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 0.3 OUTLIER -80.63 -42.97 21.24 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.597 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.587 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 39.2 m-80 -63.85 -23.83 67.51 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -176.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.558 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 10.4 ptm180 -84.98 12.87 6.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.29 0.567 . . . . 0.0 111.929 -178.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -58.61 177.74 0.13 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.303 1.049 . . . . 0.0 113.437 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 68.8 t -136.32 144.7 32.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.766 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -131.1 137.3 49.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.115 0.483 . . . . 0.0 111.376 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.422 HG23 HG12 ' A' ' 257' ' ' ILE . 2.1 mp -98.7 120.34 47.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.629 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.68 135.06 50.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 89.4 t -95.43 141.89 14.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.185 0.517 . . . . 0.0 111.694 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 . . . . . 0 C--N 1.311 -1.091 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.765 178.454 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.564 0 CA-C-O 120.594 0.235 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.04 69.43 3.32 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.058 0.456 . . . . 0.0 110.039 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.52 ' O ' HG12 ' A' ' 215' ' ' ILE . 35.4 mt -55.53 -27.24 47.67 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.342 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -55.95 -60.38 3.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.274 0.559 . . . . 0.0 109.968 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 39.9 t -69.44 -27.1 64.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.178 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -69.46 -49.32 55.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.273 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 211' ' ' LEU . 29.3 pt -74.08 -40.51 51.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 121.054 -0.259 . . . . 0.0 111.304 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -60.9 -29.6 69.68 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.089 0.471 . . . . 0.0 110.584 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.47 -27.76 68.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.178 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.9 t -89.55 -45.01 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.229 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.46 ' HA ' HG22 ' A' ' 239' ' ' ILE . 75.8 p -67.0 -38.33 85.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.443 0.64 . . . . 0.0 109.861 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.74 21.75 61.1 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.89 -122.64 4.19 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . 0.422 ' HA ' ' HG2' ' A' ' 322' ' ' GLU . 84.0 Cg_endo -89.17 159.88 5.73 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.74 2.293 . . . . 0.0 113.979 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.5 mm -78.32 107.99 11.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.406 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 121.026 0.441 . . . . 0.0 110.005 177.418 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 . . . . . 0 N--CA 1.446 -0.66 0 CA-C-O 120.535 0.207 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.46 HG22 ' HA ' ' A' ' 219' ' ' THR . 90.4 mt -61.63 -37.61 78.34 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 46.6 mt -66.27 -35.07 79.45 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.451 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -69.88 -37.12 75.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -46.77 71.34 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.762 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.63 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.8 t -61.79 -46.06 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.77 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.08 -31.51 72.76 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.441 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.04 -44.06 97.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.42 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 243' ' ' VAL . 0.6 OUTLIER -75.48 -27.21 58.75 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.596 -179.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 43.9 mt -65.39 -28.41 69.24 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 121.205 0.526 . . . . 0.0 109.622 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -78.55 -22.36 47.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.318 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.94 -30.55 66.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.36 0.6 . . . . 0.0 110.068 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 13.3 t -132.74 69.85 79.27 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.97 -2.01 7.99 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.442 2.762 . . . . 0.0 114.231 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.46 -18.39 28.35 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.443 0.64 . . . . 0.0 109.939 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -71.88 131.01 42.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.005 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -91.58 138.52 31.5 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.4 m -114.89 130.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-O 121.204 0.526 . . . . 0.0 111.603 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.1 m -107.87 107.48 18.23 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.193 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 21.6 mt -90.15 117.32 33.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.768 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -105.8 126.92 52.73 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.787 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -107.22 145.78 16.06 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 6.9 m-85 -124.29 158.57 32.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.944 0.402 . . . . 0.0 109.996 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.551 ' OG1' ' HB2' ' A' ' 270' ' ' ASN . 16.6 p -144.54 170.1 16.69 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.611 0.764 . . . . 0.0 109.935 177.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 C--N 1.312 -1.041 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.091 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.443 -0.782 0 CA-C-O 121.331 0.586 . . . . 0.0 109.926 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.551 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 3.7 p30 -65.4 -27.58 68.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.544 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.479 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 27.4 mm -62.65 -63.88 3.68 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-O 119.664 -0.208 . . . . 0.0 110.989 178.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.479 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 1.6 Cg_endo -53.97 -37.16 85.87 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.428 2.085 . . . . 0.0 111.313 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 25.2 tp -62.22 -52.55 63.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.428 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 22.3 m -61.48 -30.97 70.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.783 0.325 . . . . 0.0 110.401 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.8 -28.91 64.99 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.885 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -71.51 -45.54 62.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 22.1 mmm180 -56.59 -46.84 80.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.524 178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.85 88.91 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.462 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.483 ' HA ' HG23 ' A' ' 297' ' ' THR . 16.8 ttpt -62.97 -32.06 73.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.912 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 64.4 mt -56.22 -43.63 77.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.203 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.707 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 7.8 t -69.62 -44.24 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.126 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.17 73.77 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 123.291 0.369 . . . . 0.0 110.663 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.8 -40.42 84.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.863 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -69.8 -40.35 76.03 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.265 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 46.6 mt -64.77 -47.61 77.53 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 92.3 t -60.92 -39.22 81.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.284 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.91 -28.42 69.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.834 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.611 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 2.4 mmp_? -86.86 4.57 40.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.301 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.9 5.43 44.37 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.043 -1.075 . . . . 0.0 114.649 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 58.0 t -84.18 145.24 8.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 117.801 0.801 . . . . 0.0 109.904 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.3 112.79 6.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.42 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.58 -33.88 87.86 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.067 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -69.76 -12.6 61.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.589 0.233 . . . . 0.0 111.318 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -104.52 1.71 30.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.847 0.356 . . . . 0.0 110.615 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 70.4 mt -105.12 131.45 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.922 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.58 125.7 49.43 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.068 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.483 HG23 ' HA ' ' A' ' 279' ' ' LYS . 11.6 p -107.51 129.51 54.95 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.888 0.375 . . . . 0.0 111.406 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.48 136.98 52.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.803 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.49 114.49 4.12 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 17.5 mt -91.48 -5.33 54.41 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 71.3 -135.59 24.1 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.073 -1.061 . . . . 0.0 111.397 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 261' ' ' THR . 7.5 t -87.99 114.56 24.72 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.151 0.5 . . . . 0.0 110.029 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.9 p -176.65 150.31 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 44.7 t30 65.9 78.87 0.25 Allowed Pre-proline 0 C--N 1.311 -1.076 0 O-C-N 123.75 0.656 . . . . 0.0 111.1 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.594 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 39.7 Cg_endo -68.69 138.24 40.87 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.818 2.345 . . . . 0.0 113.154 -177.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 7.4 tt -110.79 -25.43 3.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.768 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -152.45 163.62 39.16 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 47.8 t -62.84 134.23 55.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.042 0.449 . . . . 0.0 110.988 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -80.61 -11.61 59.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.63 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.2 36.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.169 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 3.1 t -124.74 138.03 30.56 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.916 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.99 -26.63 82.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.894 2.396 . . . . 0.0 111.78 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 8.4 mm-40 -65.33 -41.87 93.52 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.3 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.41 -38.38 93.51 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.49 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -63.6 -37.87 88.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.37 68.89 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.827 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 9.0 mmtp -84.65 -38.45 19.81 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.822 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.594 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 38.5 m-80 -63.74 -21.16 66.27 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 13.0 ptm180 -82.11 14.55 2.79 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.156 0.503 . . . . 0.0 111.232 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -65.42 -174.38 0.18 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.106 0.963 . . . . 0.0 113.13 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.5 t -141.81 148.28 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.722 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.422 ' HG2' ' HA ' ' A' ' 222' ' ' PRO . 47.6 mt-10 -133.84 135.9 44.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.747 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 mp -94.23 119.34 42.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.37 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 91.6 t -106.62 136.67 40.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.49 139.61 22.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.341 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.353 177.469 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.431 0 CA-C-O 120.728 0.299 . . . . 0.0 111.272 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.73 85.86 1.22 Allowed 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.523 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.421 ' O ' HG12 ' A' ' 215' ' ' ILE . 23.7 mt -70.35 -33.64 71.69 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.939 -177.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -63.76 -45.74 88.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.24 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 31.5 t -75.63 -23.34 56.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.057 0.456 . . . . 0.0 109.917 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -72.49 -49.91 29.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.206 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 211' ' ' LEU . 26.7 pt -70.63 -38.27 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.868 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -55.7 -37.21 68.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.951 0.405 . . . . 0.0 110.975 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.5 -26.87 68.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.492 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.8 t -92.26 -47.96 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 120.921 0.391 . . . . 0.0 110.63 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.441 ' HA ' HG21 ' A' ' 239' ' ' ILE . 81.6 p -64.35 -39.17 93.36 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.615 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.8 22.51 59.63 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.4 -130.55 6.84 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.19 156.31 25.98 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.573 2.182 . . . . 0.0 112.044 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -74.1 109.29 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.092 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 175.288 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 120.516 0.198 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 243' ' ' VAL . 77.8 mt -64.41 -39.8 86.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.33 -33.4 75.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.894 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -71.73 -36.03 70.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.583 0.706 . . . . 0.0 109.177 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -42.28 78.73 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.719 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.616 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 44.6 t -62.5 -43.9 98.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.334 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -55.82 -37.24 68.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.713 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -49.06 -53.31 20.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.56 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.416 ' HB2' HD23 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -82.51 -14.53 54.83 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.821 -176.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.4 mt -80.47 -26.09 38.47 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.339 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -83.54 -23.15 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.628 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.84 -37.32 76.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.203 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 24.6 t -130.09 71.97 82.06 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-O 121.339 0.59 . . . . 0.0 109.505 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.35 -1.4 11.25 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.164 2.576 . . . . 0.0 113.244 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -79.15 -29.69 43.19 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.872 0.844 . . . . 0.0 108.872 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -81.46 134.68 35.57 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.733 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -90.79 147.02 23.48 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.953 0.406 . . . . 0.0 110.508 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.13 137.75 52.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.587 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.0 m -114.13 113.1 24.24 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.551 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.432 HG12 HG22 ' A' ' 323' ' ' ILE . 21.4 mt -94.15 113.85 29.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.578 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -98.47 126.66 44.1 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.37 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -107.48 146.82 16.25 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 36.3 m-85 -127.4 161.89 27.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.1 0.476 . . . . 0.0 110.688 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 56.9 p -140.58 173.28 11.65 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.529 175.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.318 -0.776 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.859 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 121.465 0.65 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -62.87 -36.54 83.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.427 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.493 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 27.3 mm -56.58 -64.22 2.67 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.019 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.493 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 5.1 Cg_endo -56.79 -35.65 98.14 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 121.944 1.763 . . . . 0.0 111.914 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.481 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 60.2 tp -63.07 -52.92 60.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.686 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 13.0 p -62.98 -31.52 72.66 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.99 0.424 . . . . 0.0 110.468 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.45 -34.04 77.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.742 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -66.92 -44.96 79.38 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 38.8 mmt180 -56.86 -47.38 80.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.008 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.75 88.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.018 0.437 . . . . 0.0 110.373 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.473 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.9 tptt -65.97 -32.36 73.8 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.092 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.55 -45.76 90.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.197 0.522 . . . . 0.0 109.684 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.688 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.2 t -65.8 -48.08 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.792 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.52 -41.98 70.32 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.076 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.64 -42.63 88.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.472 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -66.84 -43.06 84.69 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.491 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 41.7 mt -64.03 -51.05 66.02 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.887 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.9 t -59.41 -40.55 81.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.91 71.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.555 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.507 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 1.2 mmp_? -83.72 6.23 21.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.064 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.04 9.5 51.73 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.748 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.502 ' CG1' HD13 ' A' ' 295' ' ' ILE . 59.0 t -84.9 141.4 14.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.28 113.86 7.01 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.346 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.01 -32.7 76.34 Favored Glycine 0 C--N 1.318 -0.43 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.707 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.59 -19.15 62.88 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.798 0.332 . . . . 0.0 111.593 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.64 0.32 49.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.473 0.654 . . . . 0.0 110.005 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . 0.502 HD13 ' CG1' ' A' ' 290' ' ' VAL . 63.5 mt -110.81 133.32 56.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.142 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -121.4 129.67 53.15 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.473 HG21 ' HA ' ' A' ' 279' ' ' LYS . 29.9 p -109.02 125.94 52.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.899 0.381 . . . . 0.0 111.429 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.9 t -127.89 117.41 46.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.12 111.96 3.9 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.442 174.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 20.9 mt -96.75 1.1 50.5 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 58.91 -127.47 45.36 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 44.4 t -102.34 122.34 44.07 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.85 -59.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -117.46 92.93 41.91 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -66.45 174.24 6.57 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.857 2.371 . . . . 0.0 113.267 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 5.3 tt -131.27 -48.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.591 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -120.51 172.43 7.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.254 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 27.9 m -67.19 139.75 57.44 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.037 0.446 . . . . 0.0 111.351 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -81.01 -10.08 59.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.646 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.14 -16.37 61.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.349 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.6 t -115.82 144.44 32.66 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.513 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.97 -31.32 24.36 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.215 1.943 . . . . 0.0 110.942 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.88 -35.41 81.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.653 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -71.34 -36.97 63.14 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.4 ' O ' ' HG2' ' A' ' 319' ' ' ARG . 11.3 mtp85 -57.66 -39.46 77.1 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.59 -30.93 71.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.22 -46.34 20.64 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.807 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -61.69 -26.03 67.78 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 14.9 ptp180 -83.62 10.65 8.69 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.015 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -57.14 177.76 0.08 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.01 0.91 . . . . 0.0 112.715 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 58.4 t -137.37 144.64 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.054 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -131.98 138.42 48.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.984 0.421 . . . . 0.0 111.115 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.432 HG22 HG12 ' A' ' 257' ' ' ILE . 1.6 mp -100.0 120.47 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.992 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 75.1 t -108.45 134.24 50.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 53.5 t -98.1 133.47 40.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--N 1.318 -0.762 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.867 -178.772 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -84.0 88.83 7.17 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.339 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.7 mm? -67.86 -39.3 83.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.766 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -57.83 -55.65 32.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.423 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.4 t -67.33 -34.68 77.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.65 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.89 -46.74 80.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.686 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 211' ' ' LEU . 23.6 pt -71.67 -38.6 67.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.501 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -57.68 -33.79 68.72 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.588 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.26 -26.33 68.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.216 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.573 HG11 ' CB ' ' A' ' 242' ' ' ARG . 8.2 t -92.79 -45.73 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.447 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 75.5 p -64.36 -42.91 95.95 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.274 0.559 . . . . 0.0 110.397 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.96 13.45 83.06 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 143.32 -131.25 4.44 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.67 164.77 5.17 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.029 2.486 . . . . 0.0 113.593 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.1 mm -81.69 109.8 16.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.324 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.047 0.451 . . . . 0.0 110.833 178.813 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 CA--C 1.507 -0.699 0 N-CA-C 111.379 0.14 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 243' ' ' VAL . 58.6 mt -67.6 -49.01 74.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.795 -175.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.482 ' CD2' HG12 ' A' ' 281' ' ' VAL . 37.6 mt -59.3 -40.41 86.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.206 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -70.78 -36.27 72.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 110.185 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.573 ' CB ' HG11 ' A' ' 218' ' ' VAL . 7.8 mmt180 -63.68 -54.99 26.99 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.5 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.653 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 69.2 t -53.47 -46.8 59.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.646 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.84 85.13 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.764 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -60.15 -45.62 92.42 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.665 0.269 . . . . 0.0 111.605 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 243' ' ' VAL . 0.4 OUTLIER -74.38 -26.27 60.01 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.735 -179.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 35.0 mt -69.16 -28.87 66.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.258 0.551 . . . . 0.0 110.279 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -77.08 -24.94 51.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.843 176.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -73.1 -40.7 64.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.533 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 50.0 t -125.13 73.74 66.47 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 121.332 0.587 . . . . 0.0 109.848 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.65 -0.03 8.8 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.442 2.761 . . . . 0.0 113.424 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.96 -26.7 57.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.887 0.851 . . . . 0.0 109.538 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -78.82 130.09 35.32 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -94.98 142.22 27.74 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.2 m -118.15 135.73 57.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.429 0.633 . . . . 0.0 112.315 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.0 m -108.15 108.25 19.23 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 323' ' ' ILE . 26.2 mt -91.47 114.3 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.767 -178.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -102.93 129.09 49.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.352 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.433 ' C ' ' HG ' ' A' ' 274' ' ' SER . . . -105.28 156.62 16.68 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.641 177.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 19.9 m-85 -132.53 159.31 39.78 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.005 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.8 p -143.1 166.13 25.5 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.406 ' CG ' ' HE ' ' A' ' 315' ' ' ARG . 2.7 p30 . . . . . 0 C--N 1.317 -0.845 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.009 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 42.6 mm . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 121.843 0.83 . . . . 0.0 109.071 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -67.08 -32.69 74.02 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.786 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.419 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 22.4 mm -57.44 -63.64 3.52 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.43 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.419 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 17.9 Cg_endo -61.58 -30.12 85.42 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 122.248 1.966 . . . . 0.0 111.96 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.18 -50.14 64.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 110.455 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.433 ' HG ' ' C ' ' A' ' 259' ' ' GLY . 10.0 t -57.24 -40.95 78.62 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.01 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.63 -30.98 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.749 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -69.95 -45.14 68.08 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.993 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -64.07 -39.73 94.72 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.342 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.6 87.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.002 0.43 . . . . 0.0 109.871 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.476 ' HA ' HG21 ' A' ' 297' ' ' THR . 7.8 ttpt -60.54 -36.91 79.57 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.735 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 58.9 mt -56.39 -47.05 82.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.811 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.534 ' O ' HD13 ' A' ' 285' ' ' LEU . 17.1 t -63.34 -46.89 94.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.941 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.54 -43.16 89.17 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -61.37 -39.91 92.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.16 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.601 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 8.0 m-85 -70.65 -42.38 70.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.993 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 281' ' ' VAL . 1.8 mp -61.94 -48.85 78.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 84.2 t -60.45 -40.38 84.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.501 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.5 -30.95 71.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.182 0.515 . . . . 0.0 110.608 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 20.7 mmm180 -83.12 5.45 22.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.735 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.51 2.24 40.67 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.075 -1.059 . . . . 0.0 114.45 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 61.4 t -80.55 145.24 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 117.842 0.821 . . . . 0.0 109.829 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.5 ' HB3' ' ND1' ' A' ' 294' ' ' HIS . . . -77.46 118.86 20.31 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.148 0.499 . . . . 0.0 111.376 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.65 -30.88 62.99 Favored Glycine 0 C--O 1.222 -0.612 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.873 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -68.81 -16.92 63.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.5 ' ND1' ' HB3' ' A' ' 291' ' ' ALA . 29.4 m170 -95.85 -5.24 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.724 0.297 . . . . 0.0 110.808 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . 0.425 HD11 ' CG1' ' A' ' 290' ' ' VAL . 40.6 mt -110.83 130.17 64.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.228 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.69 125.71 51.18 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.126 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.476 HG21 ' HA ' ' A' ' 279' ' ' LYS . 29.7 p -111.75 122.56 48.13 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.262 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 28.2 m -120.09 164.24 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.483 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.401 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -134.36 105.15 0.55 Allowed Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 14.4 mt -89.59 2.54 54.54 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 69.99 -126.4 17.07 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.561 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 11.8 p -97.18 120.64 37.9 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.828 0.347 . . . . 0.0 110.651 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.4 p -176.31 150.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.339 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 61.66 81.98 0.23 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 123.488 0.715 . . . . 0.0 111.636 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.584 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 94.3 Cg_endo -80.7 154.55 20.49 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.458 2.106 . . . . 0.0 113.004 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.1 tt -119.0 -53.41 3.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.665 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -119.21 166.56 12.82 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.7 p -65.01 143.9 57.64 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.111 0.482 . . . . 0.0 111.491 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -80.19 -7.52 59.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.416 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.17 -18.71 63.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.846 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.7 t -113.72 135.54 21.98 Favored Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.697 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.6 -33.41 86.86 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.789 2.326 . . . . 0.0 111.137 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.0 mm-40 -66.36 -39.94 89.47 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.247 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -69.03 -37.66 83.2 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.123 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.406 ' HE ' ' CG ' ' A' ' 262' ' ' ASP . 80.6 mtp180 -61.49 -37.67 84.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.112 0.482 . . . . 0.0 109.724 176.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.63 68.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.661 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 1.0 OUTLIER -80.71 -39.76 26.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.367 177.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.584 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 44.3 m-80 -65.7 -22.13 66.6 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 39.0 ptt180 -84.41 10.78 9.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.279 0.561 . . . . 0.0 111.507 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 18.7 ptt-85 -58.74 178.58 0.11 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.952 0.882 . . . . 0.0 112.698 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 49.7 t -138.35 145.4 28.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.562 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -130.21 137.01 49.83 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.932 0.396 . . . . 0.0 110.61 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.406 HG23 HG12 ' A' ' 257' ' ' ILE . 2.2 mp -97.22 116.97 40.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.407 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.67 137.38 39.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 49.2 t -100.25 138.81 23.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 C--N 1.31 -1.125 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.416 178.906 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.935 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.89 73.7 2.13 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.153 0.501 . . . . 0.0 110.199 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 247' ' ' LEU . 16.4 mt -56.83 -27.67 60.47 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.81 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.05 -42.87 88.92 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.758 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 26.0 t -73.19 -31.88 64.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.469 ' HB1' ' HZ1' ' A' ' 246' ' ' LYS . . . -64.53 -47.88 77.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.894 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 20.9 pt -73.85 -33.7 37.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.121 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -56.36 -37.88 70.67 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.079 0.466 . . . . 0.0 110.466 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.28 -29.74 70.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.877 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.5 t -82.38 -52.52 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.671 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 76.0 p -64.86 -36.23 83.68 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.424 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.67 12.62 79.78 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.27 -125.87 2.78 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -91.35 167.23 3.5 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.839 2.359 . . . . 0.0 112.936 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.6 mm -84.22 110.46 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.008 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.835 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.996 179.144 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.424 ' O ' HG21 ' A' ' 243' ' ' VAL . 71.6 mt -64.09 -44.72 97.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.149 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.411 HD11 ' CD2' ' A' ' 284' ' ' TYR . 28.9 mt -57.2 -36.17 70.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.228 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -79.94 -38.2 32.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.171 0.51 . . . . 0.0 110.321 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -40.48 95.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.105 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.59 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 28.1 t -59.07 -41.42 83.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.971 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.22 78.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.826 -177.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.57 -44.9 73.35 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.469 ' HZ1' ' HB1' ' A' ' 214' ' ' ALA . 0.0 OUTLIER -82.19 -16.18 50.64 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.709 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 23.5 mt -81.06 -22.56 39.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -71.82 -25.05 61.83 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.685 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -64.03 -46.47 84.3 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.394 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.417 ' SG ' ' HB1' ' A' ' 253' ' ' ALA . 52.1 t -128.92 75.94 79.68 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.42 -2.61 11.53 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.958 2.439 . . . . 0.0 113.243 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.09 -23.38 23.73 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.417 ' HB1' ' SG ' ' A' ' 250' ' ' CYS . . . -62.3 138.26 58.4 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.604 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -93.88 133.21 37.53 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.59 129.2 68.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-O 121.141 0.496 . . . . 0.0 110.751 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 33.3 m -103.84 108.66 20.08 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.051 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.404 HG12 HG21 ' A' ' 323' ' ' ILE . 24.5 mt -93.83 108.86 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -98.15 128.46 44.65 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.921 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.467 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -104.67 144.86 15.87 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 177.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 8.6 m-85 -126.13 163.62 22.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.692 0.282 . . . . 0.0 110.327 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 45.6 p -143.21 162.47 35.54 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.296 0.638 . . . . 0.0 109.616 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--N 1.323 -0.552 0 CA-C-O 121.075 0.464 . . . . 0.0 110.889 179.106 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.7 mp . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 121.557 0.694 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.64 -38.87 67.38 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.149 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.41 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 19.6 mm -60.43 -63.9 3.72 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.072 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.41 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 11.8 Cg_endo -60.74 -30.97 91.37 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.867 1.711 . . . . 0.0 112.33 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 60.3 tp -65.52 -53.09 47.31 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.776 0.322 . . . . 0.0 111.477 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.467 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.9 p -61.82 -30.39 70.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 120.933 0.396 . . . . 0.0 110.767 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.38 -32.76 66.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.255 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -66.17 -49.7 66.46 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.762 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -61.95 -38.63 89.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.908 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.34 97.13 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.841 0.353 . . . . 0.0 110.295 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.468 ' HA ' HG23 ' A' ' 297' ' ' THR . 11.5 tmtt? -61.7 -38.33 87.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.15 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 57.4 mt -55.59 -47.38 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.724 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 9.7 t -65.19 -48.92 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -53.64 -45.77 70.31 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -58.48 -41.69 85.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.706 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.6 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 6.9 m-85 -68.41 -41.32 80.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.716 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 43.8 mt -62.93 -46.44 87.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 95.0 t -58.78 -41.68 83.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.176 176.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.29 -28.5 68.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.503 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.6 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -83.54 -1.27 53.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.169 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 111.05 5.91 26.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.478 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.6 t -89.92 141.81 13.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 117.605 0.703 . . . . 0.0 110.443 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.42 115.34 6.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.478 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.72 -35.61 92.24 Favored Glycine 0 CA--C 1.508 -0.346 0 CA-C-N 115.689 -0.687 . . . . 0.0 113.221 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -68.99 -14.52 63.09 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.055 0.455 . . . . 0.0 111.441 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -102.52 2.58 36.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.112 0.482 . . . . 0.0 110.402 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 76.0 mt -105.97 132.44 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.38 127.87 54.09 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.783 0.325 . . . . 0.0 110.482 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 279' ' ' LYS . 18.8 p -110.95 126.63 54.96 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.54 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.58 123.69 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -94.2 104.04 3.1 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 174.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.6 -3.08 58.99 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 78.98 -125.59 7.08 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.148 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 18.5 t -101.67 119.4 38.72 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.9 p -176.8 148.2 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 62.39 78.64 0.29 Allowed Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 123.186 0.595 . . . . 0.0 111.018 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.475 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 59.4 Cg_endo -73.03 151.4 49.97 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.36 2.04 . . . . 0.0 112.716 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.443 HG21 ' HA ' ' A' ' 318' ' ' ASN . 4.2 tt -111.16 -54.64 5.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.307 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -120.15 170.54 9.22 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.765 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 15.5 m -62.38 137.49 58.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.263 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -80.92 -14.43 58.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.863 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.16 -18.45 65.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.229 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 3.7 t -114.87 142.24 28.08 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.378 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.29 -28.05 40.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.494 2.129 . . . . 0.0 111.366 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 4.9 mt-10 -65.07 -38.98 92.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.411 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -70.15 -38.45 72.7 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.666 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -61.02 -39.04 88.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.101 0.477 . . . . 0.0 109.886 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.92 -26.77 68.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.629 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 3.6 mmtp -85.61 -37.17 19.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.475 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 35.9 m-80 -63.57 -20.94 66.05 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 14.6 ptp180 -88.06 15.19 7.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.313 0.577 . . . . 0.0 111.162 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 26.2 ptt-85 -61.33 -176.32 0.07 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.085 0.945 . . . . 0.0 112.609 175.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 70.7 t -137.71 145.55 28.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.944 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -131.83 140.66 49.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.951 0.405 . . . . 0.0 110.827 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.404 HG21 HG12 ' A' ' 257' ' ' ILE . 1.3 mp -99.0 117.05 43.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.364 -178.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.64 135.02 47.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 211' ' ' LEU . 74.9 t -101.49 136.83 31.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 C--N 1.31 -1.142 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.921 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.392 0 CA-C-O 120.659 0.266 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -80.39 56.52 2.55 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.006 0.432 . . . . 0.0 110.509 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 20.4 mt -53.18 -25.9 15.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -66.21 -37.79 86.41 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.327 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.0 t -77.67 -30.67 52.11 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.49 -46.24 80.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.81 -1.087 . . . . 0.0 111.011 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 25.2 pt -73.73 -37.46 49.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.422 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.15 -31.67 69.18 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.916 0.389 . . . . 0.0 110.863 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.7 -27.05 67.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.894 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.0 p -99.17 -34.84 4.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.282 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.49 ' HA ' HG23 ' A' ' 239' ' ' ILE . 66.8 p -70.28 -37.23 74.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.279 0.561 . . . . 0.0 110.039 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.28 22.62 56.55 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.31 -132.34 7.75 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -80.95 163.34 20.56 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.622 2.215 . . . . 0.0 112.632 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.6 mm -83.17 101.96 8.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.333 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.149 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.513 -179.36 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 120.747 0.308 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.49 HG23 ' HA ' ' A' ' 219' ' ' THR . 88.0 mt -56.69 -38.34 57.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.842 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 57.5 mt -65.23 -31.65 72.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.854 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -71.14 -37.74 72.27 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -40.89 83.56 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.201 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.596 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.9 t -57.03 -42.76 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.014 177.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.01 82.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.328 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -52.22 -49.65 63.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.412 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -73.45 -30.27 63.09 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.469 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.7 mt -69.97 -30.96 68.43 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.627 0.727 . . . . 0.0 109.17 177.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -62.79 -35.08 78.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.042 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -73.23 -35.7 66.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.785 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 43.7 t -128.33 69.99 78.87 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.92 2.13 4.5 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.55 2.834 . . . . 0.0 114.656 -174.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -80.48 -26.29 38.33 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.418 0.628 . . . . 0.0 109.99 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.94 133.94 56.02 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.023 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -96.6 135.66 38.21 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.7 m -113.35 133.26 59.81 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.873 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 34.1 m -108.85 107.3 17.65 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.025 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.427 HG12 HG22 ' A' ' 323' ' ' ILE . 19.8 mt -94.97 115.4 33.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.991 -177.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -101.41 131.34 47.56 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.896 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.451 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -111.41 141.43 16.55 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 318' ' ' ASN . 2.1 m-85 -124.17 161.46 25.64 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 50.6 p -136.58 173.42 11.73 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 C--N 1.312 -1.043 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 176.786 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 46.2 mm . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 121.72 0.772 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -63.82 -35.31 80.2 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.136 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.42 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 19.7 mm -58.68 -64.36 2.98 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.71 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.42 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 19.6 Cg_endo -62.12 -26.85 78.34 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 121.819 1.679 . . . . 0.0 111.662 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 46.7 tp -65.22 -56.44 12.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.732 0.301 . . . . 0.0 110.999 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.451 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 6.9 p -65.48 -28.17 69.02 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.719 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.42 -32.16 68.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.045 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -47.33 61.53 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -55.37 -43.87 75.51 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.032 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.81 -39.19 93.19 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 110.659 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.478 ' HA ' HG22 ' A' ' 297' ' ' THR . 0.9 OUTLIER -63.21 -33.92 76.53 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.524 179.137 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 60.4 mt -57.25 -42.98 81.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.985 0.422 . . . . 0.0 110.073 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.553 ' O ' HD12 ' A' ' 285' ' ' LEU . 3.7 t -70.28 -43.47 78.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.759 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.36 -45.72 80.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.395 178.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.25 -41.93 89.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.396 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.482 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 1.5 m-85 -65.12 -43.94 90.32 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.108 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 281' ' ' VAL . 3.8 mp -63.57 -47.59 80.89 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 99.1 t -60.02 -42.65 90.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.288 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.72 -27.12 68.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.566 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.576 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 2.8 mmp_? -86.21 5.02 36.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.999 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.89 5.9 43.79 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.258 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 57.4 t -86.32 143.61 11.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.604 0.702 . . . . 0.0 109.908 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.58 112.06 8.3 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.042 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.52 -32.66 73.82 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.243 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.29 -20.28 64.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.053 0.454 . . . . 0.0 111.222 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -102.74 3.48 36.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.938 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.5 mt -107.65 129.9 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-O 120.876 0.37 . . . . 0.0 110.845 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.69 125.74 49.43 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.071 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 279' ' ' LYS . 22.3 p -110.33 129.15 55.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.943 0.401 . . . . 0.0 111.074 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.4 t -132.43 116.58 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.012 0.434 . . . . 0.0 111.927 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -92.08 109.58 3.77 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 20.7 mt -87.67 -32.19 19.35 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 95.81 -142.08 15.92 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.4 p -77.58 109.11 11.27 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.737 0.303 . . . . 0.0 110.512 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 15.0 p -174.46 150.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.2 t30 66.46 79.96 0.23 Allowed Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.273 175.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.685 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 38.1 Cg_endo -69.61 135.6 31.22 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.556 2.171 . . . . 0.0 113.075 -178.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.438 HG21 ' HA ' ' A' ' 318' ' ' ASN . 5.2 tt -112.92 -29.27 2.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.748 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -145.83 174.95 10.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.925 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.476 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 29.4 m -62.61 121.19 12.73 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.549 0.53 . . . . 0.0 110.846 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -80.65 -14.29 58.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.45 -16.06 62.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.159 0.504 . . . . 0.0 111.128 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 4.9 t -117.6 143.9 33.18 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.948 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.07 -31.03 76.21 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.441 2.094 . . . . 0.0 111.551 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 4.0 mt-10 -59.14 -44.7 92.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.066 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -69.94 -37.64 74.44 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.894 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.68 -38.42 87.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.401 . . . . 0.0 110.066 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.19 -28.22 69.52 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.483 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 8.2 mmtp -81.81 -45.81 15.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.455 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.685 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 33.5 m-80 -57.98 -29.48 65.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 5.1 ptp180 -80.62 15.75 1.6 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -176.98 1.05 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.084 0.945 . . . . 0.0 112.704 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 89.2 t -131.9 143.32 40.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.756 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -132.53 142.16 49.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.02 0.438 . . . . 0.0 111.079 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.427 HG22 HG12 ' A' ' 257' ' ' ILE . 1.5 mp -101.73 120.54 51.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.853 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 66.9 t -109.72 135.31 49.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.14 140.01 21.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.92 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.1 t30 . . . . . 0 C--N 1.311 -1.092 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.721 178.169 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.524 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.56 86.04 4.59 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.299 0.571 . . . . 0.0 110.343 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.464 ' O ' HG12 ' A' ' 215' ' ' ILE . 48.0 mt -71.17 -23.19 62.01 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.104 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.403 ' N ' HG22 ' A' ' 325' ' ' VAL . 51.7 tt0 -66.18 -38.99 89.36 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.355 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.3 t -73.25 -40.59 64.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.13 75.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.579 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.476 ' CG2' HG11 ' A' ' 243' ' ' VAL . 23.3 pt -70.37 -38.61 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.349 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -62.95 -27.41 69.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.034 0.445 . . . . 0.0 110.524 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.19 -28.41 67.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.935 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 t -89.93 -44.67 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.384 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.488 ' HA ' HG21 ' A' ' 239' ' ' ILE . 70.8 p -67.81 -36.79 81.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.763 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.1 26.73 47.6 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.64 -141.13 13.38 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.05 160.18 36.92 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.832 2.355 . . . . 0.0 111.79 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 46.1 mm -73.49 106.36 3.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.756 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.733 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.302 176.74 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.447 -0.606 0 CA-C-O 120.564 0.221 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.488 HG21 ' HA ' ' A' ' 219' ' ' THR . 79.2 mt -61.88 -38.47 80.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.9 mt -69.45 -25.37 64.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.709 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -72.71 -38.14 67.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.11 -38.39 82.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.193 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.592 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.9 t -62.04 -45.02 99.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.562 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.95 74.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.986 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -46.6 -51.11 16.4 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.016 0.926 . . . . 0.0 112.522 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.423 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -84.68 -15.97 43.44 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.903 -177.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.6 mt -78.85 -28.83 44.31 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -82.51 -17.11 46.25 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.916 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.38 -37.77 83.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.978 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 48.3 t -131.38 71.0 81.87 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.44 0.85 6.87 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.951 2.434 . . . . 0.0 112.846 -177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.35 -31.1 42.93 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -72.52 141.7 48.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.473 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.19 142.16 27.95 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 5.4 m -113.93 130.87 67.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 CA-C-O 121.277 0.56 . . . . 0.0 110.725 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.4 m -106.88 108.09 19.43 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.178 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 29.8 mt -92.95 113.75 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.27 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -98.63 122.53 41.96 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.018 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.445 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -105.28 151.75 17.2 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.368 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -125.14 167.43 14.82 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.376 0.608 . . . . 0.0 110.948 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 8.1 t -160.25 156.81 27.07 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.965 174.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 11.7 t70 . . . . . 0 C--N 1.318 -0.789 0 CA-C-O 120.912 0.387 . . . . 0.0 110.831 -177.501 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 34.3 mm . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.86 -43.21 76.9 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.007 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.425 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 26.1 mm -55.51 -64.43 2.19 Favored Pre-proline 0 CA--C 1.557 1.246 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.796 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.425 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 18.9 Cg_endo -62.74 -27.17 75.41 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.79 1.66 . . . . 0.0 112.647 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.6 tp -66.45 -53.54 34.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 110.87 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.445 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.0 p -60.81 -31.4 70.8 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.24 0.543 . . . . 0.0 110.157 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.56 -42.31 91.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.719 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -60.06 -43.71 95.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.093 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -58.78 -47.09 85.93 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.11 73.48 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.115 0.483 . . . . 0.0 110.729 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.449 ' HA ' HG22 ' A' ' 297' ' ' THR . 54.2 tptt -67.34 -31.5 71.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.051 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 53.4 mt -58.9 -40.35 80.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 0.0 109.895 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.686 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.7 t -68.76 -44.46 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.904 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.59 73.74 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.851 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.22 -42.31 81.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.533 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.63 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 0.8 OUTLIER -64.29 -47.4 79.64 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.446 178.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 34.8 mt -63.85 -49.5 72.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.055 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.02 -39.17 81.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.151 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.5 -26.09 68.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.192 0.52 . . . . 0.0 110.686 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.63 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.1 mmp_? -86.44 2.47 47.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.974 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.88 12.79 48.87 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.911 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 58.6 t -85.22 140.62 15.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.53 110.03 4.01 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.987 0.422 . . . . 0.0 111.365 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.98 -33.09 63.3 Favored Glycine 0 C--O 1.225 -0.451 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.89 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.23 -19.46 65.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.821 0.343 . . . . 0.0 111.622 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -102.06 1.76 36.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.051 0.453 . . . . 0.0 110.375 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.5 mt -105.62 127.02 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.122 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.97 125.51 50.55 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.39 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.449 HG22 ' HA ' ' A' ' 279' ' ' LYS . 40.8 p -105.49 121.85 44.78 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.8 t -125.63 115.9 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.156 0.503 . . . . 0.0 111.793 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.0 108.64 3.49 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 21.8 mt -91.15 0.37 57.55 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.77 0.319 . . . . 0.0 111.206 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.32 -126.12 30.34 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.022 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 15.4 m -103.32 116.45 32.47 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 304' ' ' ASN . 6.0 m -140.46 -64.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.354 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.439 ' H ' HG22 ' A' ' 303' ' ' VAL . 33.9 m-80 -117.96 90.67 37.59 Favored Pre-proline 0 N--CA 1.439 -0.997 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.62 176.77 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.577 2.185 . . . . 0.0 112.345 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -128.78 -49.03 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.694 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -110.45 176.79 4.91 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.633 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 18.5 m -65.77 131.63 46.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.525 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -79.22 -8.23 58.86 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.458 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -80.6 -11.2 59.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.55 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.6 t -119.44 138.88 26.98 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.337 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.46 -32.52 70.95 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.594 2.196 . . . . 0.0 111.656 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -67.43 -35.42 79.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.757 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.59 -38.11 85.82 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -66.08 -21.88 66.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.478 0.656 . . . . 0.0 109.787 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -78.73 -28.97 45.06 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.308 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -77.62 -42.93 33.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.157 0.503 . . . . 0.0 109.765 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -64.96 -8.87 17.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 18.7 ptp180 -98.93 11.66 38.21 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -69.03 -174.67 0.64 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 76.2 t -137.03 151.74 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.623 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.54 138.55 50.25 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 122.672 0.389 . . . . 0.0 110.64 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.74 122.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.834 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 95.1 t -113.18 137.41 46.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 211' ' ' LEU . 85.1 t -101.93 136.38 34.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 120.8 0.333 . . . . 0.0 110.713 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 C--N 1.313 -0.993 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.06 -178.685 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 121.154 0.502 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -82.67 77.48 9.43 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.992 -0.443 . . . . 0.0 110.007 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.424 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.2 mm? -68.06 -35.31 78.01 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.762 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.407 ' N ' HG22 ' A' ' 325' ' ' VAL . 63.7 tt0 -63.33 -42.7 98.97 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.558 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 31.0 t -75.38 -27.97 59.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.282 0.563 . . . . 0.0 109.508 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.404 ' HB3' ' HZ3' ' A' ' 246' ' ' LYS . . . -69.82 -46.72 65.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.627 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.453 ' CG2' HG13 ' A' ' 243' ' ' VAL . 23.4 pt -77.1 -41.43 31.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -61.34 -29.74 70.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.943 0.402 . . . . 0.0 110.876 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.37 -24.26 67.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.173 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.93 -45.46 13.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.033 0.444 . . . . 0.0 110.298 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.473 ' HA ' HG22 ' A' ' 239' ' ' ILE . 74.3 p -64.79 -38.2 90.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.013 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.79 20.54 53.52 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.197 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.67 -134.7 8.36 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.52 161.22 28.31 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.282 1.988 . . . . 0.0 112.337 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.86 108.9 13.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.635 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.955 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.507 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.668 0.27 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 219' ' ' THR . 82.4 mt -62.88 -37.79 80.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.045 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.457 ' CD2' HG11 ' A' ' 281' ' ' VAL . 47.3 mt -62.84 -34.75 77.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 110.644 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -73.8 -39.36 64.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.572 177.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.483 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -65.09 -44.87 87.43 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.762 179.551 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.588 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 29.9 t -57.82 -43.59 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.704 177.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.11 85.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.114 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -52.38 -49.91 63.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.483 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -77.98 -20.05 53.33 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.878 -178.319 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 35.1 mt -78.13 -32.33 50.32 Favored 'General case' 0 C--O 1.214 -0.779 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.599 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -74.95 -18.64 60.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.864 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.09 -34.49 75.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.326 0.584 . . . . 0.0 109.646 175.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 253' ' ' ALA . 53.4 t -128.67 71.8 80.97 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.056 174.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.62 0.14 6.75 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.681 2.254 . . . . 0.0 112.981 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -88.62 -25.34 22.49 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.411 ' HB3' ' SG ' ' A' ' 250' ' ' CYS . . . -57.67 138.13 55.73 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.78 130.29 45.97 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 12.3 m -122.03 134.61 64.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-O 121.39 0.614 . . . . 0.0 111.937 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.3 m -110.58 113.31 25.83 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.221 -0.899 . . . . 0.0 108.827 178.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.417 HG12 HG22 ' A' ' 323' ' ' ILE . 23.1 mt -92.68 113.83 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -101.98 126.25 48.85 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.363 -176.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -106.15 150.54 16.89 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.668 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -127.9 159.75 33.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.017 0.437 . . . . 0.0 110.436 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 70.1 p -141.02 169.83 16.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.331 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 C--N 1.32 -0.683 0 CA-C-O 120.682 0.277 . . . . 0.0 110.801 178.404 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 111.813 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -55.46 -34.96 64.99 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.703 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.505 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.6 mm -58.17 -67.12 1.01 Allowed Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.269 177.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.505 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.5 Cg_endo -57.98 -30.69 90.72 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 121.934 1.756 . . . . 0.0 111.78 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.75 -54.63 32.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.463 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 9.8 p -60.94 -32.7 72.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.793 0.33 . . . . 0.0 110.437 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.91 -31.64 71.56 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.079 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -69.68 -48.9 58.11 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -60.24 -41.96 94.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.21 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.91 -39.07 90.76 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.019 0.438 . . . . 0.0 110.525 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.484 ' HA ' HG21 ' A' ' 297' ' ' THR . 21.6 ttpt -66.18 -30.16 70.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.361 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 64.1 mt -55.96 -45.4 80.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 110.023 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.721 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.8 t -64.56 -46.99 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.728 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.69 -43.05 76.07 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.362 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.61 -41.66 86.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.359 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -71.12 -40.83 71.2 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.413 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.721 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 46.6 mt -64.59 -48.53 74.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.8 t -61.23 -39.66 83.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.466 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.29 -30.8 71.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.127 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -81.65 2.1 31.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.664 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.72 3.13 46.46 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.233 -0.984 . . . . 0.0 114.449 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.445 ' CG1' HD11 ' A' ' 295' ' ' ILE . 58.9 t -79.26 143.36 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 117.896 0.848 . . . . 0.0 109.782 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.02 110.06 4.28 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.032 0.444 . . . . 0.0 111.446 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.01 -18.47 64.66 Favored Glycine 0 CA--C 1.508 -0.389 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.339 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -72.14 -22.53 61.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.161 0.505 . . . . 0.0 110.425 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -104.5 5.43 34.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.035 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . 0.445 HD11 ' CG1' ' A' ' 290' ' ' VAL . 63.8 mt -109.42 128.79 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.32 128.43 55.05 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.1 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.484 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.1 p -115.05 120.66 40.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 120.915 0.388 . . . . 0.0 111.251 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.84 166.42 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.341 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -134.41 109.71 0.81 Allowed Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 14.8 mt -97.04 -1.24 45.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.595 0.236 . . . . 0.0 111.304 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.06 -123.76 26.82 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.319 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 3.8 t -106.28 120.1 40.98 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.6 m -141.74 -58.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.344 -177.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -116.86 92.32 38.2 Favored Pre-proline 0 N--CA 1.442 -0.846 0 CA-C-O 120.687 0.279 . . . . 0.0 110.259 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.421 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 24.1 Cg_exo -61.26 166.29 11.29 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.681 2.254 . . . . 0.0 112.478 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.5 tt -121.48 -45.35 2.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.874 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -128.11 168.78 14.89 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.305 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 35.5 t -62.58 135.33 57.34 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.685 0.615 . . . . 0.0 110.983 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.79 -9.35 59.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.386 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.39 66.96 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.777 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.9 t -114.16 140.18 24.64 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.84 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.28 -27.79 55.69 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.247 1.965 . . . . 0.0 111.105 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.8 mt-10 -62.77 -41.45 99.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.72 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.49 -38.06 86.19 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.477 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -63.6 -30.23 71.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.384 0.612 . . . . 0.0 109.929 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.22 -27.47 63.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.279 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 13.3 mmtp -80.14 -40.58 27.12 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.372 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.421 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 27.3 m-80 -58.13 -24.38 58.57 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -177.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 18.0 ptp180 -83.47 9.75 10.48 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.977 0.418 . . . . 0.0 112.017 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -57.16 176.28 0.12 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.949 0.881 . . . . 0.0 112.909 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.6 t -139.73 147.48 23.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.158 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.17 138.1 50.45 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 110.992 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.417 HG22 HG12 ' A' ' 257' ' ' ILE . 2.4 mp -96.1 116.03 36.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.496 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.94 136.79 42.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 212' ' ' GLN . 56.9 t -101.27 139.52 22.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 . . . . . 0 C--N 1.325 -0.483 0 O-C-N 123.926 0.766 . . . . 0.0 111.132 178.617 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.542 0 CA-C-O 120.983 0.42 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.72 83.75 4.85 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.463 ' O ' HG12 ' A' ' 215' ' ' ILE . 25.6 mt -79.36 -24.72 42.48 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.452 -178.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -60.97 -51.05 70.88 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.8 t -70.92 -36.4 72.66 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.818 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.449 ' HB2' ' HZ1' ' A' ' 246' ' ' LYS . . . -59.42 -44.53 92.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.798 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 211' ' ' LEU . 27.1 pt -75.89 -39.52 37.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.177 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -60.16 -34.44 73.57 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 110.688 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.97 -24.03 67.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.726 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.8 t -94.98 -45.19 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 120.899 0.38 . . . . 0.0 110.296 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.482 ' HA ' HG23 ' A' ' 239' ' ' ILE . 80.6 p -66.46 -39.66 88.95 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.127 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.1 30.29 55.46 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 119.02 -132.15 9.48 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . 0.496 ' HA ' ' HG2' ' A' ' 322' ' ' GLU . 63.7 Cg_endo -79.76 157.22 24.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.457 2.104 . . . . 0.0 113.322 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 38.6 mm -73.99 108.45 5.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.892 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.139 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.39 176.022 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 N--CA 1.445 -0.678 0 CA-C-O 120.48 0.181 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.482 HG23 ' HA ' ' A' ' 219' ' ' THR . 75.6 mt -64.38 -38.02 81.49 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 8.3 mp -64.62 -36.13 83.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.803 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -69.93 -39.0 76.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.864 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.439 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -66.14 -41.99 89.7 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.032 178.308 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.614 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.1 t -57.93 -42.83 83.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.364 177.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.75 86.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.262 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.15 -49.18 67.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.449 ' HZ1' ' HB2' ' A' ' 214' ' ' ALA . 0.0 OUTLIER -72.09 -29.75 64.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.315 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 26.2 mt -70.53 -27.93 64.54 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -63.63 -34.44 77.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.675 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.59 -39.53 73.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.432 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 38.4 t -127.17 68.48 72.49 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.21 0.21 7.66 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.385 2.723 . . . . 0.0 113.976 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -91.04 -18.24 24.92 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.673 0.749 . . . . 0.0 109.36 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -63.33 150.86 42.34 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.357 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -104.22 133.97 48.24 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.164 0.507 . . . . 0.0 110.434 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 325' ' ' VAL . 12.5 m -117.84 136.49 54.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.174 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.3 m -112.54 109.8 19.58 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.332 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.421 HG12 HG22 ' A' ' 323' ' ' ILE . 21.8 mt -92.24 115.0 30.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -103.12 129.54 50.01 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.691 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.402 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -108.04 151.64 16.98 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.364 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -126.71 163.47 23.43 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.082 0.468 . . . . 0.0 110.977 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 71.9 p -142.88 163.7 32.08 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.971 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.637 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.487 HD13 ' N ' ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.75 0.786 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -34.95 67.02 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.431 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.475 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.1 mm -60.99 -65.07 2.4 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.093 177.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.475 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.2 Cg_endo -58.3 -30.02 89.71 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 121.91 1.74 . . . . 0.0 111.974 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 59.6 tp -64.29 -54.94 25.26 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.24 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.402 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 5.2 p -63.4 -26.79 68.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.749 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.47 -28.4 64.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.852 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -76.18 -42.09 47.51 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 277' ' ' ARG . 10.6 mmt180 -59.25 -46.42 88.56 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.142 177.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.33 74.88 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.98 0.419 . . . . 0.0 110.454 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.475 ' HA ' HG22 ' A' ' 297' ' ' THR . 23.8 tptm -63.53 -32.44 73.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.098 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 54.6 mt -58.87 -43.17 87.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.017 0.437 . . . . 0.0 110.077 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.688 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.8 t -66.86 -46.58 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.946 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.35 -41.45 76.12 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.889 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.13 -43.74 78.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.964 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . 0.541 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 8.5 m-85 -70.77 -41.61 71.5 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.483 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 42.7 mt -63.76 -49.15 74.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 68.8 t -59.74 -42.2 87.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.284 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.55 -28.48 69.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.944 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.9 mmp_? -84.42 4.11 33.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.751 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.13 6.83 41.88 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 119.859 -1.162 . . . . 0.0 114.375 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 53.0 t -86.18 143.76 10.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 117.717 0.759 . . . . 0.0 109.725 177.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.47 114.42 10.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.898 0.38 . . . . 0.0 111.514 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.72 -32.79 70.4 Favored Glycine 0 C--O 1.23 -0.143 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.998 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.45 -21.44 66.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.087 0.47 . . . . 0.0 111.66 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -100.48 1.27 40.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.914 0.387 . . . . 0.0 110.57 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.35 129.12 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.854 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.54 127.69 53.86 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.202 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 279' ' ' LYS . 10.7 p -110.62 120.4 42.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.726 0.298 . . . . 0.0 111.002 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.16 130.52 60.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.945 0.402 . . . . 0.0 111.331 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -97.51 117.5 5.81 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.341 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 27.1 mt -91.3 -3.53 56.76 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.39 0.138 . . . . 0.0 111.176 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.63 -138.71 48.24 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.351 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 2.1 m -89.25 115.91 27.09 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 4.6 p -143.79 -61.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.611 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -116.04 93.95 40.12 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.422 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 7.8 Cg_exo -67.74 167.14 21.99 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.544 2.163 . . . . 0.0 112.782 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.5 tt -125.07 -49.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.279 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -124.66 170.8 10.6 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.393 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.3 p -71.11 139.61 50.36 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 123.547 0.53 . . . . 0.0 111.874 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -81.46 -11.07 59.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.418 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -61.63 -26.63 68.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.103 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 4.4 t -113.65 139.42 23.37 Favored Pre-proline 0 N--CA 1.436 -1.164 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.693 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.14 -32.42 91.15 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.905 2.404 . . . . 0.0 111.84 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 35.5 mm-40 -63.8 -40.99 97.96 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.262 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.53 -37.87 92.95 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.379 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.4 -39.73 84.35 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.04 -29.94 70.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.686 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 10.9 mmpt? -77.6 -44.62 27.74 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.297 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 43.8 m-80 -60.88 -29.87 69.81 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.414 ' H ' ' HG2' ' A' ' 319' ' ' ARG . 3.5 ptm180 -83.41 11.71 6.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.2 ptt-85 -57.43 178.87 0.06 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.254 1.022 . . . . 0.0 112.898 174.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 94.1 t -137.74 147.68 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.583 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 222' ' ' PRO . 48.5 mt-10 -132.66 137.81 47.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.397 . . . . 0.0 111.415 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.421 HG22 HG12 ' A' ' 257' ' ' ILE . 2.8 mp -98.98 121.25 49.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.041 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.83 138.73 39.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.4 HG23 HG12 ' A' ' 255' ' ' VAL . 52.8 t -104.21 143.28 16.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 C--N 1.32 -0.706 0 O-C-N 123.519 0.512 . . . . 0.0 110.349 177.461 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.07 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -133.98 116.95 16.15 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -53.06 132.39 50.19 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.5 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.1 128.66 31.51 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.897 2.398 . . . . 0.0 112.04 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.43 53.59 2.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.053 2.502 . . . . 0.0 112.442 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -117.62 81.02 0.31 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.405 ' CB ' ' HB2' ' A' ' 205' ' ' SER . 7.7 Cg_endo -90.5 109.39 0.36 Allowed 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 123.394 2.729 . . . . 0.0 111.913 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.92 -59.8 0.57 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.071 2.514 . . . . 0.0 112.598 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -118.54 16.39 13.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.118 0.485 . . . . 0.0 110.741 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.405 ' HB2' ' CB ' ' A' ' 202' ' ' PRO . 75.0 m -107.22 146.86 30.88 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.462 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 118.34 -77.92 0.3 Allowed Glycine 0 C--N 1.312 -0.77 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.59 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.58 115.64 2.81 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.425 2.083 . . . . 0.0 110.877 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 35.1 t -146.62 -176.89 5.36 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.735 -176.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -47.43 153.44 0.52 Allowed 'General case' 0 C--O 1.238 0.45 0 O-C-N 123.84 0.713 . . . . 0.0 110.505 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.88 81.31 2.79 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.093 0.473 . . . . 0.0 110.758 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.447 ' O ' HG12 ' A' ' 215' ' ' ILE . 32.5 mt -72.87 -26.67 61.53 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.509 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 59.9 tp60 -59.47 -56.29 23.8 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.542 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 4.2 p -66.38 -31.3 71.99 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 120.882 0.372 . . . . 0.0 110.293 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.16 -54.14 42.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.449 ' CG2' HG12 ' A' ' 243' ' ' VAL . 19.8 pt -69.04 -38.13 77.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.844 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.49 -34.44 69.05 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.598 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.29 -29.74 70.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.379 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.6 t -89.01 -45.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.895 0.379 . . . . 0.0 110.741 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.492 ' HA ' HG23 ' A' ' 239' ' ' ILE . 76.6 p -67.15 -35.42 79.67 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.251 0.548 . . . . 0.0 110.743 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.49 24.78 60.12 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 125.84 -134.66 8.8 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.2 164.98 14.92 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.449 2.099 . . . . 0.0 112.77 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.9 mm -82.61 109.21 16.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.976 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.33 125.65 34.79 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.034 0.445 . . . . 0.0 111.103 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -99.04 164.8 12.03 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.66 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -152.72 33.02 0.82 Allowed Glycine 0 C--N 1.306 -1.117 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -156.98 128.59 7.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.043 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -140.17 126.44 19.95 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 113.28 -24.85 11.92 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.376 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -130.22 -177.21 4.22 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.3 m -100.97 164.15 11.95 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.224 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.98 118.62 10.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.095 0.474 . . . . 0.0 110.934 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 26.9 pt -77.69 161.57 71.28 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.284 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.14 157.97 1.61 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.961 2.441 . . . . 0.0 112.559 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 68.47 35.18 3.38 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.769 0.795 . . . . 0.0 108.923 -174.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -100.09 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.935 -177.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -135.88 113.49 10.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.836 0.351 . . . . 0.0 111.023 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.75 -19.13 65.69 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.073 0.463 . . . . 0.0 110.194 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.492 HG23 ' HA ' ' A' ' 219' ' ' THR . 87.7 mt -62.0 -41.07 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.129 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.12 -32.07 73.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.067 0.461 . . . . 0.0 110.427 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.29 -37.27 69.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -45.78 69.76 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.328 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.559 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 42.5 t -56.78 -44.43 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.969 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -58.86 -34.32 71.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.434 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.2 -45.83 75.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -14.69 53.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.98 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.4 mt -79.29 -26.55 42.29 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -82.54 -21.83 35.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.386 176.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.06 -37.69 84.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.056 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 48.0 t -130.23 74.4 80.42 Favored Pre-proline 0 N--CA 1.434 -1.242 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.834 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -74.16 1.3 7.39 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.1 2.533 . . . . 0.0 112.283 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -74.96 -29.15 60.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.93 0.872 . . . . 0.0 108.773 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -73.63 164.47 26.6 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.058 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.75 137.23 54.61 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.675 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.2 m -120.37 134.61 63.29 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 121.198 0.523 . . . . 0.0 111.562 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 49.9 m -111.43 113.24 25.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.515 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 21.8 mt -91.87 111.58 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -98.87 125.54 44.3 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.532 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.419 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -106.58 144.16 15.83 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.389 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.58 165.04 17.83 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.961 0.41 . . . . 0.0 110.56 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 68.5 p -143.98 172.48 12.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.761 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' A' ' 264' ' ' THR . 2.3 p30 -79.93 155.2 27.82 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 175.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 263' ' ' ASN . 6.0 p-10 -90.07 0.95 56.86 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.518 HG22 ' OD1' ' A' ' 262' ' ' ASP . 9.3 t -79.53 -15.46 57.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.119 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.78 178.82 53.59 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.111 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 36.3 t -76.33 120.28 21.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.741 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 33.8 tt0 -62.66 138.68 58.56 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.338 0.59 . . . . 0.0 111.064 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 113.0 -40.54 2.49 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp -80.88 -27.77 11.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 122.005 0.907 . . . . 0.0 109.076 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.741 ' OD1' ' HA ' ' A' ' 267' ' ' GLU . 1.0 OUTLIER -59.67 -33.6 71.77 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.873 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.515 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 32.8 mm -60.02 -65.53 2.04 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.043 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.515 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 8.3 Cg_endo -57.21 -32.67 94.23 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.211 1.94 . . . . 0.0 112.106 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.16 -55.13 20.41 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.718 0.294 . . . . 0.0 111.617 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.419 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 8.3 p -64.34 -27.87 69.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.788 0.328 . . . . 0.0 111.128 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.94 -27.55 64.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -73.89 -44.44 55.26 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -57.62 -46.49 84.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.568 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.58 91.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.287 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.469 ' HA ' HG23 ' A' ' 297' ' ' THR . 2.2 tmtp? -60.49 -35.8 76.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.333 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 56.6 mt -55.41 -45.09 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.855 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.706 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 9.1 t -67.42 -45.7 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.978 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.24 -44.26 79.46 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.43 -38.89 78.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.558 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.568 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 5.5 m-85 -69.51 -41.82 75.54 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.935 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 44.6 mt -64.11 -49.89 70.41 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.496 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 97.2 t -60.55 -38.9 79.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.533 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.93 -25.98 68.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.721 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.8 mmp_? -89.11 4.01 49.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.902 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.9 10.93 41.63 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.956 -1.116 . . . . 0.0 114.284 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.3 t -85.58 141.88 13.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.908 0.854 . . . . 0.0 109.752 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.1 108.1 2.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.995 0.426 . . . . 0.0 111.473 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.84 -33.36 68.04 Favored Glycine 0 C--O 1.228 -0.264 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.321 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.28 -15.08 63.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.173 0.511 . . . . 0.0 111.58 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -104.62 2.04 30.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.976 0.417 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . 0.424 HD13 ' CG1' ' A' ' 290' ' ' VAL . 55.5 mt -107.69 129.8 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -116.69 125.28 51.49 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.469 HG23 ' HA ' ' A' ' 279' ' ' LYS . 24.7 p -111.43 122.55 48.14 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.665 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.24 161.14 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-O 121.167 0.508 . . . . 0.0 111.158 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -126.49 111.61 1.44 Allowed Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 18.4 mt -97.38 -8.5 29.37 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.435 ' HA3' HD21 ' A' ' 270' ' ' ASN . . . 63.24 -130.92 41.76 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 119.806 -1.188 . . . . 0.0 111.579 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 55.9 p -91.91 114.33 26.84 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.035 0.445 . . . . 0.0 109.902 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.98 -67.72 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.4 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -108.09 91.34 7.79 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.221 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.601 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 7.6 Cg_exo -70.47 127.11 13.59 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.558 2.172 . . . . 0.0 111.891 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.7 tt -85.32 -42.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.774 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -131.08 170.36 14.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.128 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 27.7 m -69.62 136.16 50.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.86 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -76.62 -7.31 54.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.554 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -59.32 -29.77 67.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.942 0.401 . . . . 0.0 110.654 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.6 t -114.25 141.0 25.73 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.475 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.42 -31.45 94.83 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.723 2.282 . . . . 0.0 111.651 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -55.37 -50.75 68.89 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.953 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -63.01 -36.96 94.18 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.833 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -62.68 -35.56 80.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.846 0.355 . . . . 0.0 110.197 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.7 70.54 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.443 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -77.51 -41.31 39.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.947 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.601 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 42.0 m-20 -63.57 -24.4 67.79 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 12.0 ptm180 -83.68 6.44 20.96 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -58.18 170.86 0.62 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.153 0.978 . . . . 0.0 113.372 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 71.4 t -131.8 144.58 36.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.191 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -130.92 138.19 49.65 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.099 0.476 . . . . 0.0 111.186 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.4 mp -96.27 116.39 38.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.461 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.402 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 98.5 t -109.66 138.16 38.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.533 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 59.3 t -98.74 132.93 43.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.681 -179.33 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.246 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -102.1 -5.02 24.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.388 0.137 . . . . 0.0 110.942 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 62.24 88.89 0.11 Allowed Pre-proline 0 N--CA 1.466 0.362 0 O-C-N 123.719 0.637 . . . . 0.0 111.644 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.72 141.95 31.48 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.737 2.291 . . . . 0.0 111.662 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.88 127.79 20.38 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 122.505 2.137 . . . . 0.0 112.078 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -143.2 61.41 0.52 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.767 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -86.44 143.59 7.56 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.909 2.406 . . . . 0.0 111.563 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.58 -29.32 89.59 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.623 2.215 . . . . 0.0 112.56 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -103.43 21.33 16.19 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.709 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 21.2 t 63.16 -179.32 0.15 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.593 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -91.85 -161.31 36.8 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.592 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.35 -32.17 51.11 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.214 1.943 . . . . 0.0 111.398 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 13.5 t -154.34 -178.78 7.37 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.903 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -56.11 153.19 9.43 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 122.811 0.445 . . . . 0.0 111.817 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -78.68 66.3 4.15 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.379 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.457 ' O ' HG12 ' A' ' 215' ' ' ILE . 22.1 mt -53.55 -27.09 24.12 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -60.18 -51.83 67.9 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 121.018 0.437 . . . . 0.0 110.205 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.7 t -72.45 -28.25 62.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.415 0.626 . . . . 0.0 109.687 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -67.16 -51.39 54.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.134 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 211' ' ' LEU . 26.1 pt -70.78 -38.5 73.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.485 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.79 -30.01 68.6 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.003 0.43 . . . . 0.0 110.767 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.17 -26.09 65.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.088 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.03 -46.28 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.993 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.509 ' HA ' HG22 ' A' ' 239' ' ' ILE . 40.1 p -67.13 -35.96 80.85 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.147 0.499 . . . . 0.0 110.855 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.96 18.97 68.5 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 129.27 -138.02 9.97 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.886 -0.657 . . . . 0.0 111.52 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.605 ' HB2' ' NE ' ' A' ' 320' ' ' ARG . 1.4 Cg_endo -82.8 160.49 16.25 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.051 2.5 . . . . 0.0 112.498 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.557 ' O ' ' HB2' ' A' ' 320' ' ' ARG . 47.2 mm -81.1 115.88 24.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.201 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.01 155.47 19.47 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 174.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -113.08 140.73 47.62 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.987 0.422 . . . . 0.0 111.29 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.39 25.63 27.57 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -160.12 158.58 30.53 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -68.97 -22.28 64.12 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.247 0.546 . . . . 0.0 110.894 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 119.95 45.14 0.43 Allowed Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.695 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -119.31 -74.69 0.6 Allowed 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 9.4 p -94.61 -66.82 0.89 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.328 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 57.5 tp 67.57 98.01 0.06 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.199 0.6 . . . . 0.0 110.903 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.8 pt -88.61 149.65 44.6 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.804 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.06 128.41 21.71 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.479 2.119 . . . . 0.0 111.138 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -142.28 -85.01 0.17 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.864 0.364 . . . . 0.0 111.095 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -100.56 18.25 19.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.311 0.577 . . . . 0.0 110.373 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -84.02 15.33 3.48 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.059 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.49 -19.18 64.52 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.509 HG22 ' HA ' ' A' ' 219' ' ' THR . 96.9 mt -59.01 -36.82 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.902 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.32 -30.48 70.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.431 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -70.59 -40.8 73.04 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -47.04 79.22 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.645 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.59 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 39.0 t -58.12 -44.06 86.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.042 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.74 -34.61 73.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.361 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.31 -44.67 80.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.011 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -15.01 55.09 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.798 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.7 mt -79.83 -28.09 40.16 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -81.47 -18.22 45.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.216 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.5 -38.08 80.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.723 176.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 29.1 t -135.18 72.87 65.91 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.568 176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.69 2.25 5.48 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.948 2.432 . . . . 0.0 113.165 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.13 -29.84 54.89 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.811 0.815 . . . . 0.0 109.285 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -77.57 135.86 38.21 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.526 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.86 142.26 27.96 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.5 m -114.83 131.38 67.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.134 0.493 . . . . 0.0 111.213 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.2 m -107.86 110.16 21.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.323 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.0 mt -93.07 109.43 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -98.13 128.47 44.65 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.537 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -110.47 145.9 17.32 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.496 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 28.5 m-85 -127.27 162.17 26.85 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.82 0.343 . . . . 0.0 110.309 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 59.2 p -138.75 173.68 11.32 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.618 177.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.14 147.34 34.62 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -79.2 3.15 18.63 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.39 -18.69 32.97 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.304 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -73.47 168.1 54.04 Favored Glycine 0 C--O 1.24 0.49 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.492 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 45.8 m -69.08 127.32 32.71 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 120.849 0.357 . . . . 0.0 111.365 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -59.83 115.86 3.69 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.579 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 119.85 -35.49 3.8 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.031 -1.081 . . . . 0.0 111.984 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 43.6 mm -83.67 -28.11 7.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.828 0.823 . . . . 0.0 108.811 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -63.37 -34.92 78.77 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.197 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.458 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 29.7 mm -56.44 -65.68 1.51 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.764 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.458 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 21.0 Cg_endo -61.83 -28.19 81.26 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 121.95 1.767 . . . . 0.0 111.964 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.3 -55.75 16.54 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.738 0.304 . . . . 0.0 111.168 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 6.2 p -62.3 -31.08 71.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.706 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.63 -28.22 65.73 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.305 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.39 -40.87 49.74 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -61.67 -41.82 98.07 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.498 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.27 -32.99 74.93 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.059 0.457 . . . . 0.0 110.214 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.415 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.9 tmtt? -64.72 -36.06 83.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.387 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 53.0 mt -57.15 -42.42 79.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.034 0.445 . . . . 0.0 110.228 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.682 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 7.2 t -68.72 -47.15 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.057 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.77 -43.38 80.77 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.95 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -57.25 -42.11 80.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 1.5 m-85 -65.1 -52.05 57.71 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.511 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 33.8 mt -55.23 -50.72 68.72 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.591 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 77.6 t -60.71 -40.38 84.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.621 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.18 -23.54 67.48 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.232 0.539 . . . . 0.0 110.733 178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.545 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 4.5 mmp_? -88.93 5.03 45.95 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.228 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 98.06 12.67 45.36 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 119.93 -1.128 . . . . 0.0 114.109 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 48.5 t -88.61 145.95 6.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 117.604 0.702 . . . . 0.0 109.48 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -71.34 111.57 6.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.47 -34.84 77.07 Favored Glycine 0 N--CA 1.46 0.235 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.264 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.38 -18.41 65.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.242 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -101.64 -0.03 35.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.162 0.506 . . . . 0.0 110.364 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 66.5 mt -106.38 132.57 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.87 126.41 51.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.691 0.281 . . . . 0.0 110.726 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.415 HG21 ' HA ' ' A' ' 279' ' ' LYS . 53.0 p -104.98 121.14 43.14 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.14 113.18 35.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.256 0.551 . . . . 0.0 112.241 -175.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.9 103.72 3.04 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 24.5 mt -87.69 -0.24 56.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.47 -138.73 36.4 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.662 -176.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 7.8 p -84.27 114.3 21.74 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 120.728 0.299 . . . . 0.0 110.285 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.0 p -174.9 148.45 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 55.6 t30 64.08 75.03 0.4 Allowed Pre-proline 0 C--N 1.31 -1.128 0 O-C-N 123.712 0.633 . . . . 0.0 110.862 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.632 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 5.2 Cg_endo -80.87 133.61 9.17 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 122.305 2.003 . . . . 0.0 112.6 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.8 tt -94.37 -48.36 13.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.205 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -123.92 176.78 6.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.725 0.298 . . . . 0.0 111.025 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.428 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 47.8 m -66.39 128.08 34.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.43 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -80.54 -12.25 59.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.648 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.86 -18.32 63.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.956 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 5.2 t -116.39 144.23 32.69 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.858 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.49 -37.36 71.35 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.627 2.218 . . . . 0.0 111.894 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 1.8 mt-10 -58.96 -41.19 86.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.278 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -69.82 -40.3 75.35 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.859 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -60.24 -36.38 77.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.887 0.375 . . . . 0.0 110.253 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.8 -30.01 71.15 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.645 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 11.8 mmtp -80.64 -44.4 18.91 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.632 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 44.6 m-80 -61.66 -28.09 69.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 10.7 ptm85 -84.91 11.47 9.3 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.605 ' NE ' ' HB2' ' A' ' 222' ' ' PRO . 9.2 ptm180 -73.57 -178.0 2.91 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 99.6 t -135.18 151.76 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.866 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -131.72 142.05 49.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.843 0.354 . . . . 0.0 110.971 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.45 116.02 41.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.39 141.96 24.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.46 135.41 36.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 57.7 t30 . . . . . 0 C--N 1.313 -0.995 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.406 -179.811 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.198 0 N-CA-C 111.726 -0.549 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.85 20.11 15.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.829 0.347 . . . . 0.0 110.438 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 71.29 83.85 0.14 Allowed Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.378 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -84.12 146.59 11.4 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.715 2.277 . . . . 0.0 112.076 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.99 176.1 8.59 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.632 2.222 . . . . 0.0 111.249 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.05 -70.24 1.23 Allowed Glycine 0 C--N 1.314 -0.672 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.307 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.66 168.48 21.31 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.742 2.294 . . . . 0.0 111.547 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -63.51 106.02 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.414 2.076 . . . . 0.0 111.335 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -106.42 -5.35 19.01 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.719 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 70.1 m -153.06 152.85 31.8 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.266 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -105.44 -106.06 3.09 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.487 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.03 32.91 0.52 Allowed 'Trans proline' 0 N--CA 1.476 0.475 0 C-N-CA 123.234 2.622 . . . . 0.0 112.299 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 37.1 t -151.86 165.49 34.36 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.764 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -57.55 167.95 0.94 Allowed 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.775 0.43 . . . . 0.0 110.86 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.62 71.94 3.25 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.027 0.441 . . . . 0.0 110.035 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 246' ' ' LYS . 29.9 mt -70.22 -31.09 68.36 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.603 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -65.39 -41.61 93.53 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.53 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.5 t -71.73 -37.11 70.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.401 ' HB3' ' HZ1' ' A' ' 246' ' ' LYS . . . -63.91 -51.02 66.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.206 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.463 ' CG2' HG11 ' A' ' 243' ' ' VAL . 26.6 pt -67.63 -38.09 79.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.685 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.46 -36.25 73.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.115 0.484 . . . . 0.0 110.496 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.28 -26.02 68.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.574 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.7 t -91.87 -47.81 13.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.552 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.466 ' HA ' HG22 ' A' ' 239' ' ' ILE . 72.7 p -64.76 -39.75 94.14 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.878 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.12 15.22 79.23 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 140.99 -139.22 9.43 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.87 166.43 13.2 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.601 2.201 . . . . 0.0 112.559 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.0 mm -81.3 109.58 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.538 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -99.49 124.57 44.77 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.934 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -94.03 174.44 7.16 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.268 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -64.87 167.91 29.39 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.078 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -62.53 -29.48 70.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.701 0.286 . . . . 0.0 111.514 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -140.71 141.55 34.94 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -81.2 40.35 2.54 Favored Glycine 0 C--N 1.317 -0.474 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.682 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -54.22 -57.04 12.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.897 0.379 . . . . 0.0 111.276 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 11.0 p -162.06 113.56 1.66 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.051 0.453 . . . . 0.0 111.289 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 18.2 tp -95.04 18.65 11.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.641 0.734 . . . . 0.0 109.098 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.591 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 62.6 mt -61.75 -48.68 88.95 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.217 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 233' ' ' ILE . 5.5 Cg_endo -48.02 127.39 14.79 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.529 2.153 . . . . 0.0 112.125 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -80.25 87.57 5.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.214 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -122.08 -27.05 4.63 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.723 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -77.06 57.51 1.38 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.176 0.513 . . . . 0.0 111.587 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.94 -18.93 65.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.497 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.466 HG22 ' HA ' ' A' ' 219' ' ' THR . 75.3 mt -59.97 -38.41 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.638 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 62.8 mt -67.85 -28.32 67.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.709 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -74.99 -36.8 61.98 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.45 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -65.9 -43.13 89.14 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.899 176.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.579 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 40.1 t -61.65 -46.18 97.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.818 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.53 -37.07 69.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.305 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -49.8 -50.49 44.74 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -83.14 -14.42 53.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.382 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 33.9 mt -81.37 -29.49 34.0 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -82.32 -22.27 35.69 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.506 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -71.75 -32.09 67.34 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.06 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 42.2 t -132.65 70.78 79.19 Favored Pre-proline 0 N--CA 1.434 -1.24 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.439 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.09 2.5 6.03 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.165 2.577 . . . . 0.0 113.194 -177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -75.26 -25.26 57.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.866 0.841 . . . . 0.0 109.597 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -77.51 169.82 17.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.603 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.44 144.9 48.76 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.67 125.47 74.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.296 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 41.9 m -103.1 108.6 19.85 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.92 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 21.2 mt -96.36 108.79 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.84 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.61 128.4 45.71 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.856 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -106.9 148.1 16.34 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.565 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 318' ' ' ASN . 24.7 m-85 -124.4 162.82 23.06 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.854 0.359 . . . . 0.0 110.39 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 270' ' ' ASN . 72.2 p -144.69 172.2 13.33 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.15 170.95 13.28 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -94.52 17.23 13.54 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 70.8 p -65.14 -27.45 68.74 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.925 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.14 73.55 0.35 Allowed Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.684 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 45.2 m -86.63 24.1 1.51 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.777 0.323 . . . . 0.0 111.184 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -95.25 3.98 53.99 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.694 -0.403 . . . . 0.0 111.81 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 272' ' ' PRO . . . 122.91 -39.72 2.18 Favored Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 119.532 -1.318 . . . . 0.0 114.289 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.436 HD11 ' N ' ' A' ' 269' ' ' ILE . 1.8 mp -56.39 -23.88 17.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 122.844 0.458 . . . . 0.0 112.178 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.489 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 8.4 p30 -57.92 -38.44 75.89 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.771 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.433 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 23.0 mm -59.55 -64.53 2.89 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.754 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 268' ' ' GLY . 11.6 Cg_endo -59.98 -26.57 82.76 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 121.905 1.736 . . . . 0.0 112.073 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 59.0 tp -68.68 -54.22 17.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 111.227 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.8 p -63.71 -31.53 72.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.515 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.36 67.71 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.959 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -70.56 -47.31 60.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.579 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -61.36 -40.04 92.85 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.393 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.95 92.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.176 0.512 . . . . 0.0 109.816 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.405 ' HA ' HG23 ' A' ' 297' ' ' THR . 54.5 tptt -61.49 -35.46 77.75 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.939 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 59.8 mt -57.49 -44.31 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.017 0.437 . . . . 0.0 110.369 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.5 t -68.4 -46.28 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.746 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.6 -45.21 73.6 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -61.15 -37.79 84.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.937 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.504 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 2.0 m-85 -66.63 -44.05 83.04 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.074 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 39.1 mt -64.87 -51.16 63.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.795 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 84.4 t -60.23 -38.77 78.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.298 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.68 -31.13 71.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.288 0.566 . . . . 0.0 110.287 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 19.9 mmm180 -84.86 4.95 30.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.489 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.61 46.86 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.352 -0.928 . . . . 0.0 114.094 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 66.7 t -84.77 140.73 15.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 117.752 0.776 . . . . 0.0 109.026 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.72 108.11 2.81 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.639 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.38 -30.07 67.34 Favored Glycine 0 CA--C 1.509 -0.302 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.968 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.85 -21.18 64.45 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.537 0.335 . . . . 0.0 111.748 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -106.9 5.58 28.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 68.6 mt -106.23 128.45 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.42 127.59 53.81 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.25 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 279' ' ' LYS . 31.7 p -111.99 124.87 53.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.689 0.28 . . . . 0.0 110.683 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.79 121.25 52.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.093 0.473 . . . . 0.0 111.822 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -90.77 112.13 4.05 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 26.1 mt -90.45 -32.07 16.54 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 88.75 -140.13 15.76 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 47.2 t -88.62 114.27 25.07 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.94 -61.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.852 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -115.33 92.08 30.83 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.717 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 8.3 Cg_exo -67.98 127.82 16.69 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.803 2.336 . . . . 0.0 112.81 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.8 tt -85.74 -44.28 16.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.614 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -127.4 167.03 16.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.469 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 53.8 p -63.34 133.0 53.38 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.506 0.504 . . . . 0.0 111.104 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -80.84 -8.43 59.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.949 0.404 . . . . 0.0 110.651 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -62.69 -23.62 67.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.687 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.5 t -117.11 140.77 27.5 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -55.99 -35.78 94.99 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.82 2.347 . . . . 0.0 111.332 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -57.65 -47.01 83.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.853 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -63.43 -38.47 96.43 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.844 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -60.57 -37.19 80.49 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.16 -30.81 71.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.699 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -76.16 -41.96 48.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.08 0.467 . . . . 0.0 109.927 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.717 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 43.7 m-80 -61.75 -28.29 69.33 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 11.8 ptp180 -81.4 9.38 7.36 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -57.5 177.6 0.1 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.07 0.938 . . . . 0.0 113.341 174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 74.8 t -136.07 144.96 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.577 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -127.74 140.77 51.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.729 0.299 . . . . 0.0 111.057 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.93 117.17 49.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.17 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.62 132.66 53.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.074 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.68 130.48 40.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.316 0.579 . . . . 0.0 111.234 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 C--N 1.309 -1.17 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.314 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.206 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -92.87 -11.77 32.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.967 0.413 . . . . 0.0 110.921 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.19 137.16 89.18 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.391 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -53.41 132.16 47.12 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.724 2.282 . . . . 0.0 111.212 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.5 103.31 1.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.508 2.138 . . . . 0.0 112.473 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -122.16 -121.84 2.77 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.192 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.54 153.47 65.33 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.617 2.212 . . . . 0.0 112.021 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.74 139.2 73.65 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.487 2.125 . . . . 0.0 111.525 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.45 -35.84 68.37 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.116 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.0 t 54.45 -154.27 0.27 Allowed 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.336 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 98.16 -176.72 30.71 Favored Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.48 110.33 2.47 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.171 1.914 . . . . 0.0 111.09 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.8 t -104.07 141.04 36.91 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.39 162.46 10.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.563 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.34 85.73 2.5 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.488 ' O ' HG12 ' A' ' 215' ' ' ILE . 23.4 mt -75.22 -34.57 61.47 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.447 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -62.62 -44.95 95.01 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 120.922 0.391 . . . . 0.0 110.061 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 36.2 t -65.49 -43.05 91.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.163 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.523 ' O ' HG21 ' A' ' 218' ' ' VAL . . . -64.44 -47.03 80.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.927 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 211' ' ' LEU . 17.7 pt -69.37 -38.04 76.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.467 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -60.25 -37.81 81.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.099 0.476 . . . . 0.0 110.023 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.82 -27.66 67.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.039 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 214' ' ' ALA . 43.1 t -83.01 -47.78 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 CA-C-O 121.069 0.461 . . . . 0.0 110.056 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.478 ' HA ' HG22 ' A' ' 239' ' ' ILE . 37.9 p -66.13 -35.25 79.98 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.017 -178.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.83 28.05 57.54 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 121.8 -132.24 8.86 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 114.54 -0.83 . . . . 0.0 111.192 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -89.34 169.25 5.0 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.734 2.289 . . . . 0.0 113.308 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.8 mm -85.67 105.18 14.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.196 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -91.57 134.82 34.34 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.906 0.384 . . . . 0.0 111.371 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -105.53 169.96 8.16 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.924 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -110.18 133.1 11.38 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.083 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -94.71 -5.24 45.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.739 0.27 . . . . 0.0 110.862 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -54.6 -63.03 1.28 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.009 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -115.05 7.87 21.36 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 65.82 171.65 0.23 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.607 0.763 . . . . 0.0 111.583 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.7 t 58.23 -155.62 0.34 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.314 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 36.3 tp -92.96 110.79 22.26 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.37 -56.57 25.97 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.751 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.95 158.28 52.33 Favored 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 121.714 1.609 . . . . 0.0 111.146 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -70.33 -29.81 66.61 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.829 0.347 . . . . 0.0 111.247 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -151.34 177.52 10.18 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -133.63 105.0 6.62 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.448 ' HA ' ' OD1' ' A' ' 241' ' ' ASN . 32.1 mt-10 -52.35 -38.61 59.18 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.169 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 219' ' ' THR . 82.8 mt -61.86 -37.62 78.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.694 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.1 mt -71.97 -21.63 61.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 238' ' ' GLU . 3.7 m120 -76.84 -41.74 43.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -42.82 84.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.954 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.613 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.4 t -58.35 -40.92 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.486 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.48 -36.83 76.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.317 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -48.54 -52.35 23.09 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.657 0.783 . . . . 0.0 112.813 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.432 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -81.01 -17.75 49.24 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.668 -176.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 36.2 mt -79.14 -30.81 43.81 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.241 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -82.63 -18.78 39.92 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.563 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.57 85.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.438 0.637 . . . . 0.0 110.01 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 49.9 t -128.98 69.06 80.62 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.08 -1.29 9.82 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.416 2.744 . . . . 0.0 114.715 -173.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.45 -23.76 29.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.558 0.694 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.98 141.01 58.34 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.4 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -96.31 136.55 36.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 5.9 m -113.53 137.24 47.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 121.191 0.52 . . . . 0.0 111.685 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.7 m -113.43 109.0 17.97 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.187 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.7 mt -91.92 112.47 25.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -99.41 130.98 45.72 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.843 -176.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.528 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -107.3 145.43 16.05 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.552 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 9.2 m-85 -123.26 171.73 9.16 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.644 ' O ' ' HA ' ' A' ' 302' ' ' SER . 10.0 t -175.3 174.18 2.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.798 0.332 . . . . 0.0 110.765 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -86.31 166.97 15.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.199 0.523 . . . . 0.0 111.358 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -115.9 6.56 14.26 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.619 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 55.3 p -70.55 -11.39 60.9 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.06 -74.75 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.211 -1.471 . . . . 0.0 114.08 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 50.6 m -80.92 100.14 8.74 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -175.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -83.13 138.7 33.56 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 80.01 -57.25 4.59 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.214 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.33 -20.95 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 123.736 0.814 . . . . 0.0 111.126 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.405 ' HB2' ' CG2' ' A' ' 261' ' ' THR . 9.5 p30 -57.89 -31.55 66.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.526 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.464 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 24.8 mm -62.31 -65.49 2.11 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.567 176.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.464 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.0 Cg_endo -57.54 -30.82 89.76 Favored 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 121.821 1.68 . . . . 0.0 111.807 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 40.1 tp -61.96 -56.64 17.06 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.169 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.528 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.5 p -63.41 -27.28 69.19 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.965 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.98 -30.05 62.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.28 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -49.2 65.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 48.0 mmt-85 -59.49 -37.14 77.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.296 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.47 -34.86 79.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.01 0.434 . . . . 0.0 110.539 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.503 ' HA ' HG23 ' A' ' 297' ' ' THR . 0.3 OUTLIER -68.06 -30.74 70.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.441 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 57.5 mt -60.13 -45.37 95.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.956 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.685 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 10.5 t -65.62 -45.14 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.788 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -53.15 -44.84 68.1 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.776 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.17 -43.12 87.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.51 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -66.17 -41.07 90.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.139 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 27.0 mt -67.6 -47.2 70.38 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.739 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.55 -41.48 87.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.36 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.8 -26.69 68.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.303 0.573 . . . . 0.0 110.515 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -86.95 4.98 39.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.426 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.64 8.42 49.05 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.043 -1.075 . . . . 0.0 114.4 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 63.0 t -85.29 143.68 11.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.91 106.72 3.28 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.829 0.347 . . . . 0.0 111.421 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.55 -31.45 77.73 Favored Glycine 0 CA--C 1.503 -0.703 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.304 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.62 -17.47 64.61 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.734 0.302 . . . . 0.0 110.946 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -105.05 3.85 30.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.525 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 67.5 mt -105.49 131.18 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -121.57 128.84 52.41 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.291 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.503 HG23 ' HA ' ' A' ' 279' ' ' LYS . 56.1 p -107.73 128.57 54.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.401 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 95.6 t -134.98 132.18 53.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.118 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -102.08 117.56 5.86 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 23.6 mt -91.56 -7.33 50.55 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 68.64 -136.93 29.97 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.445 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 261' ' ' THR . 7.3 p -74.52 97.76 3.2 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 120.927 0.394 . . . . 0.0 110.73 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.2 t -152.94 130.81 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.935 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 52.22 77.59 0.44 Allowed Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 123.786 0.679 . . . . 0.0 112.47 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.46 171.65 17.69 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.468 2.112 . . . . 0.0 112.394 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.7 -55.72 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.592 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.401 ' HB2' ' HA2' ' A' ' 314' ' ' GLY . . . -110.22 171.36 7.5 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.881 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 24.7 m -62.39 134.76 56.9 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 123.553 0.533 . . . . 0.0 111.261 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -81.31 -8.36 59.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.469 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.15 -10.38 59.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.001 0.429 . . . . 0.0 111.366 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.4 t -118.0 143.54 32.92 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.317 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.03 -31.06 56.06 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.22 1.946 . . . . 0.0 111.37 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 2.8 mt-10 -70.83 -35.4 72.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.779 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 307' ' ' ALA . . . -72.49 -40.19 54.85 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.82 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -65.2 -31.91 73.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.11 -26.73 68.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.107 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 10.6 mmtp -87.16 -37.07 17.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.806 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.4 ' N ' HD21 ' A' ' 318' ' ' ASN . 0.9 OUTLIER -62.35 -25.85 68.12 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 14.3 ptp180 -87.75 17.2 4.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.248 0.547 . . . . 0.0 111.556 -178.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -57.42 170.69 0.5 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.244 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 87.1 t -133.16 146.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.447 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -132.03 137.02 47.67 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.044 0.449 . . . . 0.0 110.788 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.9 mp -93.07 117.19 35.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.722 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 44.6 t -113.35 143.87 22.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 211' ' ' LEU . 46.9 t -106.06 140.29 24.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.0 t30 . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.306 -179.615 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.226 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -73.32 143.69 46.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.794 0.297 . . . . 0.0 110.284 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 70.39 128.19 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 123.572 0.749 . . . . 0.0 111.853 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.34 152.55 76.04 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.808 2.339 . . . . 0.0 112.066 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.13 117.0 3.66 Favored 'Trans proline' 0 C--O 1.241 0.639 0 C-N-CA 122.839 2.359 . . . . 0.0 112.712 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -143.9 -76.58 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.906 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.02 170.96 14.65 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.751 2.301 . . . . 0.0 111.213 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.66 140.31 83.92 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.295 1.997 . . . . 0.0 111.04 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -93.36 -47.81 6.71 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.381 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.0 m 58.6 88.33 0.07 Allowed 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 122.926 0.49 . . . . 0.0 111.678 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 177.0 -87.0 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.837 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.43 -44.63 42.38 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 123.542 2.828 . . . . 0.0 112.829 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 14.3 t -153.14 -177.28 6.2 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.57 144.83 56.19 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.411 0.445 . . . . 0.0 110.158 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -75.47 78.99 2.51 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.128 0.489 . . . . 0.0 110.57 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 215' ' ' ILE . 40.1 mt -57.66 -21.59 40.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.246 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.418 ' N ' HG23 ' A' ' 325' ' ' VAL . 20.3 tt0 -63.44 -45.05 92.7 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 120.966 0.413 . . . . 0.0 109.937 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 36.3 t -73.8 -35.41 64.91 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.82 82.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.444 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 211' ' ' LEU . 18.8 pt -72.24 -39.93 64.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.396 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.444 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 12.3 t-20 -61.25 -28.75 69.39 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.128 0.489 . . . . 0.0 110.755 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.88 69.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.983 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.435 HG13 ' CG ' ' A' ' 242' ' ' ARG . 2.5 t -93.37 -41.63 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.199 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.476 ' HA ' HG21 ' A' ' 239' ' ' ILE . 80.9 p -65.11 -36.52 84.56 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.251 0.548 . . . . 0.0 110.266 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.22 22.13 63.62 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 130.86 -125.2 4.44 Favored Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.14 162.27 5.77 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 122.499 2.133 . . . . 0.0 112.044 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.9 mm -73.46 111.14 7.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.756 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -83.45 147.22 27.96 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.865 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -119.36 148.32 43.33 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.563 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -82.14 70.65 3.1 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -79.18 -8.98 59.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -173.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -56.04 -43.25 77.67 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.966 0.412 . . . . 0.0 110.529 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -98.31 3.33 59.76 Favored Glycine 0 N--CA 1.453 -0.188 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 70.86 -56.57 0.62 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.627 1.171 . . . . 0.0 112.363 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.1 m -81.68 36.46 0.44 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 63.6 104.94 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 48.2 pt -105.25 158.26 32.55 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.59 127.14 24.17 Favored 'Trans proline' 0 C--O 1.24 0.583 0 C-N-CA 122.425 2.083 . . . . 0.0 112.238 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -152.3 -71.18 0.15 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.033 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 237' ' ' TYR . 4.9 p-10 -118.06 -75.96 0.58 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.791 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.486 ' H ' ' CG ' ' A' ' 236' ' ' ASP . 59.4 t80 71.47 -51.94 0.69 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.914 0.886 . . . . 0.0 112.432 176.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -57.96 -20.53 38.59 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 243' ' ' VAL . 58.1 mt -65.34 -36.15 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.484 ' CD2' HG11 ' A' ' 281' ' ' VAL . 41.0 mt -64.96 -35.62 81.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.492 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -71.54 -39.86 70.43 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.435 ' CG ' HG13 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -64.19 -48.66 75.07 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.037 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.623 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 55.2 t -55.47 -42.69 68.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.196 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.88 -37.51 87.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.936 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -52.49 -49.45 64.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.424 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -73.94 -29.42 62.01 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 119.491 -0.883 . . . . 0.0 111.292 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 24.5 mt -69.75 -27.78 65.23 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 121.614 0.721 . . . . 0.0 109.254 176.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -68.38 -33.9 75.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.549 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.96 70.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.439 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 52.1 t -126.16 72.5 71.23 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.78 -0.79 9.44 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.99 2.46 . . . . 0.0 113.074 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.55 -30.05 59.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.521 0.676 . . . . 0.0 109.271 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.58 135.98 50.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.652 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.44 145.07 24.93 Favored 'General case' 0 CA--C 1.479 -1.758 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.0 m -120.43 125.38 74.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.896 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 54.9 m -101.35 108.87 20.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.469 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.443 HG12 HG21 ' A' ' 323' ' ' ILE . 22.3 mt -94.92 112.19 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.109 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -103.48 124.34 48.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.109 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.446 ' C ' ' HG ' ' A' ' 274' ' ' SER . . . -103.65 163.62 15.46 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.352 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 32.4 m-85 -136.15 159.55 41.38 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.014 0.435 . . . . 0.0 110.63 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 63.2 p -141.3 164.87 29.07 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.51 156.23 29.39 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.969 0.414 . . . . 0.0 110.695 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -89.81 2.23 55.19 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.68 -18.19 58.58 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.17 0.51 . . . . 0.0 111.162 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -142.29 46.22 0.88 Allowed Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.5 t -84.85 122.41 29.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -160.98 -46.02 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 176.1 -26.98 0.07 OUTLIER Glycine 0 CA--C 1.499 -0.965 0 C-N-CA 119.912 -1.137 . . . . 0.0 113.026 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 35.1 mm -73.12 -20.37 18.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.736 0.779 . . . . 0.0 109.599 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -63.21 -36.97 85.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.607 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.446 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.3 mm -56.27 -65.24 1.68 Allowed Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.829 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.446 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 27.0 Cg_endo -63.24 -25.12 72.12 Favored 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 122.159 1.906 . . . . 0.0 112.277 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 53.8 tp -69.78 -52.24 26.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.001 0.429 . . . . 0.0 110.019 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.446 ' HG ' ' C ' ' A' ' 259' ' ' GLY . 10.1 t -57.5 -39.71 77.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.019 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.63 78.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.803 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -68.08 -46.89 69.75 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.59 0.71 . . . . 0.0 109.703 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -59.7 -44.8 93.54 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.241 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.53 84.02 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.16 0.505 . . . . 0.0 110.182 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.444 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.5 tmtt? -64.22 -30.48 71.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.69 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.2 mt -57.2 -41.37 77.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.977 0.417 . . . . 0.0 109.963 177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.737 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 13.8 t -69.77 -47.91 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.868 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.09 -43.73 78.32 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.908 0.385 . . . . 0.0 110.919 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.1 -38.69 80.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.3 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.522 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 3.9 m-85 -72.83 -40.55 65.69 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.315 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.737 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 44.5 mt -64.18 -48.32 76.38 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 86.3 t -60.32 -39.66 81.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.1 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.43 -23.75 67.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.207 0.527 . . . . 0.0 110.895 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 5.0 mmp_? -89.02 2.9 53.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.394 178.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 97.83 13.14 44.51 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.203 -0.999 . . . . 0.0 114.053 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 62.0 t -87.63 139.96 16.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 117.514 0.657 . . . . 0.0 109.328 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.9 113.5 3.88 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.195 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -66.83 -11.27 57.51 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.893 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.71 -11.91 54.88 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 120.869 0.366 . . . . 0.0 110.224 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -110.23 2.25 19.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.736 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 57.7 mt -107.41 123.69 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -115.67 127.57 55.27 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.592 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 279' ' ' LYS . 47.5 p -104.89 126.28 51.79 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.39 113.04 30.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.305 0.574 . . . . 0.0 112.252 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.433 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -89.11 105.02 3.15 Favored Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.504 175.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 21.0 mt -94.06 1.4 56.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.665 0.269 . . . . 0.0 110.922 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.77 -128.08 42.31 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.539 -175.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 43.0 p -97.67 123.43 41.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.21 -60.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -112.32 94.07 25.14 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-O 120.906 0.384 . . . . 0.0 110.039 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -70.88 172.77 13.07 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.874 2.383 . . . . 0.0 113.311 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.4 tt -134.13 -48.62 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.685 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -126.25 171.02 11.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.581 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.43 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 14.6 m -65.16 124.48 22.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.072 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -80.06 -8.38 59.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -62.33 -23.31 66.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.25 0.548 . . . . 0.0 110.361 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.9 t -117.8 140.43 27.67 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.613 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -52.12 -38.32 70.61 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.133 2.555 . . . . 0.0 111.667 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -53.04 -52.27 59.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.715 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -65.61 -37.98 94.16 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.746 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -59.54 -37.51 78.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.37 . . . . 0.0 110.361 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.34 -31.37 72.54 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.386 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.87 -44.36 20.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.23 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -58.7 -26.28 63.74 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 13.4 ptp180 -83.08 11.09 6.77 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -58.34 179.0 0.08 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 121.61 0.719 . . . . 0.0 112.765 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.7 t -140.43 149.09 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.088 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -131.38 147.12 52.53 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.918 0.389 . . . . 0.0 111.003 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.443 HG21 HG12 ' A' ' 257' ' ' ILE . 1.3 mp -109.17 119.81 59.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.057 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.84 134.52 48.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.942 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 212' ' ' GLN . 91.2 t -94.8 135.21 29.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.501 0.667 . . . . 0.0 112.409 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.257 178.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.209 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -80.4 105.95 12.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.05 0.452 . . . . 0.0 110.7 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -109.44 133.87 20.7 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.374 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -62.05 113.85 2.05 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.497 2.131 . . . . 0.0 111.863 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.31 39.86 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.9 2.4 . . . . 0.0 111.976 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 161.4 135.22 1.78 Allowed Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.927 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.83 152.57 32.58 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.473 2.115 . . . . 0.0 111.335 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.511 ' C ' ' H ' ' A' ' 205' ' ' SER . 52.1 Cg_exo -56.92 149.0 64.07 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.441 2.094 . . . . 0.0 111.535 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.27 27.34 0.08 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.242 0.544 . . . . 0.0 112.076 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 203' ' ' PRO . 20.1 m -102.76 -3.72 26.02 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.241 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 66.72 70.62 1.07 Allowed Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.805 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.56 -25.12 11.32 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.415 2.076 . . . . 0.0 112.946 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 253' ' ' ALA . 46.7 t -143.17 155.17 44.49 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.509 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.58 169.08 8.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.162 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -83.18 77.96 9.68 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.413 ' O ' HG12 ' A' ' 215' ' ' ILE . 29.4 mt -67.34 -29.71 69.33 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.126 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.496 HE21 ' HA ' ' A' ' 324' ' ' VAL . 35.5 tt0 -62.2 -44.32 96.84 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.821 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.0 m -69.25 -36.2 76.91 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.115 0.483 . . . . 0.0 109.769 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.46 -51.08 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.069 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 211' ' ' LEU . 20.7 pt -68.37 -39.79 81.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.298 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -58.57 -32.11 68.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.861 0.362 . . . . 0.0 110.376 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.26 -32.59 73.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.185 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 t -85.96 -47.93 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 120.779 0.323 . . . . 0.0 110.686 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.475 ' HA ' HG21 ' A' ' 239' ' ' ILE . 58.1 p -62.71 -32.95 74.15 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.384 0.612 . . . . 0.0 110.055 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.52 22.47 47.1 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.95 -127.13 6.39 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.455 ' CB ' ' HD2' ' A' ' 320' ' ' ARG . 71.6 Cg_endo -84.39 164.3 12.76 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.201 1.934 . . . . 0.0 111.738 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 42.1 mm -71.65 98.0 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.573 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -78.8 144.24 35.29 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.719 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -111.44 142.34 43.84 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.853 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.07 -5.61 52.91 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.445 HD22 ' HA ' ' A' ' 232' ' ' LEU . 7.3 p30 -164.56 160.17 19.97 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -108.03 95.05 5.41 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.141 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 76.79 25.53 64.63 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.159 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -117.55 -164.33 0.99 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 33.1 t -74.51 125.97 29.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.784 0.326 . . . . 0.0 110.507 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.445 ' HA ' HD22 ' A' ' 227' ' ' ASN . 6.6 mp -77.54 100.47 6.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.179 0.514 . . . . 0.0 110.652 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 63.8 mt -75.72 -46.88 4.07 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.892 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -51.52 139.9 45.85 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.231 1.954 . . . . 0.0 112.277 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.66 2.31 3.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.582 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.38 -8.68 19.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.42 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -64.88 -22.66 67.03 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.911 0.386 . . . . 0.0 110.484 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -67.34 -20.09 65.54 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.025 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.475 HG21 ' HA ' ' A' ' 219' ' ' THR . 76.9 mt -62.23 -31.94 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.21 -32.26 72.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.215 0.531 . . . . 0.0 110.38 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.68 -37.07 36.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.686 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -39.93 84.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.414 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.542 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 38.6 t -61.21 -37.25 77.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.54 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 248' ' ' LYS . . . -58.23 -38.04 76.07 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.819 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -46.46 -49.18 18.64 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.821 0.848 . . . . 0.0 112.938 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.405 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -83.73 -18.16 38.79 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.1 mt -84.8 -25.41 28.19 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 244' ' ' ALA . 6.1 tptm -73.88 -29.86 62.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.701 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.87 75.85 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.268 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 45.0 t -133.44 70.81 76.6 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.71 1.81 7.15 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.845 2.363 . . . . 0.0 113.078 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.55 -31.81 57.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.746 0.784 . . . . 0.0 109.14 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.522 ' HB3' ' SG ' ' A' ' 208' ' ' CYS . . . -65.26 145.63 55.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.314 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -99.99 132.82 45.11 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.1 m -115.06 131.16 68.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.236 0.541 . . . . 0.0 111.383 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.5 m -107.35 112.02 24.64 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.734 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 18.8 mt -92.61 116.03 32.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -107.77 127.49 53.74 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.739 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.424 ' C ' ' HG ' ' A' ' 274' ' ' SER . . . -99.02 149.83 19.16 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.844 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -131.95 163.02 29.29 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 117.274 0.537 . . . . 0.0 110.171 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 3.1 t -159.08 152.48 22.65 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -62.06 155.17 24.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.161 0.505 . . . . 0.0 111.082 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -90.32 5.09 48.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.05 -175.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 13.0 t -70.18 -13.51 62.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.012 0.434 . . . . 0.0 110.731 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -74.42 171.02 53.31 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 15.9 m -69.05 -83.99 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.933 0.366 . . . . 0.0 110.33 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.412 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 11.7 pt-20 176.01 168.6 0.42 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.935 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 78.13 -49.66 3.27 Favored Glycine 0 C--O 1.221 -0.684 0 C-N-CA 121.206 -0.521 . . . . 0.0 114.354 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 40.3 mm -75.97 -23.34 16.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.703 0.763 . . . . 0.0 110.223 -174.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.412 ' OD1' ' HA ' ' A' ' 267' ' ' GLU . 0.6 OUTLIER -64.0 -32.78 74.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.477 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.65 -64.26 3.29 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.12 -30.0 88.25 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.237 1.958 . . . . 0.0 111.947 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 50.9 tp -66.77 -51.33 57.06 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.037 0.446 . . . . 0.0 110.218 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.429 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 13.1 t -56.15 -39.21 71.95 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.263 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.21 -28.54 64.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.075 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -74.21 -44.4 53.38 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.259 0.552 . . . . 0.0 110.096 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 59.8 mtp85 -62.27 -41.0 98.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.997 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.88 -36.11 83.3 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.815 0.341 . . . . 0.0 111.014 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.426 ' HA ' HG22 ' A' ' 297' ' ' THR . 54.6 tptt -59.83 -35.36 74.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.0 mt -55.1 -46.28 77.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 15.8 t -68.51 -46.22 80.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.653 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.63 -42.78 79.45 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.872 0.367 . . . . 0.0 111.185 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.61 -36.15 77.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.68 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.427 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 3.3 m-85 -74.19 -39.68 63.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.117 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 45.2 mt -65.45 -49.47 68.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.502 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 80.8 t -60.21 -38.13 76.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.163 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.23 70.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.694 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.57 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 3.7 mmp_? -87.23 7.37 28.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.684 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 97.14 10.13 54.97 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.125 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 50.4 t -84.9 139.73 17.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 117.894 0.847 . . . . 0.0 109.547 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.99 111.97 2.74 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.071 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.3 -35.2 83.76 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.097 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.82 -11.87 61.21 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -101.44 -2.64 30.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.06 0.457 . . . . 0.0 109.878 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 64.5 mt -107.4 129.65 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.152 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.21 125.78 51.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.628 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 279' ' ' LYS . 22.6 p -111.1 118.74 36.82 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.045 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 18.6 m -121.56 162.76 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.034 0 CA-C-O 121.224 0.535 . . . . 0.0 111.365 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.429 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -129.11 104.46 0.64 Allowed Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.6 mt -89.44 -31.17 17.84 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.733 0.302 . . . . 0.0 111.615 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 106.7 -122.23 6.9 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.841 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.4 t -104.98 120.12 40.68 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 8.6 p 179.81 152.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 58.3 t30 66.44 79.03 0.24 Allowed Pre-proline 0 C--N 1.314 -0.953 0 O-C-N 123.756 0.66 . . . . 0.0 111.467 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.54 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 73.3 Cg_endo -77.79 149.5 26.4 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.606 2.204 . . . . 0.0 113.136 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.9 tt -108.14 -39.16 4.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.32 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.451 ' HB2' ' HA2' ' A' ' 314' ' ' GLY . . . -139.64 174.42 10.54 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.978 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 26.2 m -74.54 129.52 37.9 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.121 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -80.16 -7.66 59.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.587 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -57.39 -19.08 21.02 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.382 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.4 t -127.77 141.33 40.74 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.928 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.87 -21.68 34.36 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.188 2.592 . . . . 0.0 112.399 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.5 mm-40 -60.04 -46.36 89.77 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.392 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 307' ' ' ALA . . . -65.77 -39.73 95.33 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.14 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -60.53 -37.02 79.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.425 0.631 . . . . 0.0 110.121 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.59 -29.38 66.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.193 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 6.7 mmtp -87.11 -35.86 18.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.307 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.54 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 27.9 m-20 -65.47 -15.48 62.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.555 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 7.6 ptm180 -88.49 16.2 6.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.558 0.694 . . . . 0.0 111.036 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.455 ' HD2' ' CB ' ' A' ' 222' ' ' PRO . 14.4 ptt180 -63.18 -173.69 0.06 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.422 1.105 . . . . 0.0 113.246 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.84 145.63 25.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.783 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -135.74 145.01 46.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.231 0.539 . . . . 0.0 111.599 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.37 115.19 42.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.106 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.496 ' HA ' HE21 ' A' ' 212' ' ' GLN . 85.1 t -105.37 136.13 40.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.834 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 212' ' ' GLN . 69.5 t -101.27 136.18 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 C--N 1.311 -1.073 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.92 179.033 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.137 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -119.16 13.85 12.96 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.924 -0.162 . . . . 0.0 110.643 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 61.52 91.88 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.216 0 O-C-N 123.672 0.608 . . . . 0.0 110.24 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.44 117.83 4.23 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.989 2.459 . . . . 0.0 112.366 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.08 84.67 1.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.357 2.038 . . . . 0.0 111.047 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.43 -137.84 16.31 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.88 118.93 5.46 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.222 1.948 . . . . 0.0 111.09 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.62 147.97 77.29 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.316 2.011 . . . . 0.0 112.329 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -75.18 -6.81 51.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.065 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.5 t 73.79 -55.32 0.67 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.752 0.821 . . . . 0.0 111.639 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -145.89 90.72 0.15 Allowed Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.522 -0.846 . . . . 0.0 112.54 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.49 161.59 45.47 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.728 2.286 . . . . 0.0 110.949 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.423 ' SG ' ' HB1' ' A' ' 253' ' ' ALA . 48.8 t -109.44 156.18 20.38 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.794 0.331 . . . . 0.0 111.096 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -68.58 163.28 23.97 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.014 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.98 82.02 4.35 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.184 0.516 . . . . 0.0 110.244 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.409 ' O ' HG22 ' A' ' 215' ' ' ILE . 52.9 mt -69.47 -24.76 63.83 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.875 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -68.86 -38.34 79.7 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.415 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 t -76.61 -32.22 57.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -67.84 -49.08 64.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.14 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.464 ' CG2' HG13 ' A' ' 243' ' ' VAL . 21.8 pt -69.39 -33.39 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.801 -0.181 . . . . 0.0 111.081 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -54.99 -34.17 63.16 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.134 0.492 . . . . 0.0 110.801 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.87 -31.76 72.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.243 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.406 HG13 ' CB ' ' A' ' 242' ' ' ARG . 2.5 t -91.81 -48.98 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.883 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.476 ' HA ' HG22 ' A' ' 239' ' ' ILE . 53.7 p -62.73 -43.61 98.35 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.302 0.573 . . . . 0.0 110.776 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.42 19.46 66.41 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.042 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 134.29 -136.95 8.92 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -82.27 162.39 17.54 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.638 2.226 . . . . 0.0 112.756 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.7 mm -78.58 104.14 6.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.546 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.29 123.78 40.05 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.389 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -88.93 168.85 12.05 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.295 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -61.65 -67.14 2.24 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.655 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -109.05 -78.26 0.59 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -178.94 115.15 0.06 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.767 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 65.07 15.24 60.31 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 116.011 -0.541 . . . . 0.0 113.57 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -101.36 168.29 9.63 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.3 m -58.92 144.74 43.78 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.171 0.51 . . . . 0.0 110.797 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.0 mp -82.32 83.43 7.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.162 0.506 . . . . 0.0 110.633 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 60.8 mt -72.55 -48.19 9.3 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.138 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.44 ' C ' ' H ' ' A' ' 236' ' ' ASP . 52.2 Cg_exo -55.58 144.76 73.18 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 121.952 1.768 . . . . 0.0 111.673 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -73.35 18.32 0.12 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 234' ' ' PRO . 29.6 t70 -77.61 -17.48 57.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.119 0.485 . . . . 0.0 110.759 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -61.85 -13.69 26.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.036 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -64.72 -21.53 66.77 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.485 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.476 HG22 ' HA ' ' A' ' 219' ' ' THR . 56.8 mt -62.5 -38.28 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 50.6 mt -65.8 -31.61 72.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.796 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -71.4 -38.97 71.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.461 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.2 OUTLIER -65.85 -47.7 74.07 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.829 178.225 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.573 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.7 t -58.26 -45.43 89.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.062 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.01 -35.81 77.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.692 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -54.49 -47.94 72.43 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.461 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -75.26 -29.99 60.34 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.462 -178.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.0 mt -65.64 -34.41 78.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.435 0.635 . . . . 0.0 109.646 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -72.44 -24.7 61.25 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.146 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.84 69.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.049 0.452 . . . . 0.0 110.84 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 35.8 t -125.53 68.88 61.25 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.61 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.07 3.26 5.81 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.075 2.516 . . . . 0.0 113.388 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.91 -32.16 61.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.968 0.89 . . . . 0.0 108.879 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.423 ' HB1' ' SG ' ' A' ' 208' ' ' CYS . . . -74.56 148.04 41.21 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.442 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -101.1 139.42 36.8 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.8 m -115.0 130.01 70.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-O 121.327 0.584 . . . . 0.0 110.835 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.9 m -105.28 110.45 22.82 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.322 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 23.9 mt -92.8 111.1 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.96 126.31 46.11 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.146 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.462 ' C ' ' HG ' ' A' ' 274' ' ' SER . . . -105.07 159.02 15.84 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.152 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 301' ' ' GLY . 76.3 m-85 -132.55 165.97 23.16 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.816 0.341 . . . . 0.0 110.775 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.523 HG22 ' NH1' ' A' ' 277' ' ' ARG . 33.2 p -144.55 169.74 17.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.738 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.71 158.62 20.72 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 175.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -76.44 12.73 1.14 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.73 -22.75 3.77 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.06 0.457 . . . . 0.0 111.638 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.52 141.74 13.14 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 7.6 t -57.84 153.54 13.74 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 117.003 0.401 . . . . 0.0 110.418 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.66 156.85 10.18 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.083 0.468 . . . . 0.0 110.669 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 111.4 -52.82 0.61 Allowed Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.026 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.9 mm -84.92 -33.97 8.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 122.119 0.961 . . . . 0.0 108.765 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -61.74 -28.54 69.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.838 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.496 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 33.9 mm -57.26 -65.19 1.88 Allowed Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.432 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.496 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.9 Cg_endo -58.59 -35.45 98.64 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 122.195 1.93 . . . . 0.0 111.979 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 54.2 tp -62.72 -53.87 47.79 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.277 0.56 . . . . 0.0 111.028 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.469 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 15.2 t -57.29 -35.59 69.99 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.005 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.35 -22.16 64.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.821 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -71.51 -53.1 14.97 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.523 ' NH1' HG22 ' A' ' 261' ' ' THR . 75.9 mtt85 -56.97 -44.14 82.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.62 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.43 77.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.962 0.41 . . . . 0.0 110.814 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.47 ' HA ' HG21 ' A' ' 297' ' ' THR . 11.9 tmtt? -69.37 -30.55 68.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.28 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 58.8 mt -59.82 -44.96 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.722 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.7 t -65.99 -48.19 82.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.047 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.77 76.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 120.919 0.39 . . . . 0.0 110.984 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.4 -42.27 91.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.935 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.683 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 5.7 m-85 -68.09 -43.36 78.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.893 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 36.4 mt -63.62 -46.15 87.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.835 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.7 t -61.27 -40.16 85.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.379 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.25 -30.74 71.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.549 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.683 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 13.8 mmm180 -81.83 5.07 19.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.472 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.6 2.75 50.1 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.164 -1.017 . . . . 0.0 114.629 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 57.9 t -80.91 145.96 8.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 117.923 0.861 . . . . 0.0 110.573 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.77 108.08 3.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.701 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.41 -33.8 82.56 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.792 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.97 -19.14 64.93 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -103.39 2.41 33.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 62.7 mt -104.35 130.36 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.52 127.21 53.77 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.646 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.47 HG21 ' HA ' ' A' ' 279' ' ' LYS . 53.8 p -106.25 119.97 40.63 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 77.2 t -124.25 114.91 43.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.357 0.599 . . . . 0.0 112.103 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.469 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -88.02 107.4 3.31 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.85 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 23.9 mt -94.64 -4.25 48.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.924 0.392 . . . . 0.0 110.43 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 260' ' ' TYR . . . 62.72 -133.07 44.11 Favored Glycine 0 N--CA 1.431 -1.657 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.66 -175.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.4 t -99.69 122.63 42.98 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.2 p -149.25 -56.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.666 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -113.33 93.73 27.96 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.441 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 14.9 Cg_endo -64.19 162.05 31.45 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.834 2.356 . . . . 0.0 112.934 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.438 HG21 ' HA ' ' A' ' 318' ' ' ASN . 4.7 tt -124.34 -53.59 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.874 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -119.8 171.41 8.43 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 22.2 m -61.91 127.33 30.88 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.564 0.54 . . . . 0.0 110.845 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -79.79 -8.16 59.1 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.015 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.79 -17.37 62.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.699 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.8 t -116.8 138.4 24.59 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.47 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.74 -34.25 97.94 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.921 2.414 . . . . 0.0 111.517 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.65 -45.92 90.57 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.35 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.37 -38.82 87.56 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -59.09 -37.31 76.83 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.032 0.444 . . . . 0.0 109.96 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.42 -27.72 68.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.57 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -80.93 -41.81 22.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.648 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.441 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 39.2 m-80 -60.19 -22.23 62.68 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -93.45 16.25 13.95 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.49 179.24 1.05 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.746 0.784 . . . . 0.0 112.358 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 98.8 t -129.27 143.34 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.504 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -131.61 140.46 49.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 111.378 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.4 119.92 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.095 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.49 141.74 27.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.268 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 96.0 t -98.38 135.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.713 -179.503 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.947 0 N-CA-C 111.774 -0.531 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -69.2 -37.66 78.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.574 0.226 . . . . 0.0 110.53 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 65.1 98.95 0.04 OUTLIER Pre-proline 0 C--O 1.237 0.406 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.834 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.44 137.18 63.43 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.863 2.375 . . . . 0.0 111.782 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -77.69 63.22 7.98 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.766 2.31 . . . . 0.0 112.092 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -72.65 159.09 53.5 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.881 -0.675 . . . . 0.0 111.742 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.77 119.38 4.69 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.96 2.44 . . . . 0.0 112.268 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.8 -50.71 7.22 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.964 2.443 . . . . 0.0 112.539 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -82.72 -44.21 15.91 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 26.0 t 66.92 87.07 0.13 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.333 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -127.35 -161.12 10.73 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -50.65 -41.08 54.94 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.932 2.422 . . . . 0.0 111.875 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 10.8 t -137.12 139.65 41.37 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.24 177.59 1.05 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.148 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -87.69 83.09 7.22 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.828 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.447 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.5 mm? -69.59 -40.71 76.52 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.167 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -64.14 -40.66 96.65 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.719 0.295 . . . . 0.0 110.861 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 33.5 t -68.35 -44.17 75.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.066 0.46 . . . . 0.0 110.115 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.29 -44.66 87.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.031 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.466 ' CG2' HG12 ' A' ' 243' ' ' VAL . 27.1 pt -69.11 -37.6 76.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.212 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -60.72 -33.02 72.26 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.336 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.49 -25.09 65.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.213 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.3 t -90.25 -43.7 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 110.047 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.527 ' HA ' HG23 ' A' ' 239' ' ' ILE . 71.5 p -68.03 -36.71 80.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.579 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.97 24.68 51.94 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.98 -136.5 9.4 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.84 164.94 20.17 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.374 2.049 . . . . 0.0 112.267 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.7 mm -77.95 104.32 5.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.6 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -93.08 119.9 32.79 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.969 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.94 -170.82 3.03 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.193 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -164.88 -38.8 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.338 -170.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -82.55 80.17 8.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -122.69 3.52 9.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.76 0.314 . . . . 0.0 111.714 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -92.01 -21.68 32.49 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.115 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -138.83 -90.47 0.2 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.673 0.273 . . . . 0.0 110.683 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 49.5 m -120.09 137.44 54.13 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 48.5 tp -62.96 -34.37 77.37 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.47 0.481 . . . . 0.0 111.69 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 70.7 mt 67.3 94.9 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.888 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.45 126.81 13.96 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.208 1.938 . . . . 0.0 112.089 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -164.99 -67.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.137 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -88.08 -12.32 44.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.692 0.758 . . . . 0.0 109.121 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -83.93 19.98 1.62 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.353 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.3 -18.41 65.34 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.418 0.627 . . . . 0.0 109.481 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.527 HG23 ' HA ' ' A' ' 219' ' ' THR . 90.3 mt -58.63 -34.57 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.147 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.45 -33.77 76.66 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.213 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.429 ' HA ' ' HG2' ' A' ' 288' ' ' ARG . 44.8 m-20 -71.33 -37.32 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -49.91 57.42 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.82 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.622 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 38.8 t -57.93 -47.65 85.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.413 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.79 -28.18 68.17 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.848 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.92 -40.19 83.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 0.0 111.434 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 243' ' ' VAL . 0.0 OUTLIER -77.88 -26.69 49.38 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.038 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 38.3 mt -66.68 -27.34 67.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.157 0.503 . . . . 0.0 110.307 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -76.65 -17.23 59.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.377 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.91 -30.21 63.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.1 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 8.4 t -137.02 67.79 56.36 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.44 4.46 4.95 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.354 2.703 . . . . 0.0 114.621 -174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -78.16 -29.69 48.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.585 0.707 . . . . 0.0 109.474 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.44 136.66 51.85 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.779 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -86.33 138.36 31.88 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.8 m -111.53 126.26 68.91 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.839 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.3 m -104.2 106.57 17.12 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.379 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 28.0 mt -92.56 113.21 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.478 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -100.51 129.36 46.45 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.689 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.416 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -108.0 144.38 16.14 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -124.33 161.48 25.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.127 0.489 . . . . 0.0 110.61 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 72.7 p -147.0 164.22 33.69 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -80.24 164.05 23.53 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.859 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -94.79 -1.62 52.5 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.587 0.708 . . . . 0.0 110.5 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.67 -26.72 20.57 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.52 -69.19 1.41 Allowed Glycine 0 C--O 1.229 -0.179 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.747 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 19.9 m -142.01 -174.24 4.04 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -137.53 125.92 23.38 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 92.99 -45.98 2.47 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.34 -20.64 24.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 123.604 0.762 . . . . 0.0 110.184 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -36.81 74.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.199 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.484 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.4 mm -61.17 -63.95 3.7 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.24 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.484 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.9 Cg_endo -58.37 -31.68 94.47 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.944 1.763 . . . . 0.0 111.866 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 62.4 tp -67.4 -54.2 22.49 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.568 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.416 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 18.5 p -62.48 -29.92 70.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.767 0.318 . . . . 0.0 110.898 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.44 -31.34 69.61 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -73.2 -41.28 63.99 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 60.7 mtp85 -61.92 -45.16 94.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.034 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.77 76.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.876 0.37 . . . . 0.0 110.872 176.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.46 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.6 tmtt? -65.94 -30.26 70.81 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.509 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.51 -44.21 80.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.23 0.538 . . . . 0.0 109.753 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.676 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.9 t -70.92 -46.54 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.574 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.87 71.01 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.877 0.37 . . . . 0.0 111.184 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -57.71 -43.28 85.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.502 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.492 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 4.8 m-85 -69.58 -38.52 77.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.461 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 41.3 mt -66.38 -46.31 77.13 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.1 -39.37 82.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.488 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.8 -26.75 68.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.295 0.569 . . . . 0.0 110.54 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -85.18 3.52 38.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.69 178.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.34 13.29 39.22 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.129 -1.034 . . . . 0.0 114.364 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 58.5 t -87.95 142.9 12.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 117.716 0.758 . . . . 0.0 109.504 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.63 112.8 4.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.433 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.18 -36.83 90.4 Favored Glycine 0 CA--C 1.511 -0.219 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.459 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -70.55 -11.41 60.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.859 0.361 . . . . 0.0 111.417 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -102.17 -1.43 31.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.058 0.456 . . . . 0.0 110.404 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 70.6 mt -106.13 130.93 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.727 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.47 125.02 49.03 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.649 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.46 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.3 p -104.24 122.44 45.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.487 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 67.5 t -127.23 115.03 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 121.153 0.501 . . . . 0.0 112.084 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.28 112.9 3.8 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.608 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 26.7 mt -97.05 -7.85 31.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.561 0.219 . . . . 0.0 111.559 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.8 -129.36 41.63 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.152 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 12.7 p -93.59 112.23 24.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.422 HG13 ' ND2' ' A' ' 304' ' ' ASN . 41.9 t -138.0 -69.38 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.422 ' ND2' HG13 ' A' ' 303' ' ' VAL . 67.7 m-80 -110.2 94.49 18.41 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.44 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 13.3 Cg_exo -65.57 163.2 30.93 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.24 1.96 . . . . 0.0 112.034 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 6.3 tt -117.9 -48.24 3.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.465 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -129.75 172.89 11.16 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 43.8 t -62.96 134.76 56.68 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 123.399 0.437 . . . . 0.0 110.734 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.17 -7.7 59.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.683 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.59 -20.31 64.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.1 t -113.54 145.34 33.13 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.891 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.86 -32.29 36.67 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.996 1.797 . . . . 0.0 110.806 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.524 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.8 mt-10 -59.66 -44.7 93.47 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.055 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -67.88 -38.87 89.56 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.707 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -63.16 -37.31 86.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.941 0.4 . . . . 0.0 110.259 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.21 -27.44 69.36 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.17 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 6.8 mmtp -84.73 -40.9 16.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.035 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.44 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 42.5 m-80 -62.31 -26.65 68.54 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -78.4 7.02 7.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.877 0.37 . . . . 0.0 111.471 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.8 ptt-85 -57.78 177.79 0.1 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.144 0.973 . . . . 0.0 113.18 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 86.5 t -136.52 143.15 36.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.583 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -129.57 137.58 50.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.831 0.348 . . . . 0.0 111.017 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.9 119.5 49.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 75.0 t -111.05 137.33 43.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 67.9 t -101.5 136.39 33.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.364 0.602 . . . . 0.0 111.221 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.084 179.264 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.264 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -93.84 -38.3 11.31 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 53.11 77.48 0.45 Allowed Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.789 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.5 115.11 3.73 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.688 2.259 . . . . 0.0 111.666 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.99 -9.64 11.78 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.723 2.282 . . . . 0.0 112.338 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -76.71 -71.48 1.18 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.099 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.35 110.18 0.31 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.848 2.365 . . . . 0.0 112.358 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.44 125.01 13.69 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.738 2.292 . . . . 0.0 110.927 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -93.57 -9.79 36.96 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.3 t 54.71 -154.89 0.27 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 122.936 0.495 . . . . 0.0 110.958 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 208' ' ' CYS . . . 167.84 -150.84 17.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.348 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.38 13.1 1.17 Allowed 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 123.577 2.852 . . . . 0.0 111.882 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.406 ' H ' ' C ' ' A' ' 206' ' ' GLY . 52.7 t -153.58 147.13 25.04 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -56.18 161.28 2.52 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.183 0.516 . . . . 0.0 112.043 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.93 63.35 2.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.548 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 246' ' ' LYS . 17.9 mt -54.08 -29.9 46.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.308 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -65.25 -43.8 90.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.026 0.441 . . . . 0.0 109.932 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.7 t -74.96 -24.68 58.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.543 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 218' ' ' VAL . . . -75.51 -49.05 19.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.831 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 211' ' ' LEU . 23.4 pt -71.72 -38.08 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.607 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -58.62 -38.39 77.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.988 0.423 . . . . 0.0 110.516 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.89 -27.72 69.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.134 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 214' ' ' ALA . 21.3 t -83.67 -50.98 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 121.038 0.447 . . . . 0.0 110.751 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.455 ' HA ' HG21 ' A' ' 239' ' ' ILE . 42.6 p -69.1 -34.86 75.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.461 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.9 14.24 82.8 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 139.79 -134.69 6.74 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.34 166.63 6.57 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.73 2.287 . . . . 0.0 113.246 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 51.0 mm -82.58 106.09 13.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.009 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.15 132.41 40.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.122 0.487 . . . . 0.0 111.864 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -100.55 173.93 6.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.512 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.01 -68.59 0.74 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.827 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 228' ' ' ASP . 24.8 t-20 -95.71 -100.82 0.17 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.492 -0.29 . . . . 0.0 110.607 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 227' ' ' ASN . 10.2 t70 170.05 -58.56 0.01 OUTLIER 'General case' 0 C--N 1.352 0.688 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -78.42 80.07 1.45 Allowed Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.5 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 77.63 -55.71 0.52 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.975 0.91 . . . . 0.0 112.579 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 25.3 m -80.44 72.46 7.33 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.194 0.521 . . . . 0.0 109.666 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.453 HD22 ' H ' ' A' ' 232' ' ' LEU . 2.5 pt? -74.32 -0.28 16.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.939 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 40.1 mt 58.26 73.15 0.76 Allowed Pre-proline 0 C--O 1.234 0.273 0 CA-C-O 121.023 0.439 . . . . 0.0 110.159 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.42 125.34 8.31 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.081 1.854 . . . . 0.0 111.655 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -145.22 -7.75 0.61 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.978 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -123.63 22.84 9.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.415 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -66.07 -27.13 67.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.072 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -67.61 -20.71 65.38 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.003 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 243' ' ' VAL . 50.6 mt -64.73 -38.86 83.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.86 -31.23 72.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.226 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -75.57 -38.31 59.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -23.42 63.86 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.095 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.534 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 24.7 t -79.79 -42.19 22.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.487 176.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.01 68.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.154 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -45.82 -50.54 14.03 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.728 0.811 . . . . 0.0 112.497 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.504 ' HB2' HD23 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -85.33 -14.43 46.5 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 41.3 mt -83.56 -31.08 26.54 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -82.93 -18.85 38.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.64 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.94 -34.13 76.0 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.283 0.563 . . . . 0.0 109.816 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 35.4 t -132.03 69.35 80.71 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.5 -2.97 10.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.25 2.633 . . . . 0.0 113.846 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -84.0 -24.14 30.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.558 0.694 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -67.75 149.29 50.14 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.861 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -102.81 140.79 36.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.09 131.95 67.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 120.97 0.414 . . . . 0.0 110.897 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.2 m -107.63 108.76 20.16 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 16.3 mt -96.36 114.98 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.68 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -99.5 125.16 45.2 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.293 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 274' ' ' SER . . . -105.71 140.76 15.23 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -123.01 161.94 23.31 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.01 0.433 . . . . 0.0 110.005 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 10.0 t -148.1 167.1 25.88 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.402 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -79.07 156.86 28.16 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.011 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -83.99 8.15 16.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 0.0 111.399 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 9.4 t -66.3 -27.94 68.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.34 164.79 53.64 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.4 t -151.56 179.02 8.73 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 117.112 0.456 . . . . 0.0 111.219 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 71.42 5.9 5.57 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.409 1.083 . . . . 0.0 112.513 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 96.7 -12.91 65.85 Favored Glycine 0 CA--C 1.494 -1.223 0 C-N-CA 119.76 -1.209 . . . . 0.0 114.179 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.45 -21.83 26.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.676 0.75 . . . . 0.0 110.901 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.94 -38.66 70.61 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.779 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.408 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 22.7 mm -58.78 -64.37 2.99 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.741 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.408 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 14.2 Cg_endo -61.21 -28.12 84.6 Favored 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 121.867 1.711 . . . . 0.0 112.426 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 53.2 tp -65.51 -52.95 48.94 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.965 0.412 . . . . 0.0 110.809 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 259' ' ' GLY . 14.5 p -62.64 -28.39 69.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.606 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.86 78.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.251 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -67.86 -39.59 83.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.73 -52.18 64.78 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.099 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.93 -35.0 75.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.214 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.452 ' HA ' HG21 ' A' ' 297' ' ' THR . 16.4 ttpt -62.68 -31.79 72.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.229 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 61.5 mt -56.36 -45.57 81.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.989 0.423 . . . . 0.0 110.118 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.734 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.5 t -67.48 -45.44 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.978 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.78 -45.37 74.26 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.919 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.84 -40.54 88.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.288 0.566 . . . . 0.0 110.635 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.673 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 6.9 m-85 -69.75 -41.41 75.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.208 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 47.6 mt -63.99 -46.91 82.45 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 79.4 t -59.9 -39.51 80.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.354 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.39 -30.54 71.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.339 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.673 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -80.93 1.51 30.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.597 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 98.81 15.69 33.23 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.136 -1.03 . . . . 0.0 114.033 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 58.2 t -90.64 142.86 12.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 117.416 0.608 . . . . 0.0 109.551 177.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.31 111.11 4.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.801 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.1 -34.12 77.94 Favored Glycine 0 C--N 1.33 0.197 0 CA-C-N 115.707 -0.679 . . . . 0.0 113.255 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.54 -21.0 66.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.922 0.391 . . . . 0.0 111.63 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.5 3.92 40.67 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.97 0.414 . . . . 0.0 110.99 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 66.4 mt -105.43 131.92 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.74 129.61 54.58 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 279' ' ' LYS . 31.8 p -115.72 125.38 52.73 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.683 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 94.7 t -130.04 127.58 63.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 0.0 111.499 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -96.02 114.12 4.83 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.87 -2.0 48.25 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 72.79 -129.85 13.85 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.661 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 23.2 t -90.49 114.92 27.21 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.1 p -179.33 147.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.6 t30 64.95 69.33 0.67 Allowed Pre-proline 0 C--N 1.314 -0.97 0 O-C-N 123.818 0.699 . . . . 0.0 110.404 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.44 168.45 12.99 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.591 2.194 . . . . 0.0 113.231 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.465 ' HB ' ' NH1' ' A' ' 320' ' ' ARG . 2.7 tt -128.12 -50.0 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.108 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.404 ' HB1' ' HA2' ' A' ' 314' ' ' GLY . . . -120.83 171.71 8.42 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.168 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 20.0 m -64.55 134.69 54.92 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.485 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -78.22 -7.72 57.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.184 0.516 . . . . 0.0 110.662 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.16 -16.88 60.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.158 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.76 144.61 31.79 Favored Pre-proline 0 CA--C 1.511 -0.522 0 CA-C-O 121.034 0.445 . . . . 0.0 110.941 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -66.22 -34.66 35.43 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 122.213 1.942 . . . . 0.0 111.354 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -60.87 -40.51 93.24 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.268 0.556 . . . . 0.0 109.85 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.404 ' HA2' ' HB1' ' A' ' 307' ' ' ALA . . . -70.25 -39.8 71.12 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.876 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.74 -33.43 72.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.125 0.488 . . . . 0.0 110.092 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -70.47 -29.14 65.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.79 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.38 -41.17 20.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.05 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -64.64 -17.42 64.02 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 19.6 ptp180 -86.98 13.19 9.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.146 0.498 . . . . 0.0 110.865 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.465 ' NH1' ' HB ' ' A' ' 306' ' ' ILE . 5.2 ptt180 -57.66 175.9 0.16 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.191 0.996 . . . . 0.0 113.189 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.48 147.76 28.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.427 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.02 136.15 48.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.146 0.498 . . . . 0.0 110.9 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.3 mp -98.38 117.27 43.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.919 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 48.8 t -112.53 141.87 26.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 97.3 t -88.93 118.85 35.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.028 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.6 t30 . . . . . 0 C--N 1.331 -0.2 0 C-N-CA 125.144 1.378 . . . . 0.0 112.549 -176.611 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -78.05 -49.64 13.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.006 0.431 . . . . 0.0 110.611 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -127.74 92.93 41.32 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.33 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.4 141.26 12.53 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.68 2.254 . . . . 0.0 110.846 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.22 108.26 0.78 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.472 2.115 . . . . 0.0 111.829 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -160.13 77.89 0.18 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.377 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -80.01 154.34 22.55 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.905 2.403 . . . . 0.0 111.064 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.38 110.71 0.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.312 2.008 . . . . 0.0 111.383 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.71 -23.25 63.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.528 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 30.1 p -108.31 114.05 27.61 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -115.37 -170.87 16.34 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.438 -0.886 . . . . 0.0 112.175 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.89 158.32 58.34 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.842 2.362 . . . . 0.0 111.479 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 12.1 t -104.37 175.07 5.61 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.458 ' O ' HD21 ' A' ' 211' ' ' LEU . . . -50.87 165.49 0.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.433 0.693 . . . . 0.0 112.859 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.65 80.75 9.02 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 209' ' ' ALA . 3.1 mm? -57.48 -53.29 59.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.71 -43.22 99.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.846 0.355 . . . . 0.0 110.697 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.4 t -70.92 -21.0 62.42 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.247 0.546 . . . . 0.0 110.346 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -84.24 -45.07 13.26 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.51 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 26.5 pt -69.48 -41.89 80.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.03 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -57.2 -32.47 66.51 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.459 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.42 67.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.236 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.2 t -87.7 -47.93 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-O 121.065 0.46 . . . . 0.0 110.091 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.409 ' HA ' HG22 ' A' ' 239' ' ' ILE . 76.2 p -66.29 -36.91 84.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.585 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.02 24.95 42.53 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.38 -136.02 10.22 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.59 ' HB2' ' NE ' ' A' ' 320' ' ' ARG . 3.4 Cg_exo -79.98 159.26 24.08 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.463 2.109 . . . . 0.0 111.851 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 320' ' ' ARG . 41.7 mm -74.88 106.65 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.661 -176.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -83.03 149.41 26.96 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -110.85 141.07 44.72 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.028 0.442 . . . . 0.0 111.322 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -91.6 -42.75 4.73 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -98.43 161.14 13.84 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.39 -29.76 70.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.135 0.493 . . . . 0.0 110.583 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 163.35 -8.65 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.193 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -84.27 90.67 7.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.695 0.283 . . . . 0.0 110.938 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 87.5 p 55.49 -174.28 0.05 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.991 0.917 . . . . 0.0 112.715 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 98.7 mt -121.08 95.35 4.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.324 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.486 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 68.3 mt -78.02 -52.72 1.51 Allowed Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.635 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 233' ' ' ILE . 16.4 Cg_endo -57.81 151.1 58.51 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 122.147 1.898 . . . . 0.0 111.935 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -79.09 72.4 5.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.197 0.523 . . . . 0.0 111.461 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -129.69 2.93 4.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.714 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -73.67 -21.4 60.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.816 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.72 -20.86 66.57 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.815 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.505 ' O ' HG22 ' A' ' 243' ' ' VAL . 76.7 mt -69.9 -42.42 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 8.1 mp -67.08 -33.52 75.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.597 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.68 -37.25 82.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.067 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -41.17 69.1 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.779 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.625 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 54.9 t -56.01 -40.82 65.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.231 0.539 . . . . 0.0 110.199 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.86 82.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.231 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -48.9 -52.98 21.53 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.436 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -73.66 -31.77 63.64 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.168 -178.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 25.6 mt -68.76 -29.64 68.07 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -64.86 -32.38 74.06 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.942 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -77.1 -29.41 54.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.57 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 7.8 t -137.82 65.02 44.88 Favored Pre-proline 0 C--N 1.316 -0.867 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.01 4.6 5.12 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.059 2.506 . . . . 0.0 114.461 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -81.21 -28.11 35.03 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.681 0.753 . . . . 0.0 109.077 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.3 141.14 54.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.639 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -93.74 137.08 33.36 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.047 0.451 . . . . 0.0 110.157 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 5.3 m -116.67 133.66 62.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.071 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 31.4 m -112.32 111.92 23.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.84 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 18.9 mt -92.79 114.36 29.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -104.79 128.21 52.85 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.597 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -109.49 144.82 16.7 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.798 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -126.24 158.72 34.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 10.0 t -174.13 114.18 0.19 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.125 0.964 . . . . 0.0 111.228 174.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.3 109.08 8.51 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.488 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.85 -56.01 1.13 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.663 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.7 p -115.34 -61.7 1.71 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.486 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 174.31 -43.29 0.14 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 302' ' ' SER . 50.9 m -149.6 -64.95 0.22 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.675 0.274 . . . . 0.0 111.378 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -99.64 165.99 11.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.963 0.411 . . . . 0.0 111.672 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 124.08 -150.65 17.03 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.185 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.75 -29.97 48.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 123.058 0.543 . . . . 0.0 110.9 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.635 HD21 ' N ' ' A' ' 271' ' ' ILE . 0.2 OUTLIER -61.06 -24.69 66.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.831 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.635 ' N ' HD21 ' A' ' 270' ' ' ASN . 19.8 mm -64.53 -64.89 2.32 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.869 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.431 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.3 Cg_endo -60.01 -30.01 90.6 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 121.779 1.653 . . . . 0.0 111.934 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 58.5 tp -68.36 -52.22 35.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.237 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 17.3 p -64.22 -27.15 68.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.15 -33.62 74.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.768 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -64.05 -50.47 68.27 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.852 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.518 ' NH1' ' HB2' ' A' ' 319' ' ' ARG . 72.8 mtt180 -61.96 -38.06 87.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.784 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.88 92.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.076 0.465 . . . . 0.0 110.172 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.483 ' HA ' HG23 ' A' ' 297' ' ' THR . 23.6 ttpt -66.71 -31.93 72.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.377 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 60.4 mt -55.09 -41.96 62.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.059 0.457 . . . . 0.0 110.145 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.7 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.6 t -70.2 -43.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.778 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.4 84.94 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.994 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -56.96 -37.58 71.77 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.937 0.398 . . . . 0.0 110.649 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.652 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 6.3 m-85 -70.86 -51.25 27.56 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.96 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 30.5 mt -55.38 -50.76 68.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.366 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.16 -41.22 85.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.007 0.432 . . . . 0.0 110.646 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.13 -21.96 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.001 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.652 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.8 mmp_? -88.52 7.1 34.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.499 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 92.42 14.8 55.12 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.683 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.41 144.9 8.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.6 111.49 5.45 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.832 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.1 -32.04 66.4 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.71 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.8 -15.47 63.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.967 0.413 . . . . 0.0 111.754 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -102.16 -1.8 30.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.023 0.44 . . . . 0.0 110.464 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 60.8 mt -106.92 129.49 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.067 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.03 124.43 48.1 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.483 HG23 ' HA ' ' A' ' 279' ' ' LYS . 18.1 p -107.68 124.9 50.67 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.887 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 69.6 t -134.02 123.45 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.057 0.456 . . . . 0.0 111.738 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -94.77 113.23 4.53 Favored Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 22.1 mt -93.06 1.43 57.25 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.775 0.321 . . . . 0.0 111.389 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.98 -131.2 33.53 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.631 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 266' ' ' SER . 45.4 t -91.02 117.6 29.72 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.7 p -178.81 151.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.716 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.35 69.43 1.64 Allowed Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 123.678 0.791 . . . . 0.0 110.831 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.571 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 74.1 Cg_endo -78.47 137.57 14.86 Favored 'Trans proline' 0 N--CA 1.44 -1.661 0 C-N-CA 122.403 2.069 . . . . 0.0 113.381 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.77 -38.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.498 176.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -131.18 169.35 16.04 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.961 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 45.0 m -77.22 146.06 37.2 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.638 0.256 . . . . 0.0 110.477 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -73.27 -7.24 50.67 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.758 0.313 . . . . 0.0 111.365 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -59.91 -24.72 64.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.453 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.6 t -115.73 137.75 23.45 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.543 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.99 -32.44 44.46 Favored 'Trans proline' 0 CA--C 1.518 -0.281 0 C-N-CA 122.452 2.101 . . . . 0.0 111.151 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -60.7 -40.84 93.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.758 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.0 -36.74 93.42 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.008 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -69.92 -25.82 63.86 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 319' ' ' ARG . . . -74.49 -26.47 60.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.062 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -37.06 29.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.571 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 57.0 m-20 -69.69 -3.56 15.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 17.5 ptm180 -98.21 9.12 43.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 120.75 0.31 . . . . 0.0 111.482 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.59 ' NE ' ' HB2' ' A' ' 222' ' ' PRO . 8.8 ptm180 -75.84 -175.95 3.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 75.7 t -135.7 153.05 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.608 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -132.64 139.23 47.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 111.193 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.94 115.05 34.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.86 137.01 39.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 211' ' ' LEU . 42.0 t -104.32 142.24 18.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 C--N 1.318 -0.763 0 O-C-N 123.542 0.526 . . . . 0.0 110.514 177.367 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -75.48 119.72 19.94 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 67.34 103.01 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.425 0 O-C-N 123.758 0.661 . . . . 0.0 110.974 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.6 141.03 96.5 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.758 2.305 . . . . 0.0 111.821 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -40.43 -52.86 2.88 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.673 2.915 . . . . 0.0 112.952 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -102.74 120.77 6.92 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.792 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.53 -46.32 28.14 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.133 2.555 . . . . 0.0 114.864 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.71 139.54 48.41 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.272 1.981 . . . . 0.0 112.594 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.5 -22.87 60.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.011 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 26.2 t 72.15 -43.45 0.56 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.629 0.772 . . . . 0.0 111.846 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -95.84 -144.66 17.34 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.082 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.73 156.68 53.01 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.897 2.398 . . . . 0.0 111.786 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 10.6 t -112.17 -178.03 3.31 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.36 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.43 152.0 35.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.427 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.15 90.15 3.09 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.033 0.444 . . . . 0.0 110.017 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.456 ' O ' HG12 ' A' ' 215' ' ' ILE . 41.9 mt -75.32 -28.6 59.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.002 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.01 -43.7 98.29 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 120.917 0.389 . . . . 0.0 110.305 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 33.0 t -71.15 -41.25 70.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.78 82.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.611 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 211' ' ' LEU . 24.5 pt -72.53 -37.84 58.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.94 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -58.24 -36.21 72.86 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.751 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.39 -26.64 68.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.288 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.1 t -92.9 -43.68 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.465 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.484 ' HA ' HG21 ' A' ' 239' ' ' ILE . 70.2 p -67.43 -40.81 85.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.081 0.467 . . . . 0.0 110.899 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.26 24.57 59.02 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.62 -134.39 8.25 Favored Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -85.38 166.18 10.75 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.797 2.332 . . . . 0.0 113.037 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.454 HG21 ' CD1' ' A' ' 225' ' ' PHE . 48.5 mm -85.2 110.97 20.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.211 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -101.31 125.06 47.91 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.573 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.454 ' CD1' HG21 ' A' ' 223' ' ' ILE . 3.3 p90 -166.94 140.73 3.78 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 120.899 0.38 . . . . 0.0 111.069 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -88.53 77.32 1.82 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.146 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -78.39 88.02 4.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.254 0.549 . . . . 0.0 109.928 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -177.95 88.72 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.258 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 76.29 12.01 84.53 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.615 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -149.62 -73.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.425 0.155 . . . . 0.0 110.818 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 48.7 m 68.24 -160.87 0.2 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.8 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.3 mp -77.63 80.34 4.1 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.158 0.504 . . . . 0.0 112.138 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 44.6 mm -90.95 -48.42 0.35 Allowed Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.062 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -65.49 155.1 70.63 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 121.969 1.779 . . . . 0.0 111.475 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -91.13 9.6 30.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 238' ' ' GLU . 4.3 p-10 -78.0 -6.81 55.69 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.295 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -81.3 35.84 0.4 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.414 0.626 . . . . 0.0 111.564 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 236' ' ' ASP . 45.8 mt-10 -61.75 -17.26 55.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.172 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.484 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.5 mt -58.97 -39.02 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.442 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.45 -32.1 73.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.103 0.478 . . . . 0.0 110.782 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -71.41 -36.62 71.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -42.62 70.77 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.753 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.608 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 46.0 t -57.59 -42.36 81.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.6 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.55 80.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.284 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -49.8 -53.18 26.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.266 0.627 . . . . 0.0 112.623 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.0 -31.57 63.01 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.561 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 33.8 mt -64.09 -36.81 85.22 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.377 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -73.06 -22.6 60.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.263 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.64 80.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 110.006 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 49.0 t -126.79 70.8 73.58 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.6 -1.33 9.63 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 123.266 2.644 . . . . 0.0 114.145 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -79.71 -24.8 41.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.642 0.734 . . . . 0.0 109.289 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -70.42 135.0 48.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.522 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.15 140.41 29.83 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.0 m -116.05 132.22 66.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.241 0.543 . . . . 0.0 111.436 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 39.8 m -109.02 108.72 19.55 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.17 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 23.3 mt -92.32 114.4 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.486 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -101.74 127.48 48.5 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.453 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -107.64 147.3 16.36 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.323 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 37.8 m-85 -123.66 162.01 23.92 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.119 0.485 . . . . 0.0 110.612 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 34.6 p -147.34 170.48 17.24 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 124.229 1.011 . . . . 0.0 108.95 175.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.66 153.18 26.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.924 0.392 . . . . 0.0 110.535 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -94.12 -1.11 54.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -13.37 59.45 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.52 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -85.95 -172.51 48.81 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.682 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.8 m -78.9 124.59 28.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.661 0.23 . . . . 0.0 110.573 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.577 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 41.2 mt-10 -59.91 152.74 22.71 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.103 0.477 . . . . 0.0 111.409 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 103.04 -44.85 1.41 Allowed Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.048 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.437 ' N ' HD11 ' A' ' 269' ' ' ILE . 1.6 mp -79.31 -25.39 12.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 121.274 0.559 . . . . 0.0 110.076 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.577 ' OD1' ' HA ' ' A' ' 267' ' ' GLU . 0.4 OUTLIER -58.44 -42.88 88.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.668 -178.22 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.451 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 25.7 mm -58.11 -64.35 2.87 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.583 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.451 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.8 Cg_endo -58.92 -29.05 89.29 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.025 1.817 . . . . 0.0 112.272 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 58.4 tp -70.3 -52.93 19.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.335 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 14.7 p -63.5 -30.51 71.62 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.906 0.384 . . . . 0.0 110.512 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.6 73.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.785 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -67.0 -48.14 69.36 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -54.25 -49.02 70.49 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.382 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.2 90.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.176 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.488 ' HA ' HG23 ' A' ' 297' ' ' THR . 41.9 tptt -64.35 -30.57 71.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.227 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.85 -42.97 90.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.22 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.699 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.2 t -68.2 -45.81 82.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.836 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.7 -44.74 73.69 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.803 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.58 -38.82 82.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.914 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.49 -43.02 77.77 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.794 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 40.2 mt -62.78 -49.11 76.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.55 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 83.1 t -59.9 -40.83 83.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.511 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.74 -28.13 69.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.683 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -85.33 0.02 53.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.917 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.29 6.75 35.97 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.611 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 60.2 t -83.55 144.57 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 117.723 0.761 . . . . 0.0 109.793 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.09 109.95 6.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.305 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.48 -29.9 74.83 Favored Glycine 0 CA--C 1.509 -0.316 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.363 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -61.94 -19.29 62.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.204 0.526 . . . . 0.0 110.948 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -107.96 5.5 26.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.484 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.8 mt -106.26 129.1 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.76 124.64 48.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.71 0.291 . . . . 0.0 110.594 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.488 HG23 ' HA ' ' A' ' 279' ' ' LYS . 14.9 p -109.16 121.99 46.33 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.207 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 73.3 t -130.25 120.44 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.389 0.614 . . . . 0.0 112.045 -176.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -90.11 110.97 3.83 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 27.2 mt -90.41 -0.15 57.53 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 68.56 -125.38 20.2 Favored Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.54 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.1 t -105.81 121.92 45.03 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.448 HG13 ' ND2' ' A' ' 304' ' ' ASN . 75.5 t -136.95 -69.41 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.897 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.448 ' ND2' HG13 ' A' ' 303' ' ' VAL . 58.4 m-80 -112.38 91.68 17.21 Favored Pre-proline 0 C--O 1.242 0.702 0 CA-C-O 120.687 0.28 . . . . 0.0 110.747 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.63 135.32 41.52 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.611 2.207 . . . . 0.0 111.24 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.0 tt -84.65 -45.76 17.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.749 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -124.2 173.61 8.22 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.317 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.9 m -62.62 136.34 57.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.679 0.612 . . . . 0.0 111.253 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -80.64 -11.73 59.6 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.156 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.71 -19.7 65.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.07 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 3.2 t -113.34 139.47 23.23 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.329 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.0 -35.41 87.79 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.619 2.212 . . . . 0.0 111.535 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.565 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 71.5 mm-40 -60.34 -46.48 89.74 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.497 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -63.78 -37.77 95.18 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.717 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -61.85 -40.43 95.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.23 0.538 . . . . 0.0 109.948 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.7 -28.69 70.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.653 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 11.0 mmtp -79.49 -39.29 32.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.036 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -55.51 -28.26 53.59 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 32.0 ptt180 -83.58 12.07 6.27 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 28.6 ptt85 -57.53 173.66 0.26 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.901 0.88 . . . . 0.0 112.966 174.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 66.3 t -133.73 148.02 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.015 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -130.31 139.02 50.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.981 0.42 . . . . 0.0 111.071 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.2 mp -101.09 117.02 45.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.891 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.3 138.12 38.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.08 137.79 27.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.385 179.325 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.975 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -113.68 4.21 15.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 69.03 88.91 0.1 OUTLIER Pre-proline 0 C--O 1.239 0.538 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.793 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.2 142.22 97.77 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.65 2.233 . . . . 0.0 111.954 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.23 -19.73 67.76 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.766 2.31 . . . . 0.0 112.085 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -102.33 -136.06 9.04 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.859 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.13 152.72 31.48 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.569 2.179 . . . . 0.0 111.9 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -71.66 82.49 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.54 2.16 . . . . 0.0 111.78 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -114.13 4.74 15.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.754 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 34.0 t -102.63 5.82 39.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.359 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -145.33 -148.5 4.83 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.592 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.29 155.54 60.36 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 123.034 2.49 . . . . 0.0 112.192 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.418 ' SG ' ' N ' ' A' ' 209' ' ' ALA . 22.8 t -104.76 -175.14 2.71 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.636 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.418 ' N ' ' SG ' ' A' ' 208' ' ' CYS . . . -59.68 178.24 0.17 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.409 0.684 . . . . 0.0 111.632 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.09 78.12 6.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.092 0.472 . . . . 0.0 110.186 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.419 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.2 mm? -69.78 -29.1 66.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.67 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -63.82 -46.49 84.88 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.796 0.332 . . . . 0.0 110.536 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.1 t -72.05 -32.13 66.8 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.37 -47.32 76.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.182 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.452 ' CG2' HG11 ' A' ' 243' ' ' VAL . 22.0 pt -75.4 -39.48 41.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.848 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.441 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 17.9 t-20 -60.8 -33.4 72.94 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.974 0.416 . . . . 0.0 110.621 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.22 -28.03 69.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.081 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.4 t -90.61 -44.51 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.22 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.458 ' HA ' HG22 ' A' ' 239' ' ' ILE . 58.4 p -63.72 -36.07 82.64 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.967 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.0 25.19 41.73 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 124.52 -132.73 8.34 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.29 166.86 10.75 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.421 2.08 . . . . 0.0 112.183 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 51.5 mm -80.96 101.9 6.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.388 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -86.83 133.27 33.65 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.398 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.1 169.07 8.72 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.546 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -93.89 -109.14 2.05 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.059 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -75.35 -31.75 60.66 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 11.2 t70 73.07 131.08 0.04 OUTLIER 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.93 0.769 . . . . 0.0 111.258 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 136.18 -17.3 3.83 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.496 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -115.87 -90.98 0.54 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.4 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 65.2 p -169.99 -155.29 0.12 Allowed 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.1 mp -81.67 76.26 8.59 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.519 0.676 . . . . 0.0 110.297 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 62.6 mt -65.61 -42.15 53.85 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.566 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -49.07 159.12 1.1 Allowed 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.501 2.134 . . . . 0.0 112.729 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.15 -37.83 69.3 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.089 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -84.7 114.16 21.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.276 0.56 . . . . 0.0 112.165 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -134.3 7.3 3.62 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.783 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.27 -19.48 65.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.12 -173.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 219' ' ' THR . 74.1 mt -61.73 -38.14 79.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.401 ' CD1' HG11 ' A' ' 281' ' ' VAL . 4.2 mm? -61.05 -36.89 80.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.077 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -78.77 -34.85 45.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.105 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.43 -43.74 84.83 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.574 177.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.533 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 34.0 t -58.51 -42.68 85.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.722 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.8 81.54 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.477 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -53.74 -50.53 65.76 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -29.45 63.52 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.214 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.1 mt -72.21 -28.57 63.26 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 109.627 176.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -64.65 -31.96 73.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.84 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.72 -37.72 73.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.235 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 53.5 t -125.76 72.59 68.88 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.59 0.46 7.53 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.774 2.316 . . . . 0.0 112.734 -178.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.03 -31.43 56.27 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.84 145.15 56.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.563 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.37 145.62 28.68 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.11 127.28 75.84 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.904 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.4 m -103.89 109.34 21.05 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.521 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.422 HG12 HG23 ' A' ' 323' ' ' ILE . 19.4 mt -96.79 114.23 33.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-O 121.024 0.44 . . . . 0.0 109.916 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -102.59 126.01 49.52 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.345 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.433 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -104.41 144.94 15.92 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.506 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -127.35 161.88 27.6 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 38.3 p -141.31 170.8 15.05 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.799 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.86 155.09 39.12 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.017 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -88.33 -2.65 58.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.978 0.418 . . . . 0.0 110.585 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.8 m -66.36 -20.75 66.16 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 121.306 0.574 . . . . 0.0 110.339 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -117.98 82.39 0.33 Allowed Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 2.0 m -92.69 34.46 1.07 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.854 0.359 . . . . 0.0 111.265 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -80.08 -23.42 41.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.033 0.444 . . . . 0.0 111.171 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 114.37 -25.37 10.54 Favored Glycine 0 CA--C 1.497 -1.085 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.57 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.87 -22.25 28.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 121.797 0.808 . . . . 0.0 109.759 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.542 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 22.2 p30 -55.56 -33.25 63.69 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.374 177.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.449 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 20.1 mm -62.72 -65.0 2.4 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.174 177.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.449 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 11.2 Cg_endo -59.99 -27.45 84.93 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 121.887 1.725 . . . . 0.0 112.18 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.8 tp -67.36 -53.83 25.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.774 0.321 . . . . 0.0 111.532 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.433 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 6.5 p -62.47 -30.37 71.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.757 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.64 -31.56 66.99 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.16 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -69.1 -51.48 38.17 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.787 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 54.3 mmt-85 -58.78 -39.26 80.53 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.954 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.69 91.96 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.21 0.528 . . . . 0.0 109.872 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.503 ' HA ' HG23 ' A' ' 297' ' ' THR . 23.5 tptm -63.03 -34.87 78.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.968 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 54.9 mt -56.73 -44.32 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.566 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.725 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.3 t -66.25 -46.11 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.623 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -54.47 -45.94 73.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.051 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.69 -36.44 82.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.904 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -68.83 -41.41 78.61 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.645 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 31.8 mt -66.14 -48.1 71.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.844 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 89.2 t -59.33 -43.05 89.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.511 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.0 -28.31 68.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.267 0.556 . . . . 0.0 110.438 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -85.98 3.04 43.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.046 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 108.5 5.08 32.21 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.74 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 49.6 t -88.26 140.29 16.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 117.782 0.791 . . . . 0.0 110.225 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.93 117.25 8.03 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.561 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.69 86.56 Favored Glycine 0 CA--C 1.51 -0.265 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.15 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -15.26 63.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.964 0.412 . . . . 0.0 111.444 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -98.52 0.31 44.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.0 110.65 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.3 mt -109.27 129.37 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.498 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.32 129.58 54.94 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.937 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.503 HG23 ' HA ' ' A' ' 279' ' ' LYS . 25.0 p -115.58 128.09 55.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.524 0.202 . . . . 0.0 111.172 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 26.9 t -133.54 128.09 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -99.81 108.64 3.57 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 18.5 mt -92.36 3.2 55.92 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 68.53 -127.74 23.56 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.559 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 15.1 m -93.6 115.61 28.1 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.834 0.35 . . . . 0.0 110.525 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.5 p -176.12 150.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 60.7 t30 70.29 74.52 0.26 Allowed Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 123.871 0.732 . . . . 0.0 111.078 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.587 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 73.5 Cg_endo -75.07 155.33 42.58 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.647 2.231 . . . . 0.0 112.792 -177.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.0 tt -124.59 -44.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.445 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -138.44 174.98 9.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.47 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 50.8 m -71.16 131.16 43.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.279 0.562 . . . . 0.0 111.702 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -80.81 -7.66 59.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.417 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.14 -16.88 63.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.808 178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 314' ' ' GLY . 5.2 t -123.23 144.39 43.49 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -54.49 -36.52 88.52 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.067 2.511 . . . . 0.0 112.118 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.1 mm-40 -55.49 -51.15 67.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.983 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -69.33 -40.85 80.2 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.693 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -56.35 -41.05 75.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.025 0.44 . . . . 0.0 110.339 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.96 70.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.737 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 0.3 OUTLIER -80.63 -42.97 21.24 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.597 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.587 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 39.2 m-80 -63.85 -23.83 67.51 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -176.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.558 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 10.4 ptm180 -84.98 12.87 6.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.29 0.567 . . . . 0.0 111.929 -178.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -58.61 177.74 0.13 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.303 1.049 . . . . 0.0 113.437 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 68.8 t -136.32 144.7 32.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.766 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -131.1 137.3 49.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.115 0.483 . . . . 0.0 111.376 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.422 HG23 HG12 ' A' ' 257' ' ' ILE . 2.1 mp -98.7 120.34 47.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.629 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.68 135.06 50.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 89.4 t -95.43 141.89 14.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.185 0.517 . . . . 0.0 111.694 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 . . . . . 0 C--N 1.311 -1.091 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.765 178.454 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.356 0 N-CA-C 112.218 -0.353 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -116.84 -27.57 6.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.591 0.234 . . . . 0.0 110.835 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 61.9 76.3 0.4 Allowed Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.428 -176.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.54 139.56 14.43 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.918 2.412 . . . . 0.0 111.913 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.14 129.41 24.23 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.69 2.26 . . . . 0.0 111.905 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.16 159.41 47.1 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.922 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.86 139.08 89.27 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.97 2.447 . . . . 0.0 112.425 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -74.62 61.0 5.26 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.837 2.358 . . . . 0.0 111.607 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -80.95 -39.16 26.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.98 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 39.4 m 54.08 -143.89 0.7 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.967 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.22 -161.76 25.56 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.909 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.16 106.95 0.32 Allowed 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.712 2.275 . . . . 0.0 111.634 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 53.9 t -104.43 146.5 28.77 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.121 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -59.28 154.26 16.84 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.19 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.04 69.43 3.32 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.058 0.456 . . . . 0.0 110.039 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.52 ' O ' HG12 ' A' ' 215' ' ' ILE . 35.4 mt -55.53 -27.24 47.67 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.342 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -55.95 -60.38 3.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.274 0.559 . . . . 0.0 109.968 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 39.9 t -69.44 -27.1 64.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.178 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -69.46 -49.32 55.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.273 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 211' ' ' LEU . 29.3 pt -74.08 -40.51 51.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 121.054 -0.259 . . . . 0.0 111.304 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -60.9 -29.6 69.68 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.089 0.471 . . . . 0.0 110.584 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.47 -27.76 68.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.178 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.9 t -89.55 -45.01 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.229 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.46 ' HA ' HG22 ' A' ' 239' ' ' ILE . 75.8 p -67.0 -38.33 85.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.443 0.64 . . . . 0.0 109.861 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.74 21.75 61.1 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.89 -122.64 4.19 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.422 ' HA ' ' HG2' ' A' ' 322' ' ' GLU . 84.0 Cg_endo -89.17 159.88 5.73 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.74 2.293 . . . . 0.0 113.979 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.5 mm -78.32 107.99 11.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.406 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.43 118.58 29.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.026 0.441 . . . . 0.0 110.005 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -86.46 152.11 22.95 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.502 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -107.97 63.2 0.28 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.05 132.26 43.02 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -138.98 7.2 2.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.369 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 169.34 -75.55 0.11 Allowed Glycine 0 CA--C 1.503 -0.677 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.896 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -152.56 20.55 0.62 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.6 p -83.72 -59.12 2.53 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.899 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 45.2 tp 58.23 73.85 0.45 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.668 0.746 . . . . 0.0 110.388 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 9.9 pt -123.67 88.45 51.95 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.573 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.46 167.37 24.24 Favored 'Trans proline' 0 C--O 1.239 0.54 0 C-N-CA 122.521 2.147 . . . . 0.0 111.803 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.7 94.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.278 0.561 . . . . 0.0 110.028 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -147.17 114.27 6.2 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.46 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -92.97 -2.1 56.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.293 0.568 . . . . 0.0 110.199 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -74.09 -19.15 60.69 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.819 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.46 HG22 ' HA ' ' A' ' 219' ' ' THR . 90.4 mt -61.63 -37.61 78.34 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 46.6 mt -66.27 -35.07 79.45 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.451 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -69.88 -37.12 75.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -46.77 71.34 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.762 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.63 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.8 t -61.79 -46.06 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.77 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.08 -31.51 72.76 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.441 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.04 -44.06 97.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.42 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 243' ' ' VAL . 0.6 OUTLIER -75.48 -27.21 58.75 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.596 -179.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 43.9 mt -65.39 -28.41 69.24 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 121.205 0.526 . . . . 0.0 109.622 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -78.55 -22.36 47.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.318 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.94 -30.55 66.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.36 0.6 . . . . 0.0 110.068 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 13.3 t -132.74 69.85 79.27 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.97 -2.01 7.99 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.442 2.762 . . . . 0.0 114.231 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.46 -18.39 28.35 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.443 0.64 . . . . 0.0 109.939 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -71.88 131.01 42.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.005 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -91.58 138.52 31.5 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.4 m -114.89 130.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-O 121.204 0.526 . . . . 0.0 111.603 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.1 m -107.87 107.48 18.23 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.193 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 21.6 mt -90.15 117.32 33.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.768 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -105.8 126.92 52.73 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.787 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -107.22 145.78 16.06 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 6.9 m-85 -124.29 158.57 32.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.944 0.402 . . . . 0.0 109.996 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.551 ' OG1' ' HB2' ' A' ' 270' ' ' ASN . 16.6 p -144.54 170.1 16.69 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.611 0.764 . . . . 0.0 109.935 177.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.417 ' OD2' ' HB ' ' A' ' 264' ' ' THR . 19.2 t70 -94.96 166.74 11.8 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.66 9.81 17.56 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.747 0.308 . . . . 0.0 110.723 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.417 ' HB ' ' OD2' ' A' ' 262' ' ' ASP . 12.2 t -64.28 -32.51 74.13 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.751 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -85.52 175.47 49.27 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.99 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 14.5 m -65.73 139.53 58.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.783 0.325 . . . . 0.0 110.702 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.03 140.19 58.82 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . 0.441 ' O ' ' HD2' ' A' ' 272' ' ' PRO . . . 96.48 -41.5 2.38 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.167 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 269' ' ' ILE . 1.6 mp -74.98 -26.68 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.331 0.586 . . . . 0.0 109.926 -178.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.551 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 3.7 p30 -65.4 -27.58 68.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.544 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.479 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 27.4 mm -62.65 -63.88 3.68 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-O 119.664 -0.208 . . . . 0.0 110.989 178.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.479 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 1.6 Cg_endo -53.97 -37.16 85.87 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.428 2.085 . . . . 0.0 111.313 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 25.2 tp -62.22 -52.55 63.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.428 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 22.3 m -61.48 -30.97 70.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.783 0.325 . . . . 0.0 110.401 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.8 -28.91 64.99 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.885 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -71.51 -45.54 62.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 22.1 mmm180 -56.59 -46.84 80.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.524 178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.85 88.91 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.462 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.483 ' HA ' HG23 ' A' ' 297' ' ' THR . 16.8 ttpt -62.97 -32.06 73.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.912 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 64.4 mt -56.22 -43.63 77.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.203 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.707 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 7.8 t -69.62 -44.24 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.126 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.17 73.77 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 123.291 0.369 . . . . 0.0 110.663 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.8 -40.42 84.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.863 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -69.8 -40.35 76.03 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.265 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 46.6 mt -64.77 -47.61 77.53 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 92.3 t -60.92 -39.22 81.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.284 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.91 -28.42 69.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.834 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.611 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 2.4 mmp_? -86.86 4.57 40.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.301 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.9 5.43 44.37 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.043 -1.075 . . . . 0.0 114.649 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 58.0 t -84.18 145.24 8.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 117.801 0.801 . . . . 0.0 109.904 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.3 112.79 6.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.42 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.58 -33.88 87.86 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.067 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -69.76 -12.6 61.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.589 0.233 . . . . 0.0 111.318 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -104.52 1.71 30.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.847 0.356 . . . . 0.0 110.615 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 70.4 mt -105.12 131.45 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.922 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.58 125.7 49.43 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.068 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.483 HG23 ' HA ' ' A' ' 279' ' ' LYS . 11.6 p -107.51 129.51 54.95 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.888 0.375 . . . . 0.0 111.406 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.48 136.98 52.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.803 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.49 114.49 4.12 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 17.5 mt -91.48 -5.33 54.41 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 71.3 -135.59 24.1 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.073 -1.061 . . . . 0.0 111.397 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 261' ' ' THR . 7.5 t -87.99 114.56 24.72 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.151 0.5 . . . . 0.0 110.029 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.9 p -176.65 150.31 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 44.7 t30 65.9 78.87 0.25 Allowed Pre-proline 0 C--N 1.311 -1.076 0 O-C-N 123.75 0.656 . . . . 0.0 111.1 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.594 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 39.7 Cg_endo -68.69 138.24 40.87 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.818 2.345 . . . . 0.0 113.154 -177.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 7.4 tt -110.79 -25.43 3.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.768 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -152.45 163.62 39.16 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 47.8 t -62.84 134.23 55.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.042 0.449 . . . . 0.0 110.988 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -80.61 -11.61 59.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.63 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.2 36.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.169 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 3.1 t -124.74 138.03 30.56 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.916 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.99 -26.63 82.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.894 2.396 . . . . 0.0 111.78 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 8.4 mm-40 -65.33 -41.87 93.52 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.3 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.41 -38.38 93.51 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.49 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -63.6 -37.87 88.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.37 68.89 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.827 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 9.0 mmtp -84.65 -38.45 19.81 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.822 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.594 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 38.5 m-80 -63.74 -21.16 66.27 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 13.0 ptm180 -82.11 14.55 2.79 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.156 0.503 . . . . 0.0 111.232 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -65.42 -174.38 0.18 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.106 0.963 . . . . 0.0 113.13 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.5 t -141.81 148.28 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.722 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.422 ' HG2' ' HA ' ' A' ' 222' ' ' PRO . 47.6 mt-10 -133.84 135.9 44.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.747 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 mp -94.23 119.34 42.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.37 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 91.6 t -106.62 136.67 40.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.49 139.61 22.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.341 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.353 177.469 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.417 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -135.71 151.52 50.25 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -157.96 71.25 4.12 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.403 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.59 -47.51 26.9 Favored 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 122.348 2.032 . . . . 0.0 112.209 175.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.07 47.24 2.19 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 121.967 1.778 . . . . 0.0 110.715 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.39 94.07 0.37 Allowed Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.632 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.93 140.34 78.9 Favored 'Trans proline' 0 C--O 1.238 0.481 0 C-N-CA 122.62 2.214 . . . . 0.0 112.373 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -52.56 121.42 9.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.613 2.209 . . . . 0.0 111.538 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -82.41 -22.59 35.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.694 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 34.6 t -99.42 129.69 45.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.253 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -82.04 -92.67 0.56 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.67 98.19 1.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.293 1.995 . . . . 0.0 111.493 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 22.3 t -104.06 176.37 5.18 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -51.76 145.04 10.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.728 0.299 . . . . 0.0 111.272 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.73 85.86 1.22 Allowed 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.523 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.421 ' O ' HG12 ' A' ' 215' ' ' ILE . 23.7 mt -70.35 -33.64 71.69 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.939 -177.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -63.76 -45.74 88.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.24 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 31.5 t -75.63 -23.34 56.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.057 0.456 . . . . 0.0 109.917 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -72.49 -49.91 29.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.206 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 211' ' ' LEU . 26.7 pt -70.63 -38.27 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.868 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -55.7 -37.21 68.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.951 0.405 . . . . 0.0 110.975 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.5 -26.87 68.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.492 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.8 t -92.26 -47.96 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 120.921 0.391 . . . . 0.0 110.63 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.441 ' HA ' HG21 ' A' ' 239' ' ' ILE . 81.6 p -64.35 -39.17 93.36 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.615 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.8 22.51 59.63 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.4 -130.55 6.84 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.19 156.31 25.98 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.573 2.182 . . . . 0.0 112.044 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -74.1 109.29 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -104.33 119.54 39.2 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.496 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -123.33 -174.66 3.01 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 232' ' ' LEU . . . -64.74 97.95 0.27 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -170.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.45 ' ND2' HD12 ' A' ' 232' ' ' LEU . 21.5 m120 -85.35 -13.01 50.85 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -64.15 -24.44 67.69 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.783 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -81.7 4.2 75.33 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.946 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 72.37 -58.49 0.59 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.142 0.977 . . . . 0.0 112.085 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.3 m -76.32 4.15 9.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.466 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.496 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 58.4 tp 61.82 87.34 0.1 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.524 0.678 . . . . 0.0 111.2 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 21.4 pt -138.39 134.32 17.49 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.176 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -85.52 126.61 3.1 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.13 1.887 . . . . 0.0 111.32 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -88.11 -53.68 4.6 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.576 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -155.58 102.92 2.26 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.582 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -121.9 111.51 17.17 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.304 0.573 . . . . 0.0 111.196 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -68.05 -20.91 65.02 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.101 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 243' ' ' VAL . 77.8 mt -64.41 -39.8 86.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.33 -33.4 75.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.894 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -71.73 -36.03 70.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.583 0.706 . . . . 0.0 109.177 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -42.28 78.73 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.719 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.616 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 44.6 t -62.5 -43.9 98.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.334 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -55.82 -37.24 68.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.713 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -49.06 -53.31 20.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.56 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.416 ' HB2' HD23 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -82.51 -14.53 54.83 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.821 -176.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.4 mt -80.47 -26.09 38.47 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.339 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -83.54 -23.15 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.628 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.84 -37.32 76.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.203 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 24.6 t -130.09 71.97 82.06 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-O 121.339 0.59 . . . . 0.0 109.505 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.35 -1.4 11.25 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.164 2.576 . . . . 0.0 113.244 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -79.15 -29.69 43.19 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.872 0.844 . . . . 0.0 108.872 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -81.46 134.68 35.57 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.733 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -90.79 147.02 23.48 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.953 0.406 . . . . 0.0 110.508 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.13 137.75 52.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.587 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.0 m -114.13 113.1 24.24 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.551 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.432 HG12 HG22 ' A' ' 323' ' ' ILE . 21.4 mt -94.15 113.85 29.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.578 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -98.47 126.66 44.1 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.37 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -107.48 146.82 16.25 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 36.3 m-85 -127.4 161.89 27.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.1 0.476 . . . . 0.0 110.688 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 56.9 p -140.58 173.28 11.65 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.529 175.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -83.62 153.63 24.18 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -95.11 12.85 27.23 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 35.7 p -62.82 -7.74 5.62 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.88 131.6 6.52 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.2 t -43.5 135.2 3.74 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.119 0.568 . . . . 0.0 112.309 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.5 ' OE2' ' HB2' ' A' ' 270' ' ' ASN . 7.1 tp10 -57.84 151.08 18.64 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.097 -177.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 140.07 -60.76 0.56 Allowed Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp -83.15 -27.44 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.465 0.65 . . . . 0.0 109.857 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.5 ' HB2' ' OE2' ' A' ' 267' ' ' GLU . 12.3 m-20 -62.87 -36.54 83.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.427 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.493 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 27.3 mm -56.58 -64.22 2.67 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.019 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.493 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 5.1 Cg_endo -56.79 -35.65 98.14 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 121.944 1.763 . . . . 0.0 111.914 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.481 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 60.2 tp -63.07 -52.92 60.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.686 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 13.0 p -62.98 -31.52 72.66 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.99 0.424 . . . . 0.0 110.468 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.45 -34.04 77.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.742 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -66.92 -44.96 79.38 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 38.8 mmt180 -56.86 -47.38 80.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.008 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.75 88.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.018 0.437 . . . . 0.0 110.373 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.473 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.9 tptt -65.97 -32.36 73.8 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.092 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 62.5 mt -58.55 -45.76 90.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.197 0.522 . . . . 0.0 109.684 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.688 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.2 t -65.8 -48.08 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.792 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.52 -41.98 70.32 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.076 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.64 -42.63 88.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.472 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -66.84 -43.06 84.69 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.491 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 41.7 mt -64.03 -51.05 66.02 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.887 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.9 t -59.41 -40.55 81.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.91 71.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.555 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.507 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 1.2 mmp_? -83.72 6.23 21.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.064 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.04 9.5 51.73 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.748 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.502 ' CG1' HD13 ' A' ' 295' ' ' ILE . 59.0 t -84.9 141.4 14.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.28 113.86 7.01 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.346 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.01 -32.7 76.34 Favored Glycine 0 C--N 1.318 -0.43 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.707 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.59 -19.15 62.88 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.798 0.332 . . . . 0.0 111.593 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.64 0.32 49.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.473 0.654 . . . . 0.0 110.005 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . 0.502 HD13 ' CG1' ' A' ' 290' ' ' VAL . 63.5 mt -110.81 133.32 56.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.142 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -121.4 129.67 53.15 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.473 HG21 ' HA ' ' A' ' 279' ' ' LYS . 29.9 p -109.02 125.94 52.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.899 0.381 . . . . 0.0 111.429 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.9 t -127.89 117.41 46.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.12 111.96 3.9 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.442 174.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 20.9 mt -96.75 1.1 50.5 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 58.91 -127.47 45.36 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 44.4 t -102.34 122.34 44.07 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.85 -59.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -117.46 92.93 41.91 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -66.45 174.24 6.57 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.857 2.371 . . . . 0.0 113.267 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 5.3 tt -131.27 -48.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.591 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -120.51 172.43 7.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.254 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 27.9 m -67.19 139.75 57.44 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.037 0.446 . . . . 0.0 111.351 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -81.01 -10.08 59.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.646 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.14 -16.37 61.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.349 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.6 t -115.82 144.44 32.66 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.513 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.97 -31.32 24.36 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.215 1.943 . . . . 0.0 110.942 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.88 -35.41 81.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.653 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -71.34 -36.97 63.14 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.4 ' O ' ' HG2' ' A' ' 319' ' ' ARG . 11.3 mtp85 -57.66 -39.46 77.1 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.59 -30.93 71.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.22 -46.34 20.64 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.807 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -61.69 -26.03 67.78 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 14.9 ptp180 -83.62 10.65 8.69 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.015 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -57.14 177.76 0.08 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.01 0.91 . . . . 0.0 112.715 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 58.4 t -137.37 144.64 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.054 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -131.98 138.42 48.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.984 0.421 . . . . 0.0 111.115 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.432 HG22 HG12 ' A' ' 257' ' ' ILE . 1.6 mp -100.0 120.47 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.992 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 75.1 t -108.45 134.24 50.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 53.5 t -98.1 133.47 40.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--N 1.318 -0.762 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.867 -178.772 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.166 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -91.16 163.15 14.37 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -117.63 91.78 39.29 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-O 120.651 0.263 . . . . 0.0 110.745 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -89.32 117.71 0.8 Allowed 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.99 2.46 . . . . 0.0 112.097 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.17 -24.94 72.67 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.531 2.154 . . . . 0.0 111.748 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 83.22 -124.54 6.59 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.01 150.32 60.44 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.138 1.892 . . . . 0.0 110.992 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.41 107.86 0.3 Allowed 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.632 2.222 . . . . 0.0 112.01 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.54 -38.72 87.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.33 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.5 t -90.63 -34.78 15.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.92 0.39 . . . . 0.0 110.492 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 82.34 88.02 0.7 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.536 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -89.75 37.55 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.944 2.429 . . . . 0.0 111.349 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 34.1 t -137.66 -179.12 5.56 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.781 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -60.92 169.31 1.98 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.288 0.635 . . . . 0.0 112.151 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -84.0 88.83 7.17 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.339 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.7 mm? -67.86 -39.3 83.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.766 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -57.83 -55.65 32.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.423 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.4 t -67.33 -34.68 77.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.65 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.89 -46.74 80.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.686 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 211' ' ' LEU . 23.6 pt -71.67 -38.6 67.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.501 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -57.68 -33.79 68.72 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.588 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.26 -26.33 68.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.216 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.573 HG11 ' CB ' ' A' ' 242' ' ' ARG . 8.2 t -92.79 -45.73 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.447 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 75.5 p -64.36 -42.91 95.95 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.274 0.559 . . . . 0.0 110.397 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.96 13.45 83.06 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 143.32 -131.25 4.44 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.67 164.77 5.17 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.029 2.486 . . . . 0.0 113.593 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.1 mm -81.69 109.8 16.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.324 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -91.27 121.91 33.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.047 0.451 . . . . 0.0 110.833 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -90.81 158.06 17.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.459 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -141.97 100.36 0.25 Allowed Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -84.72 133.11 34.38 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.777 0.322 . . . . 0.0 111.244 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -125.9 161.14 28.14 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -66.79 -8.7 49.36 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.37 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -91.64 -56.02 3.27 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 120.921 0.391 . . . . 0.0 110.489 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 12.5 t -177.32 -177.5 0.71 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 67.4 tp -78.49 103.25 8.3 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 9.0 tt -106.1 110.02 63.65 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.34 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.02 127.31 13.44 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.074 1.85 . . . . 0.0 111.664 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.96 -25.71 65.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.169 0.509 . . . . 0.0 110.02 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -133.68 91.2 2.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.021 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -81.6 -0.08 40.72 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.871 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -83.54 -27.98 28.95 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.379 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 243' ' ' VAL . 58.6 mt -67.6 -49.01 74.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.795 -175.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.482 ' CD2' HG12 ' A' ' 281' ' ' VAL . 37.6 mt -59.3 -40.41 86.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.206 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -70.78 -36.27 72.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 110.185 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.573 ' CB ' HG11 ' A' ' 218' ' ' VAL . 7.8 mmt180 -63.68 -54.99 26.99 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.5 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.653 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 69.2 t -53.47 -46.8 59.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.646 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.84 85.13 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.764 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -60.15 -45.62 92.42 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.665 0.269 . . . . 0.0 111.605 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 243' ' ' VAL . 0.4 OUTLIER -74.38 -26.27 60.01 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.735 -179.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 35.0 mt -69.16 -28.87 66.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.258 0.551 . . . . 0.0 110.279 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -77.08 -24.94 51.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.843 176.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -73.1 -40.7 64.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.533 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 50.0 t -125.13 73.74 66.47 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 121.332 0.587 . . . . 0.0 109.848 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.65 -0.03 8.8 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.442 2.761 . . . . 0.0 113.424 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.96 -26.7 57.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.887 0.851 . . . . 0.0 109.538 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -78.82 130.09 35.32 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -94.98 142.22 27.74 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.2 m -118.15 135.73 57.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.429 0.633 . . . . 0.0 112.315 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.0 m -108.15 108.25 19.23 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 323' ' ' ILE . 26.2 mt -91.47 114.3 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.767 -178.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -102.93 129.09 49.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.352 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.433 ' C ' ' HG ' ' A' ' 274' ' ' SER . . . -105.28 156.62 16.68 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.641 177.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 19.9 m-85 -132.53 159.31 39.78 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.005 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.8 p -143.1 166.13 25.5 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.406 ' CG ' ' HE ' ' A' ' 315' ' ' ARG . 2.7 p30 -76.16 151.51 36.93 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.009 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -85.09 3.37 39.17 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.577 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.77 -15.0 43.51 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.08 0.467 . . . . 0.0 111.042 177.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -77.57 173.66 54.95 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.715 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.8 t -76.04 123.83 26.41 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 120.655 0.264 . . . . 0.0 110.34 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.505 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 41.6 tt0 -63.17 133.45 54.37 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.356 -0.384 . . . . 0.0 109.997 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 113.75 -40.42 2.51 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 120.442 -0.885 . . . . 0.0 110.937 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 42.6 mm -84.76 -29.05 6.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.843 0.83 . . . . 0.0 109.071 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 267' ' ' GLU . 8.2 p30 -67.08 -32.69 74.02 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.786 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.419 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 22.4 mm -57.44 -63.64 3.52 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.43 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.419 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 17.9 Cg_endo -61.58 -30.12 85.42 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 122.248 1.966 . . . . 0.0 111.96 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.18 -50.14 64.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 110.455 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.433 ' HG ' ' C ' ' A' ' 259' ' ' GLY . 10.0 t -57.24 -40.95 78.62 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.01 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.63 -30.98 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.749 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -69.95 -45.14 68.08 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.993 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -64.07 -39.73 94.72 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.342 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.6 87.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.002 0.43 . . . . 0.0 109.871 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.476 ' HA ' HG21 ' A' ' 297' ' ' THR . 7.8 ttpt -60.54 -36.91 79.57 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.735 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 58.9 mt -56.39 -47.05 82.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.811 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.534 ' O ' HD13 ' A' ' 285' ' ' LEU . 17.1 t -63.34 -46.89 94.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.941 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.54 -43.16 89.17 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -61.37 -39.91 92.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.16 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.601 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 8.0 m-85 -70.65 -42.38 70.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.993 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 281' ' ' VAL . 1.8 mp -61.94 -48.85 78.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 84.2 t -60.45 -40.38 84.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.501 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.5 -30.95 71.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.182 0.515 . . . . 0.0 110.608 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 20.7 mmm180 -83.12 5.45 22.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.735 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.51 2.24 40.67 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.075 -1.059 . . . . 0.0 114.45 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 61.4 t -80.55 145.24 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 117.842 0.821 . . . . 0.0 109.829 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.5 ' HB3' ' ND1' ' A' ' 294' ' ' HIS . . . -77.46 118.86 20.31 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.148 0.499 . . . . 0.0 111.376 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.65 -30.88 62.99 Favored Glycine 0 C--O 1.222 -0.612 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.873 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -68.81 -16.92 63.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.5 ' ND1' ' HB3' ' A' ' 291' ' ' ALA . 29.4 m170 -95.85 -5.24 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.724 0.297 . . . . 0.0 110.808 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . 0.425 HD11 ' CG1' ' A' ' 290' ' ' VAL . 40.6 mt -110.83 130.17 64.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.228 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.69 125.71 51.18 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.126 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.476 HG21 ' HA ' ' A' ' 279' ' ' LYS . 29.7 p -111.75 122.56 48.13 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.262 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 28.2 m -120.09 164.24 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.483 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.401 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -134.36 105.15 0.55 Allowed Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 14.4 mt -89.59 2.54 54.54 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 69.99 -126.4 17.07 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.561 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 11.8 p -97.18 120.64 37.9 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.828 0.347 . . . . 0.0 110.651 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.4 p -176.31 150.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.339 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 61.66 81.98 0.23 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 123.488 0.715 . . . . 0.0 111.636 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.584 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 94.3 Cg_endo -80.7 154.55 20.49 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.458 2.106 . . . . 0.0 113.004 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.1 tt -119.0 -53.41 3.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.665 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -119.21 166.56 12.82 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.7 p -65.01 143.9 57.64 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.111 0.482 . . . . 0.0 111.491 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -80.19 -7.52 59.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.416 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.17 -18.71 63.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.846 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.7 t -113.72 135.54 21.98 Favored Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.697 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.6 -33.41 86.86 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.789 2.326 . . . . 0.0 111.137 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.0 mm-40 -66.36 -39.94 89.47 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.247 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -69.03 -37.66 83.2 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.123 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.406 ' HE ' ' CG ' ' A' ' 262' ' ' ASP . 80.6 mtp180 -61.49 -37.67 84.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.112 0.482 . . . . 0.0 109.724 176.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.63 68.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.661 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 1.0 OUTLIER -80.71 -39.76 26.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.367 177.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.584 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 44.3 m-80 -65.7 -22.13 66.6 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 39.0 ptt180 -84.41 10.78 9.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.279 0.561 . . . . 0.0 111.507 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 18.7 ptt-85 -58.74 178.58 0.11 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.952 0.882 . . . . 0.0 112.698 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 49.7 t -138.35 145.4 28.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.562 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -130.21 137.01 49.83 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.932 0.396 . . . . 0.0 110.61 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.406 HG23 HG12 ' A' ' 257' ' ' ILE . 2.2 mp -97.22 116.97 40.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.407 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.67 137.38 39.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 49.2 t -100.25 138.81 23.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 C--N 1.31 -1.125 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.416 178.906 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.454 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -143.89 -49.82 0.3 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.185 0.517 . . . . 0.0 109.644 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.37 158.43 63.58 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.541 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 201' ' ' GLY . 19.2 Cg_endo -58.85 130.54 37.26 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.335 2.024 . . . . 0.0 111.513 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.87 22.13 0.41 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.86 2.374 . . . . 0.0 112.976 -179.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 199' ' ' PRO . . . -90.19 -117.67 1.84 Allowed Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.811 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -70.27 112.8 3.26 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.822 2.348 . . . . 0.0 111.973 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.58 -70.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.424 2.082 . . . . 0.0 110.647 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -139.5 27.3 2.29 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.6 p -56.65 149.61 17.39 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.805 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 106.41 104.81 2.97 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.15 -36.8 99.23 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.844 2.363 . . . . 0.0 111.889 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 4.3 m -153.81 -177.75 6.59 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.865 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.54 149.65 42.49 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.206 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.89 73.7 2.13 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.153 0.501 . . . . 0.0 110.199 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 247' ' ' LEU . 16.4 mt -56.83 -27.67 60.47 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.81 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.05 -42.87 88.92 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.758 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 26.0 t -73.19 -31.88 64.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.469 ' HB1' ' HZ1' ' A' ' 246' ' ' LYS . . . -64.53 -47.88 77.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.894 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 20.9 pt -73.85 -33.7 37.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.121 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -56.36 -37.88 70.67 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.079 0.466 . . . . 0.0 110.466 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.28 -29.74 70.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.877 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 32.5 t -82.38 -52.52 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.671 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 76.0 p -64.86 -36.23 83.68 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.424 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.67 12.62 79.78 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.27 -125.87 2.78 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -91.35 167.23 3.5 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.839 2.359 . . . . 0.0 112.936 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.6 mm -84.22 110.46 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.008 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -100.23 124.39 45.61 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.996 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.2 141.34 1.25 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.539 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 72.92 93.54 0.1 OUTLIER Glycine 0 C--O 1.236 0.221 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.443 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -86.71 173.17 9.65 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -85.1 131.32 34.46 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.66 88.13 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.011 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -119.93 179.78 4.15 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.5 t -90.33 -178.76 5.45 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -79.71 86.13 5.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 11.0 pt -104.59 111.63 65.23 Favored Pre-proline 0 C--N 1.313 -0.984 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.637 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -83.26 134.44 6.83 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.698 2.265 . . . . 0.0 112.462 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -81.86 91.74 6.58 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.771 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.5 t70 66.44 94.6 0.06 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.294 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -81.26 5.75 16.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -64.36 -29.25 70.32 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.424 ' O ' HG21 ' A' ' 243' ' ' VAL . 71.6 mt -64.09 -44.72 97.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.149 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.411 HD11 ' CD2' ' A' ' 284' ' ' TYR . 28.9 mt -57.2 -36.17 70.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.228 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -79.94 -38.2 32.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.171 0.51 . . . . 0.0 110.321 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -40.48 95.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.105 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.59 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 28.1 t -59.07 -41.42 83.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.971 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.22 78.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.826 -177.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.57 -44.9 73.35 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.469 ' HZ1' ' HB1' ' A' ' 214' ' ' ALA . 0.0 OUTLIER -82.19 -16.18 50.64 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.709 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 23.5 mt -81.06 -22.56 39.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -71.82 -25.05 61.83 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.685 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -64.03 -46.47 84.3 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.394 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.417 ' SG ' ' HB1' ' A' ' 253' ' ' ALA . 52.1 t -128.92 75.94 79.68 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.42 -2.61 11.53 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.958 2.439 . . . . 0.0 113.243 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.09 -23.38 23.73 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.417 ' HB1' ' SG ' ' A' ' 250' ' ' CYS . . . -62.3 138.26 58.4 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.604 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -93.88 133.21 37.53 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.59 129.2 68.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-O 121.141 0.496 . . . . 0.0 110.751 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 33.3 m -103.84 108.66 20.08 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.051 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.404 HG12 HG21 ' A' ' 323' ' ' ILE . 24.5 mt -93.83 108.86 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -98.15 128.46 44.65 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.921 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.467 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -104.67 144.86 15.87 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 177.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 8.6 m-85 -126.13 163.62 22.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.692 0.282 . . . . 0.0 110.327 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 45.6 p -143.21 162.47 35.54 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.296 0.638 . . . . 0.0 109.616 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -68.77 151.78 46.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.075 0.464 . . . . 0.0 110.889 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -77.69 -5.16 49.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.717 -177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.423 HG22 ' CZ ' ' A' ' 315' ' ' ARG . 0.7 OUTLIER -84.02 -27.59 28.27 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.56 179.02 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -106.11 37.39 3.84 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.738 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.48 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 14.4 m -92.7 75.48 4.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.125 0.488 . . . . 0.0 110.505 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -128.67 25.47 5.68 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.914 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . 0.425 ' O ' ' HD2' ' A' ' 272' ' ' PRO . . . 110.44 -48.84 0.9 Allowed Glycine 0 CA--C 1.503 -0.668 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.107 177.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.7 mp -61.49 -24.79 34.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 123.615 0.766 . . . . 0.0 110.559 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.48 ' OD1' ' HA ' ' A' ' 266' ' ' SER . 0.7 OUTLIER -54.64 -38.87 67.38 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.149 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.41 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 19.6 mm -60.43 -63.9 3.72 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.072 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' A' ' 268' ' ' GLY . 11.8 Cg_endo -60.74 -30.97 91.37 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.867 1.711 . . . . 0.0 112.33 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 60.3 tp -65.52 -53.09 47.31 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.776 0.322 . . . . 0.0 111.477 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.467 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.9 p -61.82 -30.39 70.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 120.933 0.396 . . . . 0.0 110.767 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.38 -32.76 66.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.255 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -66.17 -49.7 66.46 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.762 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -61.95 -38.63 89.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.908 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.34 97.13 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.841 0.353 . . . . 0.0 110.295 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.468 ' HA ' HG23 ' A' ' 297' ' ' THR . 11.5 tmtt? -61.7 -38.33 87.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.15 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 57.4 mt -55.59 -47.38 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.724 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 9.7 t -65.19 -48.92 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -53.64 -45.77 70.31 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -58.48 -41.69 85.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.706 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.6 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 6.9 m-85 -68.41 -41.32 80.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.716 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 43.8 mt -62.93 -46.44 87.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 95.0 t -58.78 -41.68 83.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.176 176.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.29 -28.5 68.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.503 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.6 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -83.54 -1.27 53.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.169 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 111.05 5.91 26.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.478 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.6 t -89.92 141.81 13.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 117.605 0.703 . . . . 0.0 110.443 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.42 115.34 6.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.478 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.72 -35.61 92.24 Favored Glycine 0 CA--C 1.508 -0.346 0 CA-C-N 115.689 -0.687 . . . . 0.0 113.221 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -68.99 -14.52 63.09 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.055 0.455 . . . . 0.0 111.441 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -102.52 2.58 36.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.112 0.482 . . . . 0.0 110.402 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 76.0 mt -105.97 132.44 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.38 127.87 54.09 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.783 0.325 . . . . 0.0 110.482 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 279' ' ' LYS . 18.8 p -110.95 126.63 54.96 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.54 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.58 123.69 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -94.2 104.04 3.1 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 174.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.6 -3.08 58.99 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 78.98 -125.59 7.08 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.148 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 18.5 t -101.67 119.4 38.72 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.9 p -176.8 148.2 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 62.39 78.64 0.29 Allowed Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 123.186 0.595 . . . . 0.0 111.018 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.475 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 59.4 Cg_endo -73.03 151.4 49.97 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.36 2.04 . . . . 0.0 112.716 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.443 HG21 ' HA ' ' A' ' 318' ' ' ASN . 4.2 tt -111.16 -54.64 5.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.307 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -120.15 170.54 9.22 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.765 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 15.5 m -62.38 137.49 58.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.263 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -80.92 -14.43 58.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.863 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.16 -18.45 65.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.229 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 3.7 t -114.87 142.24 28.08 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.378 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.29 -28.05 40.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.494 2.129 . . . . 0.0 111.366 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 4.9 mt-10 -65.07 -38.98 92.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.411 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -70.15 -38.45 72.7 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.666 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.423 ' CZ ' HG22 ' A' ' 264' ' ' THR . 96.0 mtt180 -61.02 -39.04 88.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.101 0.477 . . . . 0.0 109.886 177.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.92 -26.77 68.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.629 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 3.6 mmtp -85.61 -37.17 19.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.475 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 35.9 m-80 -63.57 -20.94 66.05 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 14.6 ptp180 -88.06 15.19 7.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.313 0.577 . . . . 0.0 111.162 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 26.2 ptt-85 -61.33 -176.32 0.07 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.085 0.945 . . . . 0.0 112.609 175.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 70.7 t -137.71 145.55 28.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.944 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -131.83 140.66 49.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.951 0.405 . . . . 0.0 110.827 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.404 HG21 HG12 ' A' ' 257' ' ' ILE . 1.3 mp -99.0 117.05 43.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.364 -178.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.64 135.02 47.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 211' ' ' LEU . 74.9 t -101.49 136.83 31.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 C--N 1.31 -1.142 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.921 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.294 0 N-CA-C 112.274 -0.331 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -84.81 -169.82 2.83 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.815 0.34 . . . . 0.0 110.447 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -80.78 123.73 82.2 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.56 143.52 81.82 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.583 2.189 . . . . 0.0 112.187 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.63 120.28 6.78 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.887 2.391 . . . . 0.0 111.468 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 73.28 68.6 1.55 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.77 120.62 7.52 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.896 2.397 . . . . 0.0 112.098 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.33 129.75 19.79 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.417 2.078 . . . . 0.0 111.817 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -86.99 -21.01 26.43 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.018 0.437 . . . . 0.0 110.571 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 19.4 m -68.3 111.05 4.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.634 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 105.13 86.09 1.89 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.658 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.86 -11.47 29.44 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.586 2.19 . . . . 0.0 112.363 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.569 ' SG ' ' HB3' ' A' ' 253' ' ' ALA . 47.9 t -140.08 168.79 18.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.169 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -67.26 174.2 3.4 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.863 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -80.39 56.52 2.55 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.006 0.432 . . . . 0.0 110.509 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 20.4 mt -53.18 -25.9 15.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -66.21 -37.79 86.41 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.327 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.0 t -77.67 -30.67 52.11 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.49 -46.24 80.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.81 -1.087 . . . . 0.0 111.011 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 25.2 pt -73.73 -37.46 49.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.422 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.15 -31.67 69.18 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.916 0.389 . . . . 0.0 110.863 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.7 -27.05 67.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.894 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.0 p -99.17 -34.84 4.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.282 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.49 ' HA ' HG23 ' A' ' 239' ' ' ILE . 66.8 p -70.28 -37.23 74.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.279 0.561 . . . . 0.0 110.039 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.28 22.62 56.55 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.31 -132.34 7.75 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -80.95 163.34 20.56 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.622 2.215 . . . . 0.0 112.632 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.6 mm -83.17 101.96 8.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.333 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -98.02 128.8 44.79 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.513 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -169.81 140.3 2.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.445 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -138.15 48.69 0.87 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.831 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -89.47 95.44 10.27 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.88 136.86 32.79 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.491 -174.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 82.79 -59.89 4.92 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.723 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.51 -30.6 61.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.479 0.18 . . . . 0.0 111.439 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.0 m 61.08 -161.13 0.29 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.988 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 51.8 mt -95.76 82.81 3.62 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.094 0.474 . . . . 0.0 111.252 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.435 ' H ' ' HD2' ' A' ' 234' ' ' PRO . 70.8 mt -97.19 -57.45 0.18 Allowed Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.291 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.435 ' HD2' ' H ' ' A' ' 233' ' ' ILE . 49.0 Cg_endo -67.89 158.14 58.63 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.079 1.853 . . . . 0.0 111.997 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -79.67 42.22 0.52 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.152 0.501 . . . . 0.0 111.292 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.38 -34.91 73.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.509 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -99.46 77.58 2.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.358 0.599 . . . . 0.0 111.055 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.63 -17.43 62.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.406 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.49 HG23 ' HA ' ' A' ' 219' ' ' THR . 88.0 mt -56.69 -38.34 57.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.842 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 57.5 mt -65.23 -31.65 72.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.854 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -71.14 -37.74 72.27 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -40.89 83.56 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.201 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.596 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.9 t -57.03 -42.76 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.014 177.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.01 82.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.328 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -52.22 -49.65 63.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.412 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -73.45 -30.27 63.09 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.469 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.7 mt -69.97 -30.96 68.43 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.627 0.727 . . . . 0.0 109.17 177.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -62.79 -35.08 78.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.042 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -73.23 -35.7 66.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.785 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 43.7 t -128.33 69.99 78.87 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.92 2.13 4.5 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.55 2.834 . . . . 0.0 114.656 -174.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -80.48 -26.29 38.33 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.418 0.628 . . . . 0.0 109.99 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.569 ' HB3' ' SG ' ' A' ' 208' ' ' CYS . . . -61.94 133.94 56.02 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.023 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -96.6 135.66 38.21 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.7 m -113.35 133.26 59.81 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.873 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 34.1 m -108.85 107.3 17.65 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.025 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.427 HG12 HG22 ' A' ' 323' ' ' ILE . 19.8 mt -94.97 115.4 33.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.991 -177.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -101.41 131.34 47.56 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.896 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.451 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -111.41 141.43 16.55 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 318' ' ' ASN . 2.1 m-85 -124.17 161.46 25.64 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 50.6 p -136.58 173.42 11.73 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -83.55 158.93 21.78 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.554 ' ND2' HD21 ' A' ' 309' ' ' ASN . 7.0 p30 -74.81 -7.0 52.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.597 -177.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.46 -28.21 34.25 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.201 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.01 154.37 49.78 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.149 174.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 45.3 m -75.11 137.83 41.66 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.13 0.491 . . . . 0.0 111.958 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.536 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 1.1 pm0 -62.82 139.49 58.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.094 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.84 -40.84 2.32 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.484 -177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 46.2 mm -85.17 -30.26 6.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.72 0.772 . . . . 0.0 109.144 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 267' ' ' GLU . 15.0 p30 -63.82 -35.31 80.2 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.136 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.42 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 19.7 mm -58.68 -64.36 2.98 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.71 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.42 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 19.6 Cg_endo -62.12 -26.85 78.34 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 121.819 1.679 . . . . 0.0 111.662 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 46.7 tp -65.22 -56.44 12.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.732 0.301 . . . . 0.0 110.999 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.451 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 6.9 p -65.48 -28.17 69.02 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.719 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.42 -32.16 68.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.045 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -47.33 61.53 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -55.37 -43.87 75.51 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.032 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.81 -39.19 93.19 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 110.659 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.478 ' HA ' HG22 ' A' ' 297' ' ' THR . 0.9 OUTLIER -63.21 -33.92 76.53 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.524 179.137 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 60.4 mt -57.25 -42.98 81.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.985 0.422 . . . . 0.0 110.073 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.553 ' O ' HD12 ' A' ' 285' ' ' LEU . 3.7 t -70.28 -43.47 78.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.759 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.36 -45.72 80.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.395 178.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.25 -41.93 89.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.396 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.482 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 1.5 m-85 -65.12 -43.94 90.32 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.108 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 281' ' ' VAL . 3.8 mp -63.57 -47.59 80.89 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 99.1 t -60.02 -42.65 90.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.288 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.72 -27.12 68.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.566 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.576 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 2.8 mmp_? -86.21 5.02 36.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.999 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.89 5.9 43.79 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.258 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 57.4 t -86.32 143.61 11.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.604 0.702 . . . . 0.0 109.908 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.58 112.06 8.3 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.042 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.52 -32.66 73.82 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.243 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.29 -20.28 64.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.053 0.454 . . . . 0.0 111.222 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -102.74 3.48 36.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.938 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.5 mt -107.65 129.9 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-O 120.876 0.37 . . . . 0.0 110.845 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.69 125.74 49.43 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.071 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 279' ' ' LYS . 22.3 p -110.33 129.15 55.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.943 0.401 . . . . 0.0 111.074 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.4 t -132.43 116.58 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.012 0.434 . . . . 0.0 111.927 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -92.08 109.58 3.77 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 20.7 mt -87.67 -32.19 19.35 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 95.81 -142.08 15.92 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.4 p -77.58 109.11 11.27 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.737 0.303 . . . . 0.0 110.512 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 15.0 p -174.46 150.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.2 t30 66.46 79.96 0.23 Allowed Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.273 175.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.685 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 38.1 Cg_endo -69.61 135.6 31.22 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.556 2.171 . . . . 0.0 113.075 -178.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.438 HG21 ' HA ' ' A' ' 318' ' ' ASN . 5.2 tt -112.92 -29.27 2.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.748 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -145.83 174.95 10.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.925 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.476 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 29.4 m -62.61 121.19 12.73 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.549 0.53 . . . . 0.0 110.846 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.554 HD21 ' ND2' ' A' ' 263' ' ' ASN . 34.4 p-10 -80.65 -14.29 58.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -177.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.45 -16.06 62.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.159 0.504 . . . . 0.0 111.128 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 4.9 t -117.6 143.9 33.18 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.948 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.07 -31.03 76.21 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.441 2.094 . . . . 0.0 111.551 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 4.0 mt-10 -59.14 -44.7 92.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.066 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -69.94 -37.64 74.44 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.894 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.68 -38.42 87.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.401 . . . . 0.0 110.066 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.19 -28.22 69.52 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.483 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 8.2 mmtp -81.81 -45.81 15.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.455 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.685 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 33.5 m-80 -57.98 -29.48 65.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 5.1 ptp180 -80.62 15.75 1.6 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -176.98 1.05 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.084 0.945 . . . . 0.0 112.704 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 89.2 t -131.9 143.32 40.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.756 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -132.53 142.16 49.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.02 0.438 . . . . 0.0 111.079 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.427 HG22 HG12 ' A' ' 257' ' ' ILE . 1.5 mp -101.73 120.54 51.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.853 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 66.9 t -109.72 135.31 49.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.14 140.01 21.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.92 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.1 t30 . . . . . 0 C--N 1.311 -1.092 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.721 178.169 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.238 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 60.86 37.29 18.64 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.209 0.528 . . . . 0.0 111.619 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -94.78 150.18 37.51 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.035 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.64 145.93 79.03 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.282 1.988 . . . . 0.0 110.825 176.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -40.82 -47.43 4.77 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.565 2.843 . . . . 0.0 113.115 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.93 -176.14 18.4 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.023 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.57 137.84 33.96 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.988 2.459 . . . . 0.0 111.728 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.75 114.15 2.02 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.372 2.048 . . . . 0.0 111.25 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -126.13 27.45 6.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.084 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.2 m -62.26 133.66 55.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.703 -177.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 142.26 109.12 0.72 Allowed Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.933 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -57.57 -64.69 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.914 2.41 . . . . 0.0 112.139 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 14.6 t -153.13 -178.31 6.86 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -59.32 148.57 31.78 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.304 0.377 . . . . 0.0 110.325 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.56 86.04 4.59 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.299 0.571 . . . . 0.0 110.343 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.464 ' O ' HG12 ' A' ' 215' ' ' ILE . 48.0 mt -71.17 -23.19 62.01 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.104 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.403 ' N ' HG22 ' A' ' 325' ' ' VAL . 51.7 tt0 -66.18 -38.99 89.36 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.355 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.3 t -73.25 -40.59 64.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.13 75.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.579 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.476 ' CG2' HG11 ' A' ' 243' ' ' VAL . 23.3 pt -70.37 -38.61 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.349 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -62.95 -27.41 69.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.034 0.445 . . . . 0.0 110.524 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.19 -28.41 67.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.935 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 t -89.93 -44.67 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.384 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.488 ' HA ' HG21 ' A' ' 239' ' ' ILE . 70.8 p -67.81 -36.79 81.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.763 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.1 26.73 47.6 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.64 -141.13 13.38 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.05 160.18 36.92 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.832 2.355 . . . . 0.0 111.79 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 46.1 mm -73.49 106.36 3.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.756 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -80.48 118.84 22.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.302 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -88.81 151.7 22.21 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.307 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -82.92 78.8 1.97 Allowed Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 176.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.86 68.67 0.43 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.578 0.704 . . . . 0.0 112.452 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -143.44 -33.48 0.43 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.857 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -103.31 22.57 35.87 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.981 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 70.97 -60.49 0.51 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.793 0.837 . . . . 0.0 112.209 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.7 t -105.13 -176.88 3.21 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.443 HD11 ' CZ ' ' A' ' 237' ' ' TYR . 34.6 tp -84.52 157.84 21.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.018 0.437 . . . . 0.0 110.906 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 7.5 tt -93.72 120.03 66.48 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.625 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.9 154.19 58.35 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 123.097 2.531 . . . . 0.0 112.658 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 54.73 32.41 17.34 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.378 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -124.9 -41.09 2.13 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.281 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.443 ' CZ ' HD11 ' A' ' 232' ' ' LEU . 3.4 m-85 -75.02 89.62 2.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.337 0.589 . . . . 0.0 112.002 -177.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.93 -19.76 60.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.488 HG21 ' HA ' ' A' ' 219' ' ' THR . 79.2 mt -61.88 -38.47 80.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.9 mt -69.45 -25.37 64.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.709 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -72.71 -38.14 67.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.11 -38.39 82.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.193 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.592 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.9 t -62.04 -45.02 99.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.562 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.95 74.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.986 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -46.6 -51.11 16.4 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.016 0.926 . . . . 0.0 112.522 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.423 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -84.68 -15.97 43.44 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.903 -177.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.6 mt -78.85 -28.83 44.31 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -82.51 -17.11 46.25 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.916 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.38 -37.77 83.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.978 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 48.3 t -131.38 71.0 81.87 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.44 0.85 6.87 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.951 2.434 . . . . 0.0 112.846 -177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.35 -31.1 42.93 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -72.52 141.7 48.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.473 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.19 142.16 27.95 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 5.4 m -113.93 130.87 67.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 CA-C-O 121.277 0.56 . . . . 0.0 110.725 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.4 m -106.88 108.09 19.43 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.178 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 29.8 mt -92.95 113.75 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.27 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -98.63 122.53 41.96 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.018 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.445 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -105.28 151.75 17.2 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.368 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -125.14 167.43 14.82 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.376 0.608 . . . . 0.0 110.948 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 8.1 t -160.25 156.81 27.07 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.965 174.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.6 155.33 40.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.912 0.387 . . . . 0.0 110.831 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.512 HD22 ' ND2' ' A' ' 309' ' ' ASN . 7.2 p30 -83.92 4.22 30.56 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.925 -175.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.411 HG21 ' CZ ' ' A' ' 315' ' ' ARG . 1.9 p -76.83 -21.5 54.95 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.091 0.472 . . . . 0.0 110.578 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -113.77 49.15 0.87 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.416 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 11.2 t -90.57 85.21 6.05 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.068 0.461 . . . . 0.0 110.529 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -126.6 17.31 7.52 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.204 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 92.97 -16.72 59.76 Favored Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 34.3 mm -82.17 -20.91 10.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.474 -0.863 . . . . 0.0 108.883 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.416 ' OD1' ' HA ' ' A' ' 266' ' ' SER . 0.8 OUTLIER -55.86 -43.21 76.9 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.007 178.413 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.425 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 26.1 mm -55.51 -64.43 2.19 Favored Pre-proline 0 CA--C 1.557 1.246 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.796 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.425 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 18.9 Cg_endo -62.74 -27.17 75.41 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.79 1.66 . . . . 0.0 112.647 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.6 tp -66.45 -53.54 34.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 110.87 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.445 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.0 p -60.81 -31.4 70.8 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.24 0.543 . . . . 0.0 110.157 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.56 -42.31 91.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.719 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -60.06 -43.71 95.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.093 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -58.78 -47.09 85.93 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.11 73.48 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.115 0.483 . . . . 0.0 110.729 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.449 ' HA ' HG22 ' A' ' 297' ' ' THR . 54.2 tptt -67.34 -31.5 71.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.051 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 53.4 mt -58.9 -40.35 80.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 0.0 109.895 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.686 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.7 t -68.76 -44.46 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.904 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.59 73.74 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.851 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.22 -42.31 81.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.533 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.63 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 0.8 OUTLIER -64.29 -47.4 79.64 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.446 178.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 34.8 mt -63.85 -49.5 72.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.055 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.02 -39.17 81.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.151 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.5 -26.09 68.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.192 0.52 . . . . 0.0 110.686 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.63 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.1 mmp_? -86.44 2.47 47.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.974 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.88 12.79 48.87 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.911 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 58.6 t -85.22 140.62 15.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.53 110.03 4.01 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.987 0.422 . . . . 0.0 111.365 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.98 -33.09 63.3 Favored Glycine 0 C--O 1.225 -0.451 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.89 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.23 -19.46 65.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.821 0.343 . . . . 0.0 111.622 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -102.06 1.76 36.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.051 0.453 . . . . 0.0 110.375 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.5 mt -105.62 127.02 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.122 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.97 125.51 50.55 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.39 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.449 HG22 ' HA ' ' A' ' 279' ' ' LYS . 40.8 p -105.49 121.85 44.78 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.8 t -125.63 115.9 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.156 0.503 . . . . 0.0 111.793 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.0 108.64 3.49 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 21.8 mt -91.15 0.37 57.55 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.77 0.319 . . . . 0.0 111.206 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.32 -126.12 30.34 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.022 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 15.4 m -103.32 116.45 32.47 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 304' ' ' ASN . 6.0 m -140.46 -64.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.354 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.439 ' H ' HG22 ' A' ' 303' ' ' VAL . 33.9 m-80 -117.96 90.67 37.59 Favored Pre-proline 0 N--CA 1.439 -0.997 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.62 176.77 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.577 2.185 . . . . 0.0 112.345 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -128.78 -49.03 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.694 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -110.45 176.79 4.91 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.633 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 18.5 m -65.77 131.63 46.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.525 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.512 ' ND2' HD22 ' A' ' 263' ' ' ASN . 20.1 m-20 -79.22 -8.23 58.86 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.458 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -80.6 -11.2 59.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.55 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.6 t -119.44 138.88 26.98 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.337 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.46 -32.52 70.95 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.594 2.196 . . . . 0.0 111.656 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -67.43 -35.42 79.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.757 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.59 -38.11 85.82 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.411 ' CZ ' HG21 ' A' ' 264' ' ' THR . 97.9 mtt180 -66.08 -21.88 66.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.478 0.656 . . . . 0.0 109.787 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -78.73 -28.97 45.06 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.308 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -77.62 -42.93 33.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.157 0.503 . . . . 0.0 109.765 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -64.96 -8.87 17.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 18.7 ptp180 -98.93 11.66 38.21 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -69.03 -174.67 0.64 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 76.2 t -137.03 151.74 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.623 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.54 138.55 50.25 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 122.672 0.389 . . . . 0.0 110.64 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.74 122.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.834 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 95.1 t -113.18 137.41 46.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 211' ' ' LEU . 85.1 t -101.93 136.38 34.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 120.8 0.333 . . . . 0.0 110.713 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 C--N 1.313 -0.993 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.06 -178.685 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.292 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -89.03 129.7 35.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.792 0.329 . . . . 0.0 110.546 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -97.53 110.91 56.98 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.717 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.12 154.65 37.47 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.65 2.233 . . . . 0.0 111.032 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.18 -1.19 11.16 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.442 2.095 . . . . 0.0 112.025 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 76.3 -110.67 3.1 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.86 155.0 70.02 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.278 1.985 . . . . 0.0 111.501 176.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.58 173.37 7.92 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.468 2.112 . . . . 0.0 112.584 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -87.61 28.92 0.93 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.035 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.543 ' HB2' ' OD1' ' A' ' 252' ' ' ASP . 2.2 m -74.86 169.45 17.91 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.615 0.245 . . . . 0.0 110.357 -177.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -135.75 -104.15 0.75 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.307 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.79 153.01 59.02 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 122.984 2.456 . . . . 0.0 113.795 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 209' ' ' ALA . 41.2 t -146.72 -175.47 4.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.595 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.443 ' N ' ' SG ' ' A' ' 208' ' ' CYS . . . -54.03 174.6 0.05 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.36 0.664 . . . . 0.0 111.57 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -82.67 77.48 9.43 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.992 -0.443 . . . . 0.0 110.007 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.424 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.2 mm? -68.06 -35.31 78.01 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.762 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.407 ' N ' HG22 ' A' ' 325' ' ' VAL . 63.7 tt0 -63.33 -42.7 98.97 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.558 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 31.0 t -75.38 -27.97 59.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.282 0.563 . . . . 0.0 109.508 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.404 ' HB3' ' HZ3' ' A' ' 246' ' ' LYS . . . -69.82 -46.72 65.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.627 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.453 ' CG2' HG13 ' A' ' 243' ' ' VAL . 23.4 pt -77.1 -41.43 31.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -61.34 -29.74 70.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.943 0.402 . . . . 0.0 110.876 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.37 -24.26 67.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.173 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.93 -45.46 13.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.033 0.444 . . . . 0.0 110.298 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.473 ' HA ' HG22 ' A' ' 239' ' ' ILE . 74.3 p -64.79 -38.2 90.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.013 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.79 20.54 53.52 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.197 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.67 -134.7 8.36 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.52 161.22 28.31 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.282 1.988 . . . . 0.0 112.337 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.86 108.9 13.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.635 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.74 119.79 36.96 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -86.9 158.38 19.32 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.596 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.76 97.42 1.21 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -76.19 113.58 13.9 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.949 0.404 . . . . 0.0 111.346 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -95.98 -29.87 13.91 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.461 0.648 . . . . 0.0 109.471 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 120.03 -43.33 1.57 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.09 -43.62 16.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.085 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 51.1 p -157.32 -171.37 3.58 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.081 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 232' ' ' LEU . 1.1 pt? -100.76 130.12 46.75 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.061 0.457 . . . . 0.0 109.805 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 12.5 tt -143.72 101.3 5.03 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-O 121.361 0.601 . . . . 0.0 110.483 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.04 155.86 13.13 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.4 2.067 . . . . 0.0 111.506 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.18 -50.21 49.64 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.155 0.503 . . . . 0.0 110.326 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -97.09 64.2 1.94 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.36 0.6 . . . . 0.0 110.947 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -69.79 -13.32 62.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.152 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -65.72 -20.53 66.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.987 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 219' ' ' THR . 82.4 mt -62.88 -37.79 80.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.045 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.457 ' CD2' HG11 ' A' ' 281' ' ' VAL . 47.3 mt -62.84 -34.75 77.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 110.644 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -73.8 -39.36 64.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.572 177.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.483 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -65.09 -44.87 87.43 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.762 179.551 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.588 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 29.9 t -57.82 -43.59 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.704 177.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.11 85.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.114 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -52.38 -49.91 63.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.483 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -77.98 -20.05 53.33 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.878 -178.319 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 35.1 mt -78.13 -32.33 50.32 Favored 'General case' 0 C--O 1.214 -0.779 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.599 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -74.95 -18.64 60.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.864 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.09 -34.49 75.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.326 0.584 . . . . 0.0 109.646 175.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 253' ' ' ALA . 53.4 t -128.67 71.8 80.97 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.056 174.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.62 0.14 6.75 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.681 2.254 . . . . 0.0 112.981 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.543 ' OD1' ' HB2' ' A' ' 205' ' ' SER . 11.4 t70 -88.62 -25.34 22.49 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.411 ' HB3' ' SG ' ' A' ' 250' ' ' CYS . . . -57.67 138.13 55.73 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.78 130.29 45.97 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 12.3 m -122.03 134.61 64.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-O 121.39 0.614 . . . . 0.0 111.937 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.3 m -110.58 113.31 25.83 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.221 -0.899 . . . . 0.0 108.827 178.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.417 HG12 HG22 ' A' ' 323' ' ' ILE . 23.1 mt -92.68 113.83 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -101.98 126.25 48.85 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.363 -176.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -106.15 150.54 16.89 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.668 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -127.9 159.75 33.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.017 0.437 . . . . 0.0 110.436 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 70.1 p -141.02 169.83 16.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.331 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 264' ' ' THR . 18.0 t70 -73.35 153.92 40.3 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.682 0.277 . . . . 0.0 110.801 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.57 2.9 0.15 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.518 ' HB ' ' NH2' ' A' ' 315' ' ' ARG . 11.4 t -60.1 -21.05 61.04 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.486 0.314 . . . . 0.0 111.832 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -127.66 126.08 5.4 Favored Glycine 0 N--CA 1.434 -1.465 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.122 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 20.2 m -100.12 90.42 4.36 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.483 ' HA ' HD22 ' A' ' 270' ' ' ASN . 18.2 mm-40 66.05 169.44 0.22 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.92 -177.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.36 -95.46 1.53 Allowed Glycine 0 C--O 1.21 -1.352 0 C-N-CA 119.728 -1.225 . . . . 0.0 113.417 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.452 HD13 ' N ' ' A' ' 269' ' ' ILE . 1.6 mp -84.83 -42.18 16.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 122.868 0.467 . . . . 0.0 111.813 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.483 HD22 ' HA ' ' A' ' 267' ' ' GLU . 1.1 p-10 -55.46 -34.96 64.99 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.703 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.505 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.6 mm -58.17 -67.12 1.01 Allowed Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.269 177.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.505 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.5 Cg_endo -57.98 -30.69 90.72 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 121.934 1.756 . . . . 0.0 111.78 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.75 -54.63 32.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.463 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 9.8 p -60.94 -32.7 72.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.793 0.33 . . . . 0.0 110.437 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.91 -31.64 71.56 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.079 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -69.68 -48.9 58.11 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -60.24 -41.96 94.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.21 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.91 -39.07 90.76 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.019 0.438 . . . . 0.0 110.525 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.484 ' HA ' HG21 ' A' ' 297' ' ' THR . 21.6 ttpt -66.18 -30.16 70.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.361 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 64.1 mt -55.96 -45.4 80.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 110.023 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.721 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.8 t -64.56 -46.99 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.728 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.69 -43.05 76.07 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.362 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.61 -41.66 86.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.359 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -71.12 -40.83 71.2 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.413 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.721 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 46.6 mt -64.59 -48.53 74.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.8 t -61.23 -39.66 83.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.466 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.29 -30.8 71.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.127 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -81.65 2.1 31.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.664 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.72 3.13 46.46 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.233 -0.984 . . . . 0.0 114.449 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.445 ' CG1' HD11 ' A' ' 295' ' ' ILE . 58.9 t -79.26 143.36 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 117.896 0.848 . . . . 0.0 109.782 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.02 110.06 4.28 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.032 0.444 . . . . 0.0 111.446 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.01 -18.47 64.66 Favored Glycine 0 CA--C 1.508 -0.389 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.339 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -72.14 -22.53 61.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.161 0.505 . . . . 0.0 110.425 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -104.5 5.43 34.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.035 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . 0.445 HD11 ' CG1' ' A' ' 290' ' ' VAL . 63.8 mt -109.42 128.79 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.32 128.43 55.05 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.1 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.484 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.1 p -115.05 120.66 40.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 120.915 0.388 . . . . 0.0 111.251 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.84 166.42 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.341 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -134.41 109.71 0.81 Allowed Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 14.8 mt -97.04 -1.24 45.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.595 0.236 . . . . 0.0 111.304 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.06 -123.76 26.82 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.319 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 3.8 t -106.28 120.1 40.98 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.6 m -141.74 -58.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.344 -177.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -116.86 92.32 38.2 Favored Pre-proline 0 N--CA 1.442 -0.846 0 CA-C-O 120.687 0.279 . . . . 0.0 110.259 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.421 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 24.1 Cg_exo -61.26 166.29 11.29 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.681 2.254 . . . . 0.0 112.478 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.5 tt -121.48 -45.35 2.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.874 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -128.11 168.78 14.89 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.305 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 35.5 t -62.58 135.33 57.34 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.685 0.615 . . . . 0.0 110.983 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.79 -9.35 59.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.386 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.39 66.96 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.777 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.9 t -114.16 140.18 24.64 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.84 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.28 -27.79 55.69 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.247 1.965 . . . . 0.0 111.105 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.8 mt-10 -62.77 -41.45 99.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.72 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.49 -38.06 86.19 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.477 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.518 ' NH2' ' HB ' ' A' ' 264' ' ' THR . 40.9 mtp180 -63.6 -30.23 71.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.384 0.612 . . . . 0.0 109.929 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.22 -27.47 63.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.279 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 13.3 mmtp -80.14 -40.58 27.12 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.372 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.421 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 27.3 m-80 -58.13 -24.38 58.57 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -177.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 18.0 ptp180 -83.47 9.75 10.48 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.977 0.418 . . . . 0.0 112.017 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -57.16 176.28 0.12 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.949 0.881 . . . . 0.0 112.909 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.6 t -139.73 147.48 23.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.158 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.17 138.1 50.45 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 110.992 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.417 HG22 HG12 ' A' ' 257' ' ' ILE . 2.4 mp -96.1 116.03 36.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.496 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.94 136.79 42.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 212' ' ' GLN . 56.9 t -101.27 139.52 22.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 . . . . . 0 C--N 1.325 -0.483 0 O-C-N 123.926 0.766 . . . . 0.0 111.132 178.617 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.49 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -65.16 -51.93 58.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.363 0.601 . . . . 0.0 109.851 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.535 ' H ' ' HD2' ' A' ' 199' ' ' PRO . . . -139.94 -54.9 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.371 177.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.535 ' HD2' ' H ' ' A' ' 198' ' ' ALA . 86.5 Cg_endo -80.4 173.44 12.41 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 121.918 1.745 . . . . 0.0 110.202 175.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.411 ' HB2' ' H ' ' A' ' 201' ' ' GLY . 52.2 Cg_exo -55.68 -74.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.292 1.995 . . . . 0.0 112.355 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.411 ' H ' ' HB2' ' A' ' 200' ' ' PRO . . . 77.59 84.23 0.52 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.994 178.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.29 127.02 20.77 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.778 2.318 . . . . 0.0 112.43 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.61 121.06 9.37 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.893 2.395 . . . . 0.0 112.144 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -115.79 -43.87 2.98 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.476 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 40.0 m -130.95 126.81 37.05 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.439 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 140.41 87.16 0.12 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.621 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.2 121.77 8.78 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.479 2.119 . . . . 0.0 110.439 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.53 ' SG ' ' HB1' ' A' ' 253' ' ' ALA . 34.9 t -103.76 144.65 31.2 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.697 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.99 169.09 4.57 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.741 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.72 83.75 4.85 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.463 ' O ' HG12 ' A' ' 215' ' ' ILE . 25.6 mt -79.36 -24.72 42.48 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.452 -178.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -60.97 -51.05 70.88 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.8 t -70.92 -36.4 72.66 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.818 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.449 ' HB2' ' HZ1' ' A' ' 246' ' ' LYS . . . -59.42 -44.53 92.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.798 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 211' ' ' LEU . 27.1 pt -75.89 -39.52 37.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.177 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -60.16 -34.44 73.57 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 110.688 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.97 -24.03 67.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.726 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 2.8 t -94.98 -45.19 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 120.899 0.38 . . . . 0.0 110.296 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.482 ' HA ' HG23 ' A' ' 239' ' ' ILE . 80.6 p -66.46 -39.66 88.95 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.127 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.1 30.29 55.46 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 119.02 -132.15 9.48 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.496 ' HA ' ' HG2' ' A' ' 322' ' ' GLU . 63.7 Cg_endo -79.76 157.22 24.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.457 2.104 . . . . 0.0 113.322 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 38.6 mm -73.99 108.45 5.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.892 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -81.83 145.11 30.58 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.39 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -113.77 142.03 46.56 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.019 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -76.07 -56.18 4.51 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 231' ' ' SER . 10.9 m120 -113.51 165.16 12.75 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 173.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -102.98 123.94 47.54 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.899 0.381 . . . . 0.0 111.218 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 94.92 -51.4 1.95 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.502 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -153.57 169.06 24.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.507 0.194 . . . . 0.0 111.138 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.532 ' O ' ' HB2' ' A' ' 227' ' ' ASN . 48.8 m 67.86 91.11 0.09 Allowed 'General case' 0 CA--C 1.531 0.224 0 O-C-N 124.036 0.835 . . . . 0.0 112.318 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.97 43.59 1.16 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.247 0.546 . . . . 0.0 109.985 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 55.5 mt -71.27 -51.4 10.14 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.577 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.02 155.93 56.65 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.668 1.579 . . . . 0.0 110.032 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 63.21 -154.24 0.33 Allowed 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -131.45 153.92 49.24 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.991 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -115.78 12.4 15.9 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.254 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -77.28 -20.6 54.84 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.877 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.482 HG23 ' HA ' ' A' ' 219' ' ' THR . 75.6 mt -64.38 -38.02 81.49 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 8.3 mp -64.62 -36.13 83.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.803 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -69.93 -39.0 76.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.864 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.439 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -66.14 -41.99 89.7 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.032 178.308 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.614 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.1 t -57.93 -42.83 83.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.364 177.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.75 86.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.262 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.15 -49.18 67.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.449 ' HZ1' ' HB2' ' A' ' 214' ' ' ALA . 0.0 OUTLIER -72.09 -29.75 64.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.315 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 26.2 mt -70.53 -27.93 64.54 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -63.63 -34.44 77.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.675 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.59 -39.53 73.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.432 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 38.4 t -127.17 68.48 72.49 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.21 0.21 7.66 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.385 2.723 . . . . 0.0 113.976 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -91.04 -18.24 24.92 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.673 0.749 . . . . 0.0 109.36 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.53 ' HB1' ' SG ' ' A' ' 208' ' ' CYS . . . -63.33 150.86 42.34 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.357 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -104.22 133.97 48.24 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.164 0.507 . . . . 0.0 110.434 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 325' ' ' VAL . 12.5 m -117.84 136.49 54.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.174 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.3 m -112.54 109.8 19.58 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.332 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.421 HG12 HG22 ' A' ' 323' ' ' ILE . 21.8 mt -92.24 115.0 30.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -103.12 129.54 50.01 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.691 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.402 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -108.04 151.64 16.98 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.364 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -126.71 163.47 23.43 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.082 0.468 . . . . 0.0 110.977 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 71.9 p -142.88 163.7 32.08 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.971 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -73.76 151.83 40.53 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.628 HD22 ' ND2' ' A' ' 309' ' ' ASN . 0.1 OUTLIER -77.6 -0.22 25.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -177.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -48.15 13.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -83.06 48.38 4.02 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 11.5 p -96.5 113.65 25.24 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 120.877 0.37 . . . . 0.0 110.815 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -156.13 3.36 0.16 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.976 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 111.3 -31.8 6.93 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.03 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.487 HD13 ' N ' ' A' ' 269' ' ' ILE . 1.6 mp -71.98 -21.26 20.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.75 0.786 . . . . 0.0 109.619 -177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -34.95 67.02 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.431 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.475 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.1 mm -60.99 -65.07 2.4 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.093 177.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.475 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.2 Cg_endo -58.3 -30.02 89.71 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 121.91 1.74 . . . . 0.0 111.974 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 59.6 tp -64.29 -54.94 25.26 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.24 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.402 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 5.2 p -63.4 -26.79 68.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.749 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.47 -28.4 64.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.852 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -76.18 -42.09 47.51 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 277' ' ' ARG . 10.6 mmt180 -59.25 -46.42 88.56 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.142 177.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.33 74.88 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.98 0.419 . . . . 0.0 110.454 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.475 ' HA ' HG22 ' A' ' 297' ' ' THR . 23.8 tptm -63.53 -32.44 73.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.098 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 54.6 mt -58.87 -43.17 87.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.017 0.437 . . . . 0.0 110.077 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.688 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.8 t -66.86 -46.58 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.946 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.35 -41.45 76.12 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.889 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.13 -43.74 78.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.964 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . 0.541 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 8.5 m-85 -70.77 -41.61 71.5 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.483 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 42.7 mt -63.76 -49.15 74.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 68.8 t -59.74 -42.2 87.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.284 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.55 -28.48 69.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.944 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.9 mmp_? -84.42 4.11 33.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.751 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.13 6.83 41.88 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 119.859 -1.162 . . . . 0.0 114.375 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 53.0 t -86.18 143.76 10.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 117.717 0.759 . . . . 0.0 109.725 177.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.47 114.42 10.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.898 0.38 . . . . 0.0 111.514 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.72 -32.79 70.4 Favored Glycine 0 C--O 1.23 -0.143 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.998 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.45 -21.44 66.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.087 0.47 . . . . 0.0 111.66 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -100.48 1.27 40.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.914 0.387 . . . . 0.0 110.57 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.35 129.12 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.854 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.54 127.69 53.86 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.202 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 279' ' ' LYS . 10.7 p -110.62 120.4 42.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.726 0.298 . . . . 0.0 111.002 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.16 130.52 60.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.945 0.402 . . . . 0.0 111.331 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -97.51 117.5 5.81 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.341 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 27.1 mt -91.3 -3.53 56.76 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.39 0.138 . . . . 0.0 111.176 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.63 -138.71 48.24 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.351 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 2.1 m -89.25 115.91 27.09 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 4.6 p -143.79 -61.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.611 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -116.04 93.95 40.12 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.422 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 7.8 Cg_exo -67.74 167.14 21.99 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.544 2.163 . . . . 0.0 112.782 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.5 tt -125.07 -49.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.279 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -124.66 170.8 10.6 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.393 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.3 p -71.11 139.61 50.36 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 123.547 0.53 . . . . 0.0 111.874 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.628 ' ND2' HD22 ' A' ' 263' ' ' ASN . 8.9 p30 -81.46 -11.07 59.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.418 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -61.63 -26.63 68.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.103 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 4.4 t -113.65 139.42 23.37 Favored Pre-proline 0 N--CA 1.436 -1.164 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.693 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.14 -32.42 91.15 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.905 2.404 . . . . 0.0 111.84 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 35.5 mm-40 -63.8 -40.99 97.96 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.262 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.53 -37.87 92.95 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.379 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.4 -39.73 84.35 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.04 -29.94 70.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.686 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 10.9 mmpt? -77.6 -44.62 27.74 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.297 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 43.8 m-80 -60.88 -29.87 69.81 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.414 ' H ' ' HG2' ' A' ' 319' ' ' ARG . 3.5 ptm180 -83.41 11.71 6.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.2 ptt-85 -57.43 178.87 0.06 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.254 1.022 . . . . 0.0 112.898 174.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 94.1 t -137.74 147.68 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.583 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 222' ' ' PRO . 48.5 mt-10 -132.66 137.81 47.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.397 . . . . 0.0 111.415 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.421 HG22 HG12 ' A' ' 257' ' ' ILE . 2.8 mp -98.98 121.25 49.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.041 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.83 138.73 39.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.4 HG23 HG12 ' A' ' 255' ' ' VAL . 52.8 t -104.21 143.28 16.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 C--N 1.32 -0.706 0 O-C-N 123.519 0.512 . . . . 0.0 110.349 177.461 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.45 0 CA-C-O 120.706 0.288 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.435 ' HB3' ' OG ' ' A' ' 213' ' ' SER . 3.7 m-20 -75.88 81.31 2.79 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.093 0.473 . . . . 0.0 110.758 -176.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 250' ' ' CYS . 32.5 mt -72.87 -26.67 61.53 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.509 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 59.9 tp60 -59.47 -56.29 23.8 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.542 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 210' ' ' ASP . 4.2 p -66.38 -31.3 71.99 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 120.882 0.372 . . . . 0.0 110.293 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.16 -54.14 42.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.466 ' CG2' HG13 ' A' ' 243' ' ' VAL . 19.8 pt -69.04 -38.13 77.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.844 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.49 -34.44 69.05 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.598 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.29 -29.74 70.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.379 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.49 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.6 t -89.01 -45.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.895 0.379 . . . . 0.0 110.741 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.585 ' HA ' HG21 ' A' ' 239' ' ' ILE . 76.6 p -67.15 -35.42 79.67 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.251 0.548 . . . . 0.0 110.743 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.49 24.78 60.12 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 125.84 -134.66 8.8 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.2 164.98 14.92 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.449 2.099 . . . . 0.0 112.77 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.9 mm -82.61 109.21 16.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.976 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.825 0 CA-C-O 121.034 0.445 . . . . 0.0 111.103 179.193 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.073 0.463 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.585 HG21 ' HA ' ' A' ' 219' ' ' THR . 87.7 mt -62.0 -41.07 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.129 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.12 -32.07 73.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.067 0.461 . . . . 0.0 110.427 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.29 -37.27 69.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.49 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -68.98 -45.78 69.76 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.328 178.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.569 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 42.5 t -56.78 -44.43 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.969 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -58.86 -34.32 71.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.434 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.2 -45.83 75.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -14.69 53.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.98 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.4 mt -79.29 -26.55 42.29 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.639 ' HG3' HG22 ' A' ' 290' ' ' VAL . 58.6 mtpt -82.54 -21.83 35.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.386 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.06 -37.69 84.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.056 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.463 ' HB3' HD11 ' A' ' 211' ' ' LEU . 48.0 t -130.23 74.4 80.42 Favored Pre-proline 0 N--CA 1.434 -1.242 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.834 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 74.6 Cg_endo -74.16 1.3 7.39 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.1 2.533 . . . . 0.0 112.283 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -74.96 -29.15 60.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.93 0.872 . . . . 0.0 108.773 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -73.63 164.47 26.6 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.058 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 254' ' ' ARG . 0.0 OUTLIER -120.75 137.23 54.61 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.675 176.572 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.2 m -120.37 134.61 63.29 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 121.198 0.523 . . . . 0.0 111.562 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 49.9 m -111.43 113.24 25.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.515 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.413 HG12 HG23 ' A' ' 323' ' ' ILE . 21.8 mt -91.87 111.58 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -98.87 125.54 44.3 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.532 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.446 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -106.58 144.16 15.83 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.389 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.58 165.04 17.83 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.961 0.41 . . . . 0.0 110.56 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.515 HG23 ' HB3' ' A' ' 274' ' ' SER . 68.5 p -143.98 172.48 12.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.761 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 C--N 1.316 -0.849 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 175.081 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.444 -0.729 0 CA-C-O 122.005 0.907 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -59.67 -33.6 71.77 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.873 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.507 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 32.8 mm -60.02 -65.53 2.04 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.043 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.507 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 8.3 Cg_endo -57.21 -32.67 94.23 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.211 1.94 . . . . 0.0 112.106 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.16 -55.13 20.41 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.718 0.294 . . . . 0.0 111.617 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.515 ' HB3' HG23 ' A' ' 261' ' ' THR . 8.3 p -64.34 -27.87 69.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.788 0.328 . . . . 0.0 111.128 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.94 -27.55 64.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.526 ' O ' HG13 ' A' ' 280' ' ' ILE . 28.6 tt0 -73.89 -44.44 55.26 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.416 HH21 HD11 ' A' ' 280' ' ' ILE . 3.9 mmp_? -57.62 -46.49 84.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.568 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.58 91.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.287 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.524 ' HA ' HG21 ' A' ' 297' ' ' THR . 2.2 tmtp? -60.49 -35.8 76.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.333 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 276' ' ' GLN . 56.6 mt -55.41 -45.09 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.855 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.718 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 9.1 t -67.42 -45.7 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.978 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.24 -44.26 79.46 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.43 -38.89 78.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.558 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.585 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 5.5 m-85 -69.51 -41.82 75.54 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.935 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 44.6 mt -64.11 -49.89 70.41 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.496 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 97.2 t -60.55 -38.9 79.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.533 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.93 -25.98 68.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.721 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.8 mmp_? -89.11 4.01 49.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.902 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.9 10.93 41.63 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.956 -1.116 . . . . 0.0 114.284 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.639 HG22 ' HG3' ' A' ' 248' ' ' LYS . 46.3 t -85.58 141.88 13.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.908 0.854 . . . . 0.0 109.752 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.1 108.1 2.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.995 0.426 . . . . 0.0 111.473 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.84 -33.36 68.04 Favored Glycine 0 C--O 1.228 -0.264 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.321 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.28 -15.08 63.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.173 0.511 . . . . 0.0 111.58 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -104.62 2.04 30.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.976 0.417 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.438 HD11 ' CG1' ' A' ' 290' ' ' VAL . 55.5 mt -107.69 129.8 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -116.69 125.28 51.49 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.524 HG21 ' HA ' ' A' ' 279' ' ' LYS . 24.7 p -111.43 122.55 48.14 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.665 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.24 161.14 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-O 121.167 0.508 . . . . 0.0 111.158 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -126.49 111.61 1.44 Allowed Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.462 ' HB3' HG21 ' A' ' 303' ' ' VAL . 18.4 mt -97.38 -8.5 29.37 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 63.24 -130.92 41.76 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 119.806 -1.188 . . . . 0.0 111.579 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 55.9 p -91.91 114.33 26.84 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.035 0.445 . . . . 0.0 109.902 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.601 ' O ' ' HD3' ' A' ' 305' ' ' PRO . 46.2 t -134.98 -67.72 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.4 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -108.09 91.34 7.79 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.221 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.627 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 7.6 Cg_exo -70.47 127.11 13.59 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.558 2.172 . . . . 0.0 111.891 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.7 tt -85.32 -42.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.774 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -131.08 170.36 14.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.128 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 27.7 m -69.62 136.16 50.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.86 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -76.62 -7.31 54.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.554 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -59.32 -29.77 67.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.942 0.401 . . . . 0.0 110.654 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.443 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 2.6 t -114.25 141.0 25.73 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.475 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.42 -31.45 94.83 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.723 2.282 . . . . 0.0 111.651 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 13.0 mm-40 -55.37 -50.75 68.89 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.953 177.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.438 ' H ' HG23 ' A' ' 311' ' ' THR . . . -63.01 -36.96 94.18 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.833 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 311' ' ' THR . 57.1 mtt180 -62.68 -35.56 80.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.846 0.355 . . . . 0.0 110.197 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.7 70.54 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.443 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 317' ' ' LYS . 15.1 mmtp -77.51 -41.31 39.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.947 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.627 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 42.0 m-20 -63.57 -24.4 67.79 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 12.0 ptm180 -83.68 6.44 20.96 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -58.18 170.86 0.62 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.153 0.978 . . . . 0.0 113.372 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 71.4 t -131.8 144.58 36.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.191 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -130.92 138.19 49.65 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.099 0.476 . . . . 0.0 111.186 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.465 ' HB ' HD12 ' A' ' 215' ' ' ILE . 2.4 mp -96.27 116.39 38.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.461 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.409 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 98.5 t -109.66 138.16 38.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.533 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 211' ' ' LEU . 59.3 t -98.74 132.93 43.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.681 -179.33 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.485 0 CA-C-O 120.846 0.355 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -78.68 66.3 4.15 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.379 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 250' ' ' CYS . 22.1 mt -53.55 -27.09 24.12 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -60.18 -51.83 67.9 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 121.018 0.437 . . . . 0.0 110.205 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.7 t -72.45 -28.25 62.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.415 0.626 . . . . 0.0 109.687 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' A' ' 211' ' ' LEU . . . -67.16 -51.39 54.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.134 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.461 ' CG2' HG13 ' A' ' 243' ' ' VAL . 26.1 pt -70.78 -38.5 73.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.485 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.79 -30.01 68.6 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.003 0.43 . . . . 0.0 110.767 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.17 -26.09 65.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.088 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.466 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.6 t -91.03 -46.28 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.993 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.616 ' HA ' HG21 ' A' ' 239' ' ' ILE . 40.1 p -67.13 -35.96 80.85 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.147 0.499 . . . . 0.0 110.855 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.96 18.97 68.5 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 129.27 -138.02 9.97 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.886 -0.657 . . . . 0.0 111.52 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' PRO . . . . . 0.62 ' HB2' ' NE ' ' A' ' 320' ' ' ARG . 1.4 Cg_endo -82.8 160.49 16.25 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.051 2.5 . . . . 0.0 112.498 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.571 ' O ' ' HB2' ' A' ' 320' ' ' ARG . 47.2 mm -81.1 115.88 24.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.201 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.796 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 174.538 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 CA--C 1.517 -0.294 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.616 HG21 ' HA ' ' A' ' 219' ' ' THR . 96.9 mt -59.01 -36.82 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.902 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.32 -30.48 70.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.431 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.4 ' HA ' ' HG3' ' A' ' 288' ' ' ARG . 3.5 m-20 -70.59 -40.8 73.04 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.466 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -64.89 -47.04 79.22 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.645 178.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.602 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 39.0 t -58.12 -44.06 86.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.042 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.74 -34.61 73.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.361 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.31 -44.67 80.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.011 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.415 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -82.02 -15.01 55.09 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.798 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.7 mt -79.83 -28.09 40.16 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 290' ' ' VAL . 54.9 mtpt -81.47 -18.22 45.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.216 175.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.5 -38.08 80.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.723 176.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.513 ' HB3' HD11 ' A' ' 211' ' ' LEU . 29.1 t -135.18 72.87 65.91 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.568 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 65.0 Cg_endo -72.69 2.25 5.48 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.948 2.432 . . . . 0.0 113.165 -177.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.13 -29.84 54.89 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.811 0.815 . . . . 0.0 109.285 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -77.57 135.86 38.21 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.526 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.86 142.26 27.96 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.5 m -114.83 131.38 67.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.134 0.493 . . . . 0.0 111.213 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.2 m -107.86 110.16 21.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.323 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.0 mt -93.07 109.43 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -98.13 128.47 44.65 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.537 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.405 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -110.47 145.9 17.32 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.496 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 28.5 m-85 -127.27 162.17 26.85 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.82 0.343 . . . . 0.0 110.309 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 59.2 p -138.75 173.68 11.32 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.618 177.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--N 1.311 -1.098 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.901 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 CA--C 1.51 -0.561 0 CA-C-O 121.828 0.823 . . . . 0.0 108.811 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.41 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 76.5 m-20 -63.37 -34.92 78.77 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.197 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.453 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 29.7 mm -56.44 -65.68 1.51 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.764 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.453 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 21.0 Cg_endo -61.83 -28.19 81.26 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 121.95 1.767 . . . . 0.0 111.964 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.3 -55.75 16.54 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.738 0.304 . . . . 0.0 111.168 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 261' ' ' THR . 6.2 p -62.3 -31.08 71.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.706 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.63 -28.22 65.73 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.305 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.474 ' O ' HG13 ' A' ' 280' ' ' ILE . 41.1 tp60 -76.39 -40.87 49.74 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -61.67 -41.82 98.07 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.498 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.27 -32.99 74.93 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.059 0.457 . . . . 0.0 110.214 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.528 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.9 tmtt? -64.72 -36.06 83.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.387 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 276' ' ' GLN . 53.0 mt -57.15 -42.42 79.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.034 0.445 . . . . 0.0 110.228 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.692 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 7.2 t -68.72 -47.15 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.057 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.77 -43.38 80.77 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.95 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -57.25 -42.11 80.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.419 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 1.5 m-85 -65.1 -52.05 57.71 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.511 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 33.8 mt -55.23 -50.72 68.72 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.591 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 77.6 t -60.71 -40.38 84.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.621 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.18 -23.54 67.48 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.232 0.539 . . . . 0.0 110.733 178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.539 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 4.5 mmp_? -88.93 5.03 45.95 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.228 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 98.06 12.67 45.36 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 119.93 -1.128 . . . . 0.0 114.109 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 248' ' ' LYS . 48.5 t -88.61 145.95 6.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 117.604 0.702 . . . . 0.0 109.48 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -71.34 111.57 6.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.47 -34.84 77.07 Favored Glycine 0 N--CA 1.46 0.235 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.264 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.38 -18.41 65.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.242 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -101.64 -0.03 35.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.162 0.506 . . . . 0.0 110.364 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 66.5 mt -106.38 132.57 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.87 126.41 51.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.691 0.281 . . . . 0.0 110.726 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.528 HG21 ' HA ' ' A' ' 279' ' ' LYS . 53.0 p -104.98 121.14 43.14 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.14 113.18 35.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.256 0.551 . . . . 0.0 112.241 -175.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.9 103.72 3.04 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 24.5 mt -87.69 -0.24 56.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.47 -138.73 36.4 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.662 -176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 7.8 p -84.27 114.3 21.74 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 120.728 0.299 . . . . 0.0 110.285 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.0 p -174.9 148.45 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 55.6 t30 64.08 75.03 0.4 Allowed Pre-proline 0 C--N 1.31 -1.128 0 O-C-N 123.712 0.633 . . . . 0.0 110.862 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.612 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 5.2 Cg_endo -80.87 133.61 9.17 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 122.305 2.003 . . . . 0.0 112.6 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.8 tt -94.37 -48.36 13.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.205 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -123.92 176.78 6.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.725 0.298 . . . . 0.0 111.025 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.43 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 47.8 m -66.39 128.08 34.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.43 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -80.54 -12.25 59.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.648 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.86 -18.32 63.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.956 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.479 HG23 ' H ' ' A' ' 314' ' ' GLY . 5.2 t -116.39 144.23 32.69 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.858 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.49 -37.36 71.35 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.627 2.218 . . . . 0.0 111.894 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 1.8 mt-10 -58.96 -41.19 86.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.278 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.479 ' H ' HG23 ' A' ' 311' ' ' THR . . . -69.82 -40.3 75.35 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.859 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -60.24 -36.38 77.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.887 0.375 . . . . 0.0 110.253 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.8 -30.01 71.15 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.645 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 11.8 mmtp -80.64 -44.4 18.91 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.612 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 44.6 m-80 -61.66 -28.09 69.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 10.7 ptm85 -84.91 11.47 9.3 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.62 ' NE ' ' HB2' ' A' ' 222' ' ' PRO . 9.2 ptm180 -73.57 -178.0 2.91 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 99.6 t -135.18 151.76 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.866 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.473 ' HG2' ' HB3' ' A' ' 222' ' ' PRO . 43.1 mt-10 -131.72 142.05 49.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.843 0.354 . . . . 0.0 110.971 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.45 116.02 41.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.39 141.96 24.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.46 135.41 36.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 57.7 t30 . . . . . 0 C--N 1.313 -0.995 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.406 -179.811 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.339 0 CA-C-O 120.716 0.293 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.62 71.94 3.25 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.027 0.441 . . . . 0.0 110.035 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 250' ' ' CYS . 29.9 mt -70.22 -31.09 68.36 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.603 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -65.39 -41.61 93.53 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.53 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.5 t -71.73 -37.11 70.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.91 -51.02 66.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.206 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.472 ' CG2' HG13 ' A' ' 243' ' ' VAL . 26.6 pt -67.63 -38.09 79.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.685 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.46 -36.25 73.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.115 0.484 . . . . 0.0 110.496 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.28 -26.02 68.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.574 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.7 t -91.87 -47.81 13.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.552 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.553 ' HA ' HG21 ' A' ' 239' ' ' ILE . 72.7 p -64.76 -39.75 94.14 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.878 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.12 15.22 79.23 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 140.99 -139.22 9.43 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.87 166.43 13.2 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.601 2.201 . . . . 0.0 112.559 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.0 mm -81.3 109.58 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.538 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.927 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.934 177.832 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 CA--C 1.516 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 219' ' ' THR . 75.3 mt -59.97 -38.41 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.638 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 62.8 mt -67.85 -28.32 67.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.709 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -74.99 -36.8 61.98 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.478 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -65.9 -43.13 89.14 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.899 176.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.589 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 40.1 t -61.65 -46.18 97.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.818 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.53 -37.07 69.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.305 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 15.0 t70 -49.8 -50.49 44.74 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.461 ' HB2' HD22 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -83.14 -14.42 53.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.382 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 33.9 mt -81.37 -29.49 34.0 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.528 ' HG3' HG22 ' A' ' 290' ' ' VAL . 62.1 mtpt -82.32 -22.27 35.69 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.506 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -71.75 -32.09 67.34 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.06 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.502 ' HB3' HD11 ' A' ' 211' ' ' LEU . 42.2 t -132.65 70.78 79.19 Favored Pre-proline 0 N--CA 1.434 -1.24 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.439 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 82.1 Cg_endo -74.09 2.5 6.03 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.165 2.577 . . . . 0.0 113.194 -177.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -75.26 -25.26 57.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.866 0.841 . . . . 0.0 109.597 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -77.51 169.82 17.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.603 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -122.44 144.9 48.76 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.375 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.67 125.47 74.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.296 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 41.9 m -103.1 108.6 19.85 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.92 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.414 HG12 HG23 ' A' ' 323' ' ' ILE . 21.2 mt -96.36 108.79 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.84 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.61 128.4 45.71 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.856 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.419 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -106.9 148.1 16.34 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.565 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 318' ' ' ASN . 24.7 m-85 -124.4 162.82 23.06 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.854 0.359 . . . . 0.0 110.39 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 274' ' ' SER . 72.2 p -144.69 172.2 13.33 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--N 1.31 -1.135 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.352 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.462 0.145 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.514 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 8.4 p30 -57.92 -38.44 75.89 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.771 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.425 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 23.0 mm -59.55 -64.53 2.89 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.754 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.425 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 11.6 Cg_endo -59.98 -26.57 82.76 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 121.905 1.736 . . . . 0.0 112.073 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 59.0 tp -68.68 -54.22 17.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 111.227 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.52 ' HB3' HG23 ' A' ' 261' ' ' THR . 5.8 p -63.71 -31.53 72.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.515 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.36 67.71 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.959 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.516 ' O ' HG13 ' A' ' 280' ' ' ILE . 24.5 tp60 -70.56 -47.31 60.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.579 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -61.36 -40.04 92.85 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.393 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.95 92.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.176 0.512 . . . . 0.0 109.816 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.442 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.5 tptt -61.49 -35.46 77.75 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.939 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 276' ' ' GLN . 59.8 mt -57.49 -44.31 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.017 0.437 . . . . 0.0 110.369 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.722 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.5 t -68.4 -46.28 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.746 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.6 -45.21 73.6 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -61.15 -37.79 84.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.937 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.515 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 2.0 m-85 -66.63 -44.05 83.04 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.074 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 39.1 mt -64.87 -51.16 63.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.795 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 84.4 t -60.23 -38.77 78.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.298 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.68 -31.13 71.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.288 0.566 . . . . 0.0 110.287 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 19.9 mmm180 -84.86 4.95 30.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.489 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.61 46.86 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.352 -0.928 . . . . 0.0 114.094 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.528 HG22 ' HG3' ' A' ' 248' ' ' LYS . 66.7 t -84.77 140.73 15.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 117.752 0.776 . . . . 0.0 109.026 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.72 108.11 2.81 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.639 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.38 -30.07 67.34 Favored Glycine 0 CA--C 1.509 -0.302 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.968 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.85 -21.18 64.45 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.537 0.335 . . . . 0.0 111.748 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -106.9 5.58 28.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.408 HD11 ' CG1' ' A' ' 290' ' ' VAL . 68.6 mt -106.23 128.45 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.42 127.59 53.81 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.25 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.442 HG21 ' HA ' ' A' ' 279' ' ' LYS . 31.7 p -111.99 124.87 53.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.689 0.28 . . . . 0.0 110.683 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.79 121.25 52.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.093 0.473 . . . . 0.0 111.822 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -90.77 112.13 4.05 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 26.1 mt -90.45 -32.07 16.54 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 88.75 -140.13 15.76 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 47.2 t -88.62 114.27 25.07 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.501 HG13 ' H ' ' A' ' 304' ' ' ASN . 3.4 p -142.94 -61.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.852 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.501 ' H ' HG13 ' A' ' 303' ' ' VAL . 12.8 m120 -115.33 92.08 30.83 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.715 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 8.3 Cg_exo -67.98 127.82 16.69 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.803 2.336 . . . . 0.0 112.81 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.8 tt -85.74 -44.28 16.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.614 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -127.4 167.03 16.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.469 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 53.8 p -63.34 133.0 53.38 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.506 0.504 . . . . 0.0 111.104 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -80.84 -8.43 59.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.949 0.404 . . . . 0.0 110.651 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -62.69 -23.62 67.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.687 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 1.5 t -117.11 140.77 27.5 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 311' ' ' THR . 24.6 Cg_exo -55.99 -35.78 94.99 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.82 2.347 . . . . 0.0 111.332 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -57.65 -47.01 83.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.853 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -63.43 -38.47 96.43 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.844 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -60.57 -37.19 80.49 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.16 -30.81 71.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.699 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 317' ' ' LYS . 12.7 mmtp -76.16 -41.96 48.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.08 0.467 . . . . 0.0 109.927 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.715 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 43.7 m-80 -61.75 -28.29 69.33 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 11.8 ptp180 -81.4 9.38 7.36 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -57.5 177.6 0.1 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.07 0.938 . . . . 0.0 113.341 174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 74.8 t -136.07 144.96 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.577 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -127.74 140.77 51.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.729 0.299 . . . . 0.0 111.057 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.414 HG23 HG12 ' A' ' 257' ' ' ILE . 1.4 mp -103.93 117.17 49.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.17 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.62 132.66 53.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.074 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.68 130.48 40.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.316 0.579 . . . . 0.0 111.234 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 254' ' ' ARG . 27.9 t-20 . . . . . 0 C--N 1.309 -1.17 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.314 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.338 0 CA-C-O 120.912 0.387 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.34 85.73 2.5 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.596 ' HB2' HG21 ' A' ' 325' ' ' VAL . 23.4 mt -75.22 -34.57 61.47 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.447 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -62.62 -44.95 95.01 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 120.922 0.391 . . . . 0.0 110.061 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 36.2 t -65.49 -43.05 91.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.163 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.539 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -64.44 -47.03 80.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.927 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 211' ' ' LEU . 17.7 pt -69.37 -38.04 76.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.467 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -60.25 -37.81 81.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.099 0.476 . . . . 0.0 110.023 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.82 -27.66 67.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.039 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.771 HG12 HG23 ' A' ' 239' ' ' ILE . 43.1 t -83.01 -47.78 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 CA-C-O 121.069 0.461 . . . . 0.0 110.056 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.68 ' HA ' HG21 ' A' ' 239' ' ' ILE . 37.9 p -66.13 -35.25 79.98 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.017 -178.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.83 28.05 57.54 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 121.8 -132.24 8.86 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 114.54 -0.83 . . . . 0.0 111.192 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -89.34 169.25 5.0 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.734 2.289 . . . . 0.0 113.308 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.8 mm -85.67 105.18 14.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.196 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.946 0 CA-C-O 120.906 0.384 . . . . 0.0 111.371 -179.502 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.471 ' HA ' ' OD1' ' A' ' 241' ' ' ASN . 32.1 mt-10 . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 121.011 0.434 . . . . 0.0 112.169 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.771 HG23 HG12 ' A' ' 218' ' ' VAL . 82.8 mt -61.86 -37.62 78.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.694 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.1 mt -71.97 -21.63 61.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.471 ' OD1' ' HA ' ' A' ' 238' ' ' GLU . 3.7 m120 -76.84 -41.74 43.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.745 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -66.95 -42.82 84.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.954 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.622 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.4 t -58.35 -40.92 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.486 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.48 -36.83 76.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.317 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 3.5 t70 -48.54 -52.35 23.09 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.657 0.783 . . . . 0.0 112.813 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.545 ' HB3' ' NZ ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -81.01 -17.75 49.24 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.668 -176.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 36.2 mt -79.14 -30.81 43.81 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.241 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.546 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 52.3 mtpt -82.63 -18.78 39.92 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.563 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.57 85.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.438 0.637 . . . . 0.0 110.01 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.548 ' HB3' HD11 ' A' ' 211' ' ' LEU . 49.9 t -128.98 69.06 80.62 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 74.3 Cg_endo -72.08 -1.29 9.82 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.416 2.744 . . . . 0.0 114.715 -173.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.45 -23.76 29.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.558 0.694 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.98 141.01 58.34 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.4 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -96.31 136.55 36.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.462 HG12 HG22 ' A' ' 325' ' ' VAL . 5.9 m -113.53 137.24 47.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 121.191 0.52 . . . . 0.0 111.685 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.7 m -113.43 109.0 17.97 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.187 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.7 mt -91.92 112.47 25.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -99.41 130.98 45.72 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.843 -176.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.547 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -107.3 145.43 16.05 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 9.2 m-85 -123.26 171.73 9.16 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 302' ' ' SER . 10.0 t -175.3 174.18 2.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.798 0.332 . . . . 0.0 110.765 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 121.199 0.523 . . . . 0.0 111.358 -178.281 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.423 ' HB2' ' CG2' ' A' ' 261' ' ' THR . 9.5 p30 -57.89 -31.55 66.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.526 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.461 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 24.8 mm -62.31 -65.49 2.11 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.567 176.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.461 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.0 Cg_endo -57.54 -30.82 89.76 Favored 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 121.821 1.68 . . . . 0.0 111.807 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 40.1 tp -61.96 -56.64 17.06 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.169 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.547 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.5 p -63.41 -27.28 69.19 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.965 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.98 -30.05 62.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.28 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -49.2 65.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 48.0 mmt-85 -59.49 -37.14 77.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.296 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.47 -34.86 79.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.01 0.434 . . . . 0.0 110.539 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.709 ' HA ' HG21 ' A' ' 297' ' ' THR . 0.3 OUTLIER -68.06 -30.74 70.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.441 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 57.5 mt -60.13 -45.37 95.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.956 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.693 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 10.5 t -65.62 -45.14 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.788 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -53.15 -44.84 68.1 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.776 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.17 -43.12 87.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.51 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.446 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 4.4 m-85 -66.17 -41.07 90.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.139 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.693 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 27.0 mt -67.6 -47.2 70.38 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.739 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 282' ' ' ALA . 94.5 t -60.55 -41.48 87.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.36 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.8 -26.69 68.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.303 0.573 . . . . 0.0 110.515 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.446 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 2.7 mpt_? -86.95 4.98 39.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.426 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.64 8.42 49.05 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.043 -1.075 . . . . 0.0 114.4 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 63.0 t -85.29 143.68 11.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.448 ' O ' HG13 ' A' ' 295' ' ' ILE . . . -69.91 106.72 3.28 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.829 0.347 . . . . 0.0 111.421 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.55 -31.45 77.73 Favored Glycine 0 CA--C 1.503 -0.703 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.304 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.62 -17.47 64.61 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.734 0.302 . . . . 0.0 110.946 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -105.05 3.85 30.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.525 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 291' ' ' ALA . 67.5 mt -105.49 131.18 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -121.57 128.84 52.41 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.291 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.709 HG21 ' HA ' ' A' ' 279' ' ' LYS . 56.1 p -107.73 128.57 54.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.401 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 95.6 t -134.98 132.18 53.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.118 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -102.08 117.56 5.86 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 23.6 mt -91.56 -7.33 50.55 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.401 ' HA3' ' OD1' ' A' ' 270' ' ' ASN . . . 68.64 -136.93 29.97 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.445 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 261' ' ' THR . 7.3 p -74.52 97.76 3.2 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 120.927 0.394 . . . . 0.0 110.73 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.2 t -152.94 130.81 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.935 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 52.22 77.59 0.44 Allowed Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 123.786 0.679 . . . . 0.0 112.47 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.411 ' HB3' ' OD1' ' A' ' 318' ' ' ASN . 5.9 Cg_exo -74.46 171.65 17.69 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.468 2.112 . . . . 0.0 112.394 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.7 -55.72 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.592 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.456 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -110.22 171.36 7.5 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.881 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 24.7 m -62.39 134.76 56.9 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 123.553 0.533 . . . . 0.0 111.261 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -81.31 -8.36 59.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.469 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.15 -10.38 59.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.001 0.429 . . . . 0.0 111.366 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 314' ' ' GLY . 2.4 t -118.0 143.54 32.92 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.317 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.03 -31.06 56.06 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.22 1.946 . . . . 0.0 111.37 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 2.8 mt-10 -70.83 -35.4 72.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.779 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 307' ' ' ALA . . . -72.49 -40.19 54.85 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.82 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -65.2 -31.91 73.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.11 -26.73 68.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.107 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.498 ' HA ' ' HD3' ' A' ' 317' ' ' LYS . 10.6 mmtp -87.16 -37.07 17.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.806 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 305' ' ' PRO . 0.9 OUTLIER -62.35 -25.85 68.12 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 14.3 ptp180 -87.75 17.2 4.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.248 0.547 . . . . 0.0 111.556 -178.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -57.42 170.69 0.5 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.244 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 87.1 t -133.16 146.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.447 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -132.03 137.02 47.67 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.044 0.449 . . . . 0.0 110.788 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.441 ' HB ' HD12 ' A' ' 215' ' ' ILE . 2.9 mp -93.07 117.19 35.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.722 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 44.6 t -113.35 143.87 22.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 211' ' ' LEU . 46.9 t -106.06 140.29 24.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.0 t30 . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.306 -179.615 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -75.47 78.99 2.51 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.128 0.489 . . . . 0.0 110.57 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 250' ' ' CYS . 40.1 mt -57.66 -21.59 40.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.246 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -63.44 -45.05 92.7 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 120.966 0.413 . . . . 0.0 109.937 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 36.3 t -73.8 -35.41 64.91 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 211' ' ' LEU . . . -62.57 -47.82 82.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.444 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 211' ' ' LEU . 18.8 pt -72.24 -39.93 64.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.396 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.449 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 12.3 t-20 -61.25 -28.75 69.39 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.128 0.489 . . . . 0.0 110.755 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.88 69.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.983 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.506 HG11 ' HG3' ' A' ' 242' ' ' ARG . 2.5 t -93.37 -41.63 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.199 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.588 ' HA ' HG21 ' A' ' 239' ' ' ILE . 80.9 p -65.11 -36.52 84.56 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.251 0.548 . . . . 0.0 110.266 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.22 22.13 63.62 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 130.86 -125.2 4.44 Favored Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.14 162.27 5.77 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 122.499 2.133 . . . . 0.0 112.044 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.9 mm -73.46 111.14 7.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.756 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.898 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.865 176.114 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 N--CA 1.465 0.301 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.588 HG21 ' HA ' ' A' ' 219' ' ' THR . 58.1 mt -65.34 -36.15 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.499 ' CD2' HG13 ' A' ' 281' ' ' VAL . 41.0 mt -64.96 -35.62 81.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.492 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -71.54 -39.86 70.43 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.506 ' HG3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -64.19 -48.66 75.07 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.037 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.632 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 55.2 t -55.47 -42.69 68.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.196 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.88 -37.51 87.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.936 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -52.49 -49.45 64.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.501 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -73.94 -29.42 62.01 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 119.491 -0.883 . . . . 0.0 111.292 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 24.5 mt -69.75 -27.78 65.23 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 121.614 0.721 . . . . 0.0 109.254 176.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -68.38 -33.9 75.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.549 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.96 70.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.439 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.516 ' HB3' HD11 ' A' ' 211' ' ' LEU . 52.1 t -126.16 72.5 71.23 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.78 -0.79 9.44 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.99 2.46 . . . . 0.0 113.074 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.55 -30.05 59.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.521 0.676 . . . . 0.0 109.271 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.58 135.98 50.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.652 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.555 ' HB2' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -91.44 145.07 24.93 Favored 'General case' 0 CA--C 1.479 -1.758 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.745 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.0 m -120.43 125.38 74.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.896 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 54.9 m -101.35 108.87 20.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.469 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 323' ' ' ILE . 22.3 mt -94.92 112.19 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.109 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -103.48 124.34 48.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.109 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -103.65 163.62 15.46 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.352 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 32.4 m-85 -136.15 159.55 41.38 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.014 0.435 . . . . 0.0 110.63 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 63.2 p -141.3 164.87 29.07 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 C--N 1.319 -0.744 0 CA-C-O 120.969 0.414 . . . . 0.0 110.695 178.436 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 35.1 mm . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 121.736 0.779 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 1.6 m120 -63.21 -36.97 85.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.607 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.439 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.3 mm -56.27 -65.24 1.68 Allowed Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.829 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.439 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 27.0 Cg_endo -63.24 -25.12 72.12 Favored 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 122.159 1.906 . . . . 0.0 112.277 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.521 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 53.8 tp -69.78 -52.24 26.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.001 0.429 . . . . 0.0 110.019 177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.444 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 10.1 t -57.5 -39.71 77.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.019 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.63 78.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.803 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.459 ' O ' HG13 ' A' ' 280' ' ' ILE . 6.5 tp-100 -68.08 -46.89 69.75 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.59 0.71 . . . . 0.0 109.703 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 67.3 mtp85 -59.7 -44.8 93.54 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.241 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.53 84.02 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.16 0.505 . . . . 0.0 110.182 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.631 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.5 tmtt? -64.22 -30.48 71.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.69 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 276' ' ' GLN . 62.2 mt -57.2 -41.37 77.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.977 0.417 . . . . 0.0 109.963 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.747 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 13.8 t -69.77 -47.91 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.868 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.09 -43.73 78.32 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.908 0.385 . . . . 0.0 110.919 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.1 -38.69 80.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.3 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.535 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 3.9 m-85 -72.83 -40.55 65.69 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.315 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 44.5 mt -64.18 -48.32 76.38 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 86.3 t -60.32 -39.66 81.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.1 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.43 -23.75 67.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.207 0.527 . . . . 0.0 110.895 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 5.0 mmp_? -89.02 2.9 53.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.394 178.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 97.83 13.14 44.51 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.203 -0.999 . . . . 0.0 114.053 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 62.0 t -87.63 139.96 16.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 117.514 0.657 . . . . 0.0 109.328 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.9 113.5 3.88 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.195 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -66.83 -11.27 57.51 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.893 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.71 -11.91 54.88 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 120.869 0.366 . . . . 0.0 110.224 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -110.23 2.25 19.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.736 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 57.7 mt -107.41 123.69 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -115.67 127.57 55.27 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.592 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 279' ' ' LYS . 47.5 p -104.89 126.28 51.79 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.39 113.04 30.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.305 0.574 . . . . 0.0 112.252 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.444 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -89.11 105.02 3.15 Favored Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.504 175.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 21.0 mt -94.06 1.4 56.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.665 0.269 . . . . 0.0 110.922 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.77 -128.08 42.31 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.539 -175.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 43.0 p -97.67 123.43 41.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.523 ' O ' ' HD3' ' A' ' 305' ' ' PRO . 3.5 p -150.21 -60.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.453 ' H ' HG13 ' A' ' 303' ' ' VAL . 90.6 m-20 -112.32 94.07 25.14 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-O 120.906 0.384 . . . . 0.0 110.039 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 303' ' ' VAL . 2.7 Cg_exo -70.88 172.77 13.07 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.874 2.383 . . . . 0.0 113.311 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.4 tt -134.13 -48.62 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.685 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -126.25 171.02 11.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.581 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.429 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 14.6 m -65.16 124.48 22.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.072 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -80.06 -8.38 59.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -62.33 -23.31 66.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.25 0.548 . . . . 0.0 110.361 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 314' ' ' GLY . 1.9 t -117.8 140.43 27.67 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.613 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -52.12 -38.32 70.61 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.133 2.555 . . . . 0.0 111.667 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -53.04 -52.27 59.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.715 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.43 ' H ' HG23 ' A' ' 311' ' ' THR . . . -65.61 -37.98 94.16 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.746 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -59.54 -37.51 78.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.37 . . . . 0.0 110.361 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.34 -31.37 72.54 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.386 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.87 -44.36 20.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.23 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -58.7 -26.28 63.74 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 13.4 ptp180 -83.08 11.09 6.77 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -58.34 179.0 0.08 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 121.61 0.719 . . . . 0.0 112.765 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.7 t -140.43 149.09 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.088 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -131.38 147.12 52.53 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.918 0.389 . . . . 0.0 111.003 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.471 HG23 HG12 ' A' ' 257' ' ' ILE . 1.3 mp -109.17 119.81 59.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.057 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.84 134.52 48.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.942 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 91.2 t -94.8 135.21 29.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.501 0.667 . . . . 0.0 112.409 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ASN . . . . . 0.555 ' HB3' ' HB2' ' A' ' 254' ' ' ARG . 5.3 t30 . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.257 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 CA-C-O 120.949 0.404 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -83.18 77.96 9.68 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.459 ' HB2' HG21 ' A' ' 325' ' ' VAL . 29.4 mt -67.34 -29.71 69.33 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.126 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -62.2 -44.32 96.84 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.821 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.0 m -69.25 -36.2 76.91 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.115 0.483 . . . . 0.0 109.769 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.46 -51.08 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.069 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.419 ' CG2' HG13 ' A' ' 243' ' ' VAL . 20.7 pt -68.37 -39.79 81.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.298 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -58.57 -32.11 68.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.861 0.362 . . . . 0.0 110.376 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.26 -32.59 73.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.185 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.528 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.2 t -85.96 -47.93 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 120.779 0.323 . . . . 0.0 110.686 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.504 ' HA ' HG21 ' A' ' 239' ' ' ILE . 58.1 p -62.71 -32.95 74.15 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.384 0.612 . . . . 0.0 110.055 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.52 22.47 47.1 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.95 -127.13 6.39 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' PRO . . . . . 0.464 ' CB ' ' HD2' ' A' ' 320' ' ' ARG . 71.6 Cg_endo -84.39 164.3 12.76 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.201 1.934 . . . . 0.0 111.738 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 42.1 mm -71.65 98.0 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.573 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.044 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.719 177.912 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 . . . . . 0 CA--C 1.518 -0.258 0 CA-C-O 120.708 0.29 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.504 HG21 ' HA ' ' A' ' 219' ' ' THR . 76.9 mt -62.23 -31.94 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.401 HD11 HG13 ' A' ' 281' ' ' VAL . 3.9 mm? -62.21 -32.26 72.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.215 0.531 . . . . 0.0 110.38 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.68 -37.07 36.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.686 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.551 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 0.0 OUTLIER -67.78 -39.93 84.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.414 178.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.552 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 38.6 t -61.21 -37.25 77.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.54 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 248' ' ' LYS . . . -58.23 -38.04 76.07 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.819 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 4.0 t70 -46.46 -49.18 18.64 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.821 0.848 . . . . 0.0 112.938 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -83.73 -18.16 38.79 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.1 mt -84.8 -25.41 28.19 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 289' ' ' GLY . 6.1 tptm -73.88 -29.86 62.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.701 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.87 75.85 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.268 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.458 ' HB3' HD11 ' A' ' 211' ' ' LEU . 45.0 t -133.44 70.81 76.6 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.71 1.81 7.15 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.845 2.363 . . . . 0.0 113.078 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.55 -31.81 57.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.746 0.784 . . . . 0.0 109.14 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.26 145.63 55.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.314 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -99.99 132.82 45.11 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.496 HG12 HG22 ' A' ' 325' ' ' VAL . 6.1 m -115.06 131.16 68.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.236 0.541 . . . . 0.0 111.383 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.5 m -107.35 112.02 24.64 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.734 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.431 HG12 HG23 ' A' ' 323' ' ' ILE . 18.8 mt -92.61 116.03 32.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -107.77 127.49 53.74 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.739 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -99.02 149.83 19.16 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.844 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -131.95 163.02 29.29 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 117.274 0.537 . . . . 0.0 110.171 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 3.1 t -159.08 152.48 22.65 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 42.9 t0 . . . . . 0 C--N 1.322 -0.589 0 CA-C-O 121.161 0.505 . . . . 0.0 111.082 -178.402 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 40.3 mm . . . . . 0 CA--C 1.517 -0.3 0 CA-C-O 121.703 0.763 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.0 -32.78 74.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.477 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.65 -64.26 3.29 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.12 -30.0 88.25 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.237 1.958 . . . . 0.0 111.947 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.539 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 50.9 tp -66.77 -51.33 57.06 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.037 0.446 . . . . 0.0 110.218 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.445 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 13.1 t -56.15 -39.21 71.95 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.263 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.21 -28.54 64.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.075 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -74.21 -44.4 53.38 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.259 0.552 . . . . 0.0 110.096 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 59.8 mtp85 -62.27 -41.0 98.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.997 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.88 -36.11 83.3 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.815 0.341 . . . . 0.0 111.014 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.491 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.6 tptt -59.83 -35.36 74.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.0 mt -55.1 -46.28 77.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.725 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 15.8 t -68.51 -46.22 80.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.653 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.63 -42.78 79.45 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.872 0.367 . . . . 0.0 111.185 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.61 -36.15 77.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.68 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.44 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 3.3 m-85 -74.19 -39.68 63.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.117 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 45.2 mt -65.45 -49.47 68.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.502 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 80.8 t -60.21 -38.13 76.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.163 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.23 70.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.694 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.558 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 3.7 mmp_? -87.23 7.37 28.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.684 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.531 ' O ' ' HE3' ' A' ' 248' ' ' LYS . . . 97.14 10.13 54.97 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.125 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 50.4 t -84.9 139.73 17.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 117.894 0.847 . . . . 0.0 109.547 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.99 111.97 2.74 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.071 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.3 -35.2 83.76 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.097 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.82 -11.87 61.21 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -101.44 -2.64 30.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.06 0.457 . . . . 0.0 109.878 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 64.5 mt -107.4 129.65 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.152 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.21 125.78 51.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.628 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.491 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.6 p -111.1 118.74 36.82 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.045 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 18.6 m -121.56 162.76 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.034 0 CA-C-O 121.224 0.535 . . . . 0.0 111.365 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.445 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -129.11 104.46 0.64 Allowed Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.6 mt -89.44 -31.17 17.84 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.733 0.302 . . . . 0.0 111.615 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 106.7 -122.23 6.9 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.841 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.4 t -104.98 120.12 40.68 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 8.6 p 179.81 152.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 58.3 t30 66.44 79.03 0.24 Allowed Pre-proline 0 C--N 1.314 -0.953 0 O-C-N 123.756 0.66 . . . . 0.0 111.467 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.55 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 73.3 Cg_endo -77.79 149.5 26.4 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.606 2.204 . . . . 0.0 113.136 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.415 HD12 ' HG3' ' A' ' 222' ' ' PRO . 2.9 tt -108.14 -39.16 4.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.32 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.51 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -139.64 174.42 10.54 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.978 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 26.2 m -74.54 129.52 37.9 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.121 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -80.16 -7.66 59.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.587 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -57.39 -19.08 21.02 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.382 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.4 t -127.77 141.33 40.74 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.928 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.87 -21.68 34.36 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.188 2.592 . . . . 0.0 112.399 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.565 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.5 mm-40 -60.04 -46.36 89.77 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.392 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 307' ' ' ALA . . . -65.77 -39.73 95.33 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.14 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -60.53 -37.02 79.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.425 0.631 . . . . 0.0 110.121 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.59 -29.38 66.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.193 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 6.7 mmtp -87.11 -35.86 18.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.307 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 27.9 m-20 -65.47 -15.48 62.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 7.6 ptm180 -88.49 16.2 6.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.558 0.694 . . . . 0.0 111.036 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.464 ' HD2' ' CB ' ' A' ' 222' ' ' PRO . 14.4 ptt180 -63.18 -173.69 0.06 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.422 1.105 . . . . 0.0 113.246 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.84 145.63 25.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.783 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -135.74 145.01 46.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.231 0.539 . . . . 0.0 111.599 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.431 HG23 HG12 ' A' ' 257' ' ' ILE . 1.8 mp -101.37 115.19 42.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.106 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 85.1 t -105.37 136.13 40.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.834 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 255' ' ' VAL . 69.5 t -101.27 136.18 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 48.3 t30 . . . . . 0 C--N 1.311 -1.073 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.92 179.033 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.485 0 CA-C-O 120.606 0.241 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.98 82.02 4.35 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.184 0.516 . . . . 0.0 110.244 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.508 ' HB2' HG21 ' A' ' 325' ' ' VAL . 52.9 mt -69.47 -24.76 63.83 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.875 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -68.86 -38.34 79.7 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.415 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 t -76.61 -32.22 57.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -67.84 -49.08 64.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.14 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.504 HG21 HG13 ' A' ' 243' ' ' VAL . 21.8 pt -69.39 -33.39 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.801 -0.181 . . . . 0.0 111.081 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -54.99 -34.17 63.16 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.134 0.492 . . . . 0.0 110.801 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.87 -31.76 72.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.243 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.531 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.5 t -91.81 -48.98 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.883 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.583 ' HA ' HG21 ' A' ' 239' ' ' ILE . 53.7 p -62.73 -43.61 98.35 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.302 0.573 . . . . 0.0 110.776 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.42 19.46 66.41 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.042 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 134.29 -136.95 8.92 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' PRO . . . . . 0.451 ' HB2' ' HG3' ' A' ' 320' ' ' ARG . 64.5 Cg_endo -82.27 162.39 17.54 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.638 2.226 . . . . 0.0 112.756 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.7 mm -78.58 104.14 6.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.546 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.897 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.389 177.943 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 . . . . . 0 C--O 1.235 0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.583 HG21 ' HA ' ' A' ' 219' ' ' THR . 56.8 mt -62.5 -38.28 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 50.6 mt -65.8 -31.61 72.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.796 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -71.4 -38.97 71.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.531 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.2 OUTLIER -65.85 -47.7 74.07 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.829 178.225 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.58 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.7 t -58.26 -45.43 89.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.062 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.415 ' HB1' HG23 ' A' ' 290' ' ' VAL . . . -61.01 -35.81 77.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.692 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -54.49 -47.94 72.43 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -75.26 -29.99 60.34 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.462 -178.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.0 mt -65.64 -34.41 78.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.435 0.635 . . . . 0.0 109.646 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -72.44 -24.7 61.25 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.146 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.84 69.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.049 0.452 . . . . 0.0 110.84 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.479 ' HB3' HD11 ' A' ' 211' ' ' LEU . 35.8 t -125.53 68.88 61.25 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.61 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.07 3.26 5.81 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.075 2.516 . . . . 0.0 113.388 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.91 -32.16 61.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.968 0.89 . . . . 0.0 108.879 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -74.56 148.04 41.21 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.442 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -101.1 139.42 36.8 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.8 m -115.0 130.01 70.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-O 121.327 0.584 . . . . 0.0 110.835 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.9 m -105.28 110.45 22.82 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.322 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.415 HG12 HG23 ' A' ' 323' ' ' ILE . 23.9 mt -92.8 111.1 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.96 126.31 46.11 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.146 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -105.07 159.02 15.84 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.152 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 301' ' ' GLY . 76.3 m-85 -132.55 165.97 23.16 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.816 0.341 . . . . 0.0 110.775 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.515 HG22 ' NH1' ' A' ' 277' ' ' ARG . 33.2 p -144.55 169.74 17.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.738 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 C--N 1.312 -1.046 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 175.337 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.9 mm . . . . . 0 CA--C 1.512 -0.49 0 CA-C-O 122.119 0.961 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -61.74 -28.54 69.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.838 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.492 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 33.9 mm -57.26 -65.19 1.88 Allowed Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.432 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.492 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.9 Cg_endo -58.59 -35.45 98.64 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 122.195 1.93 . . . . 0.0 111.979 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 276' ' ' GLN . 54.2 tp -62.72 -53.87 47.79 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.277 0.56 . . . . 0.0 111.028 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.483 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 15.2 t -57.29 -35.59 69.99 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.005 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.35 -22.16 64.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.821 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.479 ' O ' HG13 ' A' ' 280' ' ' ILE . 11.2 tt0 -71.51 -53.1 14.97 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.515 ' NH1' HG22 ' A' ' 261' ' ' THR . 75.9 mtt85 -56.97 -44.14 82.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.62 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.43 77.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.962 0.41 . . . . 0.0 110.814 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.638 ' HA ' HG21 ' A' ' 297' ' ' THR . 11.9 tmtt? -69.37 -30.55 68.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.28 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 276' ' ' GLN . 58.8 mt -59.82 -44.96 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.732 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.7 t -65.99 -48.19 82.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.047 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.77 76.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 120.919 0.39 . . . . 0.0 110.984 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.4 -42.27 91.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.935 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.68 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 5.7 m-85 -68.09 -43.36 78.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.893 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 36.4 mt -63.62 -46.15 87.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.835 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.7 t -61.27 -40.16 85.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.379 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.25 -30.74 71.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.549 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 13.8 mmm180 -81.83 5.07 19.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.472 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.6 2.75 50.1 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.164 -1.017 . . . . 0.0 114.629 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 57.9 t -80.91 145.96 8.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 117.923 0.861 . . . . 0.0 110.573 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.401 ' O ' HG13 ' A' ' 295' ' ' ILE . . . -69.77 108.08 3.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.701 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.41 -33.8 82.56 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.792 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.97 -19.14 64.93 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -103.39 2.41 33.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 291' ' ' ALA . 62.7 mt -104.35 130.36 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.52 127.21 53.77 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.646 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.638 HG21 ' HA ' ' A' ' 279' ' ' LYS . 53.8 p -106.25 119.97 40.63 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 77.2 t -124.25 114.91 43.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.357 0.599 . . . . 0.0 112.103 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.483 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -88.02 107.4 3.31 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.85 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 23.9 mt -94.64 -4.25 48.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.924 0.392 . . . . 0.0 110.43 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 260' ' ' TYR . . . 62.72 -133.07 44.11 Favored Glycine 0 N--CA 1.431 -1.657 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.66 -175.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.4 t -99.69 122.63 42.98 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.2 p -149.25 -56.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.666 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -113.33 93.73 27.96 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.427 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 14.9 Cg_endo -64.19 162.05 31.45 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.834 2.356 . . . . 0.0 112.934 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.493 HG22 ' HA ' ' A' ' 318' ' ' ASN . 4.7 tt -124.34 -53.59 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.874 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.422 ' H ' HG23 ' A' ' 306' ' ' ILE . . . -119.8 171.41 8.43 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 22.2 m -61.91 127.33 30.88 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.564 0.54 . . . . 0.0 110.845 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -79.79 -8.16 59.1 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.015 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.79 -17.37 62.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.699 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.8 t -116.8 138.4 24.59 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.47 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.74 -34.25 97.94 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.921 2.414 . . . . 0.0 111.517 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.6 mm-40 -59.65 -45.92 90.57 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.35 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.436 ' H ' HG23 ' A' ' 311' ' ' THR . . . -68.37 -38.82 87.56 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 311' ' ' THR . 96.7 mtt180 -59.09 -37.31 76.83 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.032 0.444 . . . . 0.0 109.96 176.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.42 -27.72 68.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.57 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 3.3 mmtp -80.93 -41.81 22.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.648 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.493 ' HA ' HG22 ' A' ' 306' ' ' ILE . 39.2 m-80 -60.19 -22.23 62.68 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -93.45 16.25 13.95 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.451 ' HG3' ' HB2' ' A' ' 222' ' ' PRO . 0.0 OUTLIER -66.49 179.24 1.05 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.746 0.784 . . . . 0.0 112.358 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 98.8 t -129.27 143.34 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.504 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -131.61 140.46 49.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 111.378 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 323' ' ' ILE . 1.5 mp -101.4 119.92 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.095 -177.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.49 141.74 27.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.268 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 211' ' ' LEU . 96.0 t -98.38 135.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 67.1 t30 . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.713 -179.503 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.163 0.506 . . . . 0.0 112.148 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -87.69 83.09 7.22 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.828 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.5 mm? -69.59 -40.71 76.52 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.167 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -64.14 -40.66 96.65 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.719 0.295 . . . . 0.0 110.861 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 33.5 t -68.35 -44.17 75.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.066 0.46 . . . . 0.0 110.115 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.29 -44.66 87.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.031 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.482 ' CG2' HG13 ' A' ' 243' ' ' VAL . 27.1 pt -69.11 -37.6 76.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.212 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -60.72 -33.02 72.26 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.336 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.49 -25.09 65.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.213 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.426 HG12 HG23 ' A' ' 239' ' ' ILE . 3.3 t -90.25 -43.7 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 110.047 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.6 ' HA ' HG21 ' A' ' 239' ' ' ILE . 71.5 p -68.03 -36.71 80.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.579 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.97 24.68 51.94 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.98 -136.5 9.4 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.84 164.94 20.17 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.374 2.049 . . . . 0.0 112.267 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.7 mm -77.95 104.32 5.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.6 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.821 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.969 177.452 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 CA--C 1.511 -0.547 0 CA-C-O 121.418 0.627 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.6 HG21 ' HA ' ' A' ' 219' ' ' THR . 90.3 mt -58.63 -34.57 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.147 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.45 -33.77 76.66 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.213 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.482 ' HA ' ' HG2' ' A' ' 288' ' ' ARG . 44.8 m-20 -71.33 -37.32 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -49.91 57.42 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.82 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.63 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 38.8 t -57.93 -47.65 85.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.413 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.79 -28.18 68.17 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.848 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.92 -40.19 83.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 0.0 111.434 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 243' ' ' VAL . 0.0 OUTLIER -77.88 -26.69 49.38 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.038 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 38.3 mt -66.68 -27.34 67.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.157 0.503 . . . . 0.0 110.307 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 59.0 mtpt -76.65 -17.23 59.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.377 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.91 -30.21 63.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.1 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 8.4 t -137.02 67.79 56.36 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 71.6 Cg_endo -75.44 4.46 4.95 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.354 2.703 . . . . 0.0 114.621 -174.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -78.16 -29.69 48.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.585 0.707 . . . . 0.0 109.474 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.44 136.66 51.85 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.779 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -86.33 138.36 31.88 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.411 HG12 HG22 ' A' ' 325' ' ' VAL . 3.8 m -111.53 126.26 68.91 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.839 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.3 m -104.2 106.57 17.12 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.379 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 323' ' ' ILE . 28.0 mt -92.56 113.21 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.478 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -100.51 129.36 46.45 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.689 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.439 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -108.0 144.38 16.14 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 27.4 m-85 -124.33 161.48 25.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.127 0.489 . . . . 0.0 110.61 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.576 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 72.7 p -147.0 164.22 33.69 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--N 1.32 -0.697 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.859 176.169 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 121.532 0.682 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.576 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 0.6 OUTLIER -58.54 -36.81 74.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.199 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.473 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.4 mm -61.17 -63.95 3.7 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.24 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.9 Cg_endo -58.37 -31.68 94.47 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.944 1.763 . . . . 0.0 111.866 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.591 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 62.4 tp -67.4 -54.2 22.49 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.568 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.566 ' HB3' HG23 ' A' ' 261' ' ' THR . 18.5 p -62.48 -29.92 70.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.767 0.318 . . . . 0.0 110.898 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.44 -31.34 69.61 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.412 ' O ' HG13 ' A' ' 280' ' ' ILE . 25.8 tt0 -73.2 -41.28 63.99 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 60.7 mtp85 -61.92 -45.16 94.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.034 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.77 76.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.876 0.37 . . . . 0.0 110.872 176.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.583 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.6 tmtt? -65.94 -30.26 70.81 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.509 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 276' ' ' GLN . 60.6 mt -56.51 -44.21 80.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.23 0.538 . . . . 0.0 109.753 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.686 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.9 t -70.92 -46.54 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.574 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.87 71.01 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.877 0.37 . . . . 0.0 111.184 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -57.71 -43.28 85.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.502 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.503 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 4.8 m-85 -69.58 -38.52 77.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.461 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 41.3 mt -66.38 -46.31 77.13 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.1 -39.37 82.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.488 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.8 -26.75 68.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.295 0.569 . . . . 0.0 110.54 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -85.18 3.52 38.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.69 178.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.34 13.29 39.22 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.129 -1.034 . . . . 0.0 114.364 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.424 HG22 ' HG3' ' A' ' 248' ' ' LYS . 58.5 t -87.95 142.9 12.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 117.716 0.758 . . . . 0.0 109.504 177.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.63 112.8 4.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.433 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.18 -36.83 90.4 Favored Glycine 0 CA--C 1.511 -0.219 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.459 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -70.55 -11.41 60.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.859 0.361 . . . . 0.0 111.417 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -102.17 -1.43 31.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.058 0.456 . . . . 0.0 110.404 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.402 HD11 ' CG1' ' A' ' 290' ' ' VAL . 70.6 mt -106.13 130.93 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.727 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.47 125.02 49.03 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.649 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.583 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.3 p -104.24 122.44 45.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.487 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 67.5 t -127.23 115.03 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 121.153 0.501 . . . . 0.0 112.084 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.28 112.9 3.8 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.608 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.466 ' HB3' HG21 ' A' ' 303' ' ' VAL . 26.7 mt -97.05 -7.85 31.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.561 0.219 . . . . 0.0 111.559 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.8 -129.36 41.63 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.152 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 12.7 p -93.59 112.23 24.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.491 ' O ' ' HD3' ' A' ' 305' ' ' PRO . 41.9 t -138.0 -69.38 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -110.2 94.49 18.41 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 303' ' ' VAL . 13.3 Cg_exo -65.57 163.2 30.93 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.24 1.96 . . . . 0.0 112.034 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 6.3 tt -117.9 -48.24 3.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.465 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -129.75 172.89 11.16 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 43.8 t -62.96 134.76 56.68 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 123.399 0.437 . . . . 0.0 110.734 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.17 -7.7 59.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.683 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.59 -20.31 64.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.444 HG23 ' H ' ' A' ' 314' ' ' GLY . 2.1 t -113.54 145.34 33.13 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.891 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.86 -32.29 36.67 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.996 1.797 . . . . 0.0 110.806 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.8 mt-10 -59.66 -44.7 93.47 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.055 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.444 ' H ' HG23 ' A' ' 311' ' ' THR . . . -67.88 -38.87 89.56 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.707 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -63.16 -37.31 86.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.941 0.4 . . . . 0.0 110.259 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.21 -27.44 69.36 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.17 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 6.8 mmtp -84.73 -40.9 16.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.035 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 42.5 m-80 -62.31 -26.65 68.54 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 37.3 ptt180 -78.4 7.02 7.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.877 0.37 . . . . 0.0 111.471 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 317' ' ' LYS . 29.8 ptt-85 -57.78 177.79 0.1 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.144 0.973 . . . . 0.0 113.18 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 86.5 t -136.52 143.15 36.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.583 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -129.57 137.58 50.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.831 0.348 . . . . 0.0 111.017 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.434 ' H ' HD12 ' A' ' 323' ' ' ILE . 1.4 mp -100.9 119.5 49.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 75.0 t -111.05 137.33 43.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 255' ' ' VAL . 67.9 t -101.5 136.39 33.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.364 0.602 . . . . 0.0 111.221 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.084 179.264 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.63 0 CA-C-O 121.183 0.516 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.93 63.35 2.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.548 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.516 HD22 ' HB2' ' A' ' 246' ' ' LYS . 17.9 mt -54.08 -29.9 46.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.308 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -65.25 -43.8 90.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.026 0.441 . . . . 0.0 109.932 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.7 t -74.96 -24.68 58.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.543 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -75.51 -49.05 19.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.831 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 211' ' ' LEU . 23.4 pt -71.72 -38.08 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.607 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -58.62 -38.39 77.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.988 0.423 . . . . 0.0 110.516 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.89 -27.72 69.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.134 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.831 HG12 HG23 ' A' ' 239' ' ' ILE . 21.3 t -83.67 -50.98 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 121.038 0.447 . . . . 0.0 110.751 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.556 ' HA ' HG21 ' A' ' 239' ' ' ILE . 42.6 p -69.1 -34.86 75.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.461 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.9 14.24 82.8 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 139.79 -134.69 6.74 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.34 166.63 6.57 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.73 2.287 . . . . 0.0 113.246 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 51.0 mm -82.58 106.09 13.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.009 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.589 0 CA-C-O 121.122 0.487 . . . . 0.0 111.864 -179.746 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 CA--C 1.516 -0.345 0 CA-C-O 120.513 0.197 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.831 HG23 HG12 ' A' ' 218' ' ' VAL . 50.6 mt -64.73 -38.86 83.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.86 -31.23 72.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.226 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.448 ' HA ' ' HG2' ' A' ' 288' ' ' ARG . 3.5 m-20 -75.57 -38.31 59.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.784 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -69.24 -23.42 63.86 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.095 178.473 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 24.7 t -79.79 -42.19 22.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.487 176.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.01 68.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.154 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -45.82 -50.54 14.03 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.728 0.811 . . . . 0.0 112.497 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.516 ' HB2' HD22 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -85.33 -14.43 46.5 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.814 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 41.3 mt -83.56 -31.08 26.54 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.544 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 53.6 mtpt -82.93 -18.85 38.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.64 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.94 -34.13 76.0 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.283 0.563 . . . . 0.0 109.816 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.506 ' HB3' HD11 ' A' ' 211' ' ' LEU . 35.4 t -132.03 69.35 80.71 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 60.6 Cg_endo -69.5 -2.97 10.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.25 2.633 . . . . 0.0 113.846 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -84.0 -24.14 30.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.558 0.694 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -67.75 149.29 50.14 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.861 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -102.81 140.79 36.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.09 131.95 67.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 120.97 0.414 . . . . 0.0 110.897 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.2 m -107.63 108.76 20.16 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 16.3 mt -96.36 114.98 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.68 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -99.5 125.16 45.2 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.293 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 274' ' ' SER . . . -105.71 140.76 15.23 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -123.01 161.94 23.31 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.01 0.433 . . . . 0.0 110.005 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 10.0 t -148.1 167.1 25.88 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.402 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 C--N 1.304 -1.394 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.011 -178.276 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.676 0.75 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.94 -38.66 70.61 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.779 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.404 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 22.7 mm -58.78 -64.37 2.99 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.741 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.404 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 14.2 Cg_endo -61.21 -28.12 84.6 Favored 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 121.867 1.711 . . . . 0.0 112.426 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 53.2 tp -65.51 -52.95 48.94 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.965 0.412 . . . . 0.0 110.809 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 259' ' ' GLY . 14.5 p -62.64 -28.39 69.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.606 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.86 78.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.251 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -67.86 -39.59 83.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.73 -52.18 64.78 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.099 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.422 ' HA ' HG11 ' A' ' 321' ' ' VAL . . . -60.93 -35.0 75.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.214 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.553 ' HA ' HG21 ' A' ' 297' ' ' THR . 16.4 ttpt -62.68 -31.79 72.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.229 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 61.5 mt -56.36 -45.57 81.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.989 0.423 . . . . 0.0 110.118 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.745 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.5 t -67.48 -45.44 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.978 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.78 -45.37 74.26 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.919 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.84 -40.54 88.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.288 0.566 . . . . 0.0 110.635 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.674 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 6.9 m-85 -69.75 -41.41 75.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.208 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 47.6 mt -63.99 -46.91 82.45 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 79.4 t -59.9 -39.51 80.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.354 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.39 -30.54 71.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.339 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.674 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -80.93 1.51 30.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.597 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 98.81 15.69 33.23 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.136 -1.03 . . . . 0.0 114.033 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 58.2 t -90.64 142.86 12.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 117.416 0.608 . . . . 0.0 109.551 177.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.31 111.11 4.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.801 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.1 -34.12 77.94 Favored Glycine 0 C--N 1.33 0.197 0 CA-C-N 115.707 -0.679 . . . . 0.0 113.255 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.54 -21.0 66.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.922 0.391 . . . . 0.0 111.63 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.5 3.92 40.67 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.97 0.414 . . . . 0.0 110.99 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 66.4 mt -105.43 131.92 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.74 129.61 54.58 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.553 HG21 ' HA ' ' A' ' 279' ' ' LYS . 31.8 p -115.72 125.38 52.73 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.683 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 94.7 t -130.04 127.58 63.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 0.0 111.499 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -96.02 114.12 4.83 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.87 -2.0 48.25 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 72.79 -129.85 13.85 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.661 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 23.2 t -90.49 114.92 27.21 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.1 p -179.33 147.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.6 t30 64.95 69.33 0.67 Allowed Pre-proline 0 C--N 1.314 -0.97 0 O-C-N 123.818 0.699 . . . . 0.0 110.404 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.44 168.45 12.99 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.591 2.194 . . . . 0.0 113.231 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.463 ' HB ' ' NH1' ' A' ' 320' ' ' ARG . 2.7 tt -128.12 -50.0 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.108 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.444 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -120.83 171.71 8.42 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.168 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 20.0 m -64.55 134.69 54.92 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.485 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -78.22 -7.72 57.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.184 0.516 . . . . 0.0 110.662 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.16 -16.88 60.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.158 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.506 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 0.8 OUTLIER -113.76 144.61 31.79 Favored Pre-proline 0 CA--C 1.511 -0.522 0 CA-C-O 121.034 0.445 . . . . 0.0 110.941 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -66.22 -34.66 35.43 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 122.213 1.942 . . . . 0.0 111.354 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -60.87 -40.51 93.24 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.268 0.556 . . . . 0.0 109.85 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 307' ' ' ALA . . . -70.25 -39.8 71.12 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.876 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 311' ' ' THR . 99.4 mtt180 -60.74 -33.43 72.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.125 0.488 . . . . 0.0 110.092 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -70.47 -29.14 65.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.79 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 320' ' ' ARG . 0.2 OUTLIER -82.38 -41.17 20.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.05 179.127 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -64.64 -17.42 64.02 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 19.6 ptp180 -86.98 13.19 9.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.146 0.498 . . . . 0.0 110.865 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.463 ' NH1' ' HB ' ' A' ' 306' ' ' ILE . 5.2 ptt180 -57.66 175.9 0.16 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.191 0.996 . . . . 0.0 113.189 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 278' ' ' ALA . 60.7 t -135.48 147.76 28.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.427 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.02 136.15 48.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.146 0.498 . . . . 0.0 110.9 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.42 ' H ' HD12 ' A' ' 323' ' ' ILE . 2.3 mp -98.38 117.27 43.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.919 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 48.8 t -112.53 141.87 26.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.479 HG21 ' HB2' ' A' ' 211' ' ' LEU . 97.3 t -88.93 118.85 35.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.028 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.6 t30 . . . . . 0 C--N 1.331 -0.2 0 C-N-CA 125.144 1.378 . . . . 0.0 112.549 -176.611 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.468 ' O ' HD22 ' A' ' 211' ' ' LEU . . . . . . . . 0 N--CA 1.468 0.469 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.65 80.75 9.02 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 209' ' ' ALA . 3.1 mm? -57.48 -53.29 59.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.71 -43.22 99.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.846 0.355 . . . . 0.0 110.697 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.4 t -70.92 -21.0 62.42 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.247 0.546 . . . . 0.0 110.346 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.57 ' HB1' ' HE3' ' A' ' 246' ' ' LYS . . . -84.24 -45.07 13.26 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.51 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 26.5 pt -69.48 -41.89 80.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.03 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -57.2 -32.47 66.51 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.459 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.42 67.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.236 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 242' ' ' ARG . 8.2 t -87.7 -47.93 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-O 121.065 0.46 . . . . 0.0 110.091 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.484 ' HA ' HG21 ' A' ' 239' ' ' ILE . 76.2 p -66.29 -36.91 84.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.585 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.02 24.95 42.53 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.38 -136.02 10.22 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' PRO . . . . . 0.602 ' HB2' ' NE ' ' A' ' 320' ' ' ARG . 3.4 Cg_exo -79.98 159.26 24.08 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.463 2.109 . . . . 0.0 111.851 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 320' ' ' ARG . 41.7 mm -74.88 106.65 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.661 -176.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.939 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.34 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 CA--C 1.515 -0.366 0 CA-C-O 120.476 0.179 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 243' ' ' VAL . 76.7 mt -69.9 -42.42 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 8.1 mp -67.08 -33.52 75.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.597 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.68 -37.25 82.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.067 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.594 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 0.0 OUTLIER -71.65 -41.17 69.1 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.779 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.638 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 54.9 t -56.01 -40.82 65.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.231 0.539 . . . . 0.0 110.199 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.86 82.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.231 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.594 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 2.9 t70 -48.9 -52.98 21.53 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.57 ' HE3' ' HB1' ' A' ' 214' ' ' ALA . 0.0 OUTLIER -73.66 -31.77 63.64 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.168 -178.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 25.6 mt -68.76 -29.64 68.07 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -64.86 -32.38 74.06 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.942 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -77.1 -29.41 54.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.57 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 7.8 t -137.82 65.02 44.88 Favored Pre-proline 0 C--N 1.316 -0.867 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.01 4.6 5.12 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.059 2.506 . . . . 0.0 114.461 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -81.21 -28.11 35.03 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.681 0.753 . . . . 0.0 109.077 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.3 141.14 54.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.639 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -93.74 137.08 33.36 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.047 0.451 . . . . 0.0 110.157 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.423 HG12 HG22 ' A' ' 325' ' ' VAL . 5.3 m -116.67 133.66 62.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.071 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 31.4 m -112.32 111.92 23.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.84 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.402 HG12 HG23 ' A' ' 323' ' ' ILE . 18.9 mt -92.79 114.36 29.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -104.79 128.21 52.85 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.597 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.416 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -109.49 144.82 16.7 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.798 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -126.24 158.72 34.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 10.0 t -174.13 114.18 0.19 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.125 0.964 . . . . 0.0 111.228 174.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 C--N 1.301 -1.531 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.488 -177.607 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 C--O 1.235 0.312 0 CA-C-O 120.978 0.418 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.571 ' HB2' HG23 ' A' ' 261' ' ' THR . 19.3 p30 -61.06 -24.69 66.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.831 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.438 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 19.8 mm -64.53 -64.89 2.32 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.869 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.438 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.3 Cg_endo -60.01 -30.01 90.6 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 121.779 1.653 . . . . 0.0 111.934 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 58.5 tp -68.36 -52.22 35.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.237 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.493 ' HB3' HG22 ' A' ' 261' ' ' THR . 17.3 p -64.22 -27.15 68.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.15 -33.62 74.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.768 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.511 ' O ' HG13 ' A' ' 280' ' ' ILE . 41.2 tt0 -64.05 -50.47 68.27 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.852 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.534 ' NH1' ' HB2' ' A' ' 319' ' ' ARG . 72.8 mtt180 -61.96 -38.06 87.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.784 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.88 92.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.076 0.465 . . . . 0.0 110.172 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.651 ' HA ' HG21 ' A' ' 297' ' ' THR . 23.6 ttpt -66.71 -31.93 72.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.377 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 276' ' ' GLN . 60.4 mt -55.09 -41.96 62.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.059 0.457 . . . . 0.0 110.145 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.712 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.6 t -70.2 -43.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.778 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.4 84.94 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.994 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -56.96 -37.58 71.77 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.937 0.398 . . . . 0.0 110.649 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.667 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 6.3 m-85 -70.86 -51.25 27.56 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.96 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 30.5 mt -55.38 -50.76 68.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.366 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.16 -41.22 85.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.007 0.432 . . . . 0.0 110.646 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.13 -21.96 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.001 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.8 mmp_? -88.52 7.1 34.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.499 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 92.42 14.8 55.12 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.683 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.41 144.9 8.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.6 111.49 5.45 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.832 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.1 -32.04 66.4 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.71 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.8 -15.47 63.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.967 0.413 . . . . 0.0 111.754 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -102.16 -1.8 30.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.023 0.44 . . . . 0.0 110.464 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 60.8 mt -106.92 129.49 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.067 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.03 124.43 48.1 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.651 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.1 p -107.68 124.9 50.67 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.887 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 69.6 t -134.02 123.45 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.057 0.456 . . . . 0.0 111.738 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -94.77 113.23 4.53 Favored Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 22.1 mt -93.06 1.43 57.25 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.775 0.321 . . . . 0.0 111.389 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.98 -131.2 33.53 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.631 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 45.4 t -91.02 117.6 29.72 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.7 p -178.81 151.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.716 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.35 69.43 1.64 Allowed Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 123.678 0.791 . . . . 0.0 110.831 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.585 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 74.1 Cg_endo -78.47 137.57 14.86 Favored 'Trans proline' 0 N--CA 1.44 -1.661 0 C-N-CA 122.403 2.069 . . . . 0.0 113.381 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.77 -38.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.498 176.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -131.18 169.35 16.04 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.961 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 45.0 m -77.22 146.06 37.2 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.638 0.256 . . . . 0.0 110.477 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -73.27 -7.24 50.67 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.758 0.313 . . . . 0.0 111.365 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -59.91 -24.72 64.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.453 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.6 t -115.73 137.75 23.45 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.543 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.99 -32.44 44.46 Favored 'Trans proline' 0 CA--C 1.518 -0.281 0 C-N-CA 122.452 2.101 . . . . 0.0 111.151 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -60.7 -40.84 93.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.758 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.0 -36.74 93.42 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.008 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -69.92 -25.82 63.86 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 319' ' ' ARG . . . -74.49 -26.47 60.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.062 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -37.06 29.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.585 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 57.0 m-20 -69.69 -3.56 15.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 17.5 ptm180 -98.21 9.12 43.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 120.75 0.31 . . . . 0.0 111.482 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.602 ' NE ' ' HB2' ' A' ' 222' ' ' PRO . 8.8 ptm180 -75.84 -175.95 3.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 75.7 t -135.7 153.05 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.608 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -132.64 139.23 47.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 111.193 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.412 ' H ' HD12 ' A' ' 323' ' ' ILE . 2.7 mp -95.94 115.05 34.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.86 137.01 39.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 211' ' ' LEU . 42.0 t -104.32 142.24 18.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 C--N 1.318 -0.763 0 O-C-N 123.542 0.526 . . . . 0.0 110.514 177.367 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.388 0 CA-C-O 120.662 0.267 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.15 90.15 3.09 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.033 0.444 . . . . 0.0 110.017 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 250' ' ' CYS . 41.9 mt -75.32 -28.6 59.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.002 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -62.01 -43.7 98.29 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 120.917 0.389 . . . . 0.0 110.305 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 33.0 t -71.15 -41.25 70.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.47 ' HB1' ' HE3' ' A' ' 246' ' ' LYS . . . -58.06 -47.78 82.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.611 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 211' ' ' LEU . 24.5 pt -72.53 -37.84 58.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.94 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -58.24 -36.21 72.86 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.751 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.39 -26.64 68.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.288 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.1 t -92.9 -43.68 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.465 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.606 ' HA ' HG21 ' A' ' 239' ' ' ILE . 70.2 p -67.43 -40.81 85.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.081 0.467 . . . . 0.0 110.899 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.26 24.57 59.02 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.62 -134.39 8.25 Favored Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' PRO . . . . . 0.428 ' HB3' HH11 ' A' ' 320' ' ' ARG . 91.9 Cg_endo -85.38 166.18 10.75 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.797 2.332 . . . . 0.0 113.037 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.5 mm -85.2 110.97 20.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.211 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.573 179.125 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 CA--C 1.52 -0.209 0 CA-C-O 120.693 0.282 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.606 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.5 mt -58.97 -39.02 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.442 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.538 HD22 HG13 ' A' ' 281' ' ' VAL . 41.5 mt -66.45 -32.1 73.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.103 0.478 . . . . 0.0 110.782 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 288' ' ' ARG . 60.9 m-20 -71.41 -36.62 71.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.491 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -70.59 -42.62 70.77 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.753 178.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.616 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 46.0 t -57.59 -42.36 81.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.6 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.55 80.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.284 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 24.6 t70 -49.8 -53.18 26.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.266 0.627 . . . . 0.0 112.623 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.623 ' HB3' ' NZ ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -74.0 -31.57 63.01 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.561 -178.173 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 33.8 mt -64.09 -36.81 85.22 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.377 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.483 ' HG3' HG22 ' A' ' 290' ' ' VAL . 58.2 mtpt -73.06 -22.6 60.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.263 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.64 80.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 110.006 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.49 ' HB3' HD11 ' A' ' 211' ' ' LEU . 49.0 t -126.79 70.8 73.58 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 73.5 Cg_endo -71.6 -1.33 9.63 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 123.266 2.644 . . . . 0.0 114.145 -174.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -79.71 -24.8 41.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.642 0.734 . . . . 0.0 109.289 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -70.42 135.0 48.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.522 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.15 140.41 29.83 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.43 HG12 HG22 ' A' ' 325' ' ' VAL . 6.0 m -116.05 132.22 66.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.241 0.543 . . . . 0.0 111.436 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 39.8 m -109.02 108.72 19.55 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.17 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.43 HG12 HG23 ' A' ' 323' ' ' ILE . 23.3 mt -92.32 114.4 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.486 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -101.74 127.48 48.5 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.453 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.421 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -107.64 147.3 16.36 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.323 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 37.8 m-85 -123.66 162.01 23.92 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.119 0.485 . . . . 0.0 110.612 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.557 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 34.6 p -147.34 170.48 17.24 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 124.229 1.011 . . . . 0.0 108.95 175.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.429 ' HB2' HD22 ' A' ' 309' ' ' ASN . 5.6 p-10 . . . . . 0 C--N 1.316 -0.88 0 CA-C-O 120.924 0.392 . . . . 0.0 110.535 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.442 -0.855 0 CA-C-O 121.274 0.559 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.557 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 0.4 OUTLIER -58.44 -42.88 88.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.668 -178.22 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.446 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 25.7 mm -58.11 -64.35 2.87 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.583 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.446 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.8 Cg_endo -58.92 -29.05 89.29 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.025 1.817 . . . . 0.0 112.272 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 58.4 tp -70.3 -52.93 19.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.335 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.544 ' HB3' HG23 ' A' ' 261' ' ' THR . 14.7 p -63.5 -30.51 71.62 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.906 0.384 . . . . 0.0 110.512 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.6 73.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.785 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.619 ' O ' HG13 ' A' ' 280' ' ' ILE . 29.1 tt0 -67.0 -48.14 69.36 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.497 ' HB3' ' CG2' ' A' ' 321' ' ' VAL . 17.3 mmt180 -54.25 -49.02 70.49 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.382 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.2 90.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.176 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.636 ' HA ' HG21 ' A' ' 297' ' ' THR . 41.9 tptt -64.35 -30.57 71.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.227 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 276' ' ' GLN . 62.7 mt -59.85 -42.97 90.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.22 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.71 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.2 t -68.2 -45.81 82.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.836 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.7 -44.74 73.69 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.803 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.58 -38.82 82.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.914 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.49 -43.02 77.77 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.794 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 40.2 mt -62.78 -49.11 76.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.55 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 83.1 t -59.9 -40.83 83.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.511 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.74 -28.13 69.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.683 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 241' ' ' ASN . 15.3 mmm180 -85.33 0.02 53.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.917 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.29 6.75 35.97 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.611 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.483 HG22 ' HG3' ' A' ' 248' ' ' LYS . 60.2 t -83.55 144.57 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 117.723 0.761 . . . . 0.0 109.793 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.09 109.95 6.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.305 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.48 -29.9 74.83 Favored Glycine 0 CA--C 1.509 -0.316 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.363 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -61.94 -19.29 62.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.204 0.526 . . . . 0.0 110.948 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -107.96 5.5 26.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.484 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.8 mt -106.26 129.1 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.76 124.64 48.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.71 0.291 . . . . 0.0 110.594 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.636 HG21 ' HA ' ' A' ' 279' ' ' LYS . 14.9 p -109.16 121.99 46.33 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.207 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 73.3 t -130.25 120.44 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.389 0.614 . . . . 0.0 112.045 -176.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -90.11 110.97 3.83 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.4 ' HB3' HG21 ' A' ' 303' ' ' VAL . 27.2 mt -90.41 -0.15 57.53 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 68.56 -125.38 20.2 Favored Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.54 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.1 t -105.81 121.92 45.03 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.5 ' O ' ' HD3' ' A' ' 305' ' ' PRO . 75.5 t -136.95 -69.41 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.897 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -112.38 91.68 17.21 Favored Pre-proline 0 C--O 1.242 0.702 0 CA-C-O 120.687 0.28 . . . . 0.0 110.747 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 303' ' ' VAL . 19.3 Cg_exo -65.63 135.32 41.52 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.611 2.207 . . . . 0.0 111.24 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.0 tt -84.65 -45.76 17.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.749 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -124.2 173.61 8.22 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.317 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.9 m -62.62 136.34 57.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.679 0.612 . . . . 0.0 111.253 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.429 HD22 ' HB2' ' A' ' 262' ' ' ASP . 20.6 m120 -80.64 -11.73 59.6 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.156 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.71 -19.7 65.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.07 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 314' ' ' GLY . 3.2 t -113.34 139.47 23.23 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.329 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.0 -35.41 87.79 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.619 2.212 . . . . 0.0 111.535 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.572 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 71.5 mm-40 -60.34 -46.48 89.74 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.497 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.458 ' H ' HG23 ' A' ' 311' ' ' THR . . . -63.78 -37.77 95.18 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.717 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 311' ' ' THR . 76.1 mtp180 -61.85 -40.43 95.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.23 0.538 . . . . 0.0 109.948 177.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.7 -28.69 70.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.653 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.572 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 11.0 mmtp -79.49 -39.29 32.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.036 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -55.51 -28.26 53.59 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 32.0 ptt180 -83.58 12.07 6.27 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.428 HH11 ' HB3' ' A' ' 222' ' ' PRO . 28.6 ptt85 -57.53 173.66 0.26 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.901 0.88 . . . . 0.0 112.966 174.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.497 ' CG2' ' HB3' ' A' ' 277' ' ' ARG . 66.3 t -133.73 148.02 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.015 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -130.31 139.02 50.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.981 0.42 . . . . 0.0 111.071 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.43 HG23 HG12 ' A' ' 257' ' ' ILE . 2.2 mp -101.09 117.02 45.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.891 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.3 138.12 38.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.43 HG22 HG12 ' A' ' 255' ' ' VAL . 59.3 t -101.08 137.79 27.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.385 179.325 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 121.333 0.587 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.09 78.12 6.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.092 0.472 . . . . 0.0 110.186 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.458 ' HB2' HG21 ' A' ' 325' ' ' VAL . 3.2 mm? -69.78 -29.1 66.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.67 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -63.82 -46.49 84.88 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.796 0.332 . . . . 0.0 110.536 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.1 t -72.05 -32.13 66.8 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.37 -47.32 76.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.182 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.472 ' CG2' HG13 ' A' ' 243' ' ' VAL . 22.0 pt -75.4 -39.48 41.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.848 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.448 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 17.9 t-20 -60.8 -33.4 72.94 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.974 0.416 . . . . 0.0 110.621 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.22 -28.03 69.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.081 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.484 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.4 t -90.61 -44.51 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.22 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.524 ' HA ' HG21 ' A' ' 239' ' ' ILE . 58.4 p -63.72 -36.07 82.64 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.967 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.0 25.19 41.73 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 124.52 -132.73 8.34 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' PRO . . . . . 0.467 ' HG3' HH11 ' A' ' 320' ' ' ARG . 96.6 Cg_endo -85.29 166.86 10.75 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.421 2.08 . . . . 0.0 112.183 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 51.5 mm -80.96 101.9 6.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.388 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.398 -179.615 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 CA--C 1.519 -0.213 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.524 HG21 ' HA ' ' A' ' 219' ' ' THR . 74.1 mt -61.73 -38.14 79.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.411 ' CD1' HG13 ' A' ' 281' ' ' VAL . 4.2 mm? -61.05 -36.89 80.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.077 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -78.77 -34.85 45.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.105 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.484 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -66.43 -43.74 84.83 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.574 177.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.543 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 34.0 t -58.51 -42.68 85.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.722 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.8 81.54 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.477 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -53.74 -50.53 65.76 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.449 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -72.6 -29.45 63.52 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.214 -178.734 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.1 mt -72.21 -28.57 63.26 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 109.627 176.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.421 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 15.6 tptm -64.65 -31.96 73.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.84 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.72 -37.72 73.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.235 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 53.5 t -125.76 72.59 68.88 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 74.1 Cg_endo -72.59 0.46 7.53 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.774 2.316 . . . . 0.0 112.734 -178.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.03 -31.43 56.27 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.84 145.15 56.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.563 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.552 ' HB2' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -101.37 145.62 28.68 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.093 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.44 HG12 HG22 ' A' ' 325' ' ' VAL . 3.1 m -119.11 127.28 75.84 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.904 176.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.4 m -103.89 109.34 21.05 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.521 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.443 HG12 HG23 ' A' ' 323' ' ' ILE . 19.4 mt -96.79 114.23 33.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-O 121.024 0.44 . . . . 0.0 109.916 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -102.59 126.01 49.52 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.345 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.457 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -104.41 144.94 15.92 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.506 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -127.35 161.88 27.6 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 38.3 p -141.31 170.8 15.05 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.799 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--N 1.312 -1.061 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.017 177.5 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.797 0.808 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.563 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 22.2 p30 -55.56 -33.25 63.69 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.374 177.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.449 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 20.1 mm -62.72 -65.0 2.4 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.174 177.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.449 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 11.2 Cg_endo -59.99 -27.45 84.93 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 121.887 1.725 . . . . 0.0 112.18 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.8 tp -67.36 -53.83 25.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.774 0.321 . . . . 0.0 111.532 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.542 ' HB3' HG23 ' A' ' 261' ' ' THR . 6.5 p -62.47 -30.37 71.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.757 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.64 -31.56 66.99 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.16 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.407 ' O ' HG13 ' A' ' 280' ' ' ILE . 27.9 tt0 -69.1 -51.48 38.17 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.787 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 277' ' ' ARG . 54.3 mmt-85 -58.78 -39.26 80.53 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.954 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.69 91.96 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.21 0.528 . . . . 0.0 109.872 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.615 ' HA ' HG21 ' A' ' 297' ' ' THR . 23.5 tptm -63.03 -34.87 78.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.968 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 276' ' ' GLN . 54.9 mt -56.73 -44.32 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.566 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.734 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.3 t -66.25 -46.11 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.623 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -54.47 -45.94 73.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.051 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.69 -36.44 82.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.904 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.554 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 4.7 m-85 -68.83 -41.41 78.61 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.645 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 31.8 mt -66.14 -48.1 71.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.844 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 89.2 t -59.33 -43.05 89.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.511 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.0 -28.31 68.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.267 0.556 . . . . 0.0 110.438 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.554 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 1.4 mpt_? -85.98 3.04 43.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.046 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 108.5 5.08 32.21 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.74 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 49.6 t -88.26 140.29 16.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 117.782 0.791 . . . . 0.0 110.225 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.93 117.25 8.03 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.561 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.69 86.56 Favored Glycine 0 CA--C 1.51 -0.265 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.15 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -15.26 63.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.964 0.412 . . . . 0.0 111.444 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -98.52 0.31 44.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.0 110.65 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.3 mt -109.27 129.37 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.498 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.32 129.58 54.94 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.937 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.615 HG21 ' HA ' ' A' ' 279' ' ' LYS . 25.0 p -115.58 128.09 55.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.524 0.202 . . . . 0.0 111.172 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 26.9 t -133.54 128.09 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -99.81 108.64 3.57 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 18.5 mt -92.36 3.2 55.92 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 68.53 -127.74 23.56 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.559 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 15.1 m -93.6 115.61 28.1 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.834 0.35 . . . . 0.0 110.525 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.5 p -176.12 150.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 60.7 t30 70.29 74.52 0.26 Allowed Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 123.871 0.732 . . . . 0.0 111.078 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.588 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 73.5 Cg_endo -75.07 155.33 42.58 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.647 2.231 . . . . 0.0 112.792 -177.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.0 tt -124.59 -44.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.445 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.444 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -138.44 174.98 9.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.473 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 50.8 m -71.16 131.16 43.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.279 0.562 . . . . 0.0 111.702 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -80.81 -7.66 59.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.417 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.14 -16.88 63.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.808 178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.465 HG23 ' H ' ' A' ' 314' ' ' GLY . 5.2 t -123.23 144.39 43.49 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -54.49 -36.52 88.52 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.067 2.511 . . . . 0.0 112.118 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.1 mm-40 -55.49 -51.15 67.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.983 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -69.33 -40.85 80.2 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.693 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -56.35 -41.05 75.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.025 0.44 . . . . 0.0 110.339 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.96 70.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.737 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 0.3 OUTLIER -80.63 -42.97 21.24 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.597 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.588 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 39.2 m-80 -63.85 -23.83 67.51 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -176.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.597 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 10.4 ptm180 -84.98 12.87 6.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.29 0.567 . . . . 0.0 111.929 -178.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.467 HH11 ' HG3' ' A' ' 222' ' ' PRO . 19.0 ptt180 -58.61 177.74 0.13 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.303 1.049 . . . . 0.0 113.437 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 68.8 t -136.32 144.7 32.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.766 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -131.1 137.3 49.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.115 0.483 . . . . 0.0 111.376 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.443 HG23 HG12 ' A' ' 257' ' ' ILE . 2.1 mp -98.7 120.34 47.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.629 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.68 135.06 50.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 211' ' ' LEU . 89.4 t -95.43 141.89 14.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.185 0.517 . . . . 0.0 111.694 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 254' ' ' ARG . 41.1 t-20 . . . . . 0 C--N 1.311 -1.091 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.765 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.564 0 CA-C-O 120.594 0.235 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.04 69.43 3.32 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.058 0.456 . . . . 0.0 110.039 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 214' ' ' ALA . 35.4 mt -55.53 -27.24 47.67 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.342 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.417 HE22 HG13 ' A' ' 324' ' ' VAL . 2.4 tp-100 -55.95 -60.38 3.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.274 0.559 . . . . 0.0 109.968 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 39.9 t -69.44 -27.1 64.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.178 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.609 ' HB1' ' HE2' ' A' ' 246' ' ' LYS . . . -69.46 -49.32 55.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.273 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 211' ' ' LEU . 29.3 pt -74.08 -40.51 51.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 121.054 -0.259 . . . . 0.0 111.304 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -60.9 -29.6 69.68 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.089 0.471 . . . . 0.0 110.584 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.47 -27.76 68.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.178 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.9 t -89.55 -45.01 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.229 -178.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.53 ' HA ' HG21 ' A' ' 239' ' ' ILE . 75.8 p -67.0 -38.33 85.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.443 0.64 . . . . 0.0 109.861 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.74 21.75 61.1 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.89 -122.64 4.19 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -89.17 159.88 5.73 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.74 2.293 . . . . 0.0 113.979 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.5 mm -78.32 107.99 11.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.406 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 121.026 0.441 . . . . 0.0 110.005 177.418 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 . . . . . 0 N--CA 1.446 -0.66 0 CA-C-O 120.535 0.207 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.53 HG21 ' HA ' ' A' ' 219' ' ' THR . 90.4 mt -61.63 -37.61 78.34 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 46.6 mt -66.27 -35.07 79.45 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.451 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -69.88 -37.12 75.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.461 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -67.69 -46.77 71.34 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.762 178.481 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.639 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.8 t -61.79 -46.06 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.77 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.08 -31.51 72.76 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.441 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.04 -44.06 97.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.42 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.609 ' HE2' ' HB1' ' A' ' 214' ' ' ALA . 0.6 OUTLIER -75.48 -27.21 58.75 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.596 -179.729 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 43.9 mt -65.39 -28.41 69.24 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 121.205 0.526 . . . . 0.0 109.622 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.539 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 7.0 mtpm? -78.55 -22.36 47.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.318 177.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.94 -30.55 66.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.36 0.6 . . . . 0.0 110.068 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.473 ' HB3' HD11 ' A' ' 211' ' ' LEU . 13.3 t -132.74 69.85 79.27 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 57.5 Cg_endo -67.97 -2.01 7.99 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.442 2.762 . . . . 0.0 114.231 -173.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.46 -18.39 28.35 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.443 0.64 . . . . 0.0 109.939 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -71.88 131.01 42.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.005 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -91.58 138.52 31.5 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.4 m -114.89 130.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-O 121.204 0.526 . . . . 0.0 111.603 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.1 m -107.87 107.48 18.23 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.193 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.419 HG12 HG23 ' A' ' 323' ' ' ILE . 21.6 mt -90.15 117.32 33.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.768 -177.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -105.8 126.92 52.73 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.787 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -107.22 145.78 16.06 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 6.9 m-85 -124.29 158.57 32.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.944 0.402 . . . . 0.0 109.996 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' A' ' 270' ' ' ASN . 16.6 p -144.54 170.1 16.69 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.611 0.764 . . . . 0.0 109.935 177.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.457 ' OD2' ' HD3' ' A' ' 315' ' ' ARG . 19.2 t70 . . . . . 0 C--N 1.312 -1.041 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.443 -0.782 0 CA-C-O 121.331 0.586 . . . . 0.0 109.926 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.576 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 3.7 p30 -65.4 -27.58 68.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.544 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.472 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 27.4 mm -62.65 -63.88 3.68 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-O 119.664 -0.208 . . . . 0.0 110.989 178.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.472 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 1.6 Cg_endo -53.97 -37.16 85.87 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.428 2.085 . . . . 0.0 111.313 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.469 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 25.2 tp -62.22 -52.55 63.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.428 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 22.3 m -61.48 -30.97 70.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.783 0.325 . . . . 0.0 110.401 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.8 -28.91 64.99 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.885 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.469 ' O ' HG13 ' A' ' 280' ' ' ILE . 51.7 tt0 -71.51 -45.54 62.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 22.1 mmm180 -56.59 -46.84 80.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.524 178.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.85 88.91 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.462 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.655 ' HA ' HG21 ' A' ' 297' ' ' THR . 16.8 ttpt -62.97 -32.06 73.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.912 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 276' ' ' GLN . 64.4 mt -56.22 -43.63 77.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.203 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.718 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 7.8 t -69.62 -44.24 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.126 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.17 73.77 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 123.291 0.369 . . . . 0.0 110.663 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.8 -40.42 84.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.863 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -69.8 -40.35 76.03 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.265 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 46.6 mt -64.77 -47.61 77.53 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 92.3 t -60.92 -39.22 81.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.284 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.91 -28.42 69.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.834 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.604 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 2.4 mmp_? -86.86 4.57 40.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.301 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.9 5.43 44.37 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.043 -1.075 . . . . 0.0 114.649 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 58.0 t -84.18 145.24 8.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 117.801 0.801 . . . . 0.0 109.904 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 295' ' ' ILE . . . -69.3 112.79 6.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.42 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.58 -33.88 87.86 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.067 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -69.76 -12.6 61.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.589 0.233 . . . . 0.0 111.318 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -104.52 1.71 30.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.847 0.356 . . . . 0.0 110.615 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 291' ' ' ALA . 70.4 mt -105.12 131.45 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.922 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.58 125.7 49.43 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.068 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.655 HG21 ' HA ' ' A' ' 279' ' ' LYS . 11.6 p -107.51 129.51 54.95 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.888 0.375 . . . . 0.0 111.406 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.48 136.98 52.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.803 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.49 114.49 4.12 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.408 HD12 ' CE1' ' A' ' 260' ' ' TYR . 17.5 mt -91.48 -5.33 54.41 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 71.3 -135.59 24.1 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.073 -1.061 . . . . 0.0 111.397 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 261' ' ' THR . 7.5 t -87.99 114.56 24.72 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.151 0.5 . . . . 0.0 110.029 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.9 p -176.65 150.31 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 44.7 t30 65.9 78.87 0.25 Allowed Pre-proline 0 C--N 1.311 -1.076 0 O-C-N 123.75 0.656 . . . . 0.0 111.1 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.628 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 39.7 Cg_endo -68.69 138.24 40.87 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.818 2.345 . . . . 0.0 113.154 -177.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 7.4 tt -110.79 -25.43 3.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.768 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -152.45 163.62 39.16 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 47.8 t -62.84 134.23 55.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.042 0.449 . . . . 0.0 110.988 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -80.61 -11.61 59.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.63 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.2 36.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.169 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 3.1 t -124.74 138.03 30.56 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.916 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.99 -26.63 82.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.894 2.396 . . . . 0.0 111.78 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 8.4 mm-40 -65.33 -41.87 93.52 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.3 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.41 -38.38 93.51 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.49 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.457 ' HD3' ' OD2' ' A' ' 262' ' ' ASP . 51.9 mtt-85 -63.6 -37.87 88.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.37 68.89 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.827 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 9.0 mmtp -84.65 -38.45 19.81 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.822 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.628 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 38.5 m-80 -63.74 -21.16 66.27 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 13.0 ptm180 -82.11 14.55 2.79 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.156 0.503 . . . . 0.0 111.232 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -65.42 -174.38 0.18 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.106 0.963 . . . . 0.0 113.13 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.5 t -141.81 148.28 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.722 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -133.84 135.9 44.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.747 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.439 ' H ' HD12 ' A' ' 323' ' ' ILE . 2.6 mp -94.23 119.34 42.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.37 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.417 HG13 HE22 ' A' ' 212' ' ' GLN . 91.6 t -106.62 136.67 40.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 211' ' ' LEU . 55.0 t -101.49 139.61 22.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.341 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.353 177.469 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.431 0 CA-C-O 120.728 0.299 . . . . 0.0 111.272 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.73 85.86 1.22 Allowed 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.523 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 250' ' ' CYS . 23.7 mt -70.35 -33.64 71.69 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.939 -177.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -63.76 -45.74 88.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.24 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 31.5 t -75.63 -23.34 56.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.057 0.456 . . . . 0.0 109.917 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.517 ' HB1' ' HE3' ' A' ' 246' ' ' LYS . . . -72.49 -49.91 29.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.206 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 211' ' ' LEU . 26.7 pt -70.63 -38.27 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.868 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -55.7 -37.21 68.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.951 0.405 . . . . 0.0 110.975 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.5 -26.87 68.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.492 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.8 t -92.26 -47.96 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 120.921 0.391 . . . . 0.0 110.63 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.513 ' HA ' HG21 ' A' ' 239' ' ' ILE . 81.6 p -64.35 -39.17 93.36 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.615 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.8 22.51 59.63 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.4 -130.55 6.84 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.19 156.31 25.98 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.573 2.182 . . . . 0.0 112.044 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -74.1 109.29 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.092 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 175.288 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 120.516 0.198 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.513 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.8 mt -64.41 -39.8 86.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.33 -33.4 75.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.894 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.455 ' OD1' ' HD3' ' A' ' 288' ' ' ARG . 44.8 t30 -71.73 -36.03 70.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.583 0.706 . . . . 0.0 109.177 177.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.606 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 0.0 OUTLIER -68.52 -42.28 78.73 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.719 177.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.622 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 44.6 t -62.5 -43.9 98.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.334 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -55.82 -37.24 68.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.713 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.606 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 7.7 t70 -49.06 -53.31 20.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.56 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.559 ' HB3' ' NZ ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -82.51 -14.53 54.83 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.821 -176.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.4 mt -80.47 -26.09 38.47 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.339 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.502 ' HG3' HG22 ' A' ' 290' ' ' VAL . 59.6 mtpt -83.54 -23.15 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.628 176.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.84 -37.32 76.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.203 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.562 ' HB3' HD11 ' A' ' 211' ' ' LEU . 24.6 t -130.09 71.97 82.06 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-O 121.339 0.59 . . . . 0.0 109.505 177.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 91.4 Cg_endo -75.35 -1.4 11.25 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.164 2.576 . . . . 0.0 113.244 -178.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -79.15 -29.69 43.19 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.872 0.844 . . . . 0.0 108.872 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -81.46 134.68 35.57 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.733 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -90.79 147.02 23.48 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.953 0.406 . . . . 0.0 110.508 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.13 137.75 52.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.587 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.0 m -114.13 113.1 24.24 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.551 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.457 HG12 HG23 ' A' ' 323' ' ' ILE . 21.4 mt -94.15 113.85 29.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.578 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -98.47 126.66 44.1 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.37 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.411 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -107.48 146.82 16.25 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 36.3 m-85 -127.4 161.89 27.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.1 0.476 . . . . 0.0 110.688 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.604 HG23 ' HB3' ' A' ' 274' ' ' SER . 56.9 p -140.58 173.28 11.65 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.529 175.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.318 -0.776 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.859 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 121.465 0.65 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.528 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 12.3 m-20 -62.87 -36.54 83.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.427 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.487 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 27.3 mm -56.58 -64.22 2.67 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.019 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.487 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 5.1 Cg_endo -56.79 -35.65 98.14 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 121.944 1.763 . . . . 0.0 111.914 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.494 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 60.2 tp -63.07 -52.92 60.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.686 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.604 ' HB3' HG23 ' A' ' 261' ' ' THR . 13.0 p -62.98 -31.52 72.66 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.99 0.424 . . . . 0.0 110.468 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.45 -34.04 77.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.742 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.634 ' O ' HG13 ' A' ' 280' ' ' ILE . 64.2 tt0 -66.92 -44.96 79.38 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 38.8 mmt180 -56.86 -47.38 80.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.008 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.75 88.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.018 0.437 . . . . 0.0 110.373 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.526 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.9 tptt -65.97 -32.36 73.8 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.092 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 276' ' ' GLN . 62.5 mt -58.55 -45.76 90.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.197 0.522 . . . . 0.0 109.684 177.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.699 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.2 t -65.8 -48.08 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.792 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.52 -41.98 70.32 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.076 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.64 -42.63 88.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.472 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -66.84 -43.06 84.69 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.491 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 41.7 mt -64.03 -51.05 66.02 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.887 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.9 t -59.41 -40.55 81.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.91 71.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.555 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.497 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 1.2 mmp_? -83.72 6.23 21.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.064 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.04 9.5 51.73 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.748 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.503 ' CG1' HD11 ' A' ' 295' ' ' ILE . 59.0 t -84.9 141.4 14.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.28 113.86 7.01 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.346 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.01 -32.7 76.34 Favored Glycine 0 C--N 1.318 -0.43 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.707 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.59 -19.15 62.88 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.798 0.332 . . . . 0.0 111.593 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.64 0.32 49.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.473 0.654 . . . . 0.0 110.005 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.503 HD11 ' CG1' ' A' ' 290' ' ' VAL . 63.5 mt -110.81 133.32 56.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.142 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -121.4 129.67 53.15 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.526 HG21 ' HA ' ' A' ' 279' ' ' LYS . 29.9 p -109.02 125.94 52.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.899 0.381 . . . . 0.0 111.429 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.9 t -127.89 117.41 46.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.12 111.96 3.9 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.442 174.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 20.9 mt -96.75 1.1 50.5 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 58.91 -127.47 45.36 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 44.4 t -102.34 122.34 44.07 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.463 HG13 ' H ' ' A' ' 304' ' ' ASN . 5.9 p -146.85 -59.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.463 ' H ' HG13 ' A' ' 303' ' ' VAL . 76.1 m-20 -117.46 92.93 41.91 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -66.45 174.24 6.57 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.857 2.371 . . . . 0.0 113.267 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 5.3 tt -131.27 -48.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.591 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -120.51 172.43 7.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.254 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 27.9 m -67.19 139.75 57.44 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.037 0.446 . . . . 0.0 111.351 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -81.01 -10.08 59.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.646 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.14 -16.37 61.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.349 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.6 t -115.82 144.44 32.66 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.513 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.97 -31.32 24.36 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.215 1.943 . . . . 0.0 110.942 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.88 -35.41 81.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.653 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -71.34 -36.97 63.14 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 11.3 mtp85 -57.66 -39.46 77.1 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.59 -30.93 71.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.22 -46.34 20.64 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.807 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -61.69 -26.03 67.78 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 14.9 ptp180 -83.62 10.65 8.69 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.015 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -57.14 177.76 0.08 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.01 0.91 . . . . 0.0 112.715 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 58.4 t -137.37 144.64 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.054 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -131.98 138.42 48.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.984 0.421 . . . . 0.0 111.115 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.457 HG23 HG12 ' A' ' 257' ' ' ILE . 1.6 mp -100.0 120.47 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.992 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 75.1 t -108.45 134.24 50.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 53.5 t -98.1 133.47 40.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--N 1.318 -0.762 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.867 -178.772 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -84.0 88.83 7.17 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.339 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.438 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.7 mm? -67.86 -39.3 83.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.766 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -57.83 -55.65 32.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.423 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.4 t -67.33 -34.68 77.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.65 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.541 ' HB1' ' HE2' ' A' ' 246' ' ' LYS . . . -64.89 -46.74 80.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.686 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 211' ' ' LEU . 23.6 pt -71.67 -38.6 67.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.501 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -57.68 -33.79 68.72 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.588 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.26 -26.33 68.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.216 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.6 HG11 ' CB ' ' A' ' 242' ' ' ARG . 8.2 t -92.79 -45.73 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.447 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.438 ' HA ' HG21 ' A' ' 239' ' ' ILE . 75.5 p -64.36 -42.91 95.95 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.274 0.559 . . . . 0.0 110.397 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.96 13.45 83.06 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 143.32 -131.25 4.44 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.67 164.77 5.17 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.029 2.486 . . . . 0.0 113.593 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.1 mm -81.69 109.8 16.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.324 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.047 0.451 . . . . 0.0 110.833 178.813 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 CA--C 1.507 -0.699 0 N-CA-C 111.379 0.14 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 243' ' ' VAL . 58.6 mt -67.6 -49.01 74.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.795 -175.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.493 ' CD2' HG13 ' A' ' 281' ' ' VAL . 37.6 mt -59.3 -40.41 86.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.206 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -70.78 -36.27 72.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 110.185 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.6 ' CB ' HG11 ' A' ' 218' ' ' VAL . 7.8 mmt180 -63.68 -54.99 26.99 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.5 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.663 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 69.2 t -53.47 -46.8 59.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.646 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.84 85.13 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.764 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -60.15 -45.62 92.42 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.665 0.269 . . . . 0.0 111.605 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.541 ' HE2' ' HB1' ' A' ' 214' ' ' ALA . 0.4 OUTLIER -74.38 -26.27 60.01 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.735 -179.31 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 35.0 mt -69.16 -28.87 66.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.258 0.551 . . . . 0.0 110.279 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.497 ' HG3' HG22 ' A' ' 290' ' ' VAL . 55.6 mtpt -77.08 -24.94 51.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.843 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -73.1 -40.7 64.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.533 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 50.0 t -125.13 73.74 66.47 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 121.332 0.587 . . . . 0.0 109.848 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.65 -0.03 8.8 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.442 2.761 . . . . 0.0 113.424 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.96 -26.7 57.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.887 0.851 . . . . 0.0 109.538 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -78.82 130.09 35.32 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -94.98 142.22 27.74 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.44 HG12 HG22 ' A' ' 325' ' ' VAL . 6.2 m -118.15 135.73 57.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.429 0.633 . . . . 0.0 112.315 -178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.0 m -108.15 108.25 19.23 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.449 HG12 HG23 ' A' ' 323' ' ' ILE . 26.2 mt -91.47 114.3 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.767 -178.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -102.93 129.09 49.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.352 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -105.28 156.62 16.68 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.641 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 19.9 m-85 -132.53 159.31 39.78 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.005 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.8 p -143.1 166.13 25.5 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.434 ' CG ' ' HE ' ' A' ' 315' ' ' ARG . 2.7 p30 . . . . . 0 C--N 1.317 -0.845 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.009 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 42.6 mm . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 121.843 0.83 . . . . 0.0 109.071 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -67.08 -32.69 74.02 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.786 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.414 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 22.4 mm -57.44 -63.64 3.52 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.43 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.414 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 17.9 Cg_endo -61.58 -30.12 85.42 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 122.248 1.966 . . . . 0.0 111.96 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.18 -50.14 64.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 110.455 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.42 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 10.0 t -57.24 -40.95 78.62 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.01 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.63 -30.98 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.749 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.472 ' O ' HG13 ' A' ' 280' ' ' ILE . 8.8 tp-100 -69.95 -45.14 68.08 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.993 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -64.07 -39.73 94.72 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.342 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.6 87.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.002 0.43 . . . . 0.0 109.871 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.547 ' HA ' HG21 ' A' ' 297' ' ' THR . 7.8 ttpt -60.54 -36.91 79.57 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.735 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 276' ' ' GLN . 58.9 mt -56.39 -47.05 82.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.811 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.546 ' O ' HD13 ' A' ' 285' ' ' LEU . 17.1 t -63.34 -46.89 94.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.941 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.54 -43.16 89.17 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -61.37 -39.91 92.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.16 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.605 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 8.0 m-85 -70.65 -42.38 70.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.993 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 281' ' ' VAL . 1.8 mp -61.94 -48.85 78.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 84.2 t -60.45 -40.38 84.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.501 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.5 -30.95 71.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.182 0.515 . . . . 0.0 110.608 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 20.7 mmm180 -83.12 5.45 22.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.735 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.51 2.24 40.67 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.075 -1.059 . . . . 0.0 114.45 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 61.4 t -80.55 145.24 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 117.842 0.821 . . . . 0.0 109.829 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.512 ' HB3' ' ND1' ' A' ' 294' ' ' HIS . . . -77.46 118.86 20.31 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.148 0.499 . . . . 0.0 111.376 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.65 -30.88 62.99 Favored Glycine 0 C--O 1.222 -0.612 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.873 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -68.81 -16.92 63.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.512 ' ND1' ' HB3' ' A' ' 291' ' ' ALA . 29.4 m170 -95.85 -5.24 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.724 0.297 . . . . 0.0 110.808 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.425 HD11 ' CG1' ' A' ' 290' ' ' VAL . 40.6 mt -110.83 130.17 64.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.228 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.69 125.71 51.18 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.126 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.547 HG21 ' HA ' ' A' ' 279' ' ' LYS . 29.7 p -111.75 122.56 48.13 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.262 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 28.2 m -120.09 164.24 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.483 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.42 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -134.36 105.15 0.55 Allowed Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 14.4 mt -89.59 2.54 54.54 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 69.99 -126.4 17.07 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.561 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 11.8 p -97.18 120.64 37.9 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.828 0.347 . . . . 0.0 110.651 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.4 p -176.31 150.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.339 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 61.66 81.98 0.23 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 123.488 0.715 . . . . 0.0 111.636 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.564 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 94.3 Cg_endo -80.7 154.55 20.49 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.458 2.106 . . . . 0.0 113.004 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.1 tt -119.0 -53.41 3.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.665 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -119.21 166.56 12.82 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.7 p -65.01 143.9 57.64 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.111 0.482 . . . . 0.0 111.491 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -80.19 -7.52 59.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.416 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.17 -18.71 63.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.846 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.7 t -113.72 135.54 21.98 Favored Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.697 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.6 -33.41 86.86 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.789 2.326 . . . . 0.0 111.137 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.0 mm-40 -66.36 -39.94 89.47 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.247 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -69.03 -37.66 83.2 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.123 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.434 ' HE ' ' CG ' ' A' ' 262' ' ' ASP . 80.6 mtp180 -61.49 -37.67 84.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.112 0.482 . . . . 0.0 109.724 176.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.63 68.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.661 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 1.0 OUTLIER -80.71 -39.76 26.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.367 177.723 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.564 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 44.3 m-80 -65.7 -22.13 66.6 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 39.0 ptt180 -84.41 10.78 9.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.279 0.561 . . . . 0.0 111.507 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 18.7 ptt-85 -58.74 178.58 0.11 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.952 0.882 . . . . 0.0 112.698 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 49.7 t -138.35 145.4 28.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.562 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -130.21 137.01 49.83 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.932 0.396 . . . . 0.0 110.61 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.449 HG23 HG12 ' A' ' 257' ' ' ILE . 2.2 mp -97.22 116.97 40.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.407 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.67 137.38 39.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 255' ' ' VAL . 49.2 t -100.25 138.81 23.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 C--N 1.31 -1.125 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.416 178.906 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.935 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.89 73.7 2.13 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.153 0.501 . . . . 0.0 110.199 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.542 ' HB2' HG21 ' A' ' 325' ' ' VAL . 16.4 mt -56.83 -27.67 60.47 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.81 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.05 -42.87 88.92 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.758 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 26.0 t -73.19 -31.88 64.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.53 -47.88 77.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.894 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.416 HG21 HG13 ' A' ' 243' ' ' VAL . 20.9 pt -73.85 -33.7 37.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.121 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -56.36 -37.88 70.67 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.079 0.466 . . . . 0.0 110.466 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.28 -29.74 70.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.877 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.717 HG12 HG23 ' A' ' 239' ' ' ILE . 32.5 t -82.38 -52.52 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.671 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.468 ' HA ' HG21 ' A' ' 239' ' ' ILE . 76.0 p -64.86 -36.23 83.68 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.424 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.67 12.62 79.78 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.27 -125.87 2.78 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -91.35 167.23 3.5 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.839 2.359 . . . . 0.0 112.936 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.6 mm -84.22 110.46 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.008 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.835 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.996 179.144 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.717 HG23 HG12 ' A' ' 218' ' ' VAL . 71.6 mt -64.09 -44.72 97.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.149 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.421 HD13 ' CD2' ' A' ' 284' ' ' TYR . 28.9 mt -57.2 -36.17 70.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.228 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.444 ' HA ' ' HG2' ' A' ' 288' ' ' ARG . 3.5 m-20 -79.94 -38.2 32.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.171 0.51 . . . . 0.0 110.321 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.688 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -64.87 -40.48 95.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.105 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.602 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 28.1 t -59.07 -41.42 83.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.971 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' A' ' 288' ' ' ARG . . . -59.84 -37.22 78.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.826 -177.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.57 -44.9 73.35 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.456 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -82.19 -16.18 50.64 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.709 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 23.5 mt -81.06 -22.56 39.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.518 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 9.7 tptm -71.82 -25.05 61.83 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.685 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -64.03 -46.47 84.3 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.394 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.43 ' HB3' HD11 ' A' ' 211' ' ' LEU . 52.1 t -128.92 75.94 79.68 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 60.8 Cg_endo -71.42 -2.61 11.53 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.958 2.439 . . . . 0.0 113.243 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.09 -23.38 23.73 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.405 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -62.3 138.26 58.4 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.604 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -93.88 133.21 37.53 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 325' ' ' VAL . 5.1 m -112.59 129.2 68.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-O 121.141 0.496 . . . . 0.0 110.751 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 33.3 m -103.84 108.66 20.08 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.051 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.449 HG12 HG23 ' A' ' 323' ' ' ILE . 24.5 mt -93.83 108.86 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -98.15 128.46 44.65 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.921 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.491 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -104.67 144.86 15.87 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 177.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 8.6 m-85 -126.13 163.62 22.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.692 0.282 . . . . 0.0 110.327 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 45.6 p -143.21 162.47 35.54 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.296 0.638 . . . . 0.0 109.616 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--N 1.323 -0.552 0 CA-C-O 121.075 0.464 . . . . 0.0 110.889 179.106 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 269' ' ' ILE . 1.7 mp . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 121.557 0.694 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.64 -38.87 67.38 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.149 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.41 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 19.6 mm -60.43 -63.9 3.72 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.072 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.41 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 11.8 Cg_endo -60.74 -30.97 91.37 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.867 1.711 . . . . 0.0 112.33 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 60.3 tp -65.52 -53.09 47.31 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.776 0.322 . . . . 0.0 111.477 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.491 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.9 p -61.82 -30.39 70.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 120.933 0.396 . . . . 0.0 110.767 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.38 -32.76 66.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.255 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.496 ' O ' HG13 ' A' ' 280' ' ' ILE . 57.0 tp60 -66.17 -49.7 66.46 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.762 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -61.95 -38.63 89.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.908 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.34 97.13 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.841 0.353 . . . . 0.0 110.295 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.56 ' HA ' HG21 ' A' ' 297' ' ' THR . 11.5 tmtt? -61.7 -38.33 87.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.15 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 276' ' ' GLN . 57.4 mt -55.59 -47.38 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.733 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 9.7 t -65.19 -48.92 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -53.64 -45.77 70.31 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -58.48 -41.69 85.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.706 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.603 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 6.9 m-85 -68.41 -41.32 80.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.716 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.733 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 43.8 mt -62.93 -46.44 87.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 95.0 t -58.78 -41.68 83.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.176 176.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.29 -28.5 68.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.503 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.603 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -83.54 -1.27 53.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.169 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 111.05 5.91 26.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.478 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.6 t -89.92 141.81 13.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 117.605 0.703 . . . . 0.0 110.443 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 295' ' ' ILE . . . -67.42 115.34 6.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.478 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.72 -35.61 92.24 Favored Glycine 0 CA--C 1.508 -0.346 0 CA-C-N 115.689 -0.687 . . . . 0.0 113.221 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -68.99 -14.52 63.09 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.055 0.455 . . . . 0.0 111.441 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -102.52 2.58 36.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.112 0.482 . . . . 0.0 110.402 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 291' ' ' ALA . 76.0 mt -105.97 132.44 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.38 127.87 54.09 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.783 0.325 . . . . 0.0 110.482 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.56 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.8 p -110.95 126.63 54.96 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.54 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.58 123.69 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -94.2 104.04 3.1 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 174.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.6 -3.08 58.99 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 78.98 -125.59 7.08 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.148 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 18.5 t -101.67 119.4 38.72 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.9 p -176.8 148.2 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 62.39 78.64 0.29 Allowed Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 123.186 0.595 . . . . 0.0 111.018 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.474 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 59.4 Cg_endo -73.03 151.4 49.97 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.36 2.04 . . . . 0.0 112.716 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.491 HG22 ' HA ' ' A' ' 318' ' ' ASN . 4.2 tt -111.16 -54.64 5.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.307 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.428 ' H ' HG23 ' A' ' 306' ' ' ILE . . . -120.15 170.54 9.22 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.765 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 15.5 m -62.38 137.49 58.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.263 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -80.92 -14.43 58.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.863 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.16 -18.45 65.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.229 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 314' ' ' GLY . 3.7 t -114.87 142.24 28.08 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.378 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.29 -28.05 40.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.494 2.129 . . . . 0.0 111.366 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 4.9 mt-10 -65.07 -38.98 92.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.411 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.417 ' H ' HG23 ' A' ' 311' ' ' THR . . . -70.15 -38.45 72.7 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.666 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -61.02 -39.04 88.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.101 0.477 . . . . 0.0 109.886 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.92 -26.77 68.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.629 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 3.6 mmtp -85.61 -37.17 19.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.491 ' HA ' HG22 ' A' ' 306' ' ' ILE . 35.9 m-80 -63.57 -20.94 66.05 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 14.6 ptp180 -88.06 15.19 7.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.313 0.577 . . . . 0.0 111.162 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.457 ' HB3' ' O ' ' A' ' 317' ' ' LYS . 26.2 ptt-85 -61.33 -176.32 0.07 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.085 0.945 . . . . 0.0 112.609 175.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 70.7 t -137.71 145.55 28.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.944 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -131.83 140.66 49.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.951 0.405 . . . . 0.0 110.827 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.449 HG23 HG12 ' A' ' 257' ' ' ILE . 1.3 mp -99.0 117.05 43.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.364 -178.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.64 135.02 47.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 211' ' ' LEU . 74.9 t -101.49 136.83 31.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 C--N 1.31 -1.142 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.921 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.392 0 CA-C-O 120.659 0.266 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -80.39 56.52 2.55 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.006 0.432 . . . . 0.0 110.509 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 250' ' ' CYS . 20.4 mt -53.18 -25.9 15.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -66.21 -37.79 86.41 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.327 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.0 t -77.67 -30.67 52.11 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 211' ' ' LEU . . . -65.49 -46.24 80.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.81 -1.087 . . . . 0.0 111.011 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 25.2 pt -73.73 -37.46 49.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.422 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.15 -31.67 69.18 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.916 0.389 . . . . 0.0 110.863 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.7 -27.05 67.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.894 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.0 p -99.17 -34.84 4.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.282 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.634 ' HA ' HG21 ' A' ' 239' ' ' ILE . 66.8 p -70.28 -37.23 74.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.279 0.561 . . . . 0.0 110.039 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.28 22.62 56.55 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.31 -132.34 7.75 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' PRO . . . . . 0.551 ' HB2' ' HG3' ' A' ' 320' ' ' ARG . 58.3 Cg_endo -80.95 163.34 20.56 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.622 2.215 . . . . 0.0 112.632 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.6 mm -83.17 101.96 8.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.333 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.149 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.513 -179.36 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 120.747 0.308 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.634 HG21 ' HA ' ' A' ' 219' ' ' THR . 88.0 mt -56.69 -38.34 57.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.842 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.41 HD22 HG13 ' A' ' 281' ' ' VAL . 57.5 mt -65.23 -31.65 72.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.854 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.417 ' OD1' ' HD3' ' A' ' 288' ' ' ARG . 7.9 t30 -71.14 -37.74 72.27 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -40.89 83.56 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.201 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.605 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.9 t -57.03 -42.76 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.014 177.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.01 82.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.328 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -52.22 -49.65 63.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.504 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -73.45 -30.27 63.09 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.469 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.7 mt -69.97 -30.96 68.43 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.627 0.727 . . . . 0.0 109.17 177.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -62.79 -35.08 78.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.042 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -73.23 -35.7 66.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.785 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.529 ' HB3' HD11 ' A' ' 211' ' ' LEU . 43.7 t -128.33 69.99 78.87 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.92 2.13 4.5 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.55 2.834 . . . . 0.0 114.656 -174.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -80.48 -26.29 38.33 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.418 0.628 . . . . 0.0 109.99 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.94 133.94 56.02 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.023 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -96.6 135.66 38.21 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.505 HG12 HG22 ' A' ' 325' ' ' VAL . 6.7 m -113.35 133.26 59.81 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.873 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 34.1 m -108.85 107.3 17.65 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.025 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.453 HG12 HG23 ' A' ' 323' ' ' ILE . 19.8 mt -94.97 115.4 33.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.991 -177.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -101.41 131.34 47.56 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.896 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.474 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -111.41 141.43 16.55 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 318' ' ' ASN . 2.1 m-85 -124.17 161.46 25.64 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.542 HG23 ' HB3' ' A' ' 274' ' ' SER . 50.6 p -136.58 173.42 11.73 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 C--N 1.312 -1.043 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 176.786 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 46.2 mm . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 121.72 0.772 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -63.82 -35.31 80.2 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.136 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.414 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 19.7 mm -58.68 -64.36 2.98 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.71 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.414 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 19.6 Cg_endo -62.12 -26.85 78.34 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 121.819 1.679 . . . . 0.0 111.662 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 46.7 tp -65.22 -56.44 12.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.732 0.301 . . . . 0.0 110.999 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.542 ' HB3' HG23 ' A' ' 261' ' ' THR . 6.9 p -65.48 -28.17 69.02 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.719 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.42 -32.16 68.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.045 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.549 ' O ' HG13 ' A' ' 280' ' ' ILE . 0.0 OUTLIER -70.34 -47.33 61.53 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.121 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -55.37 -43.87 75.51 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.032 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.81 -39.19 93.19 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 110.659 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.541 ' HA ' HG21 ' A' ' 297' ' ' THR . 0.9 OUTLIER -63.21 -33.92 76.53 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.524 179.137 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 276' ' ' GLN . 60.4 mt -57.25 -42.98 81.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.985 0.422 . . . . 0.0 110.073 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.574 ' O ' HD13 ' A' ' 285' ' ' LEU . 3.7 t -70.28 -43.47 78.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.759 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.36 -45.72 80.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.395 178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.25 -41.93 89.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.396 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.498 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 1.5 m-85 -65.12 -43.94 90.32 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.108 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 281' ' ' VAL . 3.8 mp -63.57 -47.59 80.89 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 99.1 t -60.02 -42.65 90.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.288 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.72 -27.12 68.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.566 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.575 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 2.8 mmp_? -86.21 5.02 36.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.999 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.89 5.9 43.79 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.258 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 57.4 t -86.32 143.61 11.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.604 0.702 . . . . 0.0 109.908 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.58 112.06 8.3 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.042 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.52 -32.66 73.82 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.243 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.29 -20.28 64.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.053 0.454 . . . . 0.0 111.222 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -102.74 3.48 36.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.938 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.5 mt -107.65 129.9 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-O 120.876 0.37 . . . . 0.0 110.845 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.69 125.74 49.43 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.071 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.541 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.3 p -110.33 129.15 55.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.943 0.401 . . . . 0.0 111.074 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.4 t -132.43 116.58 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.012 0.434 . . . . 0.0 111.927 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -92.08 109.58 3.77 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 20.7 mt -87.67 -32.19 19.35 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 95.81 -142.08 15.92 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.4 p -77.58 109.11 11.27 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.737 0.303 . . . . 0.0 110.512 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.412 HG13 ' HD2' ' A' ' 260' ' ' TYR . 15.0 p -174.46 150.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.2 t30 66.46 79.96 0.23 Allowed Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.273 175.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.699 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 38.1 Cg_endo -69.61 135.6 31.22 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.556 2.171 . . . . 0.0 113.075 -178.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.489 HG22 ' HA ' ' A' ' 318' ' ' ASN . 5.2 tt -112.92 -29.27 2.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.748 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -145.83 174.95 10.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.925 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.476 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 29.4 m -62.61 121.19 12.73 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.549 0.53 . . . . 0.0 110.846 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -80.65 -14.29 58.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.45 -16.06 62.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.159 0.504 . . . . 0.0 111.128 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.491 ' OG1' ' HG3' ' A' ' 313' ' ' GLU . 4.9 t -117.6 143.9 33.18 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.948 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.07 -31.03 76.21 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.441 2.094 . . . . 0.0 111.551 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.491 ' HG3' ' OG1' ' A' ' 311' ' ' THR . 4.0 mt-10 -59.14 -44.7 92.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.066 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -69.94 -37.64 74.44 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.894 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.68 -38.42 87.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.401 . . . . 0.0 110.066 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.19 -28.22 69.52 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.483 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 8.2 mmtp -81.81 -45.81 15.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.455 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.699 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 33.5 m-80 -57.98 -29.48 65.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 5.1 ptp180 -80.62 15.75 1.6 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.551 ' HG3' ' HB2' ' A' ' 222' ' ' PRO . 0.0 OUTLIER -69.39 -176.98 1.05 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.084 0.945 . . . . 0.0 112.704 179.682 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 89.2 t -131.9 143.32 40.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.756 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -132.53 142.16 49.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.02 0.438 . . . . 0.0 111.079 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.453 HG23 HG12 ' A' ' 257' ' ' ILE . 1.5 mp -101.73 120.54 51.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.853 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 66.9 t -109.72 135.31 49.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.505 HG22 HG12 ' A' ' 255' ' ' VAL . 58.1 t -102.14 140.01 21.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.92 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.1 t30 . . . . . 0 C--N 1.311 -1.092 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.721 178.169 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.524 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.56 86.04 4.59 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.299 0.571 . . . . 0.0 110.343 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.568 ' HB2' HG21 ' A' ' 325' ' ' VAL . 48.0 mt -71.17 -23.19 62.01 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.104 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 216' ' ' ASN . 51.7 tt0 -66.18 -38.99 89.36 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.355 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.3 t -73.25 -40.59 64.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.13 75.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.579 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.498 ' CG2' HG13 ' A' ' 243' ' ' VAL . 23.3 pt -70.37 -38.61 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.349 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 212' ' ' GLN . 10.2 t-20 -62.95 -27.41 69.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.034 0.445 . . . . 0.0 110.524 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.19 -28.41 67.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.935 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.2 t -89.93 -44.67 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.384 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.57 ' HA ' HG21 ' A' ' 239' ' ' ILE . 70.8 p -67.81 -36.79 81.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.763 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.1 26.73 47.6 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.64 -141.13 13.38 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.05 160.18 36.92 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.832 2.355 . . . . 0.0 111.79 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 320' ' ' ARG . 46.1 mm -73.49 106.36 3.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.756 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.733 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.302 176.74 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.447 -0.606 0 CA-C-O 120.564 0.221 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.57 HG21 ' HA ' ' A' ' 219' ' ' THR . 79.2 mt -61.88 -38.47 80.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.9 mt -69.45 -25.37 64.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.709 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' A' ' 288' ' ' ARG . 7.3 t30 -72.71 -38.14 67.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.612 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -68.11 -38.39 82.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.193 177.869 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.602 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.9 t -62.04 -45.02 99.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.562 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.95 74.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.986 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.612 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 1.5 t70 -46.6 -51.11 16.4 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.016 0.926 . . . . 0.0 112.522 178.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.563 ' HB3' ' NZ ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -84.68 -15.97 43.44 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.903 -177.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.6 mt -78.85 -28.83 44.31 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.54 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 59.5 mtpt -82.51 -17.11 46.25 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.916 177.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.38 -37.77 83.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.978 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.519 ' HB3' HD11 ' A' ' 211' ' ' LEU . 48.3 t -131.38 71.0 81.87 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 176.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 61.0 Cg_endo -72.44 0.85 6.87 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.951 2.434 . . . . 0.0 112.846 -177.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.35 -31.1 42.93 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -72.52 141.7 48.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.473 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.19 142.16 27.95 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.526 HG12 HG22 ' A' ' 325' ' ' VAL . 5.4 m -113.93 130.87 67.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 CA-C-O 121.277 0.56 . . . . 0.0 110.725 177.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.4 m -106.88 108.09 19.43 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.178 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.403 HG12 HG23 ' A' ' 323' ' ' ILE . 29.8 mt -92.95 113.75 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.27 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -98.63 122.53 41.96 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.018 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.464 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -105.28 151.75 17.2 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.368 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -125.14 167.43 14.82 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.376 0.608 . . . . 0.0 110.948 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 8.1 t -160.25 156.81 27.07 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.965 174.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 11.7 t70 . . . . . 0 C--N 1.318 -0.789 0 CA-C-O 120.912 0.387 . . . . 0.0 110.831 -177.501 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 34.3 mm . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.86 -43.21 76.9 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.007 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.42 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 26.1 mm -55.51 -64.43 2.19 Favored Pre-proline 0 CA--C 1.557 1.246 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.796 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.42 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 18.9 Cg_endo -62.74 -27.17 75.41 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.79 1.66 . . . . 0.0 112.647 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.6 tp -66.45 -53.54 34.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 110.87 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.464 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.0 p -60.81 -31.4 70.8 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.24 0.543 . . . . 0.0 110.157 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.56 -42.31 91.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.719 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.512 ' O ' HG13 ' A' ' 280' ' ' ILE . 27.6 tt0 -60.06 -43.71 95.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.093 178.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -58.78 -47.09 85.93 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.11 73.48 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.115 0.483 . . . . 0.0 110.729 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.623 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.2 tptt -67.34 -31.5 71.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.051 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 276' ' ' GLN . 53.4 mt -58.9 -40.35 80.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 0.0 109.895 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.697 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.7 t -68.76 -44.46 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.904 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.59 73.74 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.851 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.22 -42.31 81.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.533 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.643 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 0.8 OUTLIER -64.29 -47.4 79.64 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.446 178.724 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 34.8 mt -63.85 -49.5 72.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.055 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.02 -39.17 81.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.151 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.5 -26.09 68.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.192 0.52 . . . . 0.0 110.686 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.1 mmp_? -86.44 2.47 47.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.974 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.88 12.79 48.87 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.911 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.532 HG22 ' HG3' ' A' ' 248' ' ' LYS . 58.6 t -85.22 140.62 15.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.53 110.03 4.01 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.987 0.422 . . . . 0.0 111.365 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.98 -33.09 63.3 Favored Glycine 0 C--O 1.225 -0.451 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.89 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.23 -19.46 65.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.821 0.343 . . . . 0.0 111.622 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -102.06 1.76 36.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.051 0.453 . . . . 0.0 110.375 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.5 mt -105.62 127.02 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.122 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.97 125.51 50.55 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.39 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.623 HG21 ' HA ' ' A' ' 279' ' ' LYS . 40.8 p -105.49 121.85 44.78 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.8 t -125.63 115.9 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.156 0.503 . . . . 0.0 111.793 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.0 108.64 3.49 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 21.8 mt -91.15 0.37 57.55 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.77 0.319 . . . . 0.0 111.206 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.32 -126.12 30.34 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.022 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 15.4 m -103.32 116.45 32.47 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.601 HG23 ' H ' ' A' ' 304' ' ' ASN . 6.0 m -140.46 -64.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.354 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.601 ' H ' HG23 ' A' ' 303' ' ' VAL . 33.9 m-80 -117.96 90.67 37.59 Favored Pre-proline 0 N--CA 1.439 -0.997 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.62 176.77 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.577 2.185 . . . . 0.0 112.345 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -128.78 -49.03 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.694 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -110.45 176.79 4.91 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.633 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 18.5 m -65.77 131.63 46.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.525 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -79.22 -8.23 58.86 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.458 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -80.6 -11.2 59.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.55 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.516 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 2.6 t -119.44 138.88 26.98 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.337 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.46 -32.52 70.95 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.594 2.196 . . . . 0.0 111.656 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -67.43 -35.42 79.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.757 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.59 -38.11 85.82 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 311' ' ' THR . 97.9 mtt180 -66.08 -21.88 66.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.478 0.656 . . . . 0.0 109.787 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.41 ' O ' ' HG2' ' A' ' 319' ' ' ARG . . . -78.73 -28.97 45.06 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.308 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -77.62 -42.93 33.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.157 0.503 . . . . 0.0 109.765 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -64.96 -8.87 17.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 18.7 ptp180 -98.93 11.66 38.21 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 223' ' ' ILE . 4.8 ptm180 -69.03 -174.67 0.64 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 76.2 t -137.03 151.74 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.623 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.54 138.55 50.25 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 122.672 0.389 . . . . 0.0 110.64 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.41 ' H ' HD12 ' A' ' 323' ' ' ILE . 2.1 mp -100.74 122.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.834 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 95.1 t -113.18 137.41 46.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.568 HG21 ' HB2' ' A' ' 211' ' ' LEU . 85.1 t -101.93 136.38 34.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 120.8 0.333 . . . . 0.0 110.713 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 C--N 1.313 -0.993 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.06 -178.685 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 121.154 0.502 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -82.67 77.48 9.43 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.992 -0.443 . . . . 0.0 110.007 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.422 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.2 mm? -68.06 -35.31 78.01 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.762 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -63.33 -42.7 98.97 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.558 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 31.0 t -75.38 -27.97 59.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.282 0.563 . . . . 0.0 109.508 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -69.82 -46.72 65.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.627 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.477 ' CG2' HG13 ' A' ' 243' ' ' VAL . 23.4 pt -77.1 -41.43 31.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -61.34 -29.74 70.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.943 0.402 . . . . 0.0 110.876 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.37 -24.26 67.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.173 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.93 -45.46 13.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.033 0.444 . . . . 0.0 110.298 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.516 ' HA ' HG21 ' A' ' 239' ' ' ILE . 74.3 p -64.79 -38.2 90.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.013 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.79 20.54 53.52 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.197 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.67 -134.7 8.36 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' PRO . . . . . 0.491 ' HB3' HH11 ' A' ' 320' ' ' ARG . 60.6 Cg_endo -78.52 161.22 28.31 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.282 1.988 . . . . 0.0 112.337 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.86 108.9 13.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.635 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.955 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.507 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.668 0.27 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.516 HG21 ' HA ' ' A' ' 219' ' ' THR . 82.4 mt -62.88 -37.79 80.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.045 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.478 ' CD2' HG13 ' A' ' 281' ' ' VAL . 47.3 mt -62.84 -34.75 77.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 110.644 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -73.8 -39.36 64.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.572 177.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.496 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -65.09 -44.87 87.43 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.762 179.551 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.599 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 29.9 t -57.82 -43.59 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.704 177.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.11 85.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.114 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -52.38 -49.91 63.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -77.98 -20.05 53.33 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.878 -178.319 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 35.1 mt -78.13 -32.33 50.32 Favored 'General case' 0 C--O 1.214 -0.779 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.599 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.531 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 61.4 mtpt -74.95 -18.64 60.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.864 176.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.09 -34.49 75.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.326 0.584 . . . . 0.0 109.646 175.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 53.4 t -128.67 71.8 80.97 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.056 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 59.8 Cg_endo -70.62 0.14 6.75 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.681 2.254 . . . . 0.0 112.981 -176.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -88.62 -25.34 22.49 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -57.67 138.13 55.73 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.78 130.29 45.97 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 325' ' ' VAL . 12.3 m -122.03 134.61 64.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-O 121.39 0.614 . . . . 0.0 111.937 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.3 m -110.58 113.31 25.83 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.221 -0.899 . . . . 0.0 108.827 178.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.442 HG12 HG23 ' A' ' 323' ' ' ILE . 23.1 mt -92.68 113.83 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -101.98 126.25 48.85 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.363 -176.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -106.15 150.54 16.89 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.668 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -127.9 159.75 33.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.017 0.437 . . . . 0.0 110.436 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 274' ' ' SER . 70.1 p -141.02 169.83 16.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.331 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.411 ' CG ' ' HE ' ' A' ' 315' ' ' ARG . 18.0 t70 . . . . . 0 C--N 1.32 -0.683 0 CA-C-O 120.682 0.277 . . . . 0.0 110.801 178.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 111.813 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -55.46 -34.96 64.99 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.703 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.501 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.6 mm -58.17 -67.12 1.01 Allowed Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.269 177.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.501 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.5 Cg_endo -57.98 -30.69 90.72 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 121.934 1.756 . . . . 0.0 111.78 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.75 -54.63 32.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.463 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.491 ' HB3' HG23 ' A' ' 261' ' ' THR . 9.8 p -60.94 -32.7 72.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.793 0.33 . . . . 0.0 110.437 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.91 -31.64 71.56 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.079 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.479 ' O ' HG13 ' A' ' 280' ' ' ILE . 51.5 tt0 -69.68 -48.9 58.11 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -60.24 -41.96 94.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.21 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.91 -39.07 90.76 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.019 0.438 . . . . 0.0 110.525 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.728 ' HA ' HG21 ' A' ' 297' ' ' THR . 21.6 ttpt -66.18 -30.16 70.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.361 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 276' ' ' GLN . 64.1 mt -55.96 -45.4 80.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 110.023 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.732 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.8 t -64.56 -46.99 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.728 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.69 -43.05 76.07 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.362 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.61 -41.66 86.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.359 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.436 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 8.4 m-85 -71.12 -40.83 71.2 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.413 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 46.6 mt -64.59 -48.53 74.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.8 t -61.23 -39.66 83.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.466 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.29 -30.8 71.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.127 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.436 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 1.2 mpt_? -81.65 2.1 31.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.664 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.72 3.13 46.46 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.233 -0.984 . . . . 0.0 114.449 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.469 HG22 ' HG3' ' A' ' 248' ' ' LYS . 58.9 t -79.26 143.36 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 117.896 0.848 . . . . 0.0 109.782 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.02 110.06 4.28 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.032 0.444 . . . . 0.0 111.446 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.01 -18.47 64.66 Favored Glycine 0 CA--C 1.508 -0.389 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.339 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -72.14 -22.53 61.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.161 0.505 . . . . 0.0 110.425 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -104.5 5.43 34.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.035 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.455 HD11 ' CG1' ' A' ' 290' ' ' VAL . 63.8 mt -109.42 128.79 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.32 128.43 55.05 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.1 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.728 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.1 p -115.05 120.66 40.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 120.915 0.388 . . . . 0.0 111.251 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.84 166.42 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.341 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -134.41 109.71 0.81 Allowed Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 14.8 mt -97.04 -1.24 45.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.595 0.236 . . . . 0.0 111.304 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.06 -123.76 26.82 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.319 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 3.8 t -106.28 120.1 40.98 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 304' ' ' ASN . 5.6 m -141.74 -58.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.344 -177.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.462 ' H ' HG23 ' A' ' 303' ' ' VAL . 22.1 m-80 -116.86 92.32 38.2 Favored Pre-proline 0 N--CA 1.442 -0.846 0 CA-C-O 120.687 0.279 . . . . 0.0 110.259 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.26 166.29 11.29 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.681 2.254 . . . . 0.0 112.478 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' A' ' 318' ' ' ASN . 3.5 tt -121.48 -45.35 2.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.874 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -128.11 168.78 14.89 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.305 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 35.5 t -62.58 135.33 57.34 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.685 0.615 . . . . 0.0 110.983 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.79 -9.35 59.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.386 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.39 66.96 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.777 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.574 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.9 t -114.16 140.18 24.64 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.84 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.28 -27.79 55.69 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.247 1.965 . . . . 0.0 111.105 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.8 mt-10 -62.77 -41.45 99.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.72 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.49 -38.06 86.19 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.477 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.574 ' HG3' ' O ' ' A' ' 311' ' ' THR . 40.9 mtp180 -63.6 -30.23 71.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.384 0.612 . . . . 0.0 109.929 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.22 -27.47 63.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.279 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 13.3 mmtp -80.14 -40.58 27.12 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.372 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.402 ' HA ' HG22 ' A' ' 306' ' ' ILE . 27.3 m-80 -58.13 -24.38 58.57 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -177.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 18.0 ptp180 -83.47 9.75 10.48 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.977 0.418 . . . . 0.0 112.017 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.491 HH11 ' HB3' ' A' ' 222' ' ' PRO . 34.3 ptt85 -57.16 176.28 0.12 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.949 0.881 . . . . 0.0 112.909 175.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.6 t -139.73 147.48 23.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.158 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.17 138.1 50.45 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 110.992 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.442 HG23 HG12 ' A' ' 257' ' ' ILE . 2.4 mp -96.1 116.03 36.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.496 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.94 136.79 42.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 255' ' ' VAL . 56.9 t -101.27 139.52 22.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 . . . . . 0 C--N 1.325 -0.483 0 O-C-N 123.926 0.766 . . . . 0.0 111.132 178.617 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.542 0 CA-C-O 120.983 0.42 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.72 83.75 4.85 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 250' ' ' CYS . 25.6 mt -79.36 -24.72 42.48 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.452 -178.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -60.97 -51.05 70.88 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.8 t -70.92 -36.4 72.66 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.818 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.519 ' HB1' ' HZ3' ' A' ' 246' ' ' LYS . . . -59.42 -44.53 92.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.798 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 211' ' ' LEU . 27.1 pt -75.89 -39.52 37.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.177 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -60.16 -34.44 73.57 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 110.688 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.97 -24.03 67.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.726 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.8 t -94.98 -45.19 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 120.899 0.38 . . . . 0.0 110.296 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.563 ' HA ' HG21 ' A' ' 239' ' ' ILE . 80.6 p -66.46 -39.66 88.95 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.127 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.1 30.29 55.46 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 119.02 -132.15 9.48 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' PRO . . . . . 0.451 ' HA ' ' HG2' ' A' ' 322' ' ' GLU . 63.7 Cg_endo -79.76 157.22 24.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.457 2.104 . . . . 0.0 113.322 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 38.6 mm -73.99 108.45 5.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.892 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.139 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.39 176.022 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 N--CA 1.445 -0.678 0 CA-C-O 120.48 0.181 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.563 HG21 ' HA ' ' A' ' 219' ' ' THR . 75.6 mt -64.38 -38.02 81.49 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 8.3 mp -64.62 -36.13 83.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.803 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -69.93 -39.0 76.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.864 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.526 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -66.14 -41.99 89.7 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.032 178.308 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.623 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.1 t -57.93 -42.83 83.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.364 177.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.75 86.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.262 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.15 -49.18 67.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.519 ' HZ3' ' HB1' ' A' ' 214' ' ' ALA . 0.0 OUTLIER -72.09 -29.75 64.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.315 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 26.2 mt -70.53 -27.93 64.54 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 18.6 tptp -63.63 -34.44 77.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.675 178.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.59 -39.53 73.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.432 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.55 ' HB3' HD11 ' A' ' 211' ' ' LEU . 38.4 t -127.17 68.48 72.49 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 73.5 Cg_endo -72.21 0.21 7.66 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.385 2.723 . . . . 0.0 113.976 -174.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -91.04 -18.24 24.92 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.673 0.749 . . . . 0.0 109.36 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -63.33 150.86 42.34 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.357 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -104.22 133.97 48.24 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.164 0.507 . . . . 0.0 110.434 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.551 HG12 HG22 ' A' ' 325' ' ' VAL . 12.5 m -117.84 136.49 54.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.174 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.3 m -112.54 109.8 19.58 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.332 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.442 HG12 HG23 ' A' ' 323' ' ' ILE . 21.8 mt -92.24 115.0 30.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -103.12 129.54 50.01 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.691 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.429 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -108.04 151.64 16.98 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.364 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 57.3 m-85 -126.71 163.47 23.43 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.082 0.468 . . . . 0.0 110.977 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.527 HG23 ' HB3' ' A' ' 274' ' ' SER . 71.9 p -142.88 163.7 32.08 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.971 176.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.637 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.75 0.786 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -34.95 67.02 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.431 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.468 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.1 mm -60.99 -65.07 2.4 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.093 177.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.468 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.2 Cg_endo -58.3 -30.02 89.71 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 121.91 1.74 . . . . 0.0 111.974 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 59.6 tp -64.29 -54.94 25.26 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.24 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.527 ' HB3' HG23 ' A' ' 261' ' ' THR . 5.2 p -63.4 -26.79 68.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.749 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.47 -28.4 64.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.852 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -76.18 -42.09 47.51 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -59.25 -46.42 88.56 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.142 177.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.33 74.88 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.98 0.419 . . . . 0.0 110.454 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.54 ' HA ' HG21 ' A' ' 297' ' ' THR . 23.8 tptm -63.53 -32.44 73.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.098 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 54.6 mt -58.87 -43.17 87.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.017 0.437 . . . . 0.0 110.077 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.697 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.8 t -66.86 -46.58 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.946 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.35 -41.45 76.12 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.889 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.13 -43.74 78.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.964 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' TYR . . . . . 0.554 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 8.5 m-85 -70.77 -41.61 71.5 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.483 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 42.7 mt -63.76 -49.15 74.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 68.8 t -59.74 -42.2 87.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.284 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.55 -28.48 69.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.944 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.9 mmp_? -84.42 4.11 33.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.751 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.13 6.83 41.88 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 119.859 -1.162 . . . . 0.0 114.375 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 53.0 t -86.18 143.76 10.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 117.717 0.759 . . . . 0.0 109.725 177.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.47 114.42 10.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.898 0.38 . . . . 0.0 111.514 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.72 -32.79 70.4 Favored Glycine 0 C--O 1.23 -0.143 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.998 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.45 -21.44 66.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.087 0.47 . . . . 0.0 111.66 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -100.48 1.27 40.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.914 0.387 . . . . 0.0 110.57 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.35 129.12 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.854 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.54 127.69 53.86 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.202 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 279' ' ' LYS . 10.7 p -110.62 120.4 42.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.726 0.298 . . . . 0.0 111.002 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.16 130.52 60.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.945 0.402 . . . . 0.0 111.331 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -97.51 117.5 5.81 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.341 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 27.1 mt -91.3 -3.53 56.76 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.39 0.138 . . . . 0.0 111.176 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.63 -138.71 48.24 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.351 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 2.1 m -89.25 115.91 27.09 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.475 HG13 ' H ' ' A' ' 304' ' ' ASN . 4.6 p -143.79 -61.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.611 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.475 ' H ' HG13 ' A' ' 303' ' ' VAL . 91.6 m-20 -116.04 93.95 40.12 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -67.74 167.14 21.99 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.544 2.163 . . . . 0.0 112.782 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.41 HD13 ' HB3' ' A' ' 317' ' ' LYS . 2.5 tt -125.07 -49.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.279 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -124.66 170.8 10.6 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.393 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.3 p -71.11 139.61 50.36 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 123.547 0.53 . . . . 0.0 111.874 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -81.46 -11.07 59.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.418 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -61.63 -26.63 68.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.103 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 314' ' ' GLY . 4.4 t -113.65 139.42 23.37 Favored Pre-proline 0 N--CA 1.436 -1.164 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.693 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.14 -32.42 91.15 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.905 2.404 . . . . 0.0 111.84 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 35.5 mm-40 -63.8 -40.99 97.96 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.262 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.458 ' H ' HG23 ' A' ' 311' ' ' THR . . . -66.53 -37.87 92.95 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.379 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.4 -39.73 84.35 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.51 ' HA ' ' HD3' ' A' ' 319' ' ' ARG . . . -61.04 -29.94 70.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.686 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 10.9 mmpt? -77.6 -44.62 27.74 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.297 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -60.88 -29.87 69.81 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.51 ' HD3' ' HA ' ' A' ' 316' ' ' ALA . 3.5 ptm180 -83.41 11.71 6.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.2 ptt-85 -57.43 178.87 0.06 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.254 1.022 . . . . 0.0 112.898 174.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 94.1 t -137.74 147.68 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.583 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 222' ' ' PRO . 48.5 mt-10 -132.66 137.81 47.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.397 . . . . 0.0 111.415 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.442 HG23 HG12 ' A' ' 257' ' ' ILE . 2.8 mp -98.98 121.25 49.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.041 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.83 138.73 39.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.551 HG22 HG12 ' A' ' 255' ' ' VAL . 52.8 t -104.21 143.28 16.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 C--N 1.32 -0.706 0 O-C-N 123.519 0.512 . . . . 0.0 110.349 177.461 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.07 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -133.98 116.95 16.15 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -53.06 132.39 50.19 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.5 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.513 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 11.3 Cg_endo -55.1 128.66 31.51 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.897 2.398 . . . . 0.0 112.04 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 199' ' ' PRO . 11.2 Cg_exo -72.43 53.59 2.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.053 2.502 . . . . 0.0 112.442 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -117.62 81.02 0.31 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 200' ' ' PRO . 7.7 Cg_endo -90.5 109.39 0.36 Allowed 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 123.394 2.729 . . . . 0.0 111.913 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.92 -59.8 0.57 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.071 2.514 . . . . 0.0 112.598 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -118.54 16.39 13.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.118 0.485 . . . . 0.0 110.741 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.427 ' HB2' ' CB ' ' A' ' 202' ' ' PRO . 75.0 m -107.22 146.86 30.88 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.462 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 118.34 -77.92 0.3 Allowed Glycine 0 C--N 1.312 -0.77 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.59 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.58 115.64 2.81 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.425 2.083 . . . . 0.0 110.877 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 35.1 t -146.62 -176.89 5.36 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.735 -176.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -47.43 153.44 0.52 Allowed 'General case' 0 C--O 1.238 0.45 0 O-C-N 123.84 0.713 . . . . 0.0 110.505 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.435 ' HB3' ' OG ' ' A' ' 213' ' ' SER . 3.7 m-20 -75.88 81.31 2.79 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.093 0.473 . . . . 0.0 110.758 -176.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 250' ' ' CYS . 32.5 mt -72.87 -26.67 61.53 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.509 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 59.9 tp60 -59.47 -56.29 23.8 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.542 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 210' ' ' ASP . 4.2 p -66.38 -31.3 71.99 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 120.882 0.372 . . . . 0.0 110.293 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.16 -54.14 42.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.466 ' CG2' HG13 ' A' ' 243' ' ' VAL . 19.8 pt -69.04 -38.13 77.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.844 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.49 -34.44 69.05 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.598 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.29 -29.74 70.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.379 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.49 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.6 t -89.01 -45.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.895 0.379 . . . . 0.0 110.741 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.585 ' HA ' HG21 ' A' ' 239' ' ' ILE . 76.6 p -67.15 -35.42 79.67 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.251 0.548 . . . . 0.0 110.743 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.49 24.78 60.12 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 125.84 -134.66 8.8 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.2 164.98 14.92 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.449 2.099 . . . . 0.0 112.77 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.9 mm -82.61 109.21 16.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.976 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.33 125.65 34.79 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.034 0.445 . . . . 0.0 111.103 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -99.04 164.8 12.03 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.66 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -152.72 33.02 0.82 Allowed Glycine 0 C--N 1.306 -1.117 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -156.98 128.59 7.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.043 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -140.17 126.44 19.95 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 113.28 -24.85 11.92 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.376 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -130.22 -177.21 4.22 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.3 m -100.97 164.15 11.95 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.224 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.98 118.62 10.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.095 0.474 . . . . 0.0 110.934 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 26.9 pt -77.69 161.57 71.28 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.284 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.14 157.97 1.61 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.961 2.441 . . . . 0.0 112.559 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 68.47 35.18 3.38 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.769 0.795 . . . . 0.0 108.923 -174.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -100.09 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.935 -177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.404 ' HB2' HD13 ' A' ' 240' ' ' LEU . 61.8 m-85 -135.88 113.49 10.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.836 0.351 . . . . 0.0 111.023 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.75 -19.13 65.69 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.073 0.463 . . . . 0.0 110.194 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.585 HG21 ' HA ' ' A' ' 219' ' ' THR . 87.7 mt -62.0 -41.07 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.129 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.404 HD13 ' HB2' ' A' ' 237' ' ' TYR . 11.2 mp -64.12 -32.07 73.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.067 0.461 . . . . 0.0 110.427 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.29 -37.27 69.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.49 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -68.98 -45.78 69.76 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.328 178.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.569 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 42.5 t -56.78 -44.43 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.969 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -58.86 -34.32 71.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.434 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.2 -45.83 75.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -14.69 53.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.98 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.4 mt -79.29 -26.55 42.29 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.639 ' HG3' HG22 ' A' ' 290' ' ' VAL . 58.6 mtpt -82.54 -21.83 35.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.386 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.06 -37.69 84.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.056 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.463 ' HB3' HD11 ' A' ' 211' ' ' LEU . 48.0 t -130.23 74.4 80.42 Favored Pre-proline 0 N--CA 1.434 -1.242 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.834 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 74.6 Cg_endo -74.16 1.3 7.39 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.1 2.533 . . . . 0.0 112.283 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -74.96 -29.15 60.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.93 0.872 . . . . 0.0 108.773 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -73.63 164.47 26.6 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.058 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 254' ' ' ARG . 0.0 OUTLIER -120.75 137.23 54.61 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.675 176.572 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.2 m -120.37 134.61 63.29 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 121.198 0.523 . . . . 0.0 111.562 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 49.9 m -111.43 113.24 25.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.515 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.413 HG12 HG23 ' A' ' 323' ' ' ILE . 21.8 mt -91.87 111.58 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -98.87 125.54 44.3 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.532 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.446 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -106.58 144.16 15.83 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.389 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.58 165.04 17.83 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.961 0.41 . . . . 0.0 110.56 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.515 HG23 ' HB3' ' A' ' 274' ' ' SER . 68.5 p -143.98 172.48 12.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.761 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.541 ' OD1' HG22 ' A' ' 264' ' ' THR . 2.3 p30 -79.93 155.2 27.82 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 175.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -90.07 0.95 56.86 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.541 HG22 ' OD1' ' A' ' 262' ' ' ASP . 9.3 t -79.53 -15.46 57.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.119 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.78 178.82 53.59 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.111 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 36.3 t -76.33 120.28 21.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.746 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 33.8 tt0 -62.66 138.68 58.56 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.338 0.59 . . . . 0.0 111.064 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLY . . . . . 0.419 ' O ' ' HD2' ' A' ' 272' ' ' PRO . . . 113.0 -40.54 2.49 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp -80.88 -27.77 11.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 122.005 0.907 . . . . 0.0 109.076 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.746 ' OD1' ' HA ' ' A' ' 267' ' ' GLU . 1.0 OUTLIER -59.67 -33.6 71.77 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.873 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.507 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 32.8 mm -60.02 -65.53 2.04 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.043 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.507 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 8.3 Cg_endo -57.21 -32.67 94.23 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.211 1.94 . . . . 0.0 112.106 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.16 -55.13 20.41 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.718 0.294 . . . . 0.0 111.617 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.515 ' HB3' HG23 ' A' ' 261' ' ' THR . 8.3 p -64.34 -27.87 69.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.788 0.328 . . . . 0.0 111.128 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.94 -27.55 64.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.526 ' O ' HG13 ' A' ' 280' ' ' ILE . 28.6 tt0 -73.89 -44.44 55.26 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.416 HH21 HD11 ' A' ' 280' ' ' ILE . 3.9 mmp_? -57.62 -46.49 84.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.568 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.58 91.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.287 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.524 ' HA ' HG21 ' A' ' 297' ' ' THR . 2.2 tmtp? -60.49 -35.8 76.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.333 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 276' ' ' GLN . 56.6 mt -55.41 -45.09 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.855 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.718 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 9.1 t -67.42 -45.7 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.978 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.24 -44.26 79.46 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.43 -38.89 78.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.558 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.585 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 5.5 m-85 -69.51 -41.82 75.54 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.935 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 44.6 mt -64.11 -49.89 70.41 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.496 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 97.2 t -60.55 -38.9 79.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.533 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.93 -25.98 68.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.721 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.8 mmp_? -89.11 4.01 49.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.902 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.9 10.93 41.63 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.956 -1.116 . . . . 0.0 114.284 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.639 HG22 ' HG3' ' A' ' 248' ' ' LYS . 46.3 t -85.58 141.88 13.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.908 0.854 . . . . 0.0 109.752 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.1 108.1 2.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.995 0.426 . . . . 0.0 111.473 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.84 -33.36 68.04 Favored Glycine 0 C--O 1.228 -0.264 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.321 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.28 -15.08 63.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.173 0.511 . . . . 0.0 111.58 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -104.62 2.04 30.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.976 0.417 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.438 HD11 ' CG1' ' A' ' 290' ' ' VAL . 55.5 mt -107.69 129.8 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -116.69 125.28 51.49 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.524 HG21 ' HA ' ' A' ' 279' ' ' LYS . 24.7 p -111.43 122.55 48.14 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.665 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.24 161.14 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-O 121.167 0.508 . . . . 0.0 111.158 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -126.49 111.61 1.44 Allowed Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.462 ' HB3' HG21 ' A' ' 303' ' ' VAL . 18.4 mt -97.38 -8.5 29.37 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.495 ' HA3' HD22 ' A' ' 270' ' ' ASN . . . 63.24 -130.92 41.76 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 119.806 -1.188 . . . . 0.0 111.579 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 55.9 p -91.91 114.33 26.84 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.035 0.445 . . . . 0.0 109.902 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.601 ' O ' ' HD3' ' A' ' 305' ' ' PRO . 46.2 t -134.98 -67.72 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.4 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -108.09 91.34 7.79 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.221 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.627 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 7.6 Cg_exo -70.47 127.11 13.59 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.558 2.172 . . . . 0.0 111.891 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.7 tt -85.32 -42.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.774 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -131.08 170.36 14.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.128 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 27.7 m -69.62 136.16 50.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.86 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -76.62 -7.31 54.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.554 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -59.32 -29.77 67.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.942 0.401 . . . . 0.0 110.654 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.443 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 2.6 t -114.25 141.0 25.73 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.475 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.42 -31.45 94.83 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.723 2.282 . . . . 0.0 111.651 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 13.0 mm-40 -55.37 -50.75 68.89 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.953 177.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.438 ' H ' HG23 ' A' ' 311' ' ' THR . . . -63.01 -36.96 94.18 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.833 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 311' ' ' THR . 57.1 mtt180 -62.68 -35.56 80.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.846 0.355 . . . . 0.0 110.197 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.7 70.54 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.443 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 317' ' ' LYS . 15.1 mmtp -77.51 -41.31 39.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.947 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.627 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 42.0 m-20 -63.57 -24.4 67.79 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 12.0 ptm180 -83.68 6.44 20.96 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -58.18 170.86 0.62 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.153 0.978 . . . . 0.0 113.372 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 71.4 t -131.8 144.58 36.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.191 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -130.92 138.19 49.65 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.099 0.476 . . . . 0.0 111.186 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.465 ' HB ' HD12 ' A' ' 215' ' ' ILE . 2.4 mp -96.27 116.39 38.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.461 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.409 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 98.5 t -109.66 138.16 38.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.533 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 211' ' ' LEU . 59.3 t -98.74 132.93 43.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.681 -179.33 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.246 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -102.1 -5.02 24.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.388 0.137 . . . . 0.0 110.942 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 62.24 88.89 0.11 Allowed Pre-proline 0 N--CA 1.466 0.362 0 O-C-N 123.719 0.637 . . . . 0.0 111.644 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.72 141.95 31.48 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.737 2.291 . . . . 0.0 111.662 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.88 127.79 20.38 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 122.505 2.137 . . . . 0.0 112.078 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.472 ' N ' ' HD3' ' A' ' 202' ' ' PRO . . . -143.2 61.41 0.52 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.767 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 201' ' ' GLY . 1.0 OUTLIER -86.44 143.59 7.56 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.909 2.406 . . . . 0.0 111.563 179.109 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.58 -29.32 89.59 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.623 2.215 . . . . 0.0 112.56 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -103.43 21.33 16.19 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.709 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 21.2 t 63.16 -179.32 0.15 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.593 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -91.85 -161.31 36.8 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.592 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.35 -32.17 51.11 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.214 1.943 . . . . 0.0 111.398 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 13.5 t -154.34 -178.78 7.37 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.903 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -56.11 153.19 9.43 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 122.811 0.445 . . . . 0.0 111.817 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -78.68 66.3 4.15 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.379 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 250' ' ' CYS . 22.1 mt -53.55 -27.09 24.12 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -60.18 -51.83 67.9 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 121.018 0.437 . . . . 0.0 110.205 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.7 t -72.45 -28.25 62.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.415 0.626 . . . . 0.0 109.687 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' A' ' 211' ' ' LEU . . . -67.16 -51.39 54.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.134 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.461 ' CG2' HG13 ' A' ' 243' ' ' VAL . 26.1 pt -70.78 -38.5 73.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.485 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.79 -30.01 68.6 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.003 0.43 . . . . 0.0 110.767 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.17 -26.09 65.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.088 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.466 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.6 t -91.03 -46.28 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.993 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.616 ' HA ' HG21 ' A' ' 239' ' ' ILE . 40.1 p -67.13 -35.96 80.85 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.147 0.499 . . . . 0.0 110.855 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.96 18.97 68.5 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 129.27 -138.02 9.97 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.886 -0.657 . . . . 0.0 111.52 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.62 ' HB2' ' NE ' ' A' ' 320' ' ' ARG . 1.4 Cg_endo -82.8 160.49 16.25 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.051 2.5 . . . . 0.0 112.498 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.571 ' O ' ' HB2' ' A' ' 320' ' ' ARG . 47.2 mm -81.1 115.88 24.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.201 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.01 155.47 19.47 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 174.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -113.08 140.73 47.62 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.987 0.422 . . . . 0.0 111.29 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.39 25.63 27.57 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -160.12 158.58 30.53 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -68.97 -22.28 64.12 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.247 0.546 . . . . 0.0 110.894 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 119.95 45.14 0.43 Allowed Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.695 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -119.31 -74.69 0.6 Allowed 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 9.4 p -94.61 -66.82 0.89 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.328 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 57.5 tp 67.57 98.01 0.06 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.199 0.6 . . . . 0.0 110.903 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.8 pt -88.61 149.65 44.6 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.804 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.06 128.41 21.71 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.479 2.119 . . . . 0.0 111.138 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -142.28 -85.01 0.17 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.864 0.364 . . . . 0.0 111.095 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -100.56 18.25 19.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.311 0.577 . . . . 0.0 110.373 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -84.02 15.33 3.48 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.059 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.49 -19.18 64.52 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.616 HG21 ' HA ' ' A' ' 219' ' ' THR . 96.9 mt -59.01 -36.82 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.902 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.32 -30.48 70.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.431 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.4 ' HA ' ' HG3' ' A' ' 288' ' ' ARG . 3.5 m-20 -70.59 -40.8 73.04 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.466 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -64.89 -47.04 79.22 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.645 178.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.602 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 39.0 t -58.12 -44.06 86.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.042 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.74 -34.61 73.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.361 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.31 -44.67 80.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.011 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.415 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -82.02 -15.01 55.09 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.798 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.7 mt -79.83 -28.09 40.16 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 290' ' ' VAL . 54.9 mtpt -81.47 -18.22 45.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.216 175.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.5 -38.08 80.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.723 176.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.513 ' HB3' HD11 ' A' ' 211' ' ' LEU . 29.1 t -135.18 72.87 65.91 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.568 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 65.0 Cg_endo -72.69 2.25 5.48 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.948 2.432 . . . . 0.0 113.165 -177.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.13 -29.84 54.89 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.811 0.815 . . . . 0.0 109.285 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -77.57 135.86 38.21 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.526 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.86 142.26 27.96 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.5 m -114.83 131.38 67.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.134 0.493 . . . . 0.0 111.213 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.2 m -107.86 110.16 21.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.323 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.0 mt -93.07 109.43 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -98.13 128.47 44.65 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.537 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.405 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -110.47 145.9 17.32 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.496 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 28.5 m-85 -127.27 162.17 26.85 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.82 0.343 . . . . 0.0 110.309 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 59.2 p -138.75 173.68 11.32 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.618 177.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.14 147.34 34.62 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -79.2 3.15 18.63 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.39 -18.69 32.97 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.304 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -73.47 168.1 54.04 Favored Glycine 0 C--O 1.24 0.49 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.492 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 45.8 m -69.08 127.32 32.71 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 120.849 0.357 . . . . 0.0 111.365 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -59.83 115.86 3.69 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.579 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 119.85 -35.49 3.8 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.031 -1.081 . . . . 0.0 111.984 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 43.6 mm -83.67 -28.11 7.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.828 0.823 . . . . 0.0 108.811 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.41 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 76.5 m-20 -63.37 -34.92 78.77 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.197 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.453 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 29.7 mm -56.44 -65.68 1.51 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.764 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.453 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 21.0 Cg_endo -61.83 -28.19 81.26 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 121.95 1.767 . . . . 0.0 111.964 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.3 -55.75 16.54 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.738 0.304 . . . . 0.0 111.168 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 261' ' ' THR . 6.2 p -62.3 -31.08 71.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.706 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.63 -28.22 65.73 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.305 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.474 ' O ' HG13 ' A' ' 280' ' ' ILE . 41.1 tp60 -76.39 -40.87 49.74 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -61.67 -41.82 98.07 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.498 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.27 -32.99 74.93 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.059 0.457 . . . . 0.0 110.214 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.528 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.9 tmtt? -64.72 -36.06 83.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.387 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 276' ' ' GLN . 53.0 mt -57.15 -42.42 79.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.034 0.445 . . . . 0.0 110.228 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.692 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 7.2 t -68.72 -47.15 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.057 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.77 -43.38 80.77 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.95 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -57.25 -42.11 80.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.419 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 1.5 m-85 -65.1 -52.05 57.71 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.511 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 33.8 mt -55.23 -50.72 68.72 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.591 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 77.6 t -60.71 -40.38 84.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.621 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.18 -23.54 67.48 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.232 0.539 . . . . 0.0 110.733 178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.539 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 4.5 mmp_? -88.93 5.03 45.95 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.228 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 98.06 12.67 45.36 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 119.93 -1.128 . . . . 0.0 114.109 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 248' ' ' LYS . 48.5 t -88.61 145.95 6.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 117.604 0.702 . . . . 0.0 109.48 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -71.34 111.57 6.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.47 -34.84 77.07 Favored Glycine 0 N--CA 1.46 0.235 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.264 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.38 -18.41 65.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.242 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -101.64 -0.03 35.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.162 0.506 . . . . 0.0 110.364 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 66.5 mt -106.38 132.57 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.87 126.41 51.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.691 0.281 . . . . 0.0 110.726 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.528 HG21 ' HA ' ' A' ' 279' ' ' LYS . 53.0 p -104.98 121.14 43.14 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.14 113.18 35.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.256 0.551 . . . . 0.0 112.241 -175.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.9 103.72 3.04 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 24.5 mt -87.69 -0.24 56.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.47 -138.73 36.4 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.662 -176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 7.8 p -84.27 114.3 21.74 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 120.728 0.299 . . . . 0.0 110.285 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.0 p -174.9 148.45 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 55.6 t30 64.08 75.03 0.4 Allowed Pre-proline 0 C--N 1.31 -1.128 0 O-C-N 123.712 0.633 . . . . 0.0 110.862 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.612 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 5.2 Cg_endo -80.87 133.61 9.17 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 122.305 2.003 . . . . 0.0 112.6 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.8 tt -94.37 -48.36 13.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.205 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -123.92 176.78 6.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.725 0.298 . . . . 0.0 111.025 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.43 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 47.8 m -66.39 128.08 34.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.43 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -80.54 -12.25 59.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.648 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.86 -18.32 63.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.956 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.479 HG23 ' H ' ' A' ' 314' ' ' GLY . 5.2 t -116.39 144.23 32.69 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.858 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.49 -37.36 71.35 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.627 2.218 . . . . 0.0 111.894 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 1.8 mt-10 -58.96 -41.19 86.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.278 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.479 ' H ' HG23 ' A' ' 311' ' ' THR . . . -69.82 -40.3 75.35 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.859 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -60.24 -36.38 77.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.887 0.375 . . . . 0.0 110.253 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.8 -30.01 71.15 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.645 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 11.8 mmtp -80.64 -44.4 18.91 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.612 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 44.6 m-80 -61.66 -28.09 69.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 10.7 ptm85 -84.91 11.47 9.3 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.62 ' NE ' ' HB2' ' A' ' 222' ' ' PRO . 9.2 ptm180 -73.57 -178.0 2.91 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 99.6 t -135.18 151.76 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.866 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.473 ' HG2' ' HB3' ' A' ' 222' ' ' PRO . 43.1 mt-10 -131.72 142.05 49.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.843 0.354 . . . . 0.0 110.971 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.45 116.02 41.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.39 141.96 24.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.46 135.41 36.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 57.7 t30 . . . . . 0 C--N 1.313 -0.995 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.406 -179.811 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.198 0 N-CA-C 111.726 -0.549 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.85 20.11 15.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.829 0.347 . . . . 0.0 110.438 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 71.29 83.85 0.14 Allowed Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.378 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -84.12 146.59 11.4 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.715 2.277 . . . . 0.0 112.076 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.99 176.1 8.59 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.632 2.222 . . . . 0.0 111.249 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.05 -70.24 1.23 Allowed Glycine 0 C--N 1.314 -0.672 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.307 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.66 168.48 21.31 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.742 2.294 . . . . 0.0 111.547 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -63.51 106.02 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.414 2.076 . . . . 0.0 111.335 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.486 ' HB1' ' HB3' ' A' ' 212' ' ' GLN . . . -106.42 -5.35 19.01 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.719 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 70.1 m -153.06 152.85 31.8 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.266 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -105.44 -106.06 3.09 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.487 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.03 32.91 0.52 Allowed 'Trans proline' 0 N--CA 1.476 0.475 0 C-N-CA 123.234 2.622 . . . . 0.0 112.299 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 37.1 t -151.86 165.49 34.36 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.764 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -57.55 167.95 0.94 Allowed 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.775 0.43 . . . . 0.0 110.86 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.62 71.94 3.25 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.027 0.441 . . . . 0.0 110.035 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 250' ' ' CYS . 29.9 mt -70.22 -31.09 68.36 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.603 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.486 ' HB3' ' HB1' ' A' ' 204' ' ' ALA . 21.5 tt0 -65.39 -41.61 93.53 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.53 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.5 t -71.73 -37.11 70.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.91 -51.02 66.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.206 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.472 ' CG2' HG13 ' A' ' 243' ' ' VAL . 26.6 pt -67.63 -38.09 79.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.685 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.46 -36.25 73.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.115 0.484 . . . . 0.0 110.496 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.28 -26.02 68.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.574 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.7 t -91.87 -47.81 13.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.552 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.553 ' HA ' HG21 ' A' ' 239' ' ' ILE . 72.7 p -64.76 -39.75 94.14 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.878 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.12 15.22 79.23 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 140.99 -139.22 9.43 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.87 166.43 13.2 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.601 2.201 . . . . 0.0 112.559 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.0 mm -81.3 109.58 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.538 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -99.49 124.57 44.77 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.934 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -94.03 174.44 7.16 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.268 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -64.87 167.91 29.39 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.078 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -62.53 -29.48 70.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.701 0.286 . . . . 0.0 111.514 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -140.71 141.55 34.94 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -81.2 40.35 2.54 Favored Glycine 0 C--N 1.317 -0.474 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.682 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -54.22 -57.04 12.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.897 0.379 . . . . 0.0 111.276 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 11.0 p -162.06 113.56 1.66 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.051 0.453 . . . . 0.0 111.289 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 18.2 tp -95.04 18.65 11.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.641 0.734 . . . . 0.0 109.098 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 62.6 mt -61.75 -48.68 88.95 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.217 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 233' ' ' ILE . 5.5 Cg_endo -48.02 127.39 14.79 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.529 2.153 . . . . 0.0 112.125 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -80.25 87.57 5.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.214 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -122.08 -27.05 4.63 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.723 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -77.06 57.51 1.38 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.176 0.513 . . . . 0.0 111.587 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.94 -18.93 65.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.497 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 219' ' ' THR . 75.3 mt -59.97 -38.41 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.638 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 62.8 mt -67.85 -28.32 67.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.709 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -74.99 -36.8 61.98 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.478 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -65.9 -43.13 89.14 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.899 176.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.589 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 40.1 t -61.65 -46.18 97.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.818 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.53 -37.07 69.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.305 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 15.0 t70 -49.8 -50.49 44.74 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.461 ' HB2' HD22 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -83.14 -14.42 53.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.382 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 33.9 mt -81.37 -29.49 34.0 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.528 ' HG3' HG22 ' A' ' 290' ' ' VAL . 62.1 mtpt -82.32 -22.27 35.69 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.506 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -71.75 -32.09 67.34 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.06 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.502 ' HB3' HD11 ' A' ' 211' ' ' LEU . 42.2 t -132.65 70.78 79.19 Favored Pre-proline 0 N--CA 1.434 -1.24 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.439 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 82.1 Cg_endo -74.09 2.5 6.03 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.165 2.577 . . . . 0.0 113.194 -177.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -75.26 -25.26 57.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.866 0.841 . . . . 0.0 109.597 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -77.51 169.82 17.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.603 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -122.44 144.9 48.76 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.375 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.67 125.47 74.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.296 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 41.9 m -103.1 108.6 19.85 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.92 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.414 HG12 HG23 ' A' ' 323' ' ' ILE . 21.2 mt -96.36 108.79 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.84 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.61 128.4 45.71 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.856 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.419 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -106.9 148.1 16.34 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.565 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 318' ' ' ASN . 24.7 m-85 -124.4 162.82 23.06 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.854 0.359 . . . . 0.0 110.39 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 274' ' ' SER . 72.2 p -144.69 172.2 13.33 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.15 170.95 13.28 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -94.52 17.23 13.54 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 70.8 p -65.14 -27.45 68.74 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.925 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.14 73.55 0.35 Allowed Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.684 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 45.2 m -86.63 24.1 1.51 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.777 0.323 . . . . 0.0 111.184 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -95.25 3.98 53.99 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.694 -0.403 . . . . 0.0 111.81 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' GLY . . . . . 0.53 ' O ' ' HD2' ' A' ' 272' ' ' PRO . . . 122.91 -39.72 2.18 Favored Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 119.532 -1.318 . . . . 0.0 114.289 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.8 mp -56.39 -23.88 17.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 122.844 0.458 . . . . 0.0 112.178 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.514 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 8.4 p30 -57.92 -38.44 75.89 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.771 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.425 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 23.0 mm -59.55 -64.53 2.89 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.754 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' A' ' 268' ' ' GLY . 11.6 Cg_endo -59.98 -26.57 82.76 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 121.905 1.736 . . . . 0.0 112.073 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 59.0 tp -68.68 -54.22 17.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 111.227 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.52 ' HB3' HG23 ' A' ' 261' ' ' THR . 5.8 p -63.71 -31.53 72.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.515 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.36 67.71 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.959 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.516 ' O ' HG13 ' A' ' 280' ' ' ILE . 24.5 tp60 -70.56 -47.31 60.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.579 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -61.36 -40.04 92.85 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.393 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.95 92.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.176 0.512 . . . . 0.0 109.816 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.442 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.5 tptt -61.49 -35.46 77.75 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.939 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 276' ' ' GLN . 59.8 mt -57.49 -44.31 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.017 0.437 . . . . 0.0 110.369 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.722 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.5 t -68.4 -46.28 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.746 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.6 -45.21 73.6 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -61.15 -37.79 84.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.937 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.515 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 2.0 m-85 -66.63 -44.05 83.04 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.074 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 39.1 mt -64.87 -51.16 63.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.795 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 84.4 t -60.23 -38.77 78.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.298 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.68 -31.13 71.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.288 0.566 . . . . 0.0 110.287 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 19.9 mmm180 -84.86 4.95 30.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.489 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.61 46.86 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.352 -0.928 . . . . 0.0 114.094 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.528 HG22 ' HG3' ' A' ' 248' ' ' LYS . 66.7 t -84.77 140.73 15.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 117.752 0.776 . . . . 0.0 109.026 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.72 108.11 2.81 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.639 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.38 -30.07 67.34 Favored Glycine 0 CA--C 1.509 -0.302 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.968 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.85 -21.18 64.45 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.537 0.335 . . . . 0.0 111.748 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -106.9 5.58 28.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.408 HD11 ' CG1' ' A' ' 290' ' ' VAL . 68.6 mt -106.23 128.45 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.42 127.59 53.81 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.25 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.442 HG21 ' HA ' ' A' ' 279' ' ' LYS . 31.7 p -111.99 124.87 53.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.689 0.28 . . . . 0.0 110.683 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.79 121.25 52.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.093 0.473 . . . . 0.0 111.822 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -90.77 112.13 4.05 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 26.1 mt -90.45 -32.07 16.54 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 88.75 -140.13 15.76 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 47.2 t -88.62 114.27 25.07 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.501 HG13 ' H ' ' A' ' 304' ' ' ASN . 3.4 p -142.94 -61.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.852 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.501 ' H ' HG13 ' A' ' 303' ' ' VAL . 12.8 m120 -115.33 92.08 30.83 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.715 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 8.3 Cg_exo -67.98 127.82 16.69 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.803 2.336 . . . . 0.0 112.81 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.8 tt -85.74 -44.28 16.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.614 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -127.4 167.03 16.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.469 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 53.8 p -63.34 133.0 53.38 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.506 0.504 . . . . 0.0 111.104 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -80.84 -8.43 59.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.949 0.404 . . . . 0.0 110.651 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -62.69 -23.62 67.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.687 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 1.5 t -117.11 140.77 27.5 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 311' ' ' THR . 24.6 Cg_exo -55.99 -35.78 94.99 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.82 2.347 . . . . 0.0 111.332 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -57.65 -47.01 83.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.853 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -63.43 -38.47 96.43 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.844 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -60.57 -37.19 80.49 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.16 -30.81 71.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.699 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 317' ' ' LYS . 12.7 mmtp -76.16 -41.96 48.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.08 0.467 . . . . 0.0 109.927 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.715 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 43.7 m-80 -61.75 -28.29 69.33 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 11.8 ptp180 -81.4 9.38 7.36 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -57.5 177.6 0.1 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.07 0.938 . . . . 0.0 113.341 174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 74.8 t -136.07 144.96 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.577 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -127.74 140.77 51.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.729 0.299 . . . . 0.0 111.057 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.414 HG23 HG12 ' A' ' 257' ' ' ILE . 1.4 mp -103.93 117.17 49.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.17 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.62 132.66 53.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.074 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.68 130.48 40.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.316 0.579 . . . . 0.0 111.234 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 254' ' ' ARG . 27.9 t-20 . . . . . 0 C--N 1.309 -1.17 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.314 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.206 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -92.87 -11.77 32.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.967 0.413 . . . . 0.0 110.921 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.19 137.16 89.18 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.391 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -53.41 132.16 47.12 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.724 2.282 . . . . 0.0 111.212 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.5 103.31 1.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.508 2.138 . . . . 0.0 112.473 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -122.16 -121.84 2.77 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.192 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.54 153.47 65.33 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.617 2.212 . . . . 0.0 112.021 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.74 139.2 73.65 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.487 2.125 . . . . 0.0 111.525 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.45 -35.84 68.37 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.116 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.0 t 54.45 -154.27 0.27 Allowed 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.336 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 98.16 -176.72 30.71 Favored Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.48 110.33 2.47 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.171 1.914 . . . . 0.0 111.09 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.8 t -104.07 141.04 36.91 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.39 162.46 10.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.563 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.34 85.73 2.5 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.596 ' HB2' HG21 ' A' ' 325' ' ' VAL . 23.4 mt -75.22 -34.57 61.47 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.447 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -62.62 -44.95 95.01 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 120.922 0.391 . . . . 0.0 110.061 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 36.2 t -65.49 -43.05 91.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.163 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.539 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -64.44 -47.03 80.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.927 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 211' ' ' LEU . 17.7 pt -69.37 -38.04 76.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.467 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -60.25 -37.81 81.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.099 0.476 . . . . 0.0 110.023 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.82 -27.66 67.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.039 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.771 HG12 HG23 ' A' ' 239' ' ' ILE . 43.1 t -83.01 -47.78 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 CA-C-O 121.069 0.461 . . . . 0.0 110.056 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.68 ' HA ' HG21 ' A' ' 239' ' ' ILE . 37.9 p -66.13 -35.25 79.98 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.017 -178.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.83 28.05 57.54 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 121.8 -132.24 8.86 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 114.54 -0.83 . . . . 0.0 111.192 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -89.34 169.25 5.0 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.734 2.289 . . . . 0.0 113.308 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.8 mm -85.67 105.18 14.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.196 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -91.57 134.82 34.34 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.906 0.384 . . . . 0.0 111.371 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -105.53 169.96 8.16 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.924 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -110.18 133.1 11.38 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.083 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -94.71 -5.24 45.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.739 0.27 . . . . 0.0 110.862 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -54.6 -63.03 1.28 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.009 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -115.05 7.87 21.36 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 65.82 171.65 0.23 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.607 0.763 . . . . 0.0 111.583 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.7 t 58.23 -155.62 0.34 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.314 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 36.3 tp -92.96 110.79 22.26 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.37 -56.57 25.97 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.751 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.95 158.28 52.33 Favored 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 121.714 1.609 . . . . 0.0 111.146 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -70.33 -29.81 66.61 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.829 0.347 . . . . 0.0 111.247 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -151.34 177.52 10.18 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -133.63 105.0 6.62 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.471 ' HA ' ' OD1' ' A' ' 241' ' ' ASN . 32.1 mt-10 -52.35 -38.61 59.18 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.169 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.771 HG23 HG12 ' A' ' 218' ' ' VAL . 82.8 mt -61.86 -37.62 78.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.694 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.1 mt -71.97 -21.63 61.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.471 ' OD1' ' HA ' ' A' ' 238' ' ' GLU . 3.7 m120 -76.84 -41.74 43.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.745 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -66.95 -42.82 84.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.954 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.622 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.4 t -58.35 -40.92 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.486 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.48 -36.83 76.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.317 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 3.5 t70 -48.54 -52.35 23.09 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.657 0.783 . . . . 0.0 112.813 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.545 ' HB3' ' NZ ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -81.01 -17.75 49.24 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.668 -176.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 36.2 mt -79.14 -30.81 43.81 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.241 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.546 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 52.3 mtpt -82.63 -18.78 39.92 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.563 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.57 85.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.438 0.637 . . . . 0.0 110.01 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.548 ' HB3' HD11 ' A' ' 211' ' ' LEU . 49.9 t -128.98 69.06 80.62 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 74.3 Cg_endo -72.08 -1.29 9.82 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.416 2.744 . . . . 0.0 114.715 -173.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.45 -23.76 29.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.558 0.694 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.98 141.01 58.34 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.4 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -96.31 136.55 36.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.462 HG12 HG22 ' A' ' 325' ' ' VAL . 5.9 m -113.53 137.24 47.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 121.191 0.52 . . . . 0.0 111.685 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.7 m -113.43 109.0 17.97 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.187 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.7 mt -91.92 112.47 25.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -99.41 130.98 45.72 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.843 -176.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.547 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -107.3 145.43 16.05 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 9.2 m-85 -123.26 171.73 9.16 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 302' ' ' SER . 10.0 t -175.3 174.18 2.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.798 0.332 . . . . 0.0 110.765 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -86.31 166.97 15.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.199 0.523 . . . . 0.0 111.358 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -115.9 6.56 14.26 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.619 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 55.3 p -70.55 -11.39 60.9 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.06 -74.75 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.211 -1.471 . . . . 0.0 114.08 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 50.6 m -80.92 100.14 8.74 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -175.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -83.13 138.7 33.56 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 80.01 -57.25 4.59 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.214 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.33 -20.95 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 123.736 0.814 . . . . 0.0 111.126 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.423 ' HB2' ' CG2' ' A' ' 261' ' ' THR . 9.5 p30 -57.89 -31.55 66.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.526 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.461 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 24.8 mm -62.31 -65.49 2.11 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.567 176.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.461 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.0 Cg_endo -57.54 -30.82 89.76 Favored 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 121.821 1.68 . . . . 0.0 111.807 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 40.1 tp -61.96 -56.64 17.06 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.169 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.547 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.5 p -63.41 -27.28 69.19 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.965 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.98 -30.05 62.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.28 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -49.2 65.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 48.0 mmt-85 -59.49 -37.14 77.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.296 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.47 -34.86 79.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.01 0.434 . . . . 0.0 110.539 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.709 ' HA ' HG21 ' A' ' 297' ' ' THR . 0.3 OUTLIER -68.06 -30.74 70.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.441 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 57.5 mt -60.13 -45.37 95.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.956 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.693 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 10.5 t -65.62 -45.14 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.788 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -53.15 -44.84 68.1 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.776 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.17 -43.12 87.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.51 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.446 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 4.4 m-85 -66.17 -41.07 90.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.139 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.693 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 27.0 mt -67.6 -47.2 70.38 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.739 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 282' ' ' ALA . 94.5 t -60.55 -41.48 87.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.36 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.8 -26.69 68.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.303 0.573 . . . . 0.0 110.515 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.446 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 2.7 mpt_? -86.95 4.98 39.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.426 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.64 8.42 49.05 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.043 -1.075 . . . . 0.0 114.4 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 63.0 t -85.29 143.68 11.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.448 ' O ' HG13 ' A' ' 295' ' ' ILE . . . -69.91 106.72 3.28 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.829 0.347 . . . . 0.0 111.421 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.55 -31.45 77.73 Favored Glycine 0 CA--C 1.503 -0.703 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.304 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.62 -17.47 64.61 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.734 0.302 . . . . 0.0 110.946 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -105.05 3.85 30.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.525 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 291' ' ' ALA . 67.5 mt -105.49 131.18 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -121.57 128.84 52.41 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.291 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.709 HG21 ' HA ' ' A' ' 279' ' ' LYS . 56.1 p -107.73 128.57 54.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.401 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 95.6 t -134.98 132.18 53.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.118 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -102.08 117.56 5.86 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 23.6 mt -91.56 -7.33 50.55 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.401 ' HA3' ' OD1' ' A' ' 270' ' ' ASN . . . 68.64 -136.93 29.97 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.445 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 261' ' ' THR . 7.3 p -74.52 97.76 3.2 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 120.927 0.394 . . . . 0.0 110.73 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.2 t -152.94 130.81 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.935 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 52.22 77.59 0.44 Allowed Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 123.786 0.679 . . . . 0.0 112.47 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.411 ' HB3' ' OD1' ' A' ' 318' ' ' ASN . 5.9 Cg_exo -74.46 171.65 17.69 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.468 2.112 . . . . 0.0 112.394 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.7 -55.72 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.592 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.456 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -110.22 171.36 7.5 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.881 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 24.7 m -62.39 134.76 56.9 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 123.553 0.533 . . . . 0.0 111.261 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -81.31 -8.36 59.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.469 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.15 -10.38 59.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.001 0.429 . . . . 0.0 111.366 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 314' ' ' GLY . 2.4 t -118.0 143.54 32.92 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.317 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.03 -31.06 56.06 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.22 1.946 . . . . 0.0 111.37 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 2.8 mt-10 -70.83 -35.4 72.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.779 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 307' ' ' ALA . . . -72.49 -40.19 54.85 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.82 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -65.2 -31.91 73.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.11 -26.73 68.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.107 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.498 ' HA ' ' HD3' ' A' ' 317' ' ' LYS . 10.6 mmtp -87.16 -37.07 17.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.806 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 305' ' ' PRO . 0.9 OUTLIER -62.35 -25.85 68.12 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 14.3 ptp180 -87.75 17.2 4.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.248 0.547 . . . . 0.0 111.556 -178.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -57.42 170.69 0.5 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.244 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 87.1 t -133.16 146.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.447 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -132.03 137.02 47.67 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.044 0.449 . . . . 0.0 110.788 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.441 ' HB ' HD12 ' A' ' 215' ' ' ILE . 2.9 mp -93.07 117.19 35.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.722 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 44.6 t -113.35 143.87 22.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 211' ' ' LEU . 46.9 t -106.06 140.29 24.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.0 t30 . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.306 -179.615 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.226 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -73.32 143.69 46.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.794 0.297 . . . . 0.0 110.284 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . . . 70.39 128.19 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 123.572 0.749 . . . . 0.0 111.853 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 198' ' ' ALA . 38.9 Cg_exo -62.34 152.55 76.04 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.808 2.339 . . . . 0.0 112.066 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.13 117.0 3.66 Favored 'Trans proline' 0 C--O 1.241 0.639 0 C-N-CA 122.839 2.359 . . . . 0.0 112.712 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -143.9 -76.58 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.906 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.02 170.96 14.65 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.751 2.301 . . . . 0.0 111.213 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.66 140.31 83.92 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.295 1.997 . . . . 0.0 111.04 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -93.36 -47.81 6.71 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.381 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.0 m 58.6 88.33 0.07 Allowed 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 122.926 0.49 . . . . 0.0 111.678 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 177.0 -87.0 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.837 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.43 -44.63 42.38 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 123.542 2.828 . . . . 0.0 112.829 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 14.3 t -153.14 -177.28 6.2 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.57 144.83 56.19 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.411 0.445 . . . . 0.0 110.158 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -75.47 78.99 2.51 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.128 0.489 . . . . 0.0 110.57 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 250' ' ' CYS . 40.1 mt -57.66 -21.59 40.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.246 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -63.44 -45.05 92.7 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 120.966 0.413 . . . . 0.0 109.937 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 36.3 t -73.8 -35.41 64.91 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 211' ' ' LEU . . . -62.57 -47.82 82.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.444 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 211' ' ' LEU . 18.8 pt -72.24 -39.93 64.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.396 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.449 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 12.3 t-20 -61.25 -28.75 69.39 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.128 0.489 . . . . 0.0 110.755 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.88 69.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.983 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.506 HG11 ' HG3' ' A' ' 242' ' ' ARG . 2.5 t -93.37 -41.63 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.199 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.588 ' HA ' HG21 ' A' ' 239' ' ' ILE . 80.9 p -65.11 -36.52 84.56 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.251 0.548 . . . . 0.0 110.266 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.22 22.13 63.62 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 130.86 -125.2 4.44 Favored Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.14 162.27 5.77 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 122.499 2.133 . . . . 0.0 112.044 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.9 mm -73.46 111.14 7.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.756 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -83.45 147.22 27.96 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.865 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -119.36 148.32 43.33 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.563 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -82.14 70.65 3.1 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -79.18 -8.98 59.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -173.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.413 ' HB3' ' CD1' ' A' ' 233' ' ' ILE . 14.7 t70 -56.04 -43.25 77.67 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.966 0.412 . . . . 0.0 110.529 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -98.31 3.33 59.76 Favored Glycine 0 N--CA 1.453 -0.188 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 70.86 -56.57 0.62 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.627 1.171 . . . . 0.0 112.363 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.1 m -81.68 36.46 0.44 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 63.6 104.94 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.413 ' CD1' ' HB3' ' A' ' 228' ' ' ASP . 48.2 pt -105.25 158.26 32.55 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.59 127.14 24.17 Favored 'Trans proline' 0 C--O 1.24 0.583 0 C-N-CA 122.425 2.083 . . . . 0.0 112.238 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -152.3 -71.18 0.15 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.033 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 237' ' ' TYR . 4.9 p-10 -118.06 -75.96 0.58 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.791 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.448 ' H ' ' CG ' ' A' ' 236' ' ' ASP . 59.4 t80 71.47 -51.94 0.69 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.914 0.886 . . . . 0.0 112.432 176.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -57.96 -20.53 38.59 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.588 HG21 ' HA ' ' A' ' 219' ' ' THR . 58.1 mt -65.34 -36.15 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.499 ' CD2' HG13 ' A' ' 281' ' ' VAL . 41.0 mt -64.96 -35.62 81.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.492 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -71.54 -39.86 70.43 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.506 ' HG3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -64.19 -48.66 75.07 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.037 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.632 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 55.2 t -55.47 -42.69 68.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.196 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.88 -37.51 87.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.936 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -52.49 -49.45 64.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.501 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -73.94 -29.42 62.01 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 119.491 -0.883 . . . . 0.0 111.292 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 24.5 mt -69.75 -27.78 65.23 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 121.614 0.721 . . . . 0.0 109.254 176.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -68.38 -33.9 75.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.549 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.96 70.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.439 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.516 ' HB3' HD11 ' A' ' 211' ' ' LEU . 52.1 t -126.16 72.5 71.23 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.78 -0.79 9.44 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.99 2.46 . . . . 0.0 113.074 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.55 -30.05 59.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.521 0.676 . . . . 0.0 109.271 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.58 135.98 50.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.652 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.555 ' HB2' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -91.44 145.07 24.93 Favored 'General case' 0 CA--C 1.479 -1.758 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.745 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.0 m -120.43 125.38 74.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.896 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 54.9 m -101.35 108.87 20.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.469 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 323' ' ' ILE . 22.3 mt -94.92 112.19 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.109 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -103.48 124.34 48.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.109 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -103.65 163.62 15.46 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.352 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 32.4 m-85 -136.15 159.55 41.38 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.014 0.435 . . . . 0.0 110.63 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 63.2 p -141.3 164.87 29.07 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.51 156.23 29.39 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.969 0.414 . . . . 0.0 110.695 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 266' ' ' SER . 9.3 p30 -89.81 2.23 55.19 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.68 -18.19 58.58 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.17 0.51 . . . . 0.0 111.162 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -142.29 46.22 0.88 Allowed Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.401 ' HB2' ' HA ' ' A' ' 263' ' ' ASN . 8.5 t -84.85 122.41 29.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -176.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -160.98 -46.02 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 176.1 -26.98 0.07 OUTLIER Glycine 0 CA--C 1.499 -0.965 0 C-N-CA 119.912 -1.137 . . . . 0.0 113.026 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 35.1 mm -73.12 -20.37 18.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.736 0.779 . . . . 0.0 109.599 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 1.6 m120 -63.21 -36.97 85.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.607 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.439 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.3 mm -56.27 -65.24 1.68 Allowed Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.829 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.439 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 27.0 Cg_endo -63.24 -25.12 72.12 Favored 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 122.159 1.906 . . . . 0.0 112.277 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.521 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 53.8 tp -69.78 -52.24 26.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.001 0.429 . . . . 0.0 110.019 177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.444 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 10.1 t -57.5 -39.71 77.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.019 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.63 78.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.803 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.459 ' O ' HG13 ' A' ' 280' ' ' ILE . 6.5 tp-100 -68.08 -46.89 69.75 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.59 0.71 . . . . 0.0 109.703 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 67.3 mtp85 -59.7 -44.8 93.54 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.241 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.53 84.02 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.16 0.505 . . . . 0.0 110.182 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.631 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.5 tmtt? -64.22 -30.48 71.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.69 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 276' ' ' GLN . 62.2 mt -57.2 -41.37 77.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.977 0.417 . . . . 0.0 109.963 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.747 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 13.8 t -69.77 -47.91 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.868 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.09 -43.73 78.32 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.908 0.385 . . . . 0.0 110.919 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.1 -38.69 80.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.3 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.535 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 3.9 m-85 -72.83 -40.55 65.69 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.315 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 44.5 mt -64.18 -48.32 76.38 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 86.3 t -60.32 -39.66 81.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.1 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.43 -23.75 67.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.207 0.527 . . . . 0.0 110.895 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 5.0 mmp_? -89.02 2.9 53.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.394 178.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 97.83 13.14 44.51 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.203 -0.999 . . . . 0.0 114.053 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 62.0 t -87.63 139.96 16.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 117.514 0.657 . . . . 0.0 109.328 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.9 113.5 3.88 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.195 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -66.83 -11.27 57.51 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.893 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.71 -11.91 54.88 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 120.869 0.366 . . . . 0.0 110.224 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -110.23 2.25 19.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.736 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 57.7 mt -107.41 123.69 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -115.67 127.57 55.27 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.592 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 279' ' ' LYS . 47.5 p -104.89 126.28 51.79 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.39 113.04 30.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.305 0.574 . . . . 0.0 112.252 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.444 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -89.11 105.02 3.15 Favored Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.504 175.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 21.0 mt -94.06 1.4 56.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.665 0.269 . . . . 0.0 110.922 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.77 -128.08 42.31 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.539 -175.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 43.0 p -97.67 123.43 41.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.523 ' O ' ' HD3' ' A' ' 305' ' ' PRO . 3.5 p -150.21 -60.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.453 ' H ' HG13 ' A' ' 303' ' ' VAL . 90.6 m-20 -112.32 94.07 25.14 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-O 120.906 0.384 . . . . 0.0 110.039 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 303' ' ' VAL . 2.7 Cg_exo -70.88 172.77 13.07 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.874 2.383 . . . . 0.0 113.311 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.4 tt -134.13 -48.62 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.685 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -126.25 171.02 11.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.581 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.429 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 14.6 m -65.16 124.48 22.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.072 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -80.06 -8.38 59.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -62.33 -23.31 66.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.25 0.548 . . . . 0.0 110.361 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 314' ' ' GLY . 1.9 t -117.8 140.43 27.67 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.613 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -52.12 -38.32 70.61 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.133 2.555 . . . . 0.0 111.667 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -53.04 -52.27 59.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.715 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.43 ' H ' HG23 ' A' ' 311' ' ' THR . . . -65.61 -37.98 94.16 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.746 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -59.54 -37.51 78.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.37 . . . . 0.0 110.361 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.34 -31.37 72.54 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.386 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.87 -44.36 20.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.23 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -58.7 -26.28 63.74 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 13.4 ptp180 -83.08 11.09 6.77 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -58.34 179.0 0.08 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 121.61 0.719 . . . . 0.0 112.765 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.7 t -140.43 149.09 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.088 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -131.38 147.12 52.53 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.918 0.389 . . . . 0.0 111.003 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.471 HG23 HG12 ' A' ' 257' ' ' ILE . 1.3 mp -109.17 119.81 59.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.057 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.84 134.52 48.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.942 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 91.2 t -94.8 135.21 29.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.501 0.667 . . . . 0.0 112.409 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.555 ' HB3' ' HB2' ' A' ' 254' ' ' ARG . 5.3 t30 . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.257 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.209 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -80.4 105.95 12.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.05 0.452 . . . . 0.0 110.7 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . . . -109.44 133.87 20.7 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.374 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 198' ' ' ALA . 33.9 Cg_exo -62.05 113.85 2.05 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.497 2.131 . . . . 0.0 111.863 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.31 39.86 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.9 2.4 . . . . 0.0 111.976 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 161.4 135.22 1.78 Allowed Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.927 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.83 152.57 32.58 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.473 2.115 . . . . 0.0 111.335 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 205' ' ' SER . 52.1 Cg_exo -56.92 149.0 64.07 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.441 2.094 . . . . 0.0 111.535 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.27 27.34 0.08 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.242 0.544 . . . . 0.0 112.076 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 203' ' ' PRO . 20.1 m -102.76 -3.72 26.02 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.241 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 66.72 70.62 1.07 Allowed Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.805 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.56 -25.12 11.32 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.415 2.076 . . . . 0.0 112.946 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 46.7 t -143.17 155.17 44.49 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.509 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.58 169.08 8.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.162 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -83.18 77.96 9.68 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.459 ' HB2' HG21 ' A' ' 325' ' ' VAL . 29.4 mt -67.34 -29.71 69.33 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.126 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -62.2 -44.32 96.84 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.821 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.0 m -69.25 -36.2 76.91 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.115 0.483 . . . . 0.0 109.769 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.46 -51.08 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.069 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.419 ' CG2' HG13 ' A' ' 243' ' ' VAL . 20.7 pt -68.37 -39.79 81.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.298 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -58.57 -32.11 68.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.861 0.362 . . . . 0.0 110.376 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.26 -32.59 73.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.185 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.528 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.2 t -85.96 -47.93 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 120.779 0.323 . . . . 0.0 110.686 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.504 ' HA ' HG21 ' A' ' 239' ' ' ILE . 58.1 p -62.71 -32.95 74.15 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.384 0.612 . . . . 0.0 110.055 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.52 22.47 47.1 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.95 -127.13 6.39 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.464 ' CB ' ' HD2' ' A' ' 320' ' ' ARG . 71.6 Cg_endo -84.39 164.3 12.76 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.201 1.934 . . . . 0.0 111.738 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 42.1 mm -71.65 98.0 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.573 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -78.8 144.24 35.29 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.719 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -111.44 142.34 43.84 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.853 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.07 -5.61 52.91 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.506 HD21 ' HA ' ' A' ' 232' ' ' LEU . 7.3 p30 -164.56 160.17 19.97 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -108.03 95.05 5.41 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.141 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 76.79 25.53 64.63 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.159 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -117.55 -164.33 0.99 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 33.1 t -74.51 125.97 29.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.784 0.326 . . . . 0.0 110.507 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.506 ' HA ' HD21 ' A' ' 227' ' ' ASN . 6.6 mp -77.54 100.47 6.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.179 0.514 . . . . 0.0 110.652 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.423 ' HB ' ' HD3' ' A' ' 234' ' ' PRO . 63.8 mt -75.72 -46.88 4.07 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.892 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.423 ' HD3' ' HB ' ' A' ' 233' ' ' ILE . 72.5 Cg_exo -51.52 139.9 45.85 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.231 1.954 . . . . 0.0 112.277 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.66 2.31 3.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.582 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.38 -8.68 19.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.42 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -64.88 -22.66 67.03 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.911 0.386 . . . . 0.0 110.484 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -67.34 -20.09 65.54 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.025 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.504 HG21 ' HA ' ' A' ' 219' ' ' THR . 76.9 mt -62.23 -31.94 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.401 HD11 HG13 ' A' ' 281' ' ' VAL . 3.9 mm? -62.21 -32.26 72.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.215 0.531 . . . . 0.0 110.38 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.68 -37.07 36.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.686 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.551 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 0.0 OUTLIER -67.78 -39.93 84.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.414 178.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.552 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 38.6 t -61.21 -37.25 77.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.54 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 248' ' ' LYS . . . -58.23 -38.04 76.07 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.819 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 4.0 t70 -46.46 -49.18 18.64 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.821 0.848 . . . . 0.0 112.938 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -83.73 -18.16 38.79 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.1 mt -84.8 -25.41 28.19 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 289' ' ' GLY . 6.1 tptm -73.88 -29.86 62.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.701 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.87 75.85 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.268 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.458 ' HB3' HD11 ' A' ' 211' ' ' LEU . 45.0 t -133.44 70.81 76.6 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.71 1.81 7.15 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.845 2.363 . . . . 0.0 113.078 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.55 -31.81 57.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.746 0.784 . . . . 0.0 109.14 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.521 ' HB2' ' SG ' ' A' ' 208' ' ' CYS . . . -65.26 145.63 55.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.314 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -99.99 132.82 45.11 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.496 HG12 HG22 ' A' ' 325' ' ' VAL . 6.1 m -115.06 131.16 68.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.236 0.541 . . . . 0.0 111.383 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.5 m -107.35 112.02 24.64 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.734 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.431 HG12 HG23 ' A' ' 323' ' ' ILE . 18.8 mt -92.61 116.03 32.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -107.77 127.49 53.74 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.739 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -99.02 149.83 19.16 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.844 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -131.95 163.02 29.29 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 117.274 0.537 . . . . 0.0 110.171 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 3.1 t -159.08 152.48 22.65 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -62.06 155.17 24.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.161 0.505 . . . . 0.0 111.082 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -90.32 5.09 48.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.05 -175.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 13.0 t -70.18 -13.51 62.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.012 0.434 . . . . 0.0 110.731 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -74.42 171.02 53.31 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 15.9 m -69.05 -83.99 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.933 0.366 . . . . 0.0 110.33 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.408 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 11.7 pt-20 176.01 168.6 0.42 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.935 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' GLY . . . . . 0.413 ' O ' ' HD2' ' A' ' 272' ' ' PRO . . . 78.13 -49.66 3.27 Favored Glycine 0 C--O 1.221 -0.684 0 C-N-CA 121.206 -0.521 . . . . 0.0 114.354 175.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 40.3 mm -75.97 -23.34 16.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.703 0.763 . . . . 0.0 110.223 -174.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.408 ' OD1' ' HA ' ' A' ' 267' ' ' GLU . 0.6 OUTLIER -64.0 -32.78 74.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.477 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.65 -64.26 3.29 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 268' ' ' GLY . 17.8 Cg_endo -61.12 -30.0 88.25 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.237 1.958 . . . . 0.0 111.947 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.539 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 50.9 tp -66.77 -51.33 57.06 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.037 0.446 . . . . 0.0 110.218 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.445 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 13.1 t -56.15 -39.21 71.95 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.263 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.21 -28.54 64.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.075 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -74.21 -44.4 53.38 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.259 0.552 . . . . 0.0 110.096 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 59.8 mtp85 -62.27 -41.0 98.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.997 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.88 -36.11 83.3 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.815 0.341 . . . . 0.0 111.014 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.491 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.6 tptt -59.83 -35.36 74.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.0 mt -55.1 -46.28 77.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.725 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 15.8 t -68.51 -46.22 80.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.653 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.63 -42.78 79.45 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.872 0.367 . . . . 0.0 111.185 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.61 -36.15 77.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.68 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.44 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 3.3 m-85 -74.19 -39.68 63.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.117 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 45.2 mt -65.45 -49.47 68.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.502 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 80.8 t -60.21 -38.13 76.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.163 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.23 70.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.694 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.558 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 3.7 mmp_? -87.23 7.37 28.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.684 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.531 ' O ' ' HE3' ' A' ' 248' ' ' LYS . . . 97.14 10.13 54.97 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.125 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 50.4 t -84.9 139.73 17.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 117.894 0.847 . . . . 0.0 109.547 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.99 111.97 2.74 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.071 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.3 -35.2 83.76 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.097 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.82 -11.87 61.21 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -101.44 -2.64 30.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.06 0.457 . . . . 0.0 109.878 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 64.5 mt -107.4 129.65 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.152 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.21 125.78 51.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.628 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.491 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.6 p -111.1 118.74 36.82 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.045 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 18.6 m -121.56 162.76 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.034 0 CA-C-O 121.224 0.535 . . . . 0.0 111.365 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.445 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -129.11 104.46 0.64 Allowed Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.6 mt -89.44 -31.17 17.84 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.733 0.302 . . . . 0.0 111.615 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 106.7 -122.23 6.9 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.841 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.4 t -104.98 120.12 40.68 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 8.6 p 179.81 152.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 58.3 t30 66.44 79.03 0.24 Allowed Pre-proline 0 C--N 1.314 -0.953 0 O-C-N 123.756 0.66 . . . . 0.0 111.467 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.55 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 73.3 Cg_endo -77.79 149.5 26.4 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.606 2.204 . . . . 0.0 113.136 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.415 HD12 ' HG3' ' A' ' 222' ' ' PRO . 2.9 tt -108.14 -39.16 4.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.32 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.51 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -139.64 174.42 10.54 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.978 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 26.2 m -74.54 129.52 37.9 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.121 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -80.16 -7.66 59.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.587 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -57.39 -19.08 21.02 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.382 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.4 t -127.77 141.33 40.74 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.928 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.87 -21.68 34.36 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.188 2.592 . . . . 0.0 112.399 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.565 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.5 mm-40 -60.04 -46.36 89.77 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.392 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 307' ' ' ALA . . . -65.77 -39.73 95.33 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.14 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -60.53 -37.02 79.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.425 0.631 . . . . 0.0 110.121 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.59 -29.38 66.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.193 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 6.7 mmtp -87.11 -35.86 18.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.307 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 27.9 m-20 -65.47 -15.48 62.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 7.6 ptm180 -88.49 16.2 6.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.558 0.694 . . . . 0.0 111.036 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.464 ' HD2' ' CB ' ' A' ' 222' ' ' PRO . 14.4 ptt180 -63.18 -173.69 0.06 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.422 1.105 . . . . 0.0 113.246 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.84 145.63 25.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.783 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -135.74 145.01 46.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.231 0.539 . . . . 0.0 111.599 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.431 HG23 HG12 ' A' ' 257' ' ' ILE . 1.8 mp -101.37 115.19 42.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.106 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 85.1 t -105.37 136.13 40.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.834 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 255' ' ' VAL . 69.5 t -101.27 136.18 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 48.3 t30 . . . . . 0 C--N 1.311 -1.073 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.92 179.033 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.137 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -119.16 13.85 12.96 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.924 -0.162 . . . . 0.0 110.643 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 61.52 91.88 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.216 0 O-C-N 123.672 0.608 . . . . 0.0 110.24 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.44 117.83 4.23 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.989 2.459 . . . . 0.0 112.366 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.08 84.67 1.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.357 2.038 . . . . 0.0 111.047 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.43 -137.84 16.31 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.88 118.93 5.46 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.222 1.948 . . . . 0.0 111.09 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.62 147.97 77.29 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.316 2.011 . . . . 0.0 112.329 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -75.18 -6.81 51.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.065 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.5 t 73.79 -55.32 0.67 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.752 0.821 . . . . 0.0 111.639 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -145.89 90.72 0.15 Allowed Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.522 -0.846 . . . . 0.0 112.54 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.49 161.59 45.47 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.728 2.286 . . . . 0.0 110.949 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 48.8 t -109.44 156.18 20.38 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.794 0.331 . . . . 0.0 111.096 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -68.58 163.28 23.97 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.014 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.98 82.02 4.35 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.184 0.516 . . . . 0.0 110.244 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.508 ' HB2' HG21 ' A' ' 325' ' ' VAL . 52.9 mt -69.47 -24.76 63.83 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.875 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -68.86 -38.34 79.7 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.415 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 t -76.61 -32.22 57.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -67.84 -49.08 64.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.14 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.504 HG21 HG13 ' A' ' 243' ' ' VAL . 21.8 pt -69.39 -33.39 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.801 -0.181 . . . . 0.0 111.081 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -54.99 -34.17 63.16 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.134 0.492 . . . . 0.0 110.801 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.87 -31.76 72.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.243 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.531 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.5 t -91.81 -48.98 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.883 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.583 ' HA ' HG21 ' A' ' 239' ' ' ILE . 53.7 p -62.73 -43.61 98.35 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.302 0.573 . . . . 0.0 110.776 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.42 19.46 66.41 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.042 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 134.29 -136.95 8.92 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.451 ' HB2' ' HG3' ' A' ' 320' ' ' ARG . 64.5 Cg_endo -82.27 162.39 17.54 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.638 2.226 . . . . 0.0 112.756 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.7 mm -78.58 104.14 6.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.546 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.29 123.78 40.05 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.389 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -88.93 168.85 12.05 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.295 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -61.65 -67.14 2.24 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.655 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -109.05 -78.26 0.59 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -178.94 115.15 0.06 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.767 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 65.07 15.24 60.31 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 116.011 -0.541 . . . . 0.0 113.57 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -101.36 168.29 9.63 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.3 m -58.92 144.74 43.78 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.171 0.51 . . . . 0.0 110.797 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.0 mp -82.32 83.43 7.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.162 0.506 . . . . 0.0 110.633 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.48 ' HB ' ' HD3' ' A' ' 234' ' ' PRO . 60.8 mt -72.55 -48.19 9.3 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.138 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.48 ' HD3' ' HB ' ' A' ' 233' ' ' ILE . 52.2 Cg_exo -55.58 144.76 73.18 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 121.952 1.768 . . . . 0.0 111.673 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -73.35 18.32 0.12 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 234' ' ' PRO . 29.6 t70 -77.61 -17.48 57.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.119 0.485 . . . . 0.0 110.759 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -61.85 -13.69 26.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.036 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -64.72 -21.53 66.77 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.485 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.583 HG21 ' HA ' ' A' ' 219' ' ' THR . 56.8 mt -62.5 -38.28 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 50.6 mt -65.8 -31.61 72.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.796 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -71.4 -38.97 71.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.531 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.2 OUTLIER -65.85 -47.7 74.07 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.829 178.225 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.58 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.7 t -58.26 -45.43 89.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.062 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.415 ' HB1' HG23 ' A' ' 290' ' ' VAL . . . -61.01 -35.81 77.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.692 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -54.49 -47.94 72.43 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -75.26 -29.99 60.34 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.462 -178.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.0 mt -65.64 -34.41 78.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.435 0.635 . . . . 0.0 109.646 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -72.44 -24.7 61.25 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.146 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.84 69.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.049 0.452 . . . . 0.0 110.84 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.479 ' HB3' HD11 ' A' ' 211' ' ' LEU . 35.8 t -125.53 68.88 61.25 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.61 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.07 3.26 5.81 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.075 2.516 . . . . 0.0 113.388 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.91 -32.16 61.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.968 0.89 . . . . 0.0 108.879 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.407 ' HB2' ' SG ' ' A' ' 208' ' ' CYS . . . -74.56 148.04 41.21 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.442 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -101.1 139.42 36.8 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.8 m -115.0 130.01 70.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-O 121.327 0.584 . . . . 0.0 110.835 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.9 m -105.28 110.45 22.82 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.322 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.415 HG12 HG23 ' A' ' 323' ' ' ILE . 23.9 mt -92.8 111.1 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.96 126.31 46.11 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.146 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -105.07 159.02 15.84 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.152 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 301' ' ' GLY . 76.3 m-85 -132.55 165.97 23.16 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.816 0.341 . . . . 0.0 110.775 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.515 HG22 ' NH1' ' A' ' 277' ' ' ARG . 33.2 p -144.55 169.74 17.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.738 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.71 158.62 20.72 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 175.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -76.44 12.73 1.14 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.73 -22.75 3.77 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.06 0.457 . . . . 0.0 111.638 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.52 141.74 13.14 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 7.6 t -57.84 153.54 13.74 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 117.003 0.401 . . . . 0.0 110.418 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.66 156.85 10.18 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.083 0.468 . . . . 0.0 110.669 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 111.4 -52.82 0.61 Allowed Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.026 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.9 mm -84.92 -33.97 8.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 122.119 0.961 . . . . 0.0 108.765 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -61.74 -28.54 69.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.838 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.492 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 33.9 mm -57.26 -65.19 1.88 Allowed Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.432 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.492 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.9 Cg_endo -58.59 -35.45 98.64 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 122.195 1.93 . . . . 0.0 111.979 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 276' ' ' GLN . 54.2 tp -62.72 -53.87 47.79 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.277 0.56 . . . . 0.0 111.028 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.483 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 15.2 t -57.29 -35.59 69.99 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.005 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.35 -22.16 64.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.821 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.479 ' O ' HG13 ' A' ' 280' ' ' ILE . 11.2 tt0 -71.51 -53.1 14.97 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.515 ' NH1' HG22 ' A' ' 261' ' ' THR . 75.9 mtt85 -56.97 -44.14 82.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.62 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.43 77.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.962 0.41 . . . . 0.0 110.814 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.638 ' HA ' HG21 ' A' ' 297' ' ' THR . 11.9 tmtt? -69.37 -30.55 68.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.28 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 276' ' ' GLN . 58.8 mt -59.82 -44.96 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.732 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.7 t -65.99 -48.19 82.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.047 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.77 76.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 120.919 0.39 . . . . 0.0 110.984 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.4 -42.27 91.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.935 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.68 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 5.7 m-85 -68.09 -43.36 78.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.893 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 36.4 mt -63.62 -46.15 87.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.835 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.7 t -61.27 -40.16 85.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.379 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.25 -30.74 71.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.549 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 13.8 mmm180 -81.83 5.07 19.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.472 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.6 2.75 50.1 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.164 -1.017 . . . . 0.0 114.629 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 57.9 t -80.91 145.96 8.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 117.923 0.861 . . . . 0.0 110.573 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.401 ' O ' HG13 ' A' ' 295' ' ' ILE . . . -69.77 108.08 3.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.701 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.41 -33.8 82.56 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.792 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.97 -19.14 64.93 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -103.39 2.41 33.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 291' ' ' ALA . 62.7 mt -104.35 130.36 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.52 127.21 53.77 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.646 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.638 HG21 ' HA ' ' A' ' 279' ' ' LYS . 53.8 p -106.25 119.97 40.63 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 77.2 t -124.25 114.91 43.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.357 0.599 . . . . 0.0 112.103 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.483 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -88.02 107.4 3.31 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.85 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 23.9 mt -94.64 -4.25 48.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.924 0.392 . . . . 0.0 110.43 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 260' ' ' TYR . . . 62.72 -133.07 44.11 Favored Glycine 0 N--CA 1.431 -1.657 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.66 -175.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.4 t -99.69 122.63 42.98 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.2 p -149.25 -56.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.666 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -113.33 93.73 27.96 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.427 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 14.9 Cg_endo -64.19 162.05 31.45 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.834 2.356 . . . . 0.0 112.934 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.493 HG22 ' HA ' ' A' ' 318' ' ' ASN . 4.7 tt -124.34 -53.59 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.874 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.422 ' H ' HG23 ' A' ' 306' ' ' ILE . . . -119.8 171.41 8.43 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 22.2 m -61.91 127.33 30.88 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.564 0.54 . . . . 0.0 110.845 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -79.79 -8.16 59.1 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.015 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.79 -17.37 62.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.699 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.8 t -116.8 138.4 24.59 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.47 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.74 -34.25 97.94 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.921 2.414 . . . . 0.0 111.517 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.6 mm-40 -59.65 -45.92 90.57 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.35 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.436 ' H ' HG23 ' A' ' 311' ' ' THR . . . -68.37 -38.82 87.56 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 311' ' ' THR . 96.7 mtt180 -59.09 -37.31 76.83 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.032 0.444 . . . . 0.0 109.96 176.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.42 -27.72 68.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.57 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 3.3 mmtp -80.93 -41.81 22.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.648 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.493 ' HA ' HG22 ' A' ' 306' ' ' ILE . 39.2 m-80 -60.19 -22.23 62.68 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -93.45 16.25 13.95 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.451 ' HG3' ' HB2' ' A' ' 222' ' ' PRO . 0.0 OUTLIER -66.49 179.24 1.05 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.746 0.784 . . . . 0.0 112.358 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 98.8 t -129.27 143.34 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.504 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -131.61 140.46 49.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 111.378 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 323' ' ' ILE . 1.5 mp -101.4 119.92 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.095 -177.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.49 141.74 27.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.268 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 211' ' ' LEU . 96.0 t -98.38 135.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 67.1 t30 . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.713 -179.503 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.947 0 N-CA-C 111.774 -0.531 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -69.2 -37.66 78.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.574 0.226 . . . . 0.0 110.53 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 65.1 98.95 0.04 OUTLIER Pre-proline 0 C--O 1.237 0.406 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.834 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.503 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 39.6 Cg_exo -62.44 137.18 63.43 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.863 2.375 . . . . 0.0 111.782 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 199' ' ' PRO . 5.1 Cg_exo -77.69 63.22 7.98 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.766 2.31 . . . . 0.0 112.092 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -72.65 159.09 53.5 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.881 -0.675 . . . . 0.0 111.742 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.467 ' HA ' ' HD2' ' A' ' 203' ' ' PRO . 72.7 Cg_exo -49.77 119.38 4.69 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.96 2.44 . . . . 0.0 112.268 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 202' ' ' PRO . 19.7 Cg_endo -59.8 -50.71 7.22 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.964 2.443 . . . . 0.0 112.539 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -82.72 -44.21 15.91 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 26.0 t 66.92 87.07 0.13 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.333 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -127.35 -161.12 10.73 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -50.65 -41.08 54.94 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.932 2.422 . . . . 0.0 111.875 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 10.8 t -137.12 139.65 41.37 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.24 177.59 1.05 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.148 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -87.69 83.09 7.22 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.828 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.5 mm? -69.59 -40.71 76.52 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.167 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -64.14 -40.66 96.65 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.719 0.295 . . . . 0.0 110.861 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 33.5 t -68.35 -44.17 75.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.066 0.46 . . . . 0.0 110.115 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.29 -44.66 87.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.031 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.482 ' CG2' HG13 ' A' ' 243' ' ' VAL . 27.1 pt -69.11 -37.6 76.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.212 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -60.72 -33.02 72.26 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.336 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.49 -25.09 65.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.213 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.426 HG12 HG23 ' A' ' 239' ' ' ILE . 3.3 t -90.25 -43.7 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 110.047 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.6 ' HA ' HG21 ' A' ' 239' ' ' ILE . 71.5 p -68.03 -36.71 80.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.579 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.97 24.68 51.94 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.98 -136.5 9.4 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.84 164.94 20.17 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.374 2.049 . . . . 0.0 112.267 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.7 mm -77.95 104.32 5.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.6 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -93.08 119.9 32.79 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.969 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.94 -170.82 3.03 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.193 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -164.88 -38.8 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.338 -170.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 231' ' ' SER . 76.0 m-20 -82.55 80.17 8.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -122.69 3.52 9.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.76 0.314 . . . . 0.0 111.714 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -92.01 -21.68 32.49 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.115 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -138.83 -90.47 0.2 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.673 0.273 . . . . 0.0 110.683 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.502 ' O ' ' HB3' ' A' ' 227' ' ' ASN . 49.5 m -120.09 137.44 54.13 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 48.5 tp -62.96 -34.37 77.37 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.47 0.481 . . . . 0.0 111.69 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 70.7 mt 67.3 94.9 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.888 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.45 126.81 13.96 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.208 1.938 . . . . 0.0 112.089 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -164.99 -67.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.137 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -88.08 -12.32 44.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.692 0.758 . . . . 0.0 109.121 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -83.93 19.98 1.62 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.353 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.3 -18.41 65.34 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.418 0.627 . . . . 0.0 109.481 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.6 HG21 ' HA ' ' A' ' 219' ' ' THR . 90.3 mt -58.63 -34.57 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.147 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.45 -33.77 76.66 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.213 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.482 ' HA ' ' HG2' ' A' ' 288' ' ' ARG . 44.8 m-20 -71.33 -37.32 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -49.91 57.42 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.82 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.63 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 38.8 t -57.93 -47.65 85.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.413 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.79 -28.18 68.17 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.848 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.92 -40.19 83.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 0.0 111.434 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 243' ' ' VAL . 0.0 OUTLIER -77.88 -26.69 49.38 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.038 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 38.3 mt -66.68 -27.34 67.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.157 0.503 . . . . 0.0 110.307 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 59.0 mtpt -76.65 -17.23 59.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.377 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.91 -30.21 63.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.1 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 8.4 t -137.02 67.79 56.36 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 71.6 Cg_endo -75.44 4.46 4.95 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.354 2.703 . . . . 0.0 114.621 -174.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -78.16 -29.69 48.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.585 0.707 . . . . 0.0 109.474 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.44 136.66 51.85 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.779 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -86.33 138.36 31.88 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.411 HG12 HG22 ' A' ' 325' ' ' VAL . 3.8 m -111.53 126.26 68.91 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.839 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.3 m -104.2 106.57 17.12 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.379 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 323' ' ' ILE . 28.0 mt -92.56 113.21 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.478 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -100.51 129.36 46.45 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.689 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.439 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -108.0 144.38 16.14 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 27.4 m-85 -124.33 161.48 25.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.127 0.489 . . . . 0.0 110.61 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.576 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 72.7 p -147.0 164.22 33.69 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -80.24 164.05 23.53 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.859 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -94.79 -1.62 52.5 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.587 0.708 . . . . 0.0 110.5 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.67 -26.72 20.57 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.52 -69.19 1.41 Allowed Glycine 0 C--O 1.229 -0.179 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.747 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 19.9 m -142.01 -174.24 4.04 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -137.53 125.92 23.38 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 92.99 -45.98 2.47 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.34 -20.64 24.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 123.604 0.762 . . . . 0.0 110.184 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.576 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 0.6 OUTLIER -58.54 -36.81 74.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.199 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.473 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.4 mm -61.17 -63.95 3.7 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.24 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.9 Cg_endo -58.37 -31.68 94.47 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.944 1.763 . . . . 0.0 111.866 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.591 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 62.4 tp -67.4 -54.2 22.49 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.568 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.566 ' HB3' HG23 ' A' ' 261' ' ' THR . 18.5 p -62.48 -29.92 70.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.767 0.318 . . . . 0.0 110.898 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.44 -31.34 69.61 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.412 ' O ' HG13 ' A' ' 280' ' ' ILE . 25.8 tt0 -73.2 -41.28 63.99 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 60.7 mtp85 -61.92 -45.16 94.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.034 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.77 76.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.876 0.37 . . . . 0.0 110.872 176.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.583 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.6 tmtt? -65.94 -30.26 70.81 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.509 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 276' ' ' GLN . 60.6 mt -56.51 -44.21 80.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.23 0.538 . . . . 0.0 109.753 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.686 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.9 t -70.92 -46.54 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.574 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.87 71.01 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.877 0.37 . . . . 0.0 111.184 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -57.71 -43.28 85.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.502 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.503 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 4.8 m-85 -69.58 -38.52 77.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.461 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 41.3 mt -66.38 -46.31 77.13 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.1 -39.37 82.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.488 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.8 -26.75 68.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.295 0.569 . . . . 0.0 110.54 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -85.18 3.52 38.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.69 178.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.34 13.29 39.22 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.129 -1.034 . . . . 0.0 114.364 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.424 HG22 ' HG3' ' A' ' 248' ' ' LYS . 58.5 t -87.95 142.9 12.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 117.716 0.758 . . . . 0.0 109.504 177.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.63 112.8 4.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.433 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.18 -36.83 90.4 Favored Glycine 0 CA--C 1.511 -0.219 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.459 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -70.55 -11.41 60.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.859 0.361 . . . . 0.0 111.417 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -102.17 -1.43 31.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.058 0.456 . . . . 0.0 110.404 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.402 HD11 ' CG1' ' A' ' 290' ' ' VAL . 70.6 mt -106.13 130.93 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.727 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.47 125.02 49.03 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.649 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.583 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.3 p -104.24 122.44 45.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.487 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 67.5 t -127.23 115.03 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 121.153 0.501 . . . . 0.0 112.084 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.28 112.9 3.8 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.608 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.466 ' HB3' HG21 ' A' ' 303' ' ' VAL . 26.7 mt -97.05 -7.85 31.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.561 0.219 . . . . 0.0 111.559 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.8 -129.36 41.63 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.152 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 12.7 p -93.59 112.23 24.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.491 ' O ' ' HD3' ' A' ' 305' ' ' PRO . 41.9 t -138.0 -69.38 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -110.2 94.49 18.41 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 303' ' ' VAL . 13.3 Cg_exo -65.57 163.2 30.93 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.24 1.96 . . . . 0.0 112.034 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 6.3 tt -117.9 -48.24 3.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.465 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -129.75 172.89 11.16 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 43.8 t -62.96 134.76 56.68 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 123.399 0.437 . . . . 0.0 110.734 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.17 -7.7 59.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.683 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.59 -20.31 64.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.444 HG23 ' H ' ' A' ' 314' ' ' GLY . 2.1 t -113.54 145.34 33.13 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.891 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.86 -32.29 36.67 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.996 1.797 . . . . 0.0 110.806 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.8 mt-10 -59.66 -44.7 93.47 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.055 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.444 ' H ' HG23 ' A' ' 311' ' ' THR . . . -67.88 -38.87 89.56 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.707 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -63.16 -37.31 86.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.941 0.4 . . . . 0.0 110.259 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.21 -27.44 69.36 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.17 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 6.8 mmtp -84.73 -40.9 16.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.035 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 42.5 m-80 -62.31 -26.65 68.54 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 37.3 ptt180 -78.4 7.02 7.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.877 0.37 . . . . 0.0 111.471 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 317' ' ' LYS . 29.8 ptt-85 -57.78 177.79 0.1 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.144 0.973 . . . . 0.0 113.18 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 86.5 t -136.52 143.15 36.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.583 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -129.57 137.58 50.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.831 0.348 . . . . 0.0 111.017 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.434 ' H ' HD12 ' A' ' 323' ' ' ILE . 1.4 mp -100.9 119.5 49.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 75.0 t -111.05 137.33 43.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 255' ' ' VAL . 67.9 t -101.5 136.39 33.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.364 0.602 . . . . 0.0 111.221 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.084 179.264 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.264 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -93.84 -38.3 11.31 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 53.11 77.48 0.45 Allowed Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.789 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.5 115.11 3.73 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.688 2.259 . . . . 0.0 111.666 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.99 -9.64 11.78 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.723 2.282 . . . . 0.0 112.338 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -76.71 -71.48 1.18 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.099 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.35 110.18 0.31 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.848 2.365 . . . . 0.0 112.358 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.44 125.01 13.69 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.738 2.292 . . . . 0.0 110.927 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -93.57 -9.79 36.96 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.3 t 54.71 -154.89 0.27 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 122.936 0.495 . . . . 0.0 110.958 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 167.84 -150.84 17.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.348 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.38 13.1 1.17 Allowed 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 123.577 2.852 . . . . 0.0 111.882 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 52.7 t -153.58 147.13 25.04 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -56.18 161.28 2.52 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.183 0.516 . . . . 0.0 112.043 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.93 63.35 2.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.548 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.516 HD22 ' HB2' ' A' ' 246' ' ' LYS . 17.9 mt -54.08 -29.9 46.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.308 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -65.25 -43.8 90.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.026 0.441 . . . . 0.0 109.932 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.7 t -74.96 -24.68 58.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.543 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -75.51 -49.05 19.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.831 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 211' ' ' LEU . 23.4 pt -71.72 -38.08 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.607 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -58.62 -38.39 77.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.988 0.423 . . . . 0.0 110.516 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.89 -27.72 69.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.134 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.831 HG12 HG23 ' A' ' 239' ' ' ILE . 21.3 t -83.67 -50.98 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 121.038 0.447 . . . . 0.0 110.751 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.556 ' HA ' HG21 ' A' ' 239' ' ' ILE . 42.6 p -69.1 -34.86 75.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.461 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.9 14.24 82.8 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 139.79 -134.69 6.74 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.34 166.63 6.57 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.73 2.287 . . . . 0.0 113.246 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 51.0 mm -82.58 106.09 13.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.009 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.15 132.41 40.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.122 0.487 . . . . 0.0 111.864 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -100.55 173.93 6.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.512 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.01 -68.59 0.74 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.827 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.58 ' HB3' ' O ' ' A' ' 231' ' ' SER . 24.8 t-20 -95.71 -100.82 0.17 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.492 -0.29 . . . . 0.0 110.607 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 227' ' ' ASN . 10.2 t70 170.05 -58.56 0.01 OUTLIER 'General case' 0 C--N 1.352 0.688 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -78.42 80.07 1.45 Allowed Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.5 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 77.63 -55.71 0.52 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.975 0.91 . . . . 0.0 112.579 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.58 ' O ' ' HB3' ' A' ' 227' ' ' ASN . 25.3 m -80.44 72.46 7.33 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.194 0.521 . . . . 0.0 109.666 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 232' ' ' LEU . 2.5 pt? -74.32 -0.28 16.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.939 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 40.1 mt 58.26 73.15 0.76 Allowed Pre-proline 0 C--O 1.234 0.273 0 CA-C-O 121.023 0.439 . . . . 0.0 110.159 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.42 125.34 8.31 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.081 1.854 . . . . 0.0 111.655 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -145.22 -7.75 0.61 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.978 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.542 ' HB3' HD12 ' A' ' 239' ' ' ILE . 5.3 m-20 -123.63 22.84 9.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.415 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -66.07 -27.13 67.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.072 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -67.61 -20.71 65.38 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.003 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.831 HG23 HG12 ' A' ' 218' ' ' VAL . 50.6 mt -64.73 -38.86 83.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.86 -31.23 72.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.226 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.448 ' HA ' ' HG2' ' A' ' 288' ' ' ARG . 3.5 m-20 -75.57 -38.31 59.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.784 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -69.24 -23.42 63.86 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.095 178.473 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 24.7 t -79.79 -42.19 22.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.487 176.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.01 68.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.154 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -45.82 -50.54 14.03 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.728 0.811 . . . . 0.0 112.497 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.516 ' HB2' HD22 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -85.33 -14.43 46.5 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 41.3 mt -83.56 -31.08 26.54 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.544 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 53.6 mtpt -82.93 -18.85 38.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.64 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.94 -34.13 76.0 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.283 0.563 . . . . 0.0 109.816 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.506 ' HB3' HD11 ' A' ' 211' ' ' LEU . 35.4 t -132.03 69.35 80.71 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 60.6 Cg_endo -69.5 -2.97 10.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.25 2.633 . . . . 0.0 113.846 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -84.0 -24.14 30.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.558 0.694 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -67.75 149.29 50.14 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.861 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -102.81 140.79 36.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.09 131.95 67.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 120.97 0.414 . . . . 0.0 110.897 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.2 m -107.63 108.76 20.16 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 16.3 mt -96.36 114.98 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.68 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -99.5 125.16 45.2 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.293 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 274' ' ' SER . . . -105.71 140.76 15.23 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -123.01 161.94 23.31 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.01 0.433 . . . . 0.0 110.005 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 10.0 t -148.1 167.1 25.88 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.402 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.494 ' HB3' HG22 ' A' ' 264' ' ' THR . 13.5 t70 -79.07 156.86 28.16 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.011 -178.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -83.99 8.15 16.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 0.0 111.399 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 262' ' ' ASP . 9.4 t -66.3 -27.94 68.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.34 164.79 53.64 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.4 t -151.56 179.02 8.73 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 117.112 0.456 . . . . 0.0 111.219 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.401 ' HB3' HD13 ' A' ' 269' ' ' ILE . 4.9 tp10 71.42 5.9 5.57 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.409 1.083 . . . . 0.0 112.513 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 96.7 -12.91 65.85 Favored Glycine 0 CA--C 1.494 -1.223 0 C-N-CA 119.76 -1.209 . . . . 0.0 114.179 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.401 HD13 ' HB3' ' A' ' 267' ' ' GLU . 1.7 mp -61.45 -21.83 26.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.676 0.75 . . . . 0.0 110.901 -177.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.94 -38.66 70.61 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.779 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.404 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 22.7 mm -58.78 -64.37 2.99 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.741 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.404 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 14.2 Cg_endo -61.21 -28.12 84.6 Favored 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 121.867 1.711 . . . . 0.0 112.426 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 53.2 tp -65.51 -52.95 48.94 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.965 0.412 . . . . 0.0 110.809 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 259' ' ' GLY . 14.5 p -62.64 -28.39 69.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.606 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.86 78.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.251 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -67.86 -39.59 83.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.73 -52.18 64.78 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.099 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.422 ' HA ' HG11 ' A' ' 321' ' ' VAL . . . -60.93 -35.0 75.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.214 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.553 ' HA ' HG21 ' A' ' 297' ' ' THR . 16.4 ttpt -62.68 -31.79 72.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.229 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 61.5 mt -56.36 -45.57 81.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.989 0.423 . . . . 0.0 110.118 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.745 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.5 t -67.48 -45.44 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.978 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.78 -45.37 74.26 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.919 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.84 -40.54 88.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.288 0.566 . . . . 0.0 110.635 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.674 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 6.9 m-85 -69.75 -41.41 75.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.208 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 47.6 mt -63.99 -46.91 82.45 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 79.4 t -59.9 -39.51 80.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.354 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.39 -30.54 71.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.339 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.674 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -80.93 1.51 30.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.597 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 98.81 15.69 33.23 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.136 -1.03 . . . . 0.0 114.033 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 58.2 t -90.64 142.86 12.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 117.416 0.608 . . . . 0.0 109.551 177.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.31 111.11 4.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.801 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.1 -34.12 77.94 Favored Glycine 0 C--N 1.33 0.197 0 CA-C-N 115.707 -0.679 . . . . 0.0 113.255 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.54 -21.0 66.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.922 0.391 . . . . 0.0 111.63 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.5 3.92 40.67 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.97 0.414 . . . . 0.0 110.99 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 66.4 mt -105.43 131.92 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.74 129.61 54.58 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.553 HG21 ' HA ' ' A' ' 279' ' ' LYS . 31.8 p -115.72 125.38 52.73 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.683 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 94.7 t -130.04 127.58 63.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 0.0 111.499 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -96.02 114.12 4.83 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.87 -2.0 48.25 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 72.79 -129.85 13.85 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.661 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 23.2 t -90.49 114.92 27.21 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.1 p -179.33 147.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.6 t30 64.95 69.33 0.67 Allowed Pre-proline 0 C--N 1.314 -0.97 0 O-C-N 123.818 0.699 . . . . 0.0 110.404 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.44 168.45 12.99 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.591 2.194 . . . . 0.0 113.231 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.463 ' HB ' ' NH1' ' A' ' 320' ' ' ARG . 2.7 tt -128.12 -50.0 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.108 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.444 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -120.83 171.71 8.42 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.168 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 20.0 m -64.55 134.69 54.92 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.485 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -78.22 -7.72 57.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.184 0.516 . . . . 0.0 110.662 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.16 -16.88 60.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.158 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.506 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 0.8 OUTLIER -113.76 144.61 31.79 Favored Pre-proline 0 CA--C 1.511 -0.522 0 CA-C-O 121.034 0.445 . . . . 0.0 110.941 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -66.22 -34.66 35.43 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 122.213 1.942 . . . . 0.0 111.354 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -60.87 -40.51 93.24 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.268 0.556 . . . . 0.0 109.85 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 307' ' ' ALA . . . -70.25 -39.8 71.12 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.876 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 311' ' ' THR . 99.4 mtt180 -60.74 -33.43 72.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.125 0.488 . . . . 0.0 110.092 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -70.47 -29.14 65.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.79 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 320' ' ' ARG . 0.2 OUTLIER -82.38 -41.17 20.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.05 179.127 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -64.64 -17.42 64.02 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 19.6 ptp180 -86.98 13.19 9.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.146 0.498 . . . . 0.0 110.865 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.463 ' NH1' ' HB ' ' A' ' 306' ' ' ILE . 5.2 ptt180 -57.66 175.9 0.16 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.191 0.996 . . . . 0.0 113.189 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 278' ' ' ALA . 60.7 t -135.48 147.76 28.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.427 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.02 136.15 48.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.146 0.498 . . . . 0.0 110.9 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.42 ' H ' HD12 ' A' ' 323' ' ' ILE . 2.3 mp -98.38 117.27 43.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.919 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 48.8 t -112.53 141.87 26.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.479 HG21 ' HB2' ' A' ' 211' ' ' LEU . 97.3 t -88.93 118.85 35.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.028 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.6 t30 . . . . . 0 C--N 1.331 -0.2 0 C-N-CA 125.144 1.378 . . . . 0.0 112.549 -176.611 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -78.05 -49.64 13.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.006 0.431 . . . . 0.0 110.611 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -127.74 92.93 41.32 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.33 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 5.3 Cg_exo -81.4 141.26 12.53 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.68 2.254 . . . . 0.0 110.846 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 199' ' ' PRO . 24.3 Cg_exo -63.22 108.26 0.78 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.472 2.115 . . . . 0.0 111.829 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -160.13 77.89 0.18 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.377 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -80.01 154.34 22.55 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.905 2.403 . . . . 0.0 111.064 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.38 110.71 0.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.312 2.008 . . . . 0.0 111.383 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.71 -23.25 63.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.528 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 30.1 p -108.31 114.05 27.61 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -115.37 -170.87 16.34 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.438 -0.886 . . . . 0.0 112.175 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.89 158.32 58.34 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.842 2.362 . . . . 0.0 111.479 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 12.1 t -104.37 175.07 5.61 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.468 ' O ' HD22 ' A' ' 211' ' ' LEU . . . -50.87 165.49 0.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.433 0.693 . . . . 0.0 112.859 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.65 80.75 9.02 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 209' ' ' ALA . 3.1 mm? -57.48 -53.29 59.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.71 -43.22 99.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.846 0.355 . . . . 0.0 110.697 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.4 t -70.92 -21.0 62.42 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.247 0.546 . . . . 0.0 110.346 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.57 ' HB1' ' HE3' ' A' ' 246' ' ' LYS . . . -84.24 -45.07 13.26 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.51 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 26.5 pt -69.48 -41.89 80.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.03 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -57.2 -32.47 66.51 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.459 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.42 67.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.236 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 242' ' ' ARG . 8.2 t -87.7 -47.93 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-O 121.065 0.46 . . . . 0.0 110.091 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.484 ' HA ' HG21 ' A' ' 239' ' ' ILE . 76.2 p -66.29 -36.91 84.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.585 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.02 24.95 42.53 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.38 -136.02 10.22 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.602 ' HB2' ' NE ' ' A' ' 320' ' ' ARG . 3.4 Cg_exo -79.98 159.26 24.08 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.463 2.109 . . . . 0.0 111.851 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 320' ' ' ARG . 41.7 mm -74.88 106.65 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.661 -176.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -83.03 149.41 26.96 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -110.85 141.07 44.72 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.028 0.442 . . . . 0.0 111.322 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -91.6 -42.75 4.73 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -98.43 161.14 13.84 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.39 -29.76 70.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.135 0.493 . . . . 0.0 110.583 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 163.35 -8.65 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.193 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -84.27 90.67 7.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.695 0.283 . . . . 0.0 110.938 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 87.5 p 55.49 -174.28 0.05 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.991 0.917 . . . . 0.0 112.715 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 98.7 mt -121.08 95.35 4.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.324 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.494 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 68.3 mt -78.02 -52.72 1.51 Allowed Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.635 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 233' ' ' ILE . 16.4 Cg_endo -57.81 151.1 58.51 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 122.147 1.898 . . . . 0.0 111.935 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -79.09 72.4 5.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.197 0.523 . . . . 0.0 111.461 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -129.69 2.93 4.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.714 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -73.67 -21.4 60.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.816 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.72 -20.86 66.57 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.815 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 243' ' ' VAL . 76.7 mt -69.9 -42.42 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 8.1 mp -67.08 -33.52 75.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.597 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.68 -37.25 82.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.067 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.594 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 0.0 OUTLIER -71.65 -41.17 69.1 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.779 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.638 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 54.9 t -56.01 -40.82 65.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.231 0.539 . . . . 0.0 110.199 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.86 82.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.231 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.594 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 2.9 t70 -48.9 -52.98 21.53 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.57 ' HE3' ' HB1' ' A' ' 214' ' ' ALA . 0.0 OUTLIER -73.66 -31.77 63.64 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.168 -178.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 25.6 mt -68.76 -29.64 68.07 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -64.86 -32.38 74.06 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.942 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -77.1 -29.41 54.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.57 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 7.8 t -137.82 65.02 44.88 Favored Pre-proline 0 C--N 1.316 -0.867 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.01 4.6 5.12 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.059 2.506 . . . . 0.0 114.461 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -81.21 -28.11 35.03 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.681 0.753 . . . . 0.0 109.077 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.3 141.14 54.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.639 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -93.74 137.08 33.36 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.047 0.451 . . . . 0.0 110.157 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.423 HG12 HG22 ' A' ' 325' ' ' VAL . 5.3 m -116.67 133.66 62.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.071 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 31.4 m -112.32 111.92 23.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.84 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.402 HG12 HG23 ' A' ' 323' ' ' ILE . 18.9 mt -92.79 114.36 29.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -104.79 128.21 52.85 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.597 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.416 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -109.49 144.82 16.7 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.798 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -126.24 158.72 34.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 10.0 t -174.13 114.18 0.19 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.125 0.964 . . . . 0.0 111.228 174.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.3 109.08 8.51 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.488 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.52 ' HB2' ' HB3' ' A' ' 270' ' ' ASN . 3.5 m-20 -129.85 -56.01 1.13 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.663 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.7 p -115.34 -61.7 1.71 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.486 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 174.31 -43.29 0.14 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 302' ' ' SER . 50.9 m -149.6 -64.95 0.22 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.675 0.274 . . . . 0.0 111.378 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -99.64 165.99 11.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.963 0.411 . . . . 0.0 111.672 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 272' ' ' PRO . . . 124.08 -150.65 17.03 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.185 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.75 -29.97 48.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 123.058 0.543 . . . . 0.0 110.9 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.571 ' HB2' HG23 ' A' ' 261' ' ' THR . 19.3 p30 -61.06 -24.69 66.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.831 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.438 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 19.8 mm -64.53 -64.89 2.32 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.869 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.438 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.3 Cg_endo -60.01 -30.01 90.6 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 121.779 1.653 . . . . 0.0 111.934 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 58.5 tp -68.36 -52.22 35.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.237 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.493 ' HB3' HG22 ' A' ' 261' ' ' THR . 17.3 p -64.22 -27.15 68.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.15 -33.62 74.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.768 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.511 ' O ' HG13 ' A' ' 280' ' ' ILE . 41.2 tt0 -64.05 -50.47 68.27 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.852 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.534 ' NH1' ' HB2' ' A' ' 319' ' ' ARG . 72.8 mtt180 -61.96 -38.06 87.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.784 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.88 92.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.076 0.465 . . . . 0.0 110.172 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.651 ' HA ' HG21 ' A' ' 297' ' ' THR . 23.6 ttpt -66.71 -31.93 72.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.377 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 276' ' ' GLN . 60.4 mt -55.09 -41.96 62.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.059 0.457 . . . . 0.0 110.145 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.712 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.6 t -70.2 -43.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.778 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.4 84.94 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.994 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -56.96 -37.58 71.77 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.937 0.398 . . . . 0.0 110.649 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.667 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 6.3 m-85 -70.86 -51.25 27.56 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.96 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 30.5 mt -55.38 -50.76 68.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.366 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.16 -41.22 85.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.007 0.432 . . . . 0.0 110.646 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.13 -21.96 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.001 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.8 mmp_? -88.52 7.1 34.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.499 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 92.42 14.8 55.12 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.683 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.41 144.9 8.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.6 111.49 5.45 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.832 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.1 -32.04 66.4 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.71 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.8 -15.47 63.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.967 0.413 . . . . 0.0 111.754 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -102.16 -1.8 30.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.023 0.44 . . . . 0.0 110.464 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 60.8 mt -106.92 129.49 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.067 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.03 124.43 48.1 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.651 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.1 p -107.68 124.9 50.67 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.887 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 69.6 t -134.02 123.45 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.057 0.456 . . . . 0.0 111.738 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -94.77 113.23 4.53 Favored Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 22.1 mt -93.06 1.43 57.25 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.775 0.321 . . . . 0.0 111.389 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.98 -131.2 33.53 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.631 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 266' ' ' SER . 45.4 t -91.02 117.6 29.72 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.7 p -178.81 151.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.716 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.35 69.43 1.64 Allowed Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 123.678 0.791 . . . . 0.0 110.831 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.585 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 74.1 Cg_endo -78.47 137.57 14.86 Favored 'Trans proline' 0 N--CA 1.44 -1.661 0 C-N-CA 122.403 2.069 . . . . 0.0 113.381 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.77 -38.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.498 176.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -131.18 169.35 16.04 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.961 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 45.0 m -77.22 146.06 37.2 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.638 0.256 . . . . 0.0 110.477 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -73.27 -7.24 50.67 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.758 0.313 . . . . 0.0 111.365 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -59.91 -24.72 64.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.453 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.6 t -115.73 137.75 23.45 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.543 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.99 -32.44 44.46 Favored 'Trans proline' 0 CA--C 1.518 -0.281 0 C-N-CA 122.452 2.101 . . . . 0.0 111.151 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -60.7 -40.84 93.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.758 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.0 -36.74 93.42 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.008 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -69.92 -25.82 63.86 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 319' ' ' ARG . . . -74.49 -26.47 60.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.062 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -37.06 29.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.585 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 57.0 m-20 -69.69 -3.56 15.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 17.5 ptm180 -98.21 9.12 43.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 120.75 0.31 . . . . 0.0 111.482 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.602 ' NE ' ' HB2' ' A' ' 222' ' ' PRO . 8.8 ptm180 -75.84 -175.95 3.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 75.7 t -135.7 153.05 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.608 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -132.64 139.23 47.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 111.193 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.412 ' H ' HD12 ' A' ' 323' ' ' ILE . 2.7 mp -95.94 115.05 34.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.86 137.01 39.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 211' ' ' LEU . 42.0 t -104.32 142.24 18.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 C--N 1.318 -0.763 0 O-C-N 123.542 0.526 . . . . 0.0 110.514 177.367 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -75.48 119.72 19.94 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 67.34 103.01 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.425 0 O-C-N 123.758 0.661 . . . . 0.0 110.974 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.6 141.03 96.5 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.758 2.305 . . . . 0.0 111.821 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -40.43 -52.86 2.88 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.673 2.915 . . . . 0.0 112.952 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -102.74 120.77 6.92 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.792 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.53 -46.32 28.14 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.133 2.555 . . . . 0.0 114.864 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.71 139.54 48.41 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.272 1.981 . . . . 0.0 112.594 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.5 -22.87 60.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.011 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 26.2 t 72.15 -43.45 0.56 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.629 0.772 . . . . 0.0 111.846 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -95.84 -144.66 17.34 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.082 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.73 156.68 53.01 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.897 2.398 . . . . 0.0 111.786 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 10.6 t -112.17 -178.03 3.31 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.36 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.43 152.0 35.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.427 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.15 90.15 3.09 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.033 0.444 . . . . 0.0 110.017 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 250' ' ' CYS . 41.9 mt -75.32 -28.6 59.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.002 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -62.01 -43.7 98.29 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 120.917 0.389 . . . . 0.0 110.305 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 33.0 t -71.15 -41.25 70.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.47 ' HB1' ' HE3' ' A' ' 246' ' ' LYS . . . -58.06 -47.78 82.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.611 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 211' ' ' LEU . 24.5 pt -72.53 -37.84 58.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.94 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -58.24 -36.21 72.86 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.751 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.39 -26.64 68.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.288 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.1 t -92.9 -43.68 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.465 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.606 ' HA ' HG21 ' A' ' 239' ' ' ILE . 70.2 p -67.43 -40.81 85.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.081 0.467 . . . . 0.0 110.899 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.26 24.57 59.02 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.62 -134.39 8.25 Favored Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.428 ' HB3' HH11 ' A' ' 320' ' ' ARG . 91.9 Cg_endo -85.38 166.18 10.75 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.797 2.332 . . . . 0.0 113.037 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.477 HG22 ' CD1' ' A' ' 225' ' ' PHE . 48.5 mm -85.2 110.97 20.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.211 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -101.31 125.06 47.91 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.573 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.477 ' CD1' HG22 ' A' ' 223' ' ' ILE . 3.3 p90 -166.94 140.73 3.78 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 120.899 0.38 . . . . 0.0 111.069 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -88.53 77.32 1.82 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.146 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -78.39 88.02 4.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.254 0.549 . . . . 0.0 109.928 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -177.95 88.72 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.258 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 76.29 12.01 84.53 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.615 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -149.62 -73.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.425 0.155 . . . . 0.0 110.818 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 48.7 m 68.24 -160.87 0.2 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.8 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.3 mp -77.63 80.34 4.1 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.158 0.504 . . . . 0.0 112.138 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.486 ' HB ' ' HD3' ' A' ' 234' ' ' PRO . 44.6 mm -90.95 -48.42 0.35 Allowed Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.062 175.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.486 ' HD3' ' HB ' ' A' ' 233' ' ' ILE . 25.4 Cg_exo -65.49 155.1 70.63 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 121.969 1.779 . . . . 0.0 111.475 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -91.13 9.6 30.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 234' ' ' PRO . 4.3 p-10 -78.0 -6.81 55.69 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.295 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -81.3 35.84 0.4 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.414 0.626 . . . . 0.0 111.564 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.75 -17.26 55.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.172 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.606 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.5 mt -58.97 -39.02 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.442 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.538 HD22 HG13 ' A' ' 281' ' ' VAL . 41.5 mt -66.45 -32.1 73.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.103 0.478 . . . . 0.0 110.782 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 288' ' ' ARG . 60.9 m-20 -71.41 -36.62 71.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.491 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -70.59 -42.62 70.77 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.753 178.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.616 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 46.0 t -57.59 -42.36 81.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.6 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.55 80.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.284 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 24.6 t70 -49.8 -53.18 26.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.266 0.627 . . . . 0.0 112.623 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.623 ' HB3' ' NZ ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -74.0 -31.57 63.01 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.561 -178.173 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 33.8 mt -64.09 -36.81 85.22 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.377 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.483 ' HG3' HG22 ' A' ' 290' ' ' VAL . 58.2 mtpt -73.06 -22.6 60.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.263 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.64 80.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 110.006 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.49 ' HB3' HD11 ' A' ' 211' ' ' LEU . 49.0 t -126.79 70.8 73.58 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 73.5 Cg_endo -71.6 -1.33 9.63 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 123.266 2.644 . . . . 0.0 114.145 -174.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -79.71 -24.8 41.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.642 0.734 . . . . 0.0 109.289 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -70.42 135.0 48.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.522 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.15 140.41 29.83 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.43 HG12 HG22 ' A' ' 325' ' ' VAL . 6.0 m -116.05 132.22 66.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.241 0.543 . . . . 0.0 111.436 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 39.8 m -109.02 108.72 19.55 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.17 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.43 HG12 HG23 ' A' ' 323' ' ' ILE . 23.3 mt -92.32 114.4 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.486 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -101.74 127.48 48.5 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.453 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.421 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -107.64 147.3 16.36 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.323 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 37.8 m-85 -123.66 162.01 23.92 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.119 0.485 . . . . 0.0 110.612 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.557 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 34.6 p -147.34 170.48 17.24 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 124.229 1.011 . . . . 0.0 108.95 175.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.429 ' HB2' HD22 ' A' ' 309' ' ' ASN . 5.6 p-10 -81.66 153.18 26.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.924 0.392 . . . . 0.0 110.535 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -94.12 -1.11 54.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -13.37 59.45 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.52 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -85.95 -172.51 48.81 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.682 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.8 m -78.9 124.59 28.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.661 0.23 . . . . 0.0 110.573 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.581 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 41.2 mt-10 -59.91 152.74 22.71 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.103 0.477 . . . . 0.0 111.409 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 103.04 -44.85 1.41 Allowed Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.048 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp -79.31 -25.39 12.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 121.274 0.559 . . . . 0.0 110.076 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.581 ' OD1' ' HA ' ' A' ' 267' ' ' GLU . 0.4 OUTLIER -58.44 -42.88 88.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.668 -178.22 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.446 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 25.7 mm -58.11 -64.35 2.87 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.583 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.446 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.8 Cg_endo -58.92 -29.05 89.29 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.025 1.817 . . . . 0.0 112.272 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 58.4 tp -70.3 -52.93 19.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.335 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.544 ' HB3' HG23 ' A' ' 261' ' ' THR . 14.7 p -63.5 -30.51 71.62 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.906 0.384 . . . . 0.0 110.512 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.6 73.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.785 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.619 ' O ' HG13 ' A' ' 280' ' ' ILE . 29.1 tt0 -67.0 -48.14 69.36 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.497 ' HB3' ' CG2' ' A' ' 321' ' ' VAL . 17.3 mmt180 -54.25 -49.02 70.49 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.382 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.2 90.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.176 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.636 ' HA ' HG21 ' A' ' 297' ' ' THR . 41.9 tptt -64.35 -30.57 71.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.227 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 276' ' ' GLN . 62.7 mt -59.85 -42.97 90.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.22 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.71 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.2 t -68.2 -45.81 82.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.836 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.7 -44.74 73.69 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.803 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.58 -38.82 82.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.914 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.49 -43.02 77.77 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.794 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 40.2 mt -62.78 -49.11 76.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.55 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 83.1 t -59.9 -40.83 83.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.511 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.74 -28.13 69.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.683 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 241' ' ' ASN . 15.3 mmm180 -85.33 0.02 53.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.917 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.29 6.75 35.97 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.611 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.483 HG22 ' HG3' ' A' ' 248' ' ' LYS . 60.2 t -83.55 144.57 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 117.723 0.761 . . . . 0.0 109.793 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.09 109.95 6.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.305 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.48 -29.9 74.83 Favored Glycine 0 CA--C 1.509 -0.316 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.363 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -61.94 -19.29 62.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.204 0.526 . . . . 0.0 110.948 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -107.96 5.5 26.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.484 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.8 mt -106.26 129.1 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.76 124.64 48.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.71 0.291 . . . . 0.0 110.594 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.636 HG21 ' HA ' ' A' ' 279' ' ' LYS . 14.9 p -109.16 121.99 46.33 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.207 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 73.3 t -130.25 120.44 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.389 0.614 . . . . 0.0 112.045 -176.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -90.11 110.97 3.83 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.4 ' HB3' HG21 ' A' ' 303' ' ' VAL . 27.2 mt -90.41 -0.15 57.53 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 68.56 -125.38 20.2 Favored Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.54 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.1 t -105.81 121.92 45.03 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.5 ' O ' ' HD3' ' A' ' 305' ' ' PRO . 75.5 t -136.95 -69.41 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.897 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -112.38 91.68 17.21 Favored Pre-proline 0 C--O 1.242 0.702 0 CA-C-O 120.687 0.28 . . . . 0.0 110.747 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 303' ' ' VAL . 19.3 Cg_exo -65.63 135.32 41.52 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.611 2.207 . . . . 0.0 111.24 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.0 tt -84.65 -45.76 17.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.749 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -124.2 173.61 8.22 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.317 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.9 m -62.62 136.34 57.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.679 0.612 . . . . 0.0 111.253 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.429 HD22 ' HB2' ' A' ' 262' ' ' ASP . 20.6 m120 -80.64 -11.73 59.6 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.156 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.71 -19.7 65.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.07 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 314' ' ' GLY . 3.2 t -113.34 139.47 23.23 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.329 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.0 -35.41 87.79 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.619 2.212 . . . . 0.0 111.535 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.572 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 71.5 mm-40 -60.34 -46.48 89.74 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.497 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.458 ' H ' HG23 ' A' ' 311' ' ' THR . . . -63.78 -37.77 95.18 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.717 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 311' ' ' THR . 76.1 mtp180 -61.85 -40.43 95.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.23 0.538 . . . . 0.0 109.948 177.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.7 -28.69 70.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.653 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.572 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 11.0 mmtp -79.49 -39.29 32.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.036 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -55.51 -28.26 53.59 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 32.0 ptt180 -83.58 12.07 6.27 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.428 HH11 ' HB3' ' A' ' 222' ' ' PRO . 28.6 ptt85 -57.53 173.66 0.26 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.901 0.88 . . . . 0.0 112.966 174.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.497 ' CG2' ' HB3' ' A' ' 277' ' ' ARG . 66.3 t -133.73 148.02 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.015 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -130.31 139.02 50.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.981 0.42 . . . . 0.0 111.071 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.43 HG23 HG12 ' A' ' 257' ' ' ILE . 2.2 mp -101.09 117.02 45.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.891 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.3 138.12 38.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.43 HG22 HG12 ' A' ' 255' ' ' VAL . 59.3 t -101.08 137.79 27.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.385 179.325 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.975 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -113.68 4.21 15.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.405 ' HA ' ' HD2' ' A' ' 199' ' ' PRO . . . 69.03 88.91 0.1 OUTLIER Pre-proline 0 C--O 1.239 0.538 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.793 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 19.3 Cg_endo -60.2 142.22 97.77 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.65 2.233 . . . . 0.0 111.954 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 199' ' ' PRO . 36.3 Cg_exo -62.23 -19.73 67.76 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.766 2.31 . . . . 0.0 112.085 178.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -102.33 -136.06 9.04 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.859 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 71.7 Cg_endo -77.13 152.72 31.48 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.569 2.179 . . . . 0.0 111.9 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 9.7 Cg_exo -71.66 82.49 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.54 2.16 . . . . 0.0 111.78 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -114.13 4.74 15.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.754 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 34.0 t -102.63 5.82 39.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.359 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -145.33 -148.5 4.83 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.592 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.29 155.54 60.36 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 123.034 2.49 . . . . 0.0 112.192 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.418 ' SG ' ' N ' ' A' ' 209' ' ' ALA . 22.8 t -104.76 -175.14 2.71 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.636 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.418 ' N ' ' SG ' ' A' ' 208' ' ' CYS . . . -59.68 178.24 0.17 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.409 0.684 . . . . 0.0 111.632 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.09 78.12 6.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.092 0.472 . . . . 0.0 110.186 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.458 ' HB2' HG21 ' A' ' 325' ' ' VAL . 3.2 mm? -69.78 -29.1 66.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.67 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -63.82 -46.49 84.88 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.796 0.332 . . . . 0.0 110.536 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.1 t -72.05 -32.13 66.8 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.37 -47.32 76.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.182 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.472 ' CG2' HG13 ' A' ' 243' ' ' VAL . 22.0 pt -75.4 -39.48 41.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.848 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.448 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 17.9 t-20 -60.8 -33.4 72.94 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.974 0.416 . . . . 0.0 110.621 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.22 -28.03 69.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.081 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.484 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.4 t -90.61 -44.51 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.22 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.524 ' HA ' HG21 ' A' ' 239' ' ' ILE . 58.4 p -63.72 -36.07 82.64 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.967 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.0 25.19 41.73 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 124.52 -132.73 8.34 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.467 ' HG3' HH11 ' A' ' 320' ' ' ARG . 96.6 Cg_endo -85.29 166.86 10.75 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.421 2.08 . . . . 0.0 112.183 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 51.5 mm -80.96 101.9 6.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.388 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -86.83 133.27 33.65 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.398 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.1 169.07 8.72 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.546 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -93.89 -109.14 2.05 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.059 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -75.35 -31.75 60.66 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 11.2 t70 73.07 131.08 0.04 OUTLIER 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.93 0.769 . . . . 0.0 111.258 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 136.18 -17.3 3.83 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.496 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -115.87 -90.98 0.54 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.4 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 65.2 p -169.99 -155.29 0.12 Allowed 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.1 mp -81.67 76.26 8.59 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.519 0.676 . . . . 0.0 110.297 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 62.6 mt -65.61 -42.15 53.85 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.566 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -49.07 159.12 1.1 Allowed 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.501 2.134 . . . . 0.0 112.729 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.15 -37.83 69.3 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.089 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -84.7 114.16 21.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.276 0.56 . . . . 0.0 112.165 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -134.3 7.3 3.62 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.783 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.27 -19.48 65.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.12 -173.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.524 HG21 ' HA ' ' A' ' 219' ' ' THR . 74.1 mt -61.73 -38.14 79.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.411 ' CD1' HG13 ' A' ' 281' ' ' VAL . 4.2 mm? -61.05 -36.89 80.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.077 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -78.77 -34.85 45.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.105 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.484 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -66.43 -43.74 84.83 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.574 177.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.543 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 34.0 t -58.51 -42.68 85.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.722 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.8 81.54 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.477 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -53.74 -50.53 65.76 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.449 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -72.6 -29.45 63.52 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.214 -178.734 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.1 mt -72.21 -28.57 63.26 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 109.627 176.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.421 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 15.6 tptm -64.65 -31.96 73.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.84 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.72 -37.72 73.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.235 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 53.5 t -125.76 72.59 68.88 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 74.1 Cg_endo -72.59 0.46 7.53 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.774 2.316 . . . . 0.0 112.734 -178.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.03 -31.43 56.27 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.84 145.15 56.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.563 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.552 ' HB2' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -101.37 145.62 28.68 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.093 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.44 HG12 HG22 ' A' ' 325' ' ' VAL . 3.1 m -119.11 127.28 75.84 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.904 176.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.4 m -103.89 109.34 21.05 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.521 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.443 HG12 HG23 ' A' ' 323' ' ' ILE . 19.4 mt -96.79 114.23 33.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-O 121.024 0.44 . . . . 0.0 109.916 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -102.59 126.01 49.52 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.345 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.457 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -104.41 144.94 15.92 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.506 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -127.35 161.88 27.6 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 38.3 p -141.31 170.8 15.05 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.799 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.86 155.09 39.12 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.017 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -88.33 -2.65 58.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.978 0.418 . . . . 0.0 110.585 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.8 m -66.36 -20.75 66.16 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 121.306 0.574 . . . . 0.0 110.339 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -117.98 82.39 0.33 Allowed Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 2.0 m -92.69 34.46 1.07 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.854 0.359 . . . . 0.0 111.265 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -80.08 -23.42 41.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.033 0.444 . . . . 0.0 111.171 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 114.37 -25.37 10.54 Favored Glycine 0 CA--C 1.497 -1.085 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.57 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.87 -22.25 28.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 121.797 0.808 . . . . 0.0 109.759 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.563 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 22.2 p30 -55.56 -33.25 63.69 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.374 177.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.449 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 20.1 mm -62.72 -65.0 2.4 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.174 177.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.449 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 11.2 Cg_endo -59.99 -27.45 84.93 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 121.887 1.725 . . . . 0.0 112.18 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.8 tp -67.36 -53.83 25.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.774 0.321 . . . . 0.0 111.532 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.542 ' HB3' HG23 ' A' ' 261' ' ' THR . 6.5 p -62.47 -30.37 71.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.757 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.64 -31.56 66.99 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.16 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.407 ' O ' HG13 ' A' ' 280' ' ' ILE . 27.9 tt0 -69.1 -51.48 38.17 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.787 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 277' ' ' ARG . 54.3 mmt-85 -58.78 -39.26 80.53 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.954 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.69 91.96 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.21 0.528 . . . . 0.0 109.872 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.615 ' HA ' HG21 ' A' ' 297' ' ' THR . 23.5 tptm -63.03 -34.87 78.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.968 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 276' ' ' GLN . 54.9 mt -56.73 -44.32 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.566 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.734 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.3 t -66.25 -46.11 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.623 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -54.47 -45.94 73.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.051 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.69 -36.44 82.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.904 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.554 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 4.7 m-85 -68.83 -41.41 78.61 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.645 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 31.8 mt -66.14 -48.1 71.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.844 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 89.2 t -59.33 -43.05 89.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.511 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.0 -28.31 68.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.267 0.556 . . . . 0.0 110.438 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.554 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 1.4 mpt_? -85.98 3.04 43.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.046 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 108.5 5.08 32.21 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.74 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 49.6 t -88.26 140.29 16.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 117.782 0.791 . . . . 0.0 110.225 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.93 117.25 8.03 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.561 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.69 86.56 Favored Glycine 0 CA--C 1.51 -0.265 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.15 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -15.26 63.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.964 0.412 . . . . 0.0 111.444 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -98.52 0.31 44.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.0 110.65 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.3 mt -109.27 129.37 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.498 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.32 129.58 54.94 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.937 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.615 HG21 ' HA ' ' A' ' 279' ' ' LYS . 25.0 p -115.58 128.09 55.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.524 0.202 . . . . 0.0 111.172 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 26.9 t -133.54 128.09 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -99.81 108.64 3.57 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 18.5 mt -92.36 3.2 55.92 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 68.53 -127.74 23.56 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.559 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 15.1 m -93.6 115.61 28.1 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.834 0.35 . . . . 0.0 110.525 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.5 p -176.12 150.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 60.7 t30 70.29 74.52 0.26 Allowed Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 123.871 0.732 . . . . 0.0 111.078 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.588 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 73.5 Cg_endo -75.07 155.33 42.58 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.647 2.231 . . . . 0.0 112.792 -177.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.0 tt -124.59 -44.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.445 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.444 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -138.44 174.98 9.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.473 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 50.8 m -71.16 131.16 43.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.279 0.562 . . . . 0.0 111.702 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -80.81 -7.66 59.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.417 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.14 -16.88 63.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.808 178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.465 HG23 ' H ' ' A' ' 314' ' ' GLY . 5.2 t -123.23 144.39 43.49 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -54.49 -36.52 88.52 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.067 2.511 . . . . 0.0 112.118 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.1 mm-40 -55.49 -51.15 67.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.983 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -69.33 -40.85 80.2 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.693 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -56.35 -41.05 75.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.025 0.44 . . . . 0.0 110.339 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.96 70.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.737 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 0.3 OUTLIER -80.63 -42.97 21.24 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.597 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.588 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 39.2 m-80 -63.85 -23.83 67.51 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -176.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.597 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 10.4 ptm180 -84.98 12.87 6.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.29 0.567 . . . . 0.0 111.929 -178.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.467 HH11 ' HG3' ' A' ' 222' ' ' PRO . 19.0 ptt180 -58.61 177.74 0.13 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.303 1.049 . . . . 0.0 113.437 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 68.8 t -136.32 144.7 32.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.766 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -131.1 137.3 49.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.115 0.483 . . . . 0.0 111.376 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.443 HG23 HG12 ' A' ' 257' ' ' ILE . 2.1 mp -98.7 120.34 47.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.629 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.68 135.06 50.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 211' ' ' LEU . 89.4 t -95.43 141.89 14.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.185 0.517 . . . . 0.0 111.694 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 254' ' ' ARG . 41.1 t-20 . . . . . 0 C--N 1.311 -1.091 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.765 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.356 0 N-CA-C 112.218 -0.353 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -116.84 -27.57 6.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.591 0.234 . . . . 0.0 110.835 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 61.9 76.3 0.4 Allowed Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.428 -176.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.54 139.56 14.43 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.918 2.412 . . . . 0.0 111.913 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.14 129.41 24.23 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.69 2.26 . . . . 0.0 111.905 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.16 159.41 47.1 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.922 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.5 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 36.5 Cg_exo -58.86 139.08 89.27 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.97 2.447 . . . . 0.0 112.425 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 5.1 Cg_exo -74.62 61.0 5.26 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.837 2.358 . . . . 0.0 111.607 178.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -80.95 -39.16 26.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.98 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 39.4 m 54.08 -143.89 0.7 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.967 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.22 -161.76 25.56 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.909 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.16 106.95 0.32 Allowed 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.712 2.275 . . . . 0.0 111.634 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 53.9 t -104.43 146.5 28.77 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.121 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -59.28 154.26 16.84 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.19 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.04 69.43 3.32 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.058 0.456 . . . . 0.0 110.039 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 214' ' ' ALA . 35.4 mt -55.53 -27.24 47.67 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.342 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.417 HE22 HG13 ' A' ' 324' ' ' VAL . 2.4 tp-100 -55.95 -60.38 3.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.274 0.559 . . . . 0.0 109.968 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 39.9 t -69.44 -27.1 64.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.178 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.609 ' HB1' ' HE2' ' A' ' 246' ' ' LYS . . . -69.46 -49.32 55.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.273 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 211' ' ' LEU . 29.3 pt -74.08 -40.51 51.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 121.054 -0.259 . . . . 0.0 111.304 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -60.9 -29.6 69.68 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.089 0.471 . . . . 0.0 110.584 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.47 -27.76 68.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.178 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.9 t -89.55 -45.01 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.229 -178.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.53 ' HA ' HG21 ' A' ' 239' ' ' ILE . 75.8 p -67.0 -38.33 85.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.443 0.64 . . . . 0.0 109.861 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.74 21.75 61.1 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.89 -122.64 4.19 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -89.17 159.88 5.73 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.74 2.293 . . . . 0.0 113.979 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.5 mm -78.32 107.99 11.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.406 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.43 118.58 29.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.026 0.441 . . . . 0.0 110.005 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -86.46 152.11 22.95 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.502 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -107.97 63.2 0.28 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.05 132.26 43.02 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -138.98 7.2 2.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.369 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 169.34 -75.55 0.11 Allowed Glycine 0 CA--C 1.503 -0.677 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.896 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -152.56 20.55 0.62 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.6 p -83.72 -59.12 2.53 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.899 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 45.2 tp 58.23 73.85 0.45 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.668 0.746 . . . . 0.0 110.388 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 9.9 pt -123.67 88.45 51.95 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.573 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.46 167.37 24.24 Favored 'Trans proline' 0 C--O 1.239 0.54 0 C-N-CA 122.521 2.147 . . . . 0.0 111.803 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.7 94.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.278 0.561 . . . . 0.0 110.028 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -147.17 114.27 6.2 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.46 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -92.97 -2.1 56.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.293 0.568 . . . . 0.0 110.199 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -74.09 -19.15 60.69 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.819 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.53 HG21 ' HA ' ' A' ' 219' ' ' THR . 90.4 mt -61.63 -37.61 78.34 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 46.6 mt -66.27 -35.07 79.45 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.451 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -69.88 -37.12 75.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.461 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -67.69 -46.77 71.34 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.762 178.481 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.639 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.8 t -61.79 -46.06 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.77 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.08 -31.51 72.76 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.441 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.04 -44.06 97.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.42 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.609 ' HE2' ' HB1' ' A' ' 214' ' ' ALA . 0.6 OUTLIER -75.48 -27.21 58.75 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.596 -179.729 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 43.9 mt -65.39 -28.41 69.24 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 121.205 0.526 . . . . 0.0 109.622 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.539 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 7.0 mtpm? -78.55 -22.36 47.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.318 177.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.94 -30.55 66.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.36 0.6 . . . . 0.0 110.068 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.473 ' HB3' HD11 ' A' ' 211' ' ' LEU . 13.3 t -132.74 69.85 79.27 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 57.5 Cg_endo -67.97 -2.01 7.99 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.442 2.762 . . . . 0.0 114.231 -173.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.46 -18.39 28.35 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.443 0.64 . . . . 0.0 109.939 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -71.88 131.01 42.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.005 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -91.58 138.52 31.5 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.4 m -114.89 130.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-O 121.204 0.526 . . . . 0.0 111.603 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.1 m -107.87 107.48 18.23 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.193 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.419 HG12 HG23 ' A' ' 323' ' ' ILE . 21.6 mt -90.15 117.32 33.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.768 -177.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -105.8 126.92 52.73 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.787 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -107.22 145.78 16.06 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 6.9 m-85 -124.29 158.57 32.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.944 0.402 . . . . 0.0 109.996 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' A' ' 270' ' ' ASN . 16.6 p -144.54 170.1 16.69 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.611 0.764 . . . . 0.0 109.935 177.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.457 ' OD2' ' HD3' ' A' ' 315' ' ' ARG . 19.2 t70 -94.96 166.74 11.8 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.66 9.81 17.56 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.747 0.308 . . . . 0.0 110.723 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.434 ' HB ' ' OD2' ' A' ' 262' ' ' ASP . 12.2 t -64.28 -32.51 74.13 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.751 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -85.52 175.47 49.27 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.99 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 14.5 m -65.73 139.53 58.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.783 0.325 . . . . 0.0 110.702 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.03 140.19 58.82 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' GLY . . . . . 0.481 ' O ' ' HD2' ' A' ' 272' ' ' PRO . . . 96.48 -41.5 2.38 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.167 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp -74.98 -26.68 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.331 0.586 . . . . 0.0 109.926 -178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.576 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 3.7 p30 -65.4 -27.58 68.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.544 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.472 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 27.4 mm -62.65 -63.88 3.68 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-O 119.664 -0.208 . . . . 0.0 110.989 178.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 268' ' ' GLY . 1.6 Cg_endo -53.97 -37.16 85.87 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.428 2.085 . . . . 0.0 111.313 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.469 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 25.2 tp -62.22 -52.55 63.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.428 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 22.3 m -61.48 -30.97 70.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.783 0.325 . . . . 0.0 110.401 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.8 -28.91 64.99 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.885 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.469 ' O ' HG13 ' A' ' 280' ' ' ILE . 51.7 tt0 -71.51 -45.54 62.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 22.1 mmm180 -56.59 -46.84 80.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.524 178.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.85 88.91 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.462 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.655 ' HA ' HG21 ' A' ' 297' ' ' THR . 16.8 ttpt -62.97 -32.06 73.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.912 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 276' ' ' GLN . 64.4 mt -56.22 -43.63 77.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.203 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.718 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 7.8 t -69.62 -44.24 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.126 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.17 73.77 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 123.291 0.369 . . . . 0.0 110.663 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.8 -40.42 84.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.863 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -69.8 -40.35 76.03 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.265 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 46.6 mt -64.77 -47.61 77.53 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 92.3 t -60.92 -39.22 81.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.284 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.91 -28.42 69.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.834 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.604 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 2.4 mmp_? -86.86 4.57 40.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.301 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.9 5.43 44.37 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.043 -1.075 . . . . 0.0 114.649 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 58.0 t -84.18 145.24 8.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 117.801 0.801 . . . . 0.0 109.904 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 295' ' ' ILE . . . -69.3 112.79 6.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.42 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.58 -33.88 87.86 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.067 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -69.76 -12.6 61.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.589 0.233 . . . . 0.0 111.318 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -104.52 1.71 30.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.847 0.356 . . . . 0.0 110.615 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 291' ' ' ALA . 70.4 mt -105.12 131.45 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.922 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.58 125.7 49.43 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.068 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.655 HG21 ' HA ' ' A' ' 279' ' ' LYS . 11.6 p -107.51 129.51 54.95 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.888 0.375 . . . . 0.0 111.406 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.48 136.98 52.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.803 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.49 114.49 4.12 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.408 HD12 ' CE1' ' A' ' 260' ' ' TYR . 17.5 mt -91.48 -5.33 54.41 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 71.3 -135.59 24.1 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.073 -1.061 . . . . 0.0 111.397 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 261' ' ' THR . 7.5 t -87.99 114.56 24.72 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.151 0.5 . . . . 0.0 110.029 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.9 p -176.65 150.31 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 44.7 t30 65.9 78.87 0.25 Allowed Pre-proline 0 C--N 1.311 -1.076 0 O-C-N 123.75 0.656 . . . . 0.0 111.1 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.628 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 39.7 Cg_endo -68.69 138.24 40.87 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.818 2.345 . . . . 0.0 113.154 -177.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 7.4 tt -110.79 -25.43 3.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.768 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -152.45 163.62 39.16 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 47.8 t -62.84 134.23 55.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.042 0.449 . . . . 0.0 110.988 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -80.61 -11.61 59.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.63 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.2 36.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.169 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 3.1 t -124.74 138.03 30.56 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.916 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.99 -26.63 82.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.894 2.396 . . . . 0.0 111.78 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 8.4 mm-40 -65.33 -41.87 93.52 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.3 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.41 -38.38 93.51 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.49 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.457 ' HD3' ' OD2' ' A' ' 262' ' ' ASP . 51.9 mtt-85 -63.6 -37.87 88.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.37 68.89 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.827 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 9.0 mmtp -84.65 -38.45 19.81 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.822 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.628 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 38.5 m-80 -63.74 -21.16 66.27 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 13.0 ptm180 -82.11 14.55 2.79 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.156 0.503 . . . . 0.0 111.232 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -65.42 -174.38 0.18 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.106 0.963 . . . . 0.0 113.13 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.5 t -141.81 148.28 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.722 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -133.84 135.9 44.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.747 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.439 ' H ' HD12 ' A' ' 323' ' ' ILE . 2.6 mp -94.23 119.34 42.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.37 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.417 HG13 HE22 ' A' ' 212' ' ' GLN . 91.6 t -106.62 136.67 40.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 211' ' ' LEU . 55.0 t -101.49 139.61 22.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.341 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.353 177.469 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.417 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -135.71 151.52 50.25 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -157.96 71.25 4.12 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.403 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.437 ' HB2' ' HD3' ' A' ' 200' ' ' PRO . 52.7 Cg_exo -53.59 -47.51 26.9 Favored 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 122.348 2.032 . . . . 0.0 112.209 175.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 199' ' ' PRO . 88.8 Cg_endo -84.07 47.24 2.19 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 121.967 1.778 . . . . 0.0 110.715 175.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.39 94.07 0.37 Allowed Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.632 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.93 140.34 78.9 Favored 'Trans proline' 0 C--O 1.238 0.481 0 C-N-CA 122.62 2.214 . . . . 0.0 112.373 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -52.56 121.42 9.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.613 2.209 . . . . 0.0 111.538 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -82.41 -22.59 35.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.694 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 34.6 t -99.42 129.69 45.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.253 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -82.04 -92.67 0.56 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.67 98.19 1.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.293 1.995 . . . . 0.0 111.493 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 22.3 t -104.06 176.37 5.18 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -51.76 145.04 10.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.728 0.299 . . . . 0.0 111.272 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.73 85.86 1.22 Allowed 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.523 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 250' ' ' CYS . 23.7 mt -70.35 -33.64 71.69 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.939 -177.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -63.76 -45.74 88.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.24 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 31.5 t -75.63 -23.34 56.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.057 0.456 . . . . 0.0 109.917 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.517 ' HB1' ' HE3' ' A' ' 246' ' ' LYS . . . -72.49 -49.91 29.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.206 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 211' ' ' LEU . 26.7 pt -70.63 -38.27 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.868 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -55.7 -37.21 68.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.951 0.405 . . . . 0.0 110.975 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.5 -26.87 68.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.492 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.8 t -92.26 -47.96 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 120.921 0.391 . . . . 0.0 110.63 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.513 ' HA ' HG21 ' A' ' 239' ' ' ILE . 81.6 p -64.35 -39.17 93.36 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.615 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.8 22.51 59.63 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.4 -130.55 6.84 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.19 156.31 25.98 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.573 2.182 . . . . 0.0 112.044 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -74.1 109.29 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -104.33 119.54 39.2 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.494 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -123.33 -174.66 3.01 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.148 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 232' ' ' LEU . . . -64.74 97.95 0.27 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -170.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -85.35 -13.01 50.85 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -64.15 -24.44 67.69 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.783 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -81.7 4.2 75.33 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.946 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 72.37 -58.49 0.59 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.142 0.977 . . . . 0.0 112.085 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.3 m -76.32 4.15 9.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.466 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.494 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 58.4 tp 61.82 87.34 0.1 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.524 0.678 . . . . 0.0 111.2 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 21.4 pt -138.39 134.32 17.49 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.176 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -85.52 126.61 3.1 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.13 1.887 . . . . 0.0 111.32 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -88.11 -53.68 4.6 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.576 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -155.58 102.92 2.26 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.582 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -121.9 111.51 17.17 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.304 0.573 . . . . 0.0 111.196 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -68.05 -20.91 65.02 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.101 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.513 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.8 mt -64.41 -39.8 86.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.33 -33.4 75.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.894 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.455 ' OD1' ' HD3' ' A' ' 288' ' ' ARG . 44.8 t30 -71.73 -36.03 70.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.583 0.706 . . . . 0.0 109.177 177.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.606 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 0.0 OUTLIER -68.52 -42.28 78.73 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.719 177.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.622 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 44.6 t -62.5 -43.9 98.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.334 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -55.82 -37.24 68.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.713 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.606 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 7.7 t70 -49.06 -53.31 20.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.56 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.559 ' HB3' ' NZ ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -82.51 -14.53 54.83 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.821 -176.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.4 mt -80.47 -26.09 38.47 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.339 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.502 ' HG3' HG22 ' A' ' 290' ' ' VAL . 59.6 mtpt -83.54 -23.15 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.628 176.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.84 -37.32 76.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.203 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.562 ' HB3' HD11 ' A' ' 211' ' ' LEU . 24.6 t -130.09 71.97 82.06 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-O 121.339 0.59 . . . . 0.0 109.505 177.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 91.4 Cg_endo -75.35 -1.4 11.25 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.164 2.576 . . . . 0.0 113.244 -178.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -79.15 -29.69 43.19 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.872 0.844 . . . . 0.0 108.872 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -81.46 134.68 35.57 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.733 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -90.79 147.02 23.48 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.953 0.406 . . . . 0.0 110.508 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.13 137.75 52.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.587 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.0 m -114.13 113.1 24.24 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.551 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.457 HG12 HG23 ' A' ' 323' ' ' ILE . 21.4 mt -94.15 113.85 29.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.578 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -98.47 126.66 44.1 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.37 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.411 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -107.48 146.82 16.25 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 36.3 m-85 -127.4 161.89 27.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.1 0.476 . . . . 0.0 110.688 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.604 HG23 ' HB3' ' A' ' 274' ' ' SER . 56.9 p -140.58 173.28 11.65 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.529 175.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -83.62 153.63 24.18 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.509 ' HB3' ' OG ' ' A' ' 302' ' ' SER . 12.3 p30 -95.11 12.85 27.23 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 35.7 p -62.82 -7.74 5.62 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.88 131.6 6.52 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.2 t -43.5 135.2 3.74 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.119 0.568 . . . . 0.0 112.309 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.503 ' OE2' ' HB2' ' A' ' 270' ' ' ASN . 7.1 tp10 -57.84 151.08 18.64 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.097 -177.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 140.07 -60.76 0.56 Allowed Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp -83.15 -27.44 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.465 0.65 . . . . 0.0 109.857 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.528 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 12.3 m-20 -62.87 -36.54 83.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.427 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.487 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 27.3 mm -56.58 -64.22 2.67 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.019 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.487 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 5.1 Cg_endo -56.79 -35.65 98.14 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 121.944 1.763 . . . . 0.0 111.914 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.494 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 60.2 tp -63.07 -52.92 60.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.686 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.604 ' HB3' HG23 ' A' ' 261' ' ' THR . 13.0 p -62.98 -31.52 72.66 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.99 0.424 . . . . 0.0 110.468 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.45 -34.04 77.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.742 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.634 ' O ' HG13 ' A' ' 280' ' ' ILE . 64.2 tt0 -66.92 -44.96 79.38 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 38.8 mmt180 -56.86 -47.38 80.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.008 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.75 88.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.018 0.437 . . . . 0.0 110.373 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.526 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.9 tptt -65.97 -32.36 73.8 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.092 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 276' ' ' GLN . 62.5 mt -58.55 -45.76 90.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.197 0.522 . . . . 0.0 109.684 177.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.699 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.2 t -65.8 -48.08 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.792 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.52 -41.98 70.32 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.076 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.64 -42.63 88.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.472 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -66.84 -43.06 84.69 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.491 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 41.7 mt -64.03 -51.05 66.02 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.887 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.9 t -59.41 -40.55 81.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.91 71.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.555 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.497 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 1.2 mmp_? -83.72 6.23 21.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.064 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.04 9.5 51.73 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.748 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.503 ' CG1' HD11 ' A' ' 295' ' ' ILE . 59.0 t -84.9 141.4 14.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.28 113.86 7.01 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.346 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.01 -32.7 76.34 Favored Glycine 0 C--N 1.318 -0.43 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.707 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.59 -19.15 62.88 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.798 0.332 . . . . 0.0 111.593 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.64 0.32 49.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.473 0.654 . . . . 0.0 110.005 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.503 HD11 ' CG1' ' A' ' 290' ' ' VAL . 63.5 mt -110.81 133.32 56.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.142 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -121.4 129.67 53.15 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.526 HG21 ' HA ' ' A' ' 279' ' ' LYS . 29.9 p -109.02 125.94 52.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.899 0.381 . . . . 0.0 111.429 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.9 t -127.89 117.41 46.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.12 111.96 3.9 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.442 174.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 20.9 mt -96.75 1.1 50.5 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 58.91 -127.47 45.36 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.509 ' OG ' ' HB3' ' A' ' 263' ' ' ASN . 44.4 t -102.34 122.34 44.07 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.463 HG13 ' H ' ' A' ' 304' ' ' ASN . 5.9 p -146.85 -59.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.463 ' H ' HG13 ' A' ' 303' ' ' VAL . 76.1 m-20 -117.46 92.93 41.91 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -66.45 174.24 6.57 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.857 2.371 . . . . 0.0 113.267 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 5.3 tt -131.27 -48.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.591 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -120.51 172.43 7.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.254 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 27.9 m -67.19 139.75 57.44 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.037 0.446 . . . . 0.0 111.351 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -81.01 -10.08 59.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.646 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.14 -16.37 61.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.349 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.6 t -115.82 144.44 32.66 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.513 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.97 -31.32 24.36 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.215 1.943 . . . . 0.0 110.942 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.88 -35.41 81.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.653 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -71.34 -36.97 63.14 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 11.3 mtp85 -57.66 -39.46 77.1 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.59 -30.93 71.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.22 -46.34 20.64 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.807 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -61.69 -26.03 67.78 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 14.9 ptp180 -83.62 10.65 8.69 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.015 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -57.14 177.76 0.08 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.01 0.91 . . . . 0.0 112.715 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 58.4 t -137.37 144.64 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.054 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -131.98 138.42 48.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.984 0.421 . . . . 0.0 111.115 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.457 HG23 HG12 ' A' ' 257' ' ' ILE . 1.6 mp -100.0 120.47 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.992 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 75.1 t -108.45 134.24 50.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 53.5 t -98.1 133.47 40.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--N 1.318 -0.762 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.867 -178.772 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.166 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -91.16 163.15 14.37 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -117.63 91.78 39.29 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-O 120.651 0.263 . . . . 0.0 110.745 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -89.32 117.71 0.8 Allowed 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.99 2.46 . . . . 0.0 112.097 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.17 -24.94 72.67 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.531 2.154 . . . . 0.0 111.748 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 83.22 -124.54 6.59 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.01 150.32 60.44 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.138 1.892 . . . . 0.0 110.992 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.433 ' HG3' ' OD2' ' A' ' 252' ' ' ASP . 11.9 Cg_endo -56.41 107.86 0.3 Allowed 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.632 2.222 . . . . 0.0 112.01 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.54 -38.72 87.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.33 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.5 t -90.63 -34.78 15.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.92 0.39 . . . . 0.0 110.492 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 82.34 88.02 0.7 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.536 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -89.75 37.55 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.944 2.429 . . . . 0.0 111.349 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 34.1 t -137.66 -179.12 5.56 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.781 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -60.92 169.31 1.98 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.288 0.635 . . . . 0.0 112.151 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -84.0 88.83 7.17 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.339 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.438 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.7 mm? -67.86 -39.3 83.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.766 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -57.83 -55.65 32.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.423 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.4 t -67.33 -34.68 77.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.65 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.541 ' HB1' ' HE2' ' A' ' 246' ' ' LYS . . . -64.89 -46.74 80.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.686 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 211' ' ' LEU . 23.6 pt -71.67 -38.6 67.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.501 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -57.68 -33.79 68.72 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.588 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.26 -26.33 68.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.216 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.6 HG11 ' CB ' ' A' ' 242' ' ' ARG . 8.2 t -92.79 -45.73 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.447 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.438 ' HA ' HG21 ' A' ' 239' ' ' ILE . 75.5 p -64.36 -42.91 95.95 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.274 0.559 . . . . 0.0 110.397 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.96 13.45 83.06 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 143.32 -131.25 4.44 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.67 164.77 5.17 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.029 2.486 . . . . 0.0 113.593 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.1 mm -81.69 109.8 16.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.324 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -91.27 121.91 33.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.047 0.451 . . . . 0.0 110.833 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -90.81 158.06 17.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.459 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -141.97 100.36 0.25 Allowed Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -84.72 133.11 34.38 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.777 0.322 . . . . 0.0 111.244 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -125.9 161.14 28.14 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -66.79 -8.7 49.36 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.37 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -91.64 -56.02 3.27 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 120.921 0.391 . . . . 0.0 110.489 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 12.5 t -177.32 -177.5 0.71 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 67.4 tp -78.49 103.25 8.3 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 9.0 tt -106.1 110.02 63.65 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.34 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.02 127.31 13.44 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.074 1.85 . . . . 0.0 111.664 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.96 -25.71 65.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.169 0.509 . . . . 0.0 110.02 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -133.68 91.2 2.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.021 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -81.6 -0.08 40.72 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.871 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -83.54 -27.98 28.95 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.379 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 243' ' ' VAL . 58.6 mt -67.6 -49.01 74.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.795 -175.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.493 ' CD2' HG13 ' A' ' 281' ' ' VAL . 37.6 mt -59.3 -40.41 86.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.206 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -70.78 -36.27 72.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 110.185 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.6 ' CB ' HG11 ' A' ' 218' ' ' VAL . 7.8 mmt180 -63.68 -54.99 26.99 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.5 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.663 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 69.2 t -53.47 -46.8 59.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.646 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.84 85.13 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.764 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -60.15 -45.62 92.42 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.665 0.269 . . . . 0.0 111.605 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.541 ' HE2' ' HB1' ' A' ' 214' ' ' ALA . 0.4 OUTLIER -74.38 -26.27 60.01 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.735 -179.31 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 35.0 mt -69.16 -28.87 66.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.258 0.551 . . . . 0.0 110.279 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.497 ' HG3' HG22 ' A' ' 290' ' ' VAL . 55.6 mtpt -77.08 -24.94 51.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.843 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -73.1 -40.7 64.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.533 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 50.0 t -125.13 73.74 66.47 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 121.332 0.587 . . . . 0.0 109.848 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.65 -0.03 8.8 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.442 2.761 . . . . 0.0 113.424 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.433 ' OD2' ' HG3' ' A' ' 203' ' ' PRO . 32.8 t70 -75.96 -26.7 57.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.887 0.851 . . . . 0.0 109.538 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -78.82 130.09 35.32 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -94.98 142.22 27.74 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.44 HG12 HG22 ' A' ' 325' ' ' VAL . 6.2 m -118.15 135.73 57.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.429 0.633 . . . . 0.0 112.315 -178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.0 m -108.15 108.25 19.23 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.449 HG12 HG23 ' A' ' 323' ' ' ILE . 26.2 mt -91.47 114.3 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.767 -178.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -102.93 129.09 49.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.352 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -105.28 156.62 16.68 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.641 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 19.9 m-85 -132.53 159.31 39.78 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.005 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.8 p -143.1 166.13 25.5 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.434 ' CG ' ' HE ' ' A' ' 315' ' ' ARG . 2.7 p30 -76.16 151.51 36.93 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.009 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -85.09 3.37 39.17 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.577 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.77 -15.0 43.51 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.08 0.467 . . . . 0.0 111.042 177.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -77.57 173.66 54.95 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.715 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.8 t -76.04 123.83 26.41 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 120.655 0.264 . . . . 0.0 110.34 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.542 ' HA ' HD21 ' A' ' 270' ' ' ASN . 41.6 tt0 -63.17 133.45 54.37 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.356 -0.384 . . . . 0.0 109.997 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 113.75 -40.42 2.51 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 120.442 -0.885 . . . . 0.0 110.937 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 42.6 mm -84.76 -29.05 6.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.843 0.83 . . . . 0.0 109.071 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.542 HD21 ' HA ' ' A' ' 267' ' ' GLU . 8.2 p30 -67.08 -32.69 74.02 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.786 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.414 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 22.4 mm -57.44 -63.64 3.52 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.43 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.414 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 17.9 Cg_endo -61.58 -30.12 85.42 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 122.248 1.966 . . . . 0.0 111.96 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.18 -50.14 64.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 110.455 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.42 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 10.0 t -57.24 -40.95 78.62 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.01 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.63 -30.98 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.749 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.472 ' O ' HG13 ' A' ' 280' ' ' ILE . 8.8 tp-100 -69.95 -45.14 68.08 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.993 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -64.07 -39.73 94.72 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.342 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.6 87.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.002 0.43 . . . . 0.0 109.871 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.547 ' HA ' HG21 ' A' ' 297' ' ' THR . 7.8 ttpt -60.54 -36.91 79.57 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.735 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 276' ' ' GLN . 58.9 mt -56.39 -47.05 82.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.811 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.546 ' O ' HD13 ' A' ' 285' ' ' LEU . 17.1 t -63.34 -46.89 94.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.941 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.54 -43.16 89.17 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -61.37 -39.91 92.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.16 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.605 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 8.0 m-85 -70.65 -42.38 70.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.993 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 281' ' ' VAL . 1.8 mp -61.94 -48.85 78.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 84.2 t -60.45 -40.38 84.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.501 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.5 -30.95 71.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.182 0.515 . . . . 0.0 110.608 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 20.7 mmm180 -83.12 5.45 22.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.735 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.51 2.24 40.67 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.075 -1.059 . . . . 0.0 114.45 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 61.4 t -80.55 145.24 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 117.842 0.821 . . . . 0.0 109.829 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.512 ' HB3' ' ND1' ' A' ' 294' ' ' HIS . . . -77.46 118.86 20.31 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.148 0.499 . . . . 0.0 111.376 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.65 -30.88 62.99 Favored Glycine 0 C--O 1.222 -0.612 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.873 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -68.81 -16.92 63.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.512 ' ND1' ' HB3' ' A' ' 291' ' ' ALA . 29.4 m170 -95.85 -5.24 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.724 0.297 . . . . 0.0 110.808 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.425 HD11 ' CG1' ' A' ' 290' ' ' VAL . 40.6 mt -110.83 130.17 64.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.228 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.69 125.71 51.18 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.126 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.547 HG21 ' HA ' ' A' ' 279' ' ' LYS . 29.7 p -111.75 122.56 48.13 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.262 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 28.2 m -120.09 164.24 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.483 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.42 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -134.36 105.15 0.55 Allowed Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 14.4 mt -89.59 2.54 54.54 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 69.99 -126.4 17.07 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.561 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 11.8 p -97.18 120.64 37.9 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.828 0.347 . . . . 0.0 110.651 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.4 p -176.31 150.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.339 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 61.66 81.98 0.23 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 123.488 0.715 . . . . 0.0 111.636 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.564 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 94.3 Cg_endo -80.7 154.55 20.49 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.458 2.106 . . . . 0.0 113.004 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.1 tt -119.0 -53.41 3.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.665 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -119.21 166.56 12.82 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.7 p -65.01 143.9 57.64 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.111 0.482 . . . . 0.0 111.491 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -80.19 -7.52 59.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.416 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.17 -18.71 63.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.846 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.7 t -113.72 135.54 21.98 Favored Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.697 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.6 -33.41 86.86 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.789 2.326 . . . . 0.0 111.137 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.0 mm-40 -66.36 -39.94 89.47 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.247 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -69.03 -37.66 83.2 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.123 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.434 ' HE ' ' CG ' ' A' ' 262' ' ' ASP . 80.6 mtp180 -61.49 -37.67 84.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.112 0.482 . . . . 0.0 109.724 176.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.63 68.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.661 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 1.0 OUTLIER -80.71 -39.76 26.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.367 177.723 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.564 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 44.3 m-80 -65.7 -22.13 66.6 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 39.0 ptt180 -84.41 10.78 9.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.279 0.561 . . . . 0.0 111.507 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 18.7 ptt-85 -58.74 178.58 0.11 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.952 0.882 . . . . 0.0 112.698 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 49.7 t -138.35 145.4 28.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.562 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -130.21 137.01 49.83 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.932 0.396 . . . . 0.0 110.61 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.449 HG23 HG12 ' A' ' 257' ' ' ILE . 2.2 mp -97.22 116.97 40.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.407 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.67 137.38 39.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 255' ' ' VAL . 49.2 t -100.25 138.81 23.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 C--N 1.31 -1.125 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.416 178.906 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.454 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -143.89 -49.82 0.3 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.185 0.517 . . . . 0.0 109.644 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.37 158.43 63.58 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.541 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.85 130.54 37.26 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.335 2.024 . . . . 0.0 111.513 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.87 22.13 0.41 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.86 2.374 . . . . 0.0 112.976 -179.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.442 ' HA3' ' HD3' ' A' ' 202' ' ' PRO . . . -90.19 -117.67 1.84 Allowed Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.811 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.442 ' HD3' ' HA3' ' A' ' 201' ' ' GLY . 14.9 Cg_exo -70.27 112.8 3.26 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.822 2.348 . . . . 0.0 111.973 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.58 -70.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.424 2.082 . . . . 0.0 110.647 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -139.5 27.3 2.29 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.6 p -56.65 149.61 17.39 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.805 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 106.41 104.81 2.97 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.15 -36.8 99.23 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.844 2.363 . . . . 0.0 111.889 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 4.3 m -153.81 -177.75 6.59 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.865 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.54 149.65 42.49 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.206 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.89 73.7 2.13 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.153 0.501 . . . . 0.0 110.199 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.542 ' HB2' HG21 ' A' ' 325' ' ' VAL . 16.4 mt -56.83 -27.67 60.47 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.81 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.05 -42.87 88.92 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.758 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 26.0 t -73.19 -31.88 64.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.53 -47.88 77.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.894 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.416 HG21 HG13 ' A' ' 243' ' ' VAL . 20.9 pt -73.85 -33.7 37.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.121 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -56.36 -37.88 70.67 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.079 0.466 . . . . 0.0 110.466 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.28 -29.74 70.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.877 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.717 HG12 HG23 ' A' ' 239' ' ' ILE . 32.5 t -82.38 -52.52 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.671 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.468 ' HA ' HG21 ' A' ' 239' ' ' ILE . 76.0 p -64.86 -36.23 83.68 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.424 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.67 12.62 79.78 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.27 -125.87 2.78 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -91.35 167.23 3.5 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.839 2.359 . . . . 0.0 112.936 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.6 mm -84.22 110.46 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.008 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -100.23 124.39 45.61 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.996 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.418 ' HD2' HD11 ' A' ' 232' ' ' LEU . 0.1 OUTLIER -172.2 141.34 1.25 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.539 -177.696 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 72.92 93.54 0.1 OUTLIER Glycine 0 C--O 1.236 0.221 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.443 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -86.71 173.17 9.65 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -85.1 131.32 34.46 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.66 88.13 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.011 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -119.93 179.78 4.15 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.5 t -90.33 -178.76 5.45 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.418 HD11 ' HD2' ' A' ' 225' ' ' PHE . 2.6 tm? -79.71 86.13 5.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 11.0 pt -104.59 111.63 65.23 Favored Pre-proline 0 C--N 1.313 -0.984 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.637 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -83.26 134.44 6.83 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.698 2.265 . . . . 0.0 112.462 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -81.86 91.74 6.58 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.771 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.5 t70 66.44 94.6 0.06 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.294 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -81.26 5.75 16.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -64.36 -29.25 70.32 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.717 HG23 HG12 ' A' ' 218' ' ' VAL . 71.6 mt -64.09 -44.72 97.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.149 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.421 HD13 ' CD2' ' A' ' 284' ' ' TYR . 28.9 mt -57.2 -36.17 70.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.228 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.444 ' HA ' ' HG2' ' A' ' 288' ' ' ARG . 3.5 m-20 -79.94 -38.2 32.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.171 0.51 . . . . 0.0 110.321 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.688 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -64.87 -40.48 95.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.105 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.602 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 28.1 t -59.07 -41.42 83.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.971 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' A' ' 288' ' ' ARG . . . -59.84 -37.22 78.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.826 -177.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.57 -44.9 73.35 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.456 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -82.19 -16.18 50.64 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.709 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 23.5 mt -81.06 -22.56 39.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.518 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 9.7 tptm -71.82 -25.05 61.83 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.685 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -64.03 -46.47 84.3 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.394 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.43 ' HB3' HD11 ' A' ' 211' ' ' LEU . 52.1 t -128.92 75.94 79.68 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 60.8 Cg_endo -71.42 -2.61 11.53 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.958 2.439 . . . . 0.0 113.243 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.09 -23.38 23.73 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.405 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -62.3 138.26 58.4 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.604 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -93.88 133.21 37.53 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 325' ' ' VAL . 5.1 m -112.59 129.2 68.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-O 121.141 0.496 . . . . 0.0 110.751 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 33.3 m -103.84 108.66 20.08 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.051 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.449 HG12 HG23 ' A' ' 323' ' ' ILE . 24.5 mt -93.83 108.86 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -98.15 128.46 44.65 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.921 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.491 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -104.67 144.86 15.87 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 177.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 8.6 m-85 -126.13 163.62 22.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.692 0.282 . . . . 0.0 110.327 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 45.6 p -143.21 162.47 35.54 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.296 0.638 . . . . 0.0 109.616 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -68.77 151.78 46.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.075 0.464 . . . . 0.0 110.889 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -77.69 -5.16 49.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.717 -177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.433 HG21 ' CZ ' ' A' ' 315' ' ' ARG . 0.7 OUTLIER -84.02 -27.59 28.27 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.56 179.02 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -106.11 37.39 3.84 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.738 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.489 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 14.4 m -92.7 75.48 4.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.125 0.488 . . . . 0.0 110.505 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -128.67 25.47 5.68 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.914 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 272' ' ' PRO . . . 110.44 -48.84 0.9 Allowed Glycine 0 CA--C 1.503 -0.668 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.107 177.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 269' ' ' ILE . 1.7 mp -61.49 -24.79 34.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 123.615 0.766 . . . . 0.0 110.559 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' A' ' 266' ' ' SER . 0.7 OUTLIER -54.64 -38.87 67.38 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.149 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.41 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 19.6 mm -60.43 -63.9 3.72 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.072 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 268' ' ' GLY . 11.8 Cg_endo -60.74 -30.97 91.37 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.867 1.711 . . . . 0.0 112.33 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 60.3 tp -65.52 -53.09 47.31 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.776 0.322 . . . . 0.0 111.477 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.491 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.9 p -61.82 -30.39 70.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 120.933 0.396 . . . . 0.0 110.767 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.38 -32.76 66.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.255 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.496 ' O ' HG13 ' A' ' 280' ' ' ILE . 57.0 tp60 -66.17 -49.7 66.46 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.762 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -61.95 -38.63 89.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.908 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.34 97.13 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.841 0.353 . . . . 0.0 110.295 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.56 ' HA ' HG21 ' A' ' 297' ' ' THR . 11.5 tmtt? -61.7 -38.33 87.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.15 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 276' ' ' GLN . 57.4 mt -55.59 -47.38 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.733 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 9.7 t -65.19 -48.92 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -53.64 -45.77 70.31 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -58.48 -41.69 85.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.706 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.603 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 6.9 m-85 -68.41 -41.32 80.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.716 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.733 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 43.8 mt -62.93 -46.44 87.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 95.0 t -58.78 -41.68 83.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.176 176.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.29 -28.5 68.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.503 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.603 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -83.54 -1.27 53.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.169 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 111.05 5.91 26.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.478 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.6 t -89.92 141.81 13.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 117.605 0.703 . . . . 0.0 110.443 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 295' ' ' ILE . . . -67.42 115.34 6.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.478 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.72 -35.61 92.24 Favored Glycine 0 CA--C 1.508 -0.346 0 CA-C-N 115.689 -0.687 . . . . 0.0 113.221 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -68.99 -14.52 63.09 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.055 0.455 . . . . 0.0 111.441 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -102.52 2.58 36.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.112 0.482 . . . . 0.0 110.402 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 291' ' ' ALA . 76.0 mt -105.97 132.44 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.38 127.87 54.09 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.783 0.325 . . . . 0.0 110.482 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.56 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.8 p -110.95 126.63 54.96 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.54 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.58 123.69 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -94.2 104.04 3.1 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 174.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.6 -3.08 58.99 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 78.98 -125.59 7.08 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.148 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 18.5 t -101.67 119.4 38.72 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.9 p -176.8 148.2 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 62.39 78.64 0.29 Allowed Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 123.186 0.595 . . . . 0.0 111.018 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.474 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 59.4 Cg_endo -73.03 151.4 49.97 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.36 2.04 . . . . 0.0 112.716 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.491 HG22 ' HA ' ' A' ' 318' ' ' ASN . 4.2 tt -111.16 -54.64 5.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.307 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.428 ' H ' HG23 ' A' ' 306' ' ' ILE . . . -120.15 170.54 9.22 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.765 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 15.5 m -62.38 137.49 58.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.263 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -80.92 -14.43 58.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.863 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.16 -18.45 65.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.229 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 314' ' ' GLY . 3.7 t -114.87 142.24 28.08 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.378 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.29 -28.05 40.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.494 2.129 . . . . 0.0 111.366 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 4.9 mt-10 -65.07 -38.98 92.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.411 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.417 ' H ' HG23 ' A' ' 311' ' ' THR . . . -70.15 -38.45 72.7 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.666 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.433 ' CZ ' HG21 ' A' ' 264' ' ' THR . 96.0 mtt180 -61.02 -39.04 88.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.101 0.477 . . . . 0.0 109.886 177.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.92 -26.77 68.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.629 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 3.6 mmtp -85.61 -37.17 19.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.491 ' HA ' HG22 ' A' ' 306' ' ' ILE . 35.9 m-80 -63.57 -20.94 66.05 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 14.6 ptp180 -88.06 15.19 7.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.313 0.577 . . . . 0.0 111.162 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.457 ' HB3' ' O ' ' A' ' 317' ' ' LYS . 26.2 ptt-85 -61.33 -176.32 0.07 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.085 0.945 . . . . 0.0 112.609 175.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 70.7 t -137.71 145.55 28.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.944 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -131.83 140.66 49.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.951 0.405 . . . . 0.0 110.827 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.449 HG23 HG12 ' A' ' 257' ' ' ILE . 1.3 mp -99.0 117.05 43.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.364 -178.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.64 135.02 47.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 211' ' ' LEU . 74.9 t -101.49 136.83 31.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 C--N 1.31 -1.142 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.921 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.294 0 N-CA-C 112.274 -0.331 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -84.81 -169.82 2.83 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.815 0.34 . . . . 0.0 110.447 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -80.78 123.73 82.2 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.56 143.52 81.82 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.583 2.189 . . . . 0.0 112.187 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.63 120.28 6.78 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.887 2.391 . . . . 0.0 111.468 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 73.28 68.6 1.55 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 15.3 Cg_exo -68.77 120.62 7.52 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.896 2.397 . . . . 0.0 112.098 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 14.1 Cg_exo -68.33 129.75 19.79 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.417 2.078 . . . . 0.0 111.817 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -86.99 -21.01 26.43 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.018 0.437 . . . . 0.0 110.571 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 19.4 m -68.3 111.05 4.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.634 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 105.13 86.09 1.89 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.658 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.86 -11.47 29.44 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.586 2.19 . . . . 0.0 112.363 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 47.9 t -140.08 168.79 18.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.169 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -67.26 174.2 3.4 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.863 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -80.39 56.52 2.55 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.006 0.432 . . . . 0.0 110.509 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 250' ' ' CYS . 20.4 mt -53.18 -25.9 15.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -66.21 -37.79 86.41 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.327 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.0 t -77.67 -30.67 52.11 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 211' ' ' LEU . . . -65.49 -46.24 80.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.81 -1.087 . . . . 0.0 111.011 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 25.2 pt -73.73 -37.46 49.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.422 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.15 -31.67 69.18 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.916 0.389 . . . . 0.0 110.863 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.7 -27.05 67.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.894 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.0 p -99.17 -34.84 4.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.282 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.634 ' HA ' HG21 ' A' ' 239' ' ' ILE . 66.8 p -70.28 -37.23 74.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.279 0.561 . . . . 0.0 110.039 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.28 22.62 56.55 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.31 -132.34 7.75 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.551 ' HB2' ' HG3' ' A' ' 320' ' ' ARG . 58.3 Cg_endo -80.95 163.34 20.56 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.622 2.215 . . . . 0.0 112.632 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.6 mm -83.17 101.96 8.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.333 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -98.02 128.8 44.79 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.513 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -169.81 140.3 2.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.445 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -138.15 48.69 0.87 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.831 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -89.47 95.44 10.27 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.88 136.86 32.79 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.491 -174.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 82.79 -59.89 4.92 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.723 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.51 -30.6 61.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.479 0.18 . . . . 0.0 111.439 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.0 m 61.08 -161.13 0.29 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.988 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 51.8 mt -95.76 82.81 3.62 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.094 0.474 . . . . 0.0 111.252 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.522 ' H ' ' HD2' ' A' ' 234' ' ' PRO . 70.8 mt -97.19 -57.45 0.18 Allowed Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.291 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.522 ' HD2' ' H ' ' A' ' 233' ' ' ILE . 49.0 Cg_endo -67.89 158.14 58.63 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.079 1.853 . . . . 0.0 111.997 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -79.67 42.22 0.52 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.152 0.501 . . . . 0.0 111.292 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.38 -34.91 73.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.509 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -99.46 77.58 2.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.358 0.599 . . . . 0.0 111.055 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.63 -17.43 62.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.406 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.634 HG21 ' HA ' ' A' ' 219' ' ' THR . 88.0 mt -56.69 -38.34 57.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.842 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.41 HD22 HG13 ' A' ' 281' ' ' VAL . 57.5 mt -65.23 -31.65 72.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.854 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.417 ' OD1' ' HD3' ' A' ' 288' ' ' ARG . 7.9 t30 -71.14 -37.74 72.27 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -40.89 83.56 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.201 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.605 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.9 t -57.03 -42.76 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.014 177.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.01 82.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.328 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -52.22 -49.65 63.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.504 ' HD2' ' H ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -73.45 -30.27 63.09 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.469 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.7 mt -69.97 -30.96 68.43 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.627 0.727 . . . . 0.0 109.17 177.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -62.79 -35.08 78.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.042 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -73.23 -35.7 66.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.785 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.529 ' HB3' HD11 ' A' ' 211' ' ' LEU . 43.7 t -128.33 69.99 78.87 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.92 2.13 4.5 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.55 2.834 . . . . 0.0 114.656 -174.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -80.48 -26.29 38.33 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.418 0.628 . . . . 0.0 109.99 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.567 ' HB2' ' SG ' ' A' ' 208' ' ' CYS . . . -61.94 133.94 56.02 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.023 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -96.6 135.66 38.21 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.505 HG12 HG22 ' A' ' 325' ' ' VAL . 6.7 m -113.35 133.26 59.81 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.873 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 34.1 m -108.85 107.3 17.65 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.025 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.453 HG12 HG23 ' A' ' 323' ' ' ILE . 19.8 mt -94.97 115.4 33.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.991 -177.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -101.41 131.34 47.56 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.896 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.474 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -111.41 141.43 16.55 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 318' ' ' ASN . 2.1 m-85 -124.17 161.46 25.64 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.542 HG23 ' HB3' ' A' ' 274' ' ' SER . 50.6 p -136.58 173.42 11.73 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -83.55 158.93 21.78 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -74.81 -7.0 52.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.597 -177.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.46 -28.21 34.25 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.201 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.01 154.37 49.78 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.149 174.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 45.3 m -75.11 137.83 41.66 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.13 0.491 . . . . 0.0 111.958 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.54 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 1.1 pm0 -62.82 139.49 58.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.094 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.84 -40.84 2.32 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.484 -177.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 46.2 mm -85.17 -30.26 6.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.72 0.772 . . . . 0.0 109.144 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.54 ' ND2' ' HA ' ' A' ' 267' ' ' GLU . 15.0 p30 -63.82 -35.31 80.2 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.136 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.414 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 19.7 mm -58.68 -64.36 2.98 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.71 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.414 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 19.6 Cg_endo -62.12 -26.85 78.34 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 121.819 1.679 . . . . 0.0 111.662 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 46.7 tp -65.22 -56.44 12.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.732 0.301 . . . . 0.0 110.999 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.542 ' HB3' HG23 ' A' ' 261' ' ' THR . 6.9 p -65.48 -28.17 69.02 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.719 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.42 -32.16 68.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.045 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.549 ' O ' HG13 ' A' ' 280' ' ' ILE . 0.0 OUTLIER -70.34 -47.33 61.53 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.121 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -55.37 -43.87 75.51 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.032 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.81 -39.19 93.19 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 110.659 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.541 ' HA ' HG21 ' A' ' 297' ' ' THR . 0.9 OUTLIER -63.21 -33.92 76.53 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.524 179.137 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 276' ' ' GLN . 60.4 mt -57.25 -42.98 81.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.985 0.422 . . . . 0.0 110.073 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.574 ' O ' HD13 ' A' ' 285' ' ' LEU . 3.7 t -70.28 -43.47 78.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.759 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.36 -45.72 80.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.395 178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.25 -41.93 89.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.396 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.498 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 1.5 m-85 -65.12 -43.94 90.32 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.108 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 281' ' ' VAL . 3.8 mp -63.57 -47.59 80.89 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 99.1 t -60.02 -42.65 90.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.288 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.72 -27.12 68.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.566 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.575 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 2.8 mmp_? -86.21 5.02 36.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.999 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.89 5.9 43.79 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.258 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 57.4 t -86.32 143.61 11.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.604 0.702 . . . . 0.0 109.908 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.58 112.06 8.3 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.042 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.52 -32.66 73.82 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.243 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.29 -20.28 64.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.053 0.454 . . . . 0.0 111.222 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -102.74 3.48 36.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.938 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.5 mt -107.65 129.9 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-O 120.876 0.37 . . . . 0.0 110.845 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.69 125.74 49.43 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.071 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.541 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.3 p -110.33 129.15 55.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.943 0.401 . . . . 0.0 111.074 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.4 t -132.43 116.58 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.012 0.434 . . . . 0.0 111.927 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -92.08 109.58 3.77 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 20.7 mt -87.67 -32.19 19.35 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 95.81 -142.08 15.92 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.4 p -77.58 109.11 11.27 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.737 0.303 . . . . 0.0 110.512 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.412 HG13 ' HD2' ' A' ' 260' ' ' TYR . 15.0 p -174.46 150.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.2 t30 66.46 79.96 0.23 Allowed Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.273 175.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.699 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 38.1 Cg_endo -69.61 135.6 31.22 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.556 2.171 . . . . 0.0 113.075 -178.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.489 HG22 ' HA ' ' A' ' 318' ' ' ASN . 5.2 tt -112.92 -29.27 2.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.748 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -145.83 174.95 10.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.925 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.476 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 29.4 m -62.61 121.19 12.73 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.549 0.53 . . . . 0.0 110.846 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -80.65 -14.29 58.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.45 -16.06 62.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.159 0.504 . . . . 0.0 111.128 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.491 ' OG1' ' HG3' ' A' ' 313' ' ' GLU . 4.9 t -117.6 143.9 33.18 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.948 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.07 -31.03 76.21 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.441 2.094 . . . . 0.0 111.551 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.491 ' HG3' ' OG1' ' A' ' 311' ' ' THR . 4.0 mt-10 -59.14 -44.7 92.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.066 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -69.94 -37.64 74.44 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.894 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.68 -38.42 87.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.401 . . . . 0.0 110.066 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.19 -28.22 69.52 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.483 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 8.2 mmtp -81.81 -45.81 15.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.455 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.699 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 33.5 m-80 -57.98 -29.48 65.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 5.1 ptp180 -80.62 15.75 1.6 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.551 ' HG3' ' HB2' ' A' ' 222' ' ' PRO . 0.0 OUTLIER -69.39 -176.98 1.05 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.084 0.945 . . . . 0.0 112.704 179.682 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 89.2 t -131.9 143.32 40.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.756 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -132.53 142.16 49.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.02 0.438 . . . . 0.0 111.079 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.453 HG23 HG12 ' A' ' 257' ' ' ILE . 1.5 mp -101.73 120.54 51.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.853 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 66.9 t -109.72 135.31 49.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.505 HG22 HG12 ' A' ' 255' ' ' VAL . 58.1 t -102.14 140.01 21.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.92 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.1 t30 . . . . . 0 C--N 1.311 -1.092 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.721 178.169 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.238 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 60.86 37.29 18.64 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.209 0.528 . . . . 0.0 111.619 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -94.78 150.18 37.51 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.035 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.64 145.93 79.03 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.282 1.988 . . . . 0.0 110.825 176.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -40.82 -47.43 4.77 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.565 2.843 . . . . 0.0 113.115 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.93 -176.14 18.4 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.023 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 13.9 Cg_exo -70.57 137.84 33.96 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.988 2.459 . . . . 0.0 111.728 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 32.4 Cg_exo -60.75 114.15 2.02 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.372 2.048 . . . . 0.0 111.25 176.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -126.13 27.45 6.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.084 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.2 m -62.26 133.66 55.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.703 -177.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 142.26 109.12 0.72 Allowed Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.933 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -57.57 -64.69 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.914 2.41 . . . . 0.0 112.139 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 14.6 t -153.13 -178.31 6.86 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -59.32 148.57 31.78 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.304 0.377 . . . . 0.0 110.325 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.56 86.04 4.59 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.299 0.571 . . . . 0.0 110.343 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.568 ' HB2' HG21 ' A' ' 325' ' ' VAL . 48.0 mt -71.17 -23.19 62.01 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.104 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 216' ' ' ASN . 51.7 tt0 -66.18 -38.99 89.36 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.355 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.3 t -73.25 -40.59 64.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.13 75.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.579 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.498 ' CG2' HG13 ' A' ' 243' ' ' VAL . 23.3 pt -70.37 -38.61 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.349 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 212' ' ' GLN . 10.2 t-20 -62.95 -27.41 69.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.034 0.445 . . . . 0.0 110.524 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.19 -28.41 67.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.935 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.2 t -89.93 -44.67 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.384 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.57 ' HA ' HG21 ' A' ' 239' ' ' ILE . 70.8 p -67.81 -36.79 81.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.763 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.1 26.73 47.6 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.64 -141.13 13.38 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.05 160.18 36.92 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.832 2.355 . . . . 0.0 111.79 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 320' ' ' ARG . 46.1 mm -73.49 106.36 3.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.756 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -80.48 118.84 22.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.302 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -88.81 151.7 22.21 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.307 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -82.92 78.8 1.97 Allowed Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 176.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.86 68.67 0.43 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.578 0.704 . . . . 0.0 112.452 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -143.44 -33.48 0.43 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.857 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -103.31 22.57 35.87 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.981 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 70.97 -60.49 0.51 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.793 0.837 . . . . 0.0 112.209 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.7 t -105.13 -176.88 3.21 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.452 HD11 ' CZ ' ' A' ' 237' ' ' TYR . 34.6 tp -84.52 157.84 21.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.018 0.437 . . . . 0.0 110.906 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 7.5 tt -93.72 120.03 66.48 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.625 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.9 154.19 58.35 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 123.097 2.531 . . . . 0.0 112.658 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 54.73 32.41 17.34 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.378 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -124.9 -41.09 2.13 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.281 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.452 ' CZ ' HD11 ' A' ' 232' ' ' LEU . 3.4 m-85 -75.02 89.62 2.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.337 0.589 . . . . 0.0 112.002 -177.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.93 -19.76 60.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.57 HG21 ' HA ' ' A' ' 219' ' ' THR . 79.2 mt -61.88 -38.47 80.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.9 mt -69.45 -25.37 64.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.709 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' A' ' 288' ' ' ARG . 7.3 t30 -72.71 -38.14 67.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.612 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -68.11 -38.39 82.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.193 177.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.602 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.9 t -62.04 -45.02 99.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.562 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.95 74.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.986 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.612 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 1.5 t70 -46.6 -51.11 16.4 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.016 0.926 . . . . 0.0 112.522 178.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.563 ' HB3' ' NZ ' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -84.68 -15.97 43.44 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.903 -177.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.6 mt -78.85 -28.83 44.31 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.54 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 59.5 mtpt -82.51 -17.11 46.25 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.916 177.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.38 -37.77 83.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.978 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.519 ' HB3' HD11 ' A' ' 211' ' ' LEU . 48.3 t -131.38 71.0 81.87 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 176.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 61.0 Cg_endo -72.44 0.85 6.87 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.951 2.434 . . . . 0.0 112.846 -177.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.35 -31.1 42.93 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -72.52 141.7 48.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.473 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.19 142.16 27.95 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.526 HG12 HG22 ' A' ' 325' ' ' VAL . 5.4 m -113.93 130.87 67.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 CA-C-O 121.277 0.56 . . . . 0.0 110.725 177.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.4 m -106.88 108.09 19.43 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.178 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.403 HG12 HG23 ' A' ' 323' ' ' ILE . 29.8 mt -92.95 113.75 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.27 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -98.63 122.53 41.96 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.018 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.464 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -105.28 151.75 17.2 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.368 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -125.14 167.43 14.82 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.376 0.608 . . . . 0.0 110.948 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 8.1 t -160.25 156.81 27.07 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.965 174.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.6 155.33 40.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.912 0.387 . . . . 0.0 110.831 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -83.92 4.22 30.56 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.925 -175.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.423 HG21 ' CZ ' ' A' ' 315' ' ' ARG . 1.9 p -76.83 -21.5 54.95 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.091 0.472 . . . . 0.0 110.578 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -113.77 49.15 0.87 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.434 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 11.2 t -90.57 85.21 6.05 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.068 0.461 . . . . 0.0 110.529 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -126.6 17.31 7.52 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.204 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 92.97 -16.72 59.76 Favored Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 34.3 mm -82.17 -20.91 10.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.474 -0.863 . . . . 0.0 108.883 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' A' ' 266' ' ' SER . 0.8 OUTLIER -55.86 -43.21 76.9 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.007 178.413 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.42 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 26.1 mm -55.51 -64.43 2.19 Favored Pre-proline 0 CA--C 1.557 1.246 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.796 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.42 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 18.9 Cg_endo -62.74 -27.17 75.41 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.79 1.66 . . . . 0.0 112.647 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.6 tp -66.45 -53.54 34.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 110.87 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.464 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.0 p -60.81 -31.4 70.8 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.24 0.543 . . . . 0.0 110.157 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.56 -42.31 91.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.719 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.512 ' O ' HG13 ' A' ' 280' ' ' ILE . 27.6 tt0 -60.06 -43.71 95.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.093 178.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -58.78 -47.09 85.93 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.11 73.48 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.115 0.483 . . . . 0.0 110.729 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.623 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.2 tptt -67.34 -31.5 71.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.051 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 276' ' ' GLN . 53.4 mt -58.9 -40.35 80.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 0.0 109.895 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.697 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.7 t -68.76 -44.46 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.904 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.59 73.74 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.851 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.22 -42.31 81.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.533 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.643 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 0.8 OUTLIER -64.29 -47.4 79.64 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.446 178.724 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 34.8 mt -63.85 -49.5 72.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.055 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.02 -39.17 81.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.151 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.5 -26.09 68.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.192 0.52 . . . . 0.0 110.686 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.1 mmp_? -86.44 2.47 47.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.974 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.88 12.79 48.87 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.911 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.532 HG22 ' HG3' ' A' ' 248' ' ' LYS . 58.6 t -85.22 140.62 15.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.53 110.03 4.01 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.987 0.422 . . . . 0.0 111.365 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.98 -33.09 63.3 Favored Glycine 0 C--O 1.225 -0.451 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.89 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.23 -19.46 65.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.821 0.343 . . . . 0.0 111.622 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -102.06 1.76 36.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.051 0.453 . . . . 0.0 110.375 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.5 mt -105.62 127.02 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.122 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.97 125.51 50.55 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.39 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.623 HG21 ' HA ' ' A' ' 279' ' ' LYS . 40.8 p -105.49 121.85 44.78 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.8 t -125.63 115.9 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.156 0.503 . . . . 0.0 111.793 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.0 108.64 3.49 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 21.8 mt -91.15 0.37 57.55 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.77 0.319 . . . . 0.0 111.206 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.32 -126.12 30.34 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.022 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 15.4 m -103.32 116.45 32.47 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.601 HG23 ' H ' ' A' ' 304' ' ' ASN . 6.0 m -140.46 -64.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.354 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.601 ' H ' HG23 ' A' ' 303' ' ' VAL . 33.9 m-80 -117.96 90.67 37.59 Favored Pre-proline 0 N--CA 1.439 -0.997 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.62 176.77 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.577 2.185 . . . . 0.0 112.345 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -128.78 -49.03 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.694 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -110.45 176.79 4.91 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.633 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 18.5 m -65.77 131.63 46.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.525 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -79.22 -8.23 58.86 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.458 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -80.6 -11.2 59.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.55 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.516 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 2.6 t -119.44 138.88 26.98 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.337 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.46 -32.52 70.95 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.594 2.196 . . . . 0.0 111.656 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -67.43 -35.42 79.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.757 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.59 -38.11 85.82 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 311' ' ' THR . 97.9 mtt180 -66.08 -21.88 66.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.478 0.656 . . . . 0.0 109.787 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.41 ' O ' ' HG2' ' A' ' 319' ' ' ARG . . . -78.73 -28.97 45.06 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.308 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -77.62 -42.93 33.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.157 0.503 . . . . 0.0 109.765 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -64.96 -8.87 17.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 18.7 ptp180 -98.93 11.66 38.21 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 223' ' ' ILE . 4.8 ptm180 -69.03 -174.67 0.64 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 76.2 t -137.03 151.74 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.623 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.54 138.55 50.25 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 122.672 0.389 . . . . 0.0 110.64 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.41 ' H ' HD12 ' A' ' 323' ' ' ILE . 2.1 mp -100.74 122.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.834 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 95.1 t -113.18 137.41 46.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.568 HG21 ' HB2' ' A' ' 211' ' ' LEU . 85.1 t -101.93 136.38 34.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 120.8 0.333 . . . . 0.0 110.713 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 C--N 1.313 -0.993 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.06 -178.685 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.292 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -89.03 129.7 35.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.792 0.329 . . . . 0.0 110.546 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . . . -97.53 110.91 56.98 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.717 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 198' ' ' ALA . 4.7 Cg_exo -76.12 154.65 37.47 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.65 2.233 . . . . 0.0 111.032 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.18 -1.19 11.16 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.442 2.095 . . . . 0.0 112.025 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 76.3 -110.67 3.1 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.86 155.0 70.02 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.278 1.985 . . . . 0.0 111.501 176.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.58 173.37 7.92 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.468 2.112 . . . . 0.0 112.584 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -87.61 28.92 0.93 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.035 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.555 ' HB2' ' OD1' ' A' ' 252' ' ' ASP . 2.2 m -74.86 169.45 17.91 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.615 0.245 . . . . 0.0 110.357 -177.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -135.75 -104.15 0.75 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.307 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.79 153.01 59.02 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 122.984 2.456 . . . . 0.0 113.795 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 209' ' ' ALA . 41.2 t -146.72 -175.47 4.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.595 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.443 ' N ' ' SG ' ' A' ' 208' ' ' CYS . . . -54.03 174.6 0.05 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.36 0.664 . . . . 0.0 111.57 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -82.67 77.48 9.43 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.992 -0.443 . . . . 0.0 110.007 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.422 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.2 mm? -68.06 -35.31 78.01 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.762 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -63.33 -42.7 98.97 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.558 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 31.0 t -75.38 -27.97 59.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.282 0.563 . . . . 0.0 109.508 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -69.82 -46.72 65.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.627 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.477 ' CG2' HG13 ' A' ' 243' ' ' VAL . 23.4 pt -77.1 -41.43 31.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -61.34 -29.74 70.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.943 0.402 . . . . 0.0 110.876 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.37 -24.26 67.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.173 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.93 -45.46 13.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.033 0.444 . . . . 0.0 110.298 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.516 ' HA ' HG21 ' A' ' 239' ' ' ILE . 74.3 p -64.79 -38.2 90.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.013 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.79 20.54 53.52 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.197 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.67 -134.7 8.36 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.491 ' HB3' HH11 ' A' ' 320' ' ' ARG . 60.6 Cg_endo -78.52 161.22 28.31 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.282 1.988 . . . . 0.0 112.337 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.86 108.9 13.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.635 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.74 119.79 36.96 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -86.9 158.38 19.32 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.596 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.76 97.42 1.21 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -76.19 113.58 13.9 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.949 0.404 . . . . 0.0 111.346 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -95.98 -29.87 13.91 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.461 0.648 . . . . 0.0 109.471 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 120.03 -43.33 1.57 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.09 -43.62 16.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.085 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 51.1 p -157.32 -171.37 3.58 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.081 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 232' ' ' LEU . 1.1 pt? -100.76 130.12 46.75 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.061 0.457 . . . . 0.0 109.805 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 12.5 tt -143.72 101.3 5.03 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-O 121.361 0.601 . . . . 0.0 110.483 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.04 155.86 13.13 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.4 2.067 . . . . 0.0 111.506 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.18 -50.21 49.64 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.155 0.503 . . . . 0.0 110.326 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -97.09 64.2 1.94 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.36 0.6 . . . . 0.0 110.947 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -69.79 -13.32 62.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.152 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -65.72 -20.53 66.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.987 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.516 HG21 ' HA ' ' A' ' 219' ' ' THR . 82.4 mt -62.88 -37.79 80.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.045 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.478 ' CD2' HG13 ' A' ' 281' ' ' VAL . 47.3 mt -62.84 -34.75 77.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 110.644 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -73.8 -39.36 64.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.572 177.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.496 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -65.09 -44.87 87.43 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.762 179.551 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.599 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 29.9 t -57.82 -43.59 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.704 177.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.11 85.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.114 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -52.38 -49.91 63.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -77.98 -20.05 53.33 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.878 -178.319 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 35.1 mt -78.13 -32.33 50.32 Favored 'General case' 0 C--O 1.214 -0.779 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.599 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.531 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 61.4 mtpt -74.95 -18.64 60.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.864 176.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.09 -34.49 75.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.326 0.584 . . . . 0.0 109.646 175.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 53.4 t -128.67 71.8 80.97 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.056 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 59.8 Cg_endo -70.62 0.14 6.75 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.681 2.254 . . . . 0.0 112.981 -176.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.555 ' OD1' ' HB2' ' A' ' 205' ' ' SER . 11.4 t70 -88.62 -25.34 22.49 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -57.67 138.13 55.73 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.78 130.29 45.97 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 325' ' ' VAL . 12.3 m -122.03 134.61 64.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-O 121.39 0.614 . . . . 0.0 111.937 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.3 m -110.58 113.31 25.83 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.221 -0.899 . . . . 0.0 108.827 178.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.442 HG12 HG23 ' A' ' 323' ' ' ILE . 23.1 mt -92.68 113.83 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -101.98 126.25 48.85 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.363 -176.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -106.15 150.54 16.89 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.668 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -127.9 159.75 33.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.017 0.437 . . . . 0.0 110.436 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 274' ' ' SER . 70.1 p -141.02 169.83 16.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.331 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.411 ' CG ' ' HE ' ' A' ' 315' ' ' ARG . 18.0 t70 -73.35 153.92 40.3 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.682 0.277 . . . . 0.0 110.801 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -61.57 2.9 0.15 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.525 ' HB ' ' NH2' ' A' ' 315' ' ' ARG . 11.4 t -60.1 -21.05 61.04 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.486 0.314 . . . . 0.0 111.832 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -127.66 126.08 5.4 Favored Glycine 0 N--CA 1.434 -1.465 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.122 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 20.2 m -100.12 90.42 4.36 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 66.05 169.44 0.22 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.92 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.36 -95.46 1.53 Allowed Glycine 0 C--O 1.21 -1.352 0 C-N-CA 119.728 -1.225 . . . . 0.0 113.417 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp -84.83 -42.18 16.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 122.868 0.467 . . . . 0.0 111.813 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.436 ' H ' ' ND2' ' A' ' 270' ' ' ASN . 1.2 p30 -55.46 -34.96 64.99 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.703 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.501 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.6 mm -58.17 -67.12 1.01 Allowed Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.269 177.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.501 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.5 Cg_endo -57.98 -30.69 90.72 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 121.934 1.756 . . . . 0.0 111.78 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.75 -54.63 32.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.463 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.491 ' HB3' HG23 ' A' ' 261' ' ' THR . 9.8 p -60.94 -32.7 72.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.793 0.33 . . . . 0.0 110.437 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.91 -31.64 71.56 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.079 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.479 ' O ' HG13 ' A' ' 280' ' ' ILE . 51.5 tt0 -69.68 -48.9 58.11 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -60.24 -41.96 94.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.21 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.91 -39.07 90.76 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.019 0.438 . . . . 0.0 110.525 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.728 ' HA ' HG21 ' A' ' 297' ' ' THR . 21.6 ttpt -66.18 -30.16 70.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.361 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 276' ' ' GLN . 64.1 mt -55.96 -45.4 80.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 110.023 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.732 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.8 t -64.56 -46.99 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.728 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.69 -43.05 76.07 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.362 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.61 -41.66 86.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.359 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.436 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 8.4 m-85 -71.12 -40.83 71.2 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.413 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 46.6 mt -64.59 -48.53 74.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.8 t -61.23 -39.66 83.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.466 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.29 -30.8 71.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.127 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.436 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 1.2 mpt_? -81.65 2.1 31.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.664 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.72 3.13 46.46 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.233 -0.984 . . . . 0.0 114.449 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.469 HG22 ' HG3' ' A' ' 248' ' ' LYS . 58.9 t -79.26 143.36 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 117.896 0.848 . . . . 0.0 109.782 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.02 110.06 4.28 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.032 0.444 . . . . 0.0 111.446 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.01 -18.47 64.66 Favored Glycine 0 CA--C 1.508 -0.389 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.339 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -72.14 -22.53 61.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.161 0.505 . . . . 0.0 110.425 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -104.5 5.43 34.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.035 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.455 HD11 ' CG1' ' A' ' 290' ' ' VAL . 63.8 mt -109.42 128.79 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.32 128.43 55.05 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.1 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.728 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.1 p -115.05 120.66 40.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 120.915 0.388 . . . . 0.0 111.251 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.84 166.42 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.341 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -134.41 109.71 0.81 Allowed Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 14.8 mt -97.04 -1.24 45.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.595 0.236 . . . . 0.0 111.304 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.06 -123.76 26.82 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.319 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 3.8 t -106.28 120.1 40.98 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 304' ' ' ASN . 5.6 m -141.74 -58.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.344 -177.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.462 ' H ' HG23 ' A' ' 303' ' ' VAL . 22.1 m-80 -116.86 92.32 38.2 Favored Pre-proline 0 N--CA 1.442 -0.846 0 CA-C-O 120.687 0.279 . . . . 0.0 110.259 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.26 166.29 11.29 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.681 2.254 . . . . 0.0 112.478 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' A' ' 318' ' ' ASN . 3.5 tt -121.48 -45.35 2.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.874 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -128.11 168.78 14.89 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.305 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 35.5 t -62.58 135.33 57.34 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.685 0.615 . . . . 0.0 110.983 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.79 -9.35 59.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.386 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.39 66.96 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.777 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.574 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.9 t -114.16 140.18 24.64 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.84 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.28 -27.79 55.69 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.247 1.965 . . . . 0.0 111.105 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.8 mt-10 -62.77 -41.45 99.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.72 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.49 -38.06 86.19 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.477 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.574 ' HG3' ' O ' ' A' ' 311' ' ' THR . 40.9 mtp180 -63.6 -30.23 71.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.384 0.612 . . . . 0.0 109.929 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.22 -27.47 63.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.279 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 13.3 mmtp -80.14 -40.58 27.12 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.372 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.402 ' HA ' HG22 ' A' ' 306' ' ' ILE . 27.3 m-80 -58.13 -24.38 58.57 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -177.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 18.0 ptp180 -83.47 9.75 10.48 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.977 0.418 . . . . 0.0 112.017 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.491 HH11 ' HB3' ' A' ' 222' ' ' PRO . 34.3 ptt85 -57.16 176.28 0.12 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.949 0.881 . . . . 0.0 112.909 175.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.6 t -139.73 147.48 23.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.158 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.17 138.1 50.45 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 110.992 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.442 HG23 HG12 ' A' ' 257' ' ' ILE . 2.4 mp -96.1 116.03 36.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.496 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.94 136.79 42.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 255' ' ' VAL . 56.9 t -101.27 139.52 22.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 . . . . . 0 C--N 1.325 -0.483 0 O-C-N 123.926 0.766 . . . . 0.0 111.132 178.617 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.49 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -65.16 -51.93 58.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.363 0.601 . . . . 0.0 109.851 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.63 ' H ' ' HD2' ' A' ' 199' ' ' PRO . . . -139.94 -54.9 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.371 177.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.63 ' HD2' ' H ' ' A' ' 198' ' ' ALA . 86.5 Cg_endo -80.4 173.44 12.41 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 121.918 1.745 . . . . 0.0 110.202 175.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.68 -74.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.292 1.995 . . . . 0.0 112.355 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 77.59 84.23 0.52 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.994 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.29 127.02 20.77 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.778 2.318 . . . . 0.0 112.43 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.61 121.06 9.37 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.893 2.395 . . . . 0.0 112.144 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -115.79 -43.87 2.98 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.476 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 40.0 m -130.95 126.81 37.05 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.439 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 140.41 87.16 0.12 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.621 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.2 121.77 8.78 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.479 2.119 . . . . 0.0 110.439 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 34.9 t -103.76 144.65 31.2 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.697 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.99 169.09 4.57 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.741 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.72 83.75 4.85 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 250' ' ' CYS . 25.6 mt -79.36 -24.72 42.48 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.452 -178.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -60.97 -51.05 70.88 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.8 t -70.92 -36.4 72.66 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.818 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.519 ' HB1' ' HZ3' ' A' ' 246' ' ' LYS . . . -59.42 -44.53 92.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.798 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 211' ' ' LEU . 27.1 pt -75.89 -39.52 37.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.177 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -60.16 -34.44 73.57 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 110.688 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.97 -24.03 67.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.726 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.8 t -94.98 -45.19 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 120.899 0.38 . . . . 0.0 110.296 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.563 ' HA ' HG21 ' A' ' 239' ' ' ILE . 80.6 p -66.46 -39.66 88.95 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.127 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.1 30.29 55.46 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 119.02 -132.15 9.48 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.451 ' HA ' ' HG2' ' A' ' 322' ' ' GLU . 63.7 Cg_endo -79.76 157.22 24.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.457 2.104 . . . . 0.0 113.322 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 38.6 mm -73.99 108.45 5.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.892 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -81.83 145.11 30.58 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.39 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -113.77 142.03 46.56 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.019 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -76.07 -56.18 4.51 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 231' ' ' SER . 85.7 m-20 -113.51 165.16 12.75 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 173.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -102.98 123.94 47.54 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.899 0.381 . . . . 0.0 111.218 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 94.92 -51.4 1.95 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.502 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -153.57 169.06 24.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.507 0.194 . . . . 0.0 111.138 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.532 ' O ' ' HB2' ' A' ' 227' ' ' ASN . 48.8 m 67.86 91.11 0.09 Allowed 'General case' 0 CA--C 1.531 0.224 0 O-C-N 124.036 0.835 . . . . 0.0 112.318 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.97 43.59 1.16 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.247 0.546 . . . . 0.0 109.985 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.559 ' HB ' ' HD3' ' A' ' 234' ' ' PRO . 55.5 mt -71.27 -51.4 10.14 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.577 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 233' ' ' ILE . 11.6 Cg_exo -72.02 155.93 56.65 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.668 1.579 . . . . 0.0 110.032 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 63.21 -154.24 0.33 Allowed 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -131.45 153.92 49.24 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.991 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -115.78 12.4 15.9 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.254 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -77.28 -20.6 54.84 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.877 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.563 HG21 ' HA ' ' A' ' 219' ' ' THR . 75.6 mt -64.38 -38.02 81.49 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 8.3 mp -64.62 -36.13 83.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.803 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -69.93 -39.0 76.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.864 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.526 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -66.14 -41.99 89.7 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.032 178.308 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.623 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.1 t -57.93 -42.83 83.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.364 177.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.75 86.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.262 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.15 -49.18 67.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.519 ' HZ3' ' HB1' ' A' ' 214' ' ' ALA . 0.0 OUTLIER -72.09 -29.75 64.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.315 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 26.2 mt -70.53 -27.93 64.54 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 18.6 tptp -63.63 -34.44 77.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.675 178.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.59 -39.53 73.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.432 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.55 ' HB3' HD11 ' A' ' 211' ' ' LEU . 38.4 t -127.17 68.48 72.49 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 73.5 Cg_endo -72.21 0.21 7.66 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.385 2.723 . . . . 0.0 113.976 -174.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -91.04 -18.24 24.92 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.673 0.749 . . . . 0.0 109.36 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.543 ' HB2' ' SG ' ' A' ' 208' ' ' CYS . . . -63.33 150.86 42.34 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.357 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -104.22 133.97 48.24 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.164 0.507 . . . . 0.0 110.434 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.551 HG12 HG22 ' A' ' 325' ' ' VAL . 12.5 m -117.84 136.49 54.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.174 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.3 m -112.54 109.8 19.58 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.332 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.442 HG12 HG23 ' A' ' 323' ' ' ILE . 21.8 mt -92.24 115.0 30.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -103.12 129.54 50.01 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.691 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.429 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -108.04 151.64 16.98 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.364 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 57.3 m-85 -126.71 163.47 23.43 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.082 0.468 . . . . 0.0 110.977 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.527 HG23 ' HB3' ' A' ' 274' ' ' SER . 71.9 p -142.88 163.7 32.08 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.971 176.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -73.76 151.83 40.53 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -77.6 -0.22 25.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -48.15 13.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -83.06 48.38 4.02 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 11.5 p -96.5 113.65 25.24 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 120.877 0.37 . . . . 0.0 110.815 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -156.13 3.36 0.16 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.976 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 111.3 -31.8 6.93 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.03 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp -71.98 -21.26 20.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.75 0.786 . . . . 0.0 109.619 -177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -34.95 67.02 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.431 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.468 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.1 mm -60.99 -65.07 2.4 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.093 177.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.468 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.2 Cg_endo -58.3 -30.02 89.71 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 121.91 1.74 . . . . 0.0 111.974 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 59.6 tp -64.29 -54.94 25.26 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.24 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.527 ' HB3' HG23 ' A' ' 261' ' ' THR . 5.2 p -63.4 -26.79 68.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.749 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.47 -28.4 64.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.852 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -76.18 -42.09 47.51 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -59.25 -46.42 88.56 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.142 177.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.33 74.88 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.98 0.419 . . . . 0.0 110.454 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.54 ' HA ' HG21 ' A' ' 297' ' ' THR . 23.8 tptm -63.53 -32.44 73.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.098 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 54.6 mt -58.87 -43.17 87.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.017 0.437 . . . . 0.0 110.077 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.697 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.8 t -66.86 -46.58 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.946 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.35 -41.45 76.12 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.889 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.13 -43.74 78.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.964 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' TYR . . . . . 0.554 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 8.5 m-85 -70.77 -41.61 71.5 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.483 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 42.7 mt -63.76 -49.15 74.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 68.8 t -59.74 -42.2 87.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.284 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.55 -28.48 69.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.944 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.9 mmp_? -84.42 4.11 33.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.751 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.13 6.83 41.88 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 119.859 -1.162 . . . . 0.0 114.375 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 53.0 t -86.18 143.76 10.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 117.717 0.759 . . . . 0.0 109.725 177.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.47 114.42 10.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.898 0.38 . . . . 0.0 111.514 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.72 -32.79 70.4 Favored Glycine 0 C--O 1.23 -0.143 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.998 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.45 -21.44 66.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.087 0.47 . . . . 0.0 111.66 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -100.48 1.27 40.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.914 0.387 . . . . 0.0 110.57 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.35 129.12 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.854 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.54 127.69 53.86 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.202 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 279' ' ' LYS . 10.7 p -110.62 120.4 42.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.726 0.298 . . . . 0.0 111.002 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.16 130.52 60.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.945 0.402 . . . . 0.0 111.331 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -97.51 117.5 5.81 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.341 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 27.1 mt -91.3 -3.53 56.76 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.39 0.138 . . . . 0.0 111.176 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.63 -138.71 48.24 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.351 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 2.1 m -89.25 115.91 27.09 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.475 HG13 ' H ' ' A' ' 304' ' ' ASN . 4.6 p -143.79 -61.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.611 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.475 ' H ' HG13 ' A' ' 303' ' ' VAL . 91.6 m-20 -116.04 93.95 40.12 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -67.74 167.14 21.99 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.544 2.163 . . . . 0.0 112.782 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.41 HD13 ' HB3' ' A' ' 317' ' ' LYS . 2.5 tt -125.07 -49.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.279 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -124.66 170.8 10.6 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.393 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.3 p -71.11 139.61 50.36 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 123.547 0.53 . . . . 0.0 111.874 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -81.46 -11.07 59.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.418 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -61.63 -26.63 68.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.103 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 314' ' ' GLY . 4.4 t -113.65 139.42 23.37 Favored Pre-proline 0 N--CA 1.436 -1.164 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.693 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.14 -32.42 91.15 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.905 2.404 . . . . 0.0 111.84 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 35.5 mm-40 -63.8 -40.99 97.96 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.262 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.458 ' H ' HG23 ' A' ' 311' ' ' THR . . . -66.53 -37.87 92.95 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.379 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.4 -39.73 84.35 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.51 ' HA ' ' HD3' ' A' ' 319' ' ' ARG . . . -61.04 -29.94 70.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.686 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 10.9 mmpt? -77.6 -44.62 27.74 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.297 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -60.88 -29.87 69.81 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.51 ' HD3' ' HA ' ' A' ' 316' ' ' ALA . 3.5 ptm180 -83.41 11.71 6.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.2 ptt-85 -57.43 178.87 0.06 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.254 1.022 . . . . 0.0 112.898 174.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 94.1 t -137.74 147.68 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.583 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 222' ' ' PRO . 48.5 mt-10 -132.66 137.81 47.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.397 . . . . 0.0 111.415 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.442 HG23 HG12 ' A' ' 257' ' ' ILE . 2.8 mp -98.98 121.25 49.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.041 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.83 138.73 39.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.551 HG22 HG12 ' A' ' 255' ' ' VAL . 52.8 t -104.21 143.28 16.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 C--N 1.32 -0.706 0 O-C-N 123.519 0.512 . . . . 0.0 110.349 177.461 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.45 0 CA-C-O 120.706 0.288 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.435 ' HB3' ' OG ' ' A' ' 213' ' ' SER . 3.7 m-20 -75.88 81.31 2.79 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.093 0.473 . . . . 0.0 110.758 -176.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 250' ' ' CYS . 32.5 mt -72.87 -26.67 61.53 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.509 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 59.9 tp60 -59.47 -56.29 23.8 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.542 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 210' ' ' ASP . 4.2 p -66.38 -31.3 71.99 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 120.882 0.372 . . . . 0.0 110.293 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.16 -54.14 42.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.466 ' CG2' HG13 ' A' ' 243' ' ' VAL . 19.8 pt -69.04 -38.13 77.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.844 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.49 -34.44 69.05 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.598 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.29 -29.74 70.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.379 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.49 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.6 t -89.01 -45.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.895 0.379 . . . . 0.0 110.741 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.585 ' HA ' HG21 ' A' ' 239' ' ' ILE . 76.6 p -67.15 -35.42 79.67 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.251 0.548 . . . . 0.0 110.743 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.49 24.78 60.12 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 125.84 -134.66 8.8 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.2 164.98 14.92 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.449 2.099 . . . . 0.0 112.77 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.9 mm -82.61 109.21 16.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.976 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.825 0 CA-C-O 121.034 0.445 . . . . 0.0 111.103 179.193 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 121.073 0.463 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.585 HG21 ' HA ' ' A' ' 219' ' ' THR . 87.7 mt -62.0 -41.07 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.129 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.12 -32.07 73.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.067 0.461 . . . . 0.0 110.427 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.29 -37.27 69.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.49 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -68.98 -45.78 69.76 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.328 178.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.569 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 42.5 t -56.78 -44.43 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.969 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -58.86 -34.32 71.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.434 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.2 -45.83 75.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -14.69 53.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.98 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.4 mt -79.29 -26.55 42.29 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.639 ' HG3' HG22 ' A' ' 290' ' ' VAL . 58.6 mtpt -82.54 -21.83 35.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.386 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.06 -37.69 84.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.056 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.463 ' HB3' HD11 ' A' ' 211' ' ' LEU . 48.0 t -130.23 74.4 80.42 Favored Pre-proline 0 N--CA 1.434 -1.242 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.834 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 74.6 Cg_endo -74.16 1.3 7.39 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.1 2.533 . . . . 0.0 112.283 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -74.96 -29.15 60.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.93 0.872 . . . . 0.0 108.773 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -73.63 164.47 26.6 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.058 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 254' ' ' ARG . 0.0 OUTLIER -120.75 137.23 54.61 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.675 176.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.2 m -120.37 134.61 63.29 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 121.198 0.523 . . . . 0.0 111.562 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 49.9 m -111.43 113.24 25.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.515 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.413 HG12 HG23 ' A' ' 323' ' ' ILE . 21.8 mt -91.87 111.58 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -98.87 125.54 44.3 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.532 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.446 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -106.58 144.16 15.83 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.389 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.58 165.04 17.83 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.961 0.41 . . . . 0.0 110.56 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.515 HG23 ' HB3' ' A' ' 274' ' ' SER . 68.5 p -143.98 172.48 12.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.761 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 C--N 1.316 -0.849 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 175.081 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.444 -0.729 0 CA-C-O 122.005 0.907 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.495 HD22 ' HA3' ' A' ' 301' ' ' GLY . 1.0 OUTLIER -59.67 -33.6 71.77 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.873 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.507 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 32.8 mm -60.02 -65.53 2.04 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.043 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.507 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 8.3 Cg_endo -57.21 -32.67 94.23 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.211 1.94 . . . . 0.0 112.106 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.16 -55.13 20.41 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.718 0.294 . . . . 0.0 111.617 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.515 ' HB3' HG23 ' A' ' 261' ' ' THR . 8.3 p -64.34 -27.87 69.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.788 0.328 . . . . 0.0 111.128 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.94 -27.55 64.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.526 ' O ' HG13 ' A' ' 280' ' ' ILE . 28.6 tt0 -73.89 -44.44 55.26 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.416 HH21 HD11 ' A' ' 280' ' ' ILE . 3.9 mmp_? -57.62 -46.49 84.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.568 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.58 91.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.287 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.524 ' HA ' HG21 ' A' ' 297' ' ' THR . 2.2 tmtp? -60.49 -35.8 76.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.333 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 276' ' ' GLN . 56.6 mt -55.41 -45.09 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.855 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.718 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 9.1 t -67.42 -45.7 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.978 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.24 -44.26 79.46 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.43 -38.89 78.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.558 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.585 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 5.5 m-85 -69.51 -41.82 75.54 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.935 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 44.6 mt -64.11 -49.89 70.41 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.496 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 97.2 t -60.55 -38.9 79.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.533 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.93 -25.98 68.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.721 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.8 mmp_? -89.11 4.01 49.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.902 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.9 10.93 41.63 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.956 -1.116 . . . . 0.0 114.284 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.639 HG22 ' HG3' ' A' ' 248' ' ' LYS . 46.3 t -85.58 141.88 13.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.908 0.854 . . . . 0.0 109.752 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.1 108.1 2.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.995 0.426 . . . . 0.0 111.473 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.84 -33.36 68.04 Favored Glycine 0 C--O 1.228 -0.264 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.321 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.28 -15.08 63.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.173 0.511 . . . . 0.0 111.58 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -104.62 2.04 30.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.976 0.417 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.438 HD11 ' CG1' ' A' ' 290' ' ' VAL . 55.5 mt -107.69 129.8 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -116.69 125.28 51.49 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.524 HG21 ' HA ' ' A' ' 279' ' ' LYS . 24.7 p -111.43 122.55 48.14 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.665 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.24 161.14 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-O 121.167 0.508 . . . . 0.0 111.158 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -126.49 111.61 1.44 Allowed Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.462 ' HB3' HG21 ' A' ' 303' ' ' VAL . 18.4 mt -97.38 -8.5 29.37 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.495 ' HA3' HD22 ' A' ' 270' ' ' ASN . . . 63.24 -130.92 41.76 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 119.806 -1.188 . . . . 0.0 111.579 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 55.9 p -91.91 114.33 26.84 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.035 0.445 . . . . 0.0 109.902 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.601 ' O ' ' HD3' ' A' ' 305' ' ' PRO . 46.2 t -134.98 -67.72 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.4 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -108.09 91.34 7.79 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.221 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.627 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 7.6 Cg_exo -70.47 127.11 13.59 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.558 2.172 . . . . 0.0 111.891 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.7 tt -85.32 -42.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.774 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -131.08 170.36 14.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.128 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 27.7 m -69.62 136.16 50.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.86 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -76.62 -7.31 54.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.554 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -59.32 -29.77 67.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.942 0.401 . . . . 0.0 110.654 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.443 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 2.6 t -114.25 141.0 25.73 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.475 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.42 -31.45 94.83 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.723 2.282 . . . . 0.0 111.651 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 13.0 mm-40 -55.37 -50.75 68.89 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.953 177.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.438 ' H ' HG23 ' A' ' 311' ' ' THR . . . -63.01 -36.96 94.18 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.833 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 311' ' ' THR . 57.1 mtt180 -62.68 -35.56 80.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.846 0.355 . . . . 0.0 110.197 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.7 70.54 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.443 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 317' ' ' LYS . 15.1 mmtp -77.51 -41.31 39.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.947 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.627 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 42.0 m-20 -63.57 -24.4 67.79 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 12.0 ptm180 -83.68 6.44 20.96 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -58.18 170.86 0.62 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.153 0.978 . . . . 0.0 113.372 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 71.4 t -131.8 144.58 36.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.191 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -130.92 138.19 49.65 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.099 0.476 . . . . 0.0 111.186 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.465 ' HB ' HD12 ' A' ' 215' ' ' ILE . 2.4 mp -96.27 116.39 38.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.461 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.409 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 98.5 t -109.66 138.16 38.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.533 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 211' ' ' LEU . 59.3 t -98.74 132.93 43.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.681 -179.33 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.485 0 CA-C-O 120.846 0.355 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -78.68 66.3 4.15 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.379 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 250' ' ' CYS . 22.1 mt -53.55 -27.09 24.12 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -60.18 -51.83 67.9 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 121.018 0.437 . . . . 0.0 110.205 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.7 t -72.45 -28.25 62.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.415 0.626 . . . . 0.0 109.687 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' A' ' 211' ' ' LEU . . . -67.16 -51.39 54.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.134 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.461 ' CG2' HG13 ' A' ' 243' ' ' VAL . 26.1 pt -70.78 -38.5 73.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.485 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.79 -30.01 68.6 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.003 0.43 . . . . 0.0 110.767 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.17 -26.09 65.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.088 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.466 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.6 t -91.03 -46.28 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.993 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.616 ' HA ' HG21 ' A' ' 239' ' ' ILE . 40.1 p -67.13 -35.96 80.85 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.147 0.499 . . . . 0.0 110.855 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.96 18.97 68.5 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 129.27 -138.02 9.97 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.886 -0.657 . . . . 0.0 111.52 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . 0.62 ' HB2' ' NE ' ' A' ' 320' ' ' ARG . 1.4 Cg_endo -82.8 160.49 16.25 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.051 2.5 . . . . 0.0 112.498 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.571 ' O ' ' HB2' ' A' ' 320' ' ' ARG . 47.2 mm -81.1 115.88 24.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.201 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.796 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 174.538 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 CA--C 1.517 -0.294 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.616 HG21 ' HA ' ' A' ' 219' ' ' THR . 96.9 mt -59.01 -36.82 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.902 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.32 -30.48 70.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.431 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.4 ' HA ' ' HG3' ' A' ' 288' ' ' ARG . 3.5 m-20 -70.59 -40.8 73.04 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.466 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -64.89 -47.04 79.22 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.645 178.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.602 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 39.0 t -58.12 -44.06 86.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.042 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.74 -34.61 73.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.361 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.31 -44.67 80.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.011 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.415 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -82.02 -15.01 55.09 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.798 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.7 mt -79.83 -28.09 40.16 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 290' ' ' VAL . 54.9 mtpt -81.47 -18.22 45.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.216 175.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.5 -38.08 80.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.723 176.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.513 ' HB3' HD11 ' A' ' 211' ' ' LEU . 29.1 t -135.18 72.87 65.91 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.568 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 65.0 Cg_endo -72.69 2.25 5.48 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.948 2.432 . . . . 0.0 113.165 -177.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.13 -29.84 54.89 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.811 0.815 . . . . 0.0 109.285 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -77.57 135.86 38.21 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.526 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.86 142.26 27.96 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.5 m -114.83 131.38 67.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.134 0.493 . . . . 0.0 111.213 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.2 m -107.86 110.16 21.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.323 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.0 mt -93.07 109.43 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -98.13 128.47 44.65 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.537 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.405 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -110.47 145.9 17.32 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.496 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 28.5 m-85 -127.27 162.17 26.85 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.82 0.343 . . . . 0.0 110.309 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 59.2 p -138.75 173.68 11.32 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.618 177.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--N 1.311 -1.098 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.901 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 CA--C 1.51 -0.561 0 CA-C-O 121.828 0.823 . . . . 0.0 108.811 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.41 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 76.5 m-20 -63.37 -34.92 78.77 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.197 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.453 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 29.7 mm -56.44 -65.68 1.51 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.764 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.453 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 21.0 Cg_endo -61.83 -28.19 81.26 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 121.95 1.767 . . . . 0.0 111.964 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.3 -55.75 16.54 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.738 0.304 . . . . 0.0 111.168 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 261' ' ' THR . 6.2 p -62.3 -31.08 71.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.706 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.63 -28.22 65.73 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.305 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.474 ' O ' HG13 ' A' ' 280' ' ' ILE . 7.3 tp-100 -76.39 -40.87 49.74 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -61.67 -41.82 98.07 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.498 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.27 -32.99 74.93 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.059 0.457 . . . . 0.0 110.214 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.528 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.9 tmtt? -64.72 -36.06 83.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.387 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 276' ' ' GLN . 53.0 mt -57.15 -42.42 79.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.034 0.445 . . . . 0.0 110.228 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.692 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 7.2 t -68.72 -47.15 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.057 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.77 -43.38 80.77 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.95 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -57.25 -42.11 80.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.419 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 1.5 m-85 -65.1 -52.05 57.71 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.511 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 33.8 mt -55.23 -50.72 68.72 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.591 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 77.6 t -60.71 -40.38 84.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.621 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.18 -23.54 67.48 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.232 0.539 . . . . 0.0 110.733 178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.539 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 4.5 mmp_? -88.93 5.03 45.95 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.228 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 98.06 12.67 45.36 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 119.93 -1.128 . . . . 0.0 114.109 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 248' ' ' LYS . 48.5 t -88.61 145.95 6.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 117.604 0.702 . . . . 0.0 109.48 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -71.34 111.57 6.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.47 -34.84 77.07 Favored Glycine 0 N--CA 1.46 0.235 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.264 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.38 -18.41 65.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.242 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -101.64 -0.03 35.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.162 0.506 . . . . 0.0 110.364 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 66.5 mt -106.38 132.57 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.87 126.41 51.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.691 0.281 . . . . 0.0 110.726 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.528 HG21 ' HA ' ' A' ' 279' ' ' LYS . 53.0 p -104.98 121.14 43.14 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.14 113.18 35.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.256 0.551 . . . . 0.0 112.241 -175.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.9 103.72 3.04 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 24.5 mt -87.69 -0.24 56.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.47 -138.73 36.4 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.662 -176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 7.8 p -84.27 114.3 21.74 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 120.728 0.299 . . . . 0.0 110.285 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.0 p -174.9 148.45 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 55.6 t30 64.08 75.03 0.4 Allowed Pre-proline 0 C--N 1.31 -1.128 0 O-C-N 123.712 0.633 . . . . 0.0 110.862 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.612 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 5.2 Cg_endo -80.87 133.61 9.17 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 122.305 2.003 . . . . 0.0 112.6 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.8 tt -94.37 -48.36 13.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.205 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -123.92 176.78 6.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.725 0.298 . . . . 0.0 111.025 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.43 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 47.8 m -66.39 128.08 34.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.43 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -80.54 -12.25 59.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.648 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.86 -18.32 63.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.956 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.479 HG23 ' H ' ' A' ' 314' ' ' GLY . 5.2 t -116.39 144.23 32.69 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.858 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.49 -37.36 71.35 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.627 2.218 . . . . 0.0 111.894 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 1.8 mt-10 -58.96 -41.19 86.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.278 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.479 ' H ' HG23 ' A' ' 311' ' ' THR . . . -69.82 -40.3 75.35 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.859 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -60.24 -36.38 77.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.887 0.375 . . . . 0.0 110.253 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.8 -30.01 71.15 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.645 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 11.8 mmtp -80.64 -44.4 18.91 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.612 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 44.6 m-80 -61.66 -28.09 69.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 10.7 ptm85 -84.91 11.47 9.3 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.62 ' NE ' ' HB2' ' A' ' 222' ' ' PRO . 9.2 ptm180 -73.57 -178.0 2.91 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 99.6 t -135.18 151.76 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.866 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.473 ' HG2' ' HB3' ' A' ' 222' ' ' PRO . 43.1 mt-10 -131.72 142.05 49.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.843 0.354 . . . . 0.0 110.971 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.45 116.02 41.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.39 141.96 24.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.46 135.41 36.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 57.7 t30 . . . . . 0 C--N 1.313 -0.995 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.406 -179.811 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.339 0 CA-C-O 120.716 0.293 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.62 71.94 3.25 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.027 0.441 . . . . 0.0 110.035 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 250' ' ' CYS . 29.9 mt -70.22 -31.09 68.36 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.603 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -65.39 -41.61 93.53 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.53 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.5 t -71.73 -37.11 70.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.91 -51.02 66.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.206 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.472 ' CG2' HG13 ' A' ' 243' ' ' VAL . 26.6 pt -67.63 -38.09 79.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.685 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.46 -36.25 73.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.115 0.484 . . . . 0.0 110.496 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.28 -26.02 68.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.574 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.7 t -91.87 -47.81 13.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.552 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.553 ' HA ' HG21 ' A' ' 239' ' ' ILE . 72.7 p -64.76 -39.75 94.14 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.878 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.12 15.22 79.23 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 140.99 -139.22 9.43 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.87 166.43 13.2 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.601 2.201 . . . . 0.0 112.559 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.0 mm -81.3 109.58 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.538 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.927 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.934 177.832 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 CA--C 1.516 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 219' ' ' THR . 75.3 mt -59.97 -38.41 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.638 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 62.8 mt -67.85 -28.32 67.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.709 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -74.99 -36.8 61.98 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.478 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -65.9 -43.13 89.14 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.899 176.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.589 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 40.1 t -61.65 -46.18 97.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.818 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.53 -37.07 69.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.305 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 15.0 t70 -49.8 -50.49 44.74 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.461 ' HB2' HD22 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -83.14 -14.42 53.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.382 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 33.9 mt -81.37 -29.49 34.0 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.528 ' HG3' HG22 ' A' ' 290' ' ' VAL . 62.1 mtpt -82.32 -22.27 35.69 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.506 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -71.75 -32.09 67.34 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.06 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.502 ' HB3' HD11 ' A' ' 211' ' ' LEU . 42.2 t -132.65 70.78 79.19 Favored Pre-proline 0 N--CA 1.434 -1.24 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.439 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 82.1 Cg_endo -74.09 2.5 6.03 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.165 2.577 . . . . 0.0 113.194 -177.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -75.26 -25.26 57.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.866 0.841 . . . . 0.0 109.597 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -77.51 169.82 17.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.603 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -122.44 144.9 48.76 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.67 125.47 74.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.296 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 41.9 m -103.1 108.6 19.85 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.92 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.414 HG12 HG23 ' A' ' 323' ' ' ILE . 21.2 mt -96.36 108.79 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.84 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.61 128.4 45.71 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.856 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.419 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -106.9 148.1 16.34 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.565 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 318' ' ' ASN . 24.7 m-85 -124.4 162.82 23.06 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.854 0.359 . . . . 0.0 110.39 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 274' ' ' SER . 72.2 p -144.69 172.2 13.33 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--N 1.31 -1.135 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.352 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.462 0.145 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.514 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 8.4 p30 -57.92 -38.44 75.89 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.771 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.425 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 23.0 mm -59.55 -64.53 2.89 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.754 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.425 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 11.6 Cg_endo -59.98 -26.57 82.76 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 121.905 1.736 . . . . 0.0 112.073 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 59.0 tp -68.68 -54.22 17.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 111.227 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.52 ' HB3' HG23 ' A' ' 261' ' ' THR . 5.8 p -63.71 -31.53 72.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.515 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.36 67.71 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.959 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.516 ' O ' HG13 ' A' ' 280' ' ' ILE . 24.5 tp60 -70.56 -47.31 60.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.579 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -61.36 -40.04 92.85 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.393 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.95 92.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.176 0.512 . . . . 0.0 109.816 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.442 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.5 tptt -61.49 -35.46 77.75 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.939 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 276' ' ' GLN . 59.8 mt -57.49 -44.31 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.017 0.437 . . . . 0.0 110.369 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.722 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.5 t -68.4 -46.28 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.746 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.6 -45.21 73.6 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -61.15 -37.79 84.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.937 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.515 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 2.0 m-85 -66.63 -44.05 83.04 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.074 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 39.1 mt -64.87 -51.16 63.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.795 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 84.4 t -60.23 -38.77 78.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.298 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.68 -31.13 71.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.288 0.566 . . . . 0.0 110.287 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 19.9 mmm180 -84.86 4.95 30.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.489 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.61 46.86 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.352 -0.928 . . . . 0.0 114.094 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.528 HG22 ' HG3' ' A' ' 248' ' ' LYS . 66.7 t -84.77 140.73 15.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 117.752 0.776 . . . . 0.0 109.026 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.72 108.11 2.81 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.639 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.38 -30.07 67.34 Favored Glycine 0 CA--C 1.509 -0.302 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.968 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.85 -21.18 64.45 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.537 0.335 . . . . 0.0 111.748 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -106.9 5.58 28.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.408 HD11 ' CG1' ' A' ' 290' ' ' VAL . 68.6 mt -106.23 128.45 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.42 127.59 53.81 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.25 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.442 HG21 ' HA ' ' A' ' 279' ' ' LYS . 31.7 p -111.99 124.87 53.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.689 0.28 . . . . 0.0 110.683 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.79 121.25 52.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.093 0.473 . . . . 0.0 111.822 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -90.77 112.13 4.05 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 26.1 mt -90.45 -32.07 16.54 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 88.75 -140.13 15.76 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 47.2 t -88.62 114.27 25.07 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.501 HG13 ' H ' ' A' ' 304' ' ' ASN . 3.4 p -142.94 -61.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.852 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.501 ' H ' HG13 ' A' ' 303' ' ' VAL . 37.3 m-80 -115.33 92.08 30.83 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.715 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 8.3 Cg_exo -67.98 127.82 16.69 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.803 2.336 . . . . 0.0 112.81 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.8 tt -85.74 -44.28 16.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.614 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -127.4 167.03 16.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.469 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 53.8 p -63.34 133.0 53.38 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.506 0.504 . . . . 0.0 111.104 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -80.84 -8.43 59.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.949 0.404 . . . . 0.0 110.651 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -62.69 -23.62 67.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.687 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 1.5 t -117.11 140.77 27.5 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 311' ' ' THR . 24.6 Cg_exo -55.99 -35.78 94.99 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.82 2.347 . . . . 0.0 111.332 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -57.65 -47.01 83.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.853 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -63.43 -38.47 96.43 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.844 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -60.57 -37.19 80.49 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.16 -30.81 71.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.699 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 317' ' ' LYS . 12.7 mmtp -76.16 -41.96 48.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.08 0.467 . . . . 0.0 109.927 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.715 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 43.7 m-80 -61.75 -28.29 69.33 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 11.8 ptp180 -81.4 9.38 7.36 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -57.5 177.6 0.1 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.07 0.938 . . . . 0.0 113.341 174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 74.8 t -136.07 144.96 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.577 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -127.74 140.77 51.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.729 0.299 . . . . 0.0 111.057 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.414 HG23 HG12 ' A' ' 257' ' ' ILE . 1.4 mp -103.93 117.17 49.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.17 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.62 132.66 53.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.074 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.68 130.48 40.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.316 0.579 . . . . 0.0 111.234 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 254' ' ' ARG . 27.9 t-20 . . . . . 0 C--N 1.309 -1.17 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.314 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.338 0 CA-C-O 120.912 0.387 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.34 85.73 2.5 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.596 ' HB2' HG21 ' A' ' 325' ' ' VAL . 23.4 mt -75.22 -34.57 61.47 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.447 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -62.62 -44.95 95.01 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 120.922 0.391 . . . . 0.0 110.061 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 36.2 t -65.49 -43.05 91.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.163 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.539 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -64.44 -47.03 80.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.927 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 211' ' ' LEU . 17.7 pt -69.37 -38.04 76.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.467 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -60.25 -37.81 81.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.099 0.476 . . . . 0.0 110.023 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.82 -27.66 67.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.039 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.771 HG12 HG23 ' A' ' 239' ' ' ILE . 43.1 t -83.01 -47.78 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 CA-C-O 121.069 0.461 . . . . 0.0 110.056 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.68 ' HA ' HG21 ' A' ' 239' ' ' ILE . 37.9 p -66.13 -35.25 79.98 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.017 -178.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.83 28.05 57.54 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 121.8 -132.24 8.86 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 114.54 -0.83 . . . . 0.0 111.192 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -89.34 169.25 5.0 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.734 2.289 . . . . 0.0 113.308 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.8 mm -85.67 105.18 14.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.196 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.946 0 CA-C-O 120.906 0.384 . . . . 0.0 111.371 -179.502 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.471 ' HA ' ' OD1' ' A' ' 241' ' ' ASN . 32.1 mt-10 . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 121.011 0.434 . . . . 0.0 112.169 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.771 HG23 HG12 ' A' ' 218' ' ' VAL . 82.8 mt -61.86 -37.62 78.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.694 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.1 mt -71.97 -21.63 61.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.471 ' OD1' ' HA ' ' A' ' 238' ' ' GLU . 3.7 m120 -76.84 -41.74 43.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.745 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -66.95 -42.82 84.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.954 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.622 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.4 t -58.35 -40.92 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.486 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.48 -36.83 76.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.317 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 3.5 t70 -48.54 -52.35 23.09 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.657 0.783 . . . . 0.0 112.813 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.545 ' NZ ' ' HB3' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -81.01 -17.75 49.24 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.668 -176.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 36.2 mt -79.14 -30.81 43.81 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.241 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.546 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 52.3 mtpt -82.63 -18.78 39.92 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.563 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.57 85.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.438 0.637 . . . . 0.0 110.01 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.548 ' HB3' HD11 ' A' ' 211' ' ' LEU . 49.9 t -128.98 69.06 80.62 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 74.3 Cg_endo -72.08 -1.29 9.82 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.416 2.744 . . . . 0.0 114.715 -173.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.45 -23.76 29.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.558 0.694 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.98 141.01 58.34 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.4 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -96.31 136.55 36.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.462 HG12 HG22 ' A' ' 325' ' ' VAL . 5.9 m -113.53 137.24 47.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 121.191 0.52 . . . . 0.0 111.685 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.7 m -113.43 109.0 17.97 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.187 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.7 mt -91.92 112.47 25.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -99.41 130.98 45.72 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.843 -176.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.547 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -107.3 145.43 16.05 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 9.2 m-85 -123.26 171.73 9.16 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 302' ' ' SER . 10.0 t -175.3 174.18 2.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.798 0.332 . . . . 0.0 110.765 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 121.199 0.523 . . . . 0.0 111.358 -178.281 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.423 ' HB2' ' CG2' ' A' ' 261' ' ' THR . 9.5 p30 -57.89 -31.55 66.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.526 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.461 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 24.8 mm -62.31 -65.49 2.11 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.567 176.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.461 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.0 Cg_endo -57.54 -30.82 89.76 Favored 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 121.821 1.68 . . . . 0.0 111.807 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 40.1 tp -61.96 -56.64 17.06 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.169 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.547 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.5 p -63.41 -27.28 69.19 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.965 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.98 -30.05 62.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.28 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -49.2 65.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 48.0 mmt-85 -59.49 -37.14 77.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.296 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.47 -34.86 79.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.01 0.434 . . . . 0.0 110.539 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.709 ' HA ' HG21 ' A' ' 297' ' ' THR . 0.3 OUTLIER -68.06 -30.74 70.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.441 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 57.5 mt -60.13 -45.37 95.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.956 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.693 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 10.5 t -65.62 -45.14 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.788 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -53.15 -44.84 68.1 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.776 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.17 -43.12 87.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.51 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.446 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 4.4 m-85 -66.17 -41.07 90.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.139 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.693 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 27.0 mt -67.6 -47.2 70.38 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.739 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 282' ' ' ALA . 94.5 t -60.55 -41.48 87.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.36 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.8 -26.69 68.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.303 0.573 . . . . 0.0 110.515 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.446 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 2.7 mpt_? -86.95 4.98 39.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.426 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.64 8.42 49.05 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.043 -1.075 . . . . 0.0 114.4 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 63.0 t -85.29 143.68 11.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.448 ' O ' HG13 ' A' ' 295' ' ' ILE . . . -69.91 106.72 3.28 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.829 0.347 . . . . 0.0 111.421 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.55 -31.45 77.73 Favored Glycine 0 CA--C 1.503 -0.703 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.304 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.62 -17.47 64.61 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.734 0.302 . . . . 0.0 110.946 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -105.05 3.85 30.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.525 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 291' ' ' ALA . 67.5 mt -105.49 131.18 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -121.57 128.84 52.41 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.291 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.709 HG21 ' HA ' ' A' ' 279' ' ' LYS . 56.1 p -107.73 128.57 54.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.401 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 95.6 t -134.98 132.18 53.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.118 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -102.08 117.56 5.86 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 23.6 mt -91.56 -7.33 50.55 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.401 ' HA3' ' OD1' ' A' ' 270' ' ' ASN . . . 68.64 -136.93 29.97 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.445 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 261' ' ' THR . 7.3 p -74.52 97.76 3.2 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 120.927 0.394 . . . . 0.0 110.73 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.2 t -152.94 130.81 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.935 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 52.22 77.59 0.44 Allowed Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 123.786 0.679 . . . . 0.0 112.47 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.411 ' HB3' ' OD1' ' A' ' 318' ' ' ASN . 5.9 Cg_exo -74.46 171.65 17.69 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.468 2.112 . . . . 0.0 112.394 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.7 -55.72 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.592 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.456 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -110.22 171.36 7.5 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.881 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 24.7 m -62.39 134.76 56.9 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 123.553 0.533 . . . . 0.0 111.261 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -81.31 -8.36 59.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.469 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.15 -10.38 59.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.001 0.429 . . . . 0.0 111.366 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 314' ' ' GLY . 2.4 t -118.0 143.54 32.92 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.317 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.03 -31.06 56.06 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.22 1.946 . . . . 0.0 111.37 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 2.8 mt-10 -70.83 -35.4 72.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.779 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 307' ' ' ALA . . . -72.49 -40.19 54.85 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.82 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -65.2 -31.91 73.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.11 -26.73 68.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.107 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.498 ' HD3' ' HA ' ' A' ' 317' ' ' LYS . 10.6 mmtp -87.16 -37.07 17.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.806 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 305' ' ' PRO . 0.9 OUTLIER -62.35 -25.85 68.12 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 14.3 ptp180 -87.75 17.2 4.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.248 0.547 . . . . 0.0 111.556 -178.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -57.42 170.69 0.5 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.244 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 87.1 t -133.16 146.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.447 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -132.03 137.02 47.67 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.044 0.449 . . . . 0.0 110.788 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.441 ' HB ' HD12 ' A' ' 215' ' ' ILE . 2.9 mp -93.07 117.19 35.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.722 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 44.6 t -113.35 143.87 22.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 211' ' ' LEU . 46.9 t -106.06 140.29 24.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.0 t30 . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.306 -179.615 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -75.47 78.99 2.51 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.128 0.489 . . . . 0.0 110.57 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 250' ' ' CYS . 40.1 mt -57.66 -21.59 40.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.246 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -63.44 -45.05 92.7 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 120.966 0.413 . . . . 0.0 109.937 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 36.3 t -73.8 -35.41 64.91 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 211' ' ' LEU . . . -62.57 -47.82 82.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.444 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 211' ' ' LEU . 18.8 pt -72.24 -39.93 64.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.396 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.449 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 12.3 t-20 -61.25 -28.75 69.39 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.128 0.489 . . . . 0.0 110.755 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.88 69.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.983 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.506 HG11 ' HG3' ' A' ' 242' ' ' ARG . 2.5 t -93.37 -41.63 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.199 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.588 ' HA ' HG21 ' A' ' 239' ' ' ILE . 80.9 p -65.11 -36.52 84.56 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.251 0.548 . . . . 0.0 110.266 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.22 22.13 63.62 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 130.86 -125.2 4.44 Favored Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.14 162.27 5.77 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 122.499 2.133 . . . . 0.0 112.044 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.9 mm -73.46 111.14 7.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.756 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.898 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.865 176.114 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 N--CA 1.465 0.301 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.588 HG21 ' HA ' ' A' ' 219' ' ' THR . 58.1 mt -65.34 -36.15 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.499 ' CD2' HG13 ' A' ' 281' ' ' VAL . 41.0 mt -64.96 -35.62 81.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.492 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -71.54 -39.86 70.43 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.506 ' HG3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -64.19 -48.66 75.07 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.037 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.632 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 55.2 t -55.47 -42.69 68.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.196 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.88 -37.51 87.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.936 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -52.49 -49.45 64.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.501 ' H ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -73.94 -29.42 62.01 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 119.491 -0.883 . . . . 0.0 111.292 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 24.5 mt -69.75 -27.78 65.23 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 121.614 0.721 . . . . 0.0 109.254 176.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -68.38 -33.9 75.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.549 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.96 70.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.439 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.516 ' HB3' HD11 ' A' ' 211' ' ' LEU . 52.1 t -126.16 72.5 71.23 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.78 -0.79 9.44 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.99 2.46 . . . . 0.0 113.074 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.55 -30.05 59.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.521 0.676 . . . . 0.0 109.271 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.58 135.98 50.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.652 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.555 ' HB2' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -91.44 145.07 24.93 Favored 'General case' 0 CA--C 1.479 -1.758 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.0 m -120.43 125.38 74.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.896 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 54.9 m -101.35 108.87 20.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.469 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 323' ' ' ILE . 22.3 mt -94.92 112.19 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.109 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -103.48 124.34 48.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.109 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -103.65 163.62 15.46 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.352 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 32.4 m-85 -136.15 159.55 41.38 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.014 0.435 . . . . 0.0 110.63 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 63.2 p -141.3 164.87 29.07 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 C--N 1.319 -0.744 0 CA-C-O 120.969 0.414 . . . . 0.0 110.695 178.436 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 35.1 mm . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 121.736 0.779 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 1.6 m120 -63.21 -36.97 85.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.607 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.439 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.3 mm -56.27 -65.24 1.68 Allowed Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.829 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.439 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 27.0 Cg_endo -63.24 -25.12 72.12 Favored 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 122.159 1.906 . . . . 0.0 112.277 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.521 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 53.8 tp -69.78 -52.24 26.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.001 0.429 . . . . 0.0 110.019 177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.444 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 10.1 t -57.5 -39.71 77.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.019 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.63 78.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.803 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.459 ' O ' HG13 ' A' ' 280' ' ' ILE . 6.5 tp-100 -68.08 -46.89 69.75 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.59 0.71 . . . . 0.0 109.703 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 67.3 mtp85 -59.7 -44.8 93.54 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.241 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.53 84.02 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.16 0.505 . . . . 0.0 110.182 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.631 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.5 tmtt? -64.22 -30.48 71.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.69 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 276' ' ' GLN . 62.2 mt -57.2 -41.37 77.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.977 0.417 . . . . 0.0 109.963 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.747 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 13.8 t -69.77 -47.91 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.868 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.09 -43.73 78.32 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.908 0.385 . . . . 0.0 110.919 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.1 -38.69 80.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.3 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.535 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 3.9 m-85 -72.83 -40.55 65.69 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.315 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 44.5 mt -64.18 -48.32 76.38 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 86.3 t -60.32 -39.66 81.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.1 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.43 -23.75 67.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.207 0.527 . . . . 0.0 110.895 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 5.0 mmp_? -89.02 2.9 53.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.394 178.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 97.83 13.14 44.51 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.203 -0.999 . . . . 0.0 114.053 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 62.0 t -87.63 139.96 16.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 117.514 0.657 . . . . 0.0 109.328 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.9 113.5 3.88 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.195 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -66.83 -11.27 57.51 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.893 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.71 -11.91 54.88 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 120.869 0.366 . . . . 0.0 110.224 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -110.23 2.25 19.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.736 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 57.7 mt -107.41 123.69 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -115.67 127.57 55.27 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.592 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 279' ' ' LYS . 47.5 p -104.89 126.28 51.79 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.39 113.04 30.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.305 0.574 . . . . 0.0 112.252 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.444 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -89.11 105.02 3.15 Favored Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.504 175.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 21.0 mt -94.06 1.4 56.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.665 0.269 . . . . 0.0 110.922 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.77 -128.08 42.31 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.539 -175.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 43.0 p -97.67 123.43 41.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.523 ' O ' ' HD3' ' A' ' 305' ' ' PRO . 3.5 p -150.21 -60.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.453 ' H ' HG13 ' A' ' 303' ' ' VAL . 90.6 m-20 -112.32 94.07 25.14 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-O 120.906 0.384 . . . . 0.0 110.039 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 303' ' ' VAL . 2.7 Cg_exo -70.88 172.77 13.07 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.874 2.383 . . . . 0.0 113.311 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.4 tt -134.13 -48.62 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.685 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -126.25 171.02 11.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.581 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.429 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 14.6 m -65.16 124.48 22.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.072 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -80.06 -8.38 59.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -62.33 -23.31 66.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.25 0.548 . . . . 0.0 110.361 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 314' ' ' GLY . 1.9 t -117.8 140.43 27.67 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.613 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -52.12 -38.32 70.61 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.133 2.555 . . . . 0.0 111.667 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -53.04 -52.27 59.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.715 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.43 ' H ' HG23 ' A' ' 311' ' ' THR . . . -65.61 -37.98 94.16 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.746 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -59.54 -37.51 78.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.37 . . . . 0.0 110.361 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.34 -31.37 72.54 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.386 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.87 -44.36 20.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.23 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -58.7 -26.28 63.74 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 13.4 ptp180 -83.08 11.09 6.77 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -58.34 179.0 0.08 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 121.61 0.719 . . . . 0.0 112.765 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.7 t -140.43 149.09 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.088 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -131.38 147.12 52.53 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.918 0.389 . . . . 0.0 111.003 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.471 HG23 HG12 ' A' ' 257' ' ' ILE . 1.3 mp -109.17 119.81 59.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.057 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.84 134.52 48.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.942 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 91.2 t -94.8 135.21 29.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.501 0.667 . . . . 0.0 112.409 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . 0.555 ' HB3' ' HB2' ' A' ' 254' ' ' ARG . 5.3 t30 . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.257 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 CA-C-O 120.949 0.404 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -83.18 77.96 9.68 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.459 ' HB2' HG21 ' A' ' 325' ' ' VAL . 29.4 mt -67.34 -29.71 69.33 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.126 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.581 HE21 ' HA ' ' A' ' 324' ' ' VAL . 35.5 tt0 -62.2 -44.32 96.84 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.821 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.0 m -69.25 -36.2 76.91 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.115 0.483 . . . . 0.0 109.769 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.46 -51.08 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.069 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.419 ' CG2' HG13 ' A' ' 243' ' ' VAL . 20.7 pt -68.37 -39.79 81.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.298 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -58.57 -32.11 68.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.861 0.362 . . . . 0.0 110.376 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.26 -32.59 73.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.185 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.528 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.2 t -85.96 -47.93 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 120.779 0.323 . . . . 0.0 110.686 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.504 ' HA ' HG21 ' A' ' 239' ' ' ILE . 58.1 p -62.71 -32.95 74.15 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.384 0.612 . . . . 0.0 110.055 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.52 22.47 47.1 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.95 -127.13 6.39 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . 0.464 ' CB ' ' HD2' ' A' ' 320' ' ' ARG . 71.6 Cg_endo -84.39 164.3 12.76 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.201 1.934 . . . . 0.0 111.738 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 42.1 mm -71.65 98.0 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.573 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.044 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.719 177.912 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 . . . . . 0 CA--C 1.518 -0.258 0 CA-C-O 120.708 0.29 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.504 HG21 ' HA ' ' A' ' 219' ' ' THR . 76.9 mt -62.23 -31.94 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.401 HD11 HG13 ' A' ' 281' ' ' VAL . 3.9 mm? -62.21 -32.26 72.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.215 0.531 . . . . 0.0 110.38 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.68 -37.07 36.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.686 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.551 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 0.0 OUTLIER -67.78 -39.93 84.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.414 178.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.552 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 38.6 t -61.21 -37.25 77.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.54 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 248' ' ' LYS . . . -58.23 -38.04 76.07 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.819 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 4.0 t70 -46.46 -49.18 18.64 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.821 0.848 . . . . 0.0 112.938 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.472 ' H ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -83.73 -18.16 38.79 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.1 mt -84.8 -25.41 28.19 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 289' ' ' GLY . 6.1 tptm -73.88 -29.86 62.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.701 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.87 75.85 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.268 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.458 ' HB3' HD11 ' A' ' 211' ' ' LEU . 45.0 t -133.44 70.81 76.6 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.71 1.81 7.15 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.845 2.363 . . . . 0.0 113.078 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.55 -31.81 57.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.746 0.784 . . . . 0.0 109.14 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.26 145.63 55.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.314 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -99.99 132.82 45.11 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.496 HG12 HG22 ' A' ' 325' ' ' VAL . 6.1 m -115.06 131.16 68.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.236 0.541 . . . . 0.0 111.383 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.5 m -107.35 112.02 24.64 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.734 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.431 HG12 HG23 ' A' ' 323' ' ' ILE . 18.8 mt -92.61 116.03 32.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -107.77 127.49 53.74 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.739 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -99.02 149.83 19.16 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.844 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -131.95 163.02 29.29 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 117.274 0.537 . . . . 0.0 110.171 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 3.1 t -159.08 152.48 22.65 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 42.9 t0 . . . . . 0 C--N 1.322 -0.589 0 CA-C-O 121.161 0.505 . . . . 0.0 111.082 -178.402 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 40.3 mm . . . . . 0 CA--C 1.517 -0.3 0 CA-C-O 121.703 0.763 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.0 -32.78 74.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.477 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.65 -64.26 3.29 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.12 -30.0 88.25 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.237 1.958 . . . . 0.0 111.947 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.539 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 50.9 tp -66.77 -51.33 57.06 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.037 0.446 . . . . 0.0 110.218 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.445 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 13.1 t -56.15 -39.21 71.95 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.263 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.21 -28.54 64.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.075 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -74.21 -44.4 53.38 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.259 0.552 . . . . 0.0 110.096 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 59.8 mtp85 -62.27 -41.0 98.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.997 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.88 -36.11 83.3 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.815 0.341 . . . . 0.0 111.014 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.491 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.6 tptt -59.83 -35.36 74.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.0 mt -55.1 -46.28 77.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.725 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 15.8 t -68.51 -46.22 80.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.653 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.63 -42.78 79.45 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.872 0.367 . . . . 0.0 111.185 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.61 -36.15 77.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.68 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.44 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 3.3 m-85 -74.19 -39.68 63.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.117 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 45.2 mt -65.45 -49.47 68.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.502 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 80.8 t -60.21 -38.13 76.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.163 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.23 70.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.694 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.558 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 3.7 mmp_? -87.23 7.37 28.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.684 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.531 ' O ' ' HE3' ' A' ' 248' ' ' LYS . . . 97.14 10.13 54.97 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.125 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 50.4 t -84.9 139.73 17.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 117.894 0.847 . . . . 0.0 109.547 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.99 111.97 2.74 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.071 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.3 -35.2 83.76 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.097 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.82 -11.87 61.21 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -101.44 -2.64 30.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.06 0.457 . . . . 0.0 109.878 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 64.5 mt -107.4 129.65 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.152 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.21 125.78 51.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.628 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.491 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.6 p -111.1 118.74 36.82 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.045 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 18.6 m -121.56 162.76 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.034 0 CA-C-O 121.224 0.535 . . . . 0.0 111.365 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.445 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -129.11 104.46 0.64 Allowed Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.6 mt -89.44 -31.17 17.84 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.733 0.302 . . . . 0.0 111.615 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 106.7 -122.23 6.9 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.841 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.4 t -104.98 120.12 40.68 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 8.6 p 179.81 152.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 58.3 t30 66.44 79.03 0.24 Allowed Pre-proline 0 C--N 1.314 -0.953 0 O-C-N 123.756 0.66 . . . . 0.0 111.467 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.55 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 73.3 Cg_endo -77.79 149.5 26.4 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.606 2.204 . . . . 0.0 113.136 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.415 HD12 ' HG3' ' A' ' 222' ' ' PRO . 2.9 tt -108.14 -39.16 4.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.32 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.51 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -139.64 174.42 10.54 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.978 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 26.2 m -74.54 129.52 37.9 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.121 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -80.16 -7.66 59.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.587 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -57.39 -19.08 21.02 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.382 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.4 t -127.77 141.33 40.74 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.928 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.87 -21.68 34.36 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.188 2.592 . . . . 0.0 112.399 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.565 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.5 mm-40 -60.04 -46.36 89.77 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.392 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 307' ' ' ALA . . . -65.77 -39.73 95.33 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.14 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -60.53 -37.02 79.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.425 0.631 . . . . 0.0 110.121 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.59 -29.38 66.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.193 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 6.7 mmtp -87.11 -35.86 18.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.307 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 27.9 m-20 -65.47 -15.48 62.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 7.6 ptm180 -88.49 16.2 6.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.558 0.694 . . . . 0.0 111.036 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.464 ' HD2' ' CB ' ' A' ' 222' ' ' PRO . 14.4 ptt180 -63.18 -173.69 0.06 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.422 1.105 . . . . 0.0 113.246 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.84 145.63 25.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.783 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -135.74 145.01 46.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.231 0.539 . . . . 0.0 111.599 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.431 HG23 HG12 ' A' ' 257' ' ' ILE . 1.8 mp -101.37 115.19 42.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.106 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.581 ' HA ' HE21 ' A' ' 212' ' ' GLN . 85.1 t -105.37 136.13 40.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.834 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 255' ' ' VAL . 69.5 t -101.27 136.18 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 C--N 1.311 -1.073 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.92 179.033 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.485 0 CA-C-O 120.606 0.241 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.98 82.02 4.35 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.184 0.516 . . . . 0.0 110.244 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.508 ' HB2' HG21 ' A' ' 325' ' ' VAL . 52.9 mt -69.47 -24.76 63.83 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.875 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -68.86 -38.34 79.7 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.415 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 t -76.61 -32.22 57.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -67.84 -49.08 64.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.14 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.504 HG21 HG13 ' A' ' 243' ' ' VAL . 21.8 pt -69.39 -33.39 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.801 -0.181 . . . . 0.0 111.081 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -54.99 -34.17 63.16 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.134 0.492 . . . . 0.0 110.801 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.87 -31.76 72.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.243 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.531 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.5 t -91.81 -48.98 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.883 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.583 ' HA ' HG21 ' A' ' 239' ' ' ILE . 53.7 p -62.73 -43.61 98.35 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.302 0.573 . . . . 0.0 110.776 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.42 19.46 66.41 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.042 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 134.29 -136.95 8.92 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . 0.451 ' HB2' ' HG3' ' A' ' 320' ' ' ARG . 64.5 Cg_endo -82.27 162.39 17.54 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.638 2.226 . . . . 0.0 112.756 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.7 mm -78.58 104.14 6.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.546 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.897 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.389 177.943 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 . . . . . 0 C--O 1.235 0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.583 HG21 ' HA ' ' A' ' 219' ' ' THR . 56.8 mt -62.5 -38.28 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 50.6 mt -65.8 -31.61 72.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.796 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -71.4 -38.97 71.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.531 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.2 OUTLIER -65.85 -47.7 74.07 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.829 178.225 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.58 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.7 t -58.26 -45.43 89.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.062 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.415 ' HB1' HG23 ' A' ' 290' ' ' VAL . . . -61.01 -35.81 77.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.692 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -54.49 -47.94 72.43 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -75.26 -29.99 60.34 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.462 -178.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.0 mt -65.64 -34.41 78.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.435 0.635 . . . . 0.0 109.646 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -72.44 -24.7 61.25 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.146 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.84 69.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.049 0.452 . . . . 0.0 110.84 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.479 ' HB3' HD11 ' A' ' 211' ' ' LEU . 35.8 t -125.53 68.88 61.25 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.61 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.07 3.26 5.81 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.075 2.516 . . . . 0.0 113.388 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.91 -32.16 61.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.968 0.89 . . . . 0.0 108.879 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -74.56 148.04 41.21 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.442 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -101.1 139.42 36.8 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.8 m -115.0 130.01 70.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-O 121.327 0.584 . . . . 0.0 110.835 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.9 m -105.28 110.45 22.82 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.322 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.415 HG12 HG23 ' A' ' 323' ' ' ILE . 23.9 mt -92.8 111.1 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.96 126.31 46.11 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.146 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -105.07 159.02 15.84 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.152 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 301' ' ' GLY . 76.3 m-85 -132.55 165.97 23.16 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.816 0.341 . . . . 0.0 110.775 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.515 HG22 ' NH1' ' A' ' 277' ' ' ARG . 33.2 p -144.55 169.74 17.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.738 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 C--N 1.312 -1.046 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 175.337 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.9 mm . . . . . 0 CA--C 1.512 -0.49 0 CA-C-O 122.119 0.961 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -61.74 -28.54 69.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.838 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.492 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 33.9 mm -57.26 -65.19 1.88 Allowed Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.432 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.492 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.9 Cg_endo -58.59 -35.45 98.64 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 122.195 1.93 . . . . 0.0 111.979 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 276' ' ' GLN . 54.2 tp -62.72 -53.87 47.79 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.277 0.56 . . . . 0.0 111.028 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.483 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 15.2 t -57.29 -35.59 69.99 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.005 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.35 -22.16 64.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.821 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.479 ' O ' HG13 ' A' ' 280' ' ' ILE . 11.2 tt0 -71.51 -53.1 14.97 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.515 ' NH1' HG22 ' A' ' 261' ' ' THR . 75.9 mtt85 -56.97 -44.14 82.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.62 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.43 77.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.962 0.41 . . . . 0.0 110.814 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.638 ' HA ' HG21 ' A' ' 297' ' ' THR . 11.9 tmtt? -69.37 -30.55 68.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.28 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 276' ' ' GLN . 58.8 mt -59.82 -44.96 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.732 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.7 t -65.99 -48.19 82.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.047 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.77 76.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 120.919 0.39 . . . . 0.0 110.984 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.4 -42.27 91.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.935 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.68 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 5.7 m-85 -68.09 -43.36 78.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.893 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 36.4 mt -63.62 -46.15 87.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.835 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.7 t -61.27 -40.16 85.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.379 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.25 -30.74 71.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.549 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 13.8 mmm180 -81.83 5.07 19.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.472 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.6 2.75 50.1 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.164 -1.017 . . . . 0.0 114.629 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 57.9 t -80.91 145.96 8.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 117.923 0.861 . . . . 0.0 110.573 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.401 ' O ' HG13 ' A' ' 295' ' ' ILE . . . -69.77 108.08 3.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.701 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.41 -33.8 82.56 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.792 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.97 -19.14 64.93 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -103.39 2.41 33.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 291' ' ' ALA . 62.7 mt -104.35 130.36 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.52 127.21 53.77 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.646 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.638 HG21 ' HA ' ' A' ' 279' ' ' LYS . 53.8 p -106.25 119.97 40.63 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 77.2 t -124.25 114.91 43.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.357 0.599 . . . . 0.0 112.103 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.483 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -88.02 107.4 3.31 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.85 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 23.9 mt -94.64 -4.25 48.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.924 0.392 . . . . 0.0 110.43 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 260' ' ' TYR . . . 62.72 -133.07 44.11 Favored Glycine 0 N--CA 1.431 -1.657 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.66 -175.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.4 t -99.69 122.63 42.98 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.2 p -149.25 -56.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.666 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -113.33 93.73 27.96 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.427 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 14.9 Cg_endo -64.19 162.05 31.45 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.834 2.356 . . . . 0.0 112.934 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.493 HG22 ' HA ' ' A' ' 318' ' ' ASN . 4.7 tt -124.34 -53.59 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.874 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.422 ' H ' HG23 ' A' ' 306' ' ' ILE . . . -119.8 171.41 8.43 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 22.2 m -61.91 127.33 30.88 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.564 0.54 . . . . 0.0 110.845 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -79.79 -8.16 59.1 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.015 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.79 -17.37 62.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.699 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.8 t -116.8 138.4 24.59 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.47 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.74 -34.25 97.94 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.921 2.414 . . . . 0.0 111.517 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.6 mm-40 -59.65 -45.92 90.57 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.35 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.436 ' H ' HG23 ' A' ' 311' ' ' THR . . . -68.37 -38.82 87.56 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 311' ' ' THR . 96.7 mtt180 -59.09 -37.31 76.83 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.032 0.444 . . . . 0.0 109.96 176.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.42 -27.72 68.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.57 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 3.3 mmtp -80.93 -41.81 22.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.648 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.493 ' HA ' HG22 ' A' ' 306' ' ' ILE . 39.2 m-80 -60.19 -22.23 62.68 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -93.45 16.25 13.95 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.451 ' HG3' ' HB2' ' A' ' 222' ' ' PRO . 0.0 OUTLIER -66.49 179.24 1.05 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.746 0.784 . . . . 0.0 112.358 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 98.8 t -129.27 143.34 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.504 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -131.61 140.46 49.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 111.378 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 323' ' ' ILE . 1.5 mp -101.4 119.92 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.095 -177.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.49 141.74 27.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.268 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 211' ' ' LEU . 96.0 t -98.38 135.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.713 -179.503 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.163 0.506 . . . . 0.0 112.148 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -87.69 83.09 7.22 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.828 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.5 mm? -69.59 -40.71 76.52 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.167 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -64.14 -40.66 96.65 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.719 0.295 . . . . 0.0 110.861 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 33.5 t -68.35 -44.17 75.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.066 0.46 . . . . 0.0 110.115 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.29 -44.66 87.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.031 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.482 ' CG2' HG13 ' A' ' 243' ' ' VAL . 27.1 pt -69.11 -37.6 76.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.212 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -60.72 -33.02 72.26 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.336 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.49 -25.09 65.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.213 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.426 HG12 HG23 ' A' ' 239' ' ' ILE . 3.3 t -90.25 -43.7 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 110.047 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.6 ' HA ' HG21 ' A' ' 239' ' ' ILE . 71.5 p -68.03 -36.71 80.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.579 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.97 24.68 51.94 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.98 -136.5 9.4 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.84 164.94 20.17 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.374 2.049 . . . . 0.0 112.267 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.7 mm -77.95 104.32 5.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.6 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.821 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.969 177.452 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 CA--C 1.511 -0.547 0 CA-C-O 121.418 0.627 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.6 HG21 ' HA ' ' A' ' 219' ' ' THR . 90.3 mt -58.63 -34.57 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.147 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.45 -33.77 76.66 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.213 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.482 ' HA ' ' HG2' ' A' ' 288' ' ' ARG . 44.8 m-20 -71.33 -37.32 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -49.91 57.42 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.82 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.63 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 38.8 t -57.93 -47.65 85.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.413 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.79 -28.18 68.17 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.848 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.92 -40.19 83.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 0.0 111.434 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 243' ' ' VAL . 0.0 OUTLIER -77.88 -26.69 49.38 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.038 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 38.3 mt -66.68 -27.34 67.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.157 0.503 . . . . 0.0 110.307 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 59.0 mtpt -76.65 -17.23 59.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.377 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.91 -30.21 63.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.1 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 8.4 t -137.02 67.79 56.36 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 71.6 Cg_endo -75.44 4.46 4.95 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.354 2.703 . . . . 0.0 114.621 -174.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -78.16 -29.69 48.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.585 0.707 . . . . 0.0 109.474 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.44 136.66 51.85 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.779 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -86.33 138.36 31.88 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.411 HG12 HG22 ' A' ' 325' ' ' VAL . 3.8 m -111.53 126.26 68.91 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.839 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.3 m -104.2 106.57 17.12 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.379 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 323' ' ' ILE . 28.0 mt -92.56 113.21 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.478 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -100.51 129.36 46.45 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.689 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.439 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -108.0 144.38 16.14 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 27.4 m-85 -124.33 161.48 25.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.127 0.489 . . . . 0.0 110.61 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.576 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 72.7 p -147.0 164.22 33.69 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--N 1.32 -0.697 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.859 176.169 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 121.532 0.682 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.576 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 0.6 OUTLIER -58.54 -36.81 74.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.199 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.473 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.4 mm -61.17 -63.95 3.7 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.24 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.9 Cg_endo -58.37 -31.68 94.47 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.944 1.763 . . . . 0.0 111.866 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.591 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 62.4 tp -67.4 -54.2 22.49 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.568 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.566 ' HB3' HG23 ' A' ' 261' ' ' THR . 18.5 p -62.48 -29.92 70.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.767 0.318 . . . . 0.0 110.898 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.44 -31.34 69.61 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.412 ' O ' HG13 ' A' ' 280' ' ' ILE . 25.8 tt0 -73.2 -41.28 63.99 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 60.7 mtp85 -61.92 -45.16 94.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.034 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.77 76.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.876 0.37 . . . . 0.0 110.872 176.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.583 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.6 tmtt? -65.94 -30.26 70.81 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.509 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 276' ' ' GLN . 60.6 mt -56.51 -44.21 80.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.23 0.538 . . . . 0.0 109.753 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.686 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.9 t -70.92 -46.54 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.574 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.87 71.01 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.877 0.37 . . . . 0.0 111.184 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -57.71 -43.28 85.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.502 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.503 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 4.8 m-85 -69.58 -38.52 77.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.461 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 41.3 mt -66.38 -46.31 77.13 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.1 -39.37 82.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.488 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.8 -26.75 68.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.295 0.569 . . . . 0.0 110.54 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -85.18 3.52 38.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.69 178.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.34 13.29 39.22 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.129 -1.034 . . . . 0.0 114.364 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.424 HG22 ' HG3' ' A' ' 248' ' ' LYS . 58.5 t -87.95 142.9 12.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 117.716 0.758 . . . . 0.0 109.504 177.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.63 112.8 4.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.433 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.18 -36.83 90.4 Favored Glycine 0 CA--C 1.511 -0.219 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.459 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -70.55 -11.41 60.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.859 0.361 . . . . 0.0 111.417 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -102.17 -1.43 31.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.058 0.456 . . . . 0.0 110.404 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.402 HD11 ' CG1' ' A' ' 290' ' ' VAL . 70.6 mt -106.13 130.93 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.727 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.47 125.02 49.03 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.649 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.583 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.3 p -104.24 122.44 45.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.487 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 67.5 t -127.23 115.03 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 121.153 0.501 . . . . 0.0 112.084 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.28 112.9 3.8 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.608 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.466 ' HB3' HG21 ' A' ' 303' ' ' VAL . 26.7 mt -97.05 -7.85 31.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.561 0.219 . . . . 0.0 111.559 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.8 -129.36 41.63 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.152 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 12.7 p -93.59 112.23 24.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.491 ' O ' ' HD3' ' A' ' 305' ' ' PRO . 41.9 t -138.0 -69.38 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.415 ' ND2' HG12 ' A' ' 303' ' ' VAL . 67.7 m-80 -110.2 94.49 18.41 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 303' ' ' VAL . 13.3 Cg_exo -65.57 163.2 30.93 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.24 1.96 . . . . 0.0 112.034 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 6.3 tt -117.9 -48.24 3.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.465 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -129.75 172.89 11.16 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 43.8 t -62.96 134.76 56.68 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 123.399 0.437 . . . . 0.0 110.734 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.17 -7.7 59.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.683 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.59 -20.31 64.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.444 HG23 ' H ' ' A' ' 314' ' ' GLY . 2.1 t -113.54 145.34 33.13 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.891 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.86 -32.29 36.67 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.996 1.797 . . . . 0.0 110.806 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.8 mt-10 -59.66 -44.7 93.47 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.055 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.444 ' H ' HG23 ' A' ' 311' ' ' THR . . . -67.88 -38.87 89.56 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.707 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -63.16 -37.31 86.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.941 0.4 . . . . 0.0 110.259 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.21 -27.44 69.36 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.17 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 6.8 mmtp -84.73 -40.9 16.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.035 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 42.5 m-80 -62.31 -26.65 68.54 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 37.3 ptt180 -78.4 7.02 7.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.877 0.37 . . . . 0.0 111.471 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 317' ' ' LYS . 29.8 ptt-85 -57.78 177.79 0.1 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.144 0.973 . . . . 0.0 113.18 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 86.5 t -136.52 143.15 36.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.583 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -129.57 137.58 50.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.831 0.348 . . . . 0.0 111.017 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.434 ' H ' HD12 ' A' ' 323' ' ' ILE . 1.4 mp -100.9 119.5 49.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 75.0 t -111.05 137.33 43.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 255' ' ' VAL . 67.9 t -101.5 136.39 33.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.364 0.602 . . . . 0.0 111.221 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.084 179.264 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.63 0 CA-C-O 121.183 0.516 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.93 63.35 2.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.548 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.516 HD22 ' HB2' ' A' ' 246' ' ' LYS . 17.9 mt -54.08 -29.9 46.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.308 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -65.25 -43.8 90.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.026 0.441 . . . . 0.0 109.932 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.7 t -74.96 -24.68 58.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.543 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -75.51 -49.05 19.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.831 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 211' ' ' LEU . 23.4 pt -71.72 -38.08 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.607 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -58.62 -38.39 77.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.988 0.423 . . . . 0.0 110.516 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.89 -27.72 69.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.134 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.831 HG12 HG23 ' A' ' 239' ' ' ILE . 21.3 t -83.67 -50.98 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 121.038 0.447 . . . . 0.0 110.751 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.556 ' HA ' HG21 ' A' ' 239' ' ' ILE . 42.6 p -69.1 -34.86 75.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.461 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.9 14.24 82.8 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 139.79 -134.69 6.74 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.34 166.63 6.57 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.73 2.287 . . . . 0.0 113.246 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 51.0 mm -82.58 106.09 13.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.009 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.589 0 CA-C-O 121.122 0.487 . . . . 0.0 111.864 -179.746 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 CA--C 1.516 -0.345 0 CA-C-O 120.513 0.197 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.831 HG23 HG12 ' A' ' 218' ' ' VAL . 50.6 mt -64.73 -38.86 83.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.86 -31.23 72.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.226 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.448 ' HA ' ' HG2' ' A' ' 288' ' ' ARG . 3.5 m-20 -75.57 -38.31 59.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.784 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -69.24 -23.42 63.86 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.095 178.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 24.7 t -79.79 -42.19 22.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.487 176.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.01 68.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.154 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -45.82 -50.54 14.03 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.728 0.811 . . . . 0.0 112.497 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.516 ' HB2' HD22 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -85.33 -14.43 46.5 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 41.3 mt -83.56 -31.08 26.54 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.544 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 53.6 mtpt -82.93 -18.85 38.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.64 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.94 -34.13 76.0 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.283 0.563 . . . . 0.0 109.816 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.506 ' HB3' HD11 ' A' ' 211' ' ' LEU . 35.4 t -132.03 69.35 80.71 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 60.6 Cg_endo -69.5 -2.97 10.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.25 2.633 . . . . 0.0 113.846 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -84.0 -24.14 30.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.558 0.694 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -67.75 149.29 50.14 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.861 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -102.81 140.79 36.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.09 131.95 67.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 120.97 0.414 . . . . 0.0 110.897 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.2 m -107.63 108.76 20.16 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 16.3 mt -96.36 114.98 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.68 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -99.5 125.16 45.2 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.293 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 274' ' ' SER . . . -105.71 140.76 15.23 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -123.01 161.94 23.31 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.01 0.433 . . . . 0.0 110.005 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 10.0 t -148.1 167.1 25.88 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.402 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 C--N 1.304 -1.394 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.011 -178.276 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.676 0.75 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.94 -38.66 70.61 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.779 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.404 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 22.7 mm -58.78 -64.37 2.99 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.741 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.404 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 14.2 Cg_endo -61.21 -28.12 84.6 Favored 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 121.867 1.711 . . . . 0.0 112.426 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 53.2 tp -65.51 -52.95 48.94 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.965 0.412 . . . . 0.0 110.809 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 259' ' ' GLY . 14.5 p -62.64 -28.39 69.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.606 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.86 78.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.251 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -67.86 -39.59 83.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.73 -52.18 64.78 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.099 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.422 ' HA ' HG11 ' A' ' 321' ' ' VAL . . . -60.93 -35.0 75.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.214 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.553 ' HA ' HG21 ' A' ' 297' ' ' THR . 16.4 ttpt -62.68 -31.79 72.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.229 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 61.5 mt -56.36 -45.57 81.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.989 0.423 . . . . 0.0 110.118 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.745 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.5 t -67.48 -45.44 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.978 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.78 -45.37 74.26 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.919 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.84 -40.54 88.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.288 0.566 . . . . 0.0 110.635 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.674 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 6.9 m-85 -69.75 -41.41 75.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.208 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 47.6 mt -63.99 -46.91 82.45 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 79.4 t -59.9 -39.51 80.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.354 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.39 -30.54 71.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.339 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.674 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -80.93 1.51 30.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.597 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 98.81 15.69 33.23 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.136 -1.03 . . . . 0.0 114.033 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 58.2 t -90.64 142.86 12.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 117.416 0.608 . . . . 0.0 109.551 177.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.31 111.11 4.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.801 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.1 -34.12 77.94 Favored Glycine 0 C--N 1.33 0.197 0 CA-C-N 115.707 -0.679 . . . . 0.0 113.255 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.54 -21.0 66.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.922 0.391 . . . . 0.0 111.63 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.5 3.92 40.67 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.97 0.414 . . . . 0.0 110.99 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 66.4 mt -105.43 131.92 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.74 129.61 54.58 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.553 HG21 ' HA ' ' A' ' 279' ' ' LYS . 31.8 p -115.72 125.38 52.73 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.683 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 94.7 t -130.04 127.58 63.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 0.0 111.499 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -96.02 114.12 4.83 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.87 -2.0 48.25 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 72.79 -129.85 13.85 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.661 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 23.2 t -90.49 114.92 27.21 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.1 p -179.33 147.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.6 t30 64.95 69.33 0.67 Allowed Pre-proline 0 C--N 1.314 -0.97 0 O-C-N 123.818 0.699 . . . . 0.0 110.404 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.44 168.45 12.99 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.591 2.194 . . . . 0.0 113.231 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.463 ' HB ' ' NH1' ' A' ' 320' ' ' ARG . 2.7 tt -128.12 -50.0 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.108 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.444 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -120.83 171.71 8.42 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.168 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 20.0 m -64.55 134.69 54.92 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.485 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -78.22 -7.72 57.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.184 0.516 . . . . 0.0 110.662 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.16 -16.88 60.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.158 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.506 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 0.8 OUTLIER -113.76 144.61 31.79 Favored Pre-proline 0 CA--C 1.511 -0.522 0 CA-C-O 121.034 0.445 . . . . 0.0 110.941 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -66.22 -34.66 35.43 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 122.213 1.942 . . . . 0.0 111.354 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -60.87 -40.51 93.24 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.268 0.556 . . . . 0.0 109.85 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 307' ' ' ALA . . . -70.25 -39.8 71.12 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.876 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 311' ' ' THR . 99.4 mtt180 -60.74 -33.43 72.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.125 0.488 . . . . 0.0 110.092 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -70.47 -29.14 65.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.79 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 320' ' ' ARG . 0.2 OUTLIER -82.38 -41.17 20.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.05 179.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -64.64 -17.42 64.02 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 19.6 ptp180 -86.98 13.19 9.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.146 0.498 . . . . 0.0 110.865 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.463 ' NH1' ' HB ' ' A' ' 306' ' ' ILE . 5.2 ptt180 -57.66 175.9 0.16 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.191 0.996 . . . . 0.0 113.189 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 278' ' ' ALA . 60.7 t -135.48 147.76 28.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.427 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.02 136.15 48.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.146 0.498 . . . . 0.0 110.9 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.42 ' H ' HD12 ' A' ' 323' ' ' ILE . 2.3 mp -98.38 117.27 43.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.919 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 48.8 t -112.53 141.87 26.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.479 HG21 ' HB2' ' A' ' 211' ' ' LEU . 97.3 t -88.93 118.85 35.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.028 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.6 t30 . . . . . 0 C--N 1.331 -0.2 0 C-N-CA 125.144 1.378 . . . . 0.0 112.549 -176.611 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.468 ' O ' HD22 ' A' ' 211' ' ' LEU . . . . . . . . 0 N--CA 1.468 0.469 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.65 80.75 9.02 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 209' ' ' ALA . 3.1 mm? -57.48 -53.29 59.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.71 -43.22 99.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.846 0.355 . . . . 0.0 110.697 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.4 t -70.92 -21.0 62.42 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.247 0.546 . . . . 0.0 110.346 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.57 ' HB1' ' HE3' ' A' ' 246' ' ' LYS . . . -84.24 -45.07 13.26 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.51 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 26.5 pt -69.48 -41.89 80.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.03 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -57.2 -32.47 66.51 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.459 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.42 67.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.236 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 242' ' ' ARG . 8.2 t -87.7 -47.93 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-O 121.065 0.46 . . . . 0.0 110.091 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.484 ' HA ' HG21 ' A' ' 239' ' ' ILE . 76.2 p -66.29 -36.91 84.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.585 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.02 24.95 42.53 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.38 -136.02 10.22 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . 0.602 ' HB2' ' NE ' ' A' ' 320' ' ' ARG . 3.4 Cg_exo -79.98 159.26 24.08 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.463 2.109 . . . . 0.0 111.851 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 320' ' ' ARG . 41.7 mm -74.88 106.65 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.661 -176.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.939 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.34 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 CA--C 1.515 -0.366 0 CA-C-O 120.476 0.179 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 243' ' ' VAL . 76.7 mt -69.9 -42.42 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 8.1 mp -67.08 -33.52 75.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.597 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.68 -37.25 82.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.067 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.594 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 0.0 OUTLIER -71.65 -41.17 69.1 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.779 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.638 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 54.9 t -56.01 -40.82 65.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.231 0.539 . . . . 0.0 110.199 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.86 82.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.231 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.594 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 2.9 t70 -48.9 -52.98 21.53 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.57 ' HE3' ' HB1' ' A' ' 214' ' ' ALA . 0.0 OUTLIER -73.66 -31.77 63.64 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.168 -178.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 25.6 mt -68.76 -29.64 68.07 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -64.86 -32.38 74.06 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.942 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -77.1 -29.41 54.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.57 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 7.8 t -137.82 65.02 44.88 Favored Pre-proline 0 C--N 1.316 -0.867 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.01 4.6 5.12 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.059 2.506 . . . . 0.0 114.461 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -81.21 -28.11 35.03 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.681 0.753 . . . . 0.0 109.077 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.3 141.14 54.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.639 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -93.74 137.08 33.36 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.047 0.451 . . . . 0.0 110.157 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.423 HG12 HG22 ' A' ' 325' ' ' VAL . 5.3 m -116.67 133.66 62.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.071 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 31.4 m -112.32 111.92 23.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.84 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.402 HG12 HG23 ' A' ' 323' ' ' ILE . 18.9 mt -92.79 114.36 29.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -104.79 128.21 52.85 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.597 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.416 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -109.49 144.82 16.7 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.798 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -126.24 158.72 34.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 10.0 t -174.13 114.18 0.19 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.125 0.964 . . . . 0.0 111.228 174.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 C--N 1.301 -1.531 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.488 -177.607 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 C--O 1.235 0.312 0 CA-C-O 120.978 0.418 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.678 HD22 ' N ' ' A' ' 271' ' ' ILE . 0.2 OUTLIER -61.06 -24.69 66.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.831 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.678 ' N ' HD22 ' A' ' 270' ' ' ASN . 19.8 mm -64.53 -64.89 2.32 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.869 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.438 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.3 Cg_endo -60.01 -30.01 90.6 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 121.779 1.653 . . . . 0.0 111.934 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 58.5 tp -68.36 -52.22 35.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.237 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.493 ' HB3' HG22 ' A' ' 261' ' ' THR . 17.3 p -64.22 -27.15 68.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.15 -33.62 74.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.768 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.511 ' O ' HG13 ' A' ' 280' ' ' ILE . 7.2 tt0 -64.05 -50.47 68.27 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.852 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.534 ' NH1' ' HB2' ' A' ' 319' ' ' ARG . 72.8 mtt180 -61.96 -38.06 87.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.784 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.88 92.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.076 0.465 . . . . 0.0 110.172 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.651 ' HA ' HG21 ' A' ' 297' ' ' THR . 23.6 ttpt -66.71 -31.93 72.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.377 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 276' ' ' GLN . 60.4 mt -55.09 -41.96 62.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.059 0.457 . . . . 0.0 110.145 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.712 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.6 t -70.2 -43.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.778 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.4 84.94 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.994 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -56.96 -37.58 71.77 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.937 0.398 . . . . 0.0 110.649 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.667 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 6.3 m-85 -70.86 -51.25 27.56 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.96 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 30.5 mt -55.38 -50.76 68.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.366 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.16 -41.22 85.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.007 0.432 . . . . 0.0 110.646 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.13 -21.96 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.001 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.8 mmp_? -88.52 7.1 34.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.499 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 92.42 14.8 55.12 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.683 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.41 144.9 8.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.6 111.49 5.45 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.832 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.1 -32.04 66.4 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.71 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.8 -15.47 63.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.967 0.413 . . . . 0.0 111.754 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -102.16 -1.8 30.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.023 0.44 . . . . 0.0 110.464 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 60.8 mt -106.92 129.49 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.067 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.03 124.43 48.1 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.651 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.1 p -107.68 124.9 50.67 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.887 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 69.6 t -134.02 123.45 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.057 0.456 . . . . 0.0 111.738 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -94.77 113.23 4.53 Favored Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 22.1 mt -93.06 1.43 57.25 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.775 0.321 . . . . 0.0 111.389 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.98 -131.2 33.53 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.631 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 45.4 t -91.02 117.6 29.72 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.7 p -178.81 151.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.716 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.35 69.43 1.64 Allowed Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 123.678 0.791 . . . . 0.0 110.831 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.585 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 74.1 Cg_endo -78.47 137.57 14.86 Favored 'Trans proline' 0 N--CA 1.44 -1.661 0 C-N-CA 122.403 2.069 . . . . 0.0 113.381 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.77 -38.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.498 176.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -131.18 169.35 16.04 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.961 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 45.0 m -77.22 146.06 37.2 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.638 0.256 . . . . 0.0 110.477 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -73.27 -7.24 50.67 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.758 0.313 . . . . 0.0 111.365 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -59.91 -24.72 64.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.453 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.6 t -115.73 137.75 23.45 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.543 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.99 -32.44 44.46 Favored 'Trans proline' 0 CA--C 1.518 -0.281 0 C-N-CA 122.452 2.101 . . . . 0.0 111.151 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -60.7 -40.84 93.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.758 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.0 -36.74 93.42 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.008 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -69.92 -25.82 63.86 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 319' ' ' ARG . . . -74.49 -26.47 60.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.062 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -37.06 29.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.585 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 57.0 m-20 -69.69 -3.56 15.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 17.5 ptm180 -98.21 9.12 43.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 120.75 0.31 . . . . 0.0 111.482 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.602 ' NE ' ' HB2' ' A' ' 222' ' ' PRO . 8.8 ptm180 -75.84 -175.95 3.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 75.7 t -135.7 153.05 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.608 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -132.64 139.23 47.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 111.193 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.412 ' H ' HD12 ' A' ' 323' ' ' ILE . 2.7 mp -95.94 115.05 34.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.86 137.01 39.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 211' ' ' LEU . 42.0 t -104.32 142.24 18.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 C--N 1.318 -0.763 0 O-C-N 123.542 0.526 . . . . 0.0 110.514 177.367 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.388 0 CA-C-O 120.662 0.267 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.15 90.15 3.09 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.033 0.444 . . . . 0.0 110.017 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 250' ' ' CYS . 41.9 mt -75.32 -28.6 59.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.002 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.01 -43.7 98.29 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 120.917 0.389 . . . . 0.0 110.305 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 33.0 t -71.15 -41.25 70.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.47 ' HB1' ' HE3' ' A' ' 246' ' ' LYS . . . -58.06 -47.78 82.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.611 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 211' ' ' LEU . 24.5 pt -72.53 -37.84 58.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.94 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -58.24 -36.21 72.86 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.751 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.39 -26.64 68.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.288 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.1 t -92.9 -43.68 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.465 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.606 ' HA ' HG21 ' A' ' 239' ' ' ILE . 70.2 p -67.43 -40.81 85.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.081 0.467 . . . . 0.0 110.899 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.26 24.57 59.02 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.62 -134.39 8.25 Favored Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . 0.428 ' HB3' HH11 ' A' ' 320' ' ' ARG . 91.9 Cg_endo -85.38 166.18 10.75 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.797 2.332 . . . . 0.0 113.037 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.5 mm -85.2 110.97 20.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.211 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.573 179.125 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 CA--C 1.52 -0.209 0 CA-C-O 120.693 0.282 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.606 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.5 mt -58.97 -39.02 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.442 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.538 HD22 HG13 ' A' ' 281' ' ' VAL . 41.5 mt -66.45 -32.1 73.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.103 0.478 . . . . 0.0 110.782 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 288' ' ' ARG . 60.9 m-20 -71.41 -36.62 71.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.491 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -70.59 -42.62 70.77 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.753 178.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.616 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 46.0 t -57.59 -42.36 81.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.6 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.55 80.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.284 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 24.6 t70 -49.8 -53.18 26.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.266 0.627 . . . . 0.0 112.623 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.623 ' NZ ' ' HB3' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -74.0 -31.57 63.01 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.561 -178.173 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 33.8 mt -64.09 -36.81 85.22 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.377 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.483 ' HG3' HG22 ' A' ' 290' ' ' VAL . 58.2 mtpt -73.06 -22.6 60.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.263 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.64 80.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 110.006 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.49 ' HB3' HD11 ' A' ' 211' ' ' LEU . 49.0 t -126.79 70.8 73.58 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 73.5 Cg_endo -71.6 -1.33 9.63 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 123.266 2.644 . . . . 0.0 114.145 -174.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -79.71 -24.8 41.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.642 0.734 . . . . 0.0 109.289 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -70.42 135.0 48.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.522 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.15 140.41 29.83 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.43 HG12 HG22 ' A' ' 325' ' ' VAL . 6.0 m -116.05 132.22 66.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.241 0.543 . . . . 0.0 111.436 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 39.8 m -109.02 108.72 19.55 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.17 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.43 HG12 HG23 ' A' ' 323' ' ' ILE . 23.3 mt -92.32 114.4 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.486 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -101.74 127.48 48.5 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.453 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.421 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -107.64 147.3 16.36 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.323 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 37.8 m-85 -123.66 162.01 23.92 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.119 0.485 . . . . 0.0 110.612 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.557 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 34.6 p -147.34 170.48 17.24 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 124.229 1.011 . . . . 0.0 108.95 175.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.429 ' HB2' HD22 ' A' ' 309' ' ' ASN . 5.6 p-10 . . . . . 0 C--N 1.316 -0.88 0 CA-C-O 120.924 0.392 . . . . 0.0 110.535 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.442 -0.855 0 CA-C-O 121.274 0.559 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.557 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 0.4 OUTLIER -58.44 -42.88 88.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.668 -178.22 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.446 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 25.7 mm -58.11 -64.35 2.87 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.583 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.446 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.8 Cg_endo -58.92 -29.05 89.29 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.025 1.817 . . . . 0.0 112.272 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 58.4 tp -70.3 -52.93 19.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.335 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.544 ' HB3' HG23 ' A' ' 261' ' ' THR . 14.7 p -63.5 -30.51 71.62 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.906 0.384 . . . . 0.0 110.512 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.6 73.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.785 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.619 ' O ' HG13 ' A' ' 280' ' ' ILE . 29.1 tt0 -67.0 -48.14 69.36 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.497 ' HB3' ' CG2' ' A' ' 321' ' ' VAL . 17.3 mmt180 -54.25 -49.02 70.49 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.382 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.2 90.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.176 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.636 ' HA ' HG21 ' A' ' 297' ' ' THR . 41.9 tptt -64.35 -30.57 71.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.227 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 276' ' ' GLN . 62.7 mt -59.85 -42.97 90.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.22 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.71 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.2 t -68.2 -45.81 82.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.836 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.7 -44.74 73.69 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.803 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.58 -38.82 82.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.914 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.49 -43.02 77.77 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.794 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 40.2 mt -62.78 -49.11 76.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.55 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 83.1 t -59.9 -40.83 83.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.511 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.74 -28.13 69.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.683 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 241' ' ' ASN . 15.3 mmm180 -85.33 0.02 53.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.917 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.29 6.75 35.97 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.611 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.483 HG22 ' HG3' ' A' ' 248' ' ' LYS . 60.2 t -83.55 144.57 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 117.723 0.761 . . . . 0.0 109.793 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.09 109.95 6.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.305 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.48 -29.9 74.83 Favored Glycine 0 CA--C 1.509 -0.316 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.363 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -61.94 -19.29 62.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.204 0.526 . . . . 0.0 110.948 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -107.96 5.5 26.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.484 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.8 mt -106.26 129.1 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.76 124.64 48.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.71 0.291 . . . . 0.0 110.594 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.636 HG21 ' HA ' ' A' ' 279' ' ' LYS . 14.9 p -109.16 121.99 46.33 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.207 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 73.3 t -130.25 120.44 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.389 0.614 . . . . 0.0 112.045 -176.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -90.11 110.97 3.83 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.4 ' HB3' HG21 ' A' ' 303' ' ' VAL . 27.2 mt -90.41 -0.15 57.53 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 68.56 -125.38 20.2 Favored Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.54 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.1 t -105.81 121.92 45.03 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.5 ' O ' ' HD3' ' A' ' 305' ' ' PRO . 75.5 t -136.95 -69.41 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.897 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.448 ' ND2' HG12 ' A' ' 303' ' ' VAL . 58.4 m-80 -112.38 91.68 17.21 Favored Pre-proline 0 C--O 1.242 0.702 0 CA-C-O 120.687 0.28 . . . . 0.0 110.747 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 303' ' ' VAL . 19.3 Cg_exo -65.63 135.32 41.52 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.611 2.207 . . . . 0.0 111.24 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.0 tt -84.65 -45.76 17.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.749 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -124.2 173.61 8.22 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.317 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.9 m -62.62 136.34 57.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.679 0.612 . . . . 0.0 111.253 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.429 HD22 ' HB2' ' A' ' 262' ' ' ASP . 20.6 m120 -80.64 -11.73 59.6 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.156 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.71 -19.7 65.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.07 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 314' ' ' GLY . 3.2 t -113.34 139.47 23.23 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.329 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.0 -35.41 87.79 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.619 2.212 . . . . 0.0 111.535 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.572 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 71.5 mm-40 -60.34 -46.48 89.74 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.497 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.458 ' H ' HG23 ' A' ' 311' ' ' THR . . . -63.78 -37.77 95.18 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.717 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 311' ' ' THR . 76.1 mtp180 -61.85 -40.43 95.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.23 0.538 . . . . 0.0 109.948 177.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.7 -28.69 70.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.653 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.572 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 11.0 mmtp -79.49 -39.29 32.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.036 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -55.51 -28.26 53.59 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 32.0 ptt180 -83.58 12.07 6.27 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.428 HH11 ' HB3' ' A' ' 222' ' ' PRO . 28.6 ptt85 -57.53 173.66 0.26 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.901 0.88 . . . . 0.0 112.966 174.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.497 ' CG2' ' HB3' ' A' ' 277' ' ' ARG . 66.3 t -133.73 148.02 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.015 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -130.31 139.02 50.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.981 0.42 . . . . 0.0 111.071 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.43 HG23 HG12 ' A' ' 257' ' ' ILE . 2.2 mp -101.09 117.02 45.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.891 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.3 138.12 38.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.43 HG22 HG12 ' A' ' 255' ' ' VAL . 59.3 t -101.08 137.79 27.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.385 179.325 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 121.333 0.587 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.09 78.12 6.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.092 0.472 . . . . 0.0 110.186 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.458 ' HB2' HG21 ' A' ' 325' ' ' VAL . 3.2 mm? -69.78 -29.1 66.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.67 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -63.82 -46.49 84.88 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.796 0.332 . . . . 0.0 110.536 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.1 t -72.05 -32.13 66.8 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.37 -47.32 76.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.182 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.472 ' CG2' HG13 ' A' ' 243' ' ' VAL . 22.0 pt -75.4 -39.48 41.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.848 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.448 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 17.9 t-20 -60.8 -33.4 72.94 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.974 0.416 . . . . 0.0 110.621 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.22 -28.03 69.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.081 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.484 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.4 t -90.61 -44.51 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.22 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.524 ' HA ' HG21 ' A' ' 239' ' ' ILE . 58.4 p -63.72 -36.07 82.64 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.967 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.0 25.19 41.73 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 124.52 -132.73 8.34 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . 0.467 ' HG3' HH11 ' A' ' 320' ' ' ARG . 96.6 Cg_endo -85.29 166.86 10.75 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.421 2.08 . . . . 0.0 112.183 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 51.5 mm -80.96 101.9 6.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.388 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.398 -179.615 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 CA--C 1.519 -0.213 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.524 HG21 ' HA ' ' A' ' 219' ' ' THR . 74.1 mt -61.73 -38.14 79.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.411 ' CD1' HG13 ' A' ' 281' ' ' VAL . 4.2 mm? -61.05 -36.89 80.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.077 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -78.77 -34.85 45.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.105 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.484 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -66.43 -43.74 84.83 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.574 177.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.543 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 34.0 t -58.51 -42.68 85.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.722 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.8 81.54 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.477 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -53.74 -50.53 65.76 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.449 ' H ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -72.6 -29.45 63.52 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.214 -178.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.1 mt -72.21 -28.57 63.26 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 109.627 176.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.421 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 15.6 tptm -64.65 -31.96 73.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.84 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.72 -37.72 73.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.235 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 53.5 t -125.76 72.59 68.88 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 74.1 Cg_endo -72.59 0.46 7.53 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.774 2.316 . . . . 0.0 112.734 -178.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.03 -31.43 56.27 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.84 145.15 56.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.563 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.552 ' HB2' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -101.37 145.62 28.68 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.44 HG12 HG22 ' A' ' 325' ' ' VAL . 3.1 m -119.11 127.28 75.84 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.904 176.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.4 m -103.89 109.34 21.05 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.521 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.443 HG12 HG23 ' A' ' 323' ' ' ILE . 19.4 mt -96.79 114.23 33.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-O 121.024 0.44 . . . . 0.0 109.916 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -102.59 126.01 49.52 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.345 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.457 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -104.41 144.94 15.92 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.506 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -127.35 161.88 27.6 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 38.3 p -141.31 170.8 15.05 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.799 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--N 1.312 -1.061 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.017 177.5 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.797 0.808 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.563 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 22.2 p30 -55.56 -33.25 63.69 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.374 177.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.449 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 20.1 mm -62.72 -65.0 2.4 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.174 177.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.449 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 11.2 Cg_endo -59.99 -27.45 84.93 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 121.887 1.725 . . . . 0.0 112.18 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.8 tp -67.36 -53.83 25.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.774 0.321 . . . . 0.0 111.532 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.542 ' HB3' HG23 ' A' ' 261' ' ' THR . 6.5 p -62.47 -30.37 71.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.757 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.64 -31.56 66.99 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.16 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.407 ' O ' HG13 ' A' ' 280' ' ' ILE . 27.9 tt0 -69.1 -51.48 38.17 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.787 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 277' ' ' ARG . 54.3 mmt-85 -58.78 -39.26 80.53 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.954 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.69 91.96 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.21 0.528 . . . . 0.0 109.872 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.615 ' HA ' HG21 ' A' ' 297' ' ' THR . 23.5 tptm -63.03 -34.87 78.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.968 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 276' ' ' GLN . 54.9 mt -56.73 -44.32 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.566 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.734 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.3 t -66.25 -46.11 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.623 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -54.47 -45.94 73.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.051 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.69 -36.44 82.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.904 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.554 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 4.7 m-85 -68.83 -41.41 78.61 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.645 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 31.8 mt -66.14 -48.1 71.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.844 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 89.2 t -59.33 -43.05 89.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.511 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.0 -28.31 68.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.267 0.556 . . . . 0.0 110.438 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.554 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 1.4 mpt_? -85.98 3.04 43.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.046 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 108.5 5.08 32.21 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.74 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 49.6 t -88.26 140.29 16.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 117.782 0.791 . . . . 0.0 110.225 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.93 117.25 8.03 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.561 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.69 86.56 Favored Glycine 0 CA--C 1.51 -0.265 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.15 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -15.26 63.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.964 0.412 . . . . 0.0 111.444 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -98.52 0.31 44.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.0 110.65 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.3 mt -109.27 129.37 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.498 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.32 129.58 54.94 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.937 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.615 HG21 ' HA ' ' A' ' 279' ' ' LYS . 25.0 p -115.58 128.09 55.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.524 0.202 . . . . 0.0 111.172 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 26.9 t -133.54 128.09 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -99.81 108.64 3.57 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 18.5 mt -92.36 3.2 55.92 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 68.53 -127.74 23.56 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.559 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 15.1 m -93.6 115.61 28.1 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.834 0.35 . . . . 0.0 110.525 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.5 p -176.12 150.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 60.7 t30 70.29 74.52 0.26 Allowed Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 123.871 0.732 . . . . 0.0 111.078 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.588 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 73.5 Cg_endo -75.07 155.33 42.58 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.647 2.231 . . . . 0.0 112.792 -177.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.0 tt -124.59 -44.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.445 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.444 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -138.44 174.98 9.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.473 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 50.8 m -71.16 131.16 43.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.279 0.562 . . . . 0.0 111.702 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -80.81 -7.66 59.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.417 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.14 -16.88 63.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.808 178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.465 HG23 ' H ' ' A' ' 314' ' ' GLY . 5.2 t -123.23 144.39 43.49 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -54.49 -36.52 88.52 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.067 2.511 . . . . 0.0 112.118 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.1 mm-40 -55.49 -51.15 67.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.983 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -69.33 -40.85 80.2 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.693 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -56.35 -41.05 75.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.025 0.44 . . . . 0.0 110.339 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.96 70.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.737 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 0.3 OUTLIER -80.63 -42.97 21.24 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.597 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.588 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 39.2 m-80 -63.85 -23.83 67.51 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -176.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.597 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 10.4 ptm180 -84.98 12.87 6.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.29 0.567 . . . . 0.0 111.929 -178.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.467 HH11 ' HG3' ' A' ' 222' ' ' PRO . 19.0 ptt180 -58.61 177.74 0.13 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.303 1.049 . . . . 0.0 113.437 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 68.8 t -136.32 144.7 32.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.766 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -131.1 137.3 49.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.115 0.483 . . . . 0.0 111.376 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.443 HG23 HG12 ' A' ' 257' ' ' ILE . 2.1 mp -98.7 120.34 47.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.629 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.68 135.06 50.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 211' ' ' LEU . 89.4 t -95.43 141.89 14.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.185 0.517 . . . . 0.0 111.694 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 254' ' ' ARG . 41.1 t-20 . . . . . 0 C--N 1.311 -1.091 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.765 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.564 0 CA-C-O 120.594 0.235 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.04 69.43 3.32 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.058 0.456 . . . . 0.0 110.039 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 214' ' ' ALA . 35.4 mt -55.53 -27.24 47.67 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.342 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.417 HE22 HG13 ' A' ' 324' ' ' VAL . 2.4 tp-100 -55.95 -60.38 3.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.274 0.559 . . . . 0.0 109.968 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 39.9 t -69.44 -27.1 64.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.178 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.609 ' HB1' ' HE2' ' A' ' 246' ' ' LYS . . . -69.46 -49.32 55.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.273 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 211' ' ' LEU . 29.3 pt -74.08 -40.51 51.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 121.054 -0.259 . . . . 0.0 111.304 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -60.9 -29.6 69.68 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.089 0.471 . . . . 0.0 110.584 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.47 -27.76 68.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.178 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.9 t -89.55 -45.01 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.229 -178.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.53 ' HA ' HG21 ' A' ' 239' ' ' ILE . 75.8 p -67.0 -38.33 85.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.443 0.64 . . . . 0.0 109.861 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.74 21.75 61.1 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.89 -122.64 4.19 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -89.17 159.88 5.73 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.74 2.293 . . . . 0.0 113.979 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.5 mm -78.32 107.99 11.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.406 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 121.026 0.441 . . . . 0.0 110.005 177.418 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 . . . . . 0 N--CA 1.446 -0.66 0 CA-C-O 120.535 0.207 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.53 HG21 ' HA ' ' A' ' 219' ' ' THR . 90.4 mt -61.63 -37.61 78.34 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 46.6 mt -66.27 -35.07 79.45 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.451 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -69.88 -37.12 75.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.461 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -67.69 -46.77 71.34 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.762 178.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.639 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.8 t -61.79 -46.06 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.77 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.08 -31.51 72.76 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.441 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.04 -44.06 97.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.42 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.609 ' HE2' ' HB1' ' A' ' 214' ' ' ALA . 0.6 OUTLIER -75.48 -27.21 58.75 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.596 -179.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 43.9 mt -65.39 -28.41 69.24 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 121.205 0.526 . . . . 0.0 109.622 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.539 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 7.0 mtpm? -78.55 -22.36 47.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.318 177.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.94 -30.55 66.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.36 0.6 . . . . 0.0 110.068 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.473 ' HB3' HD11 ' A' ' 211' ' ' LEU . 13.3 t -132.74 69.85 79.27 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 57.5 Cg_endo -67.97 -2.01 7.99 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.442 2.762 . . . . 0.0 114.231 -173.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.46 -18.39 28.35 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.443 0.64 . . . . 0.0 109.939 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -71.88 131.01 42.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.005 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -91.58 138.52 31.5 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.4 m -114.89 130.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-O 121.204 0.526 . . . . 0.0 111.603 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.1 m -107.87 107.48 18.23 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.193 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.419 HG12 HG23 ' A' ' 323' ' ' ILE . 21.6 mt -90.15 117.32 33.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.768 -177.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -105.8 126.92 52.73 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.787 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -107.22 145.78 16.06 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 6.9 m-85 -124.29 158.57 32.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.944 0.402 . . . . 0.0 109.996 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' A' ' 270' ' ' ASN . 16.6 p -144.54 170.1 16.69 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.611 0.764 . . . . 0.0 109.935 177.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.457 ' OD2' ' HD3' ' A' ' 315' ' ' ARG . 19.2 t70 . . . . . 0 C--N 1.312 -1.041 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.443 -0.782 0 CA-C-O 121.331 0.586 . . . . 0.0 109.926 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.576 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 3.7 p30 -65.4 -27.58 68.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.544 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.472 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 27.4 mm -62.65 -63.88 3.68 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-O 119.664 -0.208 . . . . 0.0 110.989 178.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.472 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 1.6 Cg_endo -53.97 -37.16 85.87 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.428 2.085 . . . . 0.0 111.313 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.469 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 25.2 tp -62.22 -52.55 63.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.428 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 22.3 m -61.48 -30.97 70.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.783 0.325 . . . . 0.0 110.401 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.8 -28.91 64.99 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.885 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.469 ' O ' HG13 ' A' ' 280' ' ' ILE . 9.3 tt0 -71.51 -45.54 62.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 22.1 mmm180 -56.59 -46.84 80.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.524 178.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.85 88.91 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.462 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.655 ' HA ' HG21 ' A' ' 297' ' ' THR . 16.8 ttpt -62.97 -32.06 73.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.912 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 276' ' ' GLN . 64.4 mt -56.22 -43.63 77.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.203 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.718 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 7.8 t -69.62 -44.24 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.126 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.17 73.77 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 123.291 0.369 . . . . 0.0 110.663 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.8 -40.42 84.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.863 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -69.8 -40.35 76.03 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.265 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 46.6 mt -64.77 -47.61 77.53 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 92.3 t -60.92 -39.22 81.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.284 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.91 -28.42 69.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.834 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.604 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 2.4 mmp_? -86.86 4.57 40.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.301 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.9 5.43 44.37 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.043 -1.075 . . . . 0.0 114.649 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 58.0 t -84.18 145.24 8.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 117.801 0.801 . . . . 0.0 109.904 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 295' ' ' ILE . . . -69.3 112.79 6.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.42 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.58 -33.88 87.86 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.067 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -69.76 -12.6 61.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.589 0.233 . . . . 0.0 111.318 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -104.52 1.71 30.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.847 0.356 . . . . 0.0 110.615 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 291' ' ' ALA . 70.4 mt -105.12 131.45 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.922 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.58 125.7 49.43 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.068 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.655 HG21 ' HA ' ' A' ' 279' ' ' LYS . 11.6 p -107.51 129.51 54.95 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.888 0.375 . . . . 0.0 111.406 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.48 136.98 52.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.803 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.49 114.49 4.12 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.408 HD12 ' CE1' ' A' ' 260' ' ' TYR . 17.5 mt -91.48 -5.33 54.41 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 71.3 -135.59 24.1 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.073 -1.061 . . . . 0.0 111.397 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 261' ' ' THR . 7.5 t -87.99 114.56 24.72 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.151 0.5 . . . . 0.0 110.029 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.9 p -176.65 150.31 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 44.7 t30 65.9 78.87 0.25 Allowed Pre-proline 0 C--N 1.311 -1.076 0 O-C-N 123.75 0.656 . . . . 0.0 111.1 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.628 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 39.7 Cg_endo -68.69 138.24 40.87 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.818 2.345 . . . . 0.0 113.154 -177.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 7.4 tt -110.79 -25.43 3.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.768 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -152.45 163.62 39.16 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 47.8 t -62.84 134.23 55.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.042 0.449 . . . . 0.0 110.988 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -80.61 -11.61 59.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.63 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.2 36.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.169 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 3.1 t -124.74 138.03 30.56 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.916 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.99 -26.63 82.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.894 2.396 . . . . 0.0 111.78 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 8.4 mm-40 -65.33 -41.87 93.52 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.3 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.41 -38.38 93.51 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.49 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.457 ' HD3' ' OD2' ' A' ' 262' ' ' ASP . 51.9 mtt-85 -63.6 -37.87 88.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.37 68.89 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.827 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 9.0 mmtp -84.65 -38.45 19.81 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.822 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.628 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 38.5 m-80 -63.74 -21.16 66.27 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 13.0 ptm180 -82.11 14.55 2.79 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.156 0.503 . . . . 0.0 111.232 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -65.42 -174.38 0.18 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.106 0.963 . . . . 0.0 113.13 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.5 t -141.81 148.28 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.722 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -133.84 135.9 44.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.747 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.439 ' H ' HD12 ' A' ' 323' ' ' ILE . 2.6 mp -94.23 119.34 42.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.37 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.417 HG13 HE22 ' A' ' 212' ' ' GLN . 91.6 t -106.62 136.67 40.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 211' ' ' LEU . 55.0 t -101.49 139.61 22.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.341 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.353 177.469 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.431 0 CA-C-O 120.728 0.299 . . . . 0.0 111.272 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.73 85.86 1.22 Allowed 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.523 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 250' ' ' CYS . 23.7 mt -70.35 -33.64 71.69 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.939 -177.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -63.76 -45.74 88.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.24 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 31.5 t -75.63 -23.34 56.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.057 0.456 . . . . 0.0 109.917 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.517 ' HB1' ' HE3' ' A' ' 246' ' ' LYS . . . -72.49 -49.91 29.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.206 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 211' ' ' LEU . 26.7 pt -70.63 -38.27 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.868 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -55.7 -37.21 68.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.951 0.405 . . . . 0.0 110.975 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.5 -26.87 68.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.492 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.8 t -92.26 -47.96 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 120.921 0.391 . . . . 0.0 110.63 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.513 ' HA ' HG21 ' A' ' 239' ' ' ILE . 81.6 p -64.35 -39.17 93.36 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.615 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.8 22.51 59.63 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.4 -130.55 6.84 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.19 156.31 25.98 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.573 2.182 . . . . 0.0 112.044 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -74.1 109.29 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.092 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 175.288 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 120.516 0.198 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.513 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.8 mt -64.41 -39.8 86.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.33 -33.4 75.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.894 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.455 ' OD1' ' HD3' ' A' ' 288' ' ' ARG . 44.8 t30 -71.73 -36.03 70.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.583 0.706 . . . . 0.0 109.177 177.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.606 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 0.0 OUTLIER -68.52 -42.28 78.73 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.719 177.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.622 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 44.6 t -62.5 -43.9 98.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.334 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -55.82 -37.24 68.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.713 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.606 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 7.7 t70 -49.06 -53.31 20.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.56 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.559 ' NZ ' ' HB3' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -82.51 -14.53 54.83 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.821 -176.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.4 mt -80.47 -26.09 38.47 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.339 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.502 ' HG3' HG22 ' A' ' 290' ' ' VAL . 59.6 mtpt -83.54 -23.15 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.628 176.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.84 -37.32 76.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.203 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.562 ' HB3' HD11 ' A' ' 211' ' ' LEU . 24.6 t -130.09 71.97 82.06 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-O 121.339 0.59 . . . . 0.0 109.505 177.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 91.4 Cg_endo -75.35 -1.4 11.25 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.164 2.576 . . . . 0.0 113.244 -178.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -79.15 -29.69 43.19 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.872 0.844 . . . . 0.0 108.872 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -81.46 134.68 35.57 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.733 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -90.79 147.02 23.48 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.953 0.406 . . . . 0.0 110.508 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.13 137.75 52.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.587 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.0 m -114.13 113.1 24.24 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.551 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.457 HG12 HG23 ' A' ' 323' ' ' ILE . 21.4 mt -94.15 113.85 29.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.578 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -98.47 126.66 44.1 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.37 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.411 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -107.48 146.82 16.25 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 36.3 m-85 -127.4 161.89 27.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.1 0.476 . . . . 0.0 110.688 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.604 HG23 ' HB3' ' A' ' 274' ' ' SER . 56.9 p -140.58 173.28 11.65 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.529 175.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.318 -0.776 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.859 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 121.465 0.65 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.528 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 12.3 m-20 -62.87 -36.54 83.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.427 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.487 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 27.3 mm -56.58 -64.22 2.67 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.019 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.487 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 5.1 Cg_endo -56.79 -35.65 98.14 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 121.944 1.763 . . . . 0.0 111.914 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.494 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 60.2 tp -63.07 -52.92 60.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.686 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.604 ' HB3' HG23 ' A' ' 261' ' ' THR . 13.0 p -62.98 -31.52 72.66 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.99 0.424 . . . . 0.0 110.468 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.45 -34.04 77.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.742 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.634 ' O ' HG13 ' A' ' 280' ' ' ILE . 9.8 tt0 -66.92 -44.96 79.38 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 38.8 mmt180 -56.86 -47.38 80.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.008 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.75 88.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.018 0.437 . . . . 0.0 110.373 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.526 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.9 tptt -65.97 -32.36 73.8 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.092 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 276' ' ' GLN . 62.5 mt -58.55 -45.76 90.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.197 0.522 . . . . 0.0 109.684 177.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.699 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.2 t -65.8 -48.08 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.792 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.52 -41.98 70.32 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.076 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.64 -42.63 88.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.472 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -66.84 -43.06 84.69 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.491 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 41.7 mt -64.03 -51.05 66.02 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.887 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.9 t -59.41 -40.55 81.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.91 71.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.555 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 1.2 mmp_? -83.72 6.23 21.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.064 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.04 9.5 51.73 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.748 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.503 ' CG1' HD11 ' A' ' 295' ' ' ILE . 59.0 t -84.9 141.4 14.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.28 113.86 7.01 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.346 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.01 -32.7 76.34 Favored Glycine 0 C--N 1.318 -0.43 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.707 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.59 -19.15 62.88 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.798 0.332 . . . . 0.0 111.593 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.64 0.32 49.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.473 0.654 . . . . 0.0 110.005 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.503 HD11 ' CG1' ' A' ' 290' ' ' VAL . 63.5 mt -110.81 133.32 56.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.142 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -121.4 129.67 53.15 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.526 HG21 ' HA ' ' A' ' 279' ' ' LYS . 29.9 p -109.02 125.94 52.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.899 0.381 . . . . 0.0 111.429 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.9 t -127.89 117.41 46.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.12 111.96 3.9 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.442 174.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 20.9 mt -96.75 1.1 50.5 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 58.91 -127.47 45.36 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 44.4 t -102.34 122.34 44.07 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.463 HG13 ' H ' ' A' ' 304' ' ' ASN . 5.9 p -146.85 -59.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.463 ' H ' HG13 ' A' ' 303' ' ' VAL . 76.1 m-20 -117.46 92.93 41.91 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -66.45 174.24 6.57 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.857 2.371 . . . . 0.0 113.267 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 5.3 tt -131.27 -48.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.591 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -120.51 172.43 7.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.254 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 27.9 m -67.19 139.75 57.44 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.037 0.446 . . . . 0.0 111.351 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -81.01 -10.08 59.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.646 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.14 -16.37 61.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.349 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.6 t -115.82 144.44 32.66 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.513 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.97 -31.32 24.36 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.215 1.943 . . . . 0.0 110.942 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.88 -35.41 81.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.653 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -71.34 -36.97 63.14 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 11.3 mtp85 -57.66 -39.46 77.1 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.59 -30.93 71.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.22 -46.34 20.64 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.807 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -61.69 -26.03 67.78 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 14.9 ptp180 -83.62 10.65 8.69 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.015 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -57.14 177.76 0.08 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.01 0.91 . . . . 0.0 112.715 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 58.4 t -137.37 144.64 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.054 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -131.98 138.42 48.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.984 0.421 . . . . 0.0 111.115 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.457 HG23 HG12 ' A' ' 257' ' ' ILE . 1.6 mp -100.0 120.47 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.992 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 75.1 t -108.45 134.24 50.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 53.5 t -98.1 133.47 40.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--N 1.318 -0.762 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.867 -178.772 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -84.0 88.83 7.17 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.339 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.438 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.7 mm? -67.86 -39.3 83.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.766 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -57.83 -55.65 32.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.423 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.4 t -67.33 -34.68 77.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.65 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.541 ' HB1' ' HE2' ' A' ' 246' ' ' LYS . . . -64.89 -46.74 80.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.686 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 211' ' ' LEU . 23.6 pt -71.67 -38.6 67.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.501 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -57.68 -33.79 68.72 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.588 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.26 -26.33 68.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.216 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.6 HG11 ' CB ' ' A' ' 242' ' ' ARG . 8.2 t -92.79 -45.73 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.447 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.438 ' HA ' HG21 ' A' ' 239' ' ' ILE . 75.5 p -64.36 -42.91 95.95 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.274 0.559 . . . . 0.0 110.397 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.96 13.45 83.06 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 143.32 -131.25 4.44 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.67 164.77 5.17 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.029 2.486 . . . . 0.0 113.593 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.1 mm -81.69 109.8 16.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.324 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.047 0.451 . . . . 0.0 110.833 178.813 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 CA--C 1.507 -0.699 0 N-CA-C 111.379 0.14 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 243' ' ' VAL . 58.6 mt -67.6 -49.01 74.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.795 -175.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.493 ' CD2' HG13 ' A' ' 281' ' ' VAL . 37.6 mt -59.3 -40.41 86.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.206 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -70.78 -36.27 72.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 110.185 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.6 ' CB ' HG11 ' A' ' 218' ' ' VAL . 7.8 mmt180 -63.68 -54.99 26.99 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.5 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.663 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 69.2 t -53.47 -46.8 59.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.646 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.84 85.13 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.764 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -60.15 -45.62 92.42 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.665 0.269 . . . . 0.0 111.605 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.541 ' HE2' ' HB1' ' A' ' 214' ' ' ALA . 0.4 OUTLIER -74.38 -26.27 60.01 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.735 -179.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 35.0 mt -69.16 -28.87 66.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.258 0.551 . . . . 0.0 110.279 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.497 ' HG3' HG22 ' A' ' 290' ' ' VAL . 55.6 mtpt -77.08 -24.94 51.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.843 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -73.1 -40.7 64.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.533 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 50.0 t -125.13 73.74 66.47 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 121.332 0.587 . . . . 0.0 109.848 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.65 -0.03 8.8 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.442 2.761 . . . . 0.0 113.424 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.96 -26.7 57.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.887 0.851 . . . . 0.0 109.538 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -78.82 130.09 35.32 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -94.98 142.22 27.74 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.44 HG12 HG22 ' A' ' 325' ' ' VAL . 6.2 m -118.15 135.73 57.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.429 0.633 . . . . 0.0 112.315 -178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.0 m -108.15 108.25 19.23 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.449 HG12 HG23 ' A' ' 323' ' ' ILE . 26.2 mt -91.47 114.3 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.767 -178.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -102.93 129.09 49.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.352 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -105.28 156.62 16.68 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.641 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 19.9 m-85 -132.53 159.31 39.78 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.005 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.8 p -143.1 166.13 25.5 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.434 ' CG ' ' HE ' ' A' ' 315' ' ' ARG . 2.7 p30 . . . . . 0 C--N 1.317 -0.845 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.009 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 42.6 mm . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 121.843 0.83 . . . . 0.0 109.071 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -67.08 -32.69 74.02 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.786 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.414 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 22.4 mm -57.44 -63.64 3.52 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.43 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.414 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 17.9 Cg_endo -61.58 -30.12 85.42 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 122.248 1.966 . . . . 0.0 111.96 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.18 -50.14 64.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 110.455 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.42 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 10.0 t -57.24 -40.95 78.62 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.01 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.63 -30.98 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.749 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.472 ' O ' HG13 ' A' ' 280' ' ' ILE . 8.8 tp-100 -69.95 -45.14 68.08 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.993 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -64.07 -39.73 94.72 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.342 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.6 87.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.002 0.43 . . . . 0.0 109.871 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.547 ' HA ' HG21 ' A' ' 297' ' ' THR . 7.8 ttpt -60.54 -36.91 79.57 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.735 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 276' ' ' GLN . 58.9 mt -56.39 -47.05 82.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.811 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.546 ' O ' HD13 ' A' ' 285' ' ' LEU . 17.1 t -63.34 -46.89 94.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.941 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.54 -43.16 89.17 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -61.37 -39.91 92.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.16 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.605 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 8.0 m-85 -70.65 -42.38 70.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.993 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 281' ' ' VAL . 1.8 mp -61.94 -48.85 78.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 84.2 t -60.45 -40.38 84.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.501 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.5 -30.95 71.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.182 0.515 . . . . 0.0 110.608 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 20.7 mmm180 -83.12 5.45 22.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.735 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.51 2.24 40.67 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.075 -1.059 . . . . 0.0 114.45 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 61.4 t -80.55 145.24 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 117.842 0.821 . . . . 0.0 109.829 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.512 ' HB3' ' ND1' ' A' ' 294' ' ' HIS . . . -77.46 118.86 20.31 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.148 0.499 . . . . 0.0 111.376 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.65 -30.88 62.99 Favored Glycine 0 C--O 1.222 -0.612 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.873 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -68.81 -16.92 63.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.512 ' ND1' ' HB3' ' A' ' 291' ' ' ALA . 29.4 m170 -95.85 -5.24 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.724 0.297 . . . . 0.0 110.808 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.425 HD11 ' CG1' ' A' ' 290' ' ' VAL . 40.6 mt -110.83 130.17 64.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.228 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.69 125.71 51.18 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.126 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.547 HG21 ' HA ' ' A' ' 279' ' ' LYS . 29.7 p -111.75 122.56 48.13 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.262 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 28.2 m -120.09 164.24 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.483 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.42 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -134.36 105.15 0.55 Allowed Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 14.4 mt -89.59 2.54 54.54 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 69.99 -126.4 17.07 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.561 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 11.8 p -97.18 120.64 37.9 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.828 0.347 . . . . 0.0 110.651 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.4 p -176.31 150.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.339 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 61.66 81.98 0.23 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 123.488 0.715 . . . . 0.0 111.636 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.564 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 94.3 Cg_endo -80.7 154.55 20.49 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.458 2.106 . . . . 0.0 113.004 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.1 tt -119.0 -53.41 3.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.665 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -119.21 166.56 12.82 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.7 p -65.01 143.9 57.64 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.111 0.482 . . . . 0.0 111.491 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -80.19 -7.52 59.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.416 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.17 -18.71 63.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.846 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.7 t -113.72 135.54 21.98 Favored Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.697 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.6 -33.41 86.86 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.789 2.326 . . . . 0.0 111.137 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.0 mm-40 -66.36 -39.94 89.47 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.247 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -69.03 -37.66 83.2 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.123 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.434 ' HE ' ' CG ' ' A' ' 262' ' ' ASP . 80.6 mtp180 -61.49 -37.67 84.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.112 0.482 . . . . 0.0 109.724 176.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.63 68.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.661 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 1.0 OUTLIER -80.71 -39.76 26.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.367 177.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.564 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 44.3 m-80 -65.7 -22.13 66.6 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 39.0 ptt180 -84.41 10.78 9.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.279 0.561 . . . . 0.0 111.507 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 18.7 ptt-85 -58.74 178.58 0.11 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.952 0.882 . . . . 0.0 112.698 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 49.7 t -138.35 145.4 28.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.562 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -130.21 137.01 49.83 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.932 0.396 . . . . 0.0 110.61 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.449 HG23 HG12 ' A' ' 257' ' ' ILE . 2.2 mp -97.22 116.97 40.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.407 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.67 137.38 39.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 255' ' ' VAL . 49.2 t -100.25 138.81 23.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 C--N 1.31 -1.125 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.416 178.906 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.935 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.89 73.7 2.13 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.153 0.501 . . . . 0.0 110.199 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.542 ' HB2' HG21 ' A' ' 325' ' ' VAL . 16.4 mt -56.83 -27.67 60.47 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.81 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.05 -42.87 88.92 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.758 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 26.0 t -73.19 -31.88 64.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.53 -47.88 77.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.894 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.416 HG21 HG13 ' A' ' 243' ' ' VAL . 20.9 pt -73.85 -33.7 37.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.121 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -56.36 -37.88 70.67 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.079 0.466 . . . . 0.0 110.466 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.28 -29.74 70.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.877 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.717 HG12 HG23 ' A' ' 239' ' ' ILE . 32.5 t -82.38 -52.52 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.671 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.468 ' HA ' HG21 ' A' ' 239' ' ' ILE . 76.0 p -64.86 -36.23 83.68 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.424 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.67 12.62 79.78 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.27 -125.87 2.78 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -91.35 167.23 3.5 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.839 2.359 . . . . 0.0 112.936 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.6 mm -84.22 110.46 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.008 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.835 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.996 179.144 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.717 HG23 HG12 ' A' ' 218' ' ' VAL . 71.6 mt -64.09 -44.72 97.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.149 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.421 HD13 ' CD2' ' A' ' 284' ' ' TYR . 28.9 mt -57.2 -36.17 70.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.228 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.444 ' HA ' ' HG2' ' A' ' 288' ' ' ARG . 3.5 m-20 -79.94 -38.2 32.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.171 0.51 . . . . 0.0 110.321 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.688 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -64.87 -40.48 95.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.105 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.602 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 28.1 t -59.07 -41.42 83.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.971 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' A' ' 288' ' ' ARG . . . -59.84 -37.22 78.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.826 -177.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.57 -44.9 73.35 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.456 ' H ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -82.19 -16.18 50.64 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.709 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 23.5 mt -81.06 -22.56 39.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.518 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 9.7 tptm -71.82 -25.05 61.83 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.685 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -64.03 -46.47 84.3 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.394 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.43 ' HB3' HD11 ' A' ' 211' ' ' LEU . 52.1 t -128.92 75.94 79.68 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 60.8 Cg_endo -71.42 -2.61 11.53 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.958 2.439 . . . . 0.0 113.243 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.09 -23.38 23.73 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.405 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -62.3 138.26 58.4 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.604 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -93.88 133.21 37.53 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 325' ' ' VAL . 5.1 m -112.59 129.2 68.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-O 121.141 0.496 . . . . 0.0 110.751 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 33.3 m -103.84 108.66 20.08 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.051 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.449 HG12 HG23 ' A' ' 323' ' ' ILE . 24.5 mt -93.83 108.86 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -98.15 128.46 44.65 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.921 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.491 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -104.67 144.86 15.87 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 177.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 8.6 m-85 -126.13 163.62 22.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.692 0.282 . . . . 0.0 110.327 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 45.6 p -143.21 162.47 35.54 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.296 0.638 . . . . 0.0 109.616 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 C--N 1.323 -0.552 0 CA-C-O 121.075 0.464 . . . . 0.0 110.889 179.106 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 269' ' ' ILE . 1.7 mp . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 121.557 0.694 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.64 -38.87 67.38 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.149 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.41 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 19.6 mm -60.43 -63.9 3.72 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.072 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.41 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 11.8 Cg_endo -60.74 -30.97 91.37 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.867 1.711 . . . . 0.0 112.33 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 60.3 tp -65.52 -53.09 47.31 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.776 0.322 . . . . 0.0 111.477 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.491 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.9 p -61.82 -30.39 70.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 120.933 0.396 . . . . 0.0 110.767 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.38 -32.76 66.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.255 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.496 ' O ' HG13 ' A' ' 280' ' ' ILE . 8.6 tp-100 -66.17 -49.7 66.46 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.762 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -61.95 -38.63 89.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.908 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.34 97.13 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.841 0.353 . . . . 0.0 110.295 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.56 ' HA ' HG21 ' A' ' 297' ' ' THR . 11.5 tmtt? -61.7 -38.33 87.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.15 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 276' ' ' GLN . 57.4 mt -55.59 -47.38 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.733 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 9.7 t -65.19 -48.92 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -53.64 -45.77 70.31 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -58.48 -41.69 85.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.706 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.603 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 6.9 m-85 -68.41 -41.32 80.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.716 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.733 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 43.8 mt -62.93 -46.44 87.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 95.0 t -58.78 -41.68 83.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.176 176.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.29 -28.5 68.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.503 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.603 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -83.54 -1.27 53.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.169 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 111.05 5.91 26.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.478 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.6 t -89.92 141.81 13.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 117.605 0.703 . . . . 0.0 110.443 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 295' ' ' ILE . . . -67.42 115.34 6.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.478 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.72 -35.61 92.24 Favored Glycine 0 CA--C 1.508 -0.346 0 CA-C-N 115.689 -0.687 . . . . 0.0 113.221 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -68.99 -14.52 63.09 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.055 0.455 . . . . 0.0 111.441 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -102.52 2.58 36.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.112 0.482 . . . . 0.0 110.402 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 291' ' ' ALA . 76.0 mt -105.97 132.44 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.38 127.87 54.09 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.783 0.325 . . . . 0.0 110.482 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.56 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.8 p -110.95 126.63 54.96 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.54 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.58 123.69 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -94.2 104.04 3.1 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 174.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.6 -3.08 58.99 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 78.98 -125.59 7.08 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.148 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 18.5 t -101.67 119.4 38.72 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.9 p -176.8 148.2 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 62.39 78.64 0.29 Allowed Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 123.186 0.595 . . . . 0.0 111.018 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.474 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 59.4 Cg_endo -73.03 151.4 49.97 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.36 2.04 . . . . 0.0 112.716 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.491 HG22 ' HA ' ' A' ' 318' ' ' ASN . 4.2 tt -111.16 -54.64 5.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.307 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.428 ' H ' HG23 ' A' ' 306' ' ' ILE . . . -120.15 170.54 9.22 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.765 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 15.5 m -62.38 137.49 58.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.263 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -80.92 -14.43 58.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.863 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.16 -18.45 65.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.229 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 314' ' ' GLY . 3.7 t -114.87 142.24 28.08 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.378 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.29 -28.05 40.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.494 2.129 . . . . 0.0 111.366 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 4.9 mt-10 -65.07 -38.98 92.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.411 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.417 ' H ' HG23 ' A' ' 311' ' ' THR . . . -70.15 -38.45 72.7 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.666 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -61.02 -39.04 88.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.101 0.477 . . . . 0.0 109.886 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.92 -26.77 68.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.629 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 3.6 mmtp -85.61 -37.17 19.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.491 ' HA ' HG22 ' A' ' 306' ' ' ILE . 35.9 m-80 -63.57 -20.94 66.05 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 14.6 ptp180 -88.06 15.19 7.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.313 0.577 . . . . 0.0 111.162 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.457 ' HB3' ' O ' ' A' ' 317' ' ' LYS . 26.2 ptt-85 -61.33 -176.32 0.07 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.085 0.945 . . . . 0.0 112.609 175.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 70.7 t -137.71 145.55 28.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.944 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -131.83 140.66 49.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.951 0.405 . . . . 0.0 110.827 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.449 HG23 HG12 ' A' ' 257' ' ' ILE . 1.3 mp -99.0 117.05 43.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.364 -178.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.64 135.02 47.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 211' ' ' LEU . 74.9 t -101.49 136.83 31.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 C--N 1.31 -1.142 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.921 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.392 0 CA-C-O 120.659 0.266 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -80.39 56.52 2.55 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.006 0.432 . . . . 0.0 110.509 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 250' ' ' CYS . 20.4 mt -53.18 -25.9 15.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -66.21 -37.79 86.41 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.327 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.0 t -77.67 -30.67 52.11 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 211' ' ' LEU . . . -65.49 -46.24 80.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.81 -1.087 . . . . 0.0 111.011 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 25.2 pt -73.73 -37.46 49.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.422 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.15 -31.67 69.18 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.916 0.389 . . . . 0.0 110.863 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.7 -27.05 67.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.894 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.0 p -99.17 -34.84 4.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.282 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.634 ' HA ' HG21 ' A' ' 239' ' ' ILE . 66.8 p -70.28 -37.23 74.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.279 0.561 . . . . 0.0 110.039 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.28 22.62 56.55 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.31 -132.34 7.75 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . 0.551 ' HB2' ' HG3' ' A' ' 320' ' ' ARG . 58.3 Cg_endo -80.95 163.34 20.56 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.622 2.215 . . . . 0.0 112.632 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.6 mm -83.17 101.96 8.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.333 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.149 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.513 -179.36 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 120.747 0.308 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.634 HG21 ' HA ' ' A' ' 219' ' ' THR . 88.0 mt -56.69 -38.34 57.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.842 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.41 HD22 HG13 ' A' ' 281' ' ' VAL . 57.5 mt -65.23 -31.65 72.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.854 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.417 ' OD1' ' HD3' ' A' ' 288' ' ' ARG . 7.9 t30 -71.14 -37.74 72.27 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -40.89 83.56 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.201 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.605 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.9 t -57.03 -42.76 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.014 177.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.01 82.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.328 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -52.22 -49.65 63.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.504 ' H ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -73.45 -30.27 63.09 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.469 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.7 mt -69.97 -30.96 68.43 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.627 0.727 . . . . 0.0 109.17 177.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -62.79 -35.08 78.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.042 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -73.23 -35.7 66.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.785 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.529 ' HB3' HD11 ' A' ' 211' ' ' LEU . 43.7 t -128.33 69.99 78.87 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.92 2.13 4.5 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.55 2.834 . . . . 0.0 114.656 -174.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -80.48 -26.29 38.33 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.418 0.628 . . . . 0.0 109.99 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.94 133.94 56.02 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.023 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -96.6 135.66 38.21 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.505 HG12 HG22 ' A' ' 325' ' ' VAL . 6.7 m -113.35 133.26 59.81 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.873 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 34.1 m -108.85 107.3 17.65 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.025 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.453 HG12 HG23 ' A' ' 323' ' ' ILE . 19.8 mt -94.97 115.4 33.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.991 -177.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -101.41 131.34 47.56 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.896 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.474 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -111.41 141.43 16.55 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 318' ' ' ASN . 2.1 m-85 -124.17 161.46 25.64 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.542 HG23 ' HB3' ' A' ' 274' ' ' SER . 50.6 p -136.58 173.42 11.73 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.9 p30 . . . . . 0 C--N 1.312 -1.043 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 176.786 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 46.2 mm . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 121.72 0.772 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -63.82 -35.31 80.2 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.136 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.414 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 19.7 mm -58.68 -64.36 2.98 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.71 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.414 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 19.6 Cg_endo -62.12 -26.85 78.34 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 121.819 1.679 . . . . 0.0 111.662 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 46.7 tp -65.22 -56.44 12.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.732 0.301 . . . . 0.0 110.999 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.542 ' HB3' HG23 ' A' ' 261' ' ' THR . 6.9 p -65.48 -28.17 69.02 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.719 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.42 -32.16 68.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.045 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.549 ' O ' HG13 ' A' ' 280' ' ' ILE . 0.0 OUTLIER -70.34 -47.33 61.53 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.121 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -55.37 -43.87 75.51 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.032 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.81 -39.19 93.19 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 110.659 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.541 ' HA ' HG21 ' A' ' 297' ' ' THR . 0.9 OUTLIER -63.21 -33.92 76.53 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.524 179.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 276' ' ' GLN . 60.4 mt -57.25 -42.98 81.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.985 0.422 . . . . 0.0 110.073 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.574 ' O ' HD13 ' A' ' 285' ' ' LEU . 3.7 t -70.28 -43.47 78.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.759 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.36 -45.72 80.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.395 178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.25 -41.93 89.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.396 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.498 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 1.5 m-85 -65.12 -43.94 90.32 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.108 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 281' ' ' VAL . 3.8 mp -63.57 -47.59 80.89 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 99.1 t -60.02 -42.65 90.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.288 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.72 -27.12 68.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.566 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.575 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 2.8 mmp_? -86.21 5.02 36.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.999 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.89 5.9 43.79 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.258 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 57.4 t -86.32 143.61 11.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.604 0.702 . . . . 0.0 109.908 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.58 112.06 8.3 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.042 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.52 -32.66 73.82 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.243 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.29 -20.28 64.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.053 0.454 . . . . 0.0 111.222 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -102.74 3.48 36.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.938 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.5 mt -107.65 129.9 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-O 120.876 0.37 . . . . 0.0 110.845 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.69 125.74 49.43 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.071 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.541 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.3 p -110.33 129.15 55.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.943 0.401 . . . . 0.0 111.074 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.4 t -132.43 116.58 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.012 0.434 . . . . 0.0 111.927 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -92.08 109.58 3.77 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 20.7 mt -87.67 -32.19 19.35 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 95.81 -142.08 15.92 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.4 p -77.58 109.11 11.27 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.737 0.303 . . . . 0.0 110.512 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.412 HG13 ' HD2' ' A' ' 260' ' ' TYR . 15.0 p -174.46 150.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.2 t30 66.46 79.96 0.23 Allowed Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.273 175.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.699 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 38.1 Cg_endo -69.61 135.6 31.22 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.556 2.171 . . . . 0.0 113.075 -178.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.489 HG22 ' HA ' ' A' ' 318' ' ' ASN . 5.2 tt -112.92 -29.27 2.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.748 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -145.83 174.95 10.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.925 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.476 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 29.4 m -62.61 121.19 12.73 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.549 0.53 . . . . 0.0 110.846 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -80.65 -14.29 58.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.45 -16.06 62.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.159 0.504 . . . . 0.0 111.128 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.491 ' OG1' ' HG3' ' A' ' 313' ' ' GLU . 4.9 t -117.6 143.9 33.18 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.948 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.07 -31.03 76.21 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.441 2.094 . . . . 0.0 111.551 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.491 ' HG3' ' OG1' ' A' ' 311' ' ' THR . 4.0 mt-10 -59.14 -44.7 92.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.066 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -69.94 -37.64 74.44 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.894 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.68 -38.42 87.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.401 . . . . 0.0 110.066 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.19 -28.22 69.52 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.483 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 8.2 mmtp -81.81 -45.81 15.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.455 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.699 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 33.5 m-80 -57.98 -29.48 65.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 5.1 ptp180 -80.62 15.75 1.6 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.551 ' HG3' ' HB2' ' A' ' 222' ' ' PRO . 0.0 OUTLIER -69.39 -176.98 1.05 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.084 0.945 . . . . 0.0 112.704 179.682 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 89.2 t -131.9 143.32 40.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.756 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -132.53 142.16 49.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.02 0.438 . . . . 0.0 111.079 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.453 HG23 HG12 ' A' ' 257' ' ' ILE . 1.5 mp -101.73 120.54 51.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.853 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 66.9 t -109.72 135.31 49.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.505 HG22 HG12 ' A' ' 255' ' ' VAL . 58.1 t -102.14 140.01 21.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.92 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.1 t30 . . . . . 0 C--N 1.311 -1.092 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.721 178.169 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.524 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.56 86.04 4.59 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.299 0.571 . . . . 0.0 110.343 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.568 ' HB2' HG21 ' A' ' 325' ' ' VAL . 48.0 mt -71.17 -23.19 62.01 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.104 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 216' ' ' ASN . 51.7 tt0 -66.18 -38.99 89.36 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.355 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.3 t -73.25 -40.59 64.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.13 75.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.579 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.498 ' CG2' HG13 ' A' ' 243' ' ' VAL . 23.3 pt -70.37 -38.61 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.349 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 212' ' ' GLN . 10.2 t-20 -62.95 -27.41 69.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.034 0.445 . . . . 0.0 110.524 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.19 -28.41 67.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.935 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.2 t -89.93 -44.67 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.384 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.57 ' HA ' HG21 ' A' ' 239' ' ' ILE . 70.8 p -67.81 -36.79 81.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.763 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.1 26.73 47.6 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.64 -141.13 13.38 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.05 160.18 36.92 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.832 2.355 . . . . 0.0 111.79 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 320' ' ' ARG . 46.1 mm -73.49 106.36 3.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.756 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.733 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.302 176.74 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.447 -0.606 0 CA-C-O 120.564 0.221 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.57 HG21 ' HA ' ' A' ' 219' ' ' THR . 79.2 mt -61.88 -38.47 80.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.9 mt -69.45 -25.37 64.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.709 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' A' ' 288' ' ' ARG . 7.3 t30 -72.71 -38.14 67.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.612 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -68.11 -38.39 82.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.193 177.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.602 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.9 t -62.04 -45.02 99.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.562 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.95 74.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.986 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.612 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 1.5 t70 -46.6 -51.11 16.4 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.016 0.926 . . . . 0.0 112.522 178.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.563 ' NZ ' ' HB3' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -84.68 -15.97 43.44 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.903 -177.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.6 mt -78.85 -28.83 44.31 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.54 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 59.5 mtpt -82.51 -17.11 46.25 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.916 177.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.38 -37.77 83.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.978 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.519 ' HB3' HD11 ' A' ' 211' ' ' LEU . 48.3 t -131.38 71.0 81.87 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 176.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 61.0 Cg_endo -72.44 0.85 6.87 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.951 2.434 . . . . 0.0 112.846 -177.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.35 -31.1 42.93 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -72.52 141.7 48.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.473 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.19 142.16 27.95 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.526 HG12 HG22 ' A' ' 325' ' ' VAL . 5.4 m -113.93 130.87 67.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 CA-C-O 121.277 0.56 . . . . 0.0 110.725 177.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.4 m -106.88 108.09 19.43 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.178 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.403 HG12 HG23 ' A' ' 323' ' ' ILE . 29.8 mt -92.95 113.75 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.27 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -98.63 122.53 41.96 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.018 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.464 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -105.28 151.75 17.2 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.368 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -125.14 167.43 14.82 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.376 0.608 . . . . 0.0 110.948 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 8.1 t -160.25 156.81 27.07 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.965 174.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 11.7 t70 . . . . . 0 C--N 1.318 -0.789 0 CA-C-O 120.912 0.387 . . . . 0.0 110.831 -177.501 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 34.3 mm . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.86 -43.21 76.9 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.007 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.42 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 26.1 mm -55.51 -64.43 2.19 Favored Pre-proline 0 CA--C 1.557 1.246 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.796 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.42 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 18.9 Cg_endo -62.74 -27.17 75.41 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.79 1.66 . . . . 0.0 112.647 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.6 tp -66.45 -53.54 34.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 110.87 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.464 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.0 p -60.81 -31.4 70.8 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.24 0.543 . . . . 0.0 110.157 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.56 -42.31 91.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.719 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.512 ' O ' HG13 ' A' ' 280' ' ' ILE . 27.6 tt0 -60.06 -43.71 95.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.093 178.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -58.78 -47.09 85.93 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.11 73.48 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.115 0.483 . . . . 0.0 110.729 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.623 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.2 tptt -67.34 -31.5 71.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.051 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 276' ' ' GLN . 53.4 mt -58.9 -40.35 80.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 0.0 109.895 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.697 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.7 t -68.76 -44.46 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.904 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.59 73.74 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.851 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.22 -42.31 81.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.533 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.643 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 0.8 OUTLIER -64.29 -47.4 79.64 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.446 178.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 34.8 mt -63.85 -49.5 72.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.055 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.02 -39.17 81.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.151 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.5 -26.09 68.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.192 0.52 . . . . 0.0 110.686 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.1 mmp_? -86.44 2.47 47.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.974 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.88 12.79 48.87 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.911 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.532 HG22 ' HG3' ' A' ' 248' ' ' LYS . 58.6 t -85.22 140.62 15.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.53 110.03 4.01 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.987 0.422 . . . . 0.0 111.365 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.98 -33.09 63.3 Favored Glycine 0 C--O 1.225 -0.451 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.89 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.23 -19.46 65.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.821 0.343 . . . . 0.0 111.622 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -102.06 1.76 36.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.051 0.453 . . . . 0.0 110.375 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.5 mt -105.62 127.02 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.122 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.97 125.51 50.55 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.39 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.623 HG21 ' HA ' ' A' ' 279' ' ' LYS . 40.8 p -105.49 121.85 44.78 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.8 t -125.63 115.9 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.156 0.503 . . . . 0.0 111.793 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.0 108.64 3.49 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 21.8 mt -91.15 0.37 57.55 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.77 0.319 . . . . 0.0 111.206 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.32 -126.12 30.34 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.022 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 15.4 m -103.32 116.45 32.47 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.601 HG23 ' H ' ' A' ' 304' ' ' ASN . 6.0 m -140.46 -64.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.354 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.601 ' H ' HG23 ' A' ' 303' ' ' VAL . 33.9 m-80 -117.96 90.67 37.59 Favored Pre-proline 0 N--CA 1.439 -0.997 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.62 176.77 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.577 2.185 . . . . 0.0 112.345 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -128.78 -49.03 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.694 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -110.45 176.79 4.91 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.633 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 18.5 m -65.77 131.63 46.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.525 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -79.22 -8.23 58.86 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.458 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -80.6 -11.2 59.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.55 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.516 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 2.6 t -119.44 138.88 26.98 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.337 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.46 -32.52 70.95 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.594 2.196 . . . . 0.0 111.656 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -67.43 -35.42 79.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.757 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.59 -38.11 85.82 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 311' ' ' THR . 97.9 mtt180 -66.08 -21.88 66.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.478 0.656 . . . . 0.0 109.787 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.41 ' O ' ' HG2' ' A' ' 319' ' ' ARG . . . -78.73 -28.97 45.06 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.308 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -77.62 -42.93 33.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.157 0.503 . . . . 0.0 109.765 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -64.96 -8.87 17.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 18.7 ptp180 -98.93 11.66 38.21 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 223' ' ' ILE . 4.8 ptm180 -69.03 -174.67 0.64 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 76.2 t -137.03 151.74 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.623 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.54 138.55 50.25 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 122.672 0.389 . . . . 0.0 110.64 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.41 ' H ' HD12 ' A' ' 323' ' ' ILE . 2.1 mp -100.74 122.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.834 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 95.1 t -113.18 137.41 46.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.568 HG21 ' HB2' ' A' ' 211' ' ' LEU . 85.1 t -101.93 136.38 34.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 120.8 0.333 . . . . 0.0 110.713 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 C--N 1.313 -0.993 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.06 -178.685 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 121.154 0.502 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -82.67 77.48 9.43 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.992 -0.443 . . . . 0.0 110.007 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.422 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.2 mm? -68.06 -35.31 78.01 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.762 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -63.33 -42.7 98.97 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.558 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 31.0 t -75.38 -27.97 59.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.282 0.563 . . . . 0.0 109.508 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -69.82 -46.72 65.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.627 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.477 ' CG2' HG13 ' A' ' 243' ' ' VAL . 23.4 pt -77.1 -41.43 31.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -61.34 -29.74 70.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.943 0.402 . . . . 0.0 110.876 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.37 -24.26 67.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.173 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.93 -45.46 13.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.033 0.444 . . . . 0.0 110.298 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.516 ' HA ' HG21 ' A' ' 239' ' ' ILE . 74.3 p -64.79 -38.2 90.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.013 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.79 20.54 53.52 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.197 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.67 -134.7 8.36 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . 0.491 ' HB3' HH11 ' A' ' 320' ' ' ARG . 60.6 Cg_endo -78.52 161.22 28.31 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.282 1.988 . . . . 0.0 112.337 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.86 108.9 13.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.635 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.955 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.507 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.668 0.27 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.516 HG21 ' HA ' ' A' ' 219' ' ' THR . 82.4 mt -62.88 -37.79 80.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.045 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.478 ' CD2' HG13 ' A' ' 281' ' ' VAL . 47.3 mt -62.84 -34.75 77.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 110.644 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -73.8 -39.36 64.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.572 177.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.496 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -65.09 -44.87 87.43 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.762 179.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.599 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 29.9 t -57.82 -43.59 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.704 177.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.11 85.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.114 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -52.38 -49.91 63.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -77.98 -20.05 53.33 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.878 -178.319 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 35.1 mt -78.13 -32.33 50.32 Favored 'General case' 0 C--O 1.214 -0.779 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.599 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.531 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 61.4 mtpt -74.95 -18.64 60.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.864 176.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.09 -34.49 75.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.326 0.584 . . . . 0.0 109.646 175.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 53.4 t -128.67 71.8 80.97 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.056 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 59.8 Cg_endo -70.62 0.14 6.75 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.681 2.254 . . . . 0.0 112.981 -176.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -88.62 -25.34 22.49 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -57.67 138.13 55.73 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.78 130.29 45.97 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 325' ' ' VAL . 12.3 m -122.03 134.61 64.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-O 121.39 0.614 . . . . 0.0 111.937 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.3 m -110.58 113.31 25.83 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.221 -0.899 . . . . 0.0 108.827 178.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.442 HG12 HG23 ' A' ' 323' ' ' ILE . 23.1 mt -92.68 113.83 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -101.98 126.25 48.85 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.363 -176.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -106.15 150.54 16.89 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.668 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -127.9 159.75 33.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.017 0.437 . . . . 0.0 110.436 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 274' ' ' SER . 70.1 p -141.02 169.83 16.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.331 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.411 ' CG ' ' HE ' ' A' ' 315' ' ' ARG . 18.0 t70 . . . . . 0 C--N 1.32 -0.683 0 CA-C-O 120.682 0.277 . . . . 0.0 110.801 178.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 111.813 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -55.46 -34.96 64.99 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.703 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.501 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.6 mm -58.17 -67.12 1.01 Allowed Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.269 177.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.501 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.5 Cg_endo -57.98 -30.69 90.72 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 121.934 1.756 . . . . 0.0 111.78 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.75 -54.63 32.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.463 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.491 ' HB3' HG23 ' A' ' 261' ' ' THR . 9.8 p -60.94 -32.7 72.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.793 0.33 . . . . 0.0 110.437 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.91 -31.64 71.56 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.079 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.479 ' O ' HG13 ' A' ' 280' ' ' ILE . 9.1 tt0 -69.68 -48.9 58.11 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -60.24 -41.96 94.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.21 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.91 -39.07 90.76 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.019 0.438 . . . . 0.0 110.525 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.728 ' HA ' HG21 ' A' ' 297' ' ' THR . 21.6 ttpt -66.18 -30.16 70.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.361 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 276' ' ' GLN . 64.1 mt -55.96 -45.4 80.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 110.023 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.732 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.8 t -64.56 -46.99 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.728 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.69 -43.05 76.07 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.362 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.61 -41.66 86.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.359 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.436 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 8.4 m-85 -71.12 -40.83 71.2 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.413 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 46.6 mt -64.59 -48.53 74.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.8 t -61.23 -39.66 83.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.466 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.29 -30.8 71.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.127 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.436 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 1.2 mpt_? -81.65 2.1 31.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.664 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.72 3.13 46.46 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.233 -0.984 . . . . 0.0 114.449 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.469 HG22 ' HG3' ' A' ' 248' ' ' LYS . 58.9 t -79.26 143.36 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 117.896 0.848 . . . . 0.0 109.782 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.02 110.06 4.28 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.032 0.444 . . . . 0.0 111.446 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.01 -18.47 64.66 Favored Glycine 0 CA--C 1.508 -0.389 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.339 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -72.14 -22.53 61.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.161 0.505 . . . . 0.0 110.425 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -104.5 5.43 34.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.035 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.455 HD11 ' CG1' ' A' ' 290' ' ' VAL . 63.8 mt -109.42 128.79 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.32 128.43 55.05 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.1 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.728 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.1 p -115.05 120.66 40.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 120.915 0.388 . . . . 0.0 111.251 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.84 166.42 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.341 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -134.41 109.71 0.81 Allowed Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 14.8 mt -97.04 -1.24 45.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.595 0.236 . . . . 0.0 111.304 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.06 -123.76 26.82 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.319 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 3.8 t -106.28 120.1 40.98 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 304' ' ' ASN . 5.6 m -141.74 -58.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.344 -177.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.462 ' H ' HG23 ' A' ' 303' ' ' VAL . 22.1 m-80 -116.86 92.32 38.2 Favored Pre-proline 0 N--CA 1.442 -0.846 0 CA-C-O 120.687 0.279 . . . . 0.0 110.259 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.26 166.29 11.29 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.681 2.254 . . . . 0.0 112.478 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' A' ' 318' ' ' ASN . 3.5 tt -121.48 -45.35 2.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.874 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -128.11 168.78 14.89 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.305 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 35.5 t -62.58 135.33 57.34 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.685 0.615 . . . . 0.0 110.983 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.79 -9.35 59.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.386 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.39 66.96 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.777 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.574 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.9 t -114.16 140.18 24.64 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.84 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.28 -27.79 55.69 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.247 1.965 . . . . 0.0 111.105 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.8 mt-10 -62.77 -41.45 99.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.72 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.49 -38.06 86.19 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.477 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.574 ' HG3' ' O ' ' A' ' 311' ' ' THR . 40.9 mtp180 -63.6 -30.23 71.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.384 0.612 . . . . 0.0 109.929 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.22 -27.47 63.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.279 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 13.3 mmtp -80.14 -40.58 27.12 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.372 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.402 ' HA ' HG22 ' A' ' 306' ' ' ILE . 27.3 m-80 -58.13 -24.38 58.57 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -177.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 18.0 ptp180 -83.47 9.75 10.48 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.977 0.418 . . . . 0.0 112.017 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.491 HH11 ' HB3' ' A' ' 222' ' ' PRO . 34.3 ptt85 -57.16 176.28 0.12 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.949 0.881 . . . . 0.0 112.909 175.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.6 t -139.73 147.48 23.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.158 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.17 138.1 50.45 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 110.992 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.442 HG23 HG12 ' A' ' 257' ' ' ILE . 2.4 mp -96.1 116.03 36.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.496 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.94 136.79 42.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 255' ' ' VAL . 56.9 t -101.27 139.52 22.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 . . . . . 0 C--N 1.325 -0.483 0 O-C-N 123.926 0.766 . . . . 0.0 111.132 178.617 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.542 0 CA-C-O 120.983 0.42 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.72 83.75 4.85 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 250' ' ' CYS . 25.6 mt -79.36 -24.72 42.48 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.452 -178.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -60.97 -51.05 70.88 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.8 t -70.92 -36.4 72.66 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.818 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.519 ' HB1' ' HZ3' ' A' ' 246' ' ' LYS . . . -59.42 -44.53 92.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.798 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 211' ' ' LEU . 27.1 pt -75.89 -39.52 37.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.177 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -60.16 -34.44 73.57 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 110.688 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.97 -24.03 67.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.726 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.8 t -94.98 -45.19 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 120.899 0.38 . . . . 0.0 110.296 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.563 ' HA ' HG21 ' A' ' 239' ' ' ILE . 80.6 p -66.46 -39.66 88.95 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.127 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.1 30.29 55.46 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 119.02 -132.15 9.48 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . 0.451 ' HA ' ' HG2' ' A' ' 322' ' ' GLU . 63.7 Cg_endo -79.76 157.22 24.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.457 2.104 . . . . 0.0 113.322 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 38.6 mm -73.99 108.45 5.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.892 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.139 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.39 176.022 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 N--CA 1.445 -0.678 0 CA-C-O 120.48 0.181 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.563 HG21 ' HA ' ' A' ' 219' ' ' THR . 75.6 mt -64.38 -38.02 81.49 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 8.3 mp -64.62 -36.13 83.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.803 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -69.93 -39.0 76.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.864 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.526 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -66.14 -41.99 89.7 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.032 178.308 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.623 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.1 t -57.93 -42.83 83.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.364 177.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.75 86.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.262 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.15 -49.18 67.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.519 ' HZ3' ' HB1' ' A' ' 214' ' ' ALA . 0.0 OUTLIER -72.09 -29.75 64.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.315 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 26.2 mt -70.53 -27.93 64.54 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 18.6 tptp -63.63 -34.44 77.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.675 178.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.59 -39.53 73.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.432 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.55 ' HB3' HD11 ' A' ' 211' ' ' LEU . 38.4 t -127.17 68.48 72.49 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 73.5 Cg_endo -72.21 0.21 7.66 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.385 2.723 . . . . 0.0 113.976 -174.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -91.04 -18.24 24.92 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.673 0.749 . . . . 0.0 109.36 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -63.33 150.86 42.34 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.357 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -104.22 133.97 48.24 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.164 0.507 . . . . 0.0 110.434 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.551 HG12 HG22 ' A' ' 325' ' ' VAL . 12.5 m -117.84 136.49 54.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.174 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.3 m -112.54 109.8 19.58 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.332 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.442 HG12 HG23 ' A' ' 323' ' ' ILE . 21.8 mt -92.24 115.0 30.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -103.12 129.54 50.01 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.691 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.429 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -108.04 151.64 16.98 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.364 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 57.3 m-85 -126.71 163.47 23.43 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.082 0.468 . . . . 0.0 110.977 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.527 HG23 ' HB3' ' A' ' 274' ' ' SER . 71.9 p -142.88 163.7 32.08 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.971 176.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.637 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.75 0.786 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -34.95 67.02 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.431 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.468 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.1 mm -60.99 -65.07 2.4 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.093 177.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.468 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.2 Cg_endo -58.3 -30.02 89.71 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 121.91 1.74 . . . . 0.0 111.974 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 59.6 tp -64.29 -54.94 25.26 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.24 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.527 ' HB3' HG23 ' A' ' 261' ' ' THR . 5.2 p -63.4 -26.79 68.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.749 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.47 -28.4 64.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.852 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -76.18 -42.09 47.51 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -59.25 -46.42 88.56 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.142 177.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.33 74.88 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.98 0.419 . . . . 0.0 110.454 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.54 ' HA ' HG21 ' A' ' 297' ' ' THR . 23.8 tptm -63.53 -32.44 73.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.098 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 54.6 mt -58.87 -43.17 87.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.017 0.437 . . . . 0.0 110.077 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.697 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.8 t -66.86 -46.58 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.946 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.35 -41.45 76.12 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.889 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.13 -43.74 78.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.964 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . 0.554 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 8.5 m-85 -70.77 -41.61 71.5 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.483 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 42.7 mt -63.76 -49.15 74.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 68.8 t -59.74 -42.2 87.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.284 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.55 -28.48 69.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.944 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.9 mmp_? -84.42 4.11 33.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.751 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.13 6.83 41.88 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 119.859 -1.162 . . . . 0.0 114.375 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 53.0 t -86.18 143.76 10.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 117.717 0.759 . . . . 0.0 109.725 177.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.47 114.42 10.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.898 0.38 . . . . 0.0 111.514 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.72 -32.79 70.4 Favored Glycine 0 C--O 1.23 -0.143 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.998 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.45 -21.44 66.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.087 0.47 . . . . 0.0 111.66 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -100.48 1.27 40.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.914 0.387 . . . . 0.0 110.57 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.35 129.12 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.854 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.54 127.69 53.86 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.202 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 279' ' ' LYS . 10.7 p -110.62 120.4 42.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.726 0.298 . . . . 0.0 111.002 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.16 130.52 60.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.945 0.402 . . . . 0.0 111.331 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -97.51 117.5 5.81 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.341 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 27.1 mt -91.3 -3.53 56.76 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.39 0.138 . . . . 0.0 111.176 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.63 -138.71 48.24 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.351 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 2.1 m -89.25 115.91 27.09 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.475 HG13 ' H ' ' A' ' 304' ' ' ASN . 4.6 p -143.79 -61.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.611 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.475 ' H ' HG13 ' A' ' 303' ' ' VAL . 91.6 m-20 -116.04 93.95 40.12 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -67.74 167.14 21.99 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.544 2.163 . . . . 0.0 112.782 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.41 HD13 ' HB3' ' A' ' 317' ' ' LYS . 2.5 tt -125.07 -49.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.279 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -124.66 170.8 10.6 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.393 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.3 p -71.11 139.61 50.36 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 123.547 0.53 . . . . 0.0 111.874 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -81.46 -11.07 59.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.418 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -61.63 -26.63 68.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.103 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 314' ' ' GLY . 4.4 t -113.65 139.42 23.37 Favored Pre-proline 0 N--CA 1.436 -1.164 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.693 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.14 -32.42 91.15 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.905 2.404 . . . . 0.0 111.84 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 35.5 mm-40 -63.8 -40.99 97.96 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.262 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.458 ' H ' HG23 ' A' ' 311' ' ' THR . . . -66.53 -37.87 92.95 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.379 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.4 -39.73 84.35 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.51 ' HA ' ' HD3' ' A' ' 319' ' ' ARG . . . -61.04 -29.94 70.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.686 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 10.9 mmpt? -77.6 -44.62 27.74 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.297 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -60.88 -29.87 69.81 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.51 ' HD3' ' HA ' ' A' ' 316' ' ' ALA . 3.5 ptm180 -83.41 11.71 6.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.2 ptt-85 -57.43 178.87 0.06 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.254 1.022 . . . . 0.0 112.898 174.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 94.1 t -137.74 147.68 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.583 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 222' ' ' PRO . 48.5 mt-10 -132.66 137.81 47.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.397 . . . . 0.0 111.415 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.442 HG23 HG12 ' A' ' 257' ' ' ILE . 2.8 mp -98.98 121.25 49.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.041 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.83 138.73 39.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.551 HG22 HG12 ' A' ' 255' ' ' VAL . 52.8 t -104.21 143.28 16.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 C--N 1.32 -0.706 0 O-C-N 123.519 0.512 . . . . 0.0 110.349 177.461 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.07 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -133.98 116.95 16.15 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -53.06 132.39 50.19 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.5 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.513 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 11.3 Cg_endo -55.1 128.66 31.51 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.897 2.398 . . . . 0.0 112.04 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 199' ' ' PRO . 11.2 Cg_exo -72.43 53.59 2.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.053 2.502 . . . . 0.0 112.442 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -117.62 81.02 0.31 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 200' ' ' PRO . 7.7 Cg_endo -90.5 109.39 0.36 Allowed 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 123.394 2.729 . . . . 0.0 111.913 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.92 -59.8 0.57 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.071 2.514 . . . . 0.0 112.598 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -118.54 16.39 13.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.118 0.485 . . . . 0.0 110.741 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.427 ' HB2' ' CB ' ' A' ' 202' ' ' PRO . 75.0 m -107.22 146.86 30.88 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.462 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 118.34 -77.92 0.3 Allowed Glycine 0 C--N 1.312 -0.77 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.59 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.58 115.64 2.81 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.425 2.083 . . . . 0.0 110.877 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 35.1 t -146.62 -176.89 5.36 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.735 -176.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -47.43 153.44 0.52 Allowed 'General case' 0 C--O 1.238 0.45 0 O-C-N 123.84 0.713 . . . . 0.0 110.505 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.435 ' HB3' ' OG ' ' A' ' 213' ' ' SER . 3.7 m-20 -75.88 81.31 2.79 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.093 0.473 . . . . 0.0 110.758 -176.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 250' ' ' CYS . 32.5 mt -72.87 -26.67 61.53 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.509 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 324' ' ' VAL . 59.9 tp60 -59.47 -56.29 23.8 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.542 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 210' ' ' ASP . 4.2 p -66.38 -31.3 71.99 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 120.882 0.372 . . . . 0.0 110.293 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.16 -54.14 42.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.466 ' CG2' HG13 ' A' ' 243' ' ' VAL . 19.8 pt -69.04 -38.13 77.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.844 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.49 -34.44 69.05 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.598 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.29 -29.74 70.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.379 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.49 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.6 t -89.01 -45.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.895 0.379 . . . . 0.0 110.741 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.585 ' HA ' HG21 ' A' ' 239' ' ' ILE . 76.6 p -67.15 -35.42 79.67 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.251 0.548 . . . . 0.0 110.743 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.49 24.78 60.12 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 125.84 -134.66 8.8 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.2 164.98 14.92 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.449 2.099 . . . . 0.0 112.77 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.9 mm -82.61 109.21 16.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.976 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -88.33 125.65 34.79 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.034 0.445 . . . . 0.0 111.103 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -99.04 164.8 12.03 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.66 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -152.72 33.02 0.82 Allowed Glycine 0 C--N 1.306 -1.117 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -156.98 128.59 7.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.043 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -140.17 126.44 19.95 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 113.28 -24.85 11.92 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.376 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -130.22 -177.21 4.22 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.3 m -100.97 164.15 11.95 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.224 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.98 118.62 10.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.095 0.474 . . . . 0.0 110.934 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 26.9 pt -77.69 161.57 71.28 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.284 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.14 157.97 1.61 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.961 2.441 . . . . 0.0 112.559 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 68.47 35.18 3.38 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.769 0.795 . . . . 0.0 108.923 -174.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -100.09 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.935 -177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.404 ' HB2' HD13 ' A' ' 240' ' ' LEU . 61.8 m-85 -135.88 113.49 10.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.836 0.351 . . . . 0.0 111.023 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.75 -19.13 65.69 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.073 0.463 . . . . 0.0 110.194 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.585 HG21 ' HA ' ' A' ' 219' ' ' THR . 87.7 mt -62.0 -41.07 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.129 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.404 HD13 ' HB2' ' A' ' 237' ' ' TYR . 11.2 mp -64.12 -32.07 73.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.067 0.461 . . . . 0.0 110.427 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.29 -37.27 69.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.49 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -68.98 -45.78 69.76 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.328 178.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.569 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 42.5 t -56.78 -44.43 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.969 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -58.86 -34.32 71.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.434 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.2 -45.83 75.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -14.69 53.49 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.98 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.4 mt -79.29 -26.55 42.29 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.639 ' HG3' HG22 ' A' ' 290' ' ' VAL . 58.6 mtpt -82.54 -21.83 35.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.386 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.06 -37.69 84.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.056 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.463 ' HB3' HD11 ' A' ' 211' ' ' LEU . 48.0 t -130.23 74.4 80.42 Favored Pre-proline 0 N--CA 1.434 -1.242 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.834 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 74.6 Cg_endo -74.16 1.3 7.39 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.1 2.533 . . . . 0.0 112.283 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -74.96 -29.15 60.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.93 0.872 . . . . 0.0 108.773 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -73.63 164.47 26.6 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.058 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 254' ' ' ARG . 0.0 OUTLIER -120.75 137.23 54.61 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.675 176.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.2 m -120.37 134.61 63.29 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 121.198 0.523 . . . . 0.0 111.562 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 49.9 m -111.43 113.24 25.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.515 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.413 HG12 HG23 ' A' ' 323' ' ' ILE . 21.8 mt -91.87 111.58 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -98.87 125.54 44.3 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.532 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.446 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -106.58 144.16 15.83 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.389 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.58 165.04 17.83 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.961 0.41 . . . . 0.0 110.56 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.515 HG23 ' HB3' ' A' ' 274' ' ' SER . 68.5 p -143.98 172.48 12.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.761 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.541 ' OD1' HG22 ' A' ' 264' ' ' THR . 2.3 p30 -79.93 155.2 27.82 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 175.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -90.07 0.95 56.86 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.541 HG22 ' OD1' ' A' ' 262' ' ' ASP . 9.3 t -79.53 -15.46 57.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.119 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.78 178.82 53.59 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.111 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 36.3 t -76.33 120.28 21.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.746 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 33.8 tt0 -62.66 138.68 58.56 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.338 0.59 . . . . 0.0 111.064 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . 0.419 ' O ' ' HD2' ' A' ' 272' ' ' PRO . . . 113.0 -40.54 2.49 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -177.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp -80.88 -27.77 11.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 122.005 0.907 . . . . 0.0 109.076 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.746 ' OD1' ' HA ' ' A' ' 267' ' ' GLU . 1.0 OUTLIER -59.67 -33.6 71.77 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.873 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.507 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 32.8 mm -60.02 -65.53 2.04 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.043 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.507 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 8.3 Cg_endo -57.21 -32.67 94.23 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.211 1.94 . . . . 0.0 112.106 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.16 -55.13 20.41 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.718 0.294 . . . . 0.0 111.617 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.515 ' HB3' HG23 ' A' ' 261' ' ' THR . 8.3 p -64.34 -27.87 69.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.788 0.328 . . . . 0.0 111.128 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.94 -27.55 64.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.526 ' O ' HG13 ' A' ' 280' ' ' ILE . 28.6 tt0 -73.89 -44.44 55.26 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.416 HH21 HD11 ' A' ' 280' ' ' ILE . 3.9 mmp_? -57.62 -46.49 84.05 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.568 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.58 91.55 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.287 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.524 ' HA ' HG21 ' A' ' 297' ' ' THR . 2.2 tmtp? -60.49 -35.8 76.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.333 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 276' ' ' GLN . 56.6 mt -55.41 -45.09 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.855 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.718 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 9.1 t -67.42 -45.7 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.978 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.24 -44.26 79.46 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.43 -38.89 78.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.558 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.585 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 5.5 m-85 -69.51 -41.82 75.54 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.935 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 44.6 mt -64.11 -49.89 70.41 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.496 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 97.2 t -60.55 -38.9 79.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.533 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.93 -25.98 68.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.721 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.8 mmp_? -89.11 4.01 49.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.902 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.9 10.93 41.63 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.956 -1.116 . . . . 0.0 114.284 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.639 HG22 ' HG3' ' A' ' 248' ' ' LYS . 46.3 t -85.58 141.88 13.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.908 0.854 . . . . 0.0 109.752 177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.1 108.1 2.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.995 0.426 . . . . 0.0 111.473 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.84 -33.36 68.04 Favored Glycine 0 C--O 1.228 -0.264 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.321 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.28 -15.08 63.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.173 0.511 . . . . 0.0 111.58 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -104.62 2.04 30.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.976 0.417 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.438 HD11 ' CG1' ' A' ' 290' ' ' VAL . 55.5 mt -107.69 129.8 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -116.69 125.28 51.49 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.524 HG21 ' HA ' ' A' ' 279' ' ' LYS . 24.7 p -111.43 122.55 48.14 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.665 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.24 161.14 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 CA-C-O 121.167 0.508 . . . . 0.0 111.158 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -126.49 111.61 1.44 Allowed Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.462 ' HB3' HG21 ' A' ' 303' ' ' VAL . 18.4 mt -97.38 -8.5 29.37 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.495 ' HA3' HD22 ' A' ' 270' ' ' ASN . . . 63.24 -130.92 41.76 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 119.806 -1.188 . . . . 0.0 111.579 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 55.9 p -91.91 114.33 26.84 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.035 0.445 . . . . 0.0 109.902 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.601 ' O ' ' HD3' ' A' ' 305' ' ' PRO . 46.2 t -134.98 -67.72 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.4 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -108.09 91.34 7.79 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.221 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.627 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 7.6 Cg_exo -70.47 127.11 13.59 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.558 2.172 . . . . 0.0 111.891 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.7 tt -85.32 -42.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.774 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -131.08 170.36 14.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.128 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 27.7 m -69.62 136.16 50.86 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.86 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -76.62 -7.31 54.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.554 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -59.32 -29.77 67.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.942 0.401 . . . . 0.0 110.654 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.443 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 2.6 t -114.25 141.0 25.73 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.475 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.42 -31.45 94.83 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.723 2.282 . . . . 0.0 111.651 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 13.0 mm-40 -55.37 -50.75 68.89 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.953 177.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.438 ' H ' HG23 ' A' ' 311' ' ' THR . . . -63.01 -36.96 94.18 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.833 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 311' ' ' THR . 57.1 mtt180 -62.68 -35.56 80.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.846 0.355 . . . . 0.0 110.197 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.7 70.54 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.443 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 317' ' ' LYS . 15.1 mmtp -77.51 -41.31 39.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.947 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.627 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 42.0 m-20 -63.57 -24.4 67.79 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 12.0 ptm180 -83.68 6.44 20.96 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.2 ptt-85 -58.18 170.86 0.62 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.153 0.978 . . . . 0.0 113.372 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 71.4 t -131.8 144.58 36.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.191 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -130.92 138.19 49.65 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.099 0.476 . . . . 0.0 111.186 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.465 ' HB ' HD12 ' A' ' 215' ' ' ILE . 2.4 mp -96.27 116.39 38.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.461 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.409 ' HA ' ' OE1' ' A' ' 212' ' ' GLN . 98.5 t -109.66 138.16 38.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.533 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 211' ' ' LEU . 59.3 t -98.74 132.93 43.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.681 -179.33 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.246 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -102.1 -5.02 24.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.388 0.137 . . . . 0.0 110.942 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 62.24 88.89 0.11 Allowed Pre-proline 0 N--CA 1.466 0.362 0 O-C-N 123.719 0.637 . . . . 0.0 111.644 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.72 141.95 31.48 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.737 2.291 . . . . 0.0 111.662 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.88 127.79 20.38 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 122.505 2.137 . . . . 0.0 112.078 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.472 ' N ' ' HD3' ' A' ' 202' ' ' PRO . . . -143.2 61.41 0.52 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.767 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 201' ' ' GLY . 1.0 OUTLIER -86.44 143.59 7.56 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.909 2.406 . . . . 0.0 111.563 179.109 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.58 -29.32 89.59 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.623 2.215 . . . . 0.0 112.56 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -103.43 21.33 16.19 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.709 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 21.2 t 63.16 -179.32 0.15 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.593 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -91.85 -161.31 36.8 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.592 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.35 -32.17 51.11 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.214 1.943 . . . . 0.0 111.398 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 13.5 t -154.34 -178.78 7.37 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.903 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -56.11 153.19 9.43 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 122.811 0.445 . . . . 0.0 111.817 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -78.68 66.3 4.15 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.379 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 250' ' ' CYS . 22.1 mt -53.55 -27.09 24.12 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -60.18 -51.83 67.9 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 121.018 0.437 . . . . 0.0 110.205 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.7 t -72.45 -28.25 62.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.415 0.626 . . . . 0.0 109.687 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' A' ' 211' ' ' LEU . . . -67.16 -51.39 54.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.134 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.461 ' CG2' HG13 ' A' ' 243' ' ' VAL . 26.1 pt -70.78 -38.5 73.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.485 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.79 -30.01 68.6 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.003 0.43 . . . . 0.0 110.767 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.17 -26.09 65.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.088 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.466 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.6 t -91.03 -46.28 14.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.993 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.616 ' HA ' HG21 ' A' ' 239' ' ' ILE . 40.1 p -67.13 -35.96 80.85 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.147 0.499 . . . . 0.0 110.855 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.96 18.97 68.5 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 129.27 -138.02 9.97 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.886 -0.657 . . . . 0.0 111.52 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.62 ' HB2' ' NE ' ' A' ' 320' ' ' ARG . 1.4 Cg_endo -82.8 160.49 16.25 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.051 2.5 . . . . 0.0 112.498 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.571 ' O ' ' HB2' ' A' ' 320' ' ' ARG . 47.2 mm -81.1 115.88 24.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.201 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.01 155.47 19.47 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 174.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -113.08 140.73 47.62 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.987 0.422 . . . . 0.0 111.29 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.39 25.63 27.57 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -160.12 158.58 30.53 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -68.97 -22.28 64.12 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.247 0.546 . . . . 0.0 110.894 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 119.95 45.14 0.43 Allowed Glycine 0 N--CA 1.436 -1.345 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.695 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -119.31 -74.69 0.6 Allowed 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 9.4 p -94.61 -66.82 0.89 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.328 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 57.5 tp 67.57 98.01 0.06 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.199 0.6 . . . . 0.0 110.903 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.8 pt -88.61 149.65 44.6 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.804 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.06 128.41 21.71 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.479 2.119 . . . . 0.0 111.138 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -142.28 -85.01 0.17 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.864 0.364 . . . . 0.0 111.095 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -100.56 18.25 19.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.311 0.577 . . . . 0.0 110.373 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -84.02 15.33 3.48 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.059 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.49 -19.18 64.52 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.616 HG21 ' HA ' ' A' ' 219' ' ' THR . 96.9 mt -59.01 -36.82 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.902 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.32 -30.48 70.32 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.431 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.4 ' HA ' ' HG3' ' A' ' 288' ' ' ARG . 3.5 m-20 -70.59 -40.8 73.04 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.466 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -64.89 -47.04 79.22 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.645 178.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.602 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 39.0 t -58.12 -44.06 86.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.042 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.74 -34.61 73.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.361 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.31 -44.67 80.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.011 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.415 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -82.02 -15.01 55.09 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.798 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.7 mt -79.83 -28.09 40.16 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 290' ' ' VAL . 54.9 mtpt -81.47 -18.22 45.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.216 175.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.5 -38.08 80.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.723 176.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.513 ' HB3' HD11 ' A' ' 211' ' ' LEU . 29.1 t -135.18 72.87 65.91 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.568 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 65.0 Cg_endo -72.69 2.25 5.48 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.948 2.432 . . . . 0.0 113.165 -177.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.13 -29.84 54.89 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.811 0.815 . . . . 0.0 109.285 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -77.57 135.86 38.21 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.526 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -90.86 142.26 27.96 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.5 m -114.83 131.38 67.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.134 0.493 . . . . 0.0 111.213 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 18.2 m -107.86 110.16 21.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.323 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.0 mt -93.07 109.43 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -98.13 128.47 44.65 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.537 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.405 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -110.47 145.9 17.32 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.496 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 28.5 m-85 -127.27 162.17 26.85 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.82 0.343 . . . . 0.0 110.309 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 59.2 p -138.75 173.68 11.32 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.618 177.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.14 147.34 34.62 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -79.2 3.15 18.63 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.39 -18.69 32.97 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.304 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -73.47 168.1 54.04 Favored Glycine 0 C--O 1.24 0.49 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.492 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 45.8 m -69.08 127.32 32.71 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 120.849 0.357 . . . . 0.0 111.365 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -59.83 115.86 3.69 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.579 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 119.85 -35.49 3.8 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.031 -1.081 . . . . 0.0 111.984 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 43.6 mm -83.67 -28.11 7.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.828 0.823 . . . . 0.0 108.811 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.41 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 76.5 m-20 -63.37 -34.92 78.77 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.197 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.453 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 29.7 mm -56.44 -65.68 1.51 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.764 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.453 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 21.0 Cg_endo -61.83 -28.19 81.26 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 121.95 1.767 . . . . 0.0 111.964 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.3 -55.75 16.54 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.738 0.304 . . . . 0.0 111.168 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 261' ' ' THR . 6.2 p -62.3 -31.08 71.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.706 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.63 -28.22 65.73 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.305 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.474 ' O ' HG13 ' A' ' 280' ' ' ILE . 7.3 tp-100 -76.39 -40.87 49.74 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -61.67 -41.82 98.07 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.498 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.27 -32.99 74.93 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.059 0.457 . . . . 0.0 110.214 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.528 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.9 tmtt? -64.72 -36.06 83.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.387 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 276' ' ' GLN . 53.0 mt -57.15 -42.42 79.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.034 0.445 . . . . 0.0 110.228 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.692 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 7.2 t -68.72 -47.15 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.057 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.77 -43.38 80.77 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.95 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -57.25 -42.11 80.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.419 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 1.5 m-85 -65.1 -52.05 57.71 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.511 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 33.8 mt -55.23 -50.72 68.72 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.591 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 77.6 t -60.71 -40.38 84.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.621 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.18 -23.54 67.48 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.232 0.539 . . . . 0.0 110.733 178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.539 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 4.5 mmp_? -88.93 5.03 45.95 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.228 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 98.06 12.67 45.36 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 119.93 -1.128 . . . . 0.0 114.109 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 248' ' ' LYS . 48.5 t -88.61 145.95 6.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 117.604 0.702 . . . . 0.0 109.48 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -71.34 111.57 6.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.923 0.392 . . . . 0.0 111.92 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.47 -34.84 77.07 Favored Glycine 0 N--CA 1.46 0.235 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.264 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.38 -18.41 65.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.085 0.469 . . . . 0.0 111.242 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -101.64 -0.03 35.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.162 0.506 . . . . 0.0 110.364 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 66.5 mt -106.38 132.57 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.87 126.41 51.75 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.691 0.281 . . . . 0.0 110.726 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.528 HG21 ' HA ' ' A' ' 279' ' ' LYS . 53.0 p -104.98 121.14 43.14 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.14 113.18 35.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.256 0.551 . . . . 0.0 112.241 -175.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.9 103.72 3.04 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 24.5 mt -87.69 -0.24 56.63 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.47 -138.73 36.4 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.662 -176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 7.8 p -84.27 114.3 21.74 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 120.728 0.299 . . . . 0.0 110.285 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.0 p -174.9 148.45 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 55.6 t30 64.08 75.03 0.4 Allowed Pre-proline 0 C--N 1.31 -1.128 0 O-C-N 123.712 0.633 . . . . 0.0 110.862 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.612 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 5.2 Cg_endo -80.87 133.61 9.17 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 122.305 2.003 . . . . 0.0 112.6 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.8 tt -94.37 -48.36 13.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.205 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -123.92 176.78 6.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.725 0.298 . . . . 0.0 111.025 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.43 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 47.8 m -66.39 128.08 34.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.43 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -80.54 -12.25 59.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.648 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.86 -18.32 63.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.956 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.479 HG23 ' H ' ' A' ' 314' ' ' GLY . 5.2 t -116.39 144.23 32.69 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.858 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.49 -37.36 71.35 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.627 2.218 . . . . 0.0 111.894 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 1.8 mt-10 -58.96 -41.19 86.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.278 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.479 ' H ' HG23 ' A' ' 311' ' ' THR . . . -69.82 -40.3 75.35 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.859 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -60.24 -36.38 77.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.887 0.375 . . . . 0.0 110.253 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.8 -30.01 71.15 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.645 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 11.8 mmtp -80.64 -44.4 18.91 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.612 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 44.6 m-80 -61.66 -28.09 69.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 10.7 ptm85 -84.91 11.47 9.3 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.62 ' NE ' ' HB2' ' A' ' 222' ' ' PRO . 9.2 ptm180 -73.57 -178.0 2.91 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 99.6 t -135.18 151.76 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.866 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.473 ' HG2' ' HB3' ' A' ' 222' ' ' PRO . 43.1 mt-10 -131.72 142.05 49.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.843 0.354 . . . . 0.0 110.971 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.45 116.02 41.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.39 141.96 24.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.46 135.41 36.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 57.7 t30 . . . . . 0 C--N 1.313 -0.995 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.406 -179.811 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.198 0 N-CA-C 111.726 -0.549 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.85 20.11 15.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.829 0.347 . . . . 0.0 110.438 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 71.29 83.85 0.14 Allowed Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.378 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -84.12 146.59 11.4 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.715 2.277 . . . . 0.0 112.076 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.99 176.1 8.59 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.632 2.222 . . . . 0.0 111.249 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.05 -70.24 1.23 Allowed Glycine 0 C--N 1.314 -0.672 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.307 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.66 168.48 21.31 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.742 2.294 . . . . 0.0 111.547 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -63.51 106.02 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.414 2.076 . . . . 0.0 111.335 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.486 ' HB1' ' HB3' ' A' ' 212' ' ' GLN . . . -106.42 -5.35 19.01 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.719 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 70.1 m -153.06 152.85 31.8 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.266 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -105.44 -106.06 3.09 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.487 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.03 32.91 0.52 Allowed 'Trans proline' 0 N--CA 1.476 0.475 0 C-N-CA 123.234 2.622 . . . . 0.0 112.299 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 37.1 t -151.86 165.49 34.36 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.764 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -57.55 167.95 0.94 Allowed 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.775 0.43 . . . . 0.0 110.86 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.62 71.94 3.25 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.027 0.441 . . . . 0.0 110.035 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 250' ' ' CYS . 29.9 mt -70.22 -31.09 68.36 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.603 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.486 ' HB3' ' HB1' ' A' ' 204' ' ' ALA . 21.5 tt0 -65.39 -41.61 93.53 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.53 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.5 t -71.73 -37.11 70.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -63.91 -51.02 66.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.206 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.472 ' CG2' HG13 ' A' ' 243' ' ' VAL . 26.6 pt -67.63 -38.09 79.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.685 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.46 -36.25 73.41 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.115 0.484 . . . . 0.0 110.496 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.28 -26.02 68.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.574 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.7 t -91.87 -47.81 13.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.552 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.553 ' HA ' HG21 ' A' ' 239' ' ' ILE . 72.7 p -64.76 -39.75 94.14 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.878 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.12 15.22 79.23 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 140.99 -139.22 9.43 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.87 166.43 13.2 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.601 2.201 . . . . 0.0 112.559 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 50.0 mm -81.3 109.58 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.538 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -99.49 124.57 44.77 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.934 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -94.03 174.44 7.16 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.268 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -64.87 167.91 29.39 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.078 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -62.53 -29.48 70.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.701 0.286 . . . . 0.0 111.514 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -140.71 141.55 34.94 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -81.2 40.35 2.54 Favored Glycine 0 C--N 1.317 -0.474 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.682 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -54.22 -57.04 12.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.897 0.379 . . . . 0.0 111.276 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 11.0 p -162.06 113.56 1.66 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.051 0.453 . . . . 0.0 111.289 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 18.2 tp -95.04 18.65 11.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.641 0.734 . . . . 0.0 109.098 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 62.6 mt -61.75 -48.68 88.95 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.217 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 233' ' ' ILE . 5.5 Cg_endo -48.02 127.39 14.79 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.529 2.153 . . . . 0.0 112.125 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -80.25 87.57 5.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.214 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -122.08 -27.05 4.63 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.723 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -77.06 57.51 1.38 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.176 0.513 . . . . 0.0 111.587 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.94 -18.93 65.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.497 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 219' ' ' THR . 75.3 mt -59.97 -38.41 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.638 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 62.8 mt -67.85 -28.32 67.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.709 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -74.99 -36.8 61.98 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.478 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -65.9 -43.13 89.14 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.899 176.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.589 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 40.1 t -61.65 -46.18 97.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.818 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.53 -37.07 69.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.305 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 15.0 t70 -49.8 -50.49 44.74 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.461 ' HB2' HD22 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -83.14 -14.42 53.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.382 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 33.9 mt -81.37 -29.49 34.0 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.528 ' HG3' HG22 ' A' ' 290' ' ' VAL . 62.1 mtpt -82.32 -22.27 35.69 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.506 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -71.75 -32.09 67.34 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.06 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.502 ' HB3' HD11 ' A' ' 211' ' ' LEU . 42.2 t -132.65 70.78 79.19 Favored Pre-proline 0 N--CA 1.434 -1.24 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.439 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 82.1 Cg_endo -74.09 2.5 6.03 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.165 2.577 . . . . 0.0 113.194 -177.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -75.26 -25.26 57.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.866 0.841 . . . . 0.0 109.597 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -77.51 169.82 17.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.603 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -122.44 144.9 48.76 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 177.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.67 125.47 74.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.296 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 41.9 m -103.1 108.6 19.85 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.92 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.414 HG12 HG23 ' A' ' 323' ' ' ILE . 21.2 mt -96.36 108.79 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.84 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.61 128.4 45.71 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.856 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.419 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -106.9 148.1 16.34 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.565 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 318' ' ' ASN . 24.7 m-85 -124.4 162.82 23.06 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.854 0.359 . . . . 0.0 110.39 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 274' ' ' SER . 72.2 p -144.69 172.2 13.33 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.15 170.95 13.28 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -94.52 17.23 13.54 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 70.8 p -65.14 -27.45 68.74 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.925 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.14 73.55 0.35 Allowed Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.684 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 45.2 m -86.63 24.1 1.51 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.777 0.323 . . . . 0.0 111.184 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -95.25 3.98 53.99 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.694 -0.403 . . . . 0.0 111.81 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . 0.53 ' O ' ' HD2' ' A' ' 272' ' ' PRO . . . 122.91 -39.72 2.18 Favored Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 119.532 -1.318 . . . . 0.0 114.289 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.8 mp -56.39 -23.88 17.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 122.844 0.458 . . . . 0.0 112.178 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.514 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 8.4 p30 -57.92 -38.44 75.89 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.771 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.425 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 23.0 mm -59.55 -64.53 2.89 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.754 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' A' ' 268' ' ' GLY . 11.6 Cg_endo -59.98 -26.57 82.76 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 121.905 1.736 . . . . 0.0 112.073 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 59.0 tp -68.68 -54.22 17.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.865 0.364 . . . . 0.0 111.227 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.52 ' HB3' HG23 ' A' ' 261' ' ' THR . 5.8 p -63.71 -31.53 72.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.515 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.36 67.71 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.959 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.516 ' O ' HG13 ' A' ' 280' ' ' ILE . 24.5 tp60 -70.56 -47.31 60.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.579 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -61.36 -40.04 92.85 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.393 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.95 92.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.176 0.512 . . . . 0.0 109.816 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.442 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.5 tptt -61.49 -35.46 77.75 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.939 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 276' ' ' GLN . 59.8 mt -57.49 -44.31 84.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.017 0.437 . . . . 0.0 110.369 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.722 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.5 t -68.4 -46.28 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.746 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.6 -45.21 73.6 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -61.15 -37.79 84.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.937 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.515 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 2.0 m-85 -66.63 -44.05 83.04 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.074 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 39.1 mt -64.87 -51.16 63.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.795 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 84.4 t -60.23 -38.77 78.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.298 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.68 -31.13 71.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.288 0.566 . . . . 0.0 110.287 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 19.9 mmm180 -84.86 4.95 30.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.489 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.61 46.86 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.352 -0.928 . . . . 0.0 114.094 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.528 HG22 ' HG3' ' A' ' 248' ' ' LYS . 66.7 t -84.77 140.73 15.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 117.752 0.776 . . . . 0.0 109.026 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.72 108.11 2.81 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.639 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.38 -30.07 67.34 Favored Glycine 0 CA--C 1.509 -0.302 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.968 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.85 -21.18 64.45 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.537 0.335 . . . . 0.0 111.748 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -106.9 5.58 28.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.408 HD11 ' CG1' ' A' ' 290' ' ' VAL . 68.6 mt -106.23 128.45 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.42 127.59 53.81 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.25 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.442 HG21 ' HA ' ' A' ' 279' ' ' LYS . 31.7 p -111.99 124.87 53.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.689 0.28 . . . . 0.0 110.683 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.79 121.25 52.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.093 0.473 . . . . 0.0 111.822 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -90.77 112.13 4.05 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 26.1 mt -90.45 -32.07 16.54 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 88.75 -140.13 15.76 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 47.2 t -88.62 114.27 25.07 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.501 HG13 ' H ' ' A' ' 304' ' ' ASN . 3.4 p -142.94 -61.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.852 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.501 ' H ' HG13 ' A' ' 303' ' ' VAL . 37.3 m-80 -115.33 92.08 30.83 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.715 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 8.3 Cg_exo -67.98 127.82 16.69 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.803 2.336 . . . . 0.0 112.81 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.8 tt -85.74 -44.28 16.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.614 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -127.4 167.03 16.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.469 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 53.8 p -63.34 133.0 53.38 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.506 0.504 . . . . 0.0 111.104 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -80.84 -8.43 59.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.949 0.404 . . . . 0.0 110.651 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -62.69 -23.62 67.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.687 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 1.5 t -117.11 140.77 27.5 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 311' ' ' THR . 24.6 Cg_exo -55.99 -35.78 94.99 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.82 2.347 . . . . 0.0 111.332 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -57.65 -47.01 83.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.853 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -63.43 -38.47 96.43 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.844 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -60.57 -37.19 80.49 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.16 -30.81 71.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.699 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 317' ' ' LYS . 12.7 mmtp -76.16 -41.96 48.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.08 0.467 . . . . 0.0 109.927 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.715 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 43.7 m-80 -61.75 -28.29 69.33 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 11.8 ptp180 -81.4 9.38 7.36 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -57.5 177.6 0.1 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.07 0.938 . . . . 0.0 113.341 174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 74.8 t -136.07 144.96 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.577 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -127.74 140.77 51.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.729 0.299 . . . . 0.0 111.057 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.414 HG23 HG12 ' A' ' 257' ' ' ILE . 1.4 mp -103.93 117.17 49.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.17 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.62 132.66 53.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.074 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.68 130.48 40.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.316 0.579 . . . . 0.0 111.234 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 254' ' ' ARG . 27.9 t-20 . . . . . 0 C--N 1.309 -1.17 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.314 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.206 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -92.87 -11.77 32.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.967 0.413 . . . . 0.0 110.921 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.19 137.16 89.18 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.391 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -53.41 132.16 47.12 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.724 2.282 . . . . 0.0 111.212 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.5 103.31 1.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.508 2.138 . . . . 0.0 112.473 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -122.16 -121.84 2.77 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.192 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.54 153.47 65.33 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.617 2.212 . . . . 0.0 112.021 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.74 139.2 73.65 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.487 2.125 . . . . 0.0 111.525 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.45 -35.84 68.37 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.116 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.0 t 54.45 -154.27 0.27 Allowed 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.336 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 98.16 -176.72 30.71 Favored Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.48 110.33 2.47 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.171 1.914 . . . . 0.0 111.09 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 48.8 t -104.07 141.04 36.91 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.39 162.46 10.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.563 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.34 85.73 2.5 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.596 ' HB2' HG21 ' A' ' 325' ' ' VAL . 23.4 mt -75.22 -34.57 61.47 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.447 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -62.62 -44.95 95.01 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 120.922 0.391 . . . . 0.0 110.061 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 36.2 t -65.49 -43.05 91.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.163 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.539 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -64.44 -47.03 80.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.927 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 211' ' ' LEU . 17.7 pt -69.37 -38.04 76.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.467 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -60.25 -37.81 81.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.099 0.476 . . . . 0.0 110.023 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.82 -27.66 67.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.039 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.771 HG12 HG23 ' A' ' 239' ' ' ILE . 43.1 t -83.01 -47.78 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 CA-C-O 121.069 0.461 . . . . 0.0 110.056 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.68 ' HA ' HG21 ' A' ' 239' ' ' ILE . 37.9 p -66.13 -35.25 79.98 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.017 -178.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.83 28.05 57.54 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 121.8 -132.24 8.86 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 114.54 -0.83 . . . . 0.0 111.192 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -89.34 169.25 5.0 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.734 2.289 . . . . 0.0 113.308 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.8 mm -85.67 105.18 14.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.196 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -91.57 134.82 34.34 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.906 0.384 . . . . 0.0 111.371 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -105.53 169.96 8.16 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.924 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -110.18 133.1 11.38 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.083 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -94.71 -5.24 45.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.739 0.27 . . . . 0.0 110.862 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -54.6 -63.03 1.28 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.009 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -115.05 7.87 21.36 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 65.82 171.65 0.23 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.607 0.763 . . . . 0.0 111.583 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.7 t 58.23 -155.62 0.34 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.314 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 36.3 tp -92.96 110.79 22.26 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.37 -56.57 25.97 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.751 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.95 158.28 52.33 Favored 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 121.714 1.609 . . . . 0.0 111.146 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -70.33 -29.81 66.61 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.829 0.347 . . . . 0.0 111.247 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -151.34 177.52 10.18 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -133.63 105.0 6.62 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.471 ' HA ' ' OD1' ' A' ' 241' ' ' ASN . 32.1 mt-10 -52.35 -38.61 59.18 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.169 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.771 HG23 HG12 ' A' ' 218' ' ' VAL . 82.8 mt -61.86 -37.62 78.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.694 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.1 mt -71.97 -21.63 61.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.471 ' OD1' ' HA ' ' A' ' 238' ' ' GLU . 3.7 m120 -76.84 -41.74 43.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.745 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -66.95 -42.82 84.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.954 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.622 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.4 t -58.35 -40.92 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.486 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -59.48 -36.83 76.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.317 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 3.5 t70 -48.54 -52.35 23.09 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.657 0.783 . . . . 0.0 112.813 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.545 ' NZ ' ' HB3' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -81.01 -17.75 49.24 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.668 -176.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 36.2 mt -79.14 -30.81 43.81 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.241 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.546 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 52.3 mtpt -82.63 -18.78 39.92 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.563 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.57 85.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.438 0.637 . . . . 0.0 110.01 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.548 ' HB3' HD11 ' A' ' 211' ' ' LEU . 49.9 t -128.98 69.06 80.62 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 74.3 Cg_endo -72.08 -1.29 9.82 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.416 2.744 . . . . 0.0 114.715 -173.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.45 -23.76 29.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.558 0.694 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.98 141.01 58.34 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.4 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -96.31 136.55 36.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.462 HG12 HG22 ' A' ' 325' ' ' VAL . 5.9 m -113.53 137.24 47.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-O 121.191 0.52 . . . . 0.0 111.685 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.7 m -113.43 109.0 17.97 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.187 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.7 mt -91.92 112.47 25.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -99.41 130.98 45.72 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.843 -176.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.547 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -107.3 145.43 16.05 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 9.2 m-85 -123.26 171.73 9.16 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 302' ' ' SER . 10.0 t -175.3 174.18 2.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.798 0.332 . . . . 0.0 110.765 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -86.31 166.97 15.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.199 0.523 . . . . 0.0 111.358 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -115.9 6.56 14.26 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.619 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 55.3 p -70.55 -11.39 60.9 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.06 -74.75 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.211 -1.471 . . . . 0.0 114.08 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 50.6 m -80.92 100.14 8.74 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -175.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -83.13 138.7 33.56 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 80.01 -57.25 4.59 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.214 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.33 -20.95 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 123.736 0.814 . . . . 0.0 111.126 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.423 ' HB2' ' CG2' ' A' ' 261' ' ' THR . 9.5 p30 -57.89 -31.55 66.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.526 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.461 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 24.8 mm -62.31 -65.49 2.11 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.567 176.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.461 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.0 Cg_endo -57.54 -30.82 89.76 Favored 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 121.821 1.68 . . . . 0.0 111.807 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 40.1 tp -61.96 -56.64 17.06 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.888 0.375 . . . . 0.0 111.169 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.547 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.5 p -63.41 -27.28 69.19 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.965 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.98 -30.05 62.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.28 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -49.2 65.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 48.0 mmt-85 -59.49 -37.14 77.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.296 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.47 -34.86 79.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.01 0.434 . . . . 0.0 110.539 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.709 ' HA ' HG21 ' A' ' 297' ' ' THR . 0.3 OUTLIER -68.06 -30.74 70.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.441 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 57.5 mt -60.13 -45.37 95.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.956 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.693 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 10.5 t -65.62 -45.14 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.788 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -53.15 -44.84 68.1 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.776 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.17 -43.12 87.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.51 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.446 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 4.4 m-85 -66.17 -41.07 90.8 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.139 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.693 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 27.0 mt -67.6 -47.2 70.38 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.739 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 282' ' ' ALA . 94.5 t -60.55 -41.48 87.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.36 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.8 -26.69 68.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.303 0.573 . . . . 0.0 110.515 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.446 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 2.7 mpt_? -86.95 4.98 39.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.426 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 100.64 8.42 49.05 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.043 -1.075 . . . . 0.0 114.4 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 63.0 t -85.29 143.68 11.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.448 ' O ' HG13 ' A' ' 295' ' ' ILE . . . -69.91 106.72 3.28 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.829 0.347 . . . . 0.0 111.421 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.55 -31.45 77.73 Favored Glycine 0 CA--C 1.503 -0.703 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.304 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.62 -17.47 64.61 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.734 0.302 . . . . 0.0 110.946 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -105.05 3.85 30.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.525 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 291' ' ' ALA . 67.5 mt -105.49 131.18 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -121.57 128.84 52.41 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.291 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.709 HG21 ' HA ' ' A' ' 279' ' ' LYS . 56.1 p -107.73 128.57 54.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.401 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 95.6 t -134.98 132.18 53.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.118 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -102.08 117.56 5.86 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 23.6 mt -91.56 -7.33 50.55 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.401 ' HA3' ' OD1' ' A' ' 270' ' ' ASN . . . 68.64 -136.93 29.97 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.445 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 261' ' ' THR . 7.3 p -74.52 97.76 3.2 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 120.927 0.394 . . . . 0.0 110.73 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 17.2 t -152.94 130.81 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.935 -177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 52.22 77.59 0.44 Allowed Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 123.786 0.679 . . . . 0.0 112.47 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.411 ' HB3' ' OD1' ' A' ' 318' ' ' ASN . 5.9 Cg_exo -74.46 171.65 17.69 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.468 2.112 . . . . 0.0 112.394 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.7 -55.72 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.592 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.456 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -110.22 171.36 7.5 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.881 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 24.7 m -62.39 134.76 56.9 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 123.553 0.533 . . . . 0.0 111.261 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -81.31 -8.36 59.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.469 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.15 -10.38 59.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.001 0.429 . . . . 0.0 111.366 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 314' ' ' GLY . 2.4 t -118.0 143.54 32.92 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.317 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.03 -31.06 56.06 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.22 1.946 . . . . 0.0 111.37 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 2.8 mt-10 -70.83 -35.4 72.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.779 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 307' ' ' ALA . . . -72.49 -40.19 54.85 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.82 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -65.2 -31.91 73.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.11 -26.73 68.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.107 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.498 ' HD3' ' HA ' ' A' ' 317' ' ' LYS . 10.6 mmtp -87.16 -37.07 17.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.806 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 305' ' ' PRO . 0.9 OUTLIER -62.35 -25.85 68.12 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 14.3 ptp180 -87.75 17.2 4.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.248 0.547 . . . . 0.0 111.556 -178.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -57.42 170.69 0.5 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.244 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 87.1 t -133.16 146.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.447 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -132.03 137.02 47.67 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.044 0.449 . . . . 0.0 110.788 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.441 ' HB ' HD12 ' A' ' 215' ' ' ILE . 2.9 mp -93.07 117.19 35.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.722 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 44.6 t -113.35 143.87 22.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 211' ' ' LEU . 46.9 t -106.06 140.29 24.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.0 t30 . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.306 -179.615 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.226 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -73.32 143.69 46.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.794 0.297 . . . . 0.0 110.284 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . . . 70.39 128.19 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 123.572 0.749 . . . . 0.0 111.853 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 198' ' ' ALA . 38.9 Cg_exo -62.34 152.55 76.04 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.808 2.339 . . . . 0.0 112.066 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.13 117.0 3.66 Favored 'Trans proline' 0 C--O 1.241 0.639 0 C-N-CA 122.839 2.359 . . . . 0.0 112.712 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -143.9 -76.58 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.906 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.02 170.96 14.65 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.751 2.301 . . . . 0.0 111.213 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.66 140.31 83.92 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.295 1.997 . . . . 0.0 111.04 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -93.36 -47.81 6.71 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.381 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 23.0 m 58.6 88.33 0.07 Allowed 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 122.926 0.49 . . . . 0.0 111.678 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 177.0 -87.0 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.837 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.43 -44.63 42.38 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 123.542 2.828 . . . . 0.0 112.829 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 14.3 t -153.14 -177.28 6.2 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.57 144.83 56.19 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 123.411 0.445 . . . . 0.0 110.158 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -75.47 78.99 2.51 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.128 0.489 . . . . 0.0 110.57 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 250' ' ' CYS . 40.1 mt -57.66 -21.59 40.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.246 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -63.44 -45.05 92.7 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 120.966 0.413 . . . . 0.0 109.937 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 36.3 t -73.8 -35.41 64.91 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 211' ' ' LEU . . . -62.57 -47.82 82.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.444 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 211' ' ' LEU . 18.8 pt -72.24 -39.93 64.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.396 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.449 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 12.3 t-20 -61.25 -28.75 69.39 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.128 0.489 . . . . 0.0 110.755 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.88 69.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.983 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.506 HG11 ' HG3' ' A' ' 242' ' ' ARG . 2.5 t -93.37 -41.63 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.199 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.588 ' HA ' HG21 ' A' ' 239' ' ' ILE . 80.9 p -65.11 -36.52 84.56 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.251 0.548 . . . . 0.0 110.266 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.22 22.13 63.62 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 130.86 -125.2 4.44 Favored Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.14 162.27 5.77 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 122.499 2.133 . . . . 0.0 112.044 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.9 mm -73.46 111.14 7.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.756 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -83.45 147.22 27.96 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.865 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -119.36 148.32 43.33 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.563 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -82.14 70.65 3.1 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -79.18 -8.98 59.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -173.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.413 ' HB3' ' CD1' ' A' ' 233' ' ' ILE . 14.7 t70 -56.04 -43.25 77.67 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.966 0.412 . . . . 0.0 110.529 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -98.31 3.33 59.76 Favored Glycine 0 N--CA 1.453 -0.188 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 70.86 -56.57 0.62 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.627 1.171 . . . . 0.0 112.363 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.1 m -81.68 36.46 0.44 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 63.6 104.94 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.413 ' CD1' ' HB3' ' A' ' 228' ' ' ASP . 48.2 pt -105.25 158.26 32.55 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.59 127.14 24.17 Favored 'Trans proline' 0 C--O 1.24 0.583 0 C-N-CA 122.425 2.083 . . . . 0.0 112.238 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -152.3 -71.18 0.15 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.033 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 237' ' ' TYR . 4.9 p-10 -118.06 -75.96 0.58 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.791 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.448 ' H ' ' CG ' ' A' ' 236' ' ' ASP . 59.4 t80 71.47 -51.94 0.69 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.914 0.886 . . . . 0.0 112.432 176.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -57.96 -20.53 38.59 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.588 HG21 ' HA ' ' A' ' 219' ' ' THR . 58.1 mt -65.34 -36.15 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.499 ' CD2' HG13 ' A' ' 281' ' ' VAL . 41.0 mt -64.96 -35.62 81.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.492 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -71.54 -39.86 70.43 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.506 ' HG3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -64.19 -48.66 75.07 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.037 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.632 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 55.2 t -55.47 -42.69 68.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.196 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.88 -37.51 87.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.936 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -52.49 -49.45 64.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.501 ' H ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -73.94 -29.42 62.01 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 119.491 -0.883 . . . . 0.0 111.292 -179.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 24.5 mt -69.75 -27.78 65.23 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 121.614 0.721 . . . . 0.0 109.254 176.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -68.38 -33.9 75.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.549 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.96 70.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.439 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.516 ' HB3' HD11 ' A' ' 211' ' ' LEU . 52.1 t -126.16 72.5 71.23 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.78 -0.79 9.44 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.99 2.46 . . . . 0.0 113.074 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.55 -30.05 59.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.521 0.676 . . . . 0.0 109.271 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.58 135.98 50.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.652 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.555 ' HB2' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -91.44 145.07 24.93 Favored 'General case' 0 CA--C 1.479 -1.758 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.0 m -120.43 125.38 74.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.896 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 54.9 m -101.35 108.87 20.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.469 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 323' ' ' ILE . 22.3 mt -94.92 112.19 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.109 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -103.48 124.34 48.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.109 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -103.65 163.62 15.46 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.352 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 32.4 m-85 -136.15 159.55 41.38 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.014 0.435 . . . . 0.0 110.63 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 63.2 p -141.3 164.87 29.07 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.51 156.23 29.39 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.969 0.414 . . . . 0.0 110.695 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 266' ' ' SER . 9.3 p30 -89.81 2.23 55.19 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.68 -18.19 58.58 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.17 0.51 . . . . 0.0 111.162 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -142.29 46.22 0.88 Allowed Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.401 ' HB2' ' HA ' ' A' ' 263' ' ' ASN . 8.5 t -84.85 122.41 29.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -176.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -160.98 -46.02 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 176.1 -26.98 0.07 OUTLIER Glycine 0 CA--C 1.499 -0.965 0 C-N-CA 119.912 -1.137 . . . . 0.0 113.026 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 35.1 mm -73.12 -20.37 18.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.736 0.779 . . . . 0.0 109.599 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 1.6 m120 -63.21 -36.97 85.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.607 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.439 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.3 mm -56.27 -65.24 1.68 Allowed Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.829 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.439 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 27.0 Cg_endo -63.24 -25.12 72.12 Favored 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 122.159 1.906 . . . . 0.0 112.277 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.521 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 53.8 tp -69.78 -52.24 26.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.001 0.429 . . . . 0.0 110.019 177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.444 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 10.1 t -57.5 -39.71 77.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.019 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.63 78.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.803 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.459 ' O ' HG13 ' A' ' 280' ' ' ILE . 6.5 tp-100 -68.08 -46.89 69.75 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.59 0.71 . . . . 0.0 109.703 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 67.3 mtp85 -59.7 -44.8 93.54 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.241 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.53 84.02 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.16 0.505 . . . . 0.0 110.182 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.631 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.5 tmtt? -64.22 -30.48 71.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.69 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 276' ' ' GLN . 62.2 mt -57.2 -41.37 77.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.977 0.417 . . . . 0.0 109.963 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.747 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 13.8 t -69.77 -47.91 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.868 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.09 -43.73 78.32 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.908 0.385 . . . . 0.0 110.919 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.1 -38.69 80.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.3 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.535 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 3.9 m-85 -72.83 -40.55 65.69 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.315 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 44.5 mt -64.18 -48.32 76.38 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 86.3 t -60.32 -39.66 81.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.1 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.43 -23.75 67.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.207 0.527 . . . . 0.0 110.895 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 5.0 mmp_? -89.02 2.9 53.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.394 178.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 97.83 13.14 44.51 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.203 -0.999 . . . . 0.0 114.053 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 62.0 t -87.63 139.96 16.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 117.514 0.657 . . . . 0.0 109.328 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -64.9 113.5 3.88 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.195 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -66.83 -11.27 57.51 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.893 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.71 -11.91 54.88 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 120.869 0.366 . . . . 0.0 110.224 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 40.6 m170 -110.23 2.25 19.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.736 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 57.7 mt -107.41 123.69 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -115.67 127.57 55.27 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.592 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 279' ' ' LYS . 47.5 p -104.89 126.28 51.79 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.39 113.04 30.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.305 0.574 . . . . 0.0 112.252 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.444 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -89.11 105.02 3.15 Favored Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.504 175.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 21.0 mt -94.06 1.4 56.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.665 0.269 . . . . 0.0 110.922 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 61.77 -128.08 42.31 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.539 -175.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 43.0 p -97.67 123.43 41.58 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.523 ' O ' ' HD3' ' A' ' 305' ' ' PRO . 3.5 p -150.21 -60.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.453 ' H ' HG13 ' A' ' 303' ' ' VAL . 90.6 m-20 -112.32 94.07 25.14 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-O 120.906 0.384 . . . . 0.0 110.039 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 303' ' ' VAL . 2.7 Cg_exo -70.88 172.77 13.07 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.874 2.383 . . . . 0.0 113.311 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.4 tt -134.13 -48.62 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.685 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -126.25 171.02 11.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.581 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.429 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 14.6 m -65.16 124.48 22.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.072 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -80.06 -8.38 59.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -62.33 -23.31 66.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.25 0.548 . . . . 0.0 110.361 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 314' ' ' GLY . 1.9 t -117.8 140.43 27.67 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.613 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -52.12 -38.32 70.61 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.133 2.555 . . . . 0.0 111.667 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -53.04 -52.27 59.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.715 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.43 ' H ' HG23 ' A' ' 311' ' ' THR . . . -65.61 -37.98 94.16 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.746 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -59.54 -37.51 78.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.876 0.37 . . . . 0.0 110.361 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.34 -31.37 72.54 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.386 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.87 -44.36 20.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.23 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -58.7 -26.28 63.74 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 13.4 ptp180 -83.08 11.09 6.77 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -58.34 179.0 0.08 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 121.61 0.719 . . . . 0.0 112.765 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.7 t -140.43 149.09 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.088 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -131.38 147.12 52.53 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.918 0.389 . . . . 0.0 111.003 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.471 HG23 HG12 ' A' ' 257' ' ' ILE . 1.3 mp -109.17 119.81 59.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.057 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.84 134.52 48.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.942 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 91.2 t -94.8 135.21 29.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.501 0.667 . . . . 0.0 112.409 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.555 ' HB3' ' HB2' ' A' ' 254' ' ' ARG . 5.3 t30 . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.257 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.209 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -80.4 105.95 12.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.05 0.452 . . . . 0.0 110.7 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . . . -109.44 133.87 20.7 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.374 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 198' ' ' ALA . 33.9 Cg_exo -62.05 113.85 2.05 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.497 2.131 . . . . 0.0 111.863 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.31 39.86 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.9 2.4 . . . . 0.0 111.976 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 161.4 135.22 1.78 Allowed Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.927 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.83 152.57 32.58 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.473 2.115 . . . . 0.0 111.335 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 205' ' ' SER . 52.1 Cg_exo -56.92 149.0 64.07 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.441 2.094 . . . . 0.0 111.535 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.27 27.34 0.08 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.242 0.544 . . . . 0.0 112.076 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 203' ' ' PRO . 20.1 m -102.76 -3.72 26.02 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.241 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 66.72 70.62 1.07 Allowed Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.805 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.56 -25.12 11.32 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.415 2.076 . . . . 0.0 112.946 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 46.7 t -143.17 155.17 44.49 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.509 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.58 169.08 8.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.162 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -83.18 77.96 9.68 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.459 ' HB2' HG21 ' A' ' 325' ' ' VAL . 29.4 mt -67.34 -29.71 69.33 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.126 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.581 HE21 ' HA ' ' A' ' 324' ' ' VAL . 35.5 tt0 -62.2 -44.32 96.84 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.821 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.0 m -69.25 -36.2 76.91 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.115 0.483 . . . . 0.0 109.769 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.46 -51.08 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.069 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.419 ' CG2' HG13 ' A' ' 243' ' ' VAL . 20.7 pt -68.37 -39.79 81.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.298 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -58.57 -32.11 68.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.861 0.362 . . . . 0.0 110.376 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.26 -32.59 73.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.185 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.528 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.2 t -85.96 -47.93 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 120.779 0.323 . . . . 0.0 110.686 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.504 ' HA ' HG21 ' A' ' 239' ' ' ILE . 58.1 p -62.71 -32.95 74.15 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.384 0.612 . . . . 0.0 110.055 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.52 22.47 47.1 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.95 -127.13 6.39 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.464 ' CB ' ' HD2' ' A' ' 320' ' ' ARG . 71.6 Cg_endo -84.39 164.3 12.76 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.201 1.934 . . . . 0.0 111.738 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 42.1 mm -71.65 98.0 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.573 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -78.8 144.24 35.29 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.719 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -111.44 142.34 43.84 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.853 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.07 -5.61 52.91 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.506 HD21 ' HA ' ' A' ' 232' ' ' LEU . 7.3 p30 -164.56 160.17 19.97 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -108.03 95.05 5.41 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.141 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 76.79 25.53 64.63 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.159 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -117.55 -164.33 0.99 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 33.1 t -74.51 125.97 29.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.784 0.326 . . . . 0.0 110.507 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.506 ' HA ' HD21 ' A' ' 227' ' ' ASN . 6.6 mp -77.54 100.47 6.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.179 0.514 . . . . 0.0 110.652 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.423 ' HB ' ' HD3' ' A' ' 234' ' ' PRO . 63.8 mt -75.72 -46.88 4.07 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.892 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.423 ' HD3' ' HB ' ' A' ' 233' ' ' ILE . 72.5 Cg_exo -51.52 139.9 45.85 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.231 1.954 . . . . 0.0 112.277 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.66 2.31 3.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.582 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.38 -8.68 19.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.42 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -64.88 -22.66 67.03 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.911 0.386 . . . . 0.0 110.484 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -67.34 -20.09 65.54 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.025 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.504 HG21 ' HA ' ' A' ' 219' ' ' THR . 76.9 mt -62.23 -31.94 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.401 HD11 HG13 ' A' ' 281' ' ' VAL . 3.9 mm? -62.21 -32.26 72.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.215 0.531 . . . . 0.0 110.38 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -79.68 -37.07 36.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.686 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.551 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 0.0 OUTLIER -67.78 -39.93 84.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.414 178.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.552 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 38.6 t -61.21 -37.25 77.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.54 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 248' ' ' LYS . . . -58.23 -38.04 76.07 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.819 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 4.0 t70 -46.46 -49.18 18.64 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.821 0.848 . . . . 0.0 112.938 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.472 ' H ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -83.73 -18.16 38.79 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.1 mt -84.8 -25.41 28.19 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 289' ' ' GLY . 6.1 tptm -73.88 -29.86 62.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.701 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.87 75.85 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.268 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.458 ' HB3' HD11 ' A' ' 211' ' ' LEU . 45.0 t -133.44 70.81 76.6 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.71 1.81 7.15 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.845 2.363 . . . . 0.0 113.078 -177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.55 -31.81 57.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.746 0.784 . . . . 0.0 109.14 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.521 ' HB2' ' SG ' ' A' ' 208' ' ' CYS . . . -65.26 145.63 55.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.314 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -99.99 132.82 45.11 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.496 HG12 HG22 ' A' ' 325' ' ' VAL . 6.1 m -115.06 131.16 68.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.236 0.541 . . . . 0.0 111.383 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.5 m -107.35 112.02 24.64 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.734 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.431 HG12 HG23 ' A' ' 323' ' ' ILE . 18.8 mt -92.61 116.03 32.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -107.77 127.49 53.74 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.739 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -99.02 149.83 19.16 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.246 -0.978 . . . . 0.0 110.844 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -131.95 163.02 29.29 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 117.274 0.537 . . . . 0.0 110.171 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 3.1 t -159.08 152.48 22.65 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -62.06 155.17 24.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.161 0.505 . . . . 0.0 111.082 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -90.32 5.09 48.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.05 -175.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 13.0 t -70.18 -13.51 62.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.012 0.434 . . . . 0.0 110.731 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -74.42 171.02 53.31 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 15.9 m -69.05 -83.99 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.933 0.366 . . . . 0.0 110.33 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.408 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 11.7 pt-20 176.01 168.6 0.42 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.935 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . 0.413 ' O ' ' HD2' ' A' ' 272' ' ' PRO . . . 78.13 -49.66 3.27 Favored Glycine 0 C--O 1.221 -0.684 0 C-N-CA 121.206 -0.521 . . . . 0.0 114.354 175.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 40.3 mm -75.97 -23.34 16.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.703 0.763 . . . . 0.0 110.223 -174.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.408 ' OD1' ' HA ' ' A' ' 267' ' ' GLU . 0.6 OUTLIER -64.0 -32.78 74.45 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.477 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.65 -64.26 3.29 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 268' ' ' GLY . 17.8 Cg_endo -61.12 -30.0 88.25 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.237 1.958 . . . . 0.0 111.947 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.539 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 50.9 tp -66.77 -51.33 57.06 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.037 0.446 . . . . 0.0 110.218 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.445 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 13.1 t -56.15 -39.21 71.95 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.263 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.21 -28.54 64.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.075 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -74.21 -44.4 53.38 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.259 0.552 . . . . 0.0 110.096 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 59.8 mtp85 -62.27 -41.0 98.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.997 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.88 -36.11 83.3 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.815 0.341 . . . . 0.0 111.014 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.491 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.6 tptt -59.83 -35.36 74.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 63.0 mt -55.1 -46.28 77.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.725 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 15.8 t -68.51 -46.22 80.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.653 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.63 -42.78 79.45 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.872 0.367 . . . . 0.0 111.185 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.61 -36.15 77.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.68 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.44 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 3.3 m-85 -74.19 -39.68 63.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.117 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 45.2 mt -65.45 -49.47 68.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.502 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 80.8 t -60.21 -38.13 76.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.163 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.23 70.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.694 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.558 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 3.7 mmp_? -87.23 7.37 28.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.684 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.531 ' O ' ' HE3' ' A' ' 248' ' ' LYS . . . 97.14 10.13 54.97 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.125 176.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 50.4 t -84.9 139.73 17.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 117.894 0.847 . . . . 0.0 109.547 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -63.99 111.97 2.74 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.071 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.3 -35.2 83.76 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.097 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.82 -11.87 61.21 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -101.44 -2.64 30.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.06 0.457 . . . . 0.0 109.878 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 64.5 mt -107.4 129.65 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.152 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.21 125.78 51.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.628 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.491 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.6 p -111.1 118.74 36.82 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.045 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 18.6 m -121.56 162.76 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.034 0 CA-C-O 121.224 0.535 . . . . 0.0 111.365 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.445 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -129.11 104.46 0.64 Allowed Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.6 mt -89.44 -31.17 17.84 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.733 0.302 . . . . 0.0 111.615 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 106.7 -122.23 6.9 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.841 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 9.4 t -104.98 120.12 40.68 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 8.6 p 179.81 152.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 58.3 t30 66.44 79.03 0.24 Allowed Pre-proline 0 C--N 1.314 -0.953 0 O-C-N 123.756 0.66 . . . . 0.0 111.467 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.55 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 73.3 Cg_endo -77.79 149.5 26.4 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.606 2.204 . . . . 0.0 113.136 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.415 HD12 ' HG3' ' A' ' 222' ' ' PRO . 2.9 tt -108.14 -39.16 4.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.32 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.51 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -139.64 174.42 10.54 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.978 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 26.2 m -74.54 129.52 37.9 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.121 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -80.16 -7.66 59.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.587 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -57.39 -19.08 21.02 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.382 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.4 t -127.77 141.33 40.74 Favored Pre-proline 0 N--CA 1.433 -1.315 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.928 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.87 -21.68 34.36 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.188 2.592 . . . . 0.0 112.399 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.565 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.5 mm-40 -60.04 -46.36 89.77 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.392 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 307' ' ' ALA . . . -65.77 -39.73 95.33 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.14 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -60.53 -37.02 79.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.425 0.631 . . . . 0.0 110.121 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.59 -29.38 66.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.193 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 6.7 mmtp -87.11 -35.86 18.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.307 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 27.9 m-20 -65.47 -15.48 62.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 7.6 ptm180 -88.49 16.2 6.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.558 0.694 . . . . 0.0 111.036 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.464 ' HD2' ' CB ' ' A' ' 222' ' ' PRO . 14.4 ptt180 -63.18 -173.69 0.06 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.422 1.105 . . . . 0.0 113.246 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.84 145.63 25.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.783 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -135.74 145.01 46.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.231 0.539 . . . . 0.0 111.599 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.431 HG23 HG12 ' A' ' 257' ' ' ILE . 1.8 mp -101.37 115.19 42.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.106 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.581 ' HA ' HE21 ' A' ' 212' ' ' GLN . 85.1 t -105.37 136.13 40.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.834 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 255' ' ' VAL . 69.5 t -101.27 136.18 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 C--N 1.311 -1.073 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.92 179.033 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.137 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -119.16 13.85 12.96 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.924 -0.162 . . . . 0.0 110.643 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 61.52 91.88 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.216 0 O-C-N 123.672 0.608 . . . . 0.0 110.24 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.44 117.83 4.23 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.989 2.459 . . . . 0.0 112.366 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.08 84.67 1.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.357 2.038 . . . . 0.0 111.047 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.43 -137.84 16.31 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.88 118.93 5.46 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.222 1.948 . . . . 0.0 111.09 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.62 147.97 77.29 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.316 2.011 . . . . 0.0 112.329 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -75.18 -6.81 51.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.065 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.5 t 73.79 -55.32 0.67 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.752 0.821 . . . . 0.0 111.639 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -145.89 90.72 0.15 Allowed Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.522 -0.846 . . . . 0.0 112.54 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.49 161.59 45.47 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.728 2.286 . . . . 0.0 110.949 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 48.8 t -109.44 156.18 20.38 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.794 0.331 . . . . 0.0 111.096 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -68.58 163.28 23.97 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.014 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.98 82.02 4.35 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.184 0.516 . . . . 0.0 110.244 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.508 ' HB2' HG21 ' A' ' 325' ' ' VAL . 52.9 mt -69.47 -24.76 63.83 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.875 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -68.86 -38.34 79.7 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.415 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 8.6 t -76.61 -32.22 57.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -67.84 -49.08 64.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.14 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.504 HG21 HG13 ' A' ' 243' ' ' VAL . 21.8 pt -69.39 -33.39 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.801 -0.181 . . . . 0.0 111.081 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -54.99 -34.17 63.16 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.134 0.492 . . . . 0.0 110.801 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.87 -31.76 72.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.243 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.531 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.5 t -91.81 -48.98 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.883 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.583 ' HA ' HG21 ' A' ' 239' ' ' ILE . 53.7 p -62.73 -43.61 98.35 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.302 0.573 . . . . 0.0 110.776 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.42 19.46 66.41 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.042 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 134.29 -136.95 8.92 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.451 ' HB2' ' HG3' ' A' ' 320' ' ' ARG . 64.5 Cg_endo -82.27 162.39 17.54 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.638 2.226 . . . . 0.0 112.756 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.7 mm -78.58 104.14 6.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.546 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.29 123.78 40.05 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.389 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -88.93 168.85 12.05 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.295 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -61.65 -67.14 2.24 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.655 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -109.05 -78.26 0.59 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -178.94 115.15 0.06 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.767 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 65.07 15.24 60.31 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 116.011 -0.541 . . . . 0.0 113.57 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -101.36 168.29 9.63 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.3 m -58.92 144.74 43.78 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.171 0.51 . . . . 0.0 110.797 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.0 mp -82.32 83.43 7.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.162 0.506 . . . . 0.0 110.633 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.48 ' HB ' ' HD3' ' A' ' 234' ' ' PRO . 60.8 mt -72.55 -48.19 9.3 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.138 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.48 ' HD3' ' HB ' ' A' ' 233' ' ' ILE . 52.2 Cg_exo -55.58 144.76 73.18 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 121.952 1.768 . . . . 0.0 111.673 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -73.35 18.32 0.12 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 234' ' ' PRO . 29.6 t70 -77.61 -17.48 57.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.119 0.485 . . . . 0.0 110.759 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -61.85 -13.69 26.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.036 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -64.72 -21.53 66.77 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.485 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.583 HG21 ' HA ' ' A' ' 219' ' ' THR . 56.8 mt -62.5 -38.28 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 50.6 mt -65.8 -31.61 72.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.796 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -71.4 -38.97 71.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.531 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.2 OUTLIER -65.85 -47.7 74.07 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.829 178.225 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.58 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.7 t -58.26 -45.43 89.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.062 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.415 ' HB1' HG23 ' A' ' 290' ' ' VAL . . . -61.01 -35.81 77.84 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.692 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -54.49 -47.94 72.43 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -75.26 -29.99 60.34 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.462 -178.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.0 mt -65.64 -34.41 78.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.435 0.635 . . . . 0.0 109.646 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -72.44 -24.7 61.25 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.146 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.84 69.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.049 0.452 . . . . 0.0 110.84 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.479 ' HB3' HD11 ' A' ' 211' ' ' LEU . 35.8 t -125.53 68.88 61.25 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.61 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.07 3.26 5.81 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.075 2.516 . . . . 0.0 113.388 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.91 -32.16 61.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.968 0.89 . . . . 0.0 108.879 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.407 ' HB2' ' SG ' ' A' ' 208' ' ' CYS . . . -74.56 148.04 41.21 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.442 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -101.1 139.42 36.8 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.8 m -115.0 130.01 70.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-O 121.327 0.584 . . . . 0.0 110.835 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.9 m -105.28 110.45 22.82 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.322 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.415 HG12 HG23 ' A' ' 323' ' ' ILE . 23.9 mt -92.8 111.1 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.96 126.31 46.11 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.146 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -105.07 159.02 15.84 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.152 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 301' ' ' GLY . 76.3 m-85 -132.55 165.97 23.16 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.816 0.341 . . . . 0.0 110.775 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.515 HG22 ' NH1' ' A' ' 277' ' ' ARG . 33.2 p -144.55 169.74 17.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.738 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.71 158.62 20.72 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 175.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -76.44 12.73 1.14 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.73 -22.75 3.77 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.06 0.457 . . . . 0.0 111.638 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.52 141.74 13.14 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 7.6 t -57.84 153.54 13.74 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 117.003 0.401 . . . . 0.0 110.418 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.66 156.85 10.18 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.083 0.468 . . . . 0.0 110.669 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 111.4 -52.82 0.61 Allowed Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.026 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 49.9 mm -84.92 -33.97 8.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 122.119 0.961 . . . . 0.0 108.765 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -61.74 -28.54 69.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.838 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.492 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 33.9 mm -57.26 -65.19 1.88 Allowed Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.432 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.492 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.9 Cg_endo -58.59 -35.45 98.64 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 122.195 1.93 . . . . 0.0 111.979 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 276' ' ' GLN . 54.2 tp -62.72 -53.87 47.79 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 121.277 0.56 . . . . 0.0 111.028 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.483 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 15.2 t -57.29 -35.59 69.99 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.005 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.35 -22.16 64.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.821 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.479 ' O ' HG13 ' A' ' 280' ' ' ILE . 11.2 tt0 -71.51 -53.1 14.97 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.515 ' NH1' HG22 ' A' ' 261' ' ' THR . 75.9 mtt85 -56.97 -44.14 82.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.62 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.43 77.69 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.962 0.41 . . . . 0.0 110.814 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.638 ' HA ' HG21 ' A' ' 297' ' ' THR . 11.9 tmtt? -69.37 -30.55 68.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.28 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 276' ' ' GLN . 58.8 mt -59.82 -44.96 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.732 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.7 t -65.99 -48.19 82.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.047 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.77 76.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 120.919 0.39 . . . . 0.0 110.984 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.4 -42.27 91.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.935 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.68 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 5.7 m-85 -68.09 -43.36 78.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.893 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 36.4 mt -63.62 -46.15 87.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.835 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.7 t -61.27 -40.16 85.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.379 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.25 -30.74 71.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.549 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 13.8 mmm180 -81.83 5.07 19.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.472 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.6 2.75 50.1 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.164 -1.017 . . . . 0.0 114.629 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 57.9 t -80.91 145.96 8.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 117.923 0.861 . . . . 0.0 110.573 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.401 ' O ' HG13 ' A' ' 295' ' ' ILE . . . -69.77 108.08 3.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.701 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.41 -33.8 82.56 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.792 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.97 -19.14 64.93 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -103.39 2.41 33.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.86 0.362 . . . . 0.0 110.955 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 291' ' ' ALA . 62.7 mt -104.35 130.36 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.52 127.21 53.77 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.646 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.638 HG21 ' HA ' ' A' ' 279' ' ' LYS . 53.8 p -106.25 119.97 40.63 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 77.2 t -124.25 114.91 43.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.357 0.599 . . . . 0.0 112.103 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.483 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -88.02 107.4 3.31 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.85 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 23.9 mt -94.64 -4.25 48.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.924 0.392 . . . . 0.0 110.43 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 260' ' ' TYR . . . 62.72 -133.07 44.11 Favored Glycine 0 N--CA 1.431 -1.657 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.66 -175.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.4 t -99.69 122.63 42.98 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 5.2 p -149.25 -56.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.666 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -113.33 93.73 27.96 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.427 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 14.9 Cg_endo -64.19 162.05 31.45 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.834 2.356 . . . . 0.0 112.934 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.493 HG22 ' HA ' ' A' ' 318' ' ' ASN . 4.7 tt -124.34 -53.59 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.874 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.422 ' H ' HG23 ' A' ' 306' ' ' ILE . . . -119.8 171.41 8.43 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 22.2 m -61.91 127.33 30.88 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.564 0.54 . . . . 0.0 110.845 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -79.79 -8.16 59.1 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.015 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.79 -17.37 62.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.699 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.8 t -116.8 138.4 24.59 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.47 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.74 -34.25 97.94 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.921 2.414 . . . . 0.0 111.517 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.6 mm-40 -59.65 -45.92 90.57 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.35 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.436 ' H ' HG23 ' A' ' 311' ' ' THR . . . -68.37 -38.82 87.56 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 311' ' ' THR . 96.7 mtt180 -59.09 -37.31 76.83 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.032 0.444 . . . . 0.0 109.96 176.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.42 -27.72 68.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.57 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 3.3 mmtp -80.93 -41.81 22.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.648 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.493 ' HA ' HG22 ' A' ' 306' ' ' ILE . 39.2 m-80 -60.19 -22.23 62.68 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -93.45 16.25 13.95 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.451 ' HG3' ' HB2' ' A' ' 222' ' ' PRO . 0.0 OUTLIER -66.49 179.24 1.05 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.746 0.784 . . . . 0.0 112.358 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 98.8 t -129.27 143.34 41.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.504 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -131.61 140.46 49.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 111.378 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 323' ' ' ILE . 1.5 mp -101.4 119.92 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.095 -177.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.49 141.74 27.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.268 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 211' ' ' LEU . 96.0 t -98.38 135.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.713 -179.503 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.947 0 N-CA-C 111.774 -0.531 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -69.2 -37.66 78.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.574 0.226 . . . . 0.0 110.53 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 65.1 98.95 0.04 OUTLIER Pre-proline 0 C--O 1.237 0.406 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.834 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.503 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 39.6 Cg_exo -62.44 137.18 63.43 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.863 2.375 . . . . 0.0 111.782 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 199' ' ' PRO . 5.1 Cg_exo -77.69 63.22 7.98 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.766 2.31 . . . . 0.0 112.092 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -72.65 159.09 53.5 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.881 -0.675 . . . . 0.0 111.742 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.467 ' HA ' ' HD2' ' A' ' 203' ' ' PRO . 72.7 Cg_exo -49.77 119.38 4.69 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.96 2.44 . . . . 0.0 112.268 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 202' ' ' PRO . 19.7 Cg_endo -59.8 -50.71 7.22 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.964 2.443 . . . . 0.0 112.539 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -82.72 -44.21 15.91 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 26.0 t 66.92 87.07 0.13 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.333 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -127.35 -161.12 10.73 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -50.65 -41.08 54.94 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.932 2.422 . . . . 0.0 111.875 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 10.8 t -137.12 139.65 41.37 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.24 177.59 1.05 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.148 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -87.69 83.09 7.22 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.828 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.5 mm? -69.59 -40.71 76.52 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.167 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -64.14 -40.66 96.65 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.719 0.295 . . . . 0.0 110.861 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 33.5 t -68.35 -44.17 75.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.066 0.46 . . . . 0.0 110.115 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.29 -44.66 87.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.031 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.482 ' CG2' HG13 ' A' ' 243' ' ' VAL . 27.1 pt -69.11 -37.6 76.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.212 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -60.72 -33.02 72.26 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.336 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.49 -25.09 65.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.213 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.426 HG12 HG23 ' A' ' 239' ' ' ILE . 3.3 t -90.25 -43.7 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 110.047 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.6 ' HA ' HG21 ' A' ' 239' ' ' ILE . 71.5 p -68.03 -36.71 80.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.579 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.97 24.68 51.94 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.98 -136.5 9.4 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.84 164.94 20.17 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.374 2.049 . . . . 0.0 112.267 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.7 mm -77.95 104.32 5.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.6 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -93.08 119.9 32.79 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.969 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.94 -170.82 3.03 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.193 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -164.88 -38.8 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.338 -170.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 231' ' ' SER . 76.0 m-20 -82.55 80.17 8.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -122.69 3.52 9.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.76 0.314 . . . . 0.0 111.714 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -92.01 -21.68 32.49 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.115 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -138.83 -90.47 0.2 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.673 0.273 . . . . 0.0 110.683 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.502 ' O ' ' HB3' ' A' ' 227' ' ' ASN . 49.5 m -120.09 137.44 54.13 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 48.5 tp -62.96 -34.37 77.37 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.47 0.481 . . . . 0.0 111.69 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 70.7 mt 67.3 94.9 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.376 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.888 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.45 126.81 13.96 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.208 1.938 . . . . 0.0 112.089 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -164.99 -67.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.137 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -88.08 -12.32 44.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.692 0.758 . . . . 0.0 109.121 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -83.93 19.98 1.62 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.353 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.3 -18.41 65.34 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.418 0.627 . . . . 0.0 109.481 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.6 HG21 ' HA ' ' A' ' 219' ' ' THR . 90.3 mt -58.63 -34.57 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.147 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.45 -33.77 76.66 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.213 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.482 ' HA ' ' HG2' ' A' ' 288' ' ' ARG . 44.8 m-20 -71.33 -37.32 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -49.91 57.42 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.82 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.63 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 38.8 t -57.93 -47.65 85.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.413 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -66.79 -28.18 68.17 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.848 -176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.92 -40.19 83.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 0.0 111.434 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 243' ' ' VAL . 0.0 OUTLIER -77.88 -26.69 49.38 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.038 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 38.3 mt -66.68 -27.34 67.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.157 0.503 . . . . 0.0 110.307 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 59.0 mtpt -76.65 -17.23 59.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.377 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.91 -30.21 63.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.1 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 8.4 t -137.02 67.79 56.36 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 71.6 Cg_endo -75.44 4.46 4.95 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.354 2.703 . . . . 0.0 114.621 -174.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -78.16 -29.69 48.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.585 0.707 . . . . 0.0 109.474 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.44 136.66 51.85 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.779 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -86.33 138.36 31.88 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.411 HG12 HG22 ' A' ' 325' ' ' VAL . 3.8 m -111.53 126.26 68.91 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.839 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.3 m -104.2 106.57 17.12 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.379 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 323' ' ' ILE . 28.0 mt -92.56 113.21 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.478 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -100.51 129.36 46.45 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.689 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.439 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -108.0 144.38 16.14 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 27.4 m-85 -124.33 161.48 25.8 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.127 0.489 . . . . 0.0 110.61 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.576 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 72.7 p -147.0 164.22 33.69 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -80.24 164.05 23.53 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.859 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -94.79 -1.62 52.5 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.587 0.708 . . . . 0.0 110.5 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.67 -26.72 20.57 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.52 -69.19 1.41 Allowed Glycine 0 C--O 1.229 -0.179 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.747 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 19.9 m -142.01 -174.24 4.04 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -137.53 125.92 23.38 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 92.99 -45.98 2.47 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.34 -20.64 24.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 123.604 0.762 . . . . 0.0 110.184 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.576 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 0.6 OUTLIER -58.54 -36.81 74.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.199 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.473 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.4 mm -61.17 -63.95 3.7 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.24 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.9 Cg_endo -58.37 -31.68 94.47 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.944 1.763 . . . . 0.0 111.866 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.591 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 62.4 tp -67.4 -54.2 22.49 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.568 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.566 ' HB3' HG23 ' A' ' 261' ' ' THR . 18.5 p -62.48 -29.92 70.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.767 0.318 . . . . 0.0 110.898 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.44 -31.34 69.61 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.412 ' O ' HG13 ' A' ' 280' ' ' ILE . 25.8 tt0 -73.2 -41.28 63.99 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 273' ' ' LEU . 60.7 mtp85 -61.92 -45.16 94.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.034 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.77 76.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.876 0.37 . . . . 0.0 110.872 176.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.583 ' HA ' HG21 ' A' ' 297' ' ' THR . 13.6 tmtt? -65.94 -30.26 70.81 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.509 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 276' ' ' GLN . 60.6 mt -56.51 -44.21 80.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.23 0.538 . . . . 0.0 109.753 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.686 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.9 t -70.92 -46.54 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.574 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.87 71.01 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.877 0.37 . . . . 0.0 111.184 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -57.71 -43.28 85.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.502 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.503 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 4.8 m-85 -69.58 -38.52 77.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.461 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 41.3 mt -66.38 -46.31 77.13 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.1 -39.37 82.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.488 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.8 -26.75 68.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.295 0.569 . . . . 0.0 110.54 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -85.18 3.52 38.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.69 178.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.34 13.29 39.22 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.129 -1.034 . . . . 0.0 114.364 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.424 HG22 ' HG3' ' A' ' 248' ' ' LYS . 58.5 t -87.95 142.9 12.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 117.716 0.758 . . . . 0.0 109.504 177.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -67.63 112.8 4.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.433 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.18 -36.83 90.4 Favored Glycine 0 CA--C 1.511 -0.219 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.459 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -70.55 -11.41 60.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.859 0.361 . . . . 0.0 111.417 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -102.17 -1.43 31.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.058 0.456 . . . . 0.0 110.404 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.402 HD11 ' CG1' ' A' ' 290' ' ' VAL . 70.6 mt -106.13 130.93 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.727 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.47 125.02 49.03 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.649 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.583 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.3 p -104.24 122.44 45.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.487 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 67.5 t -127.23 115.03 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 121.153 0.501 . . . . 0.0 112.084 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.28 112.9 3.8 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.608 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.466 ' HB3' HG21 ' A' ' 303' ' ' VAL . 26.7 mt -97.05 -7.85 31.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.561 0.219 . . . . 0.0 111.559 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 62.8 -129.36 41.63 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.152 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 12.7 p -93.59 112.23 24.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.491 ' O ' ' HD3' ' A' ' 305' ' ' PRO . 41.9 t -138.0 -69.38 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.415 ' ND2' HG12 ' A' ' 303' ' ' VAL . 67.7 m-80 -110.2 94.49 18.41 Favored Pre-proline 0 N--CA 1.44 -0.932 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 303' ' ' VAL . 13.3 Cg_exo -65.57 163.2 30.93 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.24 1.96 . . . . 0.0 112.034 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 6.3 tt -117.9 -48.24 3.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.465 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -129.75 172.89 11.16 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 43.8 t -62.96 134.76 56.68 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 123.399 0.437 . . . . 0.0 110.734 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.17 -7.7 59.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.683 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.59 -20.31 64.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.444 HG23 ' H ' ' A' ' 314' ' ' GLY . 2.1 t -113.54 145.34 33.13 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.891 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.86 -32.29 36.67 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.996 1.797 . . . . 0.0 110.806 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.8 mt-10 -59.66 -44.7 93.47 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.055 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.444 ' H ' HG23 ' A' ' 311' ' ' THR . . . -67.88 -38.87 89.56 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.707 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -63.16 -37.31 86.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.941 0.4 . . . . 0.0 110.259 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.21 -27.44 69.36 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.17 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 6.8 mmtp -84.73 -40.9 16.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.035 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 42.5 m-80 -62.31 -26.65 68.54 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 37.3 ptt180 -78.4 7.02 7.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.877 0.37 . . . . 0.0 111.471 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 317' ' ' LYS . 29.8 ptt-85 -57.78 177.79 0.1 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.144 0.973 . . . . 0.0 113.18 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 86.5 t -136.52 143.15 36.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.583 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -129.57 137.58 50.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.831 0.348 . . . . 0.0 111.017 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.434 ' H ' HD12 ' A' ' 323' ' ' ILE . 1.4 mp -100.9 119.5 49.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 75.0 t -111.05 137.33 43.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 255' ' ' VAL . 67.9 t -101.5 136.39 33.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.364 0.602 . . . . 0.0 111.221 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 . . . . . 0 C--N 1.311 -1.08 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.084 179.264 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.264 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -93.84 -38.3 11.31 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 53.11 77.48 0.45 Allowed Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.789 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.5 115.11 3.73 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.688 2.259 . . . . 0.0 111.666 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.99 -9.64 11.78 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.723 2.282 . . . . 0.0 112.338 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -76.71 -71.48 1.18 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.099 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.35 110.18 0.31 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.848 2.365 . . . . 0.0 112.358 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.44 125.01 13.69 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.738 2.292 . . . . 0.0 110.927 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -93.57 -9.79 36.96 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.3 t 54.71 -154.89 0.27 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 122.936 0.495 . . . . 0.0 110.958 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 167.84 -150.84 17.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.348 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.38 13.1 1.17 Allowed 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 123.577 2.852 . . . . 0.0 111.882 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 52.7 t -153.58 147.13 25.04 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -56.18 161.28 2.52 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.183 0.516 . . . . 0.0 112.043 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.93 63.35 2.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.548 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.516 HD22 ' HB2' ' A' ' 246' ' ' LYS . 17.9 mt -54.08 -29.9 46.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.308 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -65.25 -43.8 90.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.026 0.441 . . . . 0.0 109.932 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.7 t -74.96 -24.68 58.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.543 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -75.51 -49.05 19.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.831 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 211' ' ' LEU . 23.4 pt -71.72 -38.08 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.607 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -58.62 -38.39 77.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.988 0.423 . . . . 0.0 110.516 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.89 -27.72 69.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.134 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.831 HG12 HG23 ' A' ' 239' ' ' ILE . 21.3 t -83.67 -50.98 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 121.038 0.447 . . . . 0.0 110.751 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.556 ' HA ' HG21 ' A' ' 239' ' ' ILE . 42.6 p -69.1 -34.86 75.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.461 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.9 14.24 82.8 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 139.79 -134.69 6.74 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.34 166.63 6.57 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.73 2.287 . . . . 0.0 113.246 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 51.0 mm -82.58 106.09 13.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.009 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -95.15 132.41 40.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.122 0.487 . . . . 0.0 111.864 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -100.55 173.93 6.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.512 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -105.01 -68.59 0.74 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.827 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.58 ' HB3' ' O ' ' A' ' 231' ' ' SER . 24.8 t-20 -95.71 -100.82 0.17 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.492 -0.29 . . . . 0.0 110.607 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 227' ' ' ASN . 10.2 t70 170.05 -58.56 0.01 OUTLIER 'General case' 0 C--N 1.352 0.688 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -78.42 80.07 1.45 Allowed Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.5 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 77.63 -55.71 0.52 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.975 0.91 . . . . 0.0 112.579 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.58 ' O ' ' HB3' ' A' ' 227' ' ' ASN . 25.3 m -80.44 72.46 7.33 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.194 0.521 . . . . 0.0 109.666 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 232' ' ' LEU . 2.5 pt? -74.32 -0.28 16.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.939 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 40.1 mt 58.26 73.15 0.76 Allowed Pre-proline 0 C--O 1.234 0.273 0 CA-C-O 121.023 0.439 . . . . 0.0 110.159 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.42 125.34 8.31 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.081 1.854 . . . . 0.0 111.655 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -145.22 -7.75 0.61 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.978 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.542 ' HB3' HD12 ' A' ' 239' ' ' ILE . 5.3 m-20 -123.63 22.84 9.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.415 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -66.07 -27.13 67.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.072 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -67.61 -20.71 65.38 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.003 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.831 HG23 HG12 ' A' ' 218' ' ' VAL . 50.6 mt -64.73 -38.86 83.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.86 -31.23 72.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.226 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.448 ' HA ' ' HG2' ' A' ' 288' ' ' ARG . 3.5 m-20 -75.57 -38.31 59.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.784 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -69.24 -23.42 63.86 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.095 178.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 24.7 t -79.79 -42.19 22.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.487 176.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.01 68.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.154 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -45.82 -50.54 14.03 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.728 0.811 . . . . 0.0 112.497 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.516 ' HB2' HD22 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -85.33 -14.43 46.5 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 41.3 mt -83.56 -31.08 26.54 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.544 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 53.6 mtpt -82.93 -18.85 38.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.64 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.94 -34.13 76.0 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.283 0.563 . . . . 0.0 109.816 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.506 ' HB3' HD11 ' A' ' 211' ' ' LEU . 35.4 t -132.03 69.35 80.71 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 60.6 Cg_endo -69.5 -2.97 10.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.25 2.633 . . . . 0.0 113.846 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -84.0 -24.14 30.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.558 0.694 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -67.75 149.29 50.14 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.861 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -102.81 140.79 36.63 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.09 131.95 67.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 120.97 0.414 . . . . 0.0 110.897 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.2 m -107.63 108.76 20.16 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 16.3 mt -96.36 114.98 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.68 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -99.5 125.16 45.2 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.293 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 274' ' ' SER . . . -105.71 140.76 15.23 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -123.01 161.94 23.31 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.01 0.433 . . . . 0.0 110.005 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 10.0 t -148.1 167.1 25.88 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.402 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.494 ' HB3' HG22 ' A' ' 264' ' ' THR . 13.5 t70 -79.07 156.86 28.16 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.011 -178.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -83.99 8.15 16.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 0.0 111.399 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 262' ' ' ASP . 9.4 t -66.3 -27.94 68.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.34 164.79 53.64 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.4 t -151.56 179.02 8.73 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 117.112 0.456 . . . . 0.0 111.219 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.401 ' HB3' HD13 ' A' ' 269' ' ' ILE . 4.9 tp10 71.42 5.9 5.57 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.409 1.083 . . . . 0.0 112.513 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 96.7 -12.91 65.85 Favored Glycine 0 CA--C 1.494 -1.223 0 C-N-CA 119.76 -1.209 . . . . 0.0 114.179 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.401 HD13 ' HB3' ' A' ' 267' ' ' GLU . 1.7 mp -61.45 -21.83 26.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.676 0.75 . . . . 0.0 110.901 -177.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.94 -38.66 70.61 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.779 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.404 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 22.7 mm -58.78 -64.37 2.99 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.741 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.404 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 14.2 Cg_endo -61.21 -28.12 84.6 Favored 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 121.867 1.711 . . . . 0.0 112.426 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 53.2 tp -65.51 -52.95 48.94 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.965 0.412 . . . . 0.0 110.809 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 259' ' ' GLY . 14.5 p -62.64 -28.39 69.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.606 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.86 78.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.251 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -67.86 -39.59 83.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.73 -52.18 64.78 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.099 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.422 ' HA ' HG11 ' A' ' 321' ' ' VAL . . . -60.93 -35.0 75.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.214 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.553 ' HA ' HG21 ' A' ' 297' ' ' THR . 16.4 ttpt -62.68 -31.79 72.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.229 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 61.5 mt -56.36 -45.57 81.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.989 0.423 . . . . 0.0 110.118 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.745 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.5 t -67.48 -45.44 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.978 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.78 -45.37 74.26 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.919 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.84 -40.54 88.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.288 0.566 . . . . 0.0 110.635 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.674 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 6.9 m-85 -69.75 -41.41 75.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.208 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 47.6 mt -63.99 -46.91 82.45 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 79.4 t -59.9 -39.51 80.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.354 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.39 -30.54 71.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.339 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.674 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -80.93 1.51 30.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.597 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 98.81 15.69 33.23 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.136 -1.03 . . . . 0.0 114.033 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 58.2 t -90.64 142.86 12.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 117.416 0.608 . . . . 0.0 109.551 177.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.31 111.11 4.4 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.801 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.1 -34.12 77.94 Favored Glycine 0 C--N 1.33 0.197 0 CA-C-N 115.707 -0.679 . . . . 0.0 113.255 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.54 -21.0 66.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.922 0.391 . . . . 0.0 111.63 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -101.5 3.92 40.67 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.97 0.414 . . . . 0.0 110.99 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 66.4 mt -105.43 131.92 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.74 129.61 54.58 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.553 HG21 ' HA ' ' A' ' 279' ' ' LYS . 31.8 p -115.72 125.38 52.73 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.683 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 94.7 t -130.04 127.58 63.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 0.0 111.499 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -96.02 114.12 4.83 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.87 -2.0 48.25 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 72.79 -129.85 13.85 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.661 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 23.2 t -90.49 114.92 27.21 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.1 p -179.33 147.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.6 t30 64.95 69.33 0.67 Allowed Pre-proline 0 C--N 1.314 -0.97 0 O-C-N 123.818 0.699 . . . . 0.0 110.404 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.44 168.45 12.99 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.591 2.194 . . . . 0.0 113.231 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.463 ' HB ' ' NH1' ' A' ' 320' ' ' ARG . 2.7 tt -128.12 -50.0 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.108 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.444 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -120.83 171.71 8.42 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.168 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 20.0 m -64.55 134.69 54.92 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.485 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -78.22 -7.72 57.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.184 0.516 . . . . 0.0 110.662 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.16 -16.88 60.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.158 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.506 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 0.8 OUTLIER -113.76 144.61 31.79 Favored Pre-proline 0 CA--C 1.511 -0.522 0 CA-C-O 121.034 0.445 . . . . 0.0 110.941 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -66.22 -34.66 35.43 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 122.213 1.942 . . . . 0.0 111.354 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -60.87 -40.51 93.24 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.268 0.556 . . . . 0.0 109.85 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 307' ' ' ALA . . . -70.25 -39.8 71.12 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.876 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 311' ' ' THR . 99.4 mtt180 -60.74 -33.43 72.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.125 0.488 . . . . 0.0 110.092 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -70.47 -29.14 65.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.79 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 320' ' ' ARG . 0.2 OUTLIER -82.38 -41.17 20.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.05 179.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -64.64 -17.42 64.02 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 19.6 ptp180 -86.98 13.19 9.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.146 0.498 . . . . 0.0 110.865 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.463 ' NH1' ' HB ' ' A' ' 306' ' ' ILE . 5.2 ptt180 -57.66 175.9 0.16 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.191 0.996 . . . . 0.0 113.189 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 278' ' ' ALA . 60.7 t -135.48 147.76 28.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.427 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.02 136.15 48.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.146 0.498 . . . . 0.0 110.9 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.42 ' H ' HD12 ' A' ' 323' ' ' ILE . 2.3 mp -98.38 117.27 43.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.919 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 48.8 t -112.53 141.87 26.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.479 HG21 ' HB2' ' A' ' 211' ' ' LEU . 97.3 t -88.93 118.85 35.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.028 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.6 t30 . . . . . 0 C--N 1.331 -0.2 0 C-N-CA 125.144 1.378 . . . . 0.0 112.549 -176.611 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -78.05 -49.64 13.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.006 0.431 . . . . 0.0 110.611 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -127.74 92.93 41.32 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.33 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 5.3 Cg_exo -81.4 141.26 12.53 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.68 2.254 . . . . 0.0 110.846 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 199' ' ' PRO . 24.3 Cg_exo -63.22 108.26 0.78 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.472 2.115 . . . . 0.0 111.829 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -160.13 77.89 0.18 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.377 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -80.01 154.34 22.55 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.905 2.403 . . . . 0.0 111.064 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.38 110.71 0.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.312 2.008 . . . . 0.0 111.383 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.71 -23.25 63.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.528 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 30.1 p -108.31 114.05 27.61 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -115.37 -170.87 16.34 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.438 -0.886 . . . . 0.0 112.175 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.89 158.32 58.34 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.842 2.362 . . . . 0.0 111.479 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 12.1 t -104.37 175.07 5.61 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.468 ' O ' HD22 ' A' ' 211' ' ' LEU . . . -50.87 165.49 0.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.433 0.693 . . . . 0.0 112.859 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.65 80.75 9.02 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 209' ' ' ALA . 3.1 mm? -57.48 -53.29 59.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.71 -43.22 99.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.846 0.355 . . . . 0.0 110.697 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.4 t -70.92 -21.0 62.42 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.247 0.546 . . . . 0.0 110.346 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.57 ' HB1' ' HE3' ' A' ' 246' ' ' LYS . . . -84.24 -45.07 13.26 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.51 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 26.5 pt -69.48 -41.89 80.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.03 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -57.2 -32.47 66.51 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.459 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.42 67.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.236 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 242' ' ' ARG . 8.2 t -87.7 -47.93 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-O 121.065 0.46 . . . . 0.0 110.091 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.484 ' HA ' HG21 ' A' ' 239' ' ' ILE . 76.2 p -66.29 -36.91 84.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.585 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.02 24.95 42.53 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.38 -136.02 10.22 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.602 ' HB2' ' NE ' ' A' ' 320' ' ' ARG . 3.4 Cg_exo -79.98 159.26 24.08 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.463 2.109 . . . . 0.0 111.851 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 320' ' ' ARG . 41.7 mm -74.88 106.65 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.661 -176.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -83.03 149.41 26.96 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -110.85 141.07 44.72 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.028 0.442 . . . . 0.0 111.322 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -91.6 -42.75 4.73 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -98.43 161.14 13.84 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.39 -29.76 70.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.135 0.493 . . . . 0.0 110.583 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 163.35 -8.65 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.193 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -84.27 90.67 7.58 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.695 0.283 . . . . 0.0 110.938 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 87.5 p 55.49 -174.28 0.05 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.991 0.917 . . . . 0.0 112.715 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 98.7 mt -121.08 95.35 4.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.324 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.494 ' N ' ' HD2' ' A' ' 234' ' ' PRO . 68.3 mt -78.02 -52.72 1.51 Allowed Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.635 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 233' ' ' ILE . 16.4 Cg_endo -57.81 151.1 58.51 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 122.147 1.898 . . . . 0.0 111.935 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -79.09 72.4 5.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.197 0.523 . . . . 0.0 111.461 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -129.69 2.93 4.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.714 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -73.67 -21.4 60.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.816 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.72 -20.86 66.57 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.815 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 243' ' ' VAL . 76.7 mt -69.9 -42.42 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 8.1 mp -67.08 -33.52 75.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.597 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.68 -37.25 82.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.067 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.594 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 0.0 OUTLIER -71.65 -41.17 69.1 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.779 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.638 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 54.9 t -56.01 -40.82 65.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.231 0.539 . . . . 0.0 110.199 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.22 -35.86 82.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.231 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.594 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 2.9 t70 -48.9 -52.98 21.53 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.57 ' HE3' ' HB1' ' A' ' 214' ' ' ALA . 0.0 OUTLIER -73.66 -31.77 63.64 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.168 -178.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 25.6 mt -68.76 -29.64 68.07 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -64.86 -32.38 74.06 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.942 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -77.1 -29.41 54.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.57 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 7.8 t -137.82 65.02 44.88 Favored Pre-proline 0 C--N 1.316 -0.867 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.01 4.6 5.12 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.059 2.506 . . . . 0.0 114.461 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -81.21 -28.11 35.03 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.681 0.753 . . . . 0.0 109.077 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.3 141.14 54.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.639 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -93.74 137.08 33.36 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.047 0.451 . . . . 0.0 110.157 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.423 HG12 HG22 ' A' ' 325' ' ' VAL . 5.3 m -116.67 133.66 62.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.071 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 31.4 m -112.32 111.92 23.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.84 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.402 HG12 HG23 ' A' ' 323' ' ' ILE . 18.9 mt -92.79 114.36 29.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -104.79 128.21 52.85 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.597 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.416 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -109.49 144.82 16.7 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.798 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -126.24 158.72 34.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 10.0 t -174.13 114.18 0.19 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.125 0.964 . . . . 0.0 111.228 174.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.3 109.08 8.51 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.488 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.52 ' HB2' ' HB3' ' A' ' 270' ' ' ASN . 0.6 OUTLIER -129.85 -56.01 1.13 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.663 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.7 p -115.34 -61.7 1.71 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.486 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 174.31 -43.29 0.14 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 302' ' ' SER . 50.9 m -149.6 -64.95 0.22 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.675 0.274 . . . . 0.0 111.378 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -99.64 165.99 11.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.963 0.411 . . . . 0.0 111.672 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 272' ' ' PRO . . . 124.08 -150.65 17.03 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.185 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.75 -29.97 48.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 123.058 0.543 . . . . 0.0 110.9 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.678 HD22 ' N ' ' A' ' 271' ' ' ILE . 0.2 OUTLIER -61.06 -24.69 66.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.831 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.678 ' N ' HD22 ' A' ' 270' ' ' ASN . 19.8 mm -64.53 -64.89 2.32 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.869 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.438 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.3 Cg_endo -60.01 -30.01 90.6 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 121.779 1.653 . . . . 0.0 111.934 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 58.5 tp -68.36 -52.22 35.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.237 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.493 ' HB3' HG22 ' A' ' 261' ' ' THR . 17.3 p -64.22 -27.15 68.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.82 0.343 . . . . 0.0 110.981 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -68.15 -33.62 74.81 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.768 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.511 ' O ' HG13 ' A' ' 280' ' ' ILE . 7.2 tt0 -64.05 -50.47 68.27 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.852 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.534 ' NH1' ' HB2' ' A' ' 319' ' ' ARG . 72.8 mtt180 -61.96 -38.06 87.1 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.784 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.88 92.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.076 0.465 . . . . 0.0 110.172 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.651 ' HA ' HG21 ' A' ' 297' ' ' THR . 23.6 ttpt -66.71 -31.93 72.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.377 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 276' ' ' GLN . 60.4 mt -55.09 -41.96 62.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.059 0.457 . . . . 0.0 110.145 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.712 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.6 t -70.2 -43.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.778 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.4 84.94 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.994 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -56.96 -37.58 71.77 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.937 0.398 . . . . 0.0 110.649 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.667 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 6.3 m-85 -70.86 -51.25 27.56 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.96 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 30.5 mt -55.38 -50.76 68.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.366 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.16 -41.22 85.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.007 0.432 . . . . 0.0 110.646 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.13 -21.96 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.001 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.8 mmp_? -88.52 7.1 34.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.499 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 92.42 14.8 55.12 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.683 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.41 144.9 8.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.6 111.49 5.45 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.832 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.1 -32.04 66.4 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.71 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.8 -15.47 63.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.967 0.413 . . . . 0.0 111.754 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -102.16 -1.8 30.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.023 0.44 . . . . 0.0 110.464 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 60.8 mt -106.92 129.49 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.067 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.03 124.43 48.1 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.651 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.1 p -107.68 124.9 50.67 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.887 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 69.6 t -134.02 123.45 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.057 0.456 . . . . 0.0 111.738 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -94.77 113.23 4.53 Favored Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 22.1 mt -93.06 1.43 57.25 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.775 0.321 . . . . 0.0 111.389 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.98 -131.2 33.53 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.631 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 266' ' ' SER . 45.4 t -91.02 117.6 29.72 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.7 p -178.81 151.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.716 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.35 69.43 1.64 Allowed Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 123.678 0.791 . . . . 0.0 110.831 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.585 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 74.1 Cg_endo -78.47 137.57 14.86 Favored 'Trans proline' 0 N--CA 1.44 -1.661 0 C-N-CA 122.403 2.069 . . . . 0.0 113.381 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.77 -38.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.498 176.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -131.18 169.35 16.04 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.961 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 45.0 m -77.22 146.06 37.2 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.638 0.256 . . . . 0.0 110.477 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -73.27 -7.24 50.67 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.758 0.313 . . . . 0.0 111.365 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -59.91 -24.72 64.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.453 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.6 t -115.73 137.75 23.45 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.543 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.99 -32.44 44.46 Favored 'Trans proline' 0 CA--C 1.518 -0.281 0 C-N-CA 122.452 2.101 . . . . 0.0 111.151 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -60.7 -40.84 93.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.758 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -65.0 -36.74 93.42 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.008 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -69.92 -25.82 63.86 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 319' ' ' ARG . . . -74.49 -26.47 60.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.062 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -37.06 29.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.585 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 57.0 m-20 -69.69 -3.56 15.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 17.5 ptm180 -98.21 9.12 43.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 120.75 0.31 . . . . 0.0 111.482 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.602 ' NE ' ' HB2' ' A' ' 222' ' ' PRO . 8.8 ptm180 -75.84 -175.95 3.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 75.7 t -135.7 153.05 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.608 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -132.64 139.23 47.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 111.193 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.412 ' H ' HD12 ' A' ' 323' ' ' ILE . 2.7 mp -95.94 115.05 34.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.86 137.01 39.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 211' ' ' LEU . 42.0 t -104.32 142.24 18.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 C--N 1.318 -0.763 0 O-C-N 123.542 0.526 . . . . 0.0 110.514 177.367 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -75.48 119.72 19.94 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 67.34 103.01 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.425 0 O-C-N 123.758 0.661 . . . . 0.0 110.974 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.6 141.03 96.5 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.758 2.305 . . . . 0.0 111.821 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -40.43 -52.86 2.88 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 123.673 2.915 . . . . 0.0 112.952 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -102.74 120.77 6.92 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.792 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.53 -46.32 28.14 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.133 2.555 . . . . 0.0 114.864 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.71 139.54 48.41 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.272 1.981 . . . . 0.0 112.594 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.5 -22.87 60.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.011 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 26.2 t 72.15 -43.45 0.56 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.629 0.772 . . . . 0.0 111.846 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -95.84 -144.66 17.34 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.082 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.73 156.68 53.01 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.897 2.398 . . . . 0.0 111.786 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 10.6 t -112.17 -178.03 3.31 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.36 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.43 152.0 35.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.427 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.15 90.15 3.09 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.033 0.444 . . . . 0.0 110.017 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 250' ' ' CYS . 41.9 mt -75.32 -28.6 59.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.002 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.01 -43.7 98.29 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 120.917 0.389 . . . . 0.0 110.305 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 33.0 t -71.15 -41.25 70.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.47 ' HB1' ' HE3' ' A' ' 246' ' ' LYS . . . -58.06 -47.78 82.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.611 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 211' ' ' LEU . 24.5 pt -72.53 -37.84 58.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.94 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -58.24 -36.21 72.86 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.751 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.39 -26.64 68.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.288 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.1 t -92.9 -43.68 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.465 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.606 ' HA ' HG21 ' A' ' 239' ' ' ILE . 70.2 p -67.43 -40.81 85.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.081 0.467 . . . . 0.0 110.899 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.26 24.57 59.02 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.62 -134.39 8.25 Favored Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.428 ' HB3' HH11 ' A' ' 320' ' ' ARG . 91.9 Cg_endo -85.38 166.18 10.75 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.797 2.332 . . . . 0.0 113.037 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.477 HG22 ' CD1' ' A' ' 225' ' ' PHE . 48.5 mm -85.2 110.97 20.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.211 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -101.31 125.06 47.91 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.573 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.477 ' CD1' HG22 ' A' ' 223' ' ' ILE . 3.3 p90 -166.94 140.73 3.78 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 120.899 0.38 . . . . 0.0 111.069 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -88.53 77.32 1.82 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.146 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -78.39 88.02 4.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.254 0.549 . . . . 0.0 109.928 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -177.95 88.72 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.258 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 76.29 12.01 84.53 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.615 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -149.62 -73.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.425 0.155 . . . . 0.0 110.818 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 48.7 m 68.24 -160.87 0.2 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.8 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.3 mp -77.63 80.34 4.1 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.158 0.504 . . . . 0.0 112.138 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.486 ' HB ' ' HD3' ' A' ' 234' ' ' PRO . 44.6 mm -90.95 -48.42 0.35 Allowed Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.062 175.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.486 ' HD3' ' HB ' ' A' ' 233' ' ' ILE . 25.4 Cg_exo -65.49 155.1 70.63 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 121.969 1.779 . . . . 0.0 111.475 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -91.13 9.6 30.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 234' ' ' PRO . 4.3 p-10 -78.0 -6.81 55.69 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.295 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -81.3 35.84 0.4 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.414 0.626 . . . . 0.0 111.564 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.75 -17.26 55.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.172 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.606 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.5 mt -58.97 -39.02 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.442 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.538 HD22 HG13 ' A' ' 281' ' ' VAL . 41.5 mt -66.45 -32.1 73.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.103 0.478 . . . . 0.0 110.782 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 288' ' ' ARG . 60.9 m-20 -71.41 -36.62 71.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.491 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -70.59 -42.62 70.77 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.753 178.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.616 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 46.0 t -57.59 -42.36 81.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.6 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.55 80.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.284 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 24.6 t70 -49.8 -53.18 26.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.266 0.627 . . . . 0.0 112.623 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.623 ' NZ ' ' HB3' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -74.0 -31.57 63.01 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.561 -178.173 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 33.8 mt -64.09 -36.81 85.22 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.377 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.483 ' HG3' HG22 ' A' ' 290' ' ' VAL . 58.2 mtpt -73.06 -22.6 60.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.263 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.64 80.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 110.006 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.49 ' HB3' HD11 ' A' ' 211' ' ' LEU . 49.0 t -126.79 70.8 73.58 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 73.5 Cg_endo -71.6 -1.33 9.63 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 123.266 2.644 . . . . 0.0 114.145 -174.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -79.71 -24.8 41.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.642 0.734 . . . . 0.0 109.289 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -70.42 135.0 48.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.522 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.15 140.41 29.83 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.43 HG12 HG22 ' A' ' 325' ' ' VAL . 6.0 m -116.05 132.22 66.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.241 0.543 . . . . 0.0 111.436 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 39.8 m -109.02 108.72 19.55 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.17 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.43 HG12 HG23 ' A' ' 323' ' ' ILE . 23.3 mt -92.32 114.4 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.486 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -101.74 127.48 48.5 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.453 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.421 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -107.64 147.3 16.36 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.323 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 37.8 m-85 -123.66 162.01 23.92 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.119 0.485 . . . . 0.0 110.612 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.557 ' OG1' ' HB3' ' A' ' 270' ' ' ASN . 34.6 p -147.34 170.48 17.24 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 124.229 1.011 . . . . 0.0 108.95 175.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.429 ' HB2' HD22 ' A' ' 309' ' ' ASN . 5.6 p-10 -81.66 153.18 26.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.924 0.392 . . . . 0.0 110.535 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -94.12 -1.11 54.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -13.37 59.45 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.52 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -85.95 -172.51 48.81 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.682 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.8 m -78.9 124.59 28.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.661 0.23 . . . . 0.0 110.573 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.581 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 41.2 mt-10 -59.91 152.74 22.71 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.103 0.477 . . . . 0.0 111.409 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 103.04 -44.85 1.41 Allowed Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.048 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp -79.31 -25.39 12.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 121.274 0.559 . . . . 0.0 110.076 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.581 ' OD1' ' HA ' ' A' ' 267' ' ' GLU . 0.4 OUTLIER -58.44 -42.88 88.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.668 -178.22 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.446 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 25.7 mm -58.11 -64.35 2.87 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.583 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.446 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.8 Cg_endo -58.92 -29.05 89.29 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.025 1.817 . . . . 0.0 112.272 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 58.4 tp -70.3 -52.93 19.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.335 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.544 ' HB3' HG23 ' A' ' 261' ' ' THR . 14.7 p -63.5 -30.51 71.62 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.906 0.384 . . . . 0.0 110.512 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.6 73.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.785 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.619 ' O ' HG13 ' A' ' 280' ' ' ILE . 29.1 tt0 -67.0 -48.14 69.36 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.497 ' HB3' ' CG2' ' A' ' 321' ' ' VAL . 17.3 mmt180 -54.25 -49.02 70.49 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.382 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.2 90.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.176 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.636 ' HA ' HG21 ' A' ' 297' ' ' THR . 41.9 tptt -64.35 -30.57 71.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.227 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.619 HG13 ' O ' ' A' ' 276' ' ' GLN . 62.7 mt -59.85 -42.97 90.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.22 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.71 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.2 t -68.2 -45.81 82.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.836 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.7 -44.74 73.69 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.803 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.58 -38.82 82.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.914 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.49 -43.02 77.77 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.794 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 40.2 mt -62.78 -49.11 76.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.55 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 83.1 t -59.9 -40.83 83.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.511 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.74 -28.13 69.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.683 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 241' ' ' ASN . 15.3 mmm180 -85.33 0.02 53.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.917 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.29 6.75 35.97 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.874 -1.155 . . . . 0.0 114.611 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.483 HG22 ' HG3' ' A' ' 248' ' ' LYS . 60.2 t -83.55 144.57 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 117.723 0.761 . . . . 0.0 109.793 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.09 109.95 6.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.305 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.48 -29.9 74.83 Favored Glycine 0 CA--C 1.509 -0.316 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.363 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -61.94 -19.29 62.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.204 0.526 . . . . 0.0 110.948 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -107.96 5.5 26.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.484 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.8 mt -106.26 129.1 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.76 124.64 48.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.71 0.291 . . . . 0.0 110.594 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.636 HG21 ' HA ' ' A' ' 279' ' ' LYS . 14.9 p -109.16 121.99 46.33 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.207 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 73.3 t -130.25 120.44 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.389 0.614 . . . . 0.0 112.045 -176.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -90.11 110.97 3.83 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.4 ' HB3' HG21 ' A' ' 303' ' ' VAL . 27.2 mt -90.41 -0.15 57.53 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 68.56 -125.38 20.2 Favored Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.54 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 5.1 t -105.81 121.92 45.03 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.5 ' O ' ' HD3' ' A' ' 305' ' ' PRO . 75.5 t -136.95 -69.41 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.897 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.448 ' ND2' HG12 ' A' ' 303' ' ' VAL . 58.4 m-80 -112.38 91.68 17.21 Favored Pre-proline 0 C--O 1.242 0.702 0 CA-C-O 120.687 0.28 . . . . 0.0 110.747 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 303' ' ' VAL . 19.3 Cg_exo -65.63 135.32 41.52 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.611 2.207 . . . . 0.0 111.24 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 2.0 tt -84.65 -45.76 17.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.749 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -124.2 173.61 8.22 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.317 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 11.9 m -62.62 136.34 57.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.679 0.612 . . . . 0.0 111.253 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.429 HD22 ' HB2' ' A' ' 262' ' ' ASP . 20.6 m120 -80.64 -11.73 59.6 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.156 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.71 -19.7 65.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.07 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 314' ' ' GLY . 3.2 t -113.34 139.47 23.23 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.329 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.0 -35.41 87.79 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.619 2.212 . . . . 0.0 111.535 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.572 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 71.5 mm-40 -60.34 -46.48 89.74 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.497 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.458 ' H ' HG23 ' A' ' 311' ' ' THR . . . -63.78 -37.77 95.18 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.717 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 311' ' ' THR . 76.1 mtp180 -61.85 -40.43 95.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.23 0.538 . . . . 0.0 109.948 177.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.7 -28.69 70.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.653 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.572 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 11.0 mmtp -79.49 -39.29 32.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.036 177.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -55.51 -28.26 53.59 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 32.0 ptt180 -83.58 12.07 6.27 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.428 HH11 ' HB3' ' A' ' 222' ' ' PRO . 28.6 ptt85 -57.53 173.66 0.26 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.901 0.88 . . . . 0.0 112.966 174.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.497 ' CG2' ' HB3' ' A' ' 277' ' ' ARG . 66.3 t -133.73 148.02 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.015 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -130.31 139.02 50.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.981 0.42 . . . . 0.0 111.071 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.43 HG23 HG12 ' A' ' 257' ' ' ILE . 2.2 mp -101.09 117.02 45.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.891 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.3 138.12 38.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.43 HG22 HG12 ' A' ' 255' ' ' VAL . 59.3 t -101.08 137.79 27.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.385 179.325 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.975 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -113.68 4.21 15.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.405 ' HA ' ' HD2' ' A' ' 199' ' ' PRO . . . 69.03 88.91 0.1 OUTLIER Pre-proline 0 C--O 1.239 0.538 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.793 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 19.3 Cg_endo -60.2 142.22 97.77 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.65 2.233 . . . . 0.0 111.954 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 199' ' ' PRO . 36.3 Cg_exo -62.23 -19.73 67.76 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.766 2.31 . . . . 0.0 112.085 178.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -102.33 -136.06 9.04 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.859 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 71.7 Cg_endo -77.13 152.72 31.48 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.569 2.179 . . . . 0.0 111.9 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 9.7 Cg_exo -71.66 82.49 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.54 2.16 . . . . 0.0 111.78 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -114.13 4.74 15.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.754 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 34.0 t -102.63 5.82 39.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.359 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -145.33 -148.5 4.83 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.592 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.29 155.54 60.36 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 123.034 2.49 . . . . 0.0 112.192 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.418 ' SG ' ' N ' ' A' ' 209' ' ' ALA . 22.8 t -104.76 -175.14 2.71 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.636 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.418 ' N ' ' SG ' ' A' ' 208' ' ' CYS . . . -59.68 178.24 0.17 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.409 0.684 . . . . 0.0 111.632 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.09 78.12 6.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.092 0.472 . . . . 0.0 110.186 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.458 ' HB2' HG21 ' A' ' 325' ' ' VAL . 3.2 mm? -69.78 -29.1 66.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.67 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -63.82 -46.49 84.88 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.796 0.332 . . . . 0.0 110.536 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 23.1 t -72.05 -32.13 66.8 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.37 -47.32 76.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.182 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.472 ' CG2' HG13 ' A' ' 243' ' ' VAL . 22.0 pt -75.4 -39.48 41.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.848 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.448 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 17.9 t-20 -60.8 -33.4 72.94 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.974 0.416 . . . . 0.0 110.621 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.22 -28.03 69.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.081 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.484 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.4 t -90.61 -44.51 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.22 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.524 ' HA ' HG21 ' A' ' 239' ' ' ILE . 58.4 p -63.72 -36.07 82.64 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.967 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.0 25.19 41.73 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 124.52 -132.73 8.34 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.467 ' HG3' HH11 ' A' ' 320' ' ' ARG . 96.6 Cg_endo -85.29 166.86 10.75 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.421 2.08 . . . . 0.0 112.183 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 51.5 mm -80.96 101.9 6.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.388 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -86.83 133.27 33.65 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.398 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -106.1 169.07 8.72 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.546 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -93.89 -109.14 2.05 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.059 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -75.35 -31.75 60.66 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 11.2 t70 73.07 131.08 0.04 OUTLIER 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.93 0.769 . . . . 0.0 111.258 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 136.18 -17.3 3.83 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.496 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -115.87 -90.98 0.54 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.4 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 65.2 p -169.99 -155.29 0.12 Allowed 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.1 mp -81.67 76.26 8.59 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.519 0.676 . . . . 0.0 110.297 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 62.6 mt -65.61 -42.15 53.85 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.566 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -49.07 159.12 1.1 Allowed 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.501 2.134 . . . . 0.0 112.729 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -72.15 -37.83 69.3 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.089 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -84.7 114.16 21.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.276 0.56 . . . . 0.0 112.165 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -134.3 7.3 3.62 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.783 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.27 -19.48 65.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.12 -173.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.524 HG21 ' HA ' ' A' ' 219' ' ' THR . 74.1 mt -61.73 -38.14 79.7 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.411 ' CD1' HG13 ' A' ' 281' ' ' VAL . 4.2 mm? -61.05 -36.89 80.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.077 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -78.77 -34.85 45.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.105 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.484 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -66.43 -43.74 84.83 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.574 177.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.543 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 34.0 t -58.51 -42.68 85.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.722 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.8 81.54 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.477 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -53.74 -50.53 65.76 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.449 ' H ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -72.6 -29.45 63.52 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.214 -178.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.1 mt -72.21 -28.57 63.26 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 109.627 176.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.421 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 15.6 tptm -64.65 -31.96 73.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.84 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.72 -37.72 73.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.235 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 53.5 t -125.76 72.59 68.88 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 74.1 Cg_endo -72.59 0.46 7.53 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.774 2.316 . . . . 0.0 112.734 -178.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.03 -31.43 56.27 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.84 145.15 56.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.563 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.552 ' HB2' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -101.37 145.62 28.68 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.44 HG12 HG22 ' A' ' 325' ' ' VAL . 3.1 m -119.11 127.28 75.84 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.904 176.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.4 m -103.89 109.34 21.05 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.521 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.443 HG12 HG23 ' A' ' 323' ' ' ILE . 19.4 mt -96.79 114.23 33.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-O 121.024 0.44 . . . . 0.0 109.916 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -102.59 126.01 49.52 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.345 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.457 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -104.41 144.94 15.92 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.506 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -127.35 161.88 27.6 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 38.3 p -141.31 170.8 15.05 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.799 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.86 155.09 39.12 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.017 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -88.33 -2.65 58.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.978 0.418 . . . . 0.0 110.585 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.8 m -66.36 -20.75 66.16 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 121.306 0.574 . . . . 0.0 110.339 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -117.98 82.39 0.33 Allowed Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 2.0 m -92.69 34.46 1.07 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.854 0.359 . . . . 0.0 111.265 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -80.08 -23.42 41.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.033 0.444 . . . . 0.0 111.171 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 114.37 -25.37 10.54 Favored Glycine 0 CA--C 1.497 -1.085 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.57 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.87 -22.25 28.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 121.797 0.808 . . . . 0.0 109.759 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.563 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 22.2 p30 -55.56 -33.25 63.69 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.374 177.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.449 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 20.1 mm -62.72 -65.0 2.4 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.174 177.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.449 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 11.2 Cg_endo -59.99 -27.45 84.93 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 121.887 1.725 . . . . 0.0 112.18 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.8 tp -67.36 -53.83 25.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.774 0.321 . . . . 0.0 111.532 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.542 ' HB3' HG23 ' A' ' 261' ' ' THR . 6.5 p -62.47 -30.37 71.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.757 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.64 -31.56 66.99 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.16 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.407 ' O ' HG13 ' A' ' 280' ' ' ILE . 27.9 tt0 -69.1 -51.48 38.17 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.787 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 277' ' ' ARG . 54.3 mmt-85 -58.78 -39.26 80.53 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.954 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.14 -38.69 91.96 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.21 0.528 . . . . 0.0 109.872 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.615 ' HA ' HG21 ' A' ' 297' ' ' THR . 23.5 tptm -63.03 -34.87 78.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.968 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 276' ' ' GLN . 54.9 mt -56.73 -44.32 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.566 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.734 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.3 t -66.25 -46.11 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.623 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -54.47 -45.94 73.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.051 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.69 -36.44 82.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.904 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.554 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 4.7 m-85 -68.83 -41.41 78.61 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.645 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 31.8 mt -66.14 -48.1 71.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.844 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 89.2 t -59.33 -43.05 89.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.511 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.0 -28.31 68.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.267 0.556 . . . . 0.0 110.438 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.554 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 1.4 mpt_? -85.98 3.04 43.92 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.046 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 108.5 5.08 32.21 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.74 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 49.6 t -88.26 140.29 16.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 117.782 0.791 . . . . 0.0 110.225 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.93 117.25 8.03 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.561 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.69 86.56 Favored Glycine 0 CA--C 1.51 -0.265 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.15 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -15.26 63.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.964 0.412 . . . . 0.0 111.444 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -98.52 0.31 44.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.0 110.65 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.3 mt -109.27 129.37 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.498 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.32 129.58 54.94 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.937 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.615 HG21 ' HA ' ' A' ' 279' ' ' LYS . 25.0 p -115.58 128.09 55.71 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.524 0.202 . . . . 0.0 111.172 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 26.9 t -133.54 128.09 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -99.81 108.64 3.57 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 18.5 mt -92.36 3.2 55.92 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 68.53 -127.74 23.56 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.559 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 15.1 m -93.6 115.61 28.1 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.834 0.35 . . . . 0.0 110.525 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 9.5 p -176.12 150.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 60.7 t30 70.29 74.52 0.26 Allowed Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 123.871 0.732 . . . . 0.0 111.078 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.588 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 73.5 Cg_endo -75.07 155.33 42.58 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.647 2.231 . . . . 0.0 112.792 -177.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.0 tt -124.59 -44.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.445 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.444 ' HB3' ' HA2' ' A' ' 314' ' ' GLY . . . -138.44 174.98 9.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.473 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 50.8 m -71.16 131.16 43.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.279 0.562 . . . . 0.0 111.702 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -80.81 -7.66 59.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.417 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.14 -16.88 63.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.808 178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.465 HG23 ' H ' ' A' ' 314' ' ' GLY . 5.2 t -123.23 144.39 43.49 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -54.49 -36.52 88.52 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.067 2.511 . . . . 0.0 112.118 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.1 mm-40 -55.49 -51.15 67.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.983 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -69.33 -40.85 80.2 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.693 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -56.35 -41.05 75.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.025 0.44 . . . . 0.0 110.339 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.96 70.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.737 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 0.3 OUTLIER -80.63 -42.97 21.24 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.597 -179.402 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.588 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 39.2 m-80 -63.85 -23.83 67.51 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -176.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.597 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 10.4 ptm180 -84.98 12.87 6.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.29 0.567 . . . . 0.0 111.929 -178.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.467 HH11 ' HG3' ' A' ' 222' ' ' PRO . 19.0 ptt180 -58.61 177.74 0.13 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.303 1.049 . . . . 0.0 113.437 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 68.8 t -136.32 144.7 32.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.766 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -131.1 137.3 49.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.115 0.483 . . . . 0.0 111.376 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.443 HG23 HG12 ' A' ' 257' ' ' ILE . 2.1 mp -98.7 120.34 47.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.629 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.68 135.06 50.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 211' ' ' LEU . 89.4 t -95.43 141.89 14.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.185 0.517 . . . . 0.0 111.694 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 254' ' ' ARG . 41.1 t-20 . . . . . 0 C--N 1.311 -1.091 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.765 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.356 0 N-CA-C 112.218 -0.353 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -116.84 -27.57 6.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.591 0.234 . . . . 0.0 110.835 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 61.9 76.3 0.4 Allowed Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.428 -176.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.54 139.56 14.43 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.918 2.412 . . . . 0.0 111.913 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.14 129.41 24.23 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.69 2.26 . . . . 0.0 111.905 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.16 159.41 47.1 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.922 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.5 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 36.5 Cg_exo -58.86 139.08 89.27 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.97 2.447 . . . . 0.0 112.425 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 5.1 Cg_exo -74.62 61.0 5.26 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.837 2.358 . . . . 0.0 111.607 178.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -80.95 -39.16 26.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.98 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 39.4 m 54.08 -143.89 0.7 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.967 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.22 -161.76 25.56 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.909 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.16 106.95 0.32 Allowed 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.712 2.275 . . . . 0.0 111.634 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 53.9 t -104.43 146.5 28.77 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.121 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -59.28 154.26 16.84 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.19 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.04 69.43 3.32 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.058 0.456 . . . . 0.0 110.039 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 214' ' ' ALA . 35.4 mt -55.53 -27.24 47.67 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.342 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.417 HE22 HG13 ' A' ' 324' ' ' VAL . 2.4 tp-100 -55.95 -60.38 3.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.274 0.559 . . . . 0.0 109.968 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 39.9 t -69.44 -27.1 64.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.178 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.609 ' HB1' ' HE2' ' A' ' 246' ' ' LYS . . . -69.46 -49.32 55.96 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.273 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 211' ' ' LEU . 29.3 pt -74.08 -40.51 51.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 121.054 -0.259 . . . . 0.0 111.304 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -60.9 -29.6 69.68 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.089 0.471 . . . . 0.0 110.584 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.47 -27.76 68.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.178 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.9 t -89.55 -45.01 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.229 -178.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.53 ' HA ' HG21 ' A' ' 239' ' ' ILE . 75.8 p -67.0 -38.33 85.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.443 0.64 . . . . 0.0 109.861 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.74 21.75 61.1 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.89 -122.64 4.19 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -89.17 159.88 5.73 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.74 2.293 . . . . 0.0 113.979 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.5 mm -78.32 107.99 11.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.406 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.43 118.58 29.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.026 0.441 . . . . 0.0 110.005 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -86.46 152.11 22.95 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.502 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -107.97 63.2 0.28 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.05 132.26 43.02 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -138.98 7.2 2.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.369 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 169.34 -75.55 0.11 Allowed Glycine 0 CA--C 1.503 -0.677 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.896 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -152.56 20.55 0.62 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.6 p -83.72 -59.12 2.53 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.899 -176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 45.2 tp 58.23 73.85 0.45 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.668 0.746 . . . . 0.0 110.388 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 9.9 pt -123.67 88.45 51.95 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.573 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.46 167.37 24.24 Favored 'Trans proline' 0 C--O 1.239 0.54 0 C-N-CA 122.521 2.147 . . . . 0.0 111.803 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.7 94.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.278 0.561 . . . . 0.0 110.028 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -147.17 114.27 6.2 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.46 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -92.97 -2.1 56.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.293 0.568 . . . . 0.0 110.199 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -74.09 -19.15 60.69 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.819 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.53 HG21 ' HA ' ' A' ' 219' ' ' THR . 90.4 mt -61.63 -37.61 78.34 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 46.6 mt -66.27 -35.07 79.45 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.451 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -69.88 -37.12 75.94 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.461 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -67.69 -46.77 71.34 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.762 178.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.639 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.8 t -61.79 -46.06 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.77 178.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -65.08 -31.51 72.76 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.441 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.04 -44.06 97.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.42 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.609 ' HE2' ' HB1' ' A' ' 214' ' ' ALA . 0.6 OUTLIER -75.48 -27.21 58.75 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.596 -179.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 43.9 mt -65.39 -28.41 69.24 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 121.205 0.526 . . . . 0.0 109.622 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.539 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 7.0 mtpm? -78.55 -22.36 47.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.318 177.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.94 -30.55 66.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.36 0.6 . . . . 0.0 110.068 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.473 ' HB3' HD11 ' A' ' 211' ' ' LEU . 13.3 t -132.74 69.85 79.27 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 57.5 Cg_endo -67.97 -2.01 7.99 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.442 2.762 . . . . 0.0 114.231 -173.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.46 -18.39 28.35 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.443 0.64 . . . . 0.0 109.939 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -71.88 131.01 42.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.005 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -91.58 138.52 31.5 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 3.4 m -114.89 130.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-O 121.204 0.526 . . . . 0.0 111.603 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.1 m -107.87 107.48 18.23 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.193 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.419 HG12 HG23 ' A' ' 323' ' ' ILE . 21.6 mt -90.15 117.32 33.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.768 -177.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -105.8 126.92 52.73 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.787 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -107.22 145.78 16.06 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 6.9 m-85 -124.29 158.57 32.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.944 0.402 . . . . 0.0 109.996 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' A' ' 270' ' ' ASN . 16.6 p -144.54 170.1 16.69 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.611 0.764 . . . . 0.0 109.935 177.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.457 ' OD2' ' HD3' ' A' ' 315' ' ' ARG . 19.2 t70 -94.96 166.74 11.8 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.66 9.81 17.56 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.747 0.308 . . . . 0.0 110.723 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.434 ' HB ' ' OD2' ' A' ' 262' ' ' ASP . 12.2 t -64.28 -32.51 74.13 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.751 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -85.52 175.47 49.27 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.99 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 14.5 m -65.73 139.53 58.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.783 0.325 . . . . 0.0 110.702 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.03 140.19 58.82 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . 0.481 ' O ' ' HD2' ' A' ' 272' ' ' PRO . . . 96.48 -41.5 2.38 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.167 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp -74.98 -26.68 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.331 0.586 . . . . 0.0 109.926 -178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.576 ' HB2' ' OG1' ' A' ' 261' ' ' THR . 3.7 p30 -65.4 -27.58 68.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.544 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.472 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 27.4 mm -62.65 -63.88 3.68 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-O 119.664 -0.208 . . . . 0.0 110.989 178.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 268' ' ' GLY . 1.6 Cg_endo -53.97 -37.16 85.87 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.428 2.085 . . . . 0.0 111.313 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.469 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 25.2 tp -62.22 -52.55 63.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.428 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 22.3 m -61.48 -30.97 70.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.783 0.325 . . . . 0.0 110.401 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.8 -28.91 64.99 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.885 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.469 ' O ' HG13 ' A' ' 280' ' ' ILE . 9.3 tt0 -71.51 -45.54 62.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 22.1 mmm180 -56.59 -46.84 80.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.524 178.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.85 88.91 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.462 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.655 ' HA ' HG21 ' A' ' 297' ' ' THR . 16.8 ttpt -62.97 -32.06 73.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.912 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 276' ' ' GLN . 64.4 mt -56.22 -43.63 77.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.203 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.718 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 7.8 t -69.62 -44.24 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.126 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.17 73.77 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 123.291 0.369 . . . . 0.0 110.663 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.8 -40.42 84.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.863 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -69.8 -40.35 76.03 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.265 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 46.6 mt -64.77 -47.61 77.53 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 92.3 t -60.92 -39.22 81.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.284 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.91 -28.42 69.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.834 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.604 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 2.4 mmp_? -86.86 4.57 40.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.301 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.9 5.43 44.37 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.043 -1.075 . . . . 0.0 114.649 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 58.0 t -84.18 145.24 8.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 117.801 0.801 . . . . 0.0 109.904 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 295' ' ' ILE . . . -69.3 112.79 6.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.42 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -62.58 -33.88 87.86 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.067 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -69.76 -12.6 61.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.589 0.233 . . . . 0.0 111.318 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -104.52 1.71 30.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.847 0.356 . . . . 0.0 110.615 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 291' ' ' ALA . 70.4 mt -105.12 131.45 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.922 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.58 125.7 49.43 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.068 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.655 HG21 ' HA ' ' A' ' 279' ' ' LYS . 11.6 p -107.51 129.51 54.95 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.888 0.375 . . . . 0.0 111.406 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.48 136.98 52.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.803 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.49 114.49 4.12 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.408 HD12 ' CE1' ' A' ' 260' ' ' TYR . 17.5 mt -91.48 -5.33 54.41 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 71.3 -135.59 24.1 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.073 -1.061 . . . . 0.0 111.397 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 261' ' ' THR . 7.5 t -87.99 114.56 24.72 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.151 0.5 . . . . 0.0 110.029 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.9 p -176.65 150.31 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 44.7 t30 65.9 78.87 0.25 Allowed Pre-proline 0 C--N 1.311 -1.076 0 O-C-N 123.75 0.656 . . . . 0.0 111.1 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.628 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 39.7 Cg_endo -68.69 138.24 40.87 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.818 2.345 . . . . 0.0 113.154 -177.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 7.4 tt -110.79 -25.43 3.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.768 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -152.45 163.62 39.16 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 47.8 t -62.84 134.23 55.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.042 0.449 . . . . 0.0 110.988 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -80.61 -11.61 59.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.63 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.2 36.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.169 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 3.1 t -124.74 138.03 30.56 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.916 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.99 -26.63 82.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.894 2.396 . . . . 0.0 111.78 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 8.4 mm-40 -65.33 -41.87 93.52 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.3 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -66.41 -38.38 93.51 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.49 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.457 ' HD3' ' OD2' ' A' ' 262' ' ' ASP . 51.9 mtt-85 -63.6 -37.87 88.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.37 68.89 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.827 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 9.0 mmtp -84.65 -38.45 19.81 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.822 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.628 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 38.5 m-80 -63.74 -21.16 66.27 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 13.0 ptm180 -82.11 14.55 2.79 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.156 0.503 . . . . 0.0 111.232 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -65.42 -174.38 0.18 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.106 0.963 . . . . 0.0 113.13 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.5 t -141.81 148.28 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.722 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -133.84 135.9 44.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.747 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.439 ' H ' HD12 ' A' ' 323' ' ' ILE . 2.6 mp -94.23 119.34 42.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.37 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.417 HG13 HE22 ' A' ' 212' ' ' GLN . 91.6 t -106.62 136.67 40.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 211' ' ' LEU . 55.0 t -101.49 139.61 22.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.341 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.353 177.469 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.417 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -135.71 151.52 50.25 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -157.96 71.25 4.12 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.403 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.437 ' HB2' ' HD3' ' A' ' 200' ' ' PRO . 52.7 Cg_exo -53.59 -47.51 26.9 Favored 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 122.348 2.032 . . . . 0.0 112.209 175.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 199' ' ' PRO . 88.8 Cg_endo -84.07 47.24 2.19 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 121.967 1.778 . . . . 0.0 110.715 175.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.39 94.07 0.37 Allowed Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.632 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.93 140.34 78.9 Favored 'Trans proline' 0 C--O 1.238 0.481 0 C-N-CA 122.62 2.214 . . . . 0.0 112.373 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -52.56 121.42 9.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.613 2.209 . . . . 0.0 111.538 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -82.41 -22.59 35.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.694 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 34.6 t -99.42 129.69 45.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.253 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -82.04 -92.67 0.56 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.67 98.19 1.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.293 1.995 . . . . 0.0 111.493 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 22.3 t -104.06 176.37 5.18 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -51.76 145.04 10.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.728 0.299 . . . . 0.0 111.272 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.73 85.86 1.22 Allowed 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.523 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 250' ' ' CYS . 23.7 mt -70.35 -33.64 71.69 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.939 -177.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -63.76 -45.74 88.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.24 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 31.5 t -75.63 -23.34 56.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.057 0.456 . . . . 0.0 109.917 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.517 ' HB1' ' HE3' ' A' ' 246' ' ' LYS . . . -72.49 -49.91 29.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.206 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 211' ' ' LEU . 26.7 pt -70.63 -38.27 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.868 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -55.7 -37.21 68.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.951 0.405 . . . . 0.0 110.975 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.5 -26.87 68.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.492 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.8 t -92.26 -47.96 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 120.921 0.391 . . . . 0.0 110.63 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.513 ' HA ' HG21 ' A' ' 239' ' ' ILE . 81.6 p -64.35 -39.17 93.36 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.615 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.8 22.51 59.63 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.4 -130.55 6.84 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.19 156.31 25.98 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.573 2.182 . . . . 0.0 112.044 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -74.1 109.29 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -104.33 119.54 39.2 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.494 ' CE2' ' HG ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -123.33 -174.66 3.01 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 232' ' ' LEU . . . -64.74 97.95 0.27 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -170.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.46 ' ND2' HD13 ' A' ' 232' ' ' LEU . 21.5 m120 -85.35 -13.01 50.85 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -64.15 -24.44 67.69 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.783 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -81.7 4.2 75.33 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.946 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 72.37 -58.49 0.59 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.142 0.977 . . . . 0.0 112.085 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.3 m -76.32 4.15 9.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.466 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.494 ' HG ' ' CE2' ' A' ' 225' ' ' PHE . 58.4 tp 61.82 87.34 0.1 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.524 0.678 . . . . 0.0 111.2 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 21.4 pt -138.39 134.32 17.49 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.176 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -85.52 126.61 3.1 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 122.13 1.887 . . . . 0.0 111.32 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -88.11 -53.68 4.6 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.576 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -155.58 102.92 2.26 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.582 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -121.9 111.51 17.17 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.304 0.573 . . . . 0.0 111.196 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -68.05 -20.91 65.02 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.101 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.513 HG21 ' HA ' ' A' ' 219' ' ' THR . 77.8 mt -64.41 -39.8 86.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.33 -33.4 75.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.894 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.455 ' OD1' ' HD3' ' A' ' 288' ' ' ARG . 44.8 t30 -71.73 -36.03 70.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.583 0.706 . . . . 0.0 109.177 177.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.606 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 0.0 OUTLIER -68.52 -42.28 78.73 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.719 177.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.622 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 44.6 t -62.5 -43.9 98.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.334 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -55.82 -37.24 68.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.713 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.606 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 7.7 t70 -49.06 -53.31 20.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.56 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.559 ' NZ ' ' HB3' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -82.51 -14.53 54.83 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.821 -176.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 32.4 mt -80.47 -26.09 38.47 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.339 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.502 ' HG3' HG22 ' A' ' 290' ' ' VAL . 59.6 mtpt -83.54 -23.15 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.628 176.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.84 -37.32 76.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.203 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.562 ' HB3' HD11 ' A' ' 211' ' ' LEU . 24.6 t -130.09 71.97 82.06 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-O 121.339 0.59 . . . . 0.0 109.505 177.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 91.4 Cg_endo -75.35 -1.4 11.25 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.164 2.576 . . . . 0.0 113.244 -178.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -79.15 -29.69 43.19 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.872 0.844 . . . . 0.0 108.872 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -81.46 134.68 35.57 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.733 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -90.79 147.02 23.48 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.953 0.406 . . . . 0.0 110.508 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.13 137.75 52.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.587 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.0 m -114.13 113.1 24.24 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.551 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.457 HG12 HG23 ' A' ' 323' ' ' ILE . 21.4 mt -94.15 113.85 29.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.578 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -98.47 126.66 44.1 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.37 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.411 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -107.48 146.82 16.25 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 36.3 m-85 -127.4 161.89 27.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.1 0.476 . . . . 0.0 110.688 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.604 HG23 ' HB3' ' A' ' 274' ' ' SER . 56.9 p -140.58 173.28 11.65 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.529 175.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -83.62 153.63 24.18 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.509 ' HB3' ' OG ' ' A' ' 302' ' ' SER . 12.3 p30 -95.11 12.85 27.23 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 35.7 p -62.82 -7.74 5.62 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.88 131.6 6.52 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.2 t -43.5 135.2 3.74 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.119 0.568 . . . . 0.0 112.309 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.503 ' OE2' ' HB2' ' A' ' 270' ' ' ASN . 7.1 tp10 -57.84 151.08 18.64 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.097 -177.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 140.07 -60.76 0.56 Allowed Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp -83.15 -27.44 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.465 0.65 . . . . 0.0 109.857 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.528 ' HB3' ' OG1' ' A' ' 261' ' ' THR . 12.3 m-20 -62.87 -36.54 83.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.427 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.487 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 27.3 mm -56.58 -64.22 2.67 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.019 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.487 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 5.1 Cg_endo -56.79 -35.65 98.14 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 121.944 1.763 . . . . 0.0 111.914 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.494 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 60.2 tp -63.07 -52.92 60.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.686 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.604 ' HB3' HG23 ' A' ' 261' ' ' THR . 13.0 p -62.98 -31.52 72.66 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.99 0.424 . . . . 0.0 110.468 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.45 -34.04 77.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.742 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.634 ' O ' HG13 ' A' ' 280' ' ' ILE . 9.8 tt0 -66.92 -44.96 79.38 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 273' ' ' LEU . 38.8 mmt180 -56.86 -47.38 80.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.008 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.37 -38.75 88.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.018 0.437 . . . . 0.0 110.373 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.526 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.9 tptt -65.97 -32.36 73.8 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.092 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 276' ' ' GLN . 62.5 mt -58.55 -45.76 90.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.197 0.522 . . . . 0.0 109.684 177.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.699 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.2 t -65.8 -48.08 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.792 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.52 -41.98 70.32 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.076 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.64 -42.63 88.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.472 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -66.84 -43.06 84.69 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.491 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 41.7 mt -64.03 -51.05 66.02 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.887 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.9 t -59.41 -40.55 81.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.91 71.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.555 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 1.2 mmp_? -83.72 6.23 21.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.064 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.04 9.5 51.73 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.748 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.503 ' CG1' HD11 ' A' ' 295' ' ' ILE . 59.0 t -84.9 141.4 14.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.28 113.86 7.01 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.346 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.01 -32.7 76.34 Favored Glycine 0 C--N 1.318 -0.43 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.707 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.59 -19.15 62.88 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.798 0.332 . . . . 0.0 111.593 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.64 0.32 49.66 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.473 0.654 . . . . 0.0 110.005 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.503 HD11 ' CG1' ' A' ' 290' ' ' VAL . 63.5 mt -110.81 133.32 56.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.142 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -121.4 129.67 53.15 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.526 HG21 ' HA ' ' A' ' 279' ' ' LYS . 29.9 p -109.02 125.94 52.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.899 0.381 . . . . 0.0 111.429 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.9 t -127.89 117.41 46.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.12 111.96 3.9 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.442 174.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 20.9 mt -96.75 1.1 50.5 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 58.91 -127.47 45.36 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.509 ' OG ' ' HB3' ' A' ' 263' ' ' ASN . 44.4 t -102.34 122.34 44.07 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.463 HG13 ' H ' ' A' ' 304' ' ' ASN . 5.9 p -146.85 -59.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.01 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.463 ' H ' HG13 ' A' ' 303' ' ' VAL . 76.1 m-20 -117.46 92.93 41.91 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -66.45 174.24 6.57 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.857 2.371 . . . . 0.0 113.267 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 5.3 tt -131.27 -48.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.591 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -120.51 172.43 7.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.254 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 27.9 m -67.19 139.75 57.44 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.037 0.446 . . . . 0.0 111.351 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -81.01 -10.08 59.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.646 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.14 -16.37 61.0 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.349 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.6 t -115.82 144.44 32.66 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.513 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.97 -31.32 24.36 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.215 1.943 . . . . 0.0 110.942 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.88 -35.41 81.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.653 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -71.34 -36.97 63.14 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 11.3 mtp85 -57.66 -39.46 77.1 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.59 -30.93 71.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.22 -46.34 20.64 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.807 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -61.69 -26.03 67.78 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 14.9 ptp180 -83.62 10.65 8.69 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.015 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -57.14 177.76 0.08 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.01 0.91 . . . . 0.0 112.715 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 58.4 t -137.37 144.64 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.054 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -131.98 138.42 48.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.984 0.421 . . . . 0.0 111.115 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.457 HG23 HG12 ' A' ' 257' ' ' ILE . 1.6 mp -100.0 120.47 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.992 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 75.1 t -108.45 134.24 50.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 53.5 t -98.1 133.47 40.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--N 1.318 -0.762 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.867 -178.772 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.166 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -91.16 163.15 14.37 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -117.63 91.78 39.29 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-O 120.651 0.263 . . . . 0.0 110.745 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -89.32 117.71 0.8 Allowed 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.99 2.46 . . . . 0.0 112.097 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.17 -24.94 72.67 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.531 2.154 . . . . 0.0 111.748 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 83.22 -124.54 6.59 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.01 150.32 60.44 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.138 1.892 . . . . 0.0 110.992 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.433 ' HG3' ' OD2' ' A' ' 252' ' ' ASP . 11.9 Cg_endo -56.41 107.86 0.3 Allowed 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.632 2.222 . . . . 0.0 112.01 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.54 -38.72 87.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.33 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.5 t -90.63 -34.78 15.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.92 0.39 . . . . 0.0 110.492 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 82.34 88.02 0.7 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.536 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -89.75 37.55 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.944 2.429 . . . . 0.0 111.349 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 34.1 t -137.66 -179.12 5.56 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.781 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -60.92 169.31 1.98 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.288 0.635 . . . . 0.0 112.151 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -84.0 88.83 7.17 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.339 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.438 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.7 mm? -67.86 -39.3 83.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.766 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -57.83 -55.65 32.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.423 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.4 t -67.33 -34.68 77.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.65 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.541 ' HB1' ' HE2' ' A' ' 246' ' ' LYS . . . -64.89 -46.74 80.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.686 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 211' ' ' LEU . 23.6 pt -71.67 -38.6 67.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.501 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -57.68 -33.79 68.72 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.588 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.26 -26.33 68.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.216 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.6 HG11 ' CB ' ' A' ' 242' ' ' ARG . 8.2 t -92.79 -45.73 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.447 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.438 ' HA ' HG21 ' A' ' 239' ' ' ILE . 75.5 p -64.36 -42.91 95.95 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.274 0.559 . . . . 0.0 110.397 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.96 13.45 83.06 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 143.32 -131.25 4.44 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.67 164.77 5.17 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.029 2.486 . . . . 0.0 113.593 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.1 mm -81.69 109.8 16.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.324 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -91.27 121.91 33.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.047 0.451 . . . . 0.0 110.833 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -90.81 158.06 17.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.459 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -141.97 100.36 0.25 Allowed Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -84.72 133.11 34.38 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.777 0.322 . . . . 0.0 111.244 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -125.9 161.14 28.14 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -66.79 -8.7 49.36 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.37 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -91.64 -56.02 3.27 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 120.921 0.391 . . . . 0.0 110.489 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 12.5 t -177.32 -177.5 0.71 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 67.4 tp -78.49 103.25 8.3 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 9.0 tt -106.1 110.02 63.65 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.34 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.02 127.31 13.44 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.074 1.85 . . . . 0.0 111.664 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -67.96 -25.71 65.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.169 0.509 . . . . 0.0 110.02 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -133.68 91.2 2.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.021 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -81.6 -0.08 40.72 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.871 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -83.54 -27.98 28.95 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.379 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 243' ' ' VAL . 58.6 mt -67.6 -49.01 74.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.795 -175.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.493 ' CD2' HG13 ' A' ' 281' ' ' VAL . 37.6 mt -59.3 -40.41 86.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.206 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -70.78 -36.27 72.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 110.185 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.6 ' CB ' HG11 ' A' ' 218' ' ' VAL . 7.8 mmt180 -63.68 -54.99 26.99 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.5 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.663 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 69.2 t -53.47 -46.8 59.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.646 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.84 85.13 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.764 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -60.15 -45.62 92.42 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.665 0.269 . . . . 0.0 111.605 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.541 ' HE2' ' HB1' ' A' ' 214' ' ' ALA . 0.4 OUTLIER -74.38 -26.27 60.01 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.735 -179.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 35.0 mt -69.16 -28.87 66.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.258 0.551 . . . . 0.0 110.279 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.497 ' HG3' HG22 ' A' ' 290' ' ' VAL . 55.6 mtpt -77.08 -24.94 51.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.843 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -73.1 -40.7 64.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.533 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 50.0 t -125.13 73.74 66.47 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 121.332 0.587 . . . . 0.0 109.848 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.65 -0.03 8.8 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.442 2.761 . . . . 0.0 113.424 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.433 ' OD2' ' HG3' ' A' ' 203' ' ' PRO . 32.8 t70 -75.96 -26.7 57.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.887 0.851 . . . . 0.0 109.538 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -78.82 130.09 35.32 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -94.98 142.22 27.74 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.44 HG12 HG22 ' A' ' 325' ' ' VAL . 6.2 m -118.15 135.73 57.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.429 0.633 . . . . 0.0 112.315 -178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.0 m -108.15 108.25 19.23 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.449 HG12 HG23 ' A' ' 323' ' ' ILE . 26.2 mt -91.47 114.3 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.767 -178.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -102.93 129.09 49.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.352 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -105.28 156.62 16.68 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.641 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 19.9 m-85 -132.53 159.31 39.78 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.005 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 82.8 p -143.1 166.13 25.5 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.434 ' CG ' ' HE ' ' A' ' 315' ' ' ARG . 2.7 p30 -76.16 151.51 36.93 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.009 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -85.09 3.37 39.17 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.577 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.77 -15.0 43.51 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.08 0.467 . . . . 0.0 111.042 177.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -77.57 173.66 54.95 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.715 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.8 t -76.04 123.83 26.41 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 120.655 0.264 . . . . 0.0 110.34 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.542 ' HA ' HD21 ' A' ' 270' ' ' ASN . 41.6 tt0 -63.17 133.45 54.37 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.356 -0.384 . . . . 0.0 109.997 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 113.75 -40.42 2.51 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 120.442 -0.885 . . . . 0.0 110.937 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 42.6 mm -84.76 -29.05 6.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.843 0.83 . . . . 0.0 109.071 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.542 HD21 ' HA ' ' A' ' 267' ' ' GLU . 8.2 p30 -67.08 -32.69 74.02 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.786 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.414 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 22.4 mm -57.44 -63.64 3.52 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.43 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.414 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 17.9 Cg_endo -61.58 -30.12 85.42 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 122.248 1.966 . . . . 0.0 111.96 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.18 -50.14 64.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.991 0.424 . . . . 0.0 110.455 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.42 ' OG ' ' HA2' ' A' ' 299' ' ' GLY . 10.0 t -57.24 -40.95 78.62 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.01 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.63 -30.98 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.749 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.472 ' O ' HG13 ' A' ' 280' ' ' ILE . 8.8 tp-100 -69.95 -45.14 68.08 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.993 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -64.07 -39.73 94.72 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.342 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.6 87.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.002 0.43 . . . . 0.0 109.871 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.547 ' HA ' HG21 ' A' ' 297' ' ' THR . 7.8 ttpt -60.54 -36.91 79.57 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.735 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 276' ' ' GLN . 58.9 mt -56.39 -47.05 82.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.811 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.546 ' O ' HD13 ' A' ' 285' ' ' LEU . 17.1 t -63.34 -46.89 94.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.941 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -58.54 -43.16 89.17 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -61.37 -39.91 92.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.16 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.605 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 8.0 m-85 -70.65 -42.38 70.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.993 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 281' ' ' VAL . 1.8 mp -61.94 -48.85 78.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 84.2 t -60.45 -40.38 84.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.501 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.5 -30.95 71.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.182 0.515 . . . . 0.0 110.608 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 20.7 mmm180 -83.12 5.45 22.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.735 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.51 2.24 40.67 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.075 -1.059 . . . . 0.0 114.45 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 61.4 t -80.55 145.24 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 117.842 0.821 . . . . 0.0 109.829 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.512 ' HB3' ' ND1' ' A' ' 294' ' ' HIS . . . -77.46 118.86 20.31 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.148 0.499 . . . . 0.0 111.376 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -57.65 -30.88 62.99 Favored Glycine 0 C--O 1.222 -0.612 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.873 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -68.81 -16.92 63.92 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.512 ' ND1' ' HB3' ' A' ' 291' ' ' ALA . 29.4 m170 -95.85 -5.24 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.724 0.297 . . . . 0.0 110.808 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.425 HD11 ' CG1' ' A' ' 290' ' ' VAL . 40.6 mt -110.83 130.17 64.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.228 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.69 125.71 51.18 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.126 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.547 HG21 ' HA ' ' A' ' 279' ' ' LYS . 29.7 p -111.75 122.56 48.13 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.262 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 28.2 m -120.09 164.24 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.483 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.42 ' HA2' ' OG ' ' A' ' 274' ' ' SER . . . -134.36 105.15 0.55 Allowed Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 14.4 mt -89.59 2.54 54.54 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 69.99 -126.4 17.07 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.561 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 11.8 p -97.18 120.64 37.9 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.828 0.347 . . . . 0.0 110.651 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.4 p -176.31 150.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.339 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 61.66 81.98 0.23 Allowed Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 123.488 0.715 . . . . 0.0 111.636 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.564 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 94.3 Cg_endo -80.7 154.55 20.49 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.458 2.106 . . . . 0.0 113.004 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 3.1 tt -119.0 -53.41 3.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.665 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -119.21 166.56 12.82 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.7 p -65.01 143.9 57.64 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.111 0.482 . . . . 0.0 111.491 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -80.19 -7.52 59.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.416 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.17 -18.71 63.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.846 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.7 t -113.72 135.54 21.98 Favored Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.697 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.6 -33.41 86.86 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.789 2.326 . . . . 0.0 111.137 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.0 mm-40 -66.36 -39.94 89.47 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.247 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -69.03 -37.66 83.2 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.123 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.434 ' HE ' ' CG ' ' A' ' 262' ' ' ASP . 80.6 mtp180 -61.49 -37.67 84.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.112 0.482 . . . . 0.0 109.724 176.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.63 68.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.661 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 1.0 OUTLIER -80.71 -39.76 26.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.367 177.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.564 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 44.3 m-80 -65.7 -22.13 66.6 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 39.0 ptt180 -84.41 10.78 9.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.279 0.561 . . . . 0.0 111.507 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 18.7 ptt-85 -58.74 178.58 0.11 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.952 0.882 . . . . 0.0 112.698 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 49.7 t -138.35 145.4 28.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.562 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -130.21 137.01 49.83 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.932 0.396 . . . . 0.0 110.61 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.449 HG23 HG12 ' A' ' 257' ' ' ILE . 2.2 mp -97.22 116.97 40.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.407 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.67 137.38 39.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 255' ' ' VAL . 49.2 t -100.25 138.81 23.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 C--N 1.31 -1.125 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.416 178.906 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.454 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -143.89 -49.82 0.3 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.185 0.517 . . . . 0.0 109.644 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.37 158.43 63.58 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.541 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.85 130.54 37.26 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.335 2.024 . . . . 0.0 111.513 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.87 22.13 0.41 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.86 2.374 . . . . 0.0 112.976 -179.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.442 ' HA3' ' HD3' ' A' ' 202' ' ' PRO . . . -90.19 -117.67 1.84 Allowed Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.811 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.442 ' HD3' ' HA3' ' A' ' 201' ' ' GLY . 14.9 Cg_exo -70.27 112.8 3.26 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.822 2.348 . . . . 0.0 111.973 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.58 -70.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.424 2.082 . . . . 0.0 110.647 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -139.5 27.3 2.29 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.6 p -56.65 149.61 17.39 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.805 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 106.41 104.81 2.97 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.15 -36.8 99.23 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.844 2.363 . . . . 0.0 111.889 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 4.3 m -153.81 -177.75 6.59 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.865 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.54 149.65 42.49 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.206 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -74.89 73.7 2.13 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.153 0.501 . . . . 0.0 110.199 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.542 ' HB2' HG21 ' A' ' 325' ' ' VAL . 16.4 mt -56.83 -27.67 60.47 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.81 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -66.05 -42.87 88.92 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.758 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 26.0 t -73.19 -31.88 64.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -64.53 -47.88 77.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.894 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.416 HG21 HG13 ' A' ' 243' ' ' VAL . 20.9 pt -73.85 -33.7 37.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.121 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -56.36 -37.88 70.67 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.079 0.466 . . . . 0.0 110.466 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.28 -29.74 70.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.877 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.717 HG12 HG23 ' A' ' 239' ' ' ILE . 32.5 t -82.38 -52.52 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.671 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.468 ' HA ' HG21 ' A' ' 239' ' ' ILE . 76.0 p -64.86 -36.23 83.68 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.424 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.67 12.62 79.78 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.27 -125.87 2.78 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -91.35 167.23 3.5 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.839 2.359 . . . . 0.0 112.936 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.6 mm -84.22 110.46 18.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.008 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -100.23 124.39 45.61 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.996 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.418 ' HD2' HD11 ' A' ' 232' ' ' LEU . 0.1 OUTLIER -172.2 141.34 1.25 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.539 -177.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 72.92 93.54 0.1 OUTLIER Glycine 0 C--O 1.236 0.221 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.443 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -86.71 173.17 9.65 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -85.1 131.32 34.46 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 82.94 -1.66 88.13 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.011 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -119.93 179.78 4.15 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.5 t -90.33 -178.76 5.45 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.418 HD11 ' HD2' ' A' ' 225' ' ' PHE . 2.6 tm? -79.71 86.13 5.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 11.0 pt -104.59 111.63 65.23 Favored Pre-proline 0 C--N 1.313 -0.984 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.637 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -83.26 134.44 6.83 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.698 2.265 . . . . 0.0 112.462 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -81.86 91.74 6.58 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.771 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.5 t70 66.44 94.6 0.06 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.294 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -81.26 5.75 16.2 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -64.36 -29.25 70.32 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.717 HG23 HG12 ' A' ' 218' ' ' VAL . 71.6 mt -64.09 -44.72 97.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.149 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.421 HD13 ' CD2' ' A' ' 284' ' ' TYR . 28.9 mt -57.2 -36.17 70.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.228 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.444 ' HA ' ' HG2' ' A' ' 288' ' ' ARG . 3.5 m-20 -79.94 -38.2 32.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.171 0.51 . . . . 0.0 110.321 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.688 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -64.87 -40.48 95.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.105 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.602 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 28.1 t -59.07 -41.42 83.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.971 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' A' ' 288' ' ' ARG . . . -59.84 -37.22 78.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.826 -177.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.57 -44.9 73.35 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.456 ' H ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -82.19 -16.18 50.64 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.709 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 23.5 mt -81.06 -22.56 39.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.518 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 9.7 tptm -71.82 -25.05 61.83 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.685 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -64.03 -46.47 84.3 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.394 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.43 ' HB3' HD11 ' A' ' 211' ' ' LEU . 52.1 t -128.92 75.94 79.68 Favored Pre-proline 0 C--N 1.312 -1.026 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 60.8 Cg_endo -71.42 -2.61 11.53 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.958 2.439 . . . . 0.0 113.243 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.09 -23.38 23.73 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.405 ' HB2' ' SG ' ' A' ' 250' ' ' CYS . . . -62.3 138.26 58.4 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.604 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -93.88 133.21 37.53 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 325' ' ' VAL . 5.1 m -112.59 129.2 68.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-O 121.141 0.496 . . . . 0.0 110.751 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 33.3 m -103.84 108.66 20.08 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.051 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.449 HG12 HG23 ' A' ' 323' ' ' ILE . 24.5 mt -93.83 108.86 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -98.15 128.46 44.65 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.921 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.491 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -104.67 144.86 15.87 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 177.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 8.6 m-85 -126.13 163.62 22.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.692 0.282 . . . . 0.0 110.327 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 45.6 p -143.21 162.47 35.54 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.296 0.638 . . . . 0.0 109.616 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -68.77 151.78 46.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.075 0.464 . . . . 0.0 110.889 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -77.69 -5.16 49.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.717 -177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.433 HG21 ' CZ ' ' A' ' 315' ' ' ARG . 0.7 OUTLIER -84.02 -27.59 28.27 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.56 179.02 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -106.11 37.39 3.84 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.738 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.489 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 14.4 m -92.7 75.48 4.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.125 0.488 . . . . 0.0 110.505 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -128.67 25.47 5.68 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.914 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 272' ' ' PRO . . . 110.44 -48.84 0.9 Allowed Glycine 0 CA--C 1.503 -0.668 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.107 177.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 269' ' ' ILE . 1.7 mp -61.49 -24.79 34.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 123.615 0.766 . . . . 0.0 110.559 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' A' ' 266' ' ' SER . 0.7 OUTLIER -54.64 -38.87 67.38 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.149 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.41 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 19.6 mm -60.43 -63.9 3.72 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.072 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 268' ' ' GLY . 11.8 Cg_endo -60.74 -30.97 91.37 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.867 1.711 . . . . 0.0 112.33 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 60.3 tp -65.52 -53.09 47.31 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.776 0.322 . . . . 0.0 111.477 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.491 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.9 p -61.82 -30.39 70.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 120.933 0.396 . . . . 0.0 110.767 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.38 -32.76 66.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.255 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.496 ' O ' HG13 ' A' ' 280' ' ' ILE . 8.6 tp-100 -66.17 -49.7 66.46 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.762 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -61.95 -38.63 89.2 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.908 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.34 97.13 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.841 0.353 . . . . 0.0 110.295 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.56 ' HA ' HG21 ' A' ' 297' ' ' THR . 11.5 tmtt? -61.7 -38.33 87.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.15 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 276' ' ' GLN . 57.4 mt -55.59 -47.38 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.362 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.733 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 9.7 t -65.19 -48.92 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -53.64 -45.77 70.31 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -58.48 -41.69 85.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.706 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.603 ' O ' ' HD2' ' A' ' 288' ' ' ARG . 6.9 m-85 -68.41 -41.32 80.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.716 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.733 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 43.8 mt -62.93 -46.44 87.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 95.0 t -58.78 -41.68 83.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.176 176.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.29 -28.5 68.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.503 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.603 ' HD2' ' O ' ' A' ' 284' ' ' TYR . 0.0 OUTLIER -83.54 -1.27 53.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.169 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 111.05 5.91 26.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.478 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 46.6 t -89.92 141.81 13.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 117.605 0.703 . . . . 0.0 110.443 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 295' ' ' ILE . . . -67.42 115.34 6.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.478 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -63.72 -35.61 92.24 Favored Glycine 0 CA--C 1.508 -0.346 0 CA-C-N 115.689 -0.687 . . . . 0.0 113.221 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -68.99 -14.52 63.09 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.055 0.455 . . . . 0.0 111.441 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -102.52 2.58 36.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.112 0.482 . . . . 0.0 110.402 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 291' ' ' ALA . 76.0 mt -105.97 132.44 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.38 127.87 54.09 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.783 0.325 . . . . 0.0 110.482 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.56 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.8 p -110.95 126.63 54.96 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.54 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.58 123.69 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -94.2 104.04 3.1 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 174.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 27.2 mt -87.6 -3.08 58.99 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 78.98 -125.59 7.08 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.148 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 18.5 t -101.67 119.4 38.72 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.9 p -176.8 148.2 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 62.39 78.64 0.29 Allowed Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 123.186 0.595 . . . . 0.0 111.018 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.474 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 59.4 Cg_endo -73.03 151.4 49.97 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.36 2.04 . . . . 0.0 112.716 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.491 HG22 ' HA ' ' A' ' 318' ' ' ASN . 4.2 tt -111.16 -54.64 5.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.307 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.428 ' H ' HG23 ' A' ' 306' ' ' ILE . . . -120.15 170.54 9.22 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.765 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 15.5 m -62.38 137.49 58.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.263 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -80.92 -14.43 58.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.863 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.16 -18.45 65.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.229 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 314' ' ' GLY . 3.7 t -114.87 142.24 28.08 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.378 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.29 -28.05 40.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.494 2.129 . . . . 0.0 111.366 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 4.9 mt-10 -65.07 -38.98 92.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.411 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.417 ' H ' HG23 ' A' ' 311' ' ' THR . . . -70.15 -38.45 72.7 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.666 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.433 ' CZ ' HG21 ' A' ' 264' ' ' THR . 96.0 mtt180 -61.02 -39.04 88.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.101 0.477 . . . . 0.0 109.886 177.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.92 -26.77 68.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.629 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 3.6 mmtp -85.61 -37.17 19.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.491 ' HA ' HG22 ' A' ' 306' ' ' ILE . 35.9 m-80 -63.57 -20.94 66.05 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 260' ' ' TYR . 14.6 ptp180 -88.06 15.19 7.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.313 0.577 . . . . 0.0 111.162 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.457 ' HB3' ' O ' ' A' ' 317' ' ' LYS . 26.2 ptt-85 -61.33 -176.32 0.07 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.085 0.945 . . . . 0.0 112.609 175.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 70.7 t -137.71 145.55 28.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.944 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -131.83 140.66 49.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.951 0.405 . . . . 0.0 110.827 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.449 HG23 HG12 ' A' ' 257' ' ' ILE . 1.3 mp -99.0 117.05 43.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.364 -178.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.64 135.02 47.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 211' ' ' LEU . 74.9 t -101.49 136.83 31.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 C--N 1.31 -1.142 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.921 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.294 0 N-CA-C 112.274 -0.331 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -84.81 -169.82 2.83 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.815 0.34 . . . . 0.0 110.447 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -80.78 123.73 82.2 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.56 143.52 81.82 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.583 2.189 . . . . 0.0 112.187 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.63 120.28 6.78 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.887 2.391 . . . . 0.0 111.468 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 73.28 68.6 1.55 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 15.3 Cg_exo -68.77 120.62 7.52 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.896 2.397 . . . . 0.0 112.098 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 14.1 Cg_exo -68.33 129.75 19.79 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.417 2.078 . . . . 0.0 111.817 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -86.99 -21.01 26.43 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.018 0.437 . . . . 0.0 110.571 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 19.4 m -68.3 111.05 4.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.634 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 105.13 86.09 1.89 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.658 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.86 -11.47 29.44 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.586 2.19 . . . . 0.0 112.363 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 47.9 t -140.08 168.79 18.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.169 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -67.26 174.2 3.4 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.863 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -80.39 56.52 2.55 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.006 0.432 . . . . 0.0 110.509 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 250' ' ' CYS . 20.4 mt -53.18 -25.9 15.38 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -66.21 -37.79 86.41 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.327 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.0 t -77.67 -30.67 52.11 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 211' ' ' LEU . . . -65.49 -46.24 80.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.81 -1.087 . . . . 0.0 111.011 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 25.2 pt -73.73 -37.46 49.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.422 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -59.15 -31.67 69.18 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.916 0.389 . . . . 0.0 110.863 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -66.7 -27.05 67.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.894 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.0 p -99.17 -34.84 4.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.282 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.634 ' HA ' HG21 ' A' ' 239' ' ' ILE . 66.8 p -70.28 -37.23 74.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.279 0.561 . . . . 0.0 110.039 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.28 22.62 56.55 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.31 -132.34 7.75 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.551 ' HB2' ' HG3' ' A' ' 320' ' ' ARG . 58.3 Cg_endo -80.95 163.34 20.56 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.622 2.215 . . . . 0.0 112.632 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 49.6 mm -83.17 101.96 8.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.333 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -98.02 128.8 44.79 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.513 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -169.81 140.3 2.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.445 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -138.15 48.69 0.87 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.831 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -89.47 95.44 10.27 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.88 136.86 32.79 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.491 -174.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 82.79 -59.89 4.92 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.723 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.51 -30.6 61.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.479 0.18 . . . . 0.0 111.439 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.0 m 61.08 -161.13 0.29 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.988 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 51.8 mt -95.76 82.81 3.62 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.094 0.474 . . . . 0.0 111.252 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.522 ' H ' ' HD2' ' A' ' 234' ' ' PRO . 70.8 mt -97.19 -57.45 0.18 Allowed Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.291 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.522 ' HD2' ' H ' ' A' ' 233' ' ' ILE . 49.0 Cg_endo -67.89 158.14 58.63 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.079 1.853 . . . . 0.0 111.997 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -79.67 42.22 0.52 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.152 0.501 . . . . 0.0 111.292 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.38 -34.91 73.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.509 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -99.46 77.58 2.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.358 0.599 . . . . 0.0 111.055 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.63 -17.43 62.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.406 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.634 HG21 ' HA ' ' A' ' 219' ' ' THR . 88.0 mt -56.69 -38.34 57.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.842 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.41 HD22 HG13 ' A' ' 281' ' ' VAL . 57.5 mt -65.23 -31.65 72.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.854 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.417 ' OD1' ' HD3' ' A' ' 288' ' ' ARG . 7.9 t30 -71.14 -37.74 72.27 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -40.89 83.56 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.201 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.605 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 45.9 t -57.03 -42.76 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.014 177.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.01 82.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.328 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -52.22 -49.65 63.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.504 ' H ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -73.45 -30.27 63.09 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.469 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 28.7 mt -69.97 -30.96 68.43 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.627 0.727 . . . . 0.0 109.17 177.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -62.79 -35.08 78.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.042 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -73.23 -35.7 66.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.785 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.529 ' HB3' HD11 ' A' ' 211' ' ' LEU . 43.7 t -128.33 69.99 78.87 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.92 2.13 4.5 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.55 2.834 . . . . 0.0 114.656 -174.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -80.48 -26.29 38.33 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.418 0.628 . . . . 0.0 109.99 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.567 ' HB2' ' SG ' ' A' ' 208' ' ' CYS . . . -61.94 133.94 56.02 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.023 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -96.6 135.66 38.21 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.505 HG12 HG22 ' A' ' 325' ' ' VAL . 6.7 m -113.35 133.26 59.81 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.873 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 34.1 m -108.85 107.3 17.65 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.025 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.453 HG12 HG23 ' A' ' 323' ' ' ILE . 19.8 mt -94.97 115.4 33.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.991 -177.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -101.41 131.34 47.56 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.896 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.474 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -111.41 141.43 16.55 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 318' ' ' ASN . 2.1 m-85 -124.17 161.46 25.64 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.542 HG23 ' HB3' ' A' ' 274' ' ' SER . 50.6 p -136.58 173.42 11.73 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -83.55 158.93 21.78 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.591 ' ND2' HD22 ' A' ' 309' ' ' ASN . 7.0 p30 -74.81 -7.0 52.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.597 -177.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.46 -28.21 34.25 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.201 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.01 154.37 49.78 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.149 174.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 45.3 m -75.11 137.83 41.66 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.13 0.491 . . . . 0.0 111.958 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.54 ' HA ' ' ND2' ' A' ' 270' ' ' ASN . 1.1 pm0 -62.82 139.49 58.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.094 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.84 -40.84 2.32 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.484 -177.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 46.2 mm -85.17 -30.26 6.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.72 0.772 . . . . 0.0 109.144 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.54 ' ND2' ' HA ' ' A' ' 267' ' ' GLU . 15.0 p30 -63.82 -35.31 80.2 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.136 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.414 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 19.7 mm -58.68 -64.36 2.98 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.71 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.414 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 19.6 Cg_endo -62.12 -26.85 78.34 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 121.819 1.679 . . . . 0.0 111.662 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 46.7 tp -65.22 -56.44 12.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.732 0.301 . . . . 0.0 110.999 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.542 ' HB3' HG23 ' A' ' 261' ' ' THR . 6.9 p -65.48 -28.17 69.02 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.719 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.42 -32.16 68.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.045 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.549 ' O ' HG13 ' A' ' 280' ' ' ILE . 0.0 OUTLIER -70.34 -47.33 61.53 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.121 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -55.37 -43.87 75.51 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.032 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.81 -39.19 93.19 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 110.659 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.541 ' HA ' HG21 ' A' ' 297' ' ' THR . 0.9 OUTLIER -63.21 -33.92 76.53 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.524 179.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 276' ' ' GLN . 60.4 mt -57.25 -42.98 81.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.985 0.422 . . . . 0.0 110.073 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.574 ' O ' HD13 ' A' ' 285' ' ' LEU . 3.7 t -70.28 -43.47 78.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.759 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.36 -45.72 80.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.395 178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.25 -41.93 89.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.396 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.498 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 1.5 m-85 -65.12 -43.94 90.32 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.108 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 281' ' ' VAL . 3.8 mp -63.57 -47.59 80.89 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 99.1 t -60.02 -42.65 90.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.288 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.72 -27.12 68.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.566 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.575 ' NE ' ' HA ' ' A' ' 288' ' ' ARG . 2.8 mmp_? -86.21 5.02 36.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.999 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.89 5.9 43.79 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.055 -1.069 . . . . 0.0 114.258 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 57.4 t -86.32 143.61 11.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.604 0.702 . . . . 0.0 109.908 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.58 112.06 8.3 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.042 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.52 -32.66 73.82 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.243 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.29 -20.28 64.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.053 0.454 . . . . 0.0 111.222 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -102.74 3.48 36.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.938 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.5 mt -107.65 129.9 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-O 120.876 0.37 . . . . 0.0 110.845 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.69 125.74 49.43 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.071 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.541 HG21 ' HA ' ' A' ' 279' ' ' LYS . 22.3 p -110.33 129.15 55.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.943 0.401 . . . . 0.0 111.074 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.4 t -132.43 116.58 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.012 0.434 . . . . 0.0 111.927 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -92.08 109.58 3.77 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 20.7 mt -87.67 -32.19 19.35 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 95.81 -142.08 15.92 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 6.4 p -77.58 109.11 11.27 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.737 0.303 . . . . 0.0 110.512 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.412 HG13 ' HD2' ' A' ' 260' ' ' TYR . 15.0 p -174.46 150.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.2 t30 66.46 79.96 0.23 Allowed Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.273 175.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.699 ' HA ' ' OD1' ' A' ' 318' ' ' ASN . 38.1 Cg_endo -69.61 135.6 31.22 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.556 2.171 . . . . 0.0 113.075 -178.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.489 HG22 ' HA ' ' A' ' 318' ' ' ASN . 5.2 tt -112.92 -29.27 2.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.748 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -145.83 174.95 10.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.925 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.476 ' O ' ' HA3' ' A' ' 314' ' ' GLY . 29.4 m -62.61 121.19 12.73 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.549 0.53 . . . . 0.0 110.846 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.591 HD22 ' ND2' ' A' ' 263' ' ' ASN . 34.4 p-10 -80.65 -14.29 58.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.45 -16.06 62.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.159 0.504 . . . . 0.0 111.128 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.491 ' OG1' ' HG3' ' A' ' 313' ' ' GLU . 4.9 t -117.6 143.9 33.18 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.948 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.07 -31.03 76.21 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.441 2.094 . . . . 0.0 111.551 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.491 ' HG3' ' OG1' ' A' ' 311' ' ' THR . 4.0 mt-10 -59.14 -44.7 92.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.066 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 308' ' ' SER . . . -69.94 -37.64 74.44 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.894 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -61.68 -38.42 87.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.941 0.401 . . . . 0.0 110.066 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.19 -28.22 69.52 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.483 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 8.2 mmtp -81.81 -45.81 15.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.455 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.699 ' OD1' ' HA ' ' A' ' 305' ' ' PRO . 33.5 m-80 -57.98 -29.48 65.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 5.1 ptp180 -80.62 15.75 1.6 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.551 ' HG3' ' HB2' ' A' ' 222' ' ' PRO . 0.0 OUTLIER -69.39 -176.98 1.05 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.084 0.945 . . . . 0.0 112.704 179.682 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 89.2 t -131.9 143.32 40.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.756 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -132.53 142.16 49.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.02 0.438 . . . . 0.0 111.079 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.453 HG23 HG12 ' A' ' 257' ' ' ILE . 1.5 mp -101.73 120.54 51.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.853 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 66.9 t -109.72 135.31 49.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.505 HG22 HG12 ' A' ' 255' ' ' VAL . 58.1 t -102.14 140.01 21.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.92 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.1 t30 . . . . . 0 C--N 1.311 -1.092 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.721 178.169 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.238 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 60.86 37.29 18.64 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.209 0.528 . . . . 0.0 111.619 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -94.78 150.18 37.51 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.035 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.64 145.93 79.03 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.282 1.988 . . . . 0.0 110.825 176.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -40.82 -47.43 4.77 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.565 2.843 . . . . 0.0 113.115 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.93 -176.14 18.4 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.023 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 13.9 Cg_exo -70.57 137.84 33.96 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.988 2.459 . . . . 0.0 111.728 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 202' ' ' PRO . 32.4 Cg_exo -60.75 114.15 2.02 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.372 2.048 . . . . 0.0 111.25 176.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -126.13 27.45 6.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.084 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.2 m -62.26 133.66 55.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.703 -177.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 142.26 109.12 0.72 Allowed Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.933 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -57.57 -64.69 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.914 2.41 . . . . 0.0 112.139 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 14.6 t -153.13 -178.31 6.86 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -59.32 148.57 31.78 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.304 0.377 . . . . 0.0 110.325 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.56 86.04 4.59 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 121.299 0.571 . . . . 0.0 110.343 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.568 ' HB2' HG21 ' A' ' 325' ' ' VAL . 48.0 mt -71.17 -23.19 62.01 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.104 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 216' ' ' ASN . 51.7 tt0 -66.18 -38.99 89.36 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.355 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.3 t -73.25 -40.59 64.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -59.29 -50.13 75.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.579 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.498 ' CG2' HG13 ' A' ' 243' ' ' VAL . 23.3 pt -70.37 -38.61 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.349 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 212' ' ' GLN . 10.2 t-20 -62.95 -27.41 69.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.034 0.445 . . . . 0.0 110.524 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.19 -28.41 67.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.935 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 242' ' ' ARG . 3.2 t -89.93 -44.67 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.384 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.57 ' HA ' HG21 ' A' ' 239' ' ' ILE . 70.8 p -67.81 -36.79 81.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.763 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.1 26.73 47.6 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 123.64 -141.13 13.38 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.05 160.18 36.92 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.832 2.355 . . . . 0.0 111.79 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 320' ' ' ARG . 46.1 mm -73.49 106.36 3.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.756 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -80.48 118.84 22.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.302 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -88.81 151.7 22.21 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.307 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -82.92 78.8 1.97 Allowed Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 176.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.86 68.67 0.43 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.578 0.704 . . . . 0.0 112.452 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -143.44 -33.48 0.43 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.857 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -103.31 22.57 35.87 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.981 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 70.97 -60.49 0.51 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.793 0.837 . . . . 0.0 112.209 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.7 t -105.13 -176.88 3.21 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.452 HD11 ' CZ ' ' A' ' 237' ' ' TYR . 34.6 tp -84.52 157.84 21.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.018 0.437 . . . . 0.0 110.906 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 7.5 tt -93.72 120.03 66.48 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.625 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.9 154.19 58.35 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 123.097 2.531 . . . . 0.0 112.658 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 54.73 32.41 17.34 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.378 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -124.9 -41.09 2.13 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.281 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.452 ' CZ ' HD11 ' A' ' 232' ' ' LEU . 3.4 m-85 -75.02 89.62 2.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.337 0.589 . . . . 0.0 112.002 -177.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.93 -19.76 60.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.57 HG21 ' HA ' ' A' ' 219' ' ' THR . 79.2 mt -61.88 -38.47 80.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.9 mt -69.45 -25.37 64.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.709 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' A' ' 288' ' ' ARG . 7.3 t30 -72.71 -38.14 67.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.612 ' O ' ' HB3' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -68.11 -38.39 82.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.193 177.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.602 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.9 t -62.04 -45.02 99.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.562 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.95 74.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.986 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.612 ' HB3' ' O ' ' A' ' 242' ' ' ARG . 1.5 t70 -46.6 -51.11 16.4 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.016 0.926 . . . . 0.0 112.522 178.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.563 ' NZ ' ' HB3' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -84.68 -15.97 43.44 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.903 -177.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 34.6 mt -78.85 -28.83 44.31 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.54 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 59.5 mtpt -82.51 -17.11 46.25 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.916 177.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.38 -37.77 83.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.978 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.519 ' HB3' HD11 ' A' ' 211' ' ' LEU . 48.3 t -131.38 71.0 81.87 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 176.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 61.0 Cg_endo -72.44 0.85 6.87 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.951 2.434 . . . . 0.0 112.846 -177.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.35 -31.1 42.93 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -72.52 141.7 48.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.473 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -95.19 142.16 27.95 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.526 HG12 HG22 ' A' ' 325' ' ' VAL . 5.4 m -113.93 130.87 67.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 CA-C-O 121.277 0.56 . . . . 0.0 110.725 177.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.4 m -106.88 108.09 19.43 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.178 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.403 HG12 HG23 ' A' ' 323' ' ' ILE . 29.8 mt -92.95 113.75 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.27 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -98.63 122.53 41.96 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.018 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.464 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -105.28 151.75 17.2 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.368 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -125.14 167.43 14.82 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.376 0.608 . . . . 0.0 110.948 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 319' ' ' ARG . 8.1 t -160.25 156.81 27.07 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.965 174.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.6 155.33 40.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.912 0.387 . . . . 0.0 110.831 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.555 HD21 ' ND2' ' A' ' 309' ' ' ASN . 7.2 p30 -83.92 4.22 30.56 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.925 -175.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.423 HG21 ' CZ ' ' A' ' 315' ' ' ARG . 1.9 p -76.83 -21.5 54.95 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.091 0.472 . . . . 0.0 110.578 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -113.77 49.15 0.87 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.434 ' HA ' ' OD1' ' A' ' 270' ' ' ASN . 11.2 t -90.57 85.21 6.05 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.068 0.461 . . . . 0.0 110.529 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -126.6 17.31 7.52 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.204 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 92.97 -16.72 59.76 Favored Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 34.3 mm -82.17 -20.91 10.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.474 -0.863 . . . . 0.0 108.883 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' A' ' 266' ' ' SER . 0.8 OUTLIER -55.86 -43.21 76.9 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.007 178.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.42 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 26.1 mm -55.51 -64.43 2.19 Favored Pre-proline 0 CA--C 1.557 1.246 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.796 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.42 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 18.9 Cg_endo -62.74 -27.17 75.41 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.79 1.66 . . . . 0.0 112.647 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.6 tp -66.45 -53.54 34.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 110.87 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.464 ' HB2' ' C ' ' A' ' 259' ' ' GLY . 11.0 p -60.81 -31.4 70.8 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.24 0.543 . . . . 0.0 110.157 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -65.56 -42.31 91.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.719 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.512 ' O ' HG13 ' A' ' 280' ' ' ILE . 27.6 tt0 -60.06 -43.71 95.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.093 178.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -58.78 -47.09 85.93 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.11 73.48 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.115 0.483 . . . . 0.0 110.729 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.623 ' HA ' HG21 ' A' ' 297' ' ' THR . 54.2 tptt -67.34 -31.5 71.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.051 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 276' ' ' GLN . 53.4 mt -58.9 -40.35 80.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.06 0.457 . . . . 0.0 109.895 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.697 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 8.7 t -68.76 -44.46 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.904 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.59 73.74 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.851 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.22 -42.31 81.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.533 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.643 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 0.8 OUTLIER -64.29 -47.4 79.64 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.446 178.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 34.8 mt -63.85 -49.5 72.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.055 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.02 -39.17 81.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.151 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.5 -26.09 68.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.192 0.52 . . . . 0.0 110.686 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.1 mmp_? -86.44 2.47 47.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.974 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 96.88 12.79 48.87 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.911 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.532 HG22 ' HG3' ' A' ' 248' ' ' LYS . 58.6 t -85.22 140.62 15.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -68.53 110.03 4.01 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.987 0.422 . . . . 0.0 111.365 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.98 -33.09 63.3 Favored Glycine 0 C--O 1.225 -0.451 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.89 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.23 -19.46 65.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.821 0.343 . . . . 0.0 111.622 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -102.06 1.76 36.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.051 0.453 . . . . 0.0 110.375 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.5 mt -105.62 127.02 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.122 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.97 125.51 50.55 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.39 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.623 HG21 ' HA ' ' A' ' 279' ' ' LYS . 40.8 p -105.49 121.85 44.78 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.8 t -125.63 115.9 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.156 0.503 . . . . 0.0 111.793 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -89.0 108.64 3.49 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 21.8 mt -91.15 0.37 57.55 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.77 0.319 . . . . 0.0 111.206 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.32 -126.12 30.34 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.022 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 15.4 m -103.32 116.45 32.47 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.601 HG23 ' H ' ' A' ' 304' ' ' ASN . 6.0 m -140.46 -64.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.354 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.601 ' H ' HG23 ' A' ' 303' ' ' VAL . 33.9 m-80 -117.96 90.67 37.59 Favored Pre-proline 0 N--CA 1.439 -0.997 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.62 176.77 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.577 2.185 . . . . 0.0 112.345 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -128.78 -49.03 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.694 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -110.45 176.79 4.91 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.633 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 18.5 m -65.77 131.63 46.78 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.525 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.555 ' ND2' HD21 ' A' ' 263' ' ' ASN . 20.1 m-20 -79.22 -8.23 58.86 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.458 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -80.6 -11.2 59.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.55 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.516 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 2.6 t -119.44 138.88 26.98 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.337 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.46 -32.52 70.95 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.594 2.196 . . . . 0.0 111.656 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -67.43 -35.42 79.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.757 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.59 -38.11 85.82 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 177.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 311' ' ' THR . 97.9 mtt180 -66.08 -21.88 66.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.478 0.656 . . . . 0.0 109.787 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.41 ' O ' ' HG2' ' A' ' 319' ' ' ARG . . . -78.73 -28.97 45.06 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.308 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -77.62 -42.93 33.2 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.157 0.503 . . . . 0.0 109.765 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -64.96 -8.87 17.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 18.7 ptp180 -98.93 11.66 38.21 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 223' ' ' ILE . 4.8 ptm180 -69.03 -174.67 0.64 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 76.2 t -137.03 151.74 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.623 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.54 138.55 50.25 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 122.672 0.389 . . . . 0.0 110.64 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.41 ' H ' HD12 ' A' ' 323' ' ' ILE . 2.1 mp -100.74 122.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.834 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 95.1 t -113.18 137.41 46.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.568 HG21 ' HB2' ' A' ' 211' ' ' LEU . 85.1 t -101.93 136.38 34.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 120.8 0.333 . . . . 0.0 110.713 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 C--N 1.313 -0.993 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.06 -178.685 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.292 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -89.03 129.7 35.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.792 0.329 . . . . 0.0 110.546 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . . . -97.53 110.91 56.98 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.717 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 198' ' ' ALA . 4.7 Cg_exo -76.12 154.65 37.47 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.65 2.233 . . . . 0.0 111.032 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.18 -1.19 11.16 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.442 2.095 . . . . 0.0 112.025 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 76.3 -110.67 3.1 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.86 155.0 70.02 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.278 1.985 . . . . 0.0 111.501 176.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.58 173.37 7.92 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.468 2.112 . . . . 0.0 112.584 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -87.61 28.92 0.93 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.035 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.555 ' HB2' ' OD1' ' A' ' 252' ' ' ASP . 2.2 m -74.86 169.45 17.91 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.615 0.245 . . . . 0.0 110.357 -177.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -135.75 -104.15 0.75 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.307 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.79 153.01 59.02 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 122.984 2.456 . . . . 0.0 113.795 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 209' ' ' ALA . 41.2 t -146.72 -175.47 4.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.595 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.443 ' N ' ' SG ' ' A' ' 208' ' ' CYS . . . -54.03 174.6 0.05 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.36 0.664 . . . . 0.0 111.57 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -82.67 77.48 9.43 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.992 -0.443 . . . . 0.0 110.007 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.422 ' O ' HG12 ' A' ' 215' ' ' ILE . 3.2 mm? -68.06 -35.31 78.01 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.762 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -63.33 -42.7 98.97 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.558 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 31.0 t -75.38 -27.97 59.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.282 0.563 . . . . 0.0 109.508 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -69.82 -46.72 65.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.627 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.477 ' CG2' HG13 ' A' ' 243' ' ' VAL . 23.4 pt -77.1 -41.43 31.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -61.34 -29.74 70.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.943 0.402 . . . . 0.0 110.876 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -65.37 -24.26 67.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.173 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.93 -45.46 13.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.033 0.444 . . . . 0.0 110.298 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.516 ' HA ' HG21 ' A' ' 239' ' ' ILE . 74.3 p -64.79 -38.2 90.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.013 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.79 20.54 53.52 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.197 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 127.67 -134.7 8.36 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.491 ' HB3' HH11 ' A' ' 320' ' ' ARG . 60.6 Cg_endo -78.52 161.22 28.31 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.282 1.988 . . . . 0.0 112.337 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.86 108.9 13.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.635 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.74 119.79 36.96 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -86.9 158.38 19.32 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.596 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -106.76 97.42 1.21 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -76.19 113.58 13.9 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.949 0.404 . . . . 0.0 111.346 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -95.98 -29.87 13.91 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.461 0.648 . . . . 0.0 109.471 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 120.03 -43.33 1.57 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.09 -43.62 16.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.085 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 51.1 p -157.32 -171.37 3.58 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.081 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 232' ' ' LEU . 1.1 pt? -100.76 130.12 46.75 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.061 0.457 . . . . 0.0 109.805 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 12.5 tt -143.72 101.3 5.03 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-O 121.361 0.601 . . . . 0.0 110.483 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.04 155.86 13.13 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.4 2.067 . . . . 0.0 111.506 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -69.18 -50.21 49.64 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.155 0.503 . . . . 0.0 110.326 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -97.09 64.2 1.94 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.36 0.6 . . . . 0.0 110.947 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -69.79 -13.32 62.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.152 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -65.72 -20.53 66.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.987 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.516 HG21 ' HA ' ' A' ' 219' ' ' THR . 82.4 mt -62.88 -37.79 80.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.045 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.478 ' CD2' HG13 ' A' ' 281' ' ' VAL . 47.3 mt -62.84 -34.75 77.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 110.644 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -73.8 -39.36 64.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.572 177.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.496 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -65.09 -44.87 87.43 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.762 179.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.599 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 29.9 t -57.82 -43.59 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.704 177.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.11 85.64 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.114 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -52.38 -49.91 63.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -77.98 -20.05 53.33 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.878 -178.319 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 35.1 mt -78.13 -32.33 50.32 Favored 'General case' 0 C--O 1.214 -0.779 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.599 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.531 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 61.4 mtpt -74.95 -18.64 60.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.864 176.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.09 -34.49 75.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.326 0.584 . . . . 0.0 109.646 175.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 53.4 t -128.67 71.8 80.97 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.056 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 59.8 Cg_endo -70.62 0.14 6.75 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.681 2.254 . . . . 0.0 112.981 -176.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.555 ' OD1' ' HB2' ' A' ' 205' ' ' SER . 11.4 t70 -88.62 -25.34 22.49 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -57.67 138.13 55.73 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.78 130.29 45.97 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 325' ' ' VAL . 12.3 m -122.03 134.61 64.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-O 121.39 0.614 . . . . 0.0 111.937 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.3 m -110.58 113.31 25.83 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.221 -0.899 . . . . 0.0 108.827 178.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.442 HG12 HG23 ' A' ' 323' ' ' ILE . 23.1 mt -92.68 113.83 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -101.98 126.25 48.85 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.363 -176.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -106.15 150.54 16.89 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.668 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -127.9 159.75 33.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.017 0.437 . . . . 0.0 110.436 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 274' ' ' SER . 70.1 p -141.02 169.83 16.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.331 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.411 ' CG ' ' HE ' ' A' ' 315' ' ' ARG . 18.0 t70 -73.35 153.92 40.3 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.682 0.277 . . . . 0.0 110.801 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.57 2.9 0.15 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.525 ' HB ' ' NH2' ' A' ' 315' ' ' ARG . 11.4 t -60.1 -21.05 61.04 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.486 0.314 . . . . 0.0 111.832 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -127.66 126.08 5.4 Favored Glycine 0 N--CA 1.434 -1.465 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.122 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 20.2 m -100.12 90.42 4.36 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.523 ' HA ' HD21 ' A' ' 270' ' ' ASN . 18.2 mm-40 66.05 169.44 0.22 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.92 -177.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.36 -95.46 1.53 Allowed Glycine 0 C--O 1.21 -1.352 0 C-N-CA 119.728 -1.225 . . . . 0.0 113.417 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp -84.83 -42.18 16.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 122.868 0.467 . . . . 0.0 111.813 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.523 HD21 ' HA ' ' A' ' 267' ' ' GLU . 1.1 p-10 -55.46 -34.96 64.99 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.703 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.501 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.6 mm -58.17 -67.12 1.01 Allowed Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.269 177.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.501 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 9.5 Cg_endo -57.98 -30.69 90.72 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 121.934 1.756 . . . . 0.0 111.78 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.75 -54.63 32.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.463 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.491 ' HB3' HG23 ' A' ' 261' ' ' THR . 9.8 p -60.94 -32.7 72.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.793 0.33 . . . . 0.0 110.437 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.91 -31.64 71.56 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.079 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.479 ' O ' HG13 ' A' ' 280' ' ' ILE . 9.1 tt0 -69.68 -48.9 58.11 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -60.24 -41.96 94.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.21 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.91 -39.07 90.76 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.019 0.438 . . . . 0.0 110.525 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.728 ' HA ' HG21 ' A' ' 297' ' ' THR . 21.6 ttpt -66.18 -30.16 70.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.361 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 276' ' ' GLN . 64.1 mt -55.96 -45.4 80.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 110.023 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.732 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 11.8 t -64.56 -46.99 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.728 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.69 -43.05 76.07 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.362 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.61 -41.66 86.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.359 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.436 ' O ' ' HD3' ' A' ' 288' ' ' ARG . 8.4 m-85 -71.12 -40.83 71.2 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.413 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 46.6 mt -64.59 -48.53 74.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 70.8 t -61.23 -39.66 83.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.466 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.29 -30.8 71.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.127 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.436 ' HD3' ' O ' ' A' ' 284' ' ' TYR . 1.2 mpt_? -81.65 2.1 31.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.664 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 103.72 3.13 46.46 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.233 -0.984 . . . . 0.0 114.449 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.469 HG22 ' HG3' ' A' ' 248' ' ' LYS . 58.9 t -79.26 143.36 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 117.896 0.848 . . . . 0.0 109.782 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -69.02 110.06 4.28 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.032 0.444 . . . . 0.0 111.446 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -65.01 -18.47 64.66 Favored Glycine 0 CA--C 1.508 -0.389 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.339 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -72.14 -22.53 61.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.161 0.505 . . . . 0.0 110.425 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -104.5 5.43 34.03 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.035 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.455 HD11 ' CG1' ' A' ' 290' ' ' VAL . 63.8 mt -109.42 128.79 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -117.32 128.43 55.05 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.1 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.728 HG21 ' HA ' ' A' ' 279' ' ' LYS . 18.1 p -115.05 120.66 40.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 120.915 0.388 . . . . 0.0 111.251 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.84 166.42 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.341 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -134.41 109.71 0.81 Allowed Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 14.8 mt -97.04 -1.24 45.8 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.595 0.236 . . . . 0.0 111.304 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 65.06 -123.76 26.82 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.319 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 3.8 t -106.28 120.1 40.98 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 304' ' ' ASN . 5.6 m -141.74 -58.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.344 -177.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.462 ' H ' HG23 ' A' ' 303' ' ' VAL . 22.1 m-80 -116.86 92.32 38.2 Favored Pre-proline 0 N--CA 1.442 -0.846 0 CA-C-O 120.687 0.279 . . . . 0.0 110.259 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.26 166.29 11.29 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.681 2.254 . . . . 0.0 112.478 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' A' ' 318' ' ' ASN . 3.5 tt -121.48 -45.35 2.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.874 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -128.11 168.78 14.89 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.305 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 35.5 t -62.58 135.33 57.34 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.685 0.615 . . . . 0.0 110.983 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.79 -9.35 59.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.386 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.39 66.96 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.777 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.574 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 1.9 t -114.16 140.18 24.64 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.84 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.28 -27.79 55.69 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.247 1.965 . . . . 0.0 111.105 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 5.8 mt-10 -62.77 -41.45 99.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.72 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.49 -38.06 86.19 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.477 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.574 ' HG3' ' O ' ' A' ' 311' ' ' THR . 40.9 mtp180 -63.6 -30.23 71.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.384 0.612 . . . . 0.0 109.929 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -71.22 -27.47 63.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.279 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 13.3 mmtp -80.14 -40.58 27.12 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.372 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.402 ' HA ' HG22 ' A' ' 306' ' ' ILE . 27.3 m-80 -58.13 -24.38 58.57 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -177.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 261' ' ' THR . 18.0 ptp180 -83.47 9.75 10.48 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.977 0.418 . . . . 0.0 112.017 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.491 HH11 ' HB3' ' A' ' 222' ' ' PRO . 34.3 ptt85 -57.16 176.28 0.12 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.949 0.881 . . . . 0.0 112.909 175.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 54.6 t -139.73 147.48 23.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.158 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -130.17 138.1 50.45 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 110.992 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.442 HG23 HG12 ' A' ' 257' ' ' ILE . 2.4 mp -96.1 116.03 36.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.496 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.94 136.79 42.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 255' ' ' VAL . 56.9 t -101.27 139.52 22.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 . . . . . 0 C--N 1.325 -0.483 0 O-C-N 123.926 0.766 . . . . 0.0 111.132 178.617 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.49 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -65.16 -51.93 58.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.363 0.601 . . . . 0.0 109.851 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.63 ' H ' ' HD2' ' A' ' 199' ' ' PRO . . . -139.94 -54.9 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.371 177.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.63 ' HD2' ' H ' ' A' ' 198' ' ' ALA . 86.5 Cg_endo -80.4 173.44 12.41 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 121.918 1.745 . . . . 0.0 110.202 175.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.68 -74.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.292 1.995 . . . . 0.0 112.355 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 77.59 84.23 0.52 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.994 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.29 127.02 20.77 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.778 2.318 . . . . 0.0 112.43 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.61 121.06 9.37 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.893 2.395 . . . . 0.0 112.144 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -115.79 -43.87 2.98 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.476 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 40.0 m -130.95 126.81 37.05 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.439 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 140.41 87.16 0.12 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.621 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.2 121.77 8.78 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.479 2.119 . . . . 0.0 110.439 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 253' ' ' ALA . 34.9 t -103.76 144.65 31.2 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.697 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -63.99 169.09 4.57 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.741 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -78.72 83.75 4.85 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 250' ' ' CYS . 25.6 mt -79.36 -24.72 42.48 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.452 -178.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -60.97 -51.05 70.88 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 21.8 t -70.92 -36.4 72.66 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.818 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.519 ' HB1' ' HZ3' ' A' ' 246' ' ' LYS . . . -59.42 -44.53 92.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.798 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 211' ' ' LEU . 27.1 pt -75.89 -39.52 37.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.177 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -60.16 -34.44 73.57 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.982 0.42 . . . . 0.0 110.688 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.97 -24.03 67.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.726 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 242' ' ' ARG . 2.8 t -94.98 -45.19 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 120.899 0.38 . . . . 0.0 110.296 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.563 ' HA ' HG21 ' A' ' 239' ' ' ILE . 80.6 p -66.46 -39.66 88.95 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.127 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.1 30.29 55.46 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 119.02 -132.15 9.48 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.451 ' HA ' ' HG2' ' A' ' 322' ' ' GLU . 63.7 Cg_endo -79.76 157.22 24.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.457 2.104 . . . . 0.0 113.322 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 38.6 mm -73.99 108.45 5.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.892 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -81.83 145.11 30.58 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.39 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -113.77 142.03 46.56 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.019 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -76.07 -56.18 4.51 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 231' ' ' SER . 10.9 m120 -113.51 165.16 12.75 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 173.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -102.98 123.94 47.54 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.899 0.381 . . . . 0.0 111.218 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 94.92 -51.4 1.95 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.502 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -153.57 169.06 24.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.507 0.194 . . . . 0.0 111.138 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.532 ' O ' ' HB2' ' A' ' 227' ' ' ASN . 48.8 m 67.86 91.11 0.09 Allowed 'General case' 0 CA--C 1.531 0.224 0 O-C-N 124.036 0.835 . . . . 0.0 112.318 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 85.1 mt -88.97 43.59 1.16 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.247 0.546 . . . . 0.0 109.985 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.559 ' HB ' ' HD3' ' A' ' 234' ' ' PRO . 55.5 mt -71.27 -51.4 10.14 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.577 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 233' ' ' ILE . 11.6 Cg_exo -72.02 155.93 56.65 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.668 1.579 . . . . 0.0 110.032 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 63.21 -154.24 0.33 Allowed 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -131.45 153.92 49.24 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.991 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -115.78 12.4 15.9 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.254 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -77.28 -20.6 54.84 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.877 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.563 HG21 ' HA ' ' A' ' 219' ' ' THR . 75.6 mt -64.38 -38.02 81.49 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 8.3 mp -64.62 -36.13 83.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.803 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -69.93 -39.0 76.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.864 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.526 ' HB3' HG11 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -66.14 -41.99 89.7 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.032 178.308 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.623 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 41.1 t -57.93 -42.83 83.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.364 177.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.75 86.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.262 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.15 -49.18 67.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.519 ' HZ3' ' HB1' ' A' ' 214' ' ' ALA . 0.0 OUTLIER -72.09 -29.75 64.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.315 179.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 243' ' ' VAL . 26.2 mt -70.53 -27.93 64.54 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 18.6 tptp -63.63 -34.44 77.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.675 178.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.59 -39.53 73.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.432 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.55 ' HB3' HD11 ' A' ' 211' ' ' LEU . 38.4 t -127.17 68.48 72.49 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 248' ' ' LYS . 73.5 Cg_endo -72.21 0.21 7.66 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 123.385 2.723 . . . . 0.0 113.976 -174.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -91.04 -18.24 24.92 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.673 0.749 . . . . 0.0 109.36 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.543 ' HB2' ' SG ' ' A' ' 208' ' ' CYS . . . -63.33 150.86 42.34 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.357 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -104.22 133.97 48.24 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.164 0.507 . . . . 0.0 110.434 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.551 HG12 HG22 ' A' ' 325' ' ' VAL . 12.5 m -117.84 136.49 54.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.174 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 26.3 m -112.54 109.8 19.58 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.332 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.442 HG12 HG23 ' A' ' 323' ' ' ILE . 21.8 mt -92.24 115.0 30.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -103.12 129.54 50.01 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.691 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.429 ' C ' ' HB2' ' A' ' 274' ' ' SER . . . -108.04 151.64 16.98 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.364 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 319' ' ' ARG . 57.3 m-85 -126.71 163.47 23.43 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.082 0.468 . . . . 0.0 110.977 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.527 HG23 ' HB3' ' A' ' 274' ' ' SER . 71.9 p -142.88 163.7 32.08 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.971 176.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -73.76 151.83 40.53 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.675 HD21 ' ND2' ' A' ' 309' ' ' ASN . 0.1 OUTLIER -77.6 -0.22 25.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -177.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -48.15 13.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -83.06 48.38 4.02 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 11.5 p -96.5 113.65 25.24 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 120.877 0.37 . . . . 0.0 110.815 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -156.13 3.36 0.16 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.976 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 111.3 -31.8 6.93 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.03 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 269' ' ' ILE . 1.6 mp -71.98 -21.26 20.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.75 0.786 . . . . 0.0 109.619 -177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -34.95 67.02 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.431 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.468 ' HB ' ' CD ' ' A' ' 272' ' ' PRO . 28.1 mm -60.99 -65.07 2.4 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.093 177.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.468 ' CD ' ' HB ' ' A' ' 271' ' ' ILE . 10.2 Cg_endo -58.3 -30.02 89.71 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 121.91 1.74 . . . . 0.0 111.974 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 59.6 tp -64.29 -54.94 25.26 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.24 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.527 ' HB3' HG23 ' A' ' 261' ' ' THR . 5.2 p -63.4 -26.79 68.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.749 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.47 -28.4 64.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.852 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -76.18 -42.09 47.51 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -59.25 -46.42 88.56 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.142 177.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.33 74.88 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.98 0.419 . . . . 0.0 110.454 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.54 ' HA ' HG21 ' A' ' 297' ' ' THR . 23.8 tptm -63.53 -32.44 73.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.098 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 54.6 mt -58.87 -43.17 87.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.017 0.437 . . . . 0.0 110.077 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.697 ' O ' ' HG ' ' A' ' 285' ' ' LEU . 6.8 t -66.86 -46.58 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.946 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.35 -41.45 76.12 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.889 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.13 -43.74 78.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.964 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . 0.554 ' O ' ' HG2' ' A' ' 288' ' ' ARG . 8.5 m-85 -70.77 -41.61 71.5 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.483 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 281' ' ' VAL . 42.7 mt -63.76 -49.15 74.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 290' ' ' VAL . 68.8 t -59.74 -42.2 87.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.284 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -65.55 -28.48 69.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.944 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 284' ' ' TYR . 4.9 mmp_? -84.42 4.11 33.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.751 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.13 6.83 41.88 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 119.859 -1.162 . . . . 0.0 114.375 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 286' ' ' VAL . 53.0 t -86.18 143.76 10.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 117.717 0.759 . . . . 0.0 109.725 177.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.47 114.42 10.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.898 0.38 . . . . 0.0 111.514 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -58.72 -32.79 70.4 Favored Glycine 0 C--O 1.23 -0.143 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.998 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.45 -21.44 66.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.087 0.47 . . . . 0.0 111.66 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -100.48 1.27 40.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.914 0.387 . . . . 0.0 110.57 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.35 129.12 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.854 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -118.54 127.69 53.86 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.202 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 279' ' ' LYS . 10.7 p -110.62 120.4 42.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.726 0.298 . . . . 0.0 111.002 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.16 130.52 60.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.945 0.402 . . . . 0.0 111.331 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -97.51 117.5 5.81 Favored Glycine 0 N--CA 1.433 -1.547 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.341 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 27.1 mt -91.3 -3.53 56.76 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.39 0.138 . . . . 0.0 111.176 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 60.63 -138.71 48.24 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.351 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 2.1 m -89.25 115.91 27.09 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.475 HG13 ' H ' ' A' ' 304' ' ' ASN . 4.6 p -143.79 -61.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.611 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.475 ' H ' HG13 ' A' ' 303' ' ' VAL . 91.6 m-20 -116.04 93.95 40.12 Favored Pre-proline 0 N--CA 1.442 -0.865 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -67.74 167.14 21.99 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.544 2.163 . . . . 0.0 112.782 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.41 HD13 ' HB3' ' A' ' 317' ' ' LYS . 2.5 tt -125.07 -49.7 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.279 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -124.66 170.8 10.6 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.393 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.3 p -71.11 139.61 50.36 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 123.547 0.53 . . . . 0.0 111.874 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.675 ' ND2' HD21 ' A' ' 263' ' ' ASN . 8.9 p30 -81.46 -11.07 59.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.418 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -61.63 -26.63 68.12 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.103 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 314' ' ' GLY . 4.4 t -113.65 139.42 23.37 Favored Pre-proline 0 N--CA 1.436 -1.164 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.693 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.14 -32.42 91.15 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.905 2.404 . . . . 0.0 111.84 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 317' ' ' LYS . 35.5 mm-40 -63.8 -40.99 97.96 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.262 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.458 ' H ' HG23 ' A' ' 311' ' ' THR . . . -66.53 -37.87 92.95 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.379 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.4 -39.73 84.35 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.51 ' HA ' ' HD3' ' A' ' 319' ' ' ARG . . . -61.04 -29.94 70.02 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.686 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 313' ' ' GLU . 10.9 mmpt? -77.6 -44.62 27.74 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.297 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -60.88 -29.87 69.81 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.51 ' HD3' ' HA ' ' A' ' 316' ' ' ALA . 3.5 ptm180 -83.41 11.71 6.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.2 ptt-85 -57.43 178.87 0.06 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.254 1.022 . . . . 0.0 112.898 174.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 94.1 t -137.74 147.68 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.583 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 222' ' ' PRO . 48.5 mt-10 -132.66 137.81 47.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.397 . . . . 0.0 111.415 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.442 HG23 HG12 ' A' ' 257' ' ' ILE . 2.8 mp -98.98 121.25 49.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.041 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.83 138.73 39.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.551 HG22 HG12 ' A' ' 255' ' ' VAL . 52.8 t -104.21 143.28 16.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 C--N 1.32 -0.706 0 O-C-N 123.519 0.512 . . . . 0.0 110.349 177.461 . . . . . . . . 0 0 . 1 stop_ save_